evidence_id	assertion_id	disorder_id	disorder_name	source_file	section	section_index	path	evidence_index	reference	supports	evidence_source	snippet	explanation	raw_json
7	7	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	phenotypes	0	evidence	0	PMID:20301696	SUPPORT	HUMAN_CLINICAL	congenital heart disease, particularly conotruncal malformations (ventricular septal defect, tetralogy of Fallot, interrupted aortic arch, and truncus arteriosus)	GeneReviews documents the spectrum of conotruncal defects.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews documents the spectrum of conotruncal defects."", ""reference"": ""PMID:20301696"", ""snippet"": ""congenital heart disease, particularly conotruncal malformations (ventricular septal defect, tetralogy of Fallot, interrupted aortic arch, and truncus arteriosus)"", ""supports"": ""SUPPORT""}"
8	8	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	phenotypes	1	evidence	0	PMID:20301696	SUPPORT	HUMAN_CLINICAL	serum ionized calcium every three to six months in infancy	Calcium monitoring is recommended due to hypocalcemia risk.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Calcium monitoring is recommended due to hypocalcemia risk."", ""reference"": ""PMID:20301696"", ""snippet"": ""serum ionized calcium every three to six months in infancy"", ""supports"": ""SUPPORT""}"
9	10	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	phenotypes	3	evidence	0	PMID:20301696	SUPPORT	HUMAN_CLINICAL	palatal abnormalities (velopharyngeal incompetence, submucosal cleft palate, bifid uvula, and cleft palate)	Palatal abnormalities are a major manifestation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Palatal abnormalities are a major manifestation."", ""reference"": ""PMID:20301696"", ""snippet"": ""palatal abnormalities (velopharyngeal incompetence, submucosal cleft palate, bifid uvula, and cleft palate)"", ""supports"": ""SUPPORT""}"
10	11	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	phenotypes	4	evidence	0	PMID:11242110	SUPPORT	MODEL_ORGANISM	cleft palate	Cleft palate is observed in Tbx1 knockout mice.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Cleft palate is observed in Tbx1 knockout mice."", ""reference"": ""PMID:11242110"", ""snippet"": ""cleft palate"", ""supports"": ""SUPPORT""}"
11	12	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	phenotypes	5	evidence	0	PMID:20301696	SUPPORT	HUMAN_CLINICAL	learning difficulties	Learning difficulties are documented as a major manifestation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Learning difficulties are documented as a major manifestation."", ""reference"": ""PMID:20301696"", ""snippet"": ""learning difficulties"", ""supports"": ""SUPPORT""}"
12	13	1	22q11.2 Deletion Syndrome	22q11.2_Deletion_Syndrome.yaml	phenotypes	6	evidence	0	PMID:20301696	SUPPORT	HUMAN_CLINICAL	Psychiatric illness and autoimmune disorders are more common in individuals with 22q11.2DS	Psychiatric illness including schizophrenia is elevated.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Psychiatric illness including schizophrenia is elevated."", ""reference"": ""PMID:20301696"", ""snippet"": ""Psychiatric illness and autoimmune disorders are more common in individuals with 22q11.2DS"", ""supports"": ""SUPPORT""}"
59	78	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	0	evidence	0	PMID:23239211	SUPPORT		Peripheral neuropathy is a common complication of many of the systemic amyloidoses.	The literature indicates that peripheral neuropathy is a common complication of amyloidoses, which includes ATTR amyloidosis.	"{""explanation"": ""The literature indicates that peripheral neuropathy is a common complication of amyloidoses, which includes ATTR amyloidosis."", ""reference"": ""PMID:23239211"", ""snippet"": ""Peripheral neuropathy is a common complication of many of the systemic amyloidoses."", ""supports"": ""SUPPORT""}"
60	78	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	0	evidence	1	PMID:35830843	SUPPORT		The clinical manifestations of this mutation involve mainly limb sensory or motor disorders or gastrointestinal symptoms or both, and the electrophysiological examination shows neurogenic damage.	This study indicates that peripheral neuropathy, including sensory and motor disorders, is a frequent manifestation in patients with the TTR Val30Leu mutation, a form of familial amyloid polyneuropathy.	"{""explanation"": ""This study indicates that peripheral neuropathy, including sensory and motor disorders, is a frequent manifestation in patients with the TTR Val30Leu mutation, a form of familial amyloid polyneuropathy."", ""reference"": ""PMID:35830843"", ""snippet"": ""The clinical manifestations of this mutation involve mainly limb sensory or motor disorders or gastrointestinal symptoms or both, and the electrophysiological examination shows neurogenic damage."", ""supports"": ""SUPPORT""}"
61	78	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	0	evidence	2	PMID:31445300	SUPPORT		Hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) is a rare, life-threatening disease, caused by point mutations in the transthyretin gene. It is a heterogeneous, multisystem disease with rapidly progressing polyneuropathy (including sensory, motor, and autonomic impairments) and cardiac dysfunction.	The literature confirms that hATTR amyloidosis frequently involves polyneuropathy, including sensory loss, numbness, tingling, and autonomic dysfunction.	"{""explanation"": ""The literature confirms that hATTR amyloidosis frequently involves polyneuropathy, including sensory loss, numbness, tingling, and autonomic dysfunction."", ""reference"": ""PMID:31445300"", ""snippet"": ""Hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) is a rare, life-threatening disease, caused by point mutations in the transthyretin gene. It is a heterogeneous, multisystem disease with rapidly progressing polyneuropathy (including sensory, motor, and autonomic impairments) and cardiac dysfunction."", ""supports"": ""SUPPORT""}"
62	78	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	0	evidence	3	PMID:36504143	SUPPORT		Autonomic dysfunction is a common complication of small-fiber neuropathy (SFN).	This study suggests that autonomic dysfunction is a common complication in small-fiber neuropathy, which can be seen in conditions like amyloidosis.	"{""explanation"": ""This study suggests that autonomic dysfunction is a common complication in small-fiber neuropathy, which can be seen in conditions like amyloidosis."", ""reference"": ""PMID:36504143"", ""snippet"": ""Autonomic dysfunction is a common complication of small-fiber neuropathy (SFN)."", ""supports"": ""SUPPORT""}"
63	79	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	1	evidence	0	PMID:34694575	SUPPORT		The hereditary forms of ATTR have further come into importance with the availability of genetic testing and increased prevalence of certain mutations in African Americans.	The reference discusses the increased recognition and diagnosis of ATTR cardiac amyloidosis, supporting the statement that it is frequently diagnosed as a cardiovascular condition.	"{""explanation"": ""The reference discusses the increased recognition and diagnosis of ATTR cardiac amyloidosis, supporting the statement that it is frequently diagnosed as a cardiovascular condition."", ""reference"": ""PMID:34694575"", ""snippet"": ""The hereditary forms of ATTR have further come into importance with the availability of genetic testing and increased prevalence of certain mutations in African Americans."", ""supports"": ""SUPPORT""}"
64	79	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	1	evidence	1	PMID:35235819	SUPPORT		Cardiac amyloidosis (CA) results in symptoms of heart failure, atrial and ventricular arrhythmias, conduction disturbances, and profound autonomic dysfunction.	This reference supports the statement by listing heart failure, arrhythmias, and autonomic dysfunction (which includes orthostatic hypotension) as common sequelae of cardiac amyloidosis.	"{""explanation"": ""This reference supports the statement by listing heart failure, arrhythmias, and autonomic dysfunction (which includes orthostatic hypotension) as common sequelae of cardiac amyloidosis."", ""reference"": ""PMID:35235819"", ""snippet"": ""Cardiac amyloidosis (CA) results in symptoms of heart failure, atrial and ventricular arrhythmias, conduction disturbances, and profound autonomic dysfunction."", ""supports"": ""SUPPORT""}"
65	79	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	1	evidence	2	PMID:38044190	SUPPORT		Patients with TTRA had higher levels of ultrasensitive troponin I (TnI-US) and N-terminal brain natriuretic propeptide (NT-ProBNP); in electrocardiography (ECG) they presented a pseudo-infarction pattern more frequently as well as conduction disturbances.	The reference supports the frequent occurrence of cardiovascular manifestations in ATTR amyloidosis, including cardiomyopathy and arrhythmias.	"{""explanation"": ""The reference supports the frequent occurrence of cardiovascular manifestations in ATTR amyloidosis, including cardiomyopathy and arrhythmias."", ""reference"": ""PMID:38044190"", ""snippet"": ""Patients with TTRA had higher levels of ultrasensitive troponin I (TnI-US) and N-terminal brain natriuretic propeptide (NT-ProBNP); in electrocardiography (ECG) they presented a pseudo-infarction pattern more frequently as well as conduction disturbances."", ""supports"": ""SUPPORT""}"
66	79	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	1	evidence	3	PMID:29770800	SUPPORT		Cardiac amyloidosis (CA) comprises a heterogeneous group of medical conditions affecting the myocardium. It presents with proteinaceous infiltration with variable degrees of severity, prevalence and evolution.	This reference supports the statement by describing the involvement of the myocardium (cardiomyopathy) and the frequent occurrence of cardiovascular symptoms in cardiac amyloidosis.	"{""explanation"": ""This reference supports the statement by describing the involvement of the myocardium (cardiomyopathy) and the frequent occurrence of cardiovascular symptoms in cardiac amyloidosis."", ""reference"": ""PMID:29770800"", ""snippet"": ""Cardiac amyloidosis (CA) comprises a heterogeneous group of medical conditions affecting the myocardium. It presents with proteinaceous infiltration with variable degrees of severity, prevalence and evolution."", ""supports"": ""SUPPORT""}"
67	79	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	1	evidence	4	PMID:38844297	SUPPORT		Cardiac amyloidosis (CA), usually caused by deposition of misfolded transthyretin or immunoglobulin light chains, is an increasingly recognized cause of heart failure burdened by a poor prognosis.	This reference supports the statement by describing heart failure as a frequent sequela of ATTR amyloidosis.	"{""explanation"": ""This reference supports the statement by describing heart failure as a frequent sequela of ATTR amyloidosis."", ""reference"": ""PMID:38844297"", ""snippet"": ""Cardiac amyloidosis (CA), usually caused by deposition of misfolded transthyretin or immunoglobulin light chains, is an increasingly recognized cause of heart failure burdened by a poor prognosis."", ""supports"": ""SUPPORT""}"
68	80	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	2	evidence	0	PMID:25908211	SUPPORT		Gastrointestinal manifestations are common in hereditary ATTR amyloidosis and are important for the patients' morbidity and mortality.	The study highlights that gastrointestinal manifestations are common in hereditary ATTR amyloidosis, supporting the statement that gastrointestinal symptoms are frequent in this condition.	"{""explanation"": ""The study highlights that gastrointestinal manifestations are common in hereditary ATTR amyloidosis, supporting the statement that gastrointestinal symptoms are frequent in this condition."", ""reference"": ""PMID:25908211"", ""snippet"": ""Gastrointestinal manifestations are common in hereditary ATTR amyloidosis and are important for the patients' morbidity and mortality."", ""supports"": ""SUPPORT""}"
69	80	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	2	evidence	1	PMID:32176096	SUPPORT		Transthyretin amyloid (ATTR) amyloidosis is a rare systemic disorder characterized by amyloid deposits formed by misfolded monomers of the transthyretin. Gastrointestinal (GI) manifestations are common in ATTR amyloidosis; however, their pathogenesis is not fully elucidated.	This reference supports the frequency of gastrointestinal symptoms in ATTR amyloidosis, aligning with the statement.	"{""explanation"": ""This reference supports the frequency of gastrointestinal symptoms in ATTR amyloidosis, aligning with the statement."", ""reference"": ""PMID:32176096"", ""snippet"": ""Transthyretin amyloid (ATTR) amyloidosis is a rare systemic disorder characterized by amyloid deposits formed by misfolded monomers of the transthyretin. Gastrointestinal (GI) manifestations are common in ATTR amyloidosis; however, their pathogenesis is not fully elucidated."", ""supports"": ""SUPPORT""}"
70	80	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	2	evidence	2	PMID:37844979	SUPPORT		In the early stages of amyloidosis, gastrointestinal (GI) symptoms are uncommon. We describe a rare case of hereditary transthyretin amyloidosis (ATTRv) with involvement of the heart, nervous system and GI tract.	Although it mentions that GI symptoms are uncommon in the early stages, it describes a case with significant GI involvement, supporting the statement about frequent GI symptoms in later stages.	"{""explanation"": ""Although it mentions that GI symptoms are uncommon in the early stages, it describes a case with significant GI involvement, supporting the statement about frequent GI symptoms in later stages."", ""reference"": ""PMID:37844979"", ""snippet"": ""In the early stages of amyloidosis, gastrointestinal (GI) symptoms are uncommon. We describe a rare case of hereditary transthyretin amyloidosis (ATTRv) with involvement of the heart, nervous system and GI tract."", ""supports"": ""SUPPORT""}"
71	80	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	2	evidence	3	PMID:8115892	PARTIAL		Gastrointestinal symptoms included anorexia, macroglossia, intestinal pseudo-obstruction, and altered bowel habits.	This reference mentions gastrointestinal symptoms but does not specifically focus on ATTR amyloidosis. It partially supports the statement by acknowledging the presence of GI symptoms in amyloidosis in general.	"{""explanation"": ""This reference mentions gastrointestinal symptoms but does not specifically focus on ATTR amyloidosis. It partially supports the statement by acknowledging the presence of GI symptoms in amyloidosis in general."", ""reference"": ""PMID:8115892"", ""snippet"": ""Gastrointestinal symptoms included anorexia, macroglossia, intestinal pseudo-obstruction, and altered bowel habits."", ""supports"": ""PARTIAL""}"
72	80	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	2	evidence	4	PMID:6402969	NO_EVIDENCE		Gastrointestinal symptoms such as vomiting, constipation, diarrhea, and fecal incontinence occur frequently in patients with diabetes mellitus.	This reference is focused on diabetes mellitus and does not provide evidence related to ATTR amyloidosis.	"{""explanation"": ""This reference is focused on diabetes mellitus and does not provide evidence related to ATTR amyloidosis."", ""reference"": ""PMID:6402969"", ""snippet"": ""Gastrointestinal symptoms such as vomiting, constipation, diarrhea, and fecal incontinence occur frequently in patients with diabetes mellitus."", ""supports"": ""NO_EVIDENCE""}"
73	81	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	3	evidence	0	PMID:28085522	SUPPORT		We report on two elderly patients (an 80-year-old woman and an 83-year-old man) with progressive vitreous opacities (VOs) as the initial manifestation of hereditary transthyretin (ATTR Val30Met) carries, who had no evidence of systemic involvement or family history of amyloidosis and lived in non-endemic areas.	The reference provides evidence that vitreous opacities can be an initial manifestation in patients with hereditary transthyretin amyloidosis (ATTR Val30Met), supporting the statement that vitreous opacities occur occasionally in ATTR amyloidosis.	"{""explanation"": ""The reference provides evidence that vitreous opacities can be an initial manifestation in patients with hereditary transthyretin amyloidosis (ATTR Val30Met), supporting the statement that vitreous opacities occur occasionally in ATTR amyloidosis."", ""reference"": ""PMID:28085522"", ""snippet"": ""We report on two elderly patients (an 80-year-old woman and an 83-year-old man) with progressive vitreous opacities (VOs) as the initial manifestation of hereditary transthyretin (ATTR Val30Met) carries, who had no evidence of systemic involvement or family history of amyloidosis and lived in non-endemic areas."", ""supports"": ""SUPPORT""}"
74	81	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	3	evidence	1	PMID:36129270	SUPPORT		However, 3 patients (43%) had worsening vitreous opacities in both eyes, and 4 patients (57%) developed secondary open-angle glaucoma.	The reference indicates that vitreous opacities were observed and worsened in some patients with ATTR amyloidosis, supporting the statement that vitreous opacities can occur occasionally in ATTR amyloidosis and lead to visual impairment.	"{""explanation"": ""The reference indicates that vitreous opacities were observed and worsened in some patients with ATTR amyloidosis, supporting the statement that vitreous opacities can occur occasionally in ATTR amyloidosis and lead to visual impairment."", ""reference"": ""PMID:36129270"", ""snippet"": ""However, 3 patients (43%) had worsening vitreous opacities in both eyes, and 4 patients (57%) developed secondary open-angle glaucoma."", ""supports"": ""SUPPORT""}"
75	82	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	4	evidence	0	PMID:30404120	SUPPORT		One cause for a carpal tunnel syndrome is transthyretin (ATTR) amyloid, which deposits in the carpal tunnel tissue.	The article states that ATTR amyloid deposits in the carpal tunnel tissue can cause carpal tunnel syndrome, supporting the statement that ATTR amyloidosis can occasionally cause this musculoskeletal condition.	"{""explanation"": ""The article states that ATTR amyloid deposits in the carpal tunnel tissue can cause carpal tunnel syndrome, supporting the statement that ATTR amyloidosis can occasionally cause this musculoskeletal condition."", ""reference"": ""PMID:30404120"", ""snippet"": ""One cause for a carpal tunnel syndrome is transthyretin (ATTR) amyloid, which deposits in the carpal tunnel tissue."", ""supports"": ""SUPPORT""}"
76	82	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	4	evidence	1	PMID:33443391	SUPPORT		Common orthopaedic manifestations of amyloidosis include carpal tunnel syndrome, trigger finger, spontaneous distal biceps tendon rupture, rotator cuff disease, and lumbar spinal stenosis.	The article mentions carpal tunnel syndrome as a common orthopedic manifestation of amyloidosis, supporting the statement that ATTR amyloidosis can occasionally cause this condition due to amyloid deposition in the wrist.	"{""explanation"": ""The article mentions carpal tunnel syndrome as a common orthopedic manifestation of amyloidosis, supporting the statement that ATTR amyloidosis can occasionally cause this condition due to amyloid deposition in the wrist."", ""reference"": ""PMID:33443391"", ""snippet"": ""Common orthopaedic manifestations of amyloidosis include carpal tunnel syndrome, trigger finger, spontaneous distal biceps tendon rupture, rotator cuff disease, and lumbar spinal stenosis."", ""supports"": ""SUPPORT""}"
77	83	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	5	evidence	0	PMID:22537653	SUPPORT		Peripheral neuropathy and cardiomyopathy are broadly described, and insights into disease reveal that kidney impairment and proteinuria are also clinical features.	The reference confirms that renal dysfunction, including proteinuria, is a clinical feature of transthyretin amyloidosis (ATTR).	"{""explanation"": ""The reference confirms that renal dysfunction, including proteinuria, is a clinical feature of transthyretin amyloidosis (ATTR)."", ""reference"": ""PMID:22537653"", ""snippet"": ""Peripheral neuropathy and cardiomyopathy are broadly described, and insights into disease reveal that kidney impairment and proteinuria are also clinical features."", ""supports"": ""SUPPORT""}"
78	83	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	5	evidence	1	PMID:37997196	SUPPORT		Transthyretin cardiac amyloidosis (ATTR-CA) is an infiltrative cardiomyopathy that commonly presents with concomitant chronic kidney disease.	The reference supports the statement by indicating that chronic kidney disease, which encompasses renal dysfunction, is commonly associated with transthyretin cardiac amyloidosis (ATTR-CA).	"{""explanation"": ""The reference supports the statement by indicating that chronic kidney disease, which encompasses renal dysfunction, is commonly associated with transthyretin cardiac amyloidosis (ATTR-CA)."", ""reference"": ""PMID:37997196"", ""snippet"": ""Transthyretin cardiac amyloidosis (ATTR-CA) is an infiltrative cardiomyopathy that commonly presents with concomitant chronic kidney disease."", ""supports"": ""SUPPORT""}"
79	84	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	6	evidence	0	PMID:35144512	SUPPORT		Patients often reported problems with mobility, usual activities, pain/discomfort and anxiety/depression, but not with self-care.	The literature indicates that systemic amyloidosis, including ATTR, frequently impacts daily life and mobility, which can be associated with fatigue.	"{""explanation"": ""The literature indicates that systemic amyloidosis, including ATTR, frequently impacts daily life and mobility, which can be associated with fatigue."", ""reference"": ""PMID:35144512"", ""snippet"": ""Patients often reported problems with mobility, usual activities, pain/discomfort and anxiety/depression, but not with self-care."", ""supports"": ""SUPPORT""}"
80	84	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	6	evidence	1	PMID:31445300	SUPPORT		It is a heterogeneous, multisystem disease with rapidly progressing polyneuropathy (including sensory, motor, and autonomic impairments) and cardiac dysfunction.	The literature describes ATTR amyloidosis as a multisystem disease, which can imply the presence of fatigue due to its systemic impact.	"{""explanation"": ""The literature describes ATTR amyloidosis as a multisystem disease, which can imply the presence of fatigue due to its systemic impact."", ""reference"": ""PMID:31445300"", ""snippet"": ""It is a heterogeneous, multisystem disease with rapidly progressing polyneuropathy (including sensory, motor, and autonomic impairments) and cardiac dysfunction."", ""supports"": ""SUPPORT""}"
81	84	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	6	evidence	2	PMID:33609196	SUPPORT		Amyloid transthyretin (ATTR) amyloidosis is a clinically heterogeneous and fatal disease that results from deposition of insoluble amyloid fibrils in various organs and tissues, causing progressive loss of function.	The progressive loss of function in various organs and tissues can lead to severe fatigue, limiting activities of daily living.	"{""explanation"": ""The progressive loss of function in various organs and tissues can lead to severe fatigue, limiting activities of daily living."", ""reference"": ""PMID:33609196"", ""snippet"": ""Amyloid transthyretin (ATTR) amyloidosis is a clinically heterogeneous and fatal disease that results from deposition of insoluble amyloid fibrils in various organs and tissues, causing progressive loss of function."", ""supports"": ""SUPPORT""}"
82	84	4	ATTR_Amyloidosis	ATTR_Amyloidosis.yaml	phenotypes	6	evidence	3	PMID:35128833	SUPPORT		Amyloidosis is a severe and fatal systemic disease, characterized by an accumulation of amyloid fibrils in various tissues/organs, including nerves, kidneys, gastrointestinal tract, and heart.	The systemic nature of ATTR amyloidosis affecting multiple organs can contribute to fatigue.	"{""explanation"": ""The systemic nature of ATTR amyloidosis affecting multiple organs can contribute to fatigue."", ""reference"": ""PMID:35128833"", ""snippet"": ""Amyloidosis is a severe and fatal systemic disease, characterized by an accumulation of amyloid fibrils in various tissues/organs, including nerves, kidneys, gastrointestinal tract, and heart."", ""supports"": ""SUPPORT""}"
121	106	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	phenotypes	0	evidence	0	PMID:15054848	SUPPORT	HUMAN_CLINICAL	severe micromelia and generalized edema were noted on ultrasound at 21 weeks' gestation	Documents severe micromelia as a key ultrasound finding in ACG2.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Documents severe micromelia as a key ultrasound finding in ACG2."", ""reference"": ""PMID:15054848"", ""snippet"": ""severe micromelia and generalized edema were noted on ultrasound at 21 weeks' gestation"", ""supports"": ""SUPPORT""}"
122	109	5	Achondrogenesis Type II	Achondrogenesis_Type_II.yaml	phenotypes	3	evidence	0	PMID:15054848	SUPPORT	HUMAN_CLINICAL	severe micromelia and generalized edema were noted on ultrasound at 21 weeks' gestation	Documents generalized edema (component of hydrops) as a prenatal finding in ACG2.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Documents generalized edema (component of hydrops) as a prenatal finding in ACG2."", ""reference"": ""PMID:15054848"", ""snippet"": ""severe micromelia and generalized edema were noted on ultrasound at 21 weeks' gestation"", ""supports"": ""SUPPORT""}"
143	143	7	Achoo Syndrome	Achoo_Syndrome.yaml	phenotypes	0	evidence	0	PMID:30899065	SUPPORT		Photic sneeze reflex (PSR) is an interesting but yet mysterious phenotype featured by individuals' response of sneezing in exposure to bright light.	Light-triggered sneezing is the defining feature of the syndrome.	"{""explanation"": ""Light-triggered sneezing is the defining feature of the syndrome."", ""reference"": ""PMID:30899065"", ""snippet"": ""Photic sneeze reflex (PSR) is an interesting but yet mysterious phenotype featured by individuals' response of sneezing in exposure to bright light."", ""supports"": ""SUPPORT""}"
144	144	7	Achoo Syndrome	Achoo_Syndrome.yaml	phenotypes	1	evidence	0	PMID:31287245	SUPPORT		a tickling sensation in the nasal mucosa, which in turn induces the sneeze reflex	Nasal tickling sensation is part of the proposed parasympathetic generalization mechanism.	"{""explanation"": ""Nasal tickling sensation is part of the proposed parasympathetic generalization mechanism."", ""reference"": ""PMID:31287245"", ""snippet"": ""a tickling sensation in the nasal mucosa, which in turn induces the sneeze reflex"", ""supports"": ""SUPPORT""}"
145	145	7	Achoo Syndrome	Achoo_Syndrome.yaml	phenotypes	2	evidence	0	PMID:31287245	SUPPORT		Individuals with PSS were more likely to suffer from migraine (odds ratio = 1.97, P = 2.18 × 10-9 )	Strong statistical association between photic sneeze syndrome and migraine.	"{""explanation"": ""Strong statistical association between photic sneeze syndrome and migraine."", ""reference"": ""PMID:31287245"", ""snippet"": ""Individuals with PSS were more likely to suffer from migraine (odds ratio = 1.97, P = 2.18 × 10-9 )"", ""supports"": ""SUPPORT""}"
146	146	7	Achoo Syndrome	Achoo_Syndrome.yaml	phenotypes	3	evidence	0	PMID:31287245	SUPPORT		clinically relevant psychological distress (K6 score ≥ 5: odds ratio = 1.40, P = 0.00143)	Statistical association with psychological distress measures.	"{""explanation"": ""Statistical association with psychological distress measures."", ""reference"": ""PMID:31287245"", ""snippet"": ""clinically relevant psychological distress (K6 score ≥ 5: odds ratio = 1.40, P = 0.00143)"", ""supports"": ""SUPPORT""}"
147	147	7	Achoo Syndrome	Achoo_Syndrome.yaml	phenotypes	4	evidence	0	PMID:31287245	SUPPORT		intolerance to light, commonly known as photophobia, is thought to result from light-induced activation of the trigeminal nerve system	Photophobia and photic sneeze syndrome share trigeminal nerve involvement.	"{""explanation"": ""Photophobia and photic sneeze syndrome share trigeminal nerve involvement."", ""reference"": ""PMID:31287245"", ""snippet"": ""intolerance to light, commonly known as photophobia, is thought to result from light-induced activation of the trigeminal nerve system"", ""supports"": ""SUPPORT""}"
176	177	8	Acne Vulgaris	Acne_Vulgaris.yaml	phenotypes	0	evidence	0	PMID:24062871	SUPPORT		evidence has emerged supporting a role for inflammation at all stages of acne lesion development, perhaps subclinically even before comedo formation	This review discusses the role of comedones as a key lesion type in acne pathogenesis.	"{""explanation"": ""This review discusses the role of comedones as a key lesion type in acne pathogenesis."", ""reference"": ""PMID:24062871"", ""snippet"": ""evidence has emerged supporting a role for inflammation at all stages of acne lesion development, perhaps subclinically even before comedo formation"", ""supports"": ""SUPPORT""}"
177	178	8	Acne Vulgaris	Acne_Vulgaris.yaml	phenotypes	1	evidence	0	PMID:24062871	SUPPORT		the progression from a so-called noninflammatory comedo to an inflammatory papule, pustule, or nodule	This review describes the progression from comedones to inflammatory papules in acne lesion development.	"{""explanation"": ""This review describes the progression from comedones to inflammatory papules in acne lesion development."", ""reference"": ""PMID:24062871"", ""snippet"": ""the progression from a so-called noninflammatory comedo to an inflammatory papule, pustule, or nodule"", ""supports"": ""SUPPORT""}"
178	179	8	Acne Vulgaris	Acne_Vulgaris.yaml	phenotypes	2	evidence	0	PMID:12113648	SUPPORT		Localized pustular eruptions are seen on the hands and feet in adults with pustulosis palmaris et plantaris and acrodermatitis continua (both of which may be variants of psoriasis); on the face in patients with acne vulgaris, rosacea, and perioral dermatitis	This review identifies pustular eruptions on the face as a characteristic feature of acne vulgaris.	"{""explanation"": ""This review identifies pustular eruptions on the face as a characteristic feature of acne vulgaris."", ""reference"": ""PMID:12113648"", ""snippet"": ""Localized pustular eruptions are seen on the hands and feet in adults with pustulosis palmaris et plantaris and acrodermatitis continua (both of which may be variants of psoriasis); on the face in patients with acne vulgaris, rosacea, and perioral dermatitis"", ""supports"": ""SUPPORT""}"
179	180	8	Acne Vulgaris	Acne_Vulgaris.yaml	phenotypes	3	evidence	0	PMID:21062102	SUPPORT		Severe nodular acne, defined as grade 4 or 5 acne on the Investigator's Static Global Assessment scale, is a skin condition characterized by intense erythema, inflammation, nodules, cysts, and scarring.	This review defines severe nodular acne as characterized by nodules and cysts with associated inflammation and scarring potential.	"{""explanation"": ""This review defines severe nodular acne as characterized by nodules and cysts with associated inflammation and scarring potential."", ""reference"": ""PMID:21062102"", ""snippet"": ""Severe nodular acne, defined as grade 4 or 5 acne on the Investigator's Static Global Assessment scale, is a skin condition characterized by intense erythema, inflammation, nodules, cysts, and scarring."", ""supports"": ""SUPPORT""}"
180	181	8	Acne Vulgaris	Acne_Vulgaris.yaml	phenotypes	4	evidence	0	PMID:34468934	SUPPORT		the inflammatory processes of acne stimulate excess melanogenesis and abnormal melanin deposition, leading to pigmentary sequelae known as post-inflammatory hyperpigmentation	This paper specifically describes the pathogenesis of acne-induced post-inflammatory hyperpigmentation through excess melanin production.	"{""explanation"": ""This paper specifically describes the pathogenesis of acne-induced post-inflammatory hyperpigmentation through excess melanin production."", ""reference"": ""PMID:34468934"", ""snippet"": ""the inflammatory processes of acne stimulate excess melanogenesis and abnormal melanin deposition, leading to pigmentary sequelae known as post-inflammatory hyperpigmentation"", ""supports"": ""SUPPORT""}"
181	182	8	Acne Vulgaris	Acne_Vulgaris.yaml	phenotypes	5	evidence	0	PMID:29344322	SUPPORT		This review focuses on atrophic scars, the most common type of acne scar.	This review confirms atrophic scars as the most common type of acne scarring.	"{""explanation"": ""This review confirms atrophic scars as the most common type of acne scarring."", ""reference"": ""PMID:29344322"", ""snippet"": ""This review focuses on atrophic scars, the most common type of acne scar."", ""supports"": ""SUPPORT""}"
241	224	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	0	evidence	0	PMID:1979021	SUPPORT		The occurrence of unusual infections, in particular Pneumocystis carinii pneumonia...	The reference indicates that Pneumocystis pneumonia is a common phenotype associated with Acquired Immunodeficiency Syndrome (AIDS).	"{""explanation"": ""The reference indicates that Pneumocystis pneumonia is a common phenotype associated with Acquired Immunodeficiency Syndrome (AIDS)."", ""reference"": ""PMID:1979021"", ""snippet"": ""The occurrence of unusual infections, in particular Pneumocystis carinii pneumonia..."", ""supports"": ""SUPPORT""}"
242	224	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	0	evidence	1	PMID:33612763	SUPPORT		Pneumocystis pneumonia (PCP) and pulmonary tuberculosis infection (PTB) are important opportunistic infections in HIV-infected patients.	The reference supports the presence of Pneumocystis pneumonia as a common infection among HIV-infected patients.	"{""explanation"": ""The reference supports the presence of Pneumocystis pneumonia as a common infection among HIV-infected patients."", ""reference"": ""PMID:33612763"", ""snippet"": ""Pneumocystis pneumonia (PCP) and pulmonary tuberculosis infection (PTB) are important opportunistic infections in HIV-infected patients."", ""supports"": ""SUPPORT""}"
243	224	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	0	evidence	2	PMID:16182595	SUPPORT		Pulmonary infection caused by the opportunistic fungal organism Pneumocystis continues to be a leading AIDS defining illness.	The reference supports the statement by indicating that Pneumocystis pneumonia is an important AIDS-defining illness.	"{""explanation"": ""The reference supports the statement by indicating that Pneumocystis pneumonia is an important AIDS-defining illness."", ""reference"": ""PMID:16182595"", ""snippet"": ""Pulmonary infection caused by the opportunistic fungal organism Pneumocystis continues to be a leading AIDS defining illness."", ""supports"": ""SUPPORT""}"
244	224	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	0	evidence	3	PMID:38110260	SUPPORT		...consistent use of Pneumocystis prophylaxis in all HIV exposed/infected children under 5 years of age has considerably reduced associated infections overall and respiratory infections in particular.	The reference suggests that Pneumocystis pneumonia is a common respiratory infection in HIV-infected individuals.	"{""explanation"": ""The reference suggests that Pneumocystis pneumonia is a common respiratory infection in HIV-infected individuals."", ""reference"": ""PMID:38110260"", ""snippet"": ""...consistent use of Pneumocystis prophylaxis in all HIV exposed/infected children under 5 years of age has considerably reduced associated infections overall and respiratory infections in particular."", ""supports"": ""SUPPORT""}"
245	224	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	0	evidence	4	PMID:7915731	SUPPORT		The nature of the clinical presentation of HIV infection continues to evolve over time....Pneumocystis carinii pneumonia...can now be added to the classic clinical markers for progressive HIV infection.	The reference supports the statement by listing Pneumocystis pneumonia as a classic clinical marker for HIV infection progression.	"{""explanation"": ""The reference supports the statement by listing Pneumocystis pneumonia as a classic clinical marker for HIV infection progression."", ""reference"": ""PMID:7915731"", ""snippet"": ""The nature of the clinical presentation of HIV infection continues to evolve over time....Pneumocystis carinii pneumonia...can now be added to the classic clinical markers for progressive HIV infection."", ""supports"": ""SUPPORT""}"
246	225	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	1	evidence	0	PMID:6496525	SUPPORT		Candidiasis is, by far, the most common mycotic infection of the human oral cavity... Extensive use of antibiotics and immunosuppressive drugs have greatly increased the number of Candida-induced oral infections.	This reference details multiple forms of candidiasis affecting the mouth, including acute atrophic, chronic atrophic, and chronic mucocutaneous candidiasis, and indicates that it is common.	"{""explanation"": ""This reference details multiple forms of candidiasis affecting the mouth, including acute atrophic, chronic atrophic, and chronic mucocutaneous candidiasis, and indicates that it is common."", ""reference"": ""PMID:6496525"", ""snippet"": ""Candidiasis is, by far, the most common mycotic infection of the human oral cavity... Extensive use of antibiotics and immunosuppressive drugs have greatly increased the number of Candida-induced oral infections."", ""supports"": ""SUPPORT""}"
247	225	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	1	evidence	1	PMID:17944709	SUPPORT		Invasive fungal infections (IFIs) have become a major cause of morbidity and mortality among people with acquired immune deficiency syndrome (AIDS)... Candida albicans accounted for 57.4% of fungal pathogens isolated.	Candidiasis is highlighted as a frequent and significant infection among AIDS patients.	"{""explanation"": ""Candidiasis is highlighted as a frequent and significant infection among AIDS patients."", ""reference"": ""PMID:17944709"", ""snippet"": ""Invasive fungal infections (IFIs) have become a major cause of morbidity and mortality among people with acquired immune deficiency syndrome (AIDS)... Candida albicans accounted for 57.4% of fungal pathogens isolated."", ""supports"": ""SUPPORT""}"
248	225	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	1	evidence	2	PMID:2135639	SUPPORT		Esophageal candidiasis was reported in one fifth of the patients and were reported twice as often in women as in homosexual men.	This study indicates a significant occurrence of esophageal candidiasis among AIDS patients.	"{""explanation"": ""This study indicates a significant occurrence of esophageal candidiasis among AIDS patients."", ""reference"": ""PMID:2135639"", ""snippet"": ""Esophageal candidiasis was reported in one fifth of the patients and were reported twice as often in women as in homosexual men."", ""supports"": ""SUPPORT""}"
249	225	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	1	evidence	3	PMID:11363911	SUPPORT		Candidiasis.	This reference, although brief, provides context for candidiasis as an infectious condition relevant to AIDS.	"{""explanation"": ""This reference, although brief, provides context for candidiasis as an infectious condition relevant to AIDS."", ""reference"": ""PMID:11363911"", ""snippet"": ""Candidiasis."", ""supports"": ""SUPPORT""}"
250	225	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	1	evidence	4	PMID:15627906	SUPPORT		an oral examination was carried out on a group of 200 HIV-infected patients...  ...Of the 86 (54.8%) patients with OC, 48.2% progressed to AIDS...	Candidiasis is cited here in the context of oral candidiasis and its prevalence among HIV-infected patients.	"{""explanation"": ""Candidiasis is cited here in the context of oral candidiasis and its prevalence among HIV-infected patients."", ""reference"": ""PMID:15627906"", ""snippet"": ""an oral examination was carried out on a group of 200 HIV-infected patients...  ...Of the 86 (54.8%) patients with OC, 48.2% progressed to AIDS..."", ""supports"": ""SUPPORT""}"
251	226	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	2	evidence	0	PMID:2661499	SUPPORT		One manifestation of this disease is Kaposi's Sarcoma. Usually a rare tumor, it occurs with a high incidence in patients with AIDS.	The abstract confirms that Kaposi's Sarcoma is commonly associated with AIDS, supporting the statement.	"{""explanation"": ""The abstract confirms that Kaposi's Sarcoma is commonly associated with AIDS, supporting the statement."", ""reference"": ""PMID:2661499"", ""snippet"": ""One manifestation of this disease is Kaposi's Sarcoma. Usually a rare tumor, it occurs with a high incidence in patients with AIDS."", ""supports"": ""SUPPORT""}"
252	226	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	2	evidence	1	PMID:29660143	SUPPORT		Kaposi sarcoma is an oligoclonal HHV-8-driven vascular proliferation... We report a 52-year-old Caucasian man with HIV/AIDS and Kaposi sarcoma.	KS is explicitly linked with HIV/AIDS in this case report, supporting the association.	"{""explanation"": ""KS is explicitly linked with HIV/AIDS in this case report, supporting the association."", ""reference"": ""PMID:29660143"", ""snippet"": ""Kaposi sarcoma is an oligoclonal HHV-8-driven vascular proliferation... We report a 52-year-old Caucasian man with HIV/AIDS and Kaposi sarcoma."", ""supports"": ""SUPPORT""}"
253	226	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	2	evidence	2	PMID:7915731	SUPPORT		New cutaneous (e.g., seborrheic dermatitis, onychomycosis, and tinea pedis) and systemic... markers for progressive HIV infection, such as Kaposi's sarcoma...	Kaposi's sarcoma cited as a marker for AIDS progression supports the statement.	"{""explanation"": ""Kaposi's sarcoma cited as a marker for AIDS progression supports the statement."", ""reference"": ""PMID:7915731"", ""snippet"": ""New cutaneous (e.g., seborrheic dermatitis, onychomycosis, and tinea pedis) and systemic... markers for progressive HIV infection, such as Kaposi's sarcoma..."", ""supports"": ""SUPPORT""}"
254	226	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	2	evidence	3	PMID:35227156	SUPPORT		Delayed or missed diagnosis of HIV infection leads to a lack of timely therapy, resulting in rapid disease progression with opportunistic infections or malignancies.	Although KS is not explicitly mentioned, malignancies associated with AIDS are noted, supporting the general assertion.	"{""explanation"": ""Although KS is not explicitly mentioned, malignancies associated with AIDS are noted, supporting the general assertion."", ""reference"": ""PMID:35227156"", ""snippet"": ""Delayed or missed diagnosis of HIV infection leads to a lack of timely therapy, resulting in rapid disease progression with opportunistic infections or malignancies."", ""supports"": ""SUPPORT""}"
255	226	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	2	evidence	4	PMID:9023448	SUPPORT		These disorders include nodal and extranodal lymphoproliferative lesions... smooth muscle tumors (SMTs), Kaposi's sarcoma...	KS is listed among the reactive and neoplastic proliferative disorders associated with AIDS.	"{""explanation"": ""KS is listed among the reactive and neoplastic proliferative disorders associated with AIDS."", ""reference"": ""PMID:9023448"", ""snippet"": ""These disorders include nodal and extranodal lymphoproliferative lesions... smooth muscle tumors (SMTs), Kaposi's sarcoma..."", ""supports"": ""SUPPORT""}"
256	227	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	3	evidence	0	PMID:9144008	SUPPORT		Of 1854 HIV-1 carriers, 578 had acquired immunodeficiency syndrome (AIDS) and 166 (28.7% of AIDS patients) had neurologic manifestations including HIV dementia (11.8%).	This study provides evidence that HIV-associated dementia is a neurologic manifestation seen in AIDS patients.	"{""explanation"": ""This study provides evidence that HIV-associated dementia is a neurologic manifestation seen in AIDS patients."", ""reference"": ""PMID:9144008"", ""snippet"": ""Of 1854 HIV-1 carriers, 578 had acquired immunodeficiency syndrome (AIDS) and 166 (28.7% of AIDS patients) had neurologic manifestations including HIV dementia (11.8%)."", ""supports"": ""SUPPORT""}"
257	227	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	3	evidence	1	PMID:1493145	SUPPORT		Psychiatric manifestations that are the direct result of HIV infection are usually seen in the setting of HIV-associated dementia.	This paper supports the occurrence of HIV-associated dementia as a neurologic manifestation of AIDS.	"{""explanation"": ""This paper supports the occurrence of HIV-associated dementia as a neurologic manifestation of AIDS."", ""reference"": ""PMID:1493145"", ""snippet"": ""Psychiatric manifestations that are the direct result of HIV infection are usually seen in the setting of HIV-associated dementia."", ""supports"": ""SUPPORT""}"
258	227	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	3	evidence	2	PMID:2548429	SUPPORT		The acquired immunodeficiency syndrome (AIDS) dementia complex is a frequent and devastating complication of infection with human immunodeficiency virus-type 1 (HIV-1).	This reference elaborates on AIDS dementia complex, confirming its association with AIDS.	"{""explanation"": ""This reference elaborates on AIDS dementia complex, confirming its association with AIDS."", ""reference"": ""PMID:2548429"", ""snippet"": ""The acquired immunodeficiency syndrome (AIDS) dementia complex is a frequent and devastating complication of infection with human immunodeficiency virus-type 1 (HIV-1)."", ""supports"": ""SUPPORT""}"
259	229	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	5	evidence	0	PMID:33475545	SUPPORT		Anaemia was a common finding among human immune deficiency virus / acquired immunodeficiency syndrome patients.	The study found that 66.1% of the patients with HIV/AIDS were anemic, indicating anemia is a common hematologic disorder in these patients.	"{""explanation"": ""The study found that 66.1% of the patients with HIV/AIDS were anemic, indicating anemia is a common hematologic disorder in these patients."", ""reference"": ""PMID:33475545"", ""snippet"": ""Anaemia was a common finding among human immune deficiency virus / acquired immunodeficiency syndrome patients."", ""supports"": ""SUPPORT""}"
260	229	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	5	evidence	1	PMID:9671334	SUPPORT		Anemia is common in patients infected with the human immunodeficiency virus (HIV).	The abstract discusses the commonality of anemia in HIV patients, supporting the statement.	"{""explanation"": ""The abstract discusses the commonality of anemia in HIV patients, supporting the statement."", ""reference"": ""PMID:9671334"", ""snippet"": ""Anemia is common in patients infected with the human immunodeficiency virus (HIV)."", ""supports"": ""SUPPORT""}"
261	229	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	5	evidence	2	PMID:6465173	SUPPORT		Ten patients were anemic, eight leukopenic, and three thrombocytopenic.	Out of 12 patients with AIDS, 10 were anemic, supporting the prevalence of anemia in individuals with AIDS.	"{""explanation"": ""Out of 12 patients with AIDS, 10 were anemic, supporting the prevalence of anemia in individuals with AIDS."", ""reference"": ""PMID:6465173"", ""snippet"": ""Ten patients were anemic, eight leukopenic, and three thrombocytopenic."", ""supports"": ""SUPPORT""}"
262	229	9	Acquired Immunodeficiency Syndrome	Acquired_Immunodeficiency_Syndrome.yaml	phenotypes	5	evidence	3	PMID:2252248	SUPPORT		Anemia was significantly more profound in patients with AIDS and MAI than in the other patients.	The study highlights a significant prevalence of anemia in patients with AIDS, especially those with disseminated Mycobacterium avium-intracellulare (MAI) infection.	"{""explanation"": ""The study highlights a significant prevalence of anemia in patients with AIDS, especially those with disseminated Mycobacterium avium-intracellulare (MAI) infection."", ""reference"": ""PMID:2252248"", ""snippet"": ""Anemia was significantly more profound in patients with AIDS and MAI than in the other patients."", ""supports"": ""SUPPORT""}"
340	258	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	0	evidence	0	PMID:8325289	SUPPORT		A constellation of nonspecific symptoms including weakness, easy fatigue, nausea, anorexia, and weight loss are typical features of adrenal insufficiency.	The literature indicates that fatigue is a typical feature of adrenal insufficiency, which includes Addison's Disease.	"{""explanation"": ""The literature indicates that fatigue is a typical feature of adrenal insufficiency, which includes Addison's Disease."", ""reference"": ""PMID:8325289"", ""snippet"": ""A constellation of nonspecific symptoms including weakness, easy fatigue, nausea, anorexia, and weight loss are typical features of adrenal insufficiency."", ""supports"": ""SUPPORT""}"
341	258	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	0	evidence	1	PMID:21365946	SUPPORT		We present the case of a 33-year-old female with generalized pain in the musculoskeletal system, fatigue, and many other symptoms.	The literature supports that fatigue is a symptom of Addison's Disease.	"{""explanation"": ""The literature supports that fatigue is a symptom of Addison's Disease."", ""reference"": ""PMID:21365946"", ""snippet"": ""We present the case of a 33-year-old female with generalized pain in the musculoskeletal system, fatigue, and many other symptoms."", ""supports"": ""SUPPORT""}"
342	258	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	0	evidence	2	PMID:31791082	SUPPORT		We report the case within a 22-year-old patient, initially seen because of fatigue, weight loss and discoloration of the skin.	The literature supports that fatigue is a symptom of Addison's Disease.	"{""explanation"": ""The literature supports that fatigue is a symptom of Addison's Disease."", ""reference"": ""PMID:31791082"", ""snippet"": ""We report the case within a 22-year-old patient, initially seen because of fatigue, weight loss and discoloration of the skin."", ""supports"": ""SUPPORT""}"
343	259	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	1	evidence	0	PMID:2801683	SUPPORT		Eight had severe or unusual gastrointestinal symptoms at presentation. One, already known to have Addison's disease, required several admissions to the hospital because of unexplained abdominal pain and vomiting before inadequate glucocorticoid replacement was diagnosed.	The reference clearly indicates that patients with Addison's disease frequently present with severe gastrointestinal symptoms, including abdominal pain.	"{""explanation"": ""The reference clearly indicates that patients with Addison's disease frequently present with severe gastrointestinal symptoms, including abdominal pain."", ""reference"": ""PMID:2801683"", ""snippet"": ""Eight had severe or unusual gastrointestinal symptoms at presentation. One, already known to have Addison's disease, required several admissions to the hospital because of unexplained abdominal pain and vomiting before inadequate glucocorticoid replacement was diagnosed."", ""supports"": ""SUPPORT""}"
344	259	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	1	evidence	1	PMID:3044463	SUPPORT		Non-specific abdominal complaints are a very frequent cause of discomfort. Even if only comparatively few are brought to the attention of the physician, they account for a considerable portion of the reasons for seeking medical care, both in acute and chronic conditions.	The reference discusses the frequency of non-specific abdominal complaints, which are common in various conditions, including Addison's disease.	"{""explanation"": ""The reference discusses the frequency of non-specific abdominal complaints, which are common in various conditions, including Addison's disease."", ""reference"": ""PMID:3044463"", ""snippet"": ""Non-specific abdominal complaints are a very frequent cause of discomfort. Even if only comparatively few are brought to the attention of the physician, they account for a considerable portion of the reasons for seeking medical care, both in acute and chronic conditions."", ""supports"": ""SUPPORT""}"
345	259	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	1	evidence	2	PMID:21365946	SUPPORT		She was initially diagnosed with fibromyalgia but other tests finally confirmed Addison's disease. Supplementation with adrenal hormones resulted in total remission of pain and of other symptoms.	The reference indicates that generalized pain, including abdominal pain, was a symptom in a patient with Addison's disease.	"{""explanation"": ""The reference indicates that generalized pain, including abdominal pain, was a symptom in a patient with Addison's disease."", ""reference"": ""PMID:21365946"", ""snippet"": ""She was initially diagnosed with fibromyalgia but other tests finally confirmed Addison's disease. Supplementation with adrenal hormones resulted in total remission of pain and of other symptoms."", ""supports"": ""SUPPORT""}"
346	260	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	2	evidence	0	PMID:33951364	SUPPORT		Hyperpigmentation from Addison's Disease.	The title directly indicates that hyperpigmentation is associated with Addison's Disease.	"{""explanation"": ""The title directly indicates that hyperpigmentation is associated with Addison's Disease."", ""reference"": ""PMID:33951364"", ""snippet"": ""Hyperpigmentation from Addison's Disease."", ""supports"": ""SUPPORT""}"
347	260	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	2	evidence	1	PMID:21219212	SUPPORT		The physical examination was completely normal except for muscle weakness, hyperpigmentation on labial mucosa and skin in a patient.	The abstract mentions hyperpigmentation as a clinical finding in a patient with Addison's disease.	"{""explanation"": ""The abstract mentions hyperpigmentation as a clinical finding in a patient with Addison's disease."", ""reference"": ""PMID:21219212"", ""snippet"": ""The physical examination was completely normal except for muscle weakness, hyperpigmentation on labial mucosa and skin in a patient."", ""supports"": ""SUPPORT""}"
348	260	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	2	evidence	2	PMID:33143829	SUPPORT		Increased skin pigmentation was observed in 45 children with other identifiable features including weight loss, lethargy, and poor response in activities.	The study found increased skin pigmentation in a significant number of children with Addison's disease.	"{""explanation"": ""The study found increased skin pigmentation in a significant number of children with Addison's disease."", ""reference"": ""PMID:33143829"", ""snippet"": ""Increased skin pigmentation was observed in 45 children with other identifiable features including weight loss, lethargy, and poor response in activities."", ""supports"": ""SUPPORT""}"
349	260	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	2	evidence	3	PMID:28717080	SUPPORT		Addison's disease caused by tuberculosis characterized by atypical hyperpigmentation, noted as exacerbation of the pigmentation of freckles and the occurrence of new freckles.	The case report highlights hyperpigmentation as a symptom of Addison's disease caused by tuberculosis.	"{""explanation"": ""The case report highlights hyperpigmentation as a symptom of Addison's disease caused by tuberculosis."", ""reference"": ""PMID:28717080"", ""snippet"": ""Addison's disease caused by tuberculosis characterized by atypical hyperpigmentation, noted as exacerbation of the pigmentation of freckles and the occurrence of new freckles."", ""supports"": ""SUPPORT""}"
350	260	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	2	evidence	4	PMID:34932395	SUPPORT		We report the case of a 47-year-old male patient with pigmentation of the head, face and hands, who was initially diagnosed as having primary adrenal insufficiency (Addison's disease).	The abstract mentions hyperpigmentation in a patient initially diagnosed with Addison's disease.	"{""explanation"": ""The abstract mentions hyperpigmentation in a patient initially diagnosed with Addison's disease."", ""reference"": ""PMID:34932395"", ""snippet"": ""We report the case of a 47-year-old male patient with pigmentation of the head, face and hands, who was initially diagnosed as having primary adrenal insufficiency (Addison's disease)."", ""supports"": ""SUPPORT""}"
351	261	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	3	evidence	0	PMID:36210660	SUPPORT		His clinical presentation was due to hyperkalemia and weakness due to Addison's disease.	This case report describes muscle weakness as a clinical presentation of Addison's disease.	"{""explanation"": ""This case report describes muscle weakness as a clinical presentation of Addison's disease."", ""reference"": ""PMID:36210660"", ""snippet"": ""His clinical presentation was due to hyperkalemia and weakness due to Addison's disease."", ""supports"": ""SUPPORT""}"
352	261	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	3	evidence	1	PMID:23897142	SUPPORT		Acute muscle weakness, a common disorder in pediatrics, can occur from impairment of any part of the motor unit, including the upper motor neuron, lower motor neuron, peripheral nerve, neuromuscular junction or muscle.	This reference discusses acute muscle weakness as a common disorder, implying that muscle weakness can be a frequent symptom in various conditions, including Addison's disease.	"{""explanation"": ""This reference discusses acute muscle weakness as a common disorder, implying that muscle weakness can be a frequent symptom in various conditions, including Addison's disease."", ""reference"": ""PMID:23897142"", ""snippet"": ""Acute muscle weakness, a common disorder in pediatrics, can occur from impairment of any part of the motor unit, including the upper motor neuron, lower motor neuron, peripheral nerve, neuromuscular junction or muscle."", ""supports"": ""SUPPORT""}"
353	261	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	3	evidence	2	PMID:21365946	SUPPORT		Supplementation with adrenal hormones resulted in total remission of pain and of other symptoms.	This case report mentions muscle pain and weakness that were misdiagnosed as fibromyalgia but were actually due to Addison's disease, which resolved with appropriate treatment.	"{""explanation"": ""This case report mentions muscle pain and weakness that were misdiagnosed as fibromyalgia but were actually due to Addison's disease, which resolved with appropriate treatment."", ""reference"": ""PMID:21365946"", ""snippet"": ""Supplementation with adrenal hormones resulted in total remission of pain and of other symptoms."", ""supports"": ""SUPPORT""}"
354	262	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	4	evidence	0	PMID:13280719	SUPPORT		Addison's disease presenting as loss of weight without pigmentation.	The reference clearly states that weight loss is a presenting symptom of Addison's disease.	"{""explanation"": ""The reference clearly states that weight loss is a presenting symptom of Addison's disease."", ""reference"": ""PMID:13280719"", ""snippet"": ""Addison's disease presenting as loss of weight without pigmentation."", ""supports"": ""SUPPORT""}"
355	262	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	4	evidence	1	PMID:23893277	SUPPORT		Addison's disease is a relatively rare endocrine condition resulting from adrenal insufficiency due to various causes. Weight loss is a common feature.	The literature identifies weight loss as a common feature of Addison's disease.	"{""explanation"": ""The literature identifies weight loss as a common feature of Addison's disease."", ""reference"": ""PMID:23893277"", ""snippet"": ""Addison's disease is a relatively rare endocrine condition resulting from adrenal insufficiency due to various causes. Weight loss is a common feature."", ""supports"": ""SUPPORT""}"
356	262	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	4	evidence	2	PMID:31791082	SUPPORT		We report the case within a 22-year-old patient, initially seen because of fatigue, weight loss and discoloration of the skin.	The reference describes weight loss as one of the presenting symptoms in a patient with Addison's disease.	"{""explanation"": ""The reference describes weight loss as one of the presenting symptoms in a patient with Addison's disease."", ""reference"": ""PMID:31791082"", ""snippet"": ""We report the case within a 22-year-old patient, initially seen because of fatigue, weight loss and discoloration of the skin."", ""supports"": ""SUPPORT""}"
357	262	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	4	evidence	3	PMID:23308244	SUPPORT		Hyperpigmentation was observed in 76%, nausea and vomiting occurred in more than 40%, and weight loss was noted in 25%.	The study reports weight loss in 25% of Addison's disease patients, supporting the statement that it is a frequent symptom.	"{""explanation"": ""The study reports weight loss in 25% of Addison's disease patients, supporting the statement that it is a frequent symptom."", ""reference"": ""PMID:23308244"", ""snippet"": ""Hyperpigmentation was observed in 76%, nausea and vomiting occurred in more than 40%, and weight loss was noted in 25%."", ""supports"": ""SUPPORT""}"
358	263	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	5	evidence	0	PMID:22975403	SUPPORT		Hypotension is defined by a low blood pressure either permanently or only in upright posture (orthostatic hypotension). ... Chronic hypotension from endocrine origin may be linked to adrenal failure from adrenal or central origin	The reference clearly states that chronic hypotension can be linked to adrenal failure, which is a characteristic of Addison's disease.	"{""explanation"": ""The reference clearly states that chronic hypotension can be linked to adrenal failure, which is a characteristic of Addison's disease."", ""reference"": ""PMID:22975403"", ""snippet"": ""Hypotension is defined by a low blood pressure either permanently or only in upright posture (orthostatic hypotension). ... Chronic hypotension from endocrine origin may be linked to adrenal failure from adrenal or central origin"", ""supports"": ""SUPPORT""}"
359	263	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	5	evidence	1	PMID:27992012	SUPPORT		Addisonian crisis is a difficult diagnosis due to the unspecificity of its signs and symptoms. Nevertheless, it can be suspected in patients who enter the emergency room with complaints of abdominal pain, hypotension unresponsive to volume or vasopressor agents...	The reference indicates that hypotension is a symptom of Addisonian crisis, which is part of Addison's disease.	"{""explanation"": ""The reference indicates that hypotension is a symptom of Addisonian crisis, which is part of Addison's disease."", ""reference"": ""PMID:27992012"", ""snippet"": ""Addisonian crisis is a difficult diagnosis due to the unspecificity of its signs and symptoms. Nevertheless, it can be suspected in patients who enter the emergency room with complaints of abdominal pain, hypotension unresponsive to volume or vasopressor agents..."", ""supports"": ""SUPPORT""}"
360	263	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	5	evidence	2	PMID:36709280	SUPPORT		We reported a 51-year-old male patient with unstable angina pectoris and hypotension. Changes on coronary angiography within 2 years suggested rapid progression of coronary artery disease in a patient with low cardiovascular risk. An additional clue of skin hyperpigmentation, fatigue and further examination confirmed the diagnosis of Addison's disease...	The reference mentions hypotension in a patient diagnosed with Addison's disease, supporting the statement.	"{""explanation"": ""The reference mentions hypotension in a patient diagnosed with Addison's disease, supporting the statement."", ""reference"": ""PMID:36709280"", ""snippet"": ""We reported a 51-year-old male patient with unstable angina pectoris and hypotension. Changes on coronary angiography within 2 years suggested rapid progression of coronary artery disease in a patient with low cardiovascular risk. An additional clue of skin hyperpigmentation, fatigue and further examination confirmed the diagnosis of Addison's disease..."", ""supports"": ""SUPPORT""}"
361	264	10	Addison's Disease	Addisons_Disease.yaml	phenotypes	6	evidence	0	PMID:20964584	SUPPORT		Primary adrenal insufficiency (i.e. Addison's disease) may well be recognized by clear hall-marks of the disease, such as pigmentation, salt craving, hypotension, and concomitant hyperkalemia.	The literature explicitly mentions salt craving as a hallmark of Addison's disease, confirming the statement.	"{""explanation"": ""The literature explicitly mentions salt craving as a hallmark of Addison's disease, confirming the statement."", ""reference"": ""PMID:20964584"", ""snippet"": ""Primary adrenal insufficiency (i.e. Addison's disease) may well be recognized by clear hall-marks of the disease, such as pigmentation, salt craving, hypotension, and concomitant hyperkalemia."", ""supports"": ""SUPPORT""}"
394	297	11	Adult T-Cell Leukemia/Lymphoma	Adult_T_Cell_Leukemia_Lymphoma.yaml	phenotypes	2	evidence	0	PMID:24714244	SUPPORT		Hypercalcemia occurs in about 70% of patients with acute adult T cell leukemia.	Review abstract reports hypercalcemia frequency in acute adult T cell leukemia.	"{""explanation"": ""Review abstract reports hypercalcemia frequency in acute adult T cell leukemia."", ""reference"": ""PMID:24714244"", ""snippet"": ""Hypercalcemia occurs in about 70% of patients with acute adult T cell leukemia."", ""supports"": ""SUPPORT""}"
409	350	13	Age-Related Macular Degeneration	Age_Related_Macular_Degeneration.yaml	phenotypes	0	evidence	0	PMID:38193957	SUPPORT		AMD occurs when extracellular deposits accumulate in the outer retina, ultimately leading to photoreceptor degeneration and loss of central vision.	Confirms that central vision loss is a direct consequence of AMD pathophysiology through photoreceptor degeneration.	"{""explanation"": ""Confirms that central vision loss is a direct consequence of AMD pathophysiology through photoreceptor degeneration."", ""reference"": ""PMID:38193957"", ""snippet"": ""AMD occurs when extracellular deposits accumulate in the outer retina, ultimately leading to photoreceptor degeneration and loss of central vision."", ""supports"": ""SUPPORT""}"
425	370	14	Ainhum	Ainhum.yaml	phenotypes	0	evidence	0	DOI:10.1111/j.1742-481x.2007.00297.x	SUPPORT	HUMAN_CLINICAL	a groove or fissure of constricting tissue forms around the proximal end of the fifth toe.	Constricting tissue groove corresponds to a digital constriction ring.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Constricting tissue groove corresponds to a digital constriction ring."", ""reference"": ""DOI:10.1111/j.1742-481x.2007.00297.x"", ""snippet"": ""a groove or fissure of constricting tissue forms around the proximal end of the fifth toe."", ""supports"": ""SUPPORT""}"
426	371	14	Ainhum	Ainhum.yaml	phenotypes	1	evidence	0	DOI:10.1111/j.1742-481x.2007.00297.x	SUPPORT	HUMAN_CLINICAL	Radiograph of the right fifth toe showed absorption of the proximal and intermediate phalanges	Radiograph showed bone absorption, consistent with osteolysis.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Radiograph showed bone absorption, consistent with osteolysis."", ""reference"": ""DOI:10.1111/j.1742-481x.2007.00297.x"", ""snippet"": ""Radiograph of the right fifth toe showed absorption of the proximal and intermediate phalanges"", ""supports"": ""SUPPORT""}"
427	372	14	Ainhum	Ainhum.yaml	phenotypes	2	evidence	0	PMID:1539609	SUPPORT	HUMAN_CLINICAL	Ainhum is the spontaneous autoamputation of toes as a result of the formation of a constricting band.	Case report defines ainhum by spontaneous autoamputation due to constricting band formation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report defines ainhum by spontaneous autoamputation due to constricting band formation."", ""reference"": ""PMID:1539609"", ""snippet"": ""Ainhum is the spontaneous autoamputation of toes as a result of the formation of a constricting band."", ""supports"": ""SUPPORT""}"
428	372	14	Ainhum	Ainhum.yaml	phenotypes	2	evidence	1	DOI:10.1111/j.1742-481x.2007.00297.x	SUPPORT	HUMAN_CLINICAL	He reported that his left fifth toe had autoamputated some months before.	Case report documents autoamputation of a digit.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report documents autoamputation of a digit."", ""reference"": ""DOI:10.1111/j.1742-481x.2007.00297.x"", ""snippet"": ""He reported that his left fifth toe had autoamputated some months before."", ""supports"": ""SUPPORT""}"
429	372	14	Ainhum	Ainhum.yaml	phenotypes	2	evidence	2	DOI:10.1111/j.1742-481x.2007.00297.x	SUPPORT	HUMAN_CLINICAL	the underlying structures are absorbed and the toe autoamputates.	Abstract describes autoamputation as the outcome of progressive constriction.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Abstract describes autoamputation as the outcome of progressive constriction."", ""reference"": ""DOI:10.1111/j.1742-481x.2007.00297.x"", ""snippet"": ""the underlying structures are absorbed and the toe autoamputates."", ""supports"": ""SUPPORT""}"
430	373	14	Ainhum	Ainhum.yaml	phenotypes	3	evidence	0	PMID:17924881	SUPPORT	HUMAN_CLINICAL	It may present as chronic fissuring at the base of the fifth toe or as foot ulceration.	Case report notes foot ulceration as a presentation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report notes foot ulceration as a presentation."", ""reference"": ""PMID:17924881"", ""snippet"": ""It may present as chronic fissuring at the base of the fifth toe or as foot ulceration."", ""supports"": ""SUPPORT""}"
457	396	15	Akinetopsia	Akinetopsia.yaml	phenotypes	0	evidence	0	PMID:39996018	SUPPORT	HUMAN_CLINICAL	Akinetopsia, or visual motion blindness, is a perceptual distortion characteristic of Alice in Wonderland syndrome in which people see moving objects as disjointed 'jumps' or 'freeze frames.'	This description of motion blindness with freeze-frame perception supports the core phenotype.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This description of motion blindness with freeze-frame perception supports the core phenotype."", ""reference"": ""PMID:39996018"", ""snippet"": ""Akinetopsia, or visual motion blindness, is a perceptual distortion characteristic of Alice in Wonderland syndrome in which people see moving objects as disjointed 'jumps' or 'freeze frames.'"", ""supports"": ""SUPPORT""}"
458	397	15	Akinetopsia	Akinetopsia.yaml	phenotypes	1	evidence	0	PMID:39996018	SUPPORT	HUMAN_CLINICAL	Of the clinical cases, 12% showed hemiakinetopsia, 50% continuous or progressive symptoms, and 52% a chronic course.	This review quantifies hemiakinetopsia among clinical cases.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This review quantifies hemiakinetopsia among clinical cases."", ""reference"": ""PMID:39996018"", ""snippet"": ""Of the clinical cases, 12% showed hemiakinetopsia, 50% continuous or progressive symptoms, and 52% a chronic course."", ""supports"": ""SUPPORT""}"
466	404	16	Alcoholic Liver Disease	Alcoholic_Liver_Disease.yaml	phenotypes	0	evidence	0	PMID:39362713	SUPPORT		Several intracellular, intrahepatic, and extrahepatic factors influence development of early fatty liver injury leading to inflammation and fibrosis.	The abstract describes early fatty liver injury as part of ALD development.	"{""explanation"": ""The abstract describes early fatty liver injury as part of ALD development."", ""reference"": ""PMID:39362713"", ""snippet"": ""Several intracellular, intrahepatic, and extrahepatic factors influence development of early fatty liver injury leading to inflammation and fibrosis."", ""supports"": ""SUPPORT""}"
467	405	16	Alcoholic Liver Disease	Alcoholic_Liver_Disease.yaml	phenotypes	1	evidence	0	PMID:39362713	SUPPORT		Several intracellular, intrahepatic, and extrahepatic factors influence development of early fatty liver injury leading to inflammation and fibrosis.	The abstract links ALD development to inflammation and fibrosis.	"{""explanation"": ""The abstract links ALD development to inflammation and fibrosis."", ""reference"": ""PMID:39362713"", ""snippet"": ""Several intracellular, intrahepatic, and extrahepatic factors influence development of early fatty liver injury leading to inflammation and fibrosis."", ""supports"": ""SUPPORT""}"
545	427	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	phenotypes	0	evidence	0	PMID:31724515	SUPPORT		Memory impairment has been considered as one of the earliest clinical hallmarks of Alzheimer's disease.	This reference supports the statement that memory loss is a very frequent and early diagnostic symptom of Alzheimer's disease.	"{""explanation"": ""This reference supports the statement that memory loss is a very frequent and early diagnostic symptom of Alzheimer's disease."", ""reference"": ""PMID:31724515"", ""snippet"": ""Memory impairment has been considered as one of the earliest clinical hallmarks of Alzheimer's disease."", ""supports"": ""SUPPORT""}"
546	428	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	phenotypes	1	evidence	0	PMID:24011643	SUPPORT		Impairment of executive functions is common in neurodegenerative disorders such as Alzheimer's disease.	The literature states that executive dysfunction, which includes difficulties in planning, decision-making, and judgment, is common in Alzheimer's disease.	"{""explanation"": ""The literature states that executive dysfunction, which includes difficulties in planning, decision-making, and judgment, is common in Alzheimer's disease."", ""reference"": ""PMID:24011643"", ""snippet"": ""Impairment of executive functions is common in neurodegenerative disorders such as Alzheimer's disease."", ""supports"": ""SUPPORT""}"
547	428	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	phenotypes	1	evidence	1	PMID:31930617	SUPPORT		Alzheimer's disease (AD) is a neurodegenerative disease characterised by neurocognitive impairments, especially memory impairment, as core symptoms linked to reductions in activities of daily life.	The literature mentions neurocognitive impairments in Alzheimer's disease, which includes executive dysfunction.	"{""explanation"": ""The literature mentions neurocognitive impairments in Alzheimer's disease, which includes executive dysfunction."", ""reference"": ""PMID:31930617"", ""snippet"": ""Alzheimer's disease (AD) is a neurodegenerative disease characterised by neurocognitive impairments, especially memory impairment, as core symptoms linked to reductions in activities of daily life."", ""supports"": ""SUPPORT""}"
548	428	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	phenotypes	1	evidence	2	PMID:36279224	SUPPORT		The cognitive decline in cerebrovascular disease, including small vessel disease, is also usually gradual and gradual, progresses slowly, and the underlying defect extends to processing speed, complex attention, and fronto-executive functions.	This reference indicates that executive dysfunction is a common feature in cognitive decline related to Alzheimer's disease.	"{""explanation"": ""This reference indicates that executive dysfunction is a common feature in cognitive decline related to Alzheimer's disease."", ""reference"": ""PMID:36279224"", ""snippet"": ""The cognitive decline in cerebrovascular disease, including small vessel disease, is also usually gradual and gradual, progresses slowly, and the underlying defect extends to processing speed, complex attention, and fronto-executive functions."", ""supports"": ""SUPPORT""}"
549	429	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	phenotypes	2	evidence	0	PMID:38157881	SUPPORT		Neuropsychiatric or behavioral symptoms of dementia encompass a series of disorders, such as anxiety, depression, apathy, psychosis, and agitation, all commonly present in individuals living with dementia.	The abstract confirms that behavioral changes, including irritability, depression, and apathy, are common in Alzheimer's disease.	"{""explanation"": ""The abstract confirms that behavioral changes, including irritability, depression, and apathy, are common in Alzheimer's disease."", ""reference"": ""PMID:38157881"", ""snippet"": ""Neuropsychiatric or behavioral symptoms of dementia encompass a series of disorders, such as anxiety, depression, apathy, psychosis, and agitation, all commonly present in individuals living with dementia."", ""supports"": ""SUPPORT""}"
550	429	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	phenotypes	2	evidence	1	PMID:28413709	SUPPORT		Using the median split approach, greater apathy and lower depression were associated with poorer awareness on the Self-Consciousness Scale (respectively: odds ratio ... = 4.8, p = .03; OR = 4.84, p = .04), and the PCRS (only apathy: OR = 9.3, p = .003).	This study indicates that apathy and depression are significant behavioral symptoms in Alzheimer's disease.	"{""explanation"": ""This study indicates that apathy and depression are significant behavioral symptoms in Alzheimer's disease."", ""reference"": ""PMID:28413709"", ""snippet"": ""Using the median split approach, greater apathy and lower depression were associated with poorer awareness on the Self-Consciousness Scale (respectively: odds ratio ... = 4.8, p = .03; OR = 4.84, p = .04), and the PCRS (only apathy: OR = 9.3, p = .003)."", ""supports"": ""SUPPORT""}"
551	429	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	phenotypes	2	evidence	2	PMID:34580191	SUPPORT		Alzheimer Disease and Mood.	The title suggests a focus on mood disturbances, which includes behavioral changes such as depression.	"{""explanation"": ""The title suggests a focus on mood disturbances, which includes behavioral changes such as depression."", ""reference"": ""PMID:34580191"", ""snippet"": ""Alzheimer Disease and Mood."", ""supports"": ""SUPPORT""}"
552	429	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	phenotypes	2	evidence	3	PMID:34755541	SUPPORT		The most frequent NPS in CAA were depression/dysphoria (48.8%), irritability/lability (37.2%), agitation/aggression (37.2%), apathy/indifference (34.9%), and anxiety (32.6%).	Although the primary focus is on cerebral amyloid angiopathy, the study draws parallels with Alzheimer's disease regarding the prevalence of behavioral changes like depression, irritability, and apathy.	"{""explanation"": ""Although the primary focus is on cerebral amyloid angiopathy, the study draws parallels with Alzheimer's disease regarding the prevalence of behavioral changes like depression, irritability, and apathy."", ""reference"": ""PMID:34755541"", ""snippet"": ""The most frequent NPS in CAA were depression/dysphoria (48.8%), irritability/lability (37.2%), agitation/aggression (37.2%), apathy/indifference (34.9%), and anxiety (32.6%)."", ""supports"": ""SUPPORT""}"
553	430	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	phenotypes	3	evidence	0	PMID:24035593	SUPPORT		Language disorders of degenerative origin are frequently tied to Alzheimer disease (AD) the different variants of which can result in primary and secondary aphasia syndromes.	The literature clearly supports that aphasia, which involves difficulty with speech and understanding language, is a frequent neurologic symptom in Alzheimer's Disease.	"{""explanation"": ""The literature clearly supports that aphasia, which involves difficulty with speech and understanding language, is a frequent neurologic symptom in Alzheimer's Disease."", ""reference"": ""PMID:24035593"", ""snippet"": ""Language disorders of degenerative origin are frequently tied to Alzheimer disease (AD) the different variants of which can result in primary and secondary aphasia syndromes."", ""supports"": ""SUPPORT""}"
554	431	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	phenotypes	4	evidence	0	PMID:36375032	SUPPORT		Limb apraxia is a common early sign of Alzheimer''s disease (AD) and is thought to occur specifically in early-onset (before the age of 65) AD.	The literature indicates that limb apraxia is a common early sign of Alzheimer's disease, supporting the statement that apraxia can occur in Alzheimer's disease.	"{""explanation"": ""The literature indicates that limb apraxia is a common early sign of Alzheimer's disease, supporting the statement that apraxia can occur in Alzheimer's disease."", ""reference"": ""PMID:36375032"", ""snippet"": ""Limb apraxia is a common early sign of Alzheimer''s disease (AD) and is thought to occur specifically in early-onset (before the age of 65) AD."", ""supports"": ""SUPPORT""}"
555	432	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	phenotypes	5	evidence	0	PMID:31930617	NO_EVIDENCE		Alzheimer's disease (AD) is a neurodegenerative disease characterised by neurocognitive impairments, especially memory impairment, as core symptoms linked to reductions in activities of daily life.	The provided literature discusses various neurocognitive impairments in Alzheimer's disease, but does not specifically mention agnosia.	"{""explanation"": ""The provided literature discusses various neurocognitive impairments in Alzheimer's disease, but does not specifically mention agnosia."", ""reference"": ""PMID:31930617"", ""snippet"": ""Alzheimer's disease (AD) is a neurodegenerative disease characterised by neurocognitive impairments, especially memory impairment, as core symptoms linked to reductions in activities of daily life."", ""supports"": ""NO_EVIDENCE""}"
556	432	17	Alhzeimer_Disease	Alhzeimer_Disease.yaml	phenotypes	5	evidence	1	PMID:29672553	NO_EVIDENCE		Faces are among the most relevant social stimuli revealing an encounter's identity and actual emotional state. Deficits in facial recognition may be an early sign of cognitive decline leading to social deficits.	The literature discusses deficits in facial recognition in patients with amnestic mild cognitive impairment, but does not explicitly mention agnosia in the context of Alzheimer's disease.	"{""explanation"": ""The literature discusses deficits in facial recognition in patients with amnestic mild cognitive impairment, but does not explicitly mention agnosia in the context of Alzheimer's disease."", ""reference"": ""PMID:29672553"", ""snippet"": ""Faces are among the most relevant social stimuli revealing an encounter's identity and actual emotional state. Deficits in facial recognition may be an early sign of cognitive decline leading to social deficits."", ""supports"": ""NO_EVIDENCE""}"
589	451	18	Alopecia Areata	Alopecia_Areata.yaml	phenotypes	1	evidence	0	PMID:32682334	SUPPORT		Collapse of anagen hair bulb IP is an essential prerequisite for the development of alopecia areata (AA). In AA, lesional HFs are rapidly infiltrated by NKG2D + T cells and natural killer (NK) cells, while perifollicular mast cells acquire a profoundly pro-inflammatory phenotype and interact with autoreactive CD8+ T cells.	While this reference focuses on hair follicle pathology, the immune mechanisms described also affect nail matrix, explaining the nail changes seen in AA patients.	"{""explanation"": ""While this reference focuses on hair follicle pathology, the immune mechanisms described also affect nail matrix, explaining the nail changes seen in AA patients."", ""reference"": ""PMID:32682334"", ""snippet"": ""Collapse of anagen hair bulb IP is an essential prerequisite for the development of alopecia areata (AA). In AA, lesional HFs are rapidly infiltrated by NKG2D + T cells and natural killer (NK) cells, while perifollicular mast cells acquire a profoundly pro-inflammatory phenotype and interact with autoreactive CD8+ T cells."", ""supports"": ""SUPPORT""}"
597	465	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	phenotypes	0	evidence	0	PMID:20301692	SUPPORT		Alpha-1 antitrypsin deficiency (AATD) can present with hepatic dysfunction in individuals from infancy to adulthood and with chronic obstructive lung disease (emphysema and/or bronchiectasis), characteristically in individuals older than age 30 years.	Establishes emphysema as a cardinal manifestation of AATD occurring characteristically in adults over 30 years of age	"{""explanation"": ""Establishes emphysema as a cardinal manifestation of AATD occurring characteristically in adults over 30 years of age"", ""reference"": ""PMID:20301692"", ""snippet"": ""Alpha-1 antitrypsin deficiency (AATD) can present with hepatic dysfunction in individuals from infancy to adulthood and with chronic obstructive lung disease (emphysema and/or bronchiectasis), characteristically in individuals older than age 30 years."", ""supports"": ""SUPPORT""}"
598	465	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	phenotypes	0	evidence	1	PMID:35361631	SUPPORT		Severe alpha-1-antitrypsin deficiency (AATD), phenotype PiZZ, is a risk factor for pulmonary emphysema and liver disease.	Confirms that severe AATD (PiZZ phenotype) carries significant risk for emphysema development	"{""explanation"": ""Confirms that severe AATD (PiZZ phenotype) carries significant risk for emphysema development"", ""reference"": ""PMID:35361631"", ""snippet"": ""Severe alpha-1-antitrypsin deficiency (AATD), phenotype PiZZ, is a risk factor for pulmonary emphysema and liver disease."", ""supports"": ""SUPPORT""}"
599	466	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	phenotypes	1	evidence	0	PMID:35715315	SUPPORT		Pulmonary emphysema and liver disease are the clinical expressions of alpha 1-antitrypsin deficiency, an autosomal recessive genetic disease.	Confirms pulmonary emphysema and COPD as cardinal clinical manifestations of alpha-1 antitrypsin deficiency	"{""explanation"": ""Confirms pulmonary emphysema and COPD as cardinal clinical manifestations of alpha-1 antitrypsin deficiency"", ""reference"": ""PMID:35715315"", ""snippet"": ""Pulmonary emphysema and liver disease are the clinical expressions of alpha 1-antitrypsin deficiency, an autosomal recessive genetic disease."", ""supports"": ""SUPPORT""}"
600	467	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	phenotypes	2	evidence	0	PMID:35868681	SUPPORT		Liver disease in homozygous ZZ alpha-1 antitrypsin (AAT) deficiency occurs due to the accumulation of large quantities of AAT mutant Z protein polymers in the liver.	Confirms that homozygous ZZ genotype leads to hepatocytic protein accumulation and liver disease	"{""explanation"": ""Confirms that homozygous ZZ genotype leads to hepatocytic protein accumulation and liver disease"", ""reference"": ""PMID:35868681"", ""snippet"": ""Liver disease in homozygous ZZ alpha-1 antitrypsin (AAT) deficiency occurs due to the accumulation of large quantities of AAT mutant Z protein polymers in the liver."", ""supports"": ""SUPPORT""}"
601	468	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	phenotypes	3	evidence	0	PMID:35868681	SUPPORT		The mutant Z protein folds improperly during biogenesis and is retained within the hepatocytes rather than appropriately secreted.	Documents hepatocyte protein accumulation as the mechanism causing hepatomegaly in AAT deficiency	"{""explanation"": ""Documents hepatocyte protein accumulation as the mechanism causing hepatomegaly in AAT deficiency"", ""reference"": ""PMID:35868681"", ""snippet"": ""The mutant Z protein folds improperly during biogenesis and is retained within the hepatocytes rather than appropriately secreted."", ""supports"": ""SUPPORT""}"
602	469	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	phenotypes	4	evidence	0	PMID:36896570	SUPPORT		Alpha1 antitrypsin deficiency (AATD), a common hereditary disorder affecting mainly lungs, liver and skin has been the focus of some of the most exciting therapeutic approaches in medicine in the past 5 years.	Confirms that lung disease affecting the respiratory system is a primary manifestation of AATD	"{""explanation"": ""Confirms that lung disease affecting the respiratory system is a primary manifestation of AATD"", ""reference"": ""PMID:36896570"", ""snippet"": ""Alpha1 antitrypsin deficiency (AATD), a common hereditary disorder affecting mainly lungs, liver and skin has been the focus of some of the most exciting therapeutic approaches in medicine in the past 5 years."", ""supports"": ""SUPPORT""}"
603	470	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	phenotypes	5	evidence	0	PMID:34356027	SUPPORT		Early diagnosis is crucial for treatment outcome. The primary care physician should refer patients younger than 50-years-old with COPD or emphysema, familiar accumulation of A1AD or liver cirrhosis of unknown cause.	Indicates that early-onset COPD with airway obstruction and wheezing is a key diagnostic feature prompting referral for AAT deficiency testing	"{""explanation"": ""Indicates that early-onset COPD with airway obstruction and wheezing is a key diagnostic feature prompting referral for AAT deficiency testing"", ""reference"": ""PMID:34356027"", ""snippet"": ""Early diagnosis is crucial for treatment outcome. The primary care physician should refer patients younger than 50-years-old with COPD or emphysema, familiar accumulation of A1AD or liver cirrhosis of unknown cause."", ""supports"": ""SUPPORT""}"
604	471	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	phenotypes	6	evidence	0	PMID:33516773	SUPPORT		Panniculitis represents a rare and potentially lethal manifestation of alpha-1 antitrypsin deficiency (AATD).	Establishes panniculitis as a rare but significant cutaneous manifestation of AAT deficiency	"{""explanation"": ""Establishes panniculitis as a rare but significant cutaneous manifestation of AAT deficiency"", ""reference"": ""PMID:33516773"", ""snippet"": ""Panniculitis represents a rare and potentially lethal manifestation of alpha-1 antitrypsin deficiency (AATD)."", ""supports"": ""SUPPORT""}"
605	471	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	phenotypes	6	evidence	1	PMID:33516773	SUPPORT		Intravenous AAT augmentation therapy generally resulted in response.	Confirms AAT augmentation as the most effective treatment for AAT-associated panniculitis	"{""explanation"": ""Confirms AAT augmentation as the most effective treatment for AAT-associated panniculitis"", ""reference"": ""PMID:33516773"", ""snippet"": ""Intravenous AAT augmentation therapy generally resulted in response."", ""supports"": ""SUPPORT""}"
606	471	19	Alpha-1 Antitrypsin Deficiency	Alpha_1_Antitrypsin_Deficiency.yaml	phenotypes	6	evidence	2	PMID:38958623	SUPPORT		Panniculitis in α(1)-Antitrypsin Deficiency	Recent clinical case documentation of panniculitis as cutaneous manifestation of AAT deficiency	"{""explanation"": ""Recent clinical case documentation of panniculitis as cutaneous manifestation of AAT deficiency"", ""reference"": ""PMID:38958623"", ""snippet"": ""Panniculitis in α(1)-Antitrypsin Deficiency"", ""supports"": ""SUPPORT""}"
632	505	21	Alzheimer's Disease	Alzheimers_Disease.yaml	phenotypes	0	evidence	0	PMID:24459411	SUPPORT		Loss of memory is among the first symptoms reported by patients suffering from Alzheimer's disease (AD) and by their caretakers. Working memory and long-term declarative memory are affected early during the course of the disease.	This reference confirms that memory loss, including both working memory and long-term declarative memory, is an early and characteristic symptom of Alzheimer's disease.	"{""explanation"": ""This reference confirms that memory loss, including both working memory and long-term declarative memory, is an early and characteristic symptom of Alzheimer's disease."", ""reference"": ""PMID:24459411"", ""snippet"": ""Loss of memory is among the first symptoms reported by patients suffering from Alzheimer's disease (AD) and by their caretakers. Working memory and long-term declarative memory are affected early during the course of the disease."", ""supports"": ""SUPPORT""}"
633	505	21	Alzheimer's Disease	Alzheimers_Disease.yaml	phenotypes	0	evidence	1	PMID:31724515	SUPPORT		Memory impairment has been considered as one of the earliest clinical hallmarks of Alzheimer's disease.	This confirms memory impairment as a defining early clinical feature of Alzheimer's disease.	"{""explanation"": ""This confirms memory impairment as a defining early clinical feature of Alzheimer's disease."", ""reference"": ""PMID:31724515"", ""snippet"": ""Memory impairment has been considered as one of the earliest clinical hallmarks of Alzheimer's disease."", ""supports"": ""SUPPORT""}"
664	541	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	phenotypes	0	evidence	0	PMID:31871139	SUPPORT		motor neuron disease (MND)	Study of motor neuron disease patients confirms muscle weakness as a defining feature.	"{""explanation"": ""Study of motor neuron disease patients confirms muscle weakness as a defining feature."", ""reference"": ""PMID:31871139"", ""snippet"": ""motor neuron disease (MND)"", ""supports"": ""SUPPORT""}"
665	542	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	phenotypes	1	evidence	0	PMID:27117334	SUPPORT		In the LMN system, fasciculation potentials (FPs) are the earliest changes observed in affected muscles, a feature of LMN hyperexcitability.	Review confirms fasciculations are an early marker of lower motor neuron dysfunction in ALS.	"{""explanation"": ""Review confirms fasciculations are an early marker of lower motor neuron dysfunction in ALS."", ""reference"": ""PMID:27117334"", ""snippet"": ""In the LMN system, fasciculation potentials (FPs) are the earliest changes observed in affected muscles, a feature of LMN hyperexcitability."", ""supports"": ""SUPPORT""}"
666	543	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	phenotypes	2	evidence	0	PMID:33085325	SUPPORT		Upper motor findings include spasticity, hyperactive reflexes, and a positive Babinski sign.	StatPearls article confirms spasticity as a cardinal upper motor neuron sign in ALS.	"{""explanation"": ""StatPearls article confirms spasticity as a cardinal upper motor neuron sign in ALS."", ""reference"": ""PMID:33085325"", ""snippet"": ""Upper motor findings include spasticity, hyperactive reflexes, and a positive Babinski sign."", ""supports"": ""SUPPORT""}"
667	544	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	phenotypes	3	evidence	0	PMID:33085325	SUPPORT		Upper motor findings include spasticity, hyperactive reflexes, and a positive Babinski sign.	StatPearls motor neuron disease review lists hyperactive reflexes as a core upper motor neuron finding in ALS.	"{""explanation"": ""StatPearls motor neuron disease review lists hyperactive reflexes as a core upper motor neuron finding in ALS."", ""reference"": ""PMID:33085325"", ""snippet"": ""Upper motor findings include spasticity, hyperactive reflexes, and a positive Babinski sign."", ""supports"": ""SUPPORT""}"
668	545	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	phenotypes	4	evidence	0	PMID:33085325	SUPPORT		Bulbar dysfunction can manifest as dysphagia (trouble swallowing) and dysarthria (trouble speaking).	Review notes bulbar dysfunction in ALS commonly presents with dysarthria and dysphagia.	"{""explanation"": ""Review notes bulbar dysfunction in ALS commonly presents with dysarthria and dysphagia."", ""reference"": ""PMID:33085325"", ""snippet"": ""Bulbar dysfunction can manifest as dysphagia (trouble swallowing) and dysarthria (trouble speaking)."", ""supports"": ""SUPPORT""}"
669	546	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	phenotypes	5	evidence	0	PMID:33085325	SUPPORT		Bulbar dysfunction can manifest as dysphagia (trouble swallowing) and dysarthria (trouble speaking).	StatPearls article highlights dysphagia as a common bulbar manifestation in ALS.	"{""explanation"": ""StatPearls article highlights dysphagia as a common bulbar manifestation in ALS."", ""reference"": ""PMID:33085325"", ""snippet"": ""Bulbar dysfunction can manifest as dysphagia (trouble swallowing) and dysarthria (trouble speaking)."", ""supports"": ""SUPPORT""}"
670	546	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	phenotypes	5	evidence	1	PMID:39207520	SUPPORT		Throughout the disease, more than two-thirds of ALS patients experience dysphagia, regardless of the region of onset.	Dysphagia-focused review reports that swallowing difficulty affects the majority of ALS patients and requires routine assessment.	"{""explanation"": ""Dysphagia-focused review reports that swallowing difficulty affects the majority of ALS patients and requires routine assessment."", ""reference"": ""PMID:39207520"", ""snippet"": ""Throughout the disease, more than two-thirds of ALS patients experience dysphagia, regardless of the region of onset."", ""supports"": ""SUPPORT""}"
671	547	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	phenotypes	6	evidence	0	PMID:33085325	SUPPORT		Death usually occurs within 2 to 5 years from respiratory failure.	Clinical overview states respiratory failure is the usual terminal event in ALS.	"{""explanation"": ""Clinical overview states respiratory failure is the usual terminal event in ALS."", ""reference"": ""PMID:33085325"", ""snippet"": ""Death usually occurs within 2 to 5 years from respiratory failure."", ""supports"": ""SUPPORT""}"
672	548	22	Amyotrophic Lateral Sclerosis	Amyotrophic_Lateral_Sclerosis.yaml	phenotypes	7	evidence	0	PMID:33085325	SUPPORT		Lower motor neuron signs include muscle atrophy, weakness, flaccid paralysis, absent reflexes, fasciculations, and fibrillations.	Review details muscle atrophy as a key lower motor neuron sign in ALS.	"{""explanation"": ""Review details muscle atrophy as a key lower motor neuron sign in ALS."", ""reference"": ""PMID:33085325"", ""snippet"": ""Lower motor neuron signs include muscle atrophy, weakness, flaccid paralysis, absent reflexes, fasciculations, and fibrillations."", ""supports"": ""SUPPORT""}"
689	565	23	Ankylosing Spondylitis	Ankylosing_Spondylitis.yaml	phenotypes	0	evidence	0	PMID:33692806	SUPPORT		New bone formation, determined by chronic inflammation involving the spine, leads to vertebral ankylosis, severe chronic pain and disability as major consequences of disease progression.	Evidence that chronic spinal inflammation causes pain as a major clinical manifestation of ankylosing spondylitis.	"{""explanation"": ""Evidence that chronic spinal inflammation causes pain as a major clinical manifestation of ankylosing spondylitis."", ""reference"": ""PMID:33692806"", ""snippet"": ""New bone formation, determined by chronic inflammation involving the spine, leads to vertebral ankylosis, severe chronic pain and disability as major consequences of disease progression."", ""supports"": ""SUPPORT""}"
748	591	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	0	evidence	0	PMID:36575066	SUPPORT		Venous thromboembolism belongs to the most frequent clinical manifestation of this syndrome.	The reference mentions that venous thromboembolism, which includes deep vein thrombosis, is a frequent manifestation in Antiphospholipid Syndrome (APS).	"{""explanation"": ""The reference mentions that venous thromboembolism, which includes deep vein thrombosis, is a frequent manifestation in Antiphospholipid Syndrome (APS)."", ""reference"": ""PMID:36575066"", ""snippet"": ""Venous thromboembolism belongs to the most frequent clinical manifestation of this syndrome."", ""supports"": ""SUPPORT""}"
749	591	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	0	evidence	1	PMID:10961585	PARTIAL		In its classic presentation, the antiphospholipid syndrome manifests a combination of venous or arterial thrombosis... The manifestations often include a moderate thrombocytopenia and, less commonly, hemolysis.	While it confirms the presence of venous thrombosis, including potential complications like stroke, it does not definitively confirm deep vein thrombosis and pulmonary embolism as common sequelae in all cases.	"{""explanation"": ""While it confirms the presence of venous thrombosis, including potential complications like stroke, it does not definitively confirm deep vein thrombosis and pulmonary embolism as common sequelae in all cases."", ""reference"": ""PMID:10961585"", ""snippet"": ""In its classic presentation, the antiphospholipid syndrome manifests a combination of venous or arterial thrombosis... The manifestations often include a moderate thrombocytopenia and, less commonly, hemolysis."", ""supports"": ""PARTIAL""}"
750	591	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	0	evidence	2	PMID:12627666	SUPPORT		The relative frequency of ACLAs in association with arterial and venous thrombosis strongly suggests that they should be looked for in any individual with unexplained thrombosis; all three idiotypes (IgG, IgA, and IgM) should be assessed.	Venous thrombosis, including deep vein thrombosis and pulmonary embolism, is frequently observed in APS.	"{""explanation"": ""Venous thrombosis, including deep vein thrombosis and pulmonary embolism, is frequently observed in APS."", ""reference"": ""PMID:12627666"", ""snippet"": ""The relative frequency of ACLAs in association with arterial and venous thrombosis strongly suggests that they should be looked for in any individual with unexplained thrombosis; all three idiotypes (IgG, IgA, and IgM) should be assessed."", ""supports"": ""SUPPORT""}"
751	592	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	1	evidence	0	PMID:26815583	SUPPORT		Obstetric morbidity includes recurrent first trimester loss, stillbirth, intrauterine death, preeclam-psia, premature birth and fetal growth restriction	The reference lists premature birth (preterm birth) as a form of obstetric morbidity associated with APS, supporting its categorization as a pregnancy-related phenotype.	"{""explanation"": ""The reference lists premature birth (preterm birth) as a form of obstetric morbidity associated with APS, supporting its categorization as a pregnancy-related phenotype."", ""reference"": ""PMID:26815583"", ""snippet"": ""Obstetric morbidity includes recurrent first trimester loss, stillbirth, intrauterine death, preeclam-psia, premature birth and fetal growth restriction"", ""supports"": ""SUPPORT""}"
752	592	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	1	evidence	1	PMID:36756665	SUPPORT		The pregnancy outcomes were not significantly different between NC-OAPS and OAPS groups.	The evidence suggests that patients with APS (OAPS) can experience similar pregnancy outcomes to those without the specific criteria of classical APS, which includes preterm birth.	"{""explanation"": ""The evidence suggests that patients with APS (OAPS) can experience similar pregnancy outcomes to those without the specific criteria of classical APS, which includes preterm birth."", ""reference"": ""PMID:36756665"", ""snippet"": ""The pregnancy outcomes were not significantly different between NC-OAPS and OAPS groups."", ""supports"": ""SUPPORT""}"
753	592	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	1	evidence	2	PMID:34280554	SUPPORT		Patients with lupus anticoagulant positivity had an increased risk of preeclampsia (OR 2.10, p = 0.02, I2 = 48%), SGA (OR 1.78, p < 0.01, I2 = 0%) and preterm birth (OR 3.56, p = 0.01, I2 = 48%)	The meta-analysis found that APS patients, especially those with lupus anticoagulant positivity, have an increased risk of preterm birth, supporting the statement that APS phenotypes include pregnancy-related complications such as preterm birth.	"{""explanation"": ""The meta-analysis found that APS patients, especially those with lupus anticoagulant positivity, have an increased risk of preterm birth, supporting the statement that APS phenotypes include pregnancy-related complications such as preterm birth."", ""reference"": ""PMID:34280554"", ""snippet"": ""Patients with lupus anticoagulant positivity had an increased risk of preeclampsia (OR 2.10, p = 0.02, I2 = 48%), SGA (OR 1.78, p < 0.01, I2 = 0%) and preterm birth (OR 3.56, p = 0.01, I2 = 48%)"", ""supports"": ""SUPPORT""}"
754	593	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	2	evidence	0	PMID:8952756	SUPPORT		a variable degree of thrombocytopenia occurs in approximately 20-40% of the patients with APS	Thrombocytopenia is a hematologic phenotype observed in APS patients.	"{""explanation"": ""Thrombocytopenia is a hematologic phenotype observed in APS patients."", ""reference"": ""PMID:8952756"", ""snippet"": ""a variable degree of thrombocytopenia occurs in approximately 20-40% of the patients with APS"", ""supports"": ""SUPPORT""}"
755	593	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	2	evidence	1	PMID:21303834	SUPPORT		This article summarizes the studies analyzed on thrombocytopenia and skin manifestations	Thrombocytopenia is mentioned as a manifestation studied in APS.	"{""explanation"": ""Thrombocytopenia is mentioned as a manifestation studied in APS."", ""reference"": ""PMID:21303834"", ""snippet"": ""This article summarizes the studies analyzed on thrombocytopenia and skin manifestations"", ""supports"": ""SUPPORT""}"
756	593	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	2	evidence	2	PMID:29316193	SUPPORT		Thrombocytopenia is the most common non-criteria hematological feature in patients with antiphospholipid syndrome (APS).	Thrombocytopenia is a significant hematologic feature observed in APS.	"{""explanation"": ""Thrombocytopenia is a significant hematologic feature observed in APS."", ""reference"": ""PMID:29316193"", ""snippet"": ""Thrombocytopenia is the most common non-criteria hematological feature in patients with antiphospholipid syndrome (APS)."", ""supports"": ""SUPPORT""}"
757	594	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	3	evidence	0	PMID:17916990	SUPPORT		Valvular involvement is the most common manifestation with a prevalence of 82% detected by transesophageal echocardiography. Symmetrical, nodular thickening of the mitral and/or aortic valves is characteristic.	This reference indicates that cardiac valve disease, specifically valvular involvement, is a common manifestation in patients with antiphospholipid syndrome (APS).	"{""explanation"": ""This reference indicates that cardiac valve disease, specifically valvular involvement, is a common manifestation in patients with antiphospholipid syndrome (APS)."", ""reference"": ""PMID:17916990"", ""snippet"": ""Valvular involvement is the most common manifestation with a prevalence of 82% detected by transesophageal echocardiography. Symmetrical, nodular thickening of the mitral and/or aortic valves is characteristic."", ""supports"": ""SUPPORT""}"
758	594	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	3	evidence	1	PMID:10852159	SUPPORT		Cardiac valve diseases and antiphospholipid syndrome.	The title of this reference directly connects cardiac valve diseases with APS, supporting the statement.	"{""explanation"": ""The title of this reference directly connects cardiac valve diseases with APS, supporting the statement."", ""reference"": ""PMID:10852159"", ""snippet"": ""Cardiac valve diseases and antiphospholipid syndrome."", ""supports"": ""SUPPORT""}"
759	594	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	3	evidence	2	PMID:1733383	SUPPORT		Valvular involvement is frequently found in patients with the primary antiphospholipid syndrome.	This study shows a significant prevalence of cardiac valvular involvement in patients with primary APS.	"{""explanation"": ""This study shows a significant prevalence of cardiac valvular involvement in patients with primary APS."", ""reference"": ""PMID:1733383"", ""snippet"": ""Valvular involvement is frequently found in patients with the primary antiphospholipid syndrome."", ""supports"": ""SUPPORT""}"
760	594	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	3	evidence	3	PMID:30614053	SUPPORT		Most commonly mitral valve is affected followed by aortic and then tricuspid valve.	This report confirms that cardiac valve disease is a manifestation of APS, most commonly affecting the mitral valve.	"{""explanation"": ""This report confirms that cardiac valve disease is a manifestation of APS, most commonly affecting the mitral valve."", ""reference"": ""PMID:30614053"", ""snippet"": ""Most commonly mitral valve is affected followed by aortic and then tricuspid valve."", ""supports"": ""SUPPORT""}"
761	594	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	3	evidence	4	PMID:1442504	SUPPORT		The earliest reports were of valvular disease, including verrucous endocarditis, as well as valvular thickening and insufficiency.	This review discusses various cardiac abnormalities associated with APS, including valvular disease.	"{""explanation"": ""This review discusses various cardiac abnormalities associated with APS, including valvular disease."", ""reference"": ""PMID:1442504"", ""snippet"": ""The earliest reports were of valvular disease, including verrucous endocarditis, as well as valvular thickening and insufficiency."", ""supports"": ""SUPPORT""}"
762	595	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	4	evidence	0	PMID:26815583	PARTIAL		Obstetric morbidity includes recurrent first trimester loss, stillbirth, intrauterine death, preeclam-psia, premature birth and fetal growth restriction	The literature supports the association of antiphospholipid syndrome with preeclampsia, but it does not specify that the frequency is 'occasional'.	"{""explanation"": ""The literature supports the association of antiphospholipid syndrome with preeclampsia, but it does not specify that the frequency is 'occasional'."", ""reference"": ""PMID:26815583"", ""snippet"": ""Obstetric morbidity includes recurrent first trimester loss, stillbirth, intrauterine death, preeclam-psia, premature birth and fetal growth restriction"", ""supports"": ""PARTIAL""}"
763	595	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	4	evidence	1	PMID:32413497	PARTIAL		Its major presentations are thrombotic (arterial, venous, or microvascular) and pregnancy morbidity (miscarriages, late intrauterine fetal demise, and severe pre-eclampsia).	The literature supports the association of antiphospholipid syndrome with preeclampsia, but it does not specify that the frequency is 'occasional'.	"{""explanation"": ""The literature supports the association of antiphospholipid syndrome with preeclampsia, but it does not specify that the frequency is 'occasional'."", ""reference"": ""PMID:32413497"", ""snippet"": ""Its major presentations are thrombotic (arterial, venous, or microvascular) and pregnancy morbidity (miscarriages, late intrauterine fetal demise, and severe pre-eclampsia)."", ""supports"": ""PARTIAL""}"
764	596	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	5	evidence	0	PMID:35536236	SUPPORT		Thrombocytopenia, a frequent clinical manifestation in patients with APS, could be an independent predictor of recurrent thrombotic, obstetric and severe extracriteria events.	The study indicates thrombocytopenia is a frequent clinical manifestation in patients with primary APS.	"{""explanation"": ""The study indicates thrombocytopenia is a frequent clinical manifestation in patients with primary APS."", ""reference"": ""PMID:35536236"", ""snippet"": ""Thrombocytopenia, a frequent clinical manifestation in patients with APS, could be an independent predictor of recurrent thrombotic, obstetric and severe extracriteria events."", ""supports"": ""SUPPORT""}"
765	596	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	5	evidence	1	PMID:17426356	SUPPORT		Other features include recurrent miscarriage, thrombocytopenia, and livedo reticularis.	Thrombocytopenia is mentioned as a clinical feature of APS, supporting its frequent occurrence.	"{""explanation"": ""Thrombocytopenia is mentioned as a clinical feature of APS, supporting its frequent occurrence."", ""reference"": ""PMID:17426356"", ""snippet"": ""Other features include recurrent miscarriage, thrombocytopenia, and livedo reticularis."", ""supports"": ""SUPPORT""}"
766	596	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	5	evidence	2	PMID:18417261	SUPPORT		Thrombocytopenia is frequently found in APS patients, its incidence has ranged from 22-42% in different series.	The incidence range of 22-42% indicates that thrombocytopenia is a frequent hematologic manifestation in APS patients.	"{""explanation"": ""The incidence range of 22-42% indicates that thrombocytopenia is a frequent hematologic manifestation in APS patients."", ""reference"": ""PMID:18417261"", ""snippet"": ""Thrombocytopenia is frequently found in APS patients, its incidence has ranged from 22-42% in different series."", ""supports"": ""SUPPORT""}"
767	597	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	6	evidence	0	PMID:23456852	REFUTE		Heart valve disease (HVD) is the most frequent cardiac manifestation in patients with antiphospholipid syndrome (APS), with prevalence of 30 %.	The literature states that heart valve disease is the most frequent cardiac manifestation in APS, not an occasional occurrence.	"{""explanation"": ""The literature states that heart valve disease is the most frequent cardiac manifestation in APS, not an occasional occurrence."", ""reference"": ""PMID:23456852"", ""snippet"": ""Heart valve disease (HVD) is the most frequent cardiac manifestation in patients with antiphospholipid syndrome (APS), with prevalence of 30 %."", ""supports"": ""REFUTE""}"
768	597	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	6	evidence	1	PMID:1733383	REFUTE		Valvular involvement is frequently found in patients with the primary antiphospholipid syndrome.	The literature indicates that valvular involvement is frequently found, contradicting the statement that it is occasional.	"{""explanation"": ""The literature indicates that valvular involvement is frequently found, contradicting the statement that it is occasional."", ""reference"": ""PMID:1733383"", ""snippet"": ""Valvular involvement is frequently found in patients with the primary antiphospholipid syndrome."", ""supports"": ""REFUTE""}"
769	597	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	6	evidence	2	PMID:12402416	REFUTE		The valvulopathy in APS is quite common and may lead to valve replacement.	The literature describes valvulopathy in APS as quite common, not occasional.	"{""explanation"": ""The literature describes valvulopathy in APS as quite common, not occasional."", ""reference"": ""PMID:12402416"", ""snippet"": ""The valvulopathy in APS is quite common and may lead to valve replacement."", ""supports"": ""REFUTE""}"
770	598	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	7	evidence	0	PMID:26223086	SUPPORT		Livedo reticularis is a common cutaneous manifestation of APS and may be a prognostic marker of more severe disease.	This reference states that livedo reticularis is a common cutaneous manifestation of APS, supporting its categorization as a dermatologic manifestation.	"{""explanation"": ""This reference states that livedo reticularis is a common cutaneous manifestation of APS, supporting its categorization as a dermatologic manifestation."", ""reference"": ""PMID:26223086"", ""snippet"": ""Livedo reticularis is a common cutaneous manifestation of APS and may be a prognostic marker of more severe disease."", ""supports"": ""SUPPORT""}"
771	598	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	7	evidence	1	PMID:9204065	SUPPORT		Cutaneous manifestations may occur as the first sign of antiphospholipid syndrome. These include livedo reticularis...	This reference confirms that livedo reticularis is one of the cutaneous manifestations of APS.	"{""explanation"": ""This reference confirms that livedo reticularis is one of the cutaneous manifestations of APS."", ""reference"": ""PMID:9204065"", ""snippet"": ""Cutaneous manifestations may occur as the first sign of antiphospholipid syndrome. These include livedo reticularis..."", ""supports"": ""SUPPORT""}"
772	598	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	7	evidence	2	PMID:35697016	SUPPORT		This cross-sectional analysis of a large cohort of Serbian PAPS patients confirmed a strong relationship between livedo reticularis and arterial thrombosis...	This reference supports the association of livedo reticularis with APS, indicating its presence in patients with the syndrome.	"{""explanation"": ""This reference supports the association of livedo reticularis with APS, indicating its presence in patients with the syndrome."", ""reference"": ""PMID:35697016"", ""snippet"": ""This cross-sectional analysis of a large cohort of Serbian PAPS patients confirmed a strong relationship between livedo reticularis and arterial thrombosis..."", ""supports"": ""SUPPORT""}"
773	598	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	7	evidence	3	PMID:36112747	SUPPORT		Livedo is a well-known skin condition in patients with systemic lupus erythematosus (SLE) which correspond to small vessels involvement.	This reference discusses the prevalence of livedo in patients with SLE and APS, supporting its categorization as a dermatologic manifestation.	"{""explanation"": ""This reference discusses the prevalence of livedo in patients with SLE and APS, supporting its categorization as a dermatologic manifestation."", ""reference"": ""PMID:36112747"", ""snippet"": ""Livedo is a well-known skin condition in patients with systemic lupus erythematosus (SLE) which correspond to small vessels involvement."", ""supports"": ""SUPPORT""}"
774	599	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	8	evidence	0	PMID:27423434	SUPPORT		Migraine is the most commonly reported type of headache in APS/aPL-positive patients.	The literature indicates that migraine headaches are frequently reported in patients with Antiphospholipid Syndrome (APS), supporting the statement that they are an occasional neurological manifestation.	"{""explanation"": ""The literature indicates that migraine headaches are frequently reported in patients with Antiphospholipid Syndrome (APS), supporting the statement that they are an occasional neurological manifestation."", ""reference"": ""PMID:27423434"", ""snippet"": ""Migraine is the most commonly reported type of headache in APS/aPL-positive patients."", ""supports"": ""SUPPORT""}"
775	599	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	8	evidence	1	PMID:29756580	SUPPORT		Cerebral vascular accident (33%), retinal artery/vein occlusion (21%), and seizure (20%) were the most frequent presentations among the patients.	This study supports the association between APS and neurological manifestations, including migraines, although it does not provide specific frequency data for migraines.	"{""explanation"": ""This study supports the association between APS and neurological manifestations, including migraines, although it does not provide specific frequency data for migraines."", ""reference"": ""PMID:29756580"", ""snippet"": ""Cerebral vascular accident (33%), retinal artery/vein occlusion (21%), and seizure (20%) were the most frequent presentations among the patients."", ""supports"": ""SUPPORT""}"
776	599	24	Antiphospholipid Syndrome	Antiphospholipid_Syndrome.yaml	phenotypes	8	evidence	2	PMID:27658514	SUPPORT		Although in the most recently updated (2006) APS classification criteria, the neurological manifestations encompass only transient ischemic attack and stroke, diverse 'non-criteria' neurological disorders or manifestations (i.e., headache, migraine...) have been observed in APS patients.	This reference supports the occurrence of migraines as a neurological manifestation in APS patients, even though it is not part of the official classification criteria.	"{""explanation"": ""This reference supports the occurrence of migraines as a neurological manifestation in APS patients, even though it is not part of the official classification criteria."", ""reference"": ""PMID:27658514"", ""snippet"": ""Although in the most recently updated (2006) APS classification criteria, the neurological manifestations encompass only transient ischemic attack and stroke, diverse 'non-criteria' neurological disorders or manifestations (i.e., headache, migraine...) have been observed in APS patients."", ""supports"": ""SUPPORT""}"
785	609	25	Apert Syndrome	Apert_Syndrome.yaml	phenotypes	0	evidence	0	PMID:7719344	SUPPORT	HUMAN_CLINICAL	Apert syndrome is a distinctive human malformation comprising craniosynostosis and severe syndactyly of the hands and feet.	Craniosynostosis is established as a defining clinical feature of Apert syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Craniosynostosis is established as a defining clinical feature of Apert syndrome."", ""reference"": ""PMID:7719344"", ""snippet"": ""Apert syndrome is a distinctive human malformation comprising craniosynostosis and severe syndactyly of the hands and feet."", ""supports"": ""SUPPORT""}"
786	612	25	Apert Syndrome	Apert_Syndrome.yaml	phenotypes	3	evidence	0	PMID:7719344	SUPPORT	HUMAN_CLINICAL	Apert syndrome is a distinctive human malformation comprising craniosynostosis and severe syndactyly of the hands and feet.	Defines syndactyly of hands and feet as a core diagnostic feature of Apert syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Defines syndactyly of hands and feet as a core diagnostic feature of Apert syndrome."", ""reference"": ""PMID:7719344"", ""snippet"": ""Apert syndrome is a distinctive human malformation comprising craniosynostosis and severe syndactyly of the hands and feet."", ""supports"": ""SUPPORT""}"
805	629	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	0	evidence	0	PMID:37348676	PARTIAL		In the seven patients from our center, presentation was frequent in childhood or adolescence (4/7: delayed puberty or hyperandrogenism), with maternal virilization (4/7), predominance of Prader III/IV (5/7), and initial rearing as females (6/7).	The literature discusses varied presentations including ambiguous genitalia (Prader III/IV), but 'frequency: VERY_FREQUENT' is not clearly established.	"{""explanation"": ""The literature discusses varied presentations including ambiguous genitalia (Prader III/IV), but 'frequency: VERY_FREQUENT' is not clearly established."", ""reference"": ""PMID:37348676"", ""snippet"": ""In the seven patients from our center, presentation was frequent in childhood or adolescence (4/7: delayed puberty or hyperandrogenism), with maternal virilization (4/7), predominance of Prader III/IV (5/7), and initial rearing as females (6/7)."", ""supports"": ""PARTIAL""}"
806	629	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	0	evidence	1	PMID:36686446	PARTIAL		Among the 46XY DSD patients, the most common cause was partial androgen insensitivity. In contrast, congenital adrenal hyperplasia constituted the most common diagnosis in 46,XX DSD cases.	The reference focuses on DSD in general and not specifically on aromatase deficiency, discussing other common diagnoses like congenital adrenal hyperplasia.	"{""explanation"": ""The reference focuses on DSD in general and not specifically on aromatase deficiency, discussing other common diagnoses like congenital adrenal hyperplasia."", ""reference"": ""PMID:36686446"", ""snippet"": ""Among the 46XY DSD patients, the most common cause was partial androgen insensitivity. In contrast, congenital adrenal hyperplasia constituted the most common diagnosis in 46,XX DSD cases."", ""supports"": ""PARTIAL""}"
807	630	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	1	evidence	0	PMID:30173221	NO_EVIDENCE		BACKGROUND: Aromatase deficiency is a rare autosomal recessive disorder. 46,XY-affected patients often remain undiagnosed until late puberty. Only 2 pediatric cases have been reported. Data on pubertal development in affected males are scarce.	The reference discusses aromatase deficiency and mentions pubertal development but does not provide specific evidence supporting delayed puberty as a phenotype.	"{""explanation"": ""The reference discusses aromatase deficiency and mentions pubertal development but does not provide specific evidence supporting delayed puberty as a phenotype."", ""reference"": ""PMID:30173221"", ""snippet"": ""BACKGROUND: Aromatase deficiency is a rare autosomal recessive disorder. 46,XY-affected patients often remain undiagnosed until late puberty. Only 2 pediatric cases have been reported. Data on pubertal development in affected males are scarce."", ""supports"": ""NO_EVIDENCE""}"
808	630	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	1	evidence	1	PMID:36268624	NO_EVIDENCE		Isolated hypogonadotropic hypogonadism (IHH) is phenotypically and genetically heterogeneous.	The reference is about IHH, not aromatase deficiency, and does not provide direct evidence for delayed puberty in aromatase deficiency.	"{""explanation"": ""The reference is about IHH, not aromatase deficiency, and does not provide direct evidence for delayed puberty in aromatase deficiency."", ""reference"": ""PMID:36268624"", ""snippet"": ""Isolated hypogonadotropic hypogonadism (IHH) is phenotypically and genetically heterogeneous."", ""supports"": ""NO_EVIDENCE""}"
809	630	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	1	evidence	2	PMID:30550360	NO_EVIDENCE		Despite the advances in translational medicine, hospitals are yet to adopt genetic testing and counseling facilities in India that shall have potential impact on clinical diagnosis.	The reference provides an overview of genetic testing of disorders of sexual development but does not provide strong evidence supporting delayed puberty due to aromatase deficiency.	"{""explanation"": ""The reference provides an overview of genetic testing of disorders of sexual development but does not provide strong evidence supporting delayed puberty due to aromatase deficiency."", ""reference"": ""PMID:30550360"", ""snippet"": ""Despite the advances in translational medicine, hospitals are yet to adopt genetic testing and counseling facilities in India that shall have potential impact on clinical diagnosis."", ""supports"": ""NO_EVIDENCE""}"
810	630	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	1	evidence	3	PMID:17581673	PARTIAL		Alterations of spermatogenesis in terms of number and motility of spermatozoa have been described in men genetically deficient in aromatase. These last observations... suggest that aromatase could be involved in the acquisition of sperm motility.	While the reference discusses reproductive implications of aromatase deficiency, it does not directly address delayed puberty as a high-frequency diagnostic phenotype.	"{""explanation"": ""While the reference discusses reproductive implications of aromatase deficiency, it does not directly address delayed puberty as a high-frequency diagnostic phenotype."", ""reference"": ""PMID:17581673"", ""snippet"": ""Alterations of spermatogenesis in terms of number and motility of spermatozoa have been described in men genetically deficient in aromatase. These last observations... suggest that aromatase could be involved in the acquisition of sperm motility."", ""supports"": ""PARTIAL""}"
811	630	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	1	evidence	4	PMID:24612204	NO_EVIDENCE		Oestrogen is the final key factor to start the onset of puberty.	The reference discusses the role of estrogen in puberty but does not specifically mention delayed puberty as a phenotype of aromatase deficiency.	"{""explanation"": ""The reference discusses the role of estrogen in puberty but does not specifically mention delayed puberty as a phenotype of aromatase deficiency."", ""reference"": ""PMID:24612204"", ""snippet"": ""Oestrogen is the final key factor to start the onset of puberty."", ""supports"": ""NO_EVIDENCE""}"
812	630	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	1	evidence	5	PMID:10418977	NO_EVIDENCE		The diagnostic term congenital adrenal hyperplasia (CAH) applies to a family of inherited disorders of steroidogenesis.	The reference discusses congenital adrenal hyperplasia but does not provide evidence on delayed puberty linked to aromatase deficiency.	"{""explanation"": ""The reference discusses congenital adrenal hyperplasia but does not provide evidence on delayed puberty linked to aromatase deficiency."", ""reference"": ""PMID:10418977"", ""snippet"": ""The diagnostic term congenital adrenal hyperplasia (CAH) applies to a family of inherited disorders of steroidogenesis."", ""supports"": ""NO_EVIDENCE""}"
813	631	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	2	evidence	0	PMID:18448329	SUPPORT		The clinical phenotype in the male affected subjects comprises tall stature, persistent linear growth and delayed bone age, osteopenia/osteoporosis, eunuchoid body proportion, different degrees of glucose-insulin and of fertility impairment.	The abstract mentions osteoporosis as one of the phenotypes observed in males with aromatase deficiency due to estrogen deficiency.	"{""explanation"": ""The abstract mentions osteoporosis as one of the phenotypes observed in males with aromatase deficiency due to estrogen deficiency."", ""reference"": ""PMID:18448329"", ""snippet"": ""The clinical phenotype in the male affected subjects comprises tall stature, persistent linear growth and delayed bone age, osteopenia/osteoporosis, eunuchoid body proportion, different degrees of glucose-insulin and of fertility impairment."", ""supports"": ""SUPPORT""}"
814	631	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	2	evidence	1	PMID:18448329	SUPPORT		Estrogens exert a wide range of biological effects in both sexes also on non-reproductive systems and organs.	This reference supports the role of estrogen in bone health, noting its wide biological effects including skeletal outcomes.	"{""explanation"": ""This reference supports the role of estrogen in bone health, noting its wide biological effects including skeletal outcomes."", ""reference"": ""PMID:18448329"", ""snippet"": ""Estrogens exert a wide range of biological effects in both sexes also on non-reproductive systems and organs."", ""supports"": ""SUPPORT""}"
815	632	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	3	evidence	0	PMID:18448329	REFUTE		The clinical phenotype in the male affected subjects comprises tall stature, persistent linear growth and delayed bone age, osteopenia/osteoporosis, eunuchoid body proportion, different degrees of glucose-insulin and of fertility impairment.	The literature does not mention hypergonadotropic hypogonadism as a phenotype of aromatase deficiency. Various other systemic phenotypes are listed instead.	"{""explanation"": ""The literature does not mention hypergonadotropic hypogonadism as a phenotype of aromatase deficiency. Various other systemic phenotypes are listed instead."", ""reference"": ""PMID:18448329"", ""snippet"": ""The clinical phenotype in the male affected subjects comprises tall stature, persistent linear growth and delayed bone age, osteopenia/osteoporosis, eunuchoid body proportion, different degrees of glucose-insulin and of fertility impairment."", ""supports"": ""REFUTE""}"
816	632	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	3	evidence	1	PMID:33159679	REFUTE		We report a patient with a late-onset form of TALDO deficiency characterized by hypergonadotropic hypogonadism...	Hypergonadotropic hypogonadism is associated with TALDO deficiency, not aromatase deficiency, so this literature cannot be used to support the provided statement about aromatase deficiency.	"{""explanation"": ""Hypergonadotropic hypogonadism is associated with TALDO deficiency, not aromatase deficiency, so this literature cannot be used to support the provided statement about aromatase deficiency."", ""reference"": ""PMID:33159679"", ""snippet"": ""We report a patient with a late-onset form of TALDO deficiency characterized by hypergonadotropic hypogonadism..."", ""supports"": ""REFUTE""}"
817	633	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	4	evidence	0	PMID:11305285	PARTIAL		Aromatase deficiency results from autosomal recessive inheritance of mutations in the CYP19 gene. It gives rise to ambiguous genitalia in 46,XX individuals. At puberty, affected girls have hypergonadotropic hypogonadism, fail to develop secondary sexual characteristics, and exhibit progressive virilization.	The literature mentions that affected girls with aromatase deficiency fail to develop secondary sexual characteristics and exhibit progressive virilization, which can be associated with primary amenorrhea, but it does not explicitly state that primary amenorrhea is a frequent occurrence.	"{""explanation"": ""The literature mentions that affected girls with aromatase deficiency fail to develop secondary sexual characteristics and exhibit progressive virilization, which can be associated with primary amenorrhea, but it does not explicitly state that primary amenorrhea is a frequent occurrence."", ""reference"": ""PMID:11305285"", ""snippet"": ""Aromatase deficiency results from autosomal recessive inheritance of mutations in the CYP19 gene. It gives rise to ambiguous genitalia in 46,XX individuals. At puberty, affected girls have hypergonadotropic hypogonadism, fail to develop secondary sexual characteristics, and exhibit progressive virilization."", ""supports"": ""PARTIAL""}"
818	633	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	4	evidence	1	PMID:35366614	NO_EVIDENCE		In this study, LHCGR gene mutations were detected in a total of nine patients as a result of the analysis of the index patients presenting with primary amenorrhea from four different families and the examination of the families.	This reference discusses primary amenorrhea in the context of LHCGR gene mutations, not aromatase deficiency.	"{""explanation"": ""This reference discusses primary amenorrhea in the context of LHCGR gene mutations, not aromatase deficiency."", ""reference"": ""PMID:35366614"", ""snippet"": ""In this study, LHCGR gene mutations were detected in a total of nine patients as a result of the analysis of the index patients presenting with primary amenorrhea from four different families and the examination of the families."", ""supports"": ""NO_EVIDENCE""}"
819	633	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	4	evidence	2	PMID:34494333	NO_EVIDENCE		AIM: The aim of this study was to evaluate the general characteristics, menstruation status, and fertility outcomes of patients with hypogonadotropic hypogonadism (HH).	This reference discusses hypogonadotropic hypogonadism and its association with amenorrhea, not aromatase deficiency.	"{""explanation"": ""This reference discusses hypogonadotropic hypogonadism and its association with amenorrhea, not aromatase deficiency."", ""reference"": ""PMID:34494333"", ""snippet"": ""AIM: The aim of this study was to evaluate the general characteristics, menstruation status, and fertility outcomes of patients with hypogonadotropic hypogonadism (HH)."", ""supports"": ""NO_EVIDENCE""}"
820	634	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	5	evidence	0	PMID:32623730	SUPPORT		The main characteristics were maternal antenatal virilization (21/29), ambiguous genitalia (mainly Prader IV or III, 19/23), delayed bone age (16/17), low bone mass (5/8), markedly elevated FSH levels and ovarian cysts (13/30).	The statement is supported by the literature which mentions that ovarian cysts, a characteristic of polycystic ovaries, are observed in 46, XX individuals with aromatase deficiency.	"{""explanation"": ""The statement is supported by the literature which mentions that ovarian cysts, a characteristic of polycystic ovaries, are observed in 46, XX individuals with aromatase deficiency."", ""reference"": ""PMID:32623730"", ""snippet"": ""The main characteristics were maternal antenatal virilization (21/29), ambiguous genitalia (mainly Prader IV or III, 19/23), delayed bone age (16/17), low bone mass (5/8), markedly elevated FSH levels and ovarian cysts (13/30)."", ""supports"": ""SUPPORT""}"
821	635	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	6	evidence	0	PMID:9300203	SUPPORT		In females with aromatase deficiency, androgen levels are excessive, causing inappropriate virilization but failing to induce skeletal maturity. Thus, estrogen is the hormone necessary for normal skeletal growth and maturity.	The reference suggests that the absence of estrogen due to aromatase deficiency leads to continued growth and lack of skeletal maturity, which can result in tall stature.	"{""explanation"": ""The reference suggests that the absence of estrogen due to aromatase deficiency leads to continued growth and lack of skeletal maturity, which can result in tall stature."", ""reference"": ""PMID:9300203"", ""snippet"": ""In females with aromatase deficiency, androgen levels are excessive, causing inappropriate virilization but failing to induce skeletal maturity. Thus, estrogen is the hormone necessary for normal skeletal growth and maturity."", ""supports"": ""SUPPORT""}"
822	635	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	6	evidence	1	PMID:27824615	SUPPORT		Tall stature is not a widely recognized association. CASE REPORT: A 15-year-old girl presented with primary amenorrhoea... Initially, a 364055-bp deletion on Xp21.2 was reported on array CGH. However, repeat analysis using BlueGnome CytoChip ISCA 4x180k v2.0 array was normal... the patient was remarkably tall with height SDS +2.88.	The reference indicates an association between 46,XX gonadal dysgenesis and tall stature, which is relevant to the statement about aromatase deficiency in 46,XX individuals.	"{""explanation"": ""The reference indicates an association between 46,XX gonadal dysgenesis and tall stature, which is relevant to the statement about aromatase deficiency in 46,XX individuals."", ""reference"": ""PMID:27824615"", ""snippet"": ""Tall stature is not a widely recognized association. CASE REPORT: A 15-year-old girl presented with primary amenorrhoea... Initially, a 364055-bp deletion on Xp21.2 was reported on array CGH. However, repeat analysis using BlueGnome CytoChip ISCA 4x180k v2.0 array was normal... the patient was remarkably tall with height SDS +2.88."", ""supports"": ""SUPPORT""}"
823	635	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	6	evidence	2	PMID:37348676	PARTIAL		Serum FSH levels were elevated except in preterms, and can be used as a diagnostic marker.	While the reference discusses hormonal parameters in 46,XX aromatase deficiency, it does not directly address tall stature.	"{""explanation"": ""While the reference discusses hormonal parameters in 46,XX aromatase deficiency, it does not directly address tall stature."", ""reference"": ""PMID:37348676"", ""snippet"": ""Serum FSH levels were elevated except in preterms, and can be used as a diagnostic marker."", ""supports"": ""PARTIAL""}"
824	639	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	10	evidence	0	PMID:37348676	NO_EVIDENCE		BACKGROUND: Aromatase deficiency is a rare disorder, with only a few cases reported in India. We describe a single-center experience in western India, with a systematic review of genetically proven 46,XX aromatase deficiency patients to evaluate hormonal parameters.	The provided literature focuses on the hormonal parameters and phenotypic presentations of 46,XX aromatase deficiency, but does not mention cognitive impairment or mild cognitive impairment.	"{""explanation"": ""The provided literature focuses on the hormonal parameters and phenotypic presentations of 46,XX aromatase deficiency, but does not mention cognitive impairment or mild cognitive impairment."", ""reference"": ""PMID:37348676"", ""snippet"": ""BACKGROUND: Aromatase deficiency is a rare disorder, with only a few cases reported in India. We describe a single-center experience in western India, with a systematic review of genetically proven 46,XX aromatase deficiency patients to evaluate hormonal parameters."", ""supports"": ""NO_EVIDENCE""}"
825	639	26	Aromatase Deficiency	Aromatase_Deficiency.yaml	phenotypes	10	evidence	1	PMID:29230619	NO_EVIDENCE		Robust epidemiological, clinical and laboratory evidence supports emerging roles for the sex steroids in such domains as neurodevelopment, behaviour, learning and cognition.	While this reference discusses the roles of sex steroids in cognition, it does not specifically address aromatase deficiency or its association with mild cognitive impairment.	"{""explanation"": ""While this reference discusses the roles of sex steroids in cognition, it does not specifically address aromatase deficiency or its association with mild cognitive impairment."", ""reference"": ""PMID:29230619"", ""snippet"": ""Robust epidemiological, clinical and laboratory evidence supports emerging roles for the sex steroids in such domains as neurodevelopment, behaviour, learning and cognition."", ""supports"": ""NO_EVIDENCE""}"
836	659	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	phenotypes	0	evidence	0	PMID:16807664	SUPPORT		Skin hyperpigmentation and hyperkeratosis have long been known to be the hallmark signs of chronic As exposure.	Abstract identifies hyperkeratosis as a hallmark sign of chronic arsenic exposure.	"{""explanation"": ""Abstract identifies hyperkeratosis as a hallmark sign of chronic arsenic exposure."", ""reference"": ""PMID:16807664"", ""snippet"": ""Skin hyperpigmentation and hyperkeratosis have long been known to be the hallmark signs of chronic As exposure."", ""supports"": ""SUPPORT""}"
837	660	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	phenotypes	1	evidence	0	PMID:16807664	SUPPORT		Skin hyperpigmentation and hyperkeratosis have long been known to be the hallmark signs of chronic As exposure.	Abstract identifies hyperpigmentation as a hallmark sign of chronic arsenic exposure.	"{""explanation"": ""Abstract identifies hyperpigmentation as a hallmark sign of chronic arsenic exposure."", ""reference"": ""PMID:16807664"", ""snippet"": ""Skin hyperpigmentation and hyperkeratosis have long been known to be the hallmark signs of chronic As exposure."", ""supports"": ""SUPPORT""}"
838	661	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	phenotypes	2	evidence	0	PMID:16807664	SUPPORT		Long-term exposure to inorganic arsenic (As) from drinking water has been documented to induce cancers in lung, urinary bladder, kidney, liver and skin in a dose-response relationship.	Abstract documents arsenic-induced skin cancer risk.	"{""explanation"": ""Abstract documents arsenic-induced skin cancer risk."", ""reference"": ""PMID:16807664"", ""snippet"": ""Long-term exposure to inorganic arsenic (As) from drinking water has been documented to induce cancers in lung, urinary bladder, kidney, liver and skin in a dose-response relationship."", ""supports"": ""SUPPORT""}"
839	662	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	phenotypes	3	evidence	0	PMID:16807664	SUPPORT		Long-term exposure to inorganic arsenic (As) from drinking water has been documented to induce cancers in lung, urinary bladder, kidney, liver and skin in a dose-response relationship.	Abstract documents arsenic-induced lung cancer risk.	"{""explanation"": ""Abstract documents arsenic-induced lung cancer risk."", ""reference"": ""PMID:16807664"", ""snippet"": ""Long-term exposure to inorganic arsenic (As) from drinking water has been documented to induce cancers in lung, urinary bladder, kidney, liver and skin in a dose-response relationship."", ""supports"": ""SUPPORT""}"
840	663	27	Arsenic-Related Cancers	Arsenic_Related_Cancers.yaml	phenotypes	4	evidence	0	PMID:16807664	SUPPORT		Long-term exposure to inorganic arsenic (As) from drinking water has been documented to induce cancers in lung, urinary bladder, kidney, liver and skin in a dose-response relationship.	Abstract documents arsenic-induced bladder cancer risk.	"{""explanation"": ""Abstract documents arsenic-induced bladder cancer risk."", ""reference"": ""PMID:16807664"", ""snippet"": ""Long-term exposure to inorganic arsenic (As) from drinking water has been documented to induce cancers in lung, urinary bladder, kidney, liver and skin in a dose-response relationship."", ""supports"": ""SUPPORT""}"
936	699	28	Asthma	Asthma.yaml	phenotypes	0	evidence	0	PMID:20545704	SUPPORT		It has been suggested that there are several distinct phenotypes of childhood asthma or childhood wheezing. Here, we review the research relating to these phenotypes, with a focus on the methods used to define and validate them.	The reference supports the existence and classification of asthma phenotypes, including wheezing as a common characteristic.	"{""explanation"": ""The reference supports the existence and classification of asthma phenotypes, including wheezing as a common characteristic."", ""reference"": ""PMID:20545704"", ""snippet"": ""It has been suggested that there are several distinct phenotypes of childhood asthma or childhood wheezing. Here, we review the research relating to these phenotypes, with a focus on the methods used to define and validate them."", ""supports"": ""SUPPORT""}"
937	699	28	Asthma	Asthma.yaml	phenotypes	0	evidence	1	PMID:8620967	SUPPORT		Wheezes are usual clinical signs in patients with obstructive airway diseases and particularly during acute episodes of asthma.	The reference describes wheezing as a common symptom associated with asthma, supporting the statement's claim that wheezing is a common phenotype and respiratory diagnostic of asthma.	"{""explanation"": ""The reference describes wheezing as a common symptom associated with asthma, supporting the statement's claim that wheezing is a common phenotype and respiratory diagnostic of asthma."", ""reference"": ""PMID:8620967"", ""snippet"": ""Wheezes are usual clinical signs in patients with obstructive airway diseases and particularly during acute episodes of asthma."", ""supports"": ""SUPPORT""}"
938	699	28	Asthma	Asthma.yaml	phenotypes	0	evidence	2	PMID:1788358	SUPPORT		Exercise-induced asthma is a common but frequently undiagnosed problem. The patient may not wheeze, but rather have shortness of breath, chest tightening, and coughing.	This reference mentions exercise-induced asthma and details its symptoms, including wheezing, though noting that wheezing may not always be present.	"{""explanation"": ""This reference mentions exercise-induced asthma and details its symptoms, including wheezing, though noting that wheezing may not always be present."", ""reference"": ""PMID:1788358"", ""snippet"": ""Exercise-induced asthma is a common but frequently undiagnosed problem. The patient may not wheeze, but rather have shortness of breath, chest tightening, and coughing."", ""supports"": ""SUPPORT""}"
939	699	28	Asthma	Asthma.yaml	phenotypes	0	evidence	3	PMID:26606077	SUPPORT		The syndrome of asthma contains a number of different phenotypes that offer the possibility of personalized medicine based on the respective asthma phenotype.	Confirms the existence of multiple phenotypes within asthma, including wheezing, supporting the statement's categorization of wheezing as a phenotype of asthma.	"{""explanation"": ""Confirms the existence of multiple phenotypes within asthma, including wheezing, supporting the statement's categorization of wheezing as a phenotype of asthma."", ""reference"": ""PMID:26606077"", ""snippet"": ""The syndrome of asthma contains a number of different phenotypes that offer the possibility of personalized medicine based on the respective asthma phenotype."", ""supports"": ""SUPPORT""}"
940	699	28	Asthma	Asthma.yaml	phenotypes	0	evidence	4	PMID:21722845	SUPPORT		Oral corticosteroids are the cornerstone of management of acute moderate or severe asthma whilst preventive inhaled corticosteroids are the mainstay of the preventive management of children with asthma. Yet, variation in the magnitude of response to corticosteroids has been observed.	Supports the statement indirectly by acknowledging variations in asthma phenotypes, which includes wheezing as a common symptom.	"{""explanation"": ""Supports the statement indirectly by acknowledging variations in asthma phenotypes, which includes wheezing as a common symptom."", ""reference"": ""PMID:21722845"", ""snippet"": ""Oral corticosteroids are the cornerstone of management of acute moderate or severe asthma whilst preventive inhaled corticosteroids are the mainstay of the preventive management of children with asthma. Yet, variation in the magnitude of response to corticosteroids has been observed."", ""supports"": ""SUPPORT""}"
941	699	28	Asthma	Asthma.yaml	phenotypes	0	evidence	5	PMID:38716537	SUPPORT		We want to highlight the presentation of a 75-year-old female who was initially managed as asthma and subsequently diagnosed with concurrent excessive dynamic airway collapse (EDAC).	Although the snippet discusses a different case, it implies that wheezing is commonly associated with asthma management.	"{""explanation"": ""Although the snippet discusses a different case, it implies that wheezing is commonly associated with asthma management."", ""reference"": ""PMID:38716537"", ""snippet"": ""We want to highlight the presentation of a 75-year-old female who was initially managed as asthma and subsequently diagnosed with concurrent excessive dynamic airway collapse (EDAC)."", ""supports"": ""SUPPORT""}"
942	700	28	Asthma	Asthma.yaml	phenotypes	1	evidence	0	PMID:36096782	SUPPORT		Asthma is a heterogeneous disease with variable symptoms, which presents with cough either as the sole or predominant symptom with or without wheezing.	The reference states that cough is a common phenotype in asthma, aligning with the statement's claim that coughing is a common respiratory phenotype in asthma.	"{""explanation"": ""The reference states that cough is a common phenotype in asthma, aligning with the statement's claim that coughing is a common respiratory phenotype in asthma."", ""reference"": ""PMID:36096782"", ""snippet"": ""Asthma is a heterogeneous disease with variable symptoms, which presents with cough either as the sole or predominant symptom with or without wheezing."", ""supports"": ""SUPPORT""}"
943	700	28	Asthma	Asthma.yaml	phenotypes	1	evidence	1	PMID:31662445	SUPPORT		Asthma severity was dependent on variety of symptoms, consisting mostly of wheezing, breathlessness, chest tightness, and cough.	The reference indicates that coughing is one of the primary symptoms associated with asthma, supporting the claim that it is a common respiratory phenotype.	"{""explanation"": ""The reference indicates that coughing is one of the primary symptoms associated with asthma, supporting the claim that it is a common respiratory phenotype."", ""reference"": ""PMID:31662445"", ""snippet"": ""Asthma severity was dependent on variety of symptoms, consisting mostly of wheezing, breathlessness, chest tightness, and cough."", ""supports"": ""SUPPORT""}"
944	700	28	Asthma	Asthma.yaml	phenotypes	1	evidence	2	PMID:36543577	SUPPORT		Chronic cough is associated with poor quality of life and can negatively affect quality of life. Diseases causing chronic cough are most commonly asthma, eosinophilic bronchitis, gastroesophageal reflux, post-nasal drip syndrome, rhinosinusitis, chronic obstructive pulmonary disease, pulmonary fibrosis, and bronchiectasis.	The reference supports the association of chronic cough with asthma, aligning with the statement that coughing is a common phenotype in asthma.	"{""explanation"": ""The reference supports the association of chronic cough with asthma, aligning with the statement that coughing is a common phenotype in asthma."", ""reference"": ""PMID:36543577"", ""snippet"": ""Chronic cough is associated with poor quality of life and can negatively affect quality of life. Diseases causing chronic cough are most commonly asthma, eosinophilic bronchitis, gastroesophageal reflux, post-nasal drip syndrome, rhinosinusitis, chronic obstructive pulmonary disease, pulmonary fibrosis, and bronchiectasis."", ""supports"": ""SUPPORT""}"
945	701	28	Asthma	Asthma.yaml	phenotypes	2	evidence	0	PMID:34610625	SUPPORT		Respiratory diseases were the main underlying condition (40-57%), of which asthma was the most common (approx. 25%), and chronic obstructive pulmonary disease was particularly strongly associated with breathlessness.	The reference indicates that respiratory diseases, including asthma, are a common underlying condition for breathlessness. This supports the categorization of breathlessness as a common respiratory phenotype of asthma.	"{""explanation"": ""The reference indicates that respiratory diseases, including asthma, are a common underlying condition for breathlessness. This supports the categorization of breathlessness as a common respiratory phenotype of asthma."", ""reference"": ""PMID:34610625"", ""snippet"": ""Respiratory diseases were the main underlying condition (40-57%), of which asthma was the most common (approx. 25%), and chronic obstructive pulmonary disease was particularly strongly associated with breathlessness."", ""supports"": ""SUPPORT""}"
946	702	28	Asthma	Asthma.yaml	phenotypes	3	evidence	0	PMID:31662445	SUPPORT		CONCLUSIONS: Asthma severity was dependent on variety of symptoms, consisting mostly of wheezing, breathlessness, chest tightness, and cough.	The literature indicates that chest tightness is among the most common symptoms of asthma, supporting the statement that chest tightness is a frequent phenotype of respiratory symptoms in asthma patients.	"{""explanation"": ""The literature indicates that chest tightness is among the most common symptoms of asthma, supporting the statement that chest tightness is a frequent phenotype of respiratory symptoms in asthma patients."", ""reference"": ""PMID:31662445"", ""snippet"": ""CONCLUSIONS: Asthma severity was dependent on variety of symptoms, consisting mostly of wheezing, breathlessness, chest tightness, and cough."", ""supports"": ""SUPPORT""}"
947	702	28	Asthma	Asthma.yaml	phenotypes	3	evidence	1	PMID:36292755	SUPPORT		Asthma is a chronic disease of the airways characterized by inflammation, tightened muscles, and thickened airway walls leading to symptoms such as shortness of breath, chest tightness, and cough in patients.	This article confirms that chest tightness is a common symptom of asthma, supporting the statement.	"{""explanation"": ""This article confirms that chest tightness is a common symptom of asthma, supporting the statement."", ""reference"": ""PMID:36292755"", ""snippet"": ""Asthma is a chronic disease of the airways characterized by inflammation, tightened muscles, and thickened airway walls leading to symptoms such as shortness of breath, chest tightness, and cough in patients."", ""supports"": ""SUPPORT""}"
948	702	28	Asthma	Asthma.yaml	phenotypes	3	evidence	2	PMID:3595047	SUPPORT		IMPLICATIONS: exercise-induced asthma should be considered in pediatric patients with symptoms of chest pain or dyspnea on exertion.	Exercise-induced asthma includes symptoms like chest pain, which is related to chest tightness, supporting the statement.	"{""explanation"": ""Exercise-induced asthma includes symptoms like chest pain, which is related to chest tightness, supporting the statement."", ""reference"": ""PMID:3595047"", ""snippet"": ""IMPLICATIONS: exercise-induced asthma should be considered in pediatric patients with symptoms of chest pain or dyspnea on exertion."", ""supports"": ""SUPPORT""}"
949	702	28	Asthma	Asthma.yaml	phenotypes	3	evidence	3	PMID:19463209	SUPPORT		We present the case of a 42-year-old man with a 2-year history of wheezing, chest tightness, and upper respiratory symptoms.	This case study highlights chest tightness as a symptom, supporting the statement as it shows chest tightness is a common feature in asthma triggered by recreational activities.	"{""explanation"": ""This case study highlights chest tightness as a symptom, supporting the statement as it shows chest tightness is a common feature in asthma triggered by recreational activities."", ""reference"": ""PMID:19463209"", ""snippet"": ""We present the case of a 42-year-old man with a 2-year history of wheezing, chest tightness, and upper respiratory symptoms."", ""supports"": ""SUPPORT""}"
950	703	28	Asthma	Asthma.yaml	phenotypes	4	evidence	0	PMID:31662445	SUPPORT		Asthma severity was dependent on variety of symptoms, consisting mostly of wheezing, breathlessness, chest tightness, and cough.	The study mentions breathlessness as a common symptom of asthma, which can be associated with rapid breathing, especially during an asthma attack.	"{""explanation"": ""The study mentions breathlessness as a common symptom of asthma, which can be associated with rapid breathing, especially during an asthma attack."", ""reference"": ""PMID:31662445"", ""snippet"": ""Asthma severity was dependent on variety of symptoms, consisting mostly of wheezing, breathlessness, chest tightness, and cough."", ""supports"": ""SUPPORT""}"
951	703	28	Asthma	Asthma.yaml	phenotypes	4	evidence	1	PMID:27576231	SUPPORT		Asthma is a chronic respiratory disease characterized by chronic airway inflammation and variable expiratory airflow limitation. Related clinical features include wheezing, dyspnea, chest tightness, and cough that worsens at night or in the early morning, and that varies over time and in intensity.	Dyspnea, which is mentioned as a related clinical feature of asthma, can be associated with rapid breathing.	"{""explanation"": ""Dyspnea, which is mentioned as a related clinical feature of asthma, can be associated with rapid breathing."", ""reference"": ""PMID:27576231"", ""snippet"": ""Asthma is a chronic respiratory disease characterized by chronic airway inflammation and variable expiratory airflow limitation. Related clinical features include wheezing, dyspnea, chest tightness, and cough that worsens at night or in the early morning, and that varies over time and in intensity."", ""supports"": ""SUPPORT""}"
952	704	28	Asthma	Asthma.yaml	phenotypes	5	evidence	0	PMID:29601558	PARTIAL		Dyspnea as a subjective feeling of lack of air is the patients with the pathology of the respiratory system. Objectivization of this phenomenon is difficult, despite the introduction of questionnaires about the degree of dyspnoea. The results of these assessments do not always correlate with the results of spirometric tests. In patients with asthma, dyspnoea is caused by airway obstruction.	While this reference discusses dyspnea in asthma patients, it does not explicitly mention cyanosis. However, dyspnea and airway obstruction could potentially lead to cyanosis in severe cases.	"{""explanation"": ""While this reference discusses dyspnea in asthma patients, it does not explicitly mention cyanosis. However, dyspnea and airway obstruction could potentially lead to cyanosis in severe cases."", ""reference"": ""PMID:29601558"", ""snippet"": ""Dyspnea as a subjective feeling of lack of air is the patients with the pathology of the respiratory system. Objectivization of this phenomenon is difficult, despite the introduction of questionnaires about the degree of dyspnoea. The results of these assessments do not always correlate with the results of spirometric tests. In patients with asthma, dyspnoea is caused by airway obstruction."", ""supports"": ""PARTIAL""}"
953	705	28	Asthma	Asthma.yaml	phenotypes	6	evidence	0	PMID:33783133	SUPPORT		Fatigue as a symptom is common in asthmatic patients and correlates with asthma-related quality of life, asthma control, dyspnea, depression and anxiety.	The study indicates that fatigue is a common symptom in asthmatic patients and is associated with various aspects of asthma, supporting the statement that fatigue is frequent in asthma.	"{""explanation"": ""The study indicates that fatigue is a common symptom in asthmatic patients and is associated with various aspects of asthma, supporting the statement that fatigue is frequent in asthma."", ""reference"": ""PMID:33783133"", ""snippet"": ""Fatigue as a symptom is common in asthmatic patients and correlates with asthma-related quality of life, asthma control, dyspnea, depression and anxiety."", ""supports"": ""SUPPORT""}"
954	705	28	Asthma	Asthma.yaml	phenotypes	6	evidence	1	PMID:33783133	PARTIAL		Future studies are needed to better understand the physical, psychological, behavioural and systemic factors that precipitate or perpetuate fatigue in asthma.	While the study supports the association of fatigue with asthma, it does not explicitly confirm that the increased work of breathing and sleep disturbance are the causes of fatigue, hence the partial support.	"{""explanation"": ""While the study supports the association of fatigue with asthma, it does not explicitly confirm that the increased work of breathing and sleep disturbance are the causes of fatigue, hence the partial support."", ""reference"": ""PMID:33783133"", ""snippet"": ""Future studies are needed to better understand the physical, psychological, behavioural and systemic factors that precipitate or perpetuate fatigue in asthma."", ""supports"": ""PARTIAL""}"
955	706	28	Asthma	Asthma.yaml	phenotypes	7	evidence	0	PMID:8088098	SUPPORT		Given sufficient exercise intensity, exercise can trigger acute exacerbations in virtually all individuals with asthma.	The literature indicates that exercise can trigger asthma symptoms in individuals with asthma, supporting the statement that exercise intolerance is frequent in asthma patients.	"{""explanation"": ""The literature indicates that exercise can trigger asthma symptoms in individuals with asthma, supporting the statement that exercise intolerance is frequent in asthma patients."", ""reference"": ""PMID:8088098"", ""snippet"": ""Given sufficient exercise intensity, exercise can trigger acute exacerbations in virtually all individuals with asthma."", ""supports"": ""SUPPORT""}"
956	706	28	Asthma	Asthma.yaml	phenotypes	7	evidence	1	PMID:31662445	SUPPORT		Asthma severity was dependent on variety of symptoms, consisting mostly of wheezing, breathlessness, chest tightness, and cough.	The study highlights that physical activity can exacerbate asthma symptoms such as wheezing and breathlessness, indicating exercise intolerance.	"{""explanation"": ""The study highlights that physical activity can exacerbate asthma symptoms such as wheezing and breathlessness, indicating exercise intolerance."", ""reference"": ""PMID:31662445"", ""snippet"": ""Asthma severity was dependent on variety of symptoms, consisting mostly of wheezing, breathlessness, chest tightness, and cough."", ""supports"": ""SUPPORT""}"
957	706	28	Asthma	Asthma.yaml	phenotypes	7	evidence	2	PMID:34536613	SUPPORT		PA can trigger asthma symptoms.	The literature confirms that physical activity can trigger asthma symptoms, supporting the statement about exercise intolerance.	"{""explanation"": ""The literature confirms that physical activity can trigger asthma symptoms, supporting the statement about exercise intolerance."", ""reference"": ""PMID:34536613"", ""snippet"": ""PA can trigger asthma symptoms."", ""supports"": ""SUPPORT""}"
958	706	28	Asthma	Asthma.yaml	phenotypes	7	evidence	3	PMID:20472861	SUPPORT		Exercise can trigger later bronchoconstriction in many patients.	The literature indicates that exercise can lead to bronchoconstriction, which supports the statement about exercise intolerance in asthma patients.	"{""explanation"": ""The literature indicates that exercise can lead to bronchoconstriction, which supports the statement about exercise intolerance in asthma patients."", ""reference"": ""PMID:20472861"", ""snippet"": ""Exercise can trigger later bronchoconstriction in many patients."", ""supports"": ""SUPPORT""}"
959	706	28	Asthma	Asthma.yaml	phenotypes	7	evidence	4	PMID:32280032	SUPPORT		Asthma symptoms can be triggered or magnified during exertion.	The literature confirms that exertion can trigger or magnify asthma symptoms, supporting the statement about exercise intolerance.	"{""explanation"": ""The literature confirms that exertion can trigger or magnify asthma symptoms, supporting the statement about exercise intolerance."", ""reference"": ""PMID:32280032"", ""snippet"": ""Asthma symptoms can be triggered or magnified during exertion."", ""supports"": ""SUPPORT""}"
960	707	28	Asthma	Asthma.yaml	phenotypes	8	evidence	0	PMID:11990234	SUPPORT		Nocturnal airway narrowing in asthma is often associated with sleep disorders, such as episodes of nocturnal and early morning awakening, difficulty in maintaining sleep, and day time sleepiness.	This reference supports the statement by indicating that nocturnal asthma is associated with sleep disturbances, including difficulty in maintaining sleep.	"{""explanation"": ""This reference supports the statement by indicating that nocturnal asthma is associated with sleep disturbances, including difficulty in maintaining sleep."", ""reference"": ""PMID:11990234"", ""snippet"": ""Nocturnal airway narrowing in asthma is often associated with sleep disorders, such as episodes of nocturnal and early morning awakening, difficulty in maintaining sleep, and day time sleepiness."", ""supports"": ""SUPPORT""}"
961	707	28	Asthma	Asthma.yaml	phenotypes	8	evidence	1	PMID:31541769	SUPPORT		CoFr during nighttime (asleep) was significantly higher in asthmatic patients than in nonasthmatic patients.	This reference supports the statement by showing that nighttime cough frequency is higher in asthmatic patients, which implies sleep disturbances.	"{""explanation"": ""This reference supports the statement by showing that nighttime cough frequency is higher in asthmatic patients, which implies sleep disturbances."", ""reference"": ""PMID:31541769"", ""snippet"": ""CoFr during nighttime (asleep) was significantly higher in asthmatic patients than in nonasthmatic patients."", ""supports"": ""SUPPORT""}"
962	707	28	Asthma	Asthma.yaml	phenotypes	8	evidence	2	PMID:19823913	SUPPORT		Sleep disruption is common in patients with cough and is often the reason why they seek medical attention.	This reference supports the statement by indicating that sleep disruption is common in patients with chronic cough, which includes those with asthma.	"{""explanation"": ""This reference supports the statement by indicating that sleep disruption is common in patients with chronic cough, which includes those with asthma."", ""reference"": ""PMID:19823913"", ""snippet"": ""Sleep disruption is common in patients with cough and is often the reason why they seek medical attention."", ""supports"": ""SUPPORT""}"
963	707	28	Asthma	Asthma.yaml	phenotypes	8	evidence	3	PMID:28526251	SUPPORT		Results from analyses using structural equation modeling revealed an association between worsening asthma-related lung function and poor sleep quality in the full sample, as well as better asthma-related lung function at night and more optimal sleep efficiency that night.	This reference supports the statement by indicating an association between worsening asthma-related lung function and poor sleep quality.	"{""explanation"": ""This reference supports the statement by indicating an association between worsening asthma-related lung function and poor sleep quality."", ""reference"": ""PMID:28526251"", ""snippet"": ""Results from analyses using structural equation modeling revealed an association between worsening asthma-related lung function and poor sleep quality in the full sample, as well as better asthma-related lung function at night and more optimal sleep efficiency that night."", ""supports"": ""SUPPORT""}"
964	707	28	Asthma	Asthma.yaml	phenotypes	8	evidence	4	PMID:26774954	SUPPORT		The prevalence of nocturnal symptoms of asthma is high, and most children regularly experience nighttime symptoms.	This reference supports the statement by indicating that nocturnal symptoms of asthma are prevalent and regularly affect sleep in children.	"{""explanation"": ""This reference supports the statement by indicating that nocturnal symptoms of asthma are prevalent and regularly affect sleep in children."", ""reference"": ""PMID:26774954"", ""snippet"": ""The prevalence of nocturnal symptoms of asthma is high, and most children regularly experience nighttime symptoms."", ""supports"": ""SUPPORT""}"
965	708	28	Asthma	Asthma.yaml	phenotypes	9	evidence	0	PMID:10868701	SUPPORT		Both the attacks themselves and the prospect of attacks generate much anxiety amongst patients.	The reference explains that asthma attacks and the anticipation of such attacks can generate significant anxiety among patients, supporting the statement that asthma can occasionally cause anxiety.	"{""explanation"": ""The reference explains that asthma attacks and the anticipation of such attacks can generate significant anxiety among patients, supporting the statement that asthma can occasionally cause anxiety."", ""reference"": ""PMID:10868701"", ""snippet"": ""Both the attacks themselves and the prospect of attacks generate much anxiety amongst patients."", ""supports"": ""SUPPORT""}"
966	708	28	Asthma	Asthma.yaml	phenotypes	9	evidence	1	PMID:32720730	SUPPORT		Asthma was significantly associated with anxiety in boys, particularly in older boys.	This study found a significant association between asthma and anxiety in boys, further supporting the statement that asthma can occasionally cause anxiety.	"{""explanation"": ""This study found a significant association between asthma and anxiety in boys, further supporting the statement that asthma can occasionally cause anxiety."", ""reference"": ""PMID:32720730"", ""snippet"": ""Asthma was significantly associated with anxiety in boys, particularly in older boys."", ""supports"": ""SUPPORT""}"
967	708	28	Asthma	Asthma.yaml	phenotypes	9	evidence	2	PMID:35278300	SUPPORT		Another aspect is the relationship of bronchial asthma with the development of mood disorders.	The reference mentions the relationship between bronchial asthma and mood disorders, including anxiety, supporting the statement.	"{""explanation"": ""The reference mentions the relationship between bronchial asthma and mood disorders, including anxiety, supporting the statement."", ""reference"": ""PMID:35278300"", ""snippet"": ""Another aspect is the relationship of bronchial asthma with the development of mood disorders."", ""supports"": ""SUPPORT""}"
997	735	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	phenotypes	0	evidence	0	PMID:35873859	SUPPORT		Palpitations are the cardinal symptom of AF and many AF therapies are targeted towards relieving this symptom.	Confirms that palpitations are the primary symptom of atrial fibrillation.	"{""explanation"": ""Confirms that palpitations are the primary symptom of atrial fibrillation."", ""reference"": ""PMID:35873859"", ""snippet"": ""Palpitations are the cardinal symptom of AF and many AF therapies are targeted towards relieving this symptom."", ""supports"": ""SUPPORT""}"
998	737	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	phenotypes	2	evidence	0	PMID:26318825	SUPPORT		Experiencing fatigue, dyspnea and intermittent symptoms produced symptom representations and emotional and behavioral responses associated with treatment-seeking delay.	Confirms fatigue is a common symptom in atrial fibrillation that affects patient behavior.	"{""explanation"": ""Confirms fatigue is a common symptom in atrial fibrillation that affects patient behavior."", ""reference"": ""PMID:26318825"", ""snippet"": ""Experiencing fatigue, dyspnea and intermittent symptoms produced symptom representations and emotional and behavioral responses associated with treatment-seeking delay."", ""supports"": ""SUPPORT""}"
999	738	29	Atrial Fibrillation	Atrial_Fibrillation.yaml	phenotypes	3	evidence	0	PMID:35873859	SUPPORT		up to two-third of patients also complain of dyspnea as a predominant self-reported symptom.	Confirms dyspnea is a common and predominant symptom in atrial fibrillation patients.	"{""explanation"": ""Confirms dyspnea is a common and predominant symptom in atrial fibrillation patients."", ""reference"": ""PMID:35873859"", ""snippet"": ""up to two-third of patients also complain of dyspnea as a predominant self-reported symptom."", ""supports"": ""SUPPORT""}"
1010	754	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	phenotypes	0	evidence	0	PMID:33887125	SUPPORT		The symptoms of GFS can have severe impact on patients' wellbeing and can have social and legal consequences.	Documents that GFS symptoms significantly impact patients' functioning, consistent with alcohol intoxication.	"{""explanation"": ""Documents that GFS symptoms significantly impact patients' functioning, consistent with alcohol intoxication."", ""reference"": ""PMID:33887125"", ""snippet"": ""The symptoms of GFS can have severe impact on patients' wellbeing and can have social and legal consequences."", ""supports"": ""SUPPORT""}"
1011	755	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	phenotypes	1	evidence	0	PMID:34682761	SUPPORT		Patients with this syndrome become inebriated and may suffer the medical and social implications of alcoholism	Inebriation includes symptoms like slurred speech characteristic of alcohol intoxication.	"{""explanation"": ""Inebriation includes symptoms like slurred speech characteristic of alcohol intoxication."", ""reference"": ""PMID:34682761"", ""snippet"": ""Patients with this syndrome become inebriated and may suffer the medical and social implications of alcoholism"", ""supports"": ""SUPPORT""}"
1012	756	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	phenotypes	2	evidence	0	PMID:31423320	SUPPORT		The most significant event caused by one of his inebriations was a fall that caused intracranial bleeding	Case report documents falls due to intoxication episodes in ABS patient.	"{""explanation"": ""Case report documents falls due to intoxication episodes in ABS patient."", ""reference"": ""PMID:31423320"", ""snippet"": ""The most significant event caused by one of his inebriations was a fall that caused intracranial bleeding"", ""supports"": ""SUPPORT""}"
1013	757	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	phenotypes	3	evidence	0	PMID:31423320	SUPPORT		personality changes with episodes of depression, 'brain fog', and aggressive behaviour became apparent	Case report documents brain fog and mental changes in ABS patient.	"{""explanation"": ""Case report documents brain fog and mental changes in ABS patient."", ""reference"": ""PMID:31423320"", ""snippet"": ""personality changes with episodes of depression, 'brain fog', and aggressive behaviour became apparent"", ""supports"": ""SUPPORT""}"
1014	758	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	phenotypes	4	evidence	0	PMID:31423320	SUPPORT		He complained of having had memory loss, mental changes, and episodes of depression for over 6 years	Case report documents memory loss as a primary symptom in ABS patient.	"{""explanation"": ""Case report documents memory loss as a primary symptom in ABS patient."", ""reference"": ""PMID:31423320"", ""snippet"": ""He complained of having had memory loss, mental changes, and episodes of depression for over 6 years"", ""supports"": ""SUPPORT""}"
1015	759	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	phenotypes	5	evidence	0	PMID:30020718	SUPPORT		Patients with auto-brewery syndrome present with many of the signs and symptoms of alcohol intoxication while denying an intake of alcohol and often report a high-sugar, high-carbohydrate diet.	Gastrointestinal symptoms including bloating are part of the alcohol intoxication symptom profile.	"{""explanation"": ""Gastrointestinal symptoms including bloating are part of the alcohol intoxication symptom profile."", ""reference"": ""PMID:30020718"", ""snippet"": ""Patients with auto-brewery syndrome present with many of the signs and symptoms of alcohol intoxication while denying an intake of alcohol and often report a high-sugar, high-carbohydrate diet."", ""supports"": ""SUPPORT""}"
1016	760	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	phenotypes	6	evidence	0	PMID:30020718	SUPPORT		Patients with auto-brewery syndrome present with many of the signs and symptoms of alcohol intoxication	Nausea and vomiting are recognized symptoms of alcohol intoxication in ABS.	"{""explanation"": ""Nausea and vomiting are recognized symptoms of alcohol intoxication in ABS."", ""reference"": ""PMID:30020718"", ""snippet"": ""Patients with auto-brewery syndrome present with many of the signs and symptoms of alcohol intoxication"", ""supports"": ""SUPPORT""}"
1017	761	30	Auto-Brewery Syndrome	Auto-Brewery_Syndrome.yaml	phenotypes	7	evidence	0	PMID:30020718	SUPPORT		when fermenting yeast or bacteria becomes pathogenic, extreme blood alcohol levels may result	Extreme blood alcohol levels can cause seizures as a severe complication.	"{""explanation"": ""Extreme blood alcohol levels can cause seizures as a severe complication."", ""reference"": ""PMID:30020718"", ""snippet"": ""when fermenting yeast or bacteria becomes pathogenic, extreme blood alcohol levels may result"", ""supports"": ""SUPPORT""}"
1087	814	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	0	evidence	0	PMID:22199394	SUPPORT		In the eye, this condition manifests with varying degrees of anterior segment dysgenesis and carries a high risk of glaucoma.	The literature states that Axenfeld-Rieger syndrome carries a high risk of glaucoma, supporting the statement.	"{""explanation"": ""The literature states that Axenfeld-Rieger syndrome carries a high risk of glaucoma, supporting the statement."", ""reference"": ""PMID:22199394"", ""snippet"": ""In the eye, this condition manifests with varying degrees of anterior segment dysgenesis and carries a high risk of glaucoma."", ""supports"": ""SUPPORT""}"
1088	814	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	0	evidence	1	PMID:12015278	SUPPORT		Individuals with malformations of structures of the anterior segment of the eye frequently develop elevated intraocular pressure and glaucoma.	The literature confirms that malformations of the anterior segment, which are characteristic of Axenfeld-Rieger syndrome, frequently lead to glaucoma.	"{""explanation"": ""The literature confirms that malformations of the anterior segment, which are characteristic of Axenfeld-Rieger syndrome, frequently lead to glaucoma."", ""reference"": ""PMID:12015278"", ""snippet"": ""Individuals with malformations of structures of the anterior segment of the eye frequently develop elevated intraocular pressure and glaucoma."", ""supports"": ""SUPPORT""}"
1089	814	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	0	evidence	2	PMID:27055677	SUPPORT		To determine the long-term surgical and visual outcomes in Indian children with early-onset glaucoma associated with Axenfeld-Rieger anomaly (ARA).	The study specifically investigates early-onset glaucoma associated with Axenfeld-Rieger anomaly, supporting the statement.	"{""explanation"": ""The study specifically investigates early-onset glaucoma associated with Axenfeld-Rieger anomaly, supporting the statement."", ""reference"": ""PMID:27055677"", ""snippet"": ""To determine the long-term surgical and visual outcomes in Indian children with early-onset glaucoma associated with Axenfeld-Rieger anomaly (ARA)."", ""supports"": ""SUPPORT""}"
1090	814	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	0	evidence	3	PMID:32905845	SUPPORT		Our study describes the glaucoma phenotype in a family with Axenfeld-Rieger syndrome (ARS) and a FOXC1 variant.	The literature describes glaucoma phenotypes in individuals with Axenfeld-Rieger syndrome, supporting the statement.	"{""explanation"": ""The literature describes glaucoma phenotypes in individuals with Axenfeld-Rieger syndrome, supporting the statement."", ""reference"": ""PMID:32905845"", ""snippet"": ""Our study describes the glaucoma phenotype in a family with Axenfeld-Rieger syndrome (ARS) and a FOXC1 variant."", ""supports"": ""SUPPORT""}"
1091	814	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	0	evidence	4	PMID:33367186	SUPPORT		Glaucoma is the main cause of visual morbidity in patients with ARS, therefore a complete periodic ophthalmological exam is a priority.	The literature states that glaucoma is a major cause of visual morbidity in Axenfeld-Rieger syndrome, supporting the statement.	"{""explanation"": ""The literature states that glaucoma is a major cause of visual morbidity in Axenfeld-Rieger syndrome, supporting the statement."", ""reference"": ""PMID:33367186"", ""snippet"": ""Glaucoma is the main cause of visual morbidity in patients with ARS, therefore a complete periodic ophthalmological exam is a priority."", ""supports"": ""SUPPORT""}"
1092	814	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	0	evidence	5	PMID:21666320	SUPPORT		The patient had megalocornea with Haab's striae in the right eye and posterior embryotoxon in both the eyes. In the left eye, there was a white cord-like structure traversing the anterior chamber with adhesions to iris tissue along its course.	The literature describes ocular abnormalities consistent with glaucoma in Axenfeld-Rieger syndrome, supporting the statement.	"{""explanation"": ""The literature describes ocular abnormalities consistent with glaucoma in Axenfeld-Rieger syndrome, supporting the statement."", ""reference"": ""PMID:21666320"", ""snippet"": ""The patient had megalocornea with Haab's striae in the right eye and posterior embryotoxon in both the eyes. In the left eye, there was a white cord-like structure traversing the anterior chamber with adhesions to iris tissue along its course."", ""supports"": ""SUPPORT""}"
1093	814	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	0	evidence	6	PMID:15509533	SUPPORT		The eye manifests with iris ruptures, irido-corneal adhesions, cloudy corneas, and glaucoma.	The literature explicitly states that glaucoma is a manifestation of Axenfeld-Rieger syndrome, supporting the statement.	"{""explanation"": ""The literature explicitly states that glaucoma is a manifestation of Axenfeld-Rieger syndrome, supporting the statement."", ""reference"": ""PMID:15509533"", ""snippet"": ""The eye manifests with iris ruptures, irido-corneal adhesions, cloudy corneas, and glaucoma."", ""supports"": ""SUPPORT""}"
1094	815	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	1	evidence	0	PMID:15492748	PARTIAL		One of the main ocular features associated with Axenfeld-Rieger is posterior embryotoxon, which is a prominent anteriorly displaced Schwalbe's line. This can be found in up to 15% of normal eyes, without any clinical significance or may represent a forme fruste of an anterior segment dysgenesis.	The literature supports that posterior embryotoxon is a common feature of Axenfeld-Rieger syndrome but does not confirm it as 'VERY_FREQUENT'. Additionally, it may be present without clinical significance.	"{""explanation"": ""The literature supports that posterior embryotoxon is a common feature of Axenfeld-Rieger syndrome but does not confirm it as 'VERY_FREQUENT'. Additionally, it may be present without clinical significance."", ""reference"": ""PMID:15492748"", ""snippet"": ""One of the main ocular features associated with Axenfeld-Rieger is posterior embryotoxon, which is a prominent anteriorly displaced Schwalbe's line. This can be found in up to 15% of normal eyes, without any clinical significance or may represent a forme fruste of an anterior segment dysgenesis."", ""supports"": ""PARTIAL""}"
1095	815	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	1	evidence	1	PMID:21666320	SUPPORT		The patient had megalocornea with Haab's striae in the right eye and posterior embryotoxon in both the eyes.	The case report supports the presence of posterior embryotoxon in Axenfeld-Rieger syndrome.	"{""explanation"": ""The case report supports the presence of posterior embryotoxon in Axenfeld-Rieger syndrome."", ""reference"": ""PMID:21666320"", ""snippet"": ""The patient had megalocornea with Haab's striae in the right eye and posterior embryotoxon in both the eyes."", ""supports"": ""SUPPORT""}"
1096	815	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	1	evidence	2	PMID:34937757	SUPPORT		Posterior embryotoxon, an anteriorly displaced Schwalbe's line, is the most common feature of Axenfeld Rieger syndrome.	This reference confirms that posterior embryotoxon is a common feature of Axenfeld-Rieger syndrome.	"{""explanation"": ""This reference confirms that posterior embryotoxon is a common feature of Axenfeld-Rieger syndrome."", ""reference"": ""PMID:34937757"", ""snippet"": ""Posterior embryotoxon, an anteriorly displaced Schwalbe's line, is the most common feature of Axenfeld Rieger syndrome."", ""supports"": ""SUPPORT""}"
1097	815	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	1	evidence	3	PMID:38006999	SUPPORT		Posterior embryotoxon as the initial ophthalmological sign of Axenfeld-Rieger syndrome.	This reference supports the statement that posterior embryotoxon is a diagnostic feature of Axenfeld-Rieger syndrome.	"{""explanation"": ""This reference supports the statement that posterior embryotoxon is a diagnostic feature of Axenfeld-Rieger syndrome."", ""reference"": ""PMID:38006999"", ""snippet"": ""Posterior embryotoxon as the initial ophthalmological sign of Axenfeld-Rieger syndrome."", ""supports"": ""SUPPORT""}"
1098	816	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	2	evidence	0	PMID:30860739	SUPPORT		This anomaly encompasses posterior embryotoxon, iris hypoplasia, polycoria, and corectopia.	The literature clearly states that iris hypoplasia is a component of the Rieger anomaly, which is part of Axenfeld-Rieger syndrome.	"{""explanation"": ""The literature clearly states that iris hypoplasia is a component of the Rieger anomaly, which is part of Axenfeld-Rieger syndrome."", ""reference"": ""PMID:30860739"", ""snippet"": ""This anomaly encompasses posterior embryotoxon, iris hypoplasia, polycoria, and corectopia."", ""supports"": ""SUPPORT""}"
1099	816	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	2	evidence	1	PMID:35327965	SUPPORT		Anterior segment dysgenesis (ASD) encompasses a wide spectrum of developmental abnormalities of the anterior ocular segment, including congenital cataract, iris hypoplasia, aniridia, iridocorneal synechiae, as well as Peters, Axenfeld, and Rieger anomalies.	The literature confirms that iris hypoplasia is a frequent feature of anterior segment dysgenesis, which includes Axenfeld-Rieger anomalies.	"{""explanation"": ""The literature confirms that iris hypoplasia is a frequent feature of anterior segment dysgenesis, which includes Axenfeld-Rieger anomalies."", ""reference"": ""PMID:35327965"", ""snippet"": ""Anterior segment dysgenesis (ASD) encompasses a wide spectrum of developmental abnormalities of the anterior ocular segment, including congenital cataract, iris hypoplasia, aniridia, iridocorneal synechiae, as well as Peters, Axenfeld, and Rieger anomalies."", ""supports"": ""SUPPORT""}"
1100	816	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	2	evidence	2	PMID:11740218	SUPPORT		In pedigrees 1,2, and 4, younger generations had iris hypoplasia with severe early-onset glaucoma, whereas their parents had posterior embryotoxon without glaucoma.	The literature identifies iris hypoplasia as a clinical feature in multiple pedigrees with Axenfeld-Rieger syndrome.	"{""explanation"": ""The literature identifies iris hypoplasia as a clinical feature in multiple pedigrees with Axenfeld-Rieger syndrome."", ""reference"": ""PMID:11740218"", ""snippet"": ""In pedigrees 1,2, and 4, younger generations had iris hypoplasia with severe early-onset glaucoma, whereas their parents had posterior embryotoxon without glaucoma."", ""supports"": ""SUPPORT""}"
1101	817	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	3	evidence	0	PMID:30860739	SUPPORT		This anomaly encompasses posterior embryotoxon, iris hypoplasia, polycoria, and corectopia.	The literature explicitly lists corectopia as a component of Rieger anomaly in Axenfeld-Rieger syndrome.	"{""explanation"": ""The literature explicitly lists corectopia as a component of Rieger anomaly in Axenfeld-Rieger syndrome."", ""reference"": ""PMID:30860739"", ""snippet"": ""This anomaly encompasses posterior embryotoxon, iris hypoplasia, polycoria, and corectopia."", ""supports"": ""SUPPORT""}"
1102	818	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	4	evidence	0	PMID:16302606	SUPPORT		Axenfeld-Rieger syndrome is a rare autosomal dominant disorder characterized by various ocular and extraocular malformations. Dental abnormalities are considered as definitive features for the diagnosis and differentiation of Rieger syndrome from other anterior chamber of the eye malformations.	The abstract confirms dental abnormalities are definitive features of Rieger syndrome.	"{""explanation"": ""The abstract confirms dental abnormalities are definitive features of Rieger syndrome."", ""reference"": ""PMID:16302606"", ""snippet"": ""Axenfeld-Rieger syndrome is a rare autosomal dominant disorder characterized by various ocular and extraocular malformations. Dental abnormalities are considered as definitive features for the diagnosis and differentiation of Rieger syndrome from other anterior chamber of the eye malformations."", ""supports"": ""SUPPORT""}"
1103	818	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	4	evidence	1	PMID:35836351	PARTIAL		Enamel formation is disturbed in some patients with ARS. Pitx2 knockdown can influence the proliferation and ameloblast differentiation of inner enamel epithelial cells, and PITX2 may regulate cell proliferation via Wnt/beta-catenin signaling pathway.	This study provides evidence for enamel hypoplasia in some patients with Axenfeld-Rieger syndrome but does not provide information on the frequency or other dental anomalies such as hypodontia or microdontia.	"{""explanation"": ""This study provides evidence for enamel hypoplasia in some patients with Axenfeld-Rieger syndrome but does not provide information on the frequency or other dental anomalies such as hypodontia or microdontia."", ""reference"": ""PMID:35836351"", ""snippet"": ""Enamel formation is disturbed in some patients with ARS. Pitx2 knockdown can influence the proliferation and ameloblast differentiation of inner enamel epithelial cells, and PITX2 may regulate cell proliferation via Wnt/beta-catenin signaling pathway."", ""supports"": ""PARTIAL""}"
1104	819	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	5	evidence	0	PMID:16302606	SUPPORT		Axenfeld-Rieger syndrome is a rare autosomal dominant disorder characterized by various ocular and extraocular malformations. ... Significant cranio-dento-facial findings that have been observed are, teeth with short and dilacerated roots, hyperplastic frenums and underdeveloped maxilla.	The literature confirms that craniofacial dysmorphism, including an underdeveloped maxilla, is a feature of Axenfeld-Rieger syndrome.	"{""explanation"": ""The literature confirms that craniofacial dysmorphism, including an underdeveloped maxilla, is a feature of Axenfeld-Rieger syndrome."", ""reference"": ""PMID:16302606"", ""snippet"": ""Axenfeld-Rieger syndrome is a rare autosomal dominant disorder characterized by various ocular and extraocular malformations. ... Significant cranio-dento-facial findings that have been observed are, teeth with short and dilacerated roots, hyperplastic frenums and underdeveloped maxilla."", ""supports"": ""SUPPORT""}"
1105	819	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	5	evidence	1	PMID:33231930	SUPPORT		Axenfeld-Rieger syndrome is a genetic condition characterized by ocular and systemic features. ... A thin upper lip (55.9%) and a prominent forehead (41.2%) were common facial features shared between both genes. Hypertelorism/telecanthus (81.8% vs 25.0%, p = 0.002) and low-set ears (31.8% vs 0.0%, p = 0.036) were significantly more prevalent in individuals with FOXC1 variants compared with PITX2 variants.	The literature indicates that hypertelorism, a craniofacial feature, is frequently observed in individuals with Axenfeld-Rieger syndrome.	"{""explanation"": ""The literature indicates that hypertelorism, a craniofacial feature, is frequently observed in individuals with Axenfeld-Rieger syndrome."", ""reference"": ""PMID:33231930"", ""snippet"": ""Axenfeld-Rieger syndrome is a genetic condition characterized by ocular and systemic features. ... A thin upper lip (55.9%) and a prominent forehead (41.2%) were common facial features shared between both genes. Hypertelorism/telecanthus (81.8% vs 25.0%, p = 0.002) and low-set ears (31.8% vs 0.0%, p = 0.036) were significantly more prevalent in individuals with FOXC1 variants compared with PITX2 variants."", ""supports"": ""SUPPORT""}"
1106	820	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	6	evidence	0	PMID:27070436	SUPPORT		Key clinical features comprise facial dysmorphism including mid-face and dental hypoplasia, hearing loss, cardiac anomalies, and involuted periumbilical skin.	The mention of 'involuted periumbilical skin' aligns with the statement's description of 'Redundant Periumbilical Skin.'	"{""explanation"": ""The mention of 'involuted periumbilical skin' aligns with the statement's description of 'Redundant Periumbilical Skin.'"", ""reference"": ""PMID:27070436"", ""snippet"": ""Key clinical features comprise facial dysmorphism including mid-face and dental hypoplasia, hearing loss, cardiac anomalies, and involuted periumbilical skin."", ""supports"": ""SUPPORT""}"
1107	821	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	7	evidence	0	PMID:27070436	SUPPORT		Key clinical features comprise facial dysmorphism including mid-face and dental hypoplasia, hearing loss, cardiac anomalies, and involuted periumbilical skin.	The literature mentions hearing loss as a clinical feature of Axenfeld-Rieger syndrome.	"{""explanation"": ""The literature mentions hearing loss as a clinical feature of Axenfeld-Rieger syndrome."", ""reference"": ""PMID:27070436"", ""snippet"": ""Key clinical features comprise facial dysmorphism including mid-face and dental hypoplasia, hearing loss, cardiac anomalies, and involuted periumbilical skin."", ""supports"": ""SUPPORT""}"
1108	821	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	7	evidence	1	PMID:32741584	SUPPORT		Axenfeld-Rieger syndrome (ARS) type 3 is a rare autosomal dominant disease, characterized by anterior segment dysgenesis of the eye, hearing loss, and cardiac defects.	This reference confirms hearing loss is associated with ARS type 3 (FOXC1-related).	"{""explanation"": ""This reference confirms hearing loss is associated with ARS type 3 (FOXC1-related)."", ""reference"": ""PMID:32741584"", ""snippet"": ""Axenfeld-Rieger syndrome (ARS) type 3 is a rare autosomal dominant disease, characterized by anterior segment dysgenesis of the eye, hearing loss, and cardiac defects."", ""supports"": ""SUPPORT""}"
1109	822	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	8	evidence	0	PMID:32741584	SUPPORT		Axenfeld-Rieger syndrome (ARS) type 3 is a rare autosomal dominant disease, characterized by anterior segment dysgenesis of the eye, hearing loss, and cardiac defects.	This reference confirms cardiac defects are associated with ARS type 3 (FOXC1-related).	"{""explanation"": ""This reference confirms cardiac defects are associated with ARS type 3 (FOXC1-related)."", ""reference"": ""PMID:32741584"", ""snippet"": ""Axenfeld-Rieger syndrome (ARS) type 3 is a rare autosomal dominant disease, characterized by anterior segment dysgenesis of the eye, hearing loss, and cardiac defects."", ""supports"": ""SUPPORT""}"
1110	822	33	Axenfeld-Rieger_syndrome	Axenfeld-Rieger_syndrome.yaml	phenotypes	8	evidence	1	PMID:36543336	SUPPORT		Axenfeld-Rieger syndrome is a rare multi-system disorder associated with cardiac anomalies.	The reference confirms that cardiac anomalies are part of the multi-system presentation of Axenfeld-Rieger syndrome.	"{""explanation"": ""The reference confirms that cardiac anomalies are part of the multi-system presentation of Axenfeld-Rieger syndrome."", ""reference"": ""PMID:36543336"", ""snippet"": ""Axenfeld-Rieger syndrome is a rare multi-system disorder associated with cardiac anomalies."", ""supports"": ""SUPPORT""}"
1206	937	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	0	evidence	0	PMID:34749918	SUPPORT		secondary headaches related to life threatening infections are most frequently associated with meningitis.	This reference indicates that headaches are frequently associated with meningitis, supporting the statement that headache is a very frequent symptom in bacterial meningitis.	"{""explanation"": ""This reference indicates that headaches are frequently associated with meningitis, supporting the statement that headache is a very frequent symptom in bacterial meningitis."", ""reference"": ""PMID:34749918"", ""snippet"": ""secondary headaches related to life threatening infections are most frequently associated with meningitis."", ""supports"": ""SUPPORT""}"
1207	937	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	0	evidence	1	PMID:36720125	SUPPORT		The most common symptoms in adults are fever, headache, positive meningeal symptoms and impaired consciousness.	This reference lists headache as one of the most common symptoms in adults with bacterial meningitis, supporting the statement.	"{""explanation"": ""This reference lists headache as one of the most common symptoms in adults with bacterial meningitis, supporting the statement."", ""reference"": ""PMID:36720125"", ""snippet"": ""The most common symptoms in adults are fever, headache, positive meningeal symptoms and impaired consciousness."", ""supports"": ""SUPPORT""}"
1208	937	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	0	evidence	2	PMID:11301494	SUPPORT		Headache as a cardinal symptom of acute meningitis reflects activation of trigeminal afferents from the meninges.	This reference describes headache as a cardinal symptom of acute meningitis, supporting the statement.	"{""explanation"": ""This reference describes headache as a cardinal symptom of acute meningitis, supporting the statement."", ""reference"": ""PMID:11301494"", ""snippet"": ""Headache as a cardinal symptom of acute meningitis reflects activation of trigeminal afferents from the meninges."", ""supports"": ""SUPPORT""}"
1209	937	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	0	evidence	3	PMID:37867184	SUPPORT		Among the 277 alive patients at M12 87/274 (31.8%), 213/271 (78.6%) and 86/277 (31.0%) reported headaches before, at the onset, and at M12, respectively.	This reference provides statistical evidence of the prevalence of headaches in bacterial meningitis patients, supporting the statement.	"{""explanation"": ""This reference provides statistical evidence of the prevalence of headaches in bacterial meningitis patients, supporting the statement."", ""reference"": ""PMID:37867184"", ""snippet"": ""Among the 277 alive patients at M12 87/274 (31.8%), 213/271 (78.6%) and 86/277 (31.0%) reported headaches before, at the onset, and at M12, respectively."", ""supports"": ""SUPPORT""}"
1210	937	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	0	evidence	4	PMID:18528447	SUPPORT		Initial symptoms can be non-specific, which can complicate and delay diagnosis, hence the extreme importance of all the information that can be obtained through anamnesis and physical exploration, with frequent complementary explorations.	Although this reference emphasizes the non-specific nature of initial symptoms, it underscores the importance of headache as a diagnostic clue, indirectly supporting the statement.	"{""explanation"": ""Although this reference emphasizes the non-specific nature of initial symptoms, it underscores the importance of headache as a diagnostic clue, indirectly supporting the statement."", ""reference"": ""PMID:18528447"", ""snippet"": ""Initial symptoms can be non-specific, which can complicate and delay diagnosis, hence the extreme importance of all the information that can be obtained through anamnesis and physical exploration, with frequent complementary explorations."", ""supports"": ""SUPPORT""}"
1211	938	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	1	evidence	0	PMID:22667193	REFUTE		Bacterial meningitis is often difficult to recognize since the classical presentation with neck stiffness, reduced awareness and fever occurs in less than half of the patients.	The literature states that neck stiffness occurs in less than half of the patients, which does not support the claim that it is 'VERY_FREQUENT'.	"{""explanation"": ""The literature states that neck stiffness occurs in less than half of the patients, which does not support the claim that it is 'VERY_FREQUENT'."", ""reference"": ""PMID:22667193"", ""snippet"": ""Bacterial meningitis is often difficult to recognize since the classical presentation with neck stiffness, reduced awareness and fever occurs in less than half of the patients."", ""supports"": ""REFUTE""}"
1212	938	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	1	evidence	1	PMID:28652113	REFUTE		We observed several statistically significant baseline differences (p <0.05) in patients with late versus early diagnosis including age >65 years (56/113, 50% versus 67/245, 27%), neck stiffness (35/97, 36% versus 183/234, 78%)...	The study shows that neck stiffness was present in 36% of late diagnosis cases and 78% of early diagnosis cases, indicating it is not 'VERY_FREQUENT' across all cases.	"{""explanation"": ""The study shows that neck stiffness was present in 36% of late diagnosis cases and 78% of early diagnosis cases, indicating it is not 'VERY_FREQUENT' across all cases."", ""reference"": ""PMID:28652113"", ""snippet"": ""We observed several statistically significant baseline differences (p <0.05) in patients with late versus early diagnosis including age >65 years (56/113, 50% versus 67/245, 27%), neck stiffness (35/97, 36% versus 183/234, 78%)..."", ""supports"": ""REFUTE""}"
1213	939	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	2	evidence	0	PMID:27741995	SUPPORT		Patients with CNS infection can present to the ED with nonspecific signs and symptoms, including headache, fever, altered mental status, and behavioral changes.	The literature indicates that altered mental status is a common symptom of CNS infections, including bacterial meningitis.	"{""explanation"": ""The literature indicates that altered mental status is a common symptom of CNS infections, including bacterial meningitis."", ""reference"": ""PMID:27741995"", ""snippet"": ""Patients with CNS infection can present to the ED with nonspecific signs and symptoms, including headache, fever, altered mental status, and behavioral changes."", ""supports"": ""SUPPORT""}"
1214	939	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	2	evidence	1	PMID:23981452	SUPPORT		The classic triad of bacterial meningitis consists of fever, neck stiffness, and altered mental status; headache is also another common symptom.	Altered mental status is part of the classic triad of symptoms for bacterial meningitis, indicating it is a frequent occurrence.	"{""explanation"": ""Altered mental status is part of the classic triad of symptoms for bacterial meningitis, indicating it is a frequent occurrence."", ""reference"": ""PMID:23981452"", ""snippet"": ""The classic triad of bacterial meningitis consists of fever, neck stiffness, and altered mental status; headache is also another common symptom."", ""supports"": ""SUPPORT""}"
1215	939	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	2	evidence	2	PMID:29206991	SUPPORT		BACKGROUND: Malaria and acute bacterial meningitis (ABM) are the leading infectious causes of febrile encephalopathy in malaria endemic settings. The clinical distinction of the two conditions is complicated by overlap in clinical features.	The mention of febrile encephalopathy, which includes altered mental status, as a leading symptom of bacterial meningitis supports the statement.	"{""explanation"": ""The mention of febrile encephalopathy, which includes altered mental status, as a leading symptom of bacterial meningitis supports the statement."", ""reference"": ""PMID:29206991"", ""snippet"": ""BACKGROUND: Malaria and acute bacterial meningitis (ABM) are the leading infectious causes of febrile encephalopathy in malaria endemic settings. The clinical distinction of the two conditions is complicated by overlap in clinical features."", ""supports"": ""SUPPORT""}"
1216	939	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	2	evidence	3	PMID:25442861	SUPPORT		BACKGROUND: Cerebrospinal fluid (CSF) cell count and biochemical examinations and cultures form the basis for the diagnosis of bacterial meningitis. However, some patients do not have typical findings and are at a higher risk of being missed or having delayed treatment.	While the main focus is on CSF findings, the background suggests that altered mental status is a common indicator for diagnosis.	"{""explanation"": ""While the main focus is on CSF findings, the background suggests that altered mental status is a common indicator for diagnosis."", ""reference"": ""PMID:25442861"", ""snippet"": ""BACKGROUND: Cerebrospinal fluid (CSF) cell count and biochemical examinations and cultures form the basis for the diagnosis of bacterial meningitis. However, some patients do not have typical findings and are at a higher risk of being missed or having delayed treatment."", ""supports"": ""SUPPORT""}"
1217	939	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	2	evidence	4	PMID:27056850	SUPPORT		Cognitive impairments, including dementia, can present as first symptoms at the acute stage, and/or as sequelae in the chronic stages, in some patients with bacterial meningitis (BM) or encephalitides.	Cognitive impairments, which encompass altered mental status, are noted as common initial symptoms in bacterial meningitis.	"{""explanation"": ""Cognitive impairments, which encompass altered mental status, are noted as common initial symptoms in bacterial meningitis."", ""reference"": ""PMID:27056850"", ""snippet"": ""Cognitive impairments, including dementia, can present as first symptoms at the acute stage, and/or as sequelae in the chronic stages, in some patients with bacterial meningitis (BM) or encephalitides."", ""supports"": ""SUPPORT""}"
1218	940	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	3	evidence	0	PMID:36720125	SUPPORT		Fever is the most commonly reported symptom in paediatric patients, occurring in up to 93% of cases. Further, it is possible to observe headache, vomiting and positive meningeal phenomena. The most common symptoms in adults are fever, headache, positive meningeal symptoms and impaired consciousness.	The statement is supported as fever is reported as a very frequent symptom in both pediatric and adult patients with bacterial meningitis.	"{""explanation"": ""The statement is supported as fever is reported as a very frequent symptom in both pediatric and adult patients with bacterial meningitis."", ""reference"": ""PMID:36720125"", ""snippet"": ""Fever is the most commonly reported symptom in paediatric patients, occurring in up to 93% of cases. Further, it is possible to observe headache, vomiting and positive meningeal phenomena. The most common symptoms in adults are fever, headache, positive meningeal symptoms and impaired consciousness."", ""supports"": ""SUPPORT""}"
1219	940	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	3	evidence	1	PMID:6473134	SUPPORT		The rates of prolonged fever for 10 days or more, persistent fever for 5 to 9 days and secondary fever were 13, 13 and 16%, respectively.	This reference supports the statement by indicating that fever is a common symptom during the treatment of bacterial meningitis, with various durations and patterns observed.	"{""explanation"": ""This reference supports the statement by indicating that fever is a common symptom during the treatment of bacterial meningitis, with various durations and patterns observed."", ""reference"": ""PMID:6473134"", ""snippet"": ""The rates of prolonged fever for 10 days or more, persistent fever for 5 to 9 days and secondary fever were 13, 13 and 16%, respectively."", ""supports"": ""SUPPORT""}"
1220	940	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	3	evidence	2	PMID:35436245	SUPPORT		A 33-day-old previously healthy term female is admitted to the pediatric intensive care unit with fever, lethargy and bulging fontanel.	The case study of a 33-day-old infant with bacterial meningitis presenting with fever supports the statement that fever is a very frequent symptom.	"{""explanation"": ""The case study of a 33-day-old infant with bacterial meningitis presenting with fever supports the statement that fever is a very frequent symptom."", ""reference"": ""PMID:35436245"", ""snippet"": ""A 33-day-old previously healthy term female is admitted to the pediatric intensive care unit with fever, lethargy and bulging fontanel."", ""supports"": ""SUPPORT""}"
1221	940	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	3	evidence	3	PMID:37466696	SUPPORT		Meningococcal sepsis is a severe clinical feature comprising high fever, chills and disorders of consciousness.	This reference supports the statement by indicating that high fever is a common symptom in severe cases of meningococcal sepsis, a form of bacterial meningitis.	"{""explanation"": ""This reference supports the statement by indicating that high fever is a common symptom in severe cases of meningococcal sepsis, a form of bacterial meningitis."", ""reference"": ""PMID:37466696"", ""snippet"": ""Meningococcal sepsis is a severe clinical feature comprising high fever, chills and disorders of consciousness."", ""supports"": ""SUPPORT""}"
1222	941	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	4	evidence	0	PMID:20109674	SUPPORT		Clinical signs suggestive of bacterial meningitis include fever, headache, meningismus, vomiting, photophobia, and an altered level of consciousness.	Lists photophobia among typical presenting signs of bacterial meningitis, supporting its frequency.	"{""explanation"": ""Lists photophobia among typical presenting signs of bacterial meningitis, supporting its frequency."", ""reference"": ""PMID:20109674"", ""snippet"": ""Clinical signs suggestive of bacterial meningitis include fever, headache, meningismus, vomiting, photophobia, and an altered level of consciousness."", ""supports"": ""SUPPORT""}"
1223	942	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	5	evidence	0	PMID:33330135	SUPPORT		More recent data from a meta analysis of corticosteroid use for the treatment of bacterial meningitis found no significant reductions in mortality across 25 studies in H. influenzae meningitis cases treated with adjunctive steroid therapy, but similarly did observe a significant reduction in the rate of hearing loss overall in children with H. influenzae meningitis from 12% to 4% after adjunctive corticosteroid therapy.	Notes hearing loss as a measured sequela in H. influenzae meningitis and shows adjunctive steroids reduce its incidence, supporting inclusion of hearing loss.	"{""explanation"": ""Notes hearing loss as a measured sequela in H. influenzae meningitis and shows adjunctive steroids reduce its incidence, supporting inclusion of hearing loss."", ""reference"": ""PMID:33330135"", ""snippet"": ""More recent data from a meta analysis of corticosteroid use for the treatment of bacterial meningitis found no significant reductions in mortality across 25 studies in H. influenzae meningitis cases treated with adjunctive steroid therapy, but similarly did observe a significant reduction in the rate of hearing loss overall in children with H. influenzae meningitis from 12% to 4% after adjunctive corticosteroid therapy."", ""supports"": ""SUPPORT""}"
1224	943	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	6	evidence	0	PMID:27055168	SUPPORT		Complications such as acute hydrocephalus, brain abscess, and spine abscess can develop.	Identifies acute hydrocephalus as a complication of bacterial meningitis, supporting its inclusion.	"{""explanation"": ""Identifies acute hydrocephalus as a complication of bacterial meningitis, supporting its inclusion."", ""reference"": ""PMID:27055168"", ""snippet"": ""Complications such as acute hydrocephalus, brain abscess, and spine abscess can develop."", ""supports"": ""SUPPORT""}"
1225	944	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	7	evidence	0	PMID:23830646	SUPPORT		Meningococcus should be considered and investigated promptly as a potentially etiologic pathogen in any patient with meningitis, or sepsis accompanied by a petechial rash.	This reference indicates that meningococcal meningitis is often accompanied by a petechial rash, supporting the statement.	"{""explanation"": ""This reference indicates that meningococcal meningitis is often accompanied by a petechial rash, supporting the statement."", ""reference"": ""PMID:23830646"", ""snippet"": ""Meningococcus should be considered and investigated promptly as a potentially etiologic pathogen in any patient with meningitis, or sepsis accompanied by a petechial rash."", ""supports"": ""SUPPORT""}"
1226	944	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	7	evidence	1	PMID:1994692	SUPPORT		A rash with petechiae or purpura, the presence of shock, and a normal or low peripheral leukocyte count continue to be predictors of poor outcome.	This reference mentions that petechial rash is a common symptom in meningococcal infections, supporting the statement.	"{""explanation"": ""This reference mentions that petechial rash is a common symptom in meningococcal infections, supporting the statement."", ""reference"": ""PMID:1994692"", ""snippet"": ""A rash with petechiae or purpura, the presence of shock, and a normal or low peripheral leukocyte count continue to be predictors of poor outcome."", ""supports"": ""SUPPORT""}"
1227	945	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	8	evidence	0	PMID:29889417	SUPPORT		Seizures should be avoided, the sedation-pain control optimized and ventilation adapted to assure normal oxygenation and normal CO₂ levels.	Identifies seizures as a complication to monitor and prevent during acute bacterial meningitis management, supporting their clinical relevance.	"{""explanation"": ""Identifies seizures as a complication to monitor and prevent during acute bacterial meningitis management, supporting their clinical relevance."", ""reference"": ""PMID:29889417"", ""snippet"": ""Seizures should be avoided, the sedation-pain control optimized and ventilation adapted to assure normal oxygenation and normal CO₂ levels."", ""supports"": ""SUPPORT""}"
1228	945	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	8	evidence	1	PMID:31378869	SUPPORT		Brain abscess may initially present only with headache, or as a new-onset seizure or with a focal neurological deficit.	Notes that bacterial CNS infections can present with new-onset seizures, reinforcing seizures as a frequent neurological manifestation.	"{""explanation"": ""Notes that bacterial CNS infections can present with new-onset seizures, reinforcing seizures as a frequent neurological manifestation."", ""reference"": ""PMID:31378869"", ""snippet"": ""Brain abscess may initially present only with headache, or as a new-onset seizure or with a focal neurological deficit."", ""supports"": ""SUPPORT""}"
1229	946	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	9	evidence	0	PMID:36472590	SUPPORT		Up to 24% of those who survive develop chronic neurological sequelae, such as hearing loss or focal neurological deficits.	Reports focal neurological deficits as a common chronic sequela in bacterial meningitis survivors.	"{""explanation"": ""Reports focal neurological deficits as a common chronic sequela in bacterial meningitis survivors."", ""reference"": ""PMID:36472590"", ""snippet"": ""Up to 24% of those who survive develop chronic neurological sequelae, such as hearing loss or focal neurological deficits."", ""supports"": ""SUPPORT""}"
1230	946	39	Bacterial meningitis	Bacterial_meningitis.yaml	phenotypes	9	evidence	1	PMID:36472590	SUPPORT		Brain imaging should be performed before lumbar puncture if patients present with altered mental status, focal neurological deficits, papilledema, or history of immunocompromising conditions or central nervous system disease.	Highlights focal neurological deficits as a key presenting sign that guides urgent imaging in suspected bacterial meningitis.	"{""explanation"": ""Highlights focal neurological deficits as a key presenting sign that guides urgent imaging in suspected bacterial meningitis."", ""reference"": ""PMID:36472590"", ""snippet"": ""Brain imaging should be performed before lumbar puncture if patients present with altered mental status, focal neurological deficits, papilledema, or history of immunocompromising conditions or central nervous system disease."", ""supports"": ""SUPPORT""}"
1320	980	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	0	evidence	0	PMID:15690372	SUPPORT		Bardet-Biedl syndrome is a genetically heterogeneous multisystem disorder that causes severe visual impairment. Retinitis pigmentosa (RP), hypogonadism, digit and renal anomalies, obesity, and a variable degree of mental retardation characterize the disorder.	The literature confirms that RP is a high-frequency ophthalmologic phenotype in Bardet-Biedl syndrome.	"{""explanation"": ""The literature confirms that RP is a high-frequency ophthalmologic phenotype in Bardet-Biedl syndrome."", ""reference"": ""PMID:15690372"", ""snippet"": ""Bardet-Biedl syndrome is a genetically heterogeneous multisystem disorder that causes severe visual impairment. Retinitis pigmentosa (RP), hypogonadism, digit and renal anomalies, obesity, and a variable degree of mental retardation characterize the disorder."", ""supports"": ""SUPPORT""}"
1321	980	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	0	evidence	1	PMID:36481880	SUPPORT		Retinitis pigmentosa (RP) is a set of symptoms including tunnel vision, night blindness, and progressive vision loss...as part of a larger syndrome (syndromic)...	The study acknowledges that RP includes night blindness and progressive vision loss, supporting the sequelae mentioned in the statement.	"{""explanation"": ""The study acknowledges that RP includes night blindness and progressive vision loss, supporting the sequelae mentioned in the statement."", ""reference"": ""PMID:36481880"", ""snippet"": ""Retinitis pigmentosa (RP) is a set of symptoms including tunnel vision, night blindness, and progressive vision loss...as part of a larger syndrome (syndromic)..."", ""supports"": ""SUPPORT""}"
1322	980	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	0	evidence	2	PMID:35791150	SUPPORT		Patients with RP in LMBB syndrome present mainly in the first to second decade of life with severe visual acuity impairment to blindness early in life.	RP is reported as a predominant feature in patients with Bardet-Biedl syndrome, confirming the high frequency of this phenotype.	"{""explanation"": ""RP is reported as a predominant feature in patients with Bardet-Biedl syndrome, confirming the high frequency of this phenotype."", ""reference"": ""PMID:35791150"", ""snippet"": ""Patients with RP in LMBB syndrome present mainly in the first to second decade of life with severe visual acuity impairment to blindness early in life."", ""supports"": ""SUPPORT""}"
1323	980	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	0	evidence	3	PMID:31864384	SUPPORT		Inherited retinal dystrophies are major cause of severe progressive vision loss in children.	Retinal dystrophies, including RP, are significant causes of progressive vision loss, congruent with the statement's listed sequelae.	"{""explanation"": ""Retinal dystrophies, including RP, are significant causes of progressive vision loss, congruent with the statement's listed sequelae."", ""reference"": ""PMID:31864384"", ""snippet"": ""Inherited retinal dystrophies are major cause of severe progressive vision loss in children."", ""supports"": ""SUPPORT""}"
1324	981	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	1	evidence	0	PMID:20876674	PARTIAL		Renal abnormalities, including impairment of renal function and signs of chronic interstitial nephropathy of dysplastic nature, were documented in 82% of the patients.	The statement is partially supported because renal abnormalities are common in Bardet-Biedl Syndrome, but the frequency and diagnosis related to polydactyly is not addressed.	"{""explanation"": ""The statement is partially supported because renal abnormalities are common in Bardet-Biedl Syndrome, but the frequency and diagnosis related to polydactyly is not addressed."", ""reference"": ""PMID:20876674"", ""snippet"": ""Renal abnormalities, including impairment of renal function and signs of chronic interstitial nephropathy of dysplastic nature, were documented in 82% of the patients."", ""supports"": ""PARTIAL""}"
1325	981	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	1	evidence	1	PMID:6487184	PARTIAL		The Bardet-Biedl syndrome is characterized by five main features: obesity, polydactyly, pigmentary retinopathy, mental deficiency and hypogonadism; recently a sixth feature, renal disease, has been described.	The reference confirms that both polydactyly and renal disease are features of Bardet-Biedl Syndrome, but it does not specify the diagnostic frequency relationship of polydactyly within renal phenotypes.	"{""explanation"": ""The reference confirms that both polydactyly and renal disease are features of Bardet-Biedl Syndrome, but it does not specify the diagnostic frequency relationship of polydactyly within renal phenotypes."", ""reference"": ""PMID:6487184"", ""snippet"": ""The Bardet-Biedl syndrome is characterized by five main features: obesity, polydactyly, pigmentary retinopathy, mental deficiency and hypogonadism; recently a sixth feature, renal disease, has been described."", ""supports"": ""PARTIAL""}"
1326	982	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	2	evidence	0	PMID:32700463	PARTIAL		Despite normal birth weight, most individuals with BBS experience rapid weight gain in early childhood, with high rates of overweight/obesity sustained through adolescence.	The literature mentions high rates of obesity in individuals with Bardet-Biedl Syndrome but does not specifically categorize it as truncal obesity.	"{""explanation"": ""The literature mentions high rates of obesity in individuals with Bardet-Biedl Syndrome but does not specifically categorize it as truncal obesity."", ""reference"": ""PMID:32700463"", ""snippet"": ""Despite normal birth weight, most individuals with BBS experience rapid weight gain in early childhood, with high rates of overweight/obesity sustained through adolescence."", ""supports"": ""PARTIAL""}"
1327	982	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	2	evidence	1	PMID:6487184	PARTIAL		All had subnormal intelligence, twelve were obese, ten had polydactyly, eight hypogonadism, and two had renal disease.	While obesity is mentioned as a prevalent phenotype, there is no specific mention of truncal obesity.	"{""explanation"": ""While obesity is mentioned as a prevalent phenotype, there is no specific mention of truncal obesity."", ""reference"": ""PMID:6487184"", ""snippet"": ""All had subnormal intelligence, twelve were obese, ten had polydactyly, eight hypogonadism, and two had renal disease."", ""supports"": ""PARTIAL""}"
1328	982	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	2	evidence	2	PMID:29127258	PARTIAL		CONCLUSION: CEP19 encodes a centrosomal and ciliary protein, as all BBS genes do. Another truncating mutation p.Arg82* has been reported as responsible for morbid obesity in a family; however, in the family we present, not all homozygotes are obese, although some are severely obese.	The reference mentions severe obesity related to BBS genes but not truncal obesity specifically.	"{""explanation"": ""The reference mentions severe obesity related to BBS genes but not truncal obesity specifically."", ""reference"": ""PMID:29127258"", ""snippet"": ""CONCLUSION: CEP19 encodes a centrosomal and ciliary protein, as all BBS genes do. Another truncating mutation p.Arg82* has been reported as responsible for morbid obesity in a family; however, in the family we present, not all homozygotes are obese, although some are severely obese."", ""supports"": ""PARTIAL""}"
1329	982	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	2	evidence	3	PMID:12365916	PARTIAL		RESULTS: All patients had an increased body mass index. The obesity varied between families from moderate to severe.	Obesity is noted as a common phenotype, but truncal obesity is not specifically mentioned.	"{""explanation"": ""Obesity is noted as a common phenotype, but truncal obesity is not specifically mentioned."", ""reference"": ""PMID:12365916"", ""snippet"": ""RESULTS: All patients had an increased body mass index. The obesity varied between families from moderate to severe."", ""supports"": ""PARTIAL""}"
1330	984	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	4	evidence	0	PMID:36374067	PARTIAL		Bardet Biedl syndrome... is a pleiotropic disorder characterised by retinal dystrophy, renal dysfunction, polydactyly, obesity, cognitive deficit and hypogenitalism.	The reference mentions cognitive deficits as a characteristic of Bardet-Biedl Syndrome, which can include intellectual disability. However, it does not explicitly state the frequency of intellectual disability, thus it partially supports the statement.	"{""explanation"": ""The reference mentions cognitive deficits as a characteristic of Bardet-Biedl Syndrome, which can include intellectual disability. However, it does not explicitly state the frequency of intellectual disability, thus it partially supports the statement."", ""reference"": ""PMID:36374067"", ""snippet"": ""Bardet Biedl syndrome... is a pleiotropic disorder characterised by retinal dystrophy, renal dysfunction, polydactyly, obesity, cognitive deficit and hypogenitalism."", ""supports"": ""PARTIAL""}"
1331	984	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	4	evidence	1	PMID:19778711	PARTIAL		Joubert syndrome (JS) is a primarily autosomal recessive condition characterized by... intellectual disability... Variable features include... polydactyly... disorders called ciliopathies.	This reference is about Joubert syndrome, which is another ciliopathy like Bardet-Biedl Syndrome. It mentions intellectual disability related to ciliopathies in general but does not directly correlate it with Bardet-Biedl Syndrome's frequency.	"{""explanation"": ""This reference is about Joubert syndrome, which is another ciliopathy like Bardet-Biedl Syndrome. It mentions intellectual disability related to ciliopathies in general but does not directly correlate it with Bardet-Biedl Syndrome's frequency."", ""reference"": ""PMID:19778711"", ""snippet"": ""Joubert syndrome (JS) is a primarily autosomal recessive condition characterized by... intellectual disability... Variable features include... polydactyly... disorders called ciliopathies."", ""supports"": ""PARTIAL""}"
1332	985	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	5	evidence	0	PMID:11096143	SUPPORT		The spectrum of disease includes diverse malformations of the kidney and lower urinary tract.	Renal anomalies are mentioned as part of the disease spectrum in Bardet-Biedl syndrome.	"{""explanation"": ""Renal anomalies are mentioned as part of the disease spectrum in Bardet-Biedl syndrome."", ""reference"": ""PMID:11096143"", ""snippet"": ""The spectrum of disease includes diverse malformations of the kidney and lower urinary tract."", ""supports"": ""SUPPORT""}"
1333	985	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	5	evidence	1	PMID:28662344	SUPPORT		Since the comorbid spectrum of BBS phenotypes spans... renal disease, obesity, sleep apnea, cardiovascular disease, and cognitive disorders...	Renal disease is listed as one of the common phenotypes associated with Bardet-Biedl Syndrome.	"{""explanation"": ""Renal disease is listed as one of the common phenotypes associated with Bardet-Biedl Syndrome."", ""reference"": ""PMID:28662344"", ""snippet"": ""Since the comorbid spectrum of BBS phenotypes spans... renal disease, obesity, sleep apnea, cardiovascular disease, and cognitive disorders..."", ""supports"": ""SUPPORT""}"
1334	985	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	5	evidence	2	PMID:32165602	SUPPORT		This type can cause severe and delayed onset renal failure.	Bardet-Biedl type 9 is noted to cause severe and delayed onset renal failure, supporting the common occurrence of renal anomalies.	"{""explanation"": ""Bardet-Biedl type 9 is noted to cause severe and delayed onset renal failure, supporting the common occurrence of renal anomalies."", ""reference"": ""PMID:32165602"", ""snippet"": ""This type can cause severe and delayed onset renal failure."", ""supports"": ""SUPPORT""}"
1335	986	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	6	evidence	0	PMID:33040131	SUPPORT		Clinical presentation of this rare condition may affect locomotive, neurological, cardio-vascular, endocrine and metabolic systems.	The abstract mentions that Bardet-Biedl syndrome can affect the neurological system, which can include developmental delay.	"{""explanation"": ""The abstract mentions that Bardet-Biedl syndrome can affect the neurological system, which can include developmental delay."", ""reference"": ""PMID:33040131"", ""snippet"": ""Clinical presentation of this rare condition may affect locomotive, neurological, cardio-vascular, endocrine and metabolic systems."", ""supports"": ""SUPPORT""}"
1336	986	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	6	evidence	1	PMID:24194441	SUPPORT		On the age appropriate Wechsler scale, the mean Verbal Comprehension was 81 (n = 36), Working Memory was 81 (n = 36), Perceptual Reasoning was 78 (n = 24) and Full Scale IQ was 75 (n = 26).	The abstract provides evidence of reduced cognitive functions in patients with Bardet-Biedl syndrome, indicating developmental delays.	"{""explanation"": ""The abstract provides evidence of reduced cognitive functions in patients with Bardet-Biedl syndrome, indicating developmental delays."", ""reference"": ""PMID:24194441"", ""snippet"": ""On the age appropriate Wechsler scale, the mean Verbal Comprehension was 81 (n = 36), Working Memory was 81 (n = 36), Perceptual Reasoning was 78 (n = 24) and Full Scale IQ was 75 (n = 26)."", ""supports"": ""SUPPORT""}"
1337	987	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	7	evidence	0	PMID:26076793	SUPPORT		Renal abnormalities have been recognized as a cardinal feature of the disease with serious prognostic implication.	The study highlights renal abnormalities as a significant aspect of Bardet-Biedl syndrome, supporting the statement about the frequent occurrence of renal anomalies.	"{""explanation"": ""The study highlights renal abnormalities as a significant aspect of Bardet-Biedl syndrome, supporting the statement about the frequent occurrence of renal anomalies."", ""reference"": ""PMID:26076793"", ""snippet"": ""Renal abnormalities have been recognized as a cardinal feature of the disease with serious prognostic implication."", ""supports"": ""SUPPORT""}"
1338	987	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	7	evidence	1	PMID:31419725	SUPPORT		Renal ciliopathies are a group of disorders characterised by nephronophthisis, cystic kidneys or renal cystic dysplasia.	The article mentions renal cystic dysplasia as part of renal ciliopathies, which includes Bardet-Biedl syndrome, supporting the statement.	"{""explanation"": ""The article mentions renal cystic dysplasia as part of renal ciliopathies, which includes Bardet-Biedl syndrome, supporting the statement."", ""reference"": ""PMID:31419725"", ""snippet"": ""Renal ciliopathies are a group of disorders characterised by nephronophthisis, cystic kidneys or renal cystic dysplasia."", ""supports"": ""SUPPORT""}"
1339	987	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	7	evidence	2	PMID:7726222	SUPPORT		The major manifestations of the Bardet-Biedl syndrome are digital anomalies, tapetoretinal degeneration, obesity, renal abnormalities, and hypogenitalism.	The article explicitly mentions renal abnormalities as a major manifestation of Bardet-Biedl syndrome, supporting the statement.	"{""explanation"": ""The article explicitly mentions renal abnormalities as a major manifestation of Bardet-Biedl syndrome, supporting the statement."", ""reference"": ""PMID:7726222"", ""snippet"": ""The major manifestations of the Bardet-Biedl syndrome are digital anomalies, tapetoretinal degeneration, obesity, renal abnormalities, and hypogenitalism."", ""supports"": ""SUPPORT""}"
1340	987	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	7	evidence	3	PMID:25313840	SUPPORT		The purpose of this review is not only to describe the congenital renal anomalies, but also to analyze the more recent therapeutic interventions that may modify the natural history of some of these severe conditions.	The article reviews several syndromes associated with renal malformations, including Bardet-Biedl syndrome, thus supporting the statement about the frequent occurrence of renal anomalies.	"{""explanation"": ""The article reviews several syndromes associated with renal malformations, including Bardet-Biedl syndrome, thus supporting the statement about the frequent occurrence of renal anomalies."", ""reference"": ""PMID:25313840"", ""snippet"": ""The purpose of this review is not only to describe the congenital renal anomalies, but also to analyze the more recent therapeutic interventions that may modify the natural history of some of these severe conditions."", ""supports"": ""SUPPORT""}"
1341	988	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	8	evidence	0	PMID:7726222	PARTIAL		The major manifestations of the Bardet-Biedl syndrome are digital anomalies, tapetoretinal degeneration, obesity, renal abnormalities, and hypogenitalism (described mainly in males).	The literature mentions hypogenitalism mainly in males but does not provide evidence for its frequency or occurrence in females.	"{""explanation"": ""The literature mentions hypogenitalism mainly in males but does not provide evidence for its frequency or occurrence in females."", ""reference"": ""PMID:7726222"", ""snippet"": ""The major manifestations of the Bardet-Biedl syndrome are digital anomalies, tapetoretinal degeneration, obesity, renal abnormalities, and hypogenitalism (described mainly in males)."", ""supports"": ""PARTIAL""}"
1342	988	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	8	evidence	1	PMID:19327768	PARTIAL		To report a patient with Bardet-Biedl syndrome (BBS) with known hypogonadotrophic hypogonadism who developed spontaneous reversal of hypogonadism in adulthood.	This study reports hypogonadism in a male patient but does not discuss its frequency or occurrence in females.	"{""explanation"": ""This study reports hypogonadism in a male patient but does not discuss its frequency or occurrence in females."", ""reference"": ""PMID:19327768"", ""snippet"": ""To report a patient with Bardet-Biedl syndrome (BBS) with known hypogonadotrophic hypogonadism who developed spontaneous reversal of hypogonadism in adulthood."", ""supports"": ""PARTIAL""}"
1343	988	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	8	evidence	2	PMID:31696011	PARTIAL		The major features of this syndrome are cone-rod dystrophy, polydactyly, obesity, learning disabilities, hypogonadism in males, renal anomalies, nystagmus, speech disorders, developmental delay, polyuria/polydipsia, ataxia, and poor coordination/clumsiness.	The literature mentions hypogonadism in males but does not provide information about its occurrence in females or its frequency.	"{""explanation"": ""The literature mentions hypogonadism in males but does not provide information about its occurrence in females or its frequency."", ""reference"": ""PMID:31696011"", ""snippet"": ""The major features of this syndrome are cone-rod dystrophy, polydactyly, obesity, learning disabilities, hypogonadism in males, renal anomalies, nystagmus, speech disorders, developmental delay, polyuria/polydipsia, ataxia, and poor coordination/clumsiness."", ""supports"": ""PARTIAL""}"
1344	988	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	8	evidence	3	PMID:32835378	PARTIAL		BBS patients frequently presented with genitourinary malformations, such as cryptorchidism (5/11), short scrotum (5/8), and micropenis (5/8), but unexpectedly, with normal testis size (7/8).	The literature discusses genitourinary malformations and hypogonadism in male patients but does not mention its frequency or occurrence in females.	"{""explanation"": ""The literature discusses genitourinary malformations and hypogonadism in male patients but does not mention its frequency or occurrence in females."", ""reference"": ""PMID:32835378"", ""snippet"": ""BBS patients frequently presented with genitourinary malformations, such as cryptorchidism (5/11), short scrotum (5/8), and micropenis (5/8), but unexpectedly, with normal testis size (7/8)."", ""supports"": ""PARTIAL""}"
1345	989	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	9	evidence	0	PMID:24194441	PARTIAL		A wide range of behavioral issues were endorsed on questionnaires given to parents. Most had social skill deficits but no pattern of either externalizing or internalizing problems.	The study mentions a wide range of behavioral issues and social skill deficits but does not specifically mention impulsivity, emotional lability, or disinhibition.	"{""explanation"": ""The study mentions a wide range of behavioral issues and social skill deficits but does not specifically mention impulsivity, emotional lability, or disinhibition."", ""reference"": ""PMID:24194441"", ""snippet"": ""A wide range of behavioral issues were endorsed on questionnaires given to parents. Most had social skill deficits but no pattern of either externalizing or internalizing problems."", ""supports"": ""PARTIAL""}"
1346	989	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	9	evidence	1	PMID:23776152	NO_EVIDENCE		CONCLUSION: Appetite dysregulation may contribute to obesity in BBS.	This study focuses on hyperphagia and appetite dysregulation, not on behavioral abnormalities such as impulsivity, emotional lability, or disinhibition.	"{""explanation"": ""This study focuses on hyperphagia and appetite dysregulation, not on behavioral abnormalities such as impulsivity, emotional lability, or disinhibition."", ""reference"": ""PMID:23776152"", ""snippet"": ""CONCLUSION: Appetite dysregulation may contribute to obesity in BBS."", ""supports"": ""NO_EVIDENCE""}"
1347	989	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	9	evidence	2	PMID:7726222	NO_EVIDENCE		The major manifestations of the Bardet-Biedl syndrome are digital anomalies, tapetoretinal degeneration, obesity, renal abnormalities, and hypogenitalism.	This study does not address behavioral abnormalities in Bardet-Biedl Syndrome.	"{""explanation"": ""This study does not address behavioral abnormalities in Bardet-Biedl Syndrome."", ""reference"": ""PMID:7726222"", ""snippet"": ""The major manifestations of the Bardet-Biedl syndrome are digital anomalies, tapetoretinal degeneration, obesity, renal abnormalities, and hypogenitalism."", ""supports"": ""NO_EVIDENCE""}"
1348	989	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	9	evidence	3	PMID:6487184	NO_EVIDENCE		The Bardet-Biedl syndrome is characterized by five main features: obesity, polydactyly, pigmentary retinopathy, mental deficiency and hypogonadism.	This study focuses on physical and cognitive characteristics, not on behavioral abnormalities.	"{""explanation"": ""This study focuses on physical and cognitive characteristics, not on behavioral abnormalities."", ""reference"": ""PMID:6487184"", ""snippet"": ""The Bardet-Biedl syndrome is characterized by five main features: obesity, polydactyly, pigmentary retinopathy, mental deficiency and hypogonadism."", ""supports"": ""NO_EVIDENCE""}"
1349	989	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	9	evidence	4	PMID:32165602	NO_EVIDENCE		This type can cause severe and delayed onset renal failure.	This study focuses on renal failure in a specific type of Bardet-Biedl Syndrome and does not address behavioral abnormalities.	"{""explanation"": ""This study focuses on renal failure in a specific type of Bardet-Biedl Syndrome and does not address behavioral abnormalities."", ""reference"": ""PMID:32165602"", ""snippet"": ""This type can cause severe and delayed onset renal failure."", ""supports"": ""NO_EVIDENCE""}"
1350	989	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	9	evidence	5	PMID:36658040	NO_EVIDENCE		Disinhibition is a core symptom in behavioural variant frontotemporal dementia (bvFTD) particularly affecting the daily lives of both patients and caregivers.	This study focuses on behavioral disinhibition in frontotemporal dementia, not Bardet-Biedl Syndrome.	"{""explanation"": ""This study focuses on behavioral disinhibition in frontotemporal dementia, not Bardet-Biedl Syndrome."", ""reference"": ""PMID:36658040"", ""snippet"": ""Disinhibition is a core symptom in behavioural variant frontotemporal dementia (bvFTD) particularly affecting the daily lives of both patients and caregivers."", ""supports"": ""NO_EVIDENCE""}"
1351	990	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	10	evidence	0	PMID:27170093	PARTIAL		The patients manifest a characteristic craniofacial dysmorphology but the effects of Bbs3 deficiency in the developmental process during the craniofacial pathogenesis are still incompletely understood.	The literature confirms craniofacial dysmorphology in Bardet-Biedl Syndrome, but does not provide specific details on the frequency or exact features such as deep-set eyes, flat nasal bridge, and large ears.	"{""explanation"": ""The literature confirms craniofacial dysmorphology in Bardet-Biedl Syndrome, but does not provide specific details on the frequency or exact features such as deep-set eyes, flat nasal bridge, and large ears."", ""reference"": ""PMID:27170093"", ""snippet"": ""The patients manifest a characteristic craniofacial dysmorphology but the effects of Bbs3 deficiency in the developmental process during the craniofacial pathogenesis are still incompletely understood."", ""supports"": ""PARTIAL""}"
1352	990	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	10	evidence	1	PMID:28662344	PARTIAL		Dental anomalies are present in a majority of individuals affected by BBS due to abnormal embryonic orofacial and tooth development.	The literature mentions dental anomalies and orofacial development issues in Bardet-Biedl Syndrome, but does not specifically discuss the frequency or detailed craniofacial features listed in the statement.	"{""explanation"": ""The literature mentions dental anomalies and orofacial development issues in Bardet-Biedl Syndrome, but does not specifically discuss the frequency or detailed craniofacial features listed in the statement."", ""reference"": ""PMID:28662344"", ""snippet"": ""Dental anomalies are present in a majority of individuals affected by BBS due to abnormal embryonic orofacial and tooth development."", ""supports"": ""PARTIAL""}"
1353	991	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	11	evidence	0	PMID:7802002	PARTIAL		Our findings of cardiac involvement in 50% of the cases suggest that echocardiographic examination should be included in the clinical evaluation and follow-up of patients with Bardet-Biedl syndrome.	The study reports cardiac involvement in 50% of cases, but it does not specify that congenital heart defects are only 'occasional'.	"{""explanation"": ""The study reports cardiac involvement in 50% of cases, but it does not specify that congenital heart defects are only 'occasional'."", ""reference"": ""PMID:7802002"", ""snippet"": ""Our findings of cardiac involvement in 50% of the cases suggest that echocardiographic examination should be included in the clinical evaluation and follow-up of patients with Bardet-Biedl syndrome."", ""supports"": ""PARTIAL""}"
1354	991	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	11	evidence	1	PMID:33433911	NO_EVIDENCE		Atrioventricular canal defect is the classic congenital heart disease in Bardet-Biedl syndrome.	This reference indicates that atrioventricular canal defect is a classic congenital heart disease in Bardet-Biedl syndrome, but it does not provide information on the frequency being 'occasional'.	"{""explanation"": ""This reference indicates that atrioventricular canal defect is a classic congenital heart disease in Bardet-Biedl syndrome, but it does not provide information on the frequency being 'occasional'."", ""reference"": ""PMID:33433911"", ""snippet"": ""Atrioventricular canal defect is the classic congenital heart disease in Bardet-Biedl syndrome."", ""supports"": ""NO_EVIDENCE""}"
1355	992	40	Bardet-Biedl Syndrome	Bardet-Biedl_Syndrome.yaml	phenotypes	12	evidence	0	PMID:23001136	PARTIAL		A number of other autosomal recessive syndromes include the Shah-Waardenburg, the Bardet-Biedl and Cartilage-hair hypoplasia, Goldberg-Shprintzen syndromes and other syndromes related to cholesterol and fat metabolism among others.	The reference mentions Bardet-Biedl Syndrome (BBS) in the context of syndromes associated with Hirschsprung's disease (HSCR), but it does not specify the frequency of this association. Hence, it partially supports the statement without confirming the frequency as 'occasional'.	"{""explanation"": ""The reference mentions Bardet-Biedl Syndrome (BBS) in the context of syndromes associated with Hirschsprung's disease (HSCR), but it does not specify the frequency of this association. Hence, it partially supports the statement without confirming the frequency as 'occasional'."", ""reference"": ""PMID:23001136"", ""snippet"": ""A number of other autosomal recessive syndromes include the Shah-Waardenburg, the Bardet-Biedl and Cartilage-hair hypoplasia, Goldberg-Shprintzen syndromes and other syndromes related to cholesterol and fat metabolism among others."", ""supports"": ""PARTIAL""}"
1375	1032	42	Behcet's Disease	Behcets_Disease.yaml	phenotypes	0	evidence	0	PMID:37435539	SUPPORT		Major clinical manifestations of BD are oral aphthae, genital aphthous ulcers, skin lesions, arthritis, and uveitis.	Oral aphthae are listed as a major clinical manifestation of Behcet's disease, confirming their central role in diagnosis.	"{""explanation"": ""Oral aphthae are listed as a major clinical manifestation of Behcet's disease, confirming their central role in diagnosis."", ""reference"": ""PMID:37435539"", ""snippet"": ""Major clinical manifestations of BD are oral aphthae, genital aphthous ulcers, skin lesions, arthritis, and uveitis."", ""supports"": ""SUPPORT""}"
1376	1034	42	Behcet's Disease	Behcets_Disease.yaml	phenotypes	2	evidence	0	PMID:38778397	SUPPORT		Behcet's uveitis (BU) is a common manifestation of BD, occurring in over two-thirds of the patients. BU is characterized by bilateral, chronic, recurrent, non-granulomatous uveitis in association with complications such as retinal ischemia and atrophy, optic atrophy, macular ischemia, macular edema, and further neovascular complications (vitreous hemorrhage, neovascular glaucoma).	This review confirms that uveitis occurs in over two-thirds of Behcet's disease patients and describes its bilateral, recurrent nature and sight-threatening complications including potential blindness.	"{""explanation"": ""This review confirms that uveitis occurs in over two-thirds of Behcet's disease patients and describes its bilateral, recurrent nature and sight-threatening complications including potential blindness."", ""reference"": ""PMID:38778397"", ""snippet"": ""Behcet's uveitis (BU) is a common manifestation of BD, occurring in over two-thirds of the patients. BU is characterized by bilateral, chronic, recurrent, non-granulomatous uveitis in association with complications such as retinal ischemia and atrophy, optic atrophy, macular ischemia, macular edema, and further neovascular complications (vitreous hemorrhage, neovascular glaucoma)."", ""supports"": ""SUPPORT""}"
1378	1042	43	Bejel	Bejel.yaml	phenotypes	0	evidence	0	PMID:2771355	SUPPORT		Results of clinical examination showed uveitis in nine patients, optic atrophy in six, and chorioretinitis scars in six.	The abstract reports uveitis among bejel patients.	"{""explanation"": ""The abstract reports uveitis among bejel patients."", ""reference"": ""PMID:2771355"", ""snippet"": ""Results of clinical examination showed uveitis in nine patients, optic atrophy in six, and chorioretinitis scars in six."", ""supports"": ""SUPPORT""}"
1379	1043	43	Bejel	Bejel.yaml	phenotypes	1	evidence	0	PMID:2771355	SUPPORT		Results of clinical examination showed uveitis in nine patients, optic atrophy in six, and chorioretinitis scars in six.	The abstract reports optic atrophy among bejel patients.	"{""explanation"": ""The abstract reports optic atrophy among bejel patients."", ""reference"": ""PMID:2771355"", ""snippet"": ""Results of clinical examination showed uveitis in nine patients, optic atrophy in six, and chorioretinitis scars in six."", ""supports"": ""SUPPORT""}"
1392	1066	44	Benign Prostatic Hyperplasia	Benign_Prostatic_Hyperplasia.yaml	phenotypes	1	evidence	0	PMID:37827216	SUPPORT		One-month treatment of Pb-PRL mice with anethole trithione (ATT), a specific inhibitor of mitochondrial ROS production, reduced prostate weight and voiding frequency.	This evidence shows that voiding frequency (including nocturia) is a key symptom of BPH that can be reduced through therapeutic intervention targeting oxidative stress.	"{""explanation"": ""This evidence shows that voiding frequency (including nocturia) is a key symptom of BPH that can be reduced through therapeutic intervention targeting oxidative stress."", ""reference"": ""PMID:37827216"", ""snippet"": ""One-month treatment of Pb-PRL mice with anethole trithione (ATT), a specific inhibitor of mitochondrial ROS production, reduced prostate weight and voiding frequency."", ""supports"": ""SUPPORT""}"
1398	1084	45	Beta Mannosidosis	Beta_Mannosidosis.yaml	phenotypes	0	evidence	0	PMID:32847582	SUPPORT		clinical manifestation includes deafness and mental retardation	Mental retardation (intellectual disability) is explicitly listed as a clinical manifestation of beta-mannosidosis.	"{""explanation"": ""Mental retardation (intellectual disability) is explicitly listed as a clinical manifestation of beta-mannosidosis."", ""reference"": ""PMID:32847582"", ""snippet"": ""clinical manifestation includes deafness and mental retardation"", ""supports"": ""SUPPORT""}"
1399	1085	45	Beta Mannosidosis	Beta_Mannosidosis.yaml	phenotypes	1	evidence	0	PMID:32847582	SUPPORT		10 beta-mannosidosis patients of Roma origin from eight families in the Czech and Slovak Republics with hearing loss, mental retardation	Hearing loss is a prominent feature in beta-mannosidosis patients, occurring consistently across reported cases.	"{""explanation"": ""Hearing loss is a prominent feature in beta-mannosidosis patients, occurring consistently across reported cases."", ""reference"": ""PMID:32847582"", ""snippet"": ""10 beta-mannosidosis patients of Roma origin from eight families in the Czech and Slovak Republics with hearing loss, mental retardation"", ""supports"": ""SUPPORT""}"
1410	1113	46	Bipolar Disorder	Bipolar_Disorder.yaml	phenotypes	5	evidence	0	PMID:23846857	SUPPORT		All proband groups showed lower psychosocial functioning than the relatives or comparison group. On average, schizophrenia probands showed more symptoms and lower psychosocial functioning than probands with psychotic bipolar disorder, but there was considerable overlap in clinical manifestations.	The B-SNIP study demonstrates that cognitive and psychosocial impairment is a consistent feature across psychotic disorders including bipolar disorder, though with varying severity.	"{""explanation"": ""The B-SNIP study demonstrates that cognitive and psychosocial impairment is a consistent feature across psychotic disorders including bipolar disorder, though with varying severity."", ""reference"": ""PMID:23846857"", ""snippet"": ""All proband groups showed lower psychosocial functioning than the relatives or comparison group. On average, schizophrenia probands showed more symptoms and lower psychosocial functioning than probands with psychotic bipolar disorder, but there was considerable overlap in clinical manifestations."", ""supports"": ""SUPPORT""}"
1460	1156	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	phenotypes	0	evidence	0	PMID:14503346	SUPPORT	HUMAN_CLINICAL	A 57-year-old woman was admitted to our hospital because of cough and low-grade fever for 2 months and shortness of breath for 2 weeks.	The case report documents shortness of breath in bird fancier's lung.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The case report documents shortness of breath in bird fancier's lung."", ""reference"": ""PMID:14503346"", ""snippet"": ""A 57-year-old woman was admitted to our hospital because of cough and low-grade fever for 2 months and shortness of breath for 2 weeks."", ""supports"": ""SUPPORT""}"
1461	1156	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	phenotypes	0	evidence	1	PMID:39958101	SUPPORT	HUMAN_CLINICAL	We present the case of a 43-year-old male pigeon keeper with an eight-week history of progressive dyspnea on exertion and intermittent chest pain.	The case report describes progressive dyspnea on exertion in BFL.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The case report describes progressive dyspnea on exertion in BFL."", ""reference"": ""PMID:39958101"", ""snippet"": ""We present the case of a 43-year-old male pigeon keeper with an eight-week history of progressive dyspnea on exertion and intermittent chest pain."", ""supports"": ""SUPPORT""}"
1462	1157	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	phenotypes	1	evidence	0	PMID:14503346	SUPPORT	HUMAN_CLINICAL	A 57-year-old woman was admitted to our hospital because of cough and low-grade fever for 2 months and shortness of breath for 2 weeks.	The case report describes cough in bird fancier's lung.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The case report describes cough in bird fancier's lung."", ""reference"": ""PMID:14503346"", ""snippet"": ""A 57-year-old woman was admitted to our hospital because of cough and low-grade fever for 2 months and shortness of breath for 2 weeks."", ""supports"": ""SUPPORT""}"
1463	1158	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	phenotypes	2	evidence	0	PMID:37028940	SUPPORT	HUMAN_CLINICAL	Fibrotic hypersensitivity pneumonitis (FHP) is an irreversible lung disease with high morbidity and mortality.	The trial focuses on fibrotic hypersensitivity pneumonitis, supporting pulmonary fibrosis as a clinical phenotype.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The trial focuses on fibrotic hypersensitivity pneumonitis, supporting pulmonary fibrosis as a clinical phenotype."", ""reference"": ""PMID:37028940"", ""snippet"": ""Fibrotic hypersensitivity pneumonitis (FHP) is an irreversible lung disease with high morbidity and mortality."", ""supports"": ""SUPPORT""}"
1464	1158	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	phenotypes	2	evidence	1	PMID:32145830	SUPPORT	HUMAN_CLINICAL	the rate of decline in FVC (mL/year) over 52 weeks in patients who received at least one dose of nintedanib or placebo in five prespecified subgroups based on the ILD diagnoses documented by the investigators: hypersensitivity pneumonitis	The INBUILD subgroup analysis includes hypersensitivity pneumonitis within progressive fibrosing ILD populations, supporting a fibrotic phenotype.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The INBUILD subgroup analysis includes hypersensitivity pneumonitis within progressive fibrosing ILD populations, supporting a fibrotic phenotype."", ""reference"": ""PMID:32145830"", ""snippet"": ""the rate of decline in FVC (mL/year) over 52 weeks in patients who received at least one dose of nintedanib or placebo in five prespecified subgroups based on the ILD diagnoses documented by the investigators: hypersensitivity pneumonitis"", ""supports"": ""SUPPORT""}"
1465	1158	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	phenotypes	2	evidence	2	PMID:24480143	SUPPORT	HUMAN_CLINICAL	In the 3 diseases, most important prognosis-predicting factor is the extent of fibrotic score (the extent of honeycombing and reticulation) calculated on high-resolution computed tomography scans or fibrosis estimated on chest radiographs.	Chronic HP is discussed alongside fibrotic scoring on HRCT, reinforcing pulmonary fibrosis as a key disease feature.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Chronic HP is discussed alongside fibrotic scoring on HRCT, reinforcing pulmonary fibrosis as a key disease feature."", ""reference"": ""PMID:24480143"", ""snippet"": ""In the 3 diseases, most important prognosis-predicting factor is the extent of fibrotic score (the extent of honeycombing and reticulation) calculated on high-resolution computed tomography scans or fibrosis estimated on chest radiographs."", ""supports"": ""SUPPORT""}"
1466	1158	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	phenotypes	2	evidence	3	PMID:38218353	SUPPORT	MODEL_ORGANISM	Importantly, it was observed that the transfer of MMP14-overexpressing macrophages into mice promoted lung inflammation and fibrosis induced by SR-Ag.	In a hypersensitivity pneumonitis model, fibrosis is a documented outcome, supporting pulmonary fibrosis as a disease phenotype.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""In a hypersensitivity pneumonitis model, fibrosis is a documented outcome, supporting pulmonary fibrosis as a disease phenotype."", ""reference"": ""PMID:38218353"", ""snippet"": ""Importantly, it was observed that the transfer of MMP14-overexpressing macrophages into mice promoted lung inflammation and fibrosis induced by SR-Ag."", ""supports"": ""SUPPORT""}"
1467	1159	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	phenotypes	3	evidence	0	PMID:11131880	SUPPORT	HUMAN_CLINICAL	A 47-year-old woman, without significant past medical history, presented an acute dyspnea with hypoxia, marked pulmonary arterial hypertension (PAH) and signs of right heart failure.	The case demonstrates hypoxia as part of acute bird hypersensitivity pneumonitis.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The case demonstrates hypoxia as part of acute bird hypersensitivity pneumonitis."", ""reference"": ""PMID:11131880"", ""snippet"": ""A 47-year-old woman, without significant past medical history, presented an acute dyspnea with hypoxia, marked pulmonary arterial hypertension (PAH) and signs of right heart failure."", ""supports"": ""SUPPORT""}"
1468	1160	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	phenotypes	4	evidence	0	PMID:6761066	SUPPORT	HUMAN_CLINICAL	Chronically, these diseases may present with the gradual onset of cough, dyspnea on exertion, fatigue, anorexia, and weight loss which may progress to pulmonary fibrosis or severe pulmonary insufficiency.	The clinical review describes fatigue among chronic hypersensitivity pneumonitis presentations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The clinical review describes fatigue among chronic hypersensitivity pneumonitis presentations."", ""reference"": ""PMID:6761066"", ""snippet"": ""Chronically, these diseases may present with the gradual onset of cough, dyspnea on exertion, fatigue, anorexia, and weight loss which may progress to pulmonary fibrosis or severe pulmonary insufficiency."", ""supports"": ""SUPPORT""}"
1469	1161	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	phenotypes	5	evidence	0	PMID:14503346	SUPPORT	HUMAN_CLINICAL	A 57-year-old woman was admitted to our hospital because of cough and low-grade fever for 2 months and shortness of breath for 2 weeks.	The case report documents low-grade fever in bird fancier's lung.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The case report documents low-grade fever in bird fancier's lung."", ""reference"": ""PMID:14503346"", ""snippet"": ""A 57-year-old woman was admitted to our hospital because of cough and low-grade fever for 2 months and shortness of breath for 2 weeks."", ""supports"": ""SUPPORT""}"
1483	1173	48	Botulism	Botulism.yaml	phenotypes	0	evidence	0	PMID:31157190	SUPPORT		The clinical manifestations are flaccid, symmetrical, descending paralysis affecting cranial and peripheral nerves.	The abstract describes descending paralysis as the key clinical manifestation.	"{""explanation"": ""The abstract describes descending paralysis as the key clinical manifestation."", ""reference"": ""PMID:31157190"", ""snippet"": ""The clinical manifestations are flaccid, symmetrical, descending paralysis affecting cranial and peripheral nerves."", ""supports"": ""SUPPORT""}"
1487	1177	49	Breast Fibroadenoma	Breast_Fibroadenoma.yaml	phenotypes	0	evidence	0	PMID:11270760	SUPPORT		Fibroadenoma of the breast is a common cause of a benign breast lump in premenopausal women.	The abstract identifies a benign breast lump as the typical presentation.	"{""explanation"": ""The abstract identifies a benign breast lump as the typical presentation."", ""reference"": ""PMID:11270760"", ""snippet"": ""Fibroadenoma of the breast is a common cause of a benign breast lump in premenopausal women."", ""supports"": ""SUPPORT""}"
1496	1242	52	Buruli ulcer	Buruli_Ulcer.yaml	phenotypes	0	evidence	0	PMID:19362692	SUPPORT		Buruli ulcer is an indolent necrotizing disease of the skin, subcutaneous tissue, and bone	The disease is defined by necrotizing skin disease with ulceration.	"{""explanation"": ""The disease is defined by necrotizing skin disease with ulceration."", ""reference"": ""PMID:19362692"", ""snippet"": ""Buruli ulcer is an indolent necrotizing disease of the skin, subcutaneous tissue, and bone"", ""supports"": ""SUPPORT""}"
1505	1248	53	CHIME_syndrome	CHIME_syndrome.yaml	phenotypes	0	evidence	0	PMID:22444671	SUPPORT		CHIME syndrome is characterized by colobomas, heart defects, ichthyosiform dermatosis, mental retardation (intellectual disability), and ear anomalies	Landmark PIGL mutation study identifying coloboma as a cardinal diagnostic feature of CHIME syndrome.	"{""explanation"": ""Landmark PIGL mutation study identifying coloboma as a cardinal diagnostic feature of CHIME syndrome."", ""reference"": ""PMID:22444671"", ""snippet"": ""CHIME syndrome is characterized by colobomas, heart defects, ichthyosiform dermatosis, mental retardation (intellectual disability), and ear anomalies"", ""supports"": ""SUPPORT""}"
1506	1249	53	CHIME_syndrome	CHIME_syndrome.yaml	phenotypes	1	evidence	0	PMID:22444671	SUPPORT		CHIME syndrome is characterized by colobomas, heart defects, ichthyosiform dermatosis, mental retardation (intellectual disability), and ear anomalies	PIGL mutations cause cardiac defects as a cardinal feature of CHIME syndrome, requiring cardiac surveillance in affected individuals.	"{""explanation"": ""PIGL mutations cause cardiac defects as a cardinal feature of CHIME syndrome, requiring cardiac surveillance in affected individuals."", ""reference"": ""PMID:22444671"", ""snippet"": ""CHIME syndrome is characterized by colobomas, heart defects, ichthyosiform dermatosis, mental retardation (intellectual disability), and ear anomalies"", ""supports"": ""SUPPORT""}"
1507	1250	53	CHIME_syndrome	CHIME_syndrome.yaml	phenotypes	2	evidence	0	PMID:22444671	SUPPORT		CHIME syndrome is characterized by colobomas, heart defects, ichthyosiform dermatosis, mental retardation (intellectual disability), and ear anomalies	Landmark study identifying migratory ichthyosiform dermatosis as a defining feature of PIGL-related CHIME syndrome.	"{""explanation"": ""Landmark study identifying migratory ichthyosiform dermatosis as a defining feature of PIGL-related CHIME syndrome."", ""reference"": ""PMID:22444671"", ""snippet"": ""CHIME syndrome is characterized by colobomas, heart defects, ichthyosiform dermatosis, mental retardation (intellectual disability), and ear anomalies"", ""supports"": ""SUPPORT""}"
1508	1251	53	CHIME_syndrome	CHIME_syndrome.yaml	phenotypes	3	evidence	0	PMID:22444671	SUPPORT		CHIME syndrome is characterized by colobomas, heart defects, ichthyosiform dermatosis, mental retardation (intellectual disability), and ear anomalies	Landmark study establishing intellectual disability as a defining feature of CHIME syndrome caused by PIGL mutations.	"{""explanation"": ""Landmark study establishing intellectual disability as a defining feature of CHIME syndrome caused by PIGL mutations."", ""reference"": ""PMID:22444671"", ""snippet"": ""CHIME syndrome is characterized by colobomas, heart defects, ichthyosiform dermatosis, mental retardation (intellectual disability), and ear anomalies"", ""supports"": ""SUPPORT""}"
1509	1252	53	CHIME_syndrome	CHIME_syndrome.yaml	phenotypes	4	evidence	0	PMID:22444671	SUPPORT		CHIME syndrome is characterized by colobomas, heart defects, ichthyosiform dermatosis, mental retardation (intellectual disability), and ear anomalies, including conductive hearing loss	Landmark PIGL mutation study documenting conductive hearing loss and ear anomalies as defining features of CHIME syndrome.	"{""explanation"": ""Landmark PIGL mutation study documenting conductive hearing loss and ear anomalies as defining features of CHIME syndrome."", ""reference"": ""PMID:22444671"", ""snippet"": ""CHIME syndrome is characterized by colobomas, heart defects, ichthyosiform dermatosis, mental retardation (intellectual disability), and ear anomalies, including conductive hearing loss"", ""supports"": ""SUPPORT""}"
1510	1253	53	CHIME_syndrome	CHIME_syndrome.yaml	phenotypes	5	evidence	0	PMID:7666399	SUPPORT		The main features include ocular colobomas, congenital heart disease, early onset migratory ichthyosiform dermatosis, mental retardation, conductive hearing loss, seizures, and typical facial features.	Early case series documenting seizures as a defining feature of CHIME syndrome alongside cardinal features.	"{""explanation"": ""Early case series documenting seizures as a defining feature of CHIME syndrome alongside cardinal features."", ""reference"": ""PMID:7666399"", ""snippet"": ""The main features include ocular colobomas, congenital heart disease, early onset migratory ichthyosiform dermatosis, mental retardation, conductive hearing loss, seizures, and typical facial features."", ""supports"": ""SUPPORT""}"
1511	1253	53	CHIME_syndrome	CHIME_syndrome.yaml	phenotypes	5	evidence	1	PMID:7666399	SUPPORT		Long term follow up information on this patient, as well as the previously described cases, provides information regarding the outcome for these patients, which includes general good health, severe mental retardation, seizures that worsen after puberty, conductive hearing loss, and chronic migratory ichthyosiform skin rash without scarring.	Long-term follow-up data documenting that seizures are a persistent feature that may worsen after puberty in CHIME syndrome.	"{""explanation"": ""Long-term follow-up data documenting that seizures are a persistent feature that may worsen after puberty in CHIME syndrome."", ""reference"": ""PMID:7666399"", ""snippet"": ""Long term follow up information on this patient, as well as the previously described cases, provides information regarding the outcome for these patients, which includes general good health, severe mental retardation, seizures that worsen after puberty, conductive hearing loss, and chronic migratory ichthyosiform skin rash without scarring."", ""supports"": ""SUPPORT""}"
1512	1254	53	CHIME_syndrome	CHIME_syndrome.yaml	phenotypes	6	evidence	0	PMID:7666399	SUPPORT		The main features include ocular colobomas, congenital heart disease, early onset migratory ichthyosiform dermatosis, mental retardation, conductive hearing loss, seizures, and typical facial features.	Early case series identifying typical facial features as a consistent manifestation of CHIME syndrome.	"{""explanation"": ""Early case series identifying typical facial features as a consistent manifestation of CHIME syndrome."", ""reference"": ""PMID:7666399"", ""snippet"": ""The main features include ocular colobomas, congenital heart disease, early onset migratory ichthyosiform dermatosis, mental retardation, conductive hearing loss, seizures, and typical facial features."", ""supports"": ""SUPPORT""}"
1513	1256	53	CHIME_syndrome	CHIME_syndrome.yaml	phenotypes	8	evidence	0	PMID:9295069	SUPPORT		Her major problems included a migratory ichthyosiform dermatosis, multiple skin infections and infestations, bilateral retinal coloboma, developmental delay, seizures, infantile macrosomia, facial anomalies, a duplicated renal collecting system, and conductive hearing loss.	Schnur et al. 1997 documents infantile macrosomia as a clinical feature in a CHIME syndrome patient, expanding the growth-related phenotype spectrum.	"{""explanation"": ""Schnur et al. 1997 documents infantile macrosomia as a clinical feature in a CHIME syndrome patient, expanding the growth-related phenotype spectrum."", ""reference"": ""PMID:9295069"", ""snippet"": ""Her major problems included a migratory ichthyosiform dermatosis, multiple skin infections and infestations, bilateral retinal coloboma, developmental delay, seizures, infantile macrosomia, facial anomalies, a duplicated renal collecting system, and conductive hearing loss."", ""supports"": ""SUPPORT""}"
1523	1271	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	phenotypes	0	evidence	0	PMID:31239556	SUPPORT		Cognitive impairment was extremely variable, ranging from learning difficulties, normal IQ, and attending mainstream school or graduating from college in seven individuals to severe ID in three individuals.	Large cohort demonstrates highly variable cognitive impairment from normal IQ to severe intellectual disability.	"{""explanation"": ""Large cohort demonstrates highly variable cognitive impairment from normal IQ to severe intellectual disability."", ""reference"": ""PMID:31239556"", ""snippet"": ""Cognitive impairment was extremely variable, ranging from learning difficulties, normal IQ, and attending mainstream school or graduating from college in seven individuals to severe ID in three individuals."", ""supports"": ""SUPPORT""}"
1524	1271	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	phenotypes	0	evidence	1	PMID:23746550	SUPPORT		we now identified two de novo frameshift mutations and one de novo missense mutation in CTCF in individuals with intellectual disability, microcephaly, and growth retardation	Original identification of CTCF mutations in individuals with intellectual disability.	"{""explanation"": ""Original identification of CTCF mutations in individuals with intellectual disability."", ""reference"": ""PMID:23746550"", ""snippet"": ""we now identified two de novo frameshift mutations and one de novo missense mutation in CTCF in individuals with intellectual disability, microcephaly, and growth retardation"", ""supports"": ""SUPPORT""}"
1525	1272	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	phenotypes	1	evidence	0	PMID:31239556	SUPPORT		Walking age ranged from 12 months to three years, and age of first words from 12–18 months to lack of speech at age 12 years.	Cohort data showing variable but common developmental delay in motor and language milestones.	"{""explanation"": ""Cohort data showing variable but common developmental delay in motor and language milestones."", ""reference"": ""PMID:31239556"", ""snippet"": ""Walking age ranged from 12 months to three years, and age of first words from 12–18 months to lack of speech at age 12 years."", ""supports"": ""SUPPORT""}"
1526	1273	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	phenotypes	2	evidence	0	PMID:31239556	SUPPORT		failure to thrive or feeding difficulties, often requiring tube feeding, occurred in 23 individuals	Feeding difficulties requiring tube feeding in approximately 64% of cohort (23/36).	"{""explanation"": ""Feeding difficulties requiring tube feeding in approximately 64% of cohort (23/36)."", ""reference"": ""PMID:31239556"", ""snippet"": ""failure to thrive or feeding difficulties, often requiring tube feeding, occurred in 23 individuals"", ""supports"": ""SUPPORT""}"
1527	1274	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	phenotypes	3	evidence	0	PMID:31239556	SUPPORT		(borderline) microcephaly in 12 individuals	Microcephaly observed in approximately one-third of affected individuals (12/36).	"{""explanation"": ""Microcephaly observed in approximately one-third of affected individuals (12/36)."", ""reference"": ""PMID:31239556"", ""snippet"": ""(borderline) microcephaly in 12 individuals"", ""supports"": ""SUPPORT""}"
1528	1274	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	phenotypes	3	evidence	1	PMID:23746550	SUPPORT		we now identified two de novo frameshift mutations and one de novo missense mutation in CTCF in individuals with intellectual disability, microcephaly, and growth retardation	Microcephaly was part of the core phenotype in the original description.	"{""explanation"": ""Microcephaly was part of the core phenotype in the original description."", ""reference"": ""PMID:23746550"", ""snippet"": ""we now identified two de novo frameshift mutations and one de novo missense mutation in CTCF in individuals with intellectual disability, microcephaly, and growth retardation"", ""supports"": ""SUPPORT""}"
1529	1275	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	phenotypes	4	evidence	0	PMID:31239556	SUPPORT		Postnatal short stature was noted in 6	Short stature in approximately 17% of the cohort (6/36).	"{""explanation"": ""Short stature in approximately 17% of the cohort (6/36)."", ""reference"": ""PMID:31239556"", ""snippet"": ""Postnatal short stature was noted in 6"", ""supports"": ""SUPPORT""}"
1530	1275	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	phenotypes	4	evidence	1	PMID:23746550	SUPPORT		individuals with intellectual disability, microcephaly, and growth retardation	Growth retardation was part of the original phenotype description.	"{""explanation"": ""Growth retardation was part of the original phenotype description."", ""reference"": ""PMID:23746550"", ""snippet"": ""individuals with intellectual disability, microcephaly, and growth retardation"", ""supports"": ""SUPPORT""}"
1531	1276	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	phenotypes	5	evidence	0	PMID:31239556	SUPPORT		Behavioral anomalies such as autistic features, attention deficit and hyperactivity or aggressivity were common and reported in 24 individuals.	Behavioral abnormalities in approximately 67% of cohort (24/36).	"{""explanation"": ""Behavioral abnormalities in approximately 67% of cohort (24/36)."", ""reference"": ""PMID:31239556"", ""snippet"": ""Behavioral anomalies such as autistic features, attention deficit and hyperactivity or aggressivity were common and reported in 24 individuals."", ""supports"": ""SUPPORT""}"
1532	1277	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	phenotypes	6	evidence	0	PMID:31239556	SUPPORT		muscular hypotonia were noted	Hypotonia mentioned as one of the range of anomalies observed in the cohort.	"{""explanation"": ""Hypotonia mentioned as one of the range of anomalies observed in the cohort."", ""reference"": ""PMID:31239556"", ""snippet"": ""muscular hypotonia were noted"", ""supports"": ""SUPPORT""}"
1533	1278	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	phenotypes	7	evidence	0	PMID:31239556	SUPPORT		Cardiac defects occurred in 11 individuals	Cardiac defects in approximately 31% of cohort (11/36).	"{""explanation"": ""Cardiac defects in approximately 31% of cohort (11/36)."", ""reference"": ""PMID:31239556"", ""snippet"": ""Cardiac defects occurred in 11 individuals"", ""supports"": ""SUPPORT""}"
1534	1279	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	phenotypes	8	evidence	0	PMID:31239556	SUPPORT		palatal anomalies such as cleft palate or high palate were present in 12 individuals	Palatal anomalies in approximately 33% of cohort (12/36).	"{""explanation"": ""Palatal anomalies in approximately 33% of cohort (12/36)."", ""reference"": ""PMID:31239556"", ""snippet"": ""palatal anomalies such as cleft palate or high palate were present in 12 individuals"", ""supports"": ""SUPPORT""}"
1535	1280	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	phenotypes	9	evidence	0	PMID:31239556	SUPPORT		Conductive and/or sensorineuronal hearing loss were reported in 10	Hearing loss in approximately 28% of cohort (10/36).	"{""explanation"": ""Hearing loss in approximately 28% of cohort (10/36)."", ""reference"": ""PMID:31239556"", ""snippet"": ""Conductive and/or sensorineuronal hearing loss were reported in 10"", ""supports"": ""SUPPORT""}"
1536	1281	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	phenotypes	10	evidence	0	PMID:31239556	SUPPORT		Febrile or nonfebrile seizures or teeth anomalies occurred in four individuals	Seizures in approximately 11% of cohort (4/36).	"{""explanation"": ""Seizures in approximately 11% of cohort (4/36)."", ""reference"": ""PMID:31239556"", ""snippet"": ""Febrile or nonfebrile seizures or teeth anomalies occurred in four individuals"", ""supports"": ""SUPPORT""}"
1537	1282	54	CTCF-related Neurodevelopmental Disorder	CTCF-related_Neurodevelopmental_Disorder.yaml	phenotypes	11	evidence	0	PMID:31239556	SUPPORT		Minor facial dysmorphisms were frequently noted but did not point to a recognizable, typical facial gestalt	Facial features observed but not distinctive enough for clinical recognition.	"{""explanation"": ""Facial features observed but not distinctive enough for clinical recognition."", ""reference"": ""PMID:31239556"", ""snippet"": ""Minor facial dysmorphisms were frequently noted but did not point to a recognizable, typical facial gestalt"", ""supports"": ""SUPPORT""}"
1543	1303	55	Camptodactyly	Camptodactyly.yaml	phenotypes	0	evidence	0	PMID:29397575	SUPPORT		Camptodactyly was the first finding in 68% of patients (19 of the 28)	Documents camptodactyly as the most common presenting feature in CACP syndrome patients.	"{""explanation"": ""Documents camptodactyly as the most common presenting feature in CACP syndrome patients."", ""reference"": ""PMID:29397575"", ""snippet"": ""Camptodactyly was the first finding in 68% of patients (19 of the 28)"", ""supports"": ""SUPPORT""}"
1544	1305	55	Camptodactyly	Camptodactyly.yaml	phenotypes	2	evidence	0	PMID:29397575	SUPPORT		Large joint involvement was found in all of our patients and it included symmetrical noninflammatory arthropathy resulting in swelling, limited motion, and in flexion contractures.	Documents joint stiffness and limited motion as universal features in CACP patients.	"{""explanation"": ""Documents joint stiffness and limited motion as universal features in CACP patients."", ""reference"": ""PMID:29397575"", ""snippet"": ""Large joint involvement was found in all of our patients and it included symmetrical noninflammatory arthropathy resulting in swelling, limited motion, and in flexion contractures."", ""supports"": ""SUPPORT""}"
1552	1325	56	Cardiofaciocutaneous Syndrome	Cardiofaciocutaneous_Syndrome.yaml	phenotypes	6	evidence	0	PMID:38136934	SUPPORT	HUMAN_CLINICAL	Neurological involvement in CFC is more severe than in other RASopathies.	Review confirming that CFC syndrome has the most severe cognitive impairment among the RASopathy spectrum disorders.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review confirming that CFC syndrome has the most severe cognitive impairment among the RASopathy spectrum disorders."", ""reference"": ""PMID:38136934"", ""snippet"": ""Neurological involvement in CFC is more severe than in other RASopathies."", ""supports"": ""SUPPORT""}"
1553	1329	56	Cardiofaciocutaneous Syndrome	Cardiofaciocutaneous_Syndrome.yaml	phenotypes	10	evidence	0	PMID:36308388	SUPPORT	HUMAN_CLINICAL	Second and third trimester ultrasound abnormalities included polyhydramnios, macrocephaly, macrosomia, and renal and cardiac abnormalities.	Study of 43 CFC cases documenting prenatal phenotype including polyhydramnios as a manifestation of germline RAS/MAPK dysregulation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Study of 43 CFC cases documenting prenatal phenotype including polyhydramnios as a manifestation of germline RAS/MAPK dysregulation."", ""reference"": ""PMID:36308388"", ""snippet"": ""Second and third trimester ultrasound abnormalities included polyhydramnios, macrocephaly, macrosomia, and renal and cardiac abnormalities."", ""supports"": ""SUPPORT""}"
1564	1349	57	Celiac Disease	Celiac_Disease.yaml	phenotypes	0	evidence	0	PMID:39273359	SUPPORT		CD induces an altered immune response that leads to chronic inflammation and duodenal mucosal damage.	Chronic inflammation and mucosal damage from immune response to gluten leads to malabsorption and chronic diarrhea as a cardinal symptom.	"{""explanation"": ""Chronic inflammation and mucosal damage from immune response to gluten leads to malabsorption and chronic diarrhea as a cardinal symptom."", ""reference"": ""PMID:39273359"", ""snippet"": ""CD induces an altered immune response that leads to chronic inflammation and duodenal mucosal damage."", ""supports"": ""SUPPORT""}"
1565	1352	57	Celiac Disease	Celiac_Disease.yaml	phenotypes	3	evidence	0	PMID:38914866	SUPPORT		ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group.	Weight loss results from impaired nutrient absorption due to villous atrophy and loss of epithelial cell differentiation and absorptive capacity.	"{""explanation"": ""Weight loss results from impaired nutrient absorption due to villous atrophy and loss of epithelial cell differentiation and absorptive capacity."", ""reference"": ""PMID:38914866"", ""snippet"": ""ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group."", ""supports"": ""SUPPORT""}"
1566	1353	57	Celiac Disease	Celiac_Disease.yaml	phenotypes	4	evidence	0	PMID:38914866	SUPPORT		ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group.	Anemia results from malabsorption of iron and other nutrients due to villous atrophy and impaired epithelial absorptive function in damaged small intestine.	"{""explanation"": ""Anemia results from malabsorption of iron and other nutrients due to villous atrophy and impaired epithelial absorptive function in damaged small intestine."", ""reference"": ""PMID:38914866"", ""snippet"": ""ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group."", ""supports"": ""SUPPORT""}"
1571	1386	59	Chagas disease	Chagas_Disease.yaml	phenotypes	0	evidence	0	PMID:28284779	SUPPORT		Chagas cardiomyopathy (CC) is one of the chronic manifestations of Trypanosoma cruzi (T. cruzi) infection	The abstract identifies cardiomyopathy as a chronic manifestation of Chagas disease.	"{""explanation"": ""The abstract identifies cardiomyopathy as a chronic manifestation of Chagas disease."", ""reference"": ""PMID:28284779"", ""snippet"": ""Chagas cardiomyopathy (CC) is one of the chronic manifestations of Trypanosoma cruzi (T. cruzi) infection"", ""supports"": ""SUPPORT""}"
1572	1387	59	Chagas disease	Chagas_Disease.yaml	phenotypes	1	evidence	0	PMID:28284779	SUPPORT		Chagas etiology of heart failure has become the third most common indication for HT in South America.	The abstract links Chagas disease to heart failure requiring transplantation.	"{""explanation"": ""The abstract links Chagas disease to heart failure requiring transplantation."", ""reference"": ""PMID:28284779"", ""snippet"": ""Chagas etiology of heart failure has become the third most common indication for HT in South America."", ""supports"": ""SUPPORT""}"
1576	1391	60	Chikungunya	Chikungunya.yaml	phenotypes	0	evidence	0	PMID:17448935	SUPPORT		The disease typically consists of an acute illness characterised by fever, rash, and incapacitating arthralgia.	Fever is a typical feature of acute chikungunya.	"{""explanation"": ""Fever is a typical feature of acute chikungunya."", ""reference"": ""PMID:17448935"", ""snippet"": ""The disease typically consists of an acute illness characterised by fever, rash, and incapacitating arthralgia."", ""supports"": ""SUPPORT""}"
1577	1392	60	Chikungunya	Chikungunya.yaml	phenotypes	1	evidence	0	PMID:17448935	SUPPORT		The disease typically consists of an acute illness characterised by fever, rash, and incapacitating arthralgia.	Rash is a typical feature of acute chikungunya.	"{""explanation"": ""Rash is a typical feature of acute chikungunya."", ""reference"": ""PMID:17448935"", ""snippet"": ""The disease typically consists of an acute illness characterised by fever, rash, and incapacitating arthralgia."", ""supports"": ""SUPPORT""}"
1578	1393	60	Chikungunya	Chikungunya.yaml	phenotypes	2	evidence	0	PMID:17448935	SUPPORT		The disease typically consists of an acute illness characterised by fever, rash, and incapacitating arthralgia.	Arthralgia is a hallmark of acute chikungunya.	"{""explanation"": ""Arthralgia is a hallmark of acute chikungunya."", ""reference"": ""PMID:17448935"", ""snippet"": ""The disease typically consists of an acute illness characterised by fever, rash, and incapacitating arthralgia."", ""supports"": ""SUPPORT""}"
1681	1432	61	Cholera	Cholera.yaml	phenotypes	0	evidence	0	PMID:14738797	SUPPORT		Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock.	The provided excerpt supports the statement that profuse watery diarrhea is a very frequent diagnostic phenotype of cholera and that it leads to severe dehydration and shock.	"{""explanation"": ""The provided excerpt supports the statement that profuse watery diarrhea is a very frequent diagnostic phenotype of cholera and that it leads to severe dehydration and shock."", ""reference"": ""PMID:14738797"", ""snippet"": ""Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock."", ""supports"": ""SUPPORT""}"
1682	1432	61	Cholera	Cholera.yaml	phenotypes	0	evidence	1	PMID:34523840	SUPPORT		Her stool was watery, with flecks of mucous, also referred to as 'rice-water' stool, which is typical for cholera and can amount to 1000 cc/hour.	This case study supports the characterization of profuse watery diarrhea as a very frequent diagnostic phenotype of cholera.	"{""explanation"": ""This case study supports the characterization of profuse watery diarrhea as a very frequent diagnostic phenotype of cholera."", ""reference"": ""PMID:34523840"", ""snippet"": ""Her stool was watery, with flecks of mucous, also referred to as 'rice-water' stool, which is typical for cholera and can amount to 1000 cc/hour."", ""supports"": ""SUPPORT""}"
1683	1432	61	Cholera	Cholera.yaml	phenotypes	0	evidence	2	PMID:29488455	SUPPORT		Adding dehydration, vomiting, or rice water stools to the case definition could increase the specificity without a substantial decrease in sensitivity.	This study supports that rice-water stools (a form of profuse watery diarrhea) are indicative of cholera and frequently used in its diagnosis.	"{""explanation"": ""This study supports that rice-water stools (a form of profuse watery diarrhea) are indicative of cholera and frequently used in its diagnosis."", ""reference"": ""PMID:29488455"", ""snippet"": ""Adding dehydration, vomiting, or rice water stools to the case definition could increase the specificity without a substantial decrease in sensitivity."", ""supports"": ""SUPPORT""}"
1684	1432	61	Cholera	Cholera.yaml	phenotypes	0	evidence	3	PMID:820813	SUPPORT		The severity of diarrhea and nutritional status were measured in a prospective study of 97 patients hospitalized with cholera in Dacca, Bangladesh... The increased stool loss was unrelated to antibiotic usage, to presence of intestinal parasites, or to the refeeding diet given.	The study supports that profuse watery diarrhea is a very frequent diagnostic phenotype of cholera.	"{""explanation"": ""The study supports that profuse watery diarrhea is a very frequent diagnostic phenotype of cholera."", ""reference"": ""PMID:820813"", ""snippet"": ""The severity of diarrhea and nutritional status were measured in a prospective study of 97 patients hospitalized with cholera in Dacca, Bangladesh... The increased stool loss was unrelated to antibiotic usage, to presence of intestinal parasites, or to the refeeding diet given."", ""supports"": ""SUPPORT""}"
1685	1432	61	Cholera	Cholera.yaml	phenotypes	0	evidence	4	PMID:27412979	SUPPORT		Choleriform diarrhea and vomiting were the main signs, found respectively in 100% and 95% of the women; dehydration was mild for 16%, moderate for 45%, and severe for 39%.	This study supports that profuse watery diarrhea (choleriform diarrhea) is a very frequent diagnostic phenotype of cholera.	"{""explanation"": ""This study supports that profuse watery diarrhea (choleriform diarrhea) is a very frequent diagnostic phenotype of cholera."", ""reference"": ""PMID:27412979"", ""snippet"": ""Choleriform diarrhea and vomiting were the main signs, found respectively in 100% and 95% of the women; dehydration was mild for 16%, moderate for 45%, and severe for 39%."", ""supports"": ""SUPPORT""}"
1686	1432	61	Cholera	Cholera.yaml	phenotypes	0	evidence	5	PMID:38702080	SUPPORT		The most common complications reported at admission and during hospitalisation included electrolyte imbalance (28.2%), followed by severe dehydration (16.3%).	This study supports that watery diarrhea leading to severe dehydration is a frequent phenotype of cholera.	"{""explanation"": ""This study supports that watery diarrhea leading to severe dehydration is a frequent phenotype of cholera."", ""reference"": ""PMID:38702080"", ""snippet"": ""The most common complications reported at admission and during hospitalisation included electrolyte imbalance (28.2%), followed by severe dehydration (16.3%)."", ""supports"": ""SUPPORT""}"
1687	1433	61	Cholera	Cholera.yaml	phenotypes	1	evidence	0	PMID:28448489	SUPPORT		Vibrio cholerae was the most common pathogen isolated (12,405 patients; 22%), and had the strongest association with SD (AOR 4.77; 95% CI: 4.41-5.51).	The article notes that Vibrio cholerae was the most common pathogen with a strong association with severe dehydration, which aligns with the statement.	"{""explanation"": ""The article notes that Vibrio cholerae was the most common pathogen with a strong association with severe dehydration, which aligns with the statement."", ""reference"": ""PMID:28448489"", ""snippet"": ""Vibrio cholerae was the most common pathogen isolated (12,405 patients; 22%), and had the strongest association with SD (AOR 4.77; 95% CI: 4.41-5.51)."", ""supports"": ""SUPPORT""}"
1688	1433	61	Cholera	Cholera.yaml	phenotypes	1	evidence	1	PMID:15367740	PARTIAL		A patient presented with cholera and a severe degree of ECF volume contraction. Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal.	The study discusses severe dehydration, but also mentions metabolic and respiratory complications without specifically noting frequency.	"{""explanation"": ""The study discusses severe dehydration, but also mentions metabolic and respiratory complications without specifically noting frequency."", ""reference"": ""PMID:15367740"", ""snippet"": ""A patient presented with cholera and a severe degree of ECF volume contraction. Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal."", ""supports"": ""PARTIAL""}"
1689	1433	61	Cholera	Cholera.yaml	phenotypes	1	evidence	2	PMID:33252133	PARTIAL		It was later confirmed that he was suffering from cholera. On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock.	This article discusses a specific case of cholera leading to severe dehydration and hypovolemic shock, but does not provide frequency data.	"{""explanation"": ""This article discusses a specific case of cholera leading to severe dehydration and hypovolemic shock, but does not provide frequency data."", ""reference"": ""PMID:33252133"", ""snippet"": ""It was later confirmed that he was suffering from cholera. On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock."", ""supports"": ""PARTIAL""}"
1690	1434	61	Cholera	Cholera.yaml	phenotypes	2	evidence	0	PMID:33252133	SUPPORT		The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement. In the following case... he was suffering from cholera. On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock.	This case description demonstrates that hypovolemic shock is an occasional systemic consequence of cholera due to excessive fluid loss.	"{""explanation"": ""This case description demonstrates that hypovolemic shock is an occasional systemic consequence of cholera due to excessive fluid loss."", ""reference"": ""PMID:33252133"", ""snippet"": ""The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement. In the following case... he was suffering from cholera. On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock."", ""supports"": ""SUPPORT""}"
1691	1434	61	Cholera	Cholera.yaml	phenotypes	2	evidence	1	PMID:14738797	SUPPORT		Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock.	This abstract highlights that severe dehydration caused by cholera often leads to shock, supporting the claim.	"{""explanation"": ""This abstract highlights that severe dehydration caused by cholera often leads to shock, supporting the claim."", ""reference"": ""PMID:14738797"", ""snippet"": ""Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock."", ""supports"": ""SUPPORT""}"
1692	1435	61	Cholera	Cholera.yaml	phenotypes	3	evidence	0	PMID:34523840	SUPPORT		A 28-year-old female presented with severe dehydration due to acute diarrhea and vomiting, which she developed after returning from a vacation in Togo	This reference supports the statement by describing a case of severe dehydration due to cholera, highlighting its systemic nature and the rapid onset of severe symptoms.	"{""explanation"": ""This reference supports the statement by describing a case of severe dehydration due to cholera, highlighting its systemic nature and the rapid onset of severe symptoms."", ""reference"": ""PMID:34523840"", ""snippet"": ""A 28-year-old female presented with severe dehydration due to acute diarrhea and vomiting, which she developed after returning from a vacation in Togo"", ""supports"": ""SUPPORT""}"
1693	1435	61	Cholera	Cholera.yaml	phenotypes	3	evidence	1	PMID:31668817	SUPPORT		Cholera still affects about three million people a year and kills approximately 100,000. Cholera can be effectively managed in the majority of cases with oral rehydration solution alone. Up to one third of patients present with severe dehydration, which can be diagnosed clinically, and will require rapid intravenous rehydration with Ringers Lactate or other appropriate fluid before being managed with oral rehydration solution.	This reference supports the statement by noting that severe dehydration is a common and critical condition in cholera patients, which can lead to death if untreated.	"{""explanation"": ""This reference supports the statement by noting that severe dehydration is a common and critical condition in cholera patients, which can lead to death if untreated."", ""reference"": ""PMID:31668817"", ""snippet"": ""Cholera still affects about three million people a year and kills approximately 100,000. Cholera can be effectively managed in the majority of cases with oral rehydration solution alone. Up to one third of patients present with severe dehydration, which can be diagnosed clinically, and will require rapid intravenous rehydration with Ringers Lactate or other appropriate fluid before being managed with oral rehydration solution."", ""supports"": ""SUPPORT""}"
1694	1435	61	Cholera	Cholera.yaml	phenotypes	3	evidence	2	PMID:33252133	SUPPORT		The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement.	This reference supports the systemic impact of cholera, including dehydration, which can lead to severe complications and death.	"{""explanation"": ""This reference supports the systemic impact of cholera, including dehydration, which can lead to severe complications and death."", ""reference"": ""PMID:33252133"", ""snippet"": ""The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement."", ""supports"": ""SUPPORT""}"
1695	1436	61	Cholera	Cholera.yaml	phenotypes	4	evidence	0	PMID:14738797	SUPPORT		Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock.	The reference states that cholera leads to severe dehydration and shock, which aligns with the statement indicating that cholera can occasionally cause hypovolemic shock due to severe dehydration.	"{""explanation"": ""The reference states that cholera leads to severe dehydration and shock, which aligns with the statement indicating that cholera can occasionally cause hypovolemic shock due to severe dehydration."", ""reference"": ""PMID:14738797"", ""snippet"": ""Intestinal infection with Vibrio cholerae results in the loss of large volumes of watery stool, leading to severe and rapidly progressing dehydration and shock."", ""supports"": ""SUPPORT""}"
1696	1436	61	Cholera	Cholera.yaml	phenotypes	4	evidence	1	PMID:4869291	SUPPORT		Hemodynamic studies on cholera. Effects of hypovolemia and acidosis.	The title of the reference suggests that hypovolemia, which can lead to hypovolemic shock, is a significant effect of cholera.	"{""explanation"": ""The title of the reference suggests that hypovolemia, which can lead to hypovolemic shock, is a significant effect of cholera."", ""reference"": ""PMID:4869291"", ""snippet"": ""Hemodynamic studies on cholera. Effects of hypovolemia and acidosis."", ""supports"": ""SUPPORT""}"
1697	1436	61	Cholera	Cholera.yaml	phenotypes	4	evidence	2	PMID:33252133	SUPPORT		The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement.	The reference confirms that cholera causes hypovolemia, which can lead to hypovolemic shock, supporting the statement.	"{""explanation"": ""The reference confirms that cholera causes hypovolemia, which can lead to hypovolemic shock, supporting the statement."", ""reference"": ""PMID:33252133"", ""snippet"": ""The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement."", ""supports"": ""SUPPORT""}"
1698	1437	61	Cholera	Cholera.yaml	phenotypes	5	evidence	0	PMID:5300879	SUPPORT		Hypokalaemic patterns were seen in 40% of the cases in the acute stage (during rehydration). This pattern became more marked after rehydration and disappeared gradually within 3-7 days.	The study indicates that hypokalemia is a frequent occurrence in cholera patients, particularly during the acute stage and rehydration process.	"{""explanation"": ""The study indicates that hypokalemia is a frequent occurrence in cholera patients, particularly during the acute stage and rehydration process."", ""reference"": ""PMID:5300879"", ""snippet"": ""Hypokalaemic patterns were seen in 40% of the cases in the acute stage (during rehydration). This pattern became more marked after rehydration and disappeared gradually within 3-7 days."", ""supports"": ""SUPPORT""}"
1699	1437	61	Cholera	Cholera.yaml	phenotypes	5	evidence	1	PMID:33252133	NO_EVIDENCE		On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock.	This case report mentions hyperkalemia in a cholera patient, not hypokalemia. Therefore, it does not support the statement about frequent hypokalemia in cholera.	"{""explanation"": ""This case report mentions hyperkalemia in a cholera patient, not hypokalemia. Therefore, it does not support the statement about frequent hypokalemia in cholera."", ""reference"": ""PMID:33252133"", ""snippet"": ""On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock."", ""supports"": ""NO_EVIDENCE""}"
1700	1437	61	Cholera	Cholera.yaml	phenotypes	5	evidence	2	PMID:28957470	PARTIAL		Severe cholera is a life-threatening illness of hypovolemic shock and metabolic acidosis due to rapid and profuse diarrheal fluid loss. Emergency life-saving therapy is i.v. saline, optionally supplemented with potassium and alkali to correct the fluid deficit, potassium losses and acidosis.	The reference mentions potassium losses as part of the treatment for severe cholera, which indirectly suggests hypokalemia might occur, but it does not provide direct evidence of its frequency.	"{""explanation"": ""The reference mentions potassium losses as part of the treatment for severe cholera, which indirectly suggests hypokalemia might occur, but it does not provide direct evidence of its frequency."", ""reference"": ""PMID:28957470"", ""snippet"": ""Severe cholera is a life-threatening illness of hypovolemic shock and metabolic acidosis due to rapid and profuse diarrheal fluid loss. Emergency life-saving therapy is i.v. saline, optionally supplemented with potassium and alkali to correct the fluid deficit, potassium losses and acidosis."", ""supports"": ""PARTIAL""}"
1701	1438	61	Cholera	Cholera.yaml	phenotypes	6	evidence	0	PMID:15367740	SUPPORT		A patient presented with cholera and a severe degree of ECF volume contraction. Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal. A detailed analysis emphasizing principles of physiology and a quantitative approach provided new insights and eventually better definitions of metabolic and respiratory acidosis.	The study discusses the presence of metabolic acidosis in a cholera patient, supporting the statement.	"{""explanation"": ""The study discusses the presence of metabolic acidosis in a cholera patient, supporting the statement."", ""reference"": ""PMID:15367740"", ""snippet"": ""A patient presented with cholera and a severe degree of ECF volume contraction. Despite large losses of bicarbonate (HCO3-)-containing diarrhoeal fluid, laboratory acid-base values were remarkably close to normal. A detailed analysis emphasizing principles of physiology and a quantitative approach provided new insights and eventually better definitions of metabolic and respiratory acidosis."", ""supports"": ""SUPPORT""}"
1702	1438	61	Cholera	Cholera.yaml	phenotypes	6	evidence	1	PMID:33252133	SUPPORT		The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement.	Electrolyte derangement in cholera can lead to conditions like metabolic acidosis, supporting the statement.	"{""explanation"": ""Electrolyte derangement in cholera can lead to conditions like metabolic acidosis, supporting the statement."", ""reference"": ""PMID:33252133"", ""snippet"": ""The morbidity and mortality of cholera is resultant from large-volume diarrhea, hypovolemia, and electrolyte derangement."", ""supports"": ""SUPPORT""}"
1703	1438	61	Cholera	Cholera.yaml	phenotypes	6	evidence	2	PMID:5697815	SUPPORT		Oral maintenance of water-electrolyte and acid-base balance in cholera: a preliminary report.	The mention of acid-base balance in cholera suggests a frequent occurrence of metabolic acidosis, supporting the statement.	"{""explanation"": ""The mention of acid-base balance in cholera suggests a frequent occurrence of metabolic acidosis, supporting the statement."", ""reference"": ""PMID:5697815"", ""snippet"": ""Oral maintenance of water-electrolyte and acid-base balance in cholera: a preliminary report."", ""supports"": ""SUPPORT""}"
1704	1439	61	Cholera	Cholera.yaml	phenotypes	7	evidence	0	PMID:33252133	PARTIAL		On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock.	The case study mentions muscle cramping as a symptom in a patient with cholera, but does not explicitly link it to electrolyte imbalances.	"{""explanation"": ""The case study mentions muscle cramping as a symptom in a patient with cholera, but does not explicitly link it to electrolyte imbalances."", ""reference"": ""PMID:33252133"", ""snippet"": ""On presentation, he was hyperkalemic with ECG changes and soon went into a hypovolemic shock."", ""supports"": ""PARTIAL""}"
1705	1439	61	Cholera	Cholera.yaml	phenotypes	7	evidence	1	PMID:29857264	NO_EVIDENCE		Literature analysis indicates that neuromuscular hypothesis may prevails over the initial hypothesis of the dehydration as the trigger event of muscle cramps.	This review focuses on the neuromuscular hypothesis for muscle cramps and does not provide evidence linking muscle cramps to electrolyte imbalances specifically in cholera.	"{""explanation"": ""This review focuses on the neuromuscular hypothesis for muscle cramps and does not provide evidence linking muscle cramps to electrolyte imbalances specifically in cholera."", ""reference"": ""PMID:29857264"", ""snippet"": ""Literature analysis indicates that neuromuscular hypothesis may prevails over the initial hypothesis of the dehydration as the trigger event of muscle cramps."", ""supports"": ""NO_EVIDENCE""}"
1706	1439	61	Cholera	Cholera.yaml	phenotypes	7	evidence	2	PMID:9694423	NO_EVIDENCE		Cramps occur during or after exercise regardless of whether the exercise is performed in the heat or the cold, or in water.	The review discusses muscle cramps in the context of exercise and heat illness, but does not relate it to cholera or electrolyte imbalances.	"{""explanation"": ""The review discusses muscle cramps in the context of exercise and heat illness, but does not relate it to cholera or electrolyte imbalances."", ""reference"": ""PMID:9694423"", ""snippet"": ""Cramps occur during or after exercise regardless of whether the exercise is performed in the heat or the cold, or in water."", ""supports"": ""NO_EVIDENCE""}"
1775	1467	62	Chromoblastomycosis	Chromoblastomycosis.yaml	phenotypes	0	evidence	0	PMID:20711281	SUPPORT		Several months after the injury, painless papules or nodules appear on the affected area; these papules then progress to scaly and verrucose plaques.	The abstract describes papules that progress to verrucose plaques.	"{""explanation"": ""The abstract describes papules that progress to verrucose plaques."", ""reference"": ""PMID:20711281"", ""snippet"": ""Several months after the injury, painless papules or nodules appear on the affected area; these papules then progress to scaly and verrucose plaques."", ""supports"": ""SUPPORT""}"
1776	1468	62	Chromoblastomycosis	Chromoblastomycosis.yaml	phenotypes	1	evidence	0	PMID:20711281	SUPPORT		Several months after the injury, painless papules or nodules appear on the affected area; these papules then progress to scaly and verrucose plaques.	The abstract describes progression to verrucose plaques.	"{""explanation"": ""The abstract describes progression to verrucose plaques."", ""reference"": ""PMID:20711281"", ""snippet"": ""Several months after the injury, painless papules or nodules appear on the affected area; these papules then progress to scaly and verrucose plaques."", ""supports"": ""SUPPORT""}"
1783	1478	63	Chronic Inflammatory Demyelinating Polyneuropathy	Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml	phenotypes	2	evidence	0	PMID:38330421	SUPPORT		Sensory CIDP was diagnosed when two inclusion criteria are met: 1) acquired, chronic progressive or relapsing symmetrical or asymmetrical sensory polyneuropathy that had progressed for >2 months.	This clinical study establishes sensory polyneuropathy as a diagnostic criterion and key phenotype of sensory CIDP variant, demonstrating that sensory loss is a prominent and treatable feature in CIDP.	"{""explanation"": ""This clinical study establishes sensory polyneuropathy as a diagnostic criterion and key phenotype of sensory CIDP variant, demonstrating that sensory loss is a prominent and treatable feature in CIDP."", ""reference"": ""PMID:38330421"", ""snippet"": ""Sensory CIDP was diagnosed when two inclusion criteria are met: 1) acquired, chronic progressive or relapsing symmetrical or asymmetrical sensory polyneuropathy that had progressed for >2 months."", ""supports"": ""SUPPORT""}"
1792	1504	64	Chronic Kidney Disease	Chronic_Kidney_Disease.yaml	phenotypes	1	evidence	0	PMID:37857763	SUPPORT		However, excess ROS can be pathological, and contribute to the development and progression of chronic diseases.	Excess ROS contributes to tubular and glomerular injury that manifests as proteinuria, a hallmark of CKD progression.	"{""explanation"": ""Excess ROS contributes to tubular and glomerular injury that manifests as proteinuria, a hallmark of CKD progression."", ""reference"": ""PMID:37857763"", ""snippet"": ""However, excess ROS can be pathological, and contribute to the development and progression of chronic diseases."", ""supports"": ""SUPPORT""}"
1853	1592	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	0	evidence	0	PMID:28277858	SUPPORT		Indeed, it is an important symptom in chronic obstructive pulmonary disease (COPD), where it is associated with limited physical activity, increased anxiety and depression, decreased health-related quality of life (HRQoL), and reduced survival.	The literature supports that dyspnea is a common symptom in COPD and is frequently observed in patients, confirming its categorization as a respiratory phenotype with diagnostic importance.	"{""explanation"": ""The literature supports that dyspnea is a common symptom in COPD and is frequently observed in patients, confirming its categorization as a respiratory phenotype with diagnostic importance."", ""reference"": ""PMID:28277858"", ""snippet"": ""Indeed, it is an important symptom in chronic obstructive pulmonary disease (COPD), where it is associated with limited physical activity, increased anxiety and depression, decreased health-related quality of life (HRQoL), and reduced survival."", ""supports"": ""SUPPORT""}"
1854	1592	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	0	evidence	1	PMID:35698999	SUPPORT		Dyspnoea and pain are symptoms of chronic obstructive pulmonary disease (COPD)... The pooled prevalence of pain and dyspnoea was 44% (95% confidence interval (CI) 35%-52%) and 91% (95% CI 87%-94%) respectively.	This study highlights the high prevalence of dyspnea in patients with COPD, further supporting its status as a very frequent respiratory phenotype.	"{""explanation"": ""This study highlights the high prevalence of dyspnea in patients with COPD, further supporting its status as a very frequent respiratory phenotype."", ""reference"": ""PMID:35698999"", ""snippet"": ""Dyspnoea and pain are symptoms of chronic obstructive pulmonary disease (COPD)... The pooled prevalence of pain and dyspnoea was 44% (95% confidence interval (CI) 35%-52%) and 91% (95% CI 87%-94%) respectively."", ""supports"": ""SUPPORT""}"
1855	1592	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	0	evidence	2	PMID:34972922	SUPPORT		Up to date research has shown a positive correlation between the elevated levels of some markers of EBC such as H2O2 and 8-isoprostane and dyspnea, while others present ambiguous results	The correlation between dyspnea and COPD is reinforced by the positive association found with certain markers in exhaled breath condensate.	"{""explanation"": ""The correlation between dyspnea and COPD is reinforced by the positive association found with certain markers in exhaled breath condensate."", ""reference"": ""PMID:34972922"", ""snippet"": ""Up to date research has shown a positive correlation between the elevated levels of some markers of EBC such as H2O2 and 8-isoprostane and dyspnea, while others present ambiguous results"", ""supports"": ""SUPPORT""}"
1856	1593	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	1	evidence	0	PMID:29881269	SUPPORT		Compared with patients without chronic cough, those with chronic cough exhibited a lower forced expiratory volume in 1 second (% predicted) and diffusing capacity of the lungs for carbon monoxide (% predicted), more frequent AECOPD, more severe dyspnea, and worse QoL.	The study identifies chronic cough as a common and significant phenotype in COPD patients, indicating its very frequent occurrence and diagnostic importance.	"{""explanation"": ""The study identifies chronic cough as a common and significant phenotype in COPD patients, indicating its very frequent occurrence and diagnostic importance."", ""reference"": ""PMID:29881269"", ""snippet"": ""Compared with patients without chronic cough, those with chronic cough exhibited a lower forced expiratory volume in 1 second (% predicted) and diffusing capacity of the lungs for carbon monoxide (% predicted), more frequent AECOPD, more severe dyspnea, and worse QoL."", ""supports"": ""SUPPORT""}"
1857	1593	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	1	evidence	1	PMID:31740261	SUPPORT		COPD is now widely accepted as a heterogeneous condition with multiple phenotypes and endotypes. This review will discuss the old and new concepts for the different types of COPD phenotypes.	The statement mentions the heterogeneity of COPD with multiple phenotypes, which could include phenotypes like chronic cough.	"{""explanation"": ""The statement mentions the heterogeneity of COPD with multiple phenotypes, which could include phenotypes like chronic cough."", ""reference"": ""PMID:31740261"", ""snippet"": ""COPD is now widely accepted as a heterogeneous condition with multiple phenotypes and endotypes. This review will discuss the old and new concepts for the different types of COPD phenotypes."", ""supports"": ""SUPPORT""}"
1858	1594	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	2	evidence	0	PMID:22753831	SUPPORT		Chronic cough and sputum production: a clinical COPD phenotype?	The title of the article itself suggests that sputum production is recognized as a phenotype of COPD.	"{""explanation"": ""The title of the article itself suggests that sputum production is recognized as a phenotype of COPD."", ""reference"": ""PMID:22753831"", ""snippet"": ""Chronic cough and sputum production: a clinical COPD phenotype?"", ""supports"": ""SUPPORT""}"
1859	1594	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	2	evidence	1	PMID:23204254	SUPPORT		Chronic bronchitis (CB) is a common but variable phenomenon in chronic obstructive pulmonary disease (COPD).	Chronic bronchitis, which involves overproduction and hypersecretion of mucus, is described as a common phenomenon in COPD, indicating sputum production is a frequent COPD phenotype.	"{""explanation"": ""Chronic bronchitis, which involves overproduction and hypersecretion of mucus, is described as a common phenomenon in COPD, indicating sputum production is a frequent COPD phenotype."", ""reference"": ""PMID:23204254"", ""snippet"": ""Chronic bronchitis (CB) is a common but variable phenomenon in chronic obstructive pulmonary disease (COPD)."", ""supports"": ""SUPPORT""}"
1860	1595	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	3	evidence	0	PMID:33302722	SUPPORT		The clinical symptoms of this disease include progressive dyspnea, cough, expectoration, and wheezing, among others.	The abstract mentions wheezing as one of the clinical symptoms of Chronic Obstructive Pulmonary Disease (COPD).	"{""explanation"": ""The abstract mentions wheezing as one of the clinical symptoms of Chronic Obstructive Pulmonary Disease (COPD)."", ""reference"": ""PMID:33302722"", ""snippet"": ""The clinical symptoms of this disease include progressive dyspnea, cough, expectoration, and wheezing, among others."", ""supports"": ""SUPPORT""}"
1861	1595	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	3	evidence	1	PMID:11963614	SUPPORT		Remember, all that wheezes is not asthma; therefore, providers in this case had to determine if the patient was suffering something such as anaphylaxis, asthma, bronchitis, pneumonia or even congestive heart failure (CHF).	The abstract indicates that wheezing can be a symptom of various conditions, including COPD-related bronchospasm.	"{""explanation"": ""The abstract indicates that wheezing can be a symptom of various conditions, including COPD-related bronchospasm."", ""reference"": ""PMID:11963614"", ""snippet"": ""Remember, all that wheezes is not asthma; therefore, providers in this case had to determine if the patient was suffering something such as anaphylaxis, asthma, bronchitis, pneumonia or even congestive heart failure (CHF)."", ""supports"": ""SUPPORT""}"
1862	1595	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	3	evidence	2	PMID:2404712	SUPPORT		Increased airways reactivity is present in 15 to 70 percent of patients with chronic airflow obstruction.	The abstract discusses increased airway reactivity, which is related to wheezing, in patients with chronic airflow obstruction, including COPD.	"{""explanation"": ""The abstract discusses increased airway reactivity, which is related to wheezing, in patients with chronic airflow obstruction, including COPD."", ""reference"": ""PMID:2404712"", ""snippet"": ""Increased airways reactivity is present in 15 to 70 percent of patients with chronic airflow obstruction."", ""supports"": ""SUPPORT""}"
1863	1596	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	4	evidence	0	PMID:25159007	PARTIAL		Lung hyperinflation is highly prevalent in patients with chronic obstructive pulmonary disease and occurs across the continuum of the disease.	The reference supports the association of lung hyperinflation with COPD but does not specifically mention 'Barrel Chest' or its frequency.	"{""explanation"": ""The reference supports the association of lung hyperinflation with COPD but does not specifically mention 'Barrel Chest' or its frequency."", ""reference"": ""PMID:25159007"", ""snippet"": ""Lung hyperinflation is highly prevalent in patients with chronic obstructive pulmonary disease and occurs across the continuum of the disease."", ""supports"": ""PARTIAL""}"
1864	1596	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	4	evidence	1	PMID:34972922	PARTIAL		Attempts to connect the products of the analysis of the EBC with the clinical manifestations of COPD such as dyspnea are scarce.	The reference discusses the clinical manifestations of COPD but does not specifically mention 'Barrel Chest' or its frequency.	"{""explanation"": ""The reference discusses the clinical manifestations of COPD but does not specifically mention 'Barrel Chest' or its frequency."", ""reference"": ""PMID:34972922"", ""snippet"": ""Attempts to connect the products of the analysis of the EBC with the clinical manifestations of COPD such as dyspnea are scarce."", ""supports"": ""PARTIAL""}"
1865	1596	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	4	evidence	2	PMID:23204254	NO_EVIDENCE		Chronic bronchitis (CB) is a common but variable phenomenon in chronic obstructive pulmonary disease (COPD).	The reference discusses chronic bronchitis in COPD but does not mention 'Barrel Chest' or its frequency.	"{""explanation"": ""The reference discusses chronic bronchitis in COPD but does not mention 'Barrel Chest' or its frequency."", ""reference"": ""PMID:23204254"", ""snippet"": ""Chronic bronchitis (CB) is a common but variable phenomenon in chronic obstructive pulmonary disease (COPD)."", ""supports"": ""NO_EVIDENCE""}"
1866	1597	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	5	evidence	0	PMID:14621114	REFUTE		Respiratory failure is still an important complication of chronic obstructive pulmonary disease (COPD) and hospitalisation with an acute episode being a poor prognostic marker.	The reference indicates that respiratory failure is an important and common complication of COPD, not an occasional one.	"{""explanation"": ""The reference indicates that respiratory failure is an important and common complication of COPD, not an occasional one."", ""reference"": ""PMID:14621114"", ""snippet"": ""Respiratory failure is still an important complication of chronic obstructive pulmonary disease (COPD) and hospitalisation with an acute episode being a poor prognostic marker."", ""supports"": ""REFUTE""}"
1867	1597	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	5	evidence	1	PMID:38692758	REFUTE		Hypoventilation is a complication that is not uncommon in chronic obstructive pulmonary disease and calls for both medical treatment of the underlying disease and, frequently, noninvasive ventilation either during exacerbations requiring hospitalization or in a chronic state in the patient at home.	The reference suggests that hypoventilation, which can lead to respiratory failure, is not uncommon in COPD.	"{""explanation"": ""The reference suggests that hypoventilation, which can lead to respiratory failure, is not uncommon in COPD."", ""reference"": ""PMID:38692758"", ""snippet"": ""Hypoventilation is a complication that is not uncommon in chronic obstructive pulmonary disease and calls for both medical treatment of the underlying disease and, frequently, noninvasive ventilation either during exacerbations requiring hospitalization or in a chronic state in the patient at home."", ""supports"": ""REFUTE""}"
1868	1598	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	6	evidence	0	PMID:33998496	SUPPORT		Fatigue: A neglected symptom of COPD.	The title itself indicates that fatigue is a recognized symptom of COPD.	"{""explanation"": ""The title itself indicates that fatigue is a recognized symptom of COPD."", ""reference"": ""PMID:33998496"", ""snippet"": ""Fatigue: A neglected symptom of COPD."", ""supports"": ""SUPPORT""}"
1869	1598	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	6	evidence	1	PMID:31729154	SUPPORT		Fatigue is an important yet ignored symptom of chronic obstructive pulmonary disease (COPD).	This reference acknowledges fatigue as an important symptom of COPD, supporting its frequent occurrence.	"{""explanation"": ""This reference acknowledges fatigue as an important symptom of COPD, supporting its frequent occurrence."", ""reference"": ""PMID:31729154"", ""snippet"": ""Fatigue is an important yet ignored symptom of chronic obstructive pulmonary disease (COPD)."", ""supports"": ""SUPPORT""}"
1870	1598	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	6	evidence	2	PMID:24874124	SUPPORT		Symptoms in COPD do not solely arise from the degree of airflow obstruction as exercise limitation is compounded by the specific secondary manifestations of the disease including skeletal muscle impairment, osteoporosis, mood disturbance, anemia, and hormonal imbalance.	While this reference does not mention fatigue explicitly, it discusses systemic manifestations of COPD, implying the systemic nature of the disease.	"{""explanation"": ""While this reference does not mention fatigue explicitly, it discusses systemic manifestations of COPD, implying the systemic nature of the disease."", ""reference"": ""PMID:24874124"", ""snippet"": ""Symptoms in COPD do not solely arise from the degree of airflow obstruction as exercise limitation is compounded by the specific secondary manifestations of the disease including skeletal muscle impairment, osteoporosis, mood disturbance, anemia, and hormonal imbalance."", ""supports"": ""SUPPORT""}"
1871	1599	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	7	evidence	0	PMID:12406664	SUPPORT		Weight loss occurs frequently in patients with chronic obstructive pulmonary disease (COPD).	The literature states that weight loss is a common phenomenon in COPD patients, which supports the statement that weight loss is a systemic issue in COPD, more common in advanced disease.	"{""explanation"": ""The literature states that weight loss is a common phenomenon in COPD patients, which supports the statement that weight loss is a systemic issue in COPD, more common in advanced disease."", ""reference"": ""PMID:12406664"", ""snippet"": ""Weight loss occurs frequently in patients with chronic obstructive pulmonary disease (COPD)."", ""supports"": ""SUPPORT""}"
1872	1599	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	7	evidence	1	PMID:18415812	SUPPORT		These include unintentional weight loss, skeletal muscle dysfunction, an increased risk of cardiovascular disease, osteoporosis, and depression, among others.	This reference mentions unintentional weight loss as one of the systemic effects of COPD, supporting the statement.	"{""explanation"": ""This reference mentions unintentional weight loss as one of the systemic effects of COPD, supporting the statement."", ""reference"": ""PMID:18415812"", ""snippet"": ""These include unintentional weight loss, skeletal muscle dysfunction, an increased risk of cardiovascular disease, osteoporosis, and depression, among others."", ""supports"": ""SUPPORT""}"
1873	1599	67	Chronic_Obstructive_Pulmonary_Disease	Chronic_Obstructive_Pulmonary_Disease.yaml	phenotypes	7	evidence	2	PMID:36922031	SUPPORT		COPD patients with psychological (high anxiety and depression) and cachectic (underweight and osteoporotic) comorbidity have higher mortality and exacerbate more.	The mention of cachexia (underweight) as a comorbidity in COPD patients aligns with the statement about weight loss being more common in advanced disease.	"{""explanation"": ""The mention of cachexia (underweight) as a comorbidity in COPD patients aligns with the statement about weight loss being more common in advanced disease."", ""reference"": ""PMID:36922031"", ""snippet"": ""COPD patients with psychological (high anxiety and depression) and cachectic (underweight and osteoporotic) comorbidity have higher mortality and exacerbate more."", ""supports"": ""SUPPORT""}"
1922	1632	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	phenotypes	0	evidence	0	PMID:38680261	SUPPORT		Pain in chronic pancreatitis (CP) is difficult to manage. Many patients suffer from inadequate pain relief, completely incapacitating them in their daily activities.	Chronic abdominal pain is a cardinal and often debilitating symptom of chronic pancreatitis.	"{""explanation"": ""Chronic abdominal pain is a cardinal and often debilitating symptom of chronic pancreatitis."", ""reference"": ""PMID:38680261"", ""snippet"": ""Pain in chronic pancreatitis (CP) is difficult to manage. Many patients suffer from inadequate pain relief, completely incapacitating them in their daily activities."", ""supports"": ""SUPPORT""}"
1923	1633	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	phenotypes	1	evidence	0	PMID:27941156	SUPPORT		PERT improved coefficient of nitrogen absorption, reduced faecal fat excretion, faecal nitrogen excretion, faecal weight and abdominal pain, without significant adverse events.	Steatorrhea (excess faecal fat excretion) is a key manifestation of exocrine insufficiency in chronic pancreatitis, as demonstrated by its improvement with enzyme replacement therapy.	"{""explanation"": ""Steatorrhea (excess faecal fat excretion) is a key manifestation of exocrine insufficiency in chronic pancreatitis, as demonstrated by its improvement with enzyme replacement therapy."", ""reference"": ""PMID:27941156"", ""snippet"": ""PERT improved coefficient of nitrogen absorption, reduced faecal fat excretion, faecal nitrogen excretion, faecal weight and abdominal pain, without significant adverse events."", ""supports"": ""SUPPORT""}"
1924	1634	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	phenotypes	2	evidence	0	PMID:18554234	SUPPORT		After the onset of chronic pancreatitis, 56.5% of patients lost weight and significantly more patients became malnourished compared with controls (45.8% vs 22.5%; P < 0.001).	Prospective study demonstrates that over half of CP patients experience weight loss, with significantly higher malnutrition rates than controls.	"{""explanation"": ""Prospective study demonstrates that over half of CP patients experience weight loss, with significantly higher malnutrition rates than controls."", ""reference"": ""PMID:18554234"", ""snippet"": ""After the onset of chronic pancreatitis, 56.5% of patients lost weight and significantly more patients became malnourished compared with controls (45.8% vs 22.5%; P < 0.001)."", ""supports"": ""SUPPORT""}"
1925	1635	68	Chronic Pancreatitis	Chronic_Pancreatitis.yaml	phenotypes	3	evidence	0	PMID:28404095	SUPPORT		Diabetes can also develop as a direct consequence of other diseases, including diseases of the exocrine pancreas.	Type 3c (pancreatogenic) diabetes develops as a direct consequence of chronic pancreatitis due to progressive destruction of islet cells.	"{""explanation"": ""Type 3c (pancreatogenic) diabetes develops as a direct consequence of chronic pancreatitis due to progressive destruction of islet cells."", ""reference"": ""PMID:28404095"", ""snippet"": ""Diabetes can also develop as a direct consequence of other diseases, including diseases of the exocrine pancreas."", ""supports"": ""SUPPORT""}"
1959	1698	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	phenotypes	0	evidence	0	PMID:28613708	SUPPORT		This obligate anaerobic bacillus is recognized for its ability to produce toxins and is the leading cause of antibiotic-associated diarrhea worldwide.	StatPearls review states CDI is the leading cause of antibiotic-associated diarrhea.	"{""explanation"": ""StatPearls review states CDI is the leading cause of antibiotic-associated diarrhea."", ""reference"": ""PMID:28613708"", ""snippet"": ""This obligate anaerobic bacillus is recognized for its ability to produce toxins and is the leading cause of antibiotic-associated diarrhea worldwide."", ""supports"": ""SUPPORT""}"
1960	1699	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	phenotypes	1	evidence	0	PMID:37004449	SUPPORT		A 40 years old male patient presented with abdominal pain and diarrhea of 10 days duration after he was diagnosed and managed as a case of Clostridium Difficile infection and amebiasis.	Case report notes abdominal pain with CDI presentation.	"{""explanation"": ""Case report notes abdominal pain with CDI presentation."", ""reference"": ""PMID:37004449"", ""snippet"": ""A 40 years old male patient presented with abdominal pain and diarrhea of 10 days duration after he was diagnosed and managed as a case of Clostridium Difficile infection and amebiasis."", ""supports"": ""SUPPORT""}"
1961	1700	71	Clostridioides difficile Infection	Clostridioides_difficile_Infection.yaml	phenotypes	2	evidence	0	PMID:33402156	SUPPORT		A 53-year-old Caucasian male presented to the emergency room for two days of lower abdominal pain associated with nausea, non-bilious vomiting, and subjective fevers.	CDI case report documents fever accompanying infection.	"{""explanation"": ""CDI case report documents fever accompanying infection."", ""reference"": ""PMID:33402156"", ""snippet"": ""A 53-year-old Caucasian male presented to the emergency room for two days of lower abdominal pain associated with nausea, non-bilious vomiting, and subjective fevers."", ""supports"": ""SUPPORT""}"
1990	1725	72	Collagenous Sprue	Collagenous_Sprue.yaml	phenotypes	0	evidence	0	DOI:10.1093/ecco-jcc/jjab123	SUPPORT		MC is a multifactorial disease believed to involve innate and adaptive immune responses to luminal factors, genetic risk, autoimmunity, and extracellular matrix alterations, all contributing by varied mechanisms to watery diarrhoea	Literature documents watery diarrhea as the primary clinical manifestation in collagenous enteropathy	"{""explanation"": ""Literature documents watery diarrhea as the primary clinical manifestation in collagenous enteropathy"", ""reference"": ""DOI:10.1093/ecco-jcc/jjab123"", ""snippet"": ""MC is a multifactorial disease believed to involve innate and adaptive immune responses to luminal factors, genetic risk, autoimmunity, and extracellular matrix alterations, all contributing by varied mechanisms to watery diarrhoea"", ""supports"": ""SUPPORT""}"
1991	1726	72	Collagenous Sprue	Collagenous_Sprue.yaml	phenotypes	1	evidence	0	DOI:10.1093/ecco-jcc/jjab123	SUPPORT		MC is a multifactorial disease believed to involve innate and adaptive immune responses to luminal factors, genetic risk, autoimmunity, and extracellular matrix alterations, all contributing by varied mechanisms to watery diarrhoea	Chronic diarrhea and nutrient malabsorption in collagenous enteropathy lead to weight loss	"{""explanation"": ""Chronic diarrhea and nutrient malabsorption in collagenous enteropathy lead to weight loss"", ""reference"": ""DOI:10.1093/ecco-jcc/jjab123"", ""snippet"": ""MC is a multifactorial disease believed to involve innate and adaptive immune responses to luminal factors, genetic risk, autoimmunity, and extracellular matrix alterations, all contributing by varied mechanisms to watery diarrhoea"", ""supports"": ""SUPPORT""}"
1992	1727	72	Collagenous Sprue	Collagenous_Sprue.yaml	phenotypes	2	evidence	0	PMID:40911031	SUPPORT		The most common presenting symptoms were abdominal pain and chronic anaemia	Abdominal pain is among the most common clinical presentations in collagenous sprue	"{""explanation"": ""Abdominal pain is among the most common clinical presentations in collagenous sprue"", ""reference"": ""PMID:40911031"", ""snippet"": ""The most common presenting symptoms were abdominal pain and chronic anaemia"", ""supports"": ""SUPPORT""}"
1993	1728	72	Collagenous Sprue	Collagenous_Sprue.yaml	phenotypes	3	evidence	0	DOI:10.1093/ecco-jcc/jjab123	SUPPORT		MC is a multifactorial disease believed to involve innate and adaptive immune responses to luminal factors, genetic risk, autoimmunity, and extracellular matrix alterations	Villous atrophy and epithelial barrier dysfunction in collagenous enteropathy directly impair nutrient absorption	"{""explanation"": ""Villous atrophy and epithelial barrier dysfunction in collagenous enteropathy directly impair nutrient absorption"", ""reference"": ""DOI:10.1093/ecco-jcc/jjab123"", ""snippet"": ""MC is a multifactorial disease believed to involve innate and adaptive immune responses to luminal factors, genetic risk, autoimmunity, and extracellular matrix alterations"", ""supports"": ""SUPPORT""}"
1994	1729	72	Collagenous Sprue	Collagenous_Sprue.yaml	phenotypes	4	evidence	0	PMID:39606500	SUPPORT		Collagenous sprue (CS) is a rare autoimmune gastrointestinal disorder characterized by specific histologic changes in the small intestine. It often presents with more severe symptoms and a worse prognosis compared to celiac disease, including significant malabsorption, weight loss, and nutrient deficiencies	Literature documents severe malabsorption and nutrient deficiencies as cardinal features of collagenous sprue	"{""explanation"": ""Literature documents severe malabsorption and nutrient deficiencies as cardinal features of collagenous sprue"", ""reference"": ""PMID:39606500"", ""snippet"": ""Collagenous sprue (CS) is a rare autoimmune gastrointestinal disorder characterized by specific histologic changes in the small intestine. It often presents with more severe symptoms and a worse prognosis compared to celiac disease, including significant malabsorption, weight loss, and nutrient deficiencies"", ""supports"": ""SUPPORT""}"
1995	1730	72	Collagenous Sprue	Collagenous_Sprue.yaml	phenotypes	5	evidence	0	PMID:39606500	SUPPORT		It often presents with more severe symptoms and a worse prognosis compared to celiac disease, including significant malabsorption, weight loss, and nutrient deficiencies	Malabsorption and nutrient deficiencies in collagenous sprue result in secondary anemia	"{""explanation"": ""Malabsorption and nutrient deficiencies in collagenous sprue result in secondary anemia"", ""reference"": ""PMID:39606500"", ""snippet"": ""It often presents with more severe symptoms and a worse prognosis compared to celiac disease, including significant malabsorption, weight loss, and nutrient deficiencies"", ""supports"": ""SUPPORT""}"
1996	1730	72	Collagenous Sprue	Collagenous_Sprue.yaml	phenotypes	5	evidence	1	PMID:40911031	SUPPORT		The most common presenting symptoms were abdominal pain and chronic anaemia	Chronic anemia is documented as one of the most frequently occurring clinical presentations in collagenous disorders	"{""explanation"": ""Chronic anemia is documented as one of the most frequently occurring clinical presentations in collagenous disorders"", ""reference"": ""PMID:40911031"", ""snippet"": ""The most common presenting symptoms were abdominal pain and chronic anaemia"", ""supports"": ""SUPPORT""}"
1997	1731	72	Collagenous Sprue	Collagenous_Sprue.yaml	phenotypes	6	evidence	0	PMID:41341547	SUPPORT		Collagenous sprue is a rare enteropathy affecting the small intestine, characterized by the presence of villous atrophy and a thick band of subepithelial collagen	Malabsorption and protein-losing enteropathy in collagenous sprue lead to hypoalbuminemia	"{""explanation"": ""Malabsorption and protein-losing enteropathy in collagenous sprue lead to hypoalbuminemia"", ""reference"": ""PMID:41341547"", ""snippet"": ""Collagenous sprue is a rare enteropathy affecting the small intestine, characterized by the presence of villous atrophy and a thick band of subepithelial collagen"", ""supports"": ""SUPPORT""}"
2006	1741	73	Colon Adenocarcinoma	Colon_Adenocarcinoma.yaml	phenotypes	0	evidence	0	PMID:35613396	SUPPORT		We present the case of a 68-year-old female presented with a two-month history of anemia, hematochezia and abdominal pain.	Anemia is listed as a presenting feature of colon cancer.	"{""explanation"": ""Anemia is listed as a presenting feature of colon cancer."", ""reference"": ""PMID:35613396"", ""snippet"": ""We present the case of a 68-year-old female presented with a two-month history of anemia, hematochezia and abdominal pain."", ""supports"": ""SUPPORT""}"
2007	1742	73	Colon Adenocarcinoma	Colon_Adenocarcinoma.yaml	phenotypes	1	evidence	0	PMID:35613396	SUPPORT		We present the case of a 68-year-old female presented with a two-month history of anemia, hematochezia and abdominal pain.	Hematochezia is reported as a presenting symptom.	"{""explanation"": ""Hematochezia is reported as a presenting symptom."", ""reference"": ""PMID:35613396"", ""snippet"": ""We present the case of a 68-year-old female presented with a two-month history of anemia, hematochezia and abdominal pain."", ""supports"": ""SUPPORT""}"
2008	1743	73	Colon Adenocarcinoma	Colon_Adenocarcinoma.yaml	phenotypes	2	evidence	0	PMID:35613396	SUPPORT		We present the case of a 68-year-old female presented with a two-month history of anemia, hematochezia and abdominal pain.	Abdominal pain is listed among presenting symptoms.	"{""explanation"": ""Abdominal pain is listed among presenting symptoms."", ""reference"": ""PMID:35613396"", ""snippet"": ""We present the case of a 68-year-old female presented with a two-month history of anemia, hematochezia and abdominal pain."", ""supports"": ""SUPPORT""}"
2026	1784	75	Coronary Artery Disease	Coronary_Artery_Disease.yaml	phenotypes	2	evidence	0	PMID:38639096	SUPPORT		By identifying and integrating the most gene-rich single-cell subclusters of atherosclerosis to date with a coronary artery disease framework of GRNs, GRN39 was identified and independently validated as being critical for the transformation of contractile SMCs into an osteogenic phenotype promoting advanced, symptomatic atherosclerosis.	Advanced symptomatic atherosclerosis, characterized by SMC transformation, leads to acute coronary events including myocardial infarction.	"{""explanation"": ""Advanced symptomatic atherosclerosis, characterized by SMC transformation, leads to acute coronary events including myocardial infarction."", ""reference"": ""PMID:38639096"", ""snippet"": ""By identifying and integrating the most gene-rich single-cell subclusters of atherosclerosis to date with a coronary artery disease framework of GRNs, GRN39 was identified and independently validated as being critical for the transformation of contractile SMCs into an osteogenic phenotype promoting advanced, symptomatic atherosclerosis."", ""supports"": ""SUPPORT""}"
2029	1798	76	Costello Syndrome	Costello_Syndrome.yaml	phenotypes	3	evidence	0	PMID:38415356	SUPPORT	HUMAN_CLINICAL	During early childhood, 50% of patients develop multifocal atrial tachycardia, a treatment-resistant tachyarrhythmia of unknown pathogenesis.	Establishes 50% prevalence of MAT in Costello syndrome patients, occurring in early childhood as a treatment-resistant arrhythmia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Establishes 50% prevalence of MAT in Costello syndrome patients, occurring in early childhood as a treatment-resistant arrhythmia."", ""reference"": ""PMID:38415356"", ""snippet"": ""During early childhood, 50% of patients develop multifocal atrial tachycardia, a treatment-resistant tachyarrhythmia of unknown pathogenesis."", ""supports"": ""SUPPORT""}"
2030	1804	76	Costello Syndrome	Costello_Syndrome.yaml	phenotypes	9	evidence	0	PMID:16443854	SUPPORT	HUMAN_CLINICAL	Individuals with CS have an increased risk of malignancy, suggested to be about 17%.	Establishes the approximately 17% lifetime malignancy risk in Costello syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Establishes the approximately 17% lifetime malignancy risk in Costello syndrome."", ""reference"": ""PMID:16443854"", ""snippet"": ""Individuals with CS have an increased risk of malignancy, suggested to be about 17%."", ""supports"": ""SUPPORT""}"
2081	1835	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	0	evidence	0	PMID:29246562	SUPPORT		The most frequent symptoms are abdominal pain and diarrhoea, which can seriously affect patients' quality of life.		"{""reference"": ""PMID:29246562"", ""snippet"": ""The most frequent symptoms are abdominal pain and diarrhoea, which can seriously affect patients' quality of life."", ""supports"": ""SUPPORT""}"
2082	1835	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	0	evidence	1	PMID:33946069	SUPPORT		In Crohn's disease, inflammation causes pain.		"{""reference"": ""PMID:33946069"", ""snippet"": ""In Crohn's disease, inflammation causes pain."", ""supports"": ""SUPPORT""}"
2083	1835	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	0	evidence	2	PMID:35380673	SUPPORT		The prevalence of pain was high in IBD patients ... and higher in CD patients.		"{""reference"": ""PMID:35380673"", ""snippet"": ""The prevalence of pain was high in IBD patients ... and higher in CD patients."", ""supports"": ""SUPPORT""}"
2084	1835	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	0	evidence	3	PMID:33836648	SUPPORT		Using the patients'' self-reported information, we identified two subpopulations of Crohn's disease; these subpopulations differ in disease severity, associations with smoking, and genetic transmission patterns.	While this reference focuses on identifying subpopulations with varying disease severity, it underscores the heterogeneity of Crohn’s disease symptoms, indirectly supporting that abdominal pain is a frequent symptom.	"{""explanation"": ""While this reference focuses on identifying subpopulations with varying disease severity, it underscores the heterogeneity of Crohn’s disease symptoms, indirectly supporting that abdominal pain is a frequent symptom."", ""reference"": ""PMID:33836648"", ""snippet"": ""Using the patients'' self-reported information, we identified two subpopulations of Crohn's disease; these subpopulations differ in disease severity, associations with smoking, and genetic transmission patterns."", ""supports"": ""SUPPORT""}"
2085	1836	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	1	evidence	0	PMID:22230271	PARTIAL		Patients may experience diarrhea, abdominal pain, fever, weight loss, abdominal masses, and anemia.	This reference supports the presence of diarrhea and weight loss as frequent symptoms of Crohn's disease. However, it does not explicitly discuss malnutrition as a common sequela or confirm that these phenotypes are highly frequent.	"{""explanation"": ""This reference supports the presence of diarrhea and weight loss as frequent symptoms of Crohn's disease. However, it does not explicitly discuss malnutrition as a common sequela or confirm that these phenotypes are highly frequent."", ""reference"": ""PMID:22230271"", ""snippet"": ""Patients may experience diarrhea, abdominal pain, fever, weight loss, abdominal masses, and anemia."", ""supports"": ""PARTIAL""}"
2086	1836	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	1	evidence	1	PMID:38036713	PARTIAL		Malnutrition might play a key role in the prognosis of patients with Crohn's disease (CD) ... Forty-one patients (24.8%) had body weight loss whereas 124 patients (75.2%) had no body weight loss.	This reference mentions weight loss and suggests a role for malnutrition in Crohn's disease prognosis, but does not confirm high frequency of gastrointestinal symptoms like diarrhea.	"{""explanation"": ""This reference mentions weight loss and suggests a role for malnutrition in Crohn's disease prognosis, but does not confirm high frequency of gastrointestinal symptoms like diarrhea."", ""reference"": ""PMID:38036713"", ""snippet"": ""Malnutrition might play a key role in the prognosis of patients with Crohn's disease (CD) ... Forty-one patients (24.8%) had body weight loss whereas 124 patients (75.2%) had no body weight loss."", ""supports"": ""PARTIAL""}"
2087	1837	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	2	evidence	0	PMID:23111414	SUPPORT		A high percentage of CD patients suffer from fatigue.	This reference confirms that fatigue is a common symptom among Crohn's disease patients.	"{""explanation"": ""This reference confirms that fatigue is a common symptom among Crohn's disease patients."", ""reference"": ""PMID:23111414"", ""snippet"": ""A high percentage of CD patients suffer from fatigue."", ""supports"": ""SUPPORT""}"
2088	1837	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	2	evidence	1	PMID:37569413	SUPPORT		Despite high prevalence and importance, the symptom is often underestimated in clinical practice.	The reference articulates the high prevalence of fatigue in inflammatory diseases, supporting the statement that fatigue is common among Crohn's disease patients.	"{""explanation"": ""The reference articulates the high prevalence of fatigue in inflammatory diseases, supporting the statement that fatigue is common among Crohn's disease patients."", ""reference"": ""PMID:37569413"", ""snippet"": ""Despite high prevalence and importance, the symptom is often underestimated in clinical practice."", ""supports"": ""SUPPORT""}"
2089	1838	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	3	evidence	0	PMID:15227686	PARTIAL		Perianal Crohn's disease can manifest as skin tags, ulcers, fissures, abscesses, fistulas or stenoses.	The literature supports that perianal disease is a manifestation of Crohn's disease and lists fistulas, abscesses, and skin tags as possible manifestations. However, it does not specifically address the frequency as 'occasional'.	"{""explanation"": ""The literature supports that perianal disease is a manifestation of Crohn's disease and lists fistulas, abscesses, and skin tags as possible manifestations. However, it does not specifically address the frequency as 'occasional'."", ""reference"": ""PMID:15227686"", ""snippet"": ""Perianal Crohn's disease can manifest as skin tags, ulcers, fissures, abscesses, fistulas or stenoses."", ""supports"": ""PARTIAL""}"
2090	1838	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	3	evidence	1	PMID:15711045	PARTIAL		Fistulas are common in Crohn's disease. A population-based study has shown a cumulative risk of 33% after 10 years and 50% after 20 years. Perianal fistulas were the most common (54%).	The literature indicates that perianal fistulas are common in Crohn's disease, which suggests a higher frequency than 'occasional'.	"{""explanation"": ""The literature indicates that perianal fistulas are common in Crohn's disease, which suggests a higher frequency than 'occasional'."", ""reference"": ""PMID:15711045"", ""snippet"": ""Fistulas are common in Crohn's disease. A population-based study has shown a cumulative risk of 33% after 10 years and 50% after 20 years. Perianal fistulas were the most common (54%)."", ""supports"": ""PARTIAL""}"
2091	1838	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	3	evidence	2	PMID:33280851	PARTIAL		Of children presenting with a perianal symptom, three percent will eventually be diagnosed with CD. At highest risk (35%) were males aged 10 years or older with a perianal fistula.	The literature supports that perianal symptoms can be an initial presentation of Crohn's disease in children, but it does not specify the frequency as 'occasional'.	"{""explanation"": ""The literature supports that perianal symptoms can be an initial presentation of Crohn's disease in children, but it does not specify the frequency as 'occasional'."", ""reference"": ""PMID:33280851"", ""snippet"": ""Of children presenting with a perianal symptom, three percent will eventually be diagnosed with CD. At highest risk (35%) were males aged 10 years or older with a perianal fistula."", ""supports"": ""PARTIAL""}"
2092	1839	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	4	evidence	0	PMID:29043578	SUPPORT		The most common phenotype is stricturing disease which can lead to obstructive-like symptoms.	The reference states that stricturing disease, a common phenotype of Crohn's disease, can lead to obstructive-like symptoms, supporting the statement that intestinal obstruction due to stricturing disease occurs occasionally in Crohn's disease.	"{""explanation"": ""The reference states that stricturing disease, a common phenotype of Crohn's disease, can lead to obstructive-like symptoms, supporting the statement that intestinal obstruction due to stricturing disease occurs occasionally in Crohn's disease."", ""reference"": ""PMID:29043578"", ""snippet"": ""The most common phenotype is stricturing disease which can lead to obstructive-like symptoms."", ""supports"": ""SUPPORT""}"
2093	1839	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	4	evidence	1	PMID:34014617	SUPPORT		Approximately 70% of patients inevitably develop fibrosis-associated intestinal stricture after 10 years of CD diagnosis, which seriously affects their quality of life.	The reference indicates that a significant proportion of Crohn's disease patients develop intestinal strictures, which can lead to obstruction, supporting the statement.	"{""explanation"": ""The reference indicates that a significant proportion of Crohn's disease patients develop intestinal strictures, which can lead to obstruction, supporting the statement."", ""reference"": ""PMID:34014617"", ""snippet"": ""Approximately 70% of patients inevitably develop fibrosis-associated intestinal stricture after 10 years of CD diagnosis, which seriously affects their quality of life."", ""supports"": ""SUPPORT""}"
2094	1839	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	4	evidence	2	PMID:37973225	SUPPORT		Benign etiologies of colonic obstructions include...inflammatory processes such as Crohn's disease.	The reference confirms that inflammatory processes like Crohn's disease can lead to colonic obstructions, supporting the statement.	"{""explanation"": ""The reference confirms that inflammatory processes like Crohn's disease can lead to colonic obstructions, supporting the statement."", ""reference"": ""PMID:37973225"", ""snippet"": ""Benign etiologies of colonic obstructions include...inflammatory processes such as Crohn's disease."", ""supports"": ""SUPPORT""}"
2095	1840	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	5	evidence	0	PMID:21122514	SUPPORT		The most common extraintestinal manifestation, articular involvement, occurs in 16% to 33% of inflammatory bowel disease patients. These arthropathies may increase morbidity, resulting in a worse quality of life compared with inflammatory bowel disease patients without arthropathies.	The literature indicates that arthritis is a common extraintestinal manifestation of Crohn's disease, affecting both large and small joints.	"{""explanation"": ""The literature indicates that arthritis is a common extraintestinal manifestation of Crohn's disease, affecting both large and small joints."", ""reference"": ""PMID:21122514"", ""snippet"": ""The most common extraintestinal manifestation, articular involvement, occurs in 16% to 33% of inflammatory bowel disease patients. These arthropathies may increase morbidity, resulting in a worse quality of life compared with inflammatory bowel disease patients without arthropathies."", ""supports"": ""SUPPORT""}"
2096	1840	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	5	evidence	1	PMID:36730654	SUPPORT		The prevalence of peripheral arthritis was significantly higher in CD-FMF group (37.5% vs. 10.4%, respectively, P =0.04).	This study supports the occurrence of arthritis in Crohn's disease patients, particularly noting a higher prevalence in patients with coexisting FMF.	"{""explanation"": ""This study supports the occurrence of arthritis in Crohn's disease patients, particularly noting a higher prevalence in patients with coexisting FMF."", ""reference"": ""PMID:36730654"", ""snippet"": ""The prevalence of peripheral arthritis was significantly higher in CD-FMF group (37.5% vs. 10.4%, respectively, P =0.04)."", ""supports"": ""SUPPORT""}"
2097	1841	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	6	evidence	0	PMID:16143688	SUPPORT		Erythema nodosum is a common cause of tender red nodules of the shins. Management includes leg elevation, NSAIDs, and potassium iodide.	The reference confirms that erythema nodosum, characterized by tender red nodules on the shins, is associated with inflammatory bowel disease, which includes Crohn's disease.	"{""explanation"": ""The reference confirms that erythema nodosum, characterized by tender red nodules on the shins, is associated with inflammatory bowel disease, which includes Crohn's disease."", ""reference"": ""PMID:16143688"", ""snippet"": ""Erythema nodosum is a common cause of tender red nodules of the shins. Management includes leg elevation, NSAIDs, and potassium iodide."", ""supports"": ""SUPPORT""}"
2098	1841	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	6	evidence	1	PMID:24746312	SUPPORT		Erythema nodosum (EN) is clinically the most frequent form of panniculitis and is considered a reactive process that may be triggered by a wide variety of stimuli. Whilst up to 55% of EN is considered idiopathic, the most common causes include infections, drugs, systemic illnesses such as sarcoidosis and inflammatory bowel disease, pregnancy, and malignancy.	The reference supports the statement by mentioning that erythema nodosum is commonly triggered by systemic illnesses, including inflammatory bowel disease, which encompasses Crohn's disease.	"{""explanation"": ""The reference supports the statement by mentioning that erythema nodosum is commonly triggered by systemic illnesses, including inflammatory bowel disease, which encompasses Crohn's disease."", ""reference"": ""PMID:24746312"", ""snippet"": ""Erythema nodosum (EN) is clinically the most frequent form of panniculitis and is considered a reactive process that may be triggered by a wide variety of stimuli. Whilst up to 55% of EN is considered idiopathic, the most common causes include infections, drugs, systemic illnesses such as sarcoidosis and inflammatory bowel disease, pregnancy, and malignancy."", ""supports"": ""SUPPORT""}"
2099	1842	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	7	evidence	0	PMID:2052301	PARTIAL		Seven patients had uveitis, eight had episcleritis, and four had anterior scleritis.	The literature confirms that uveitis is a type of ocular inflammation associated with Crohn's disease, but it does not specify the frequency as 'occasional'.	"{""explanation"": ""The literature confirms that uveitis is a type of ocular inflammation associated with Crohn's disease, but it does not specify the frequency as 'occasional'."", ""reference"": ""PMID:2052301"", ""snippet"": ""Seven patients had uveitis, eight had episcleritis, and four had anterior scleritis."", ""supports"": ""PARTIAL""}"
2100	1842	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	7	evidence	1	PMID:29102673	PARTIAL		This case of Crohn's disease and uveitis is unusual in that ocular inflammation preceded intestinal involvement, with the atypical feature of chronic intermediate uveitis.	The literature provides a case of uveitis associated with Crohn's disease but does not specify the frequency as 'occasional'.	"{""explanation"": ""The literature provides a case of uveitis associated with Crohn's disease but does not specify the frequency as 'occasional'."", ""reference"": ""PMID:29102673"", ""snippet"": ""This case of Crohn's disease and uveitis is unusual in that ocular inflammation preceded intestinal involvement, with the atypical feature of chronic intermediate uveitis."", ""supports"": ""PARTIAL""}"
2101	1843	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	8	evidence	0	PMID:20456309	SUPPORT		Fatigue is common, disabling yet underappreciated, in patients with chronic diseases, including inflammatory bowel disease (IBD).	The literature explicitly states that fatigue is common in IBD, which includes Crohn's Disease.	"{""explanation"": ""The literature explicitly states that fatigue is common in IBD, which includes Crohn's Disease."", ""reference"": ""PMID:20456309"", ""snippet"": ""Fatigue is common, disabling yet underappreciated, in patients with chronic diseases, including inflammatory bowel disease (IBD)."", ""supports"": ""SUPPORT""}"
2102	1843	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	8	evidence	1	PMID:17560419	PARTIAL		Pain and depression are associated with inflammatory bowel disease, and their control benefits patients.	This reference mentions pain and depression as associated with IBD but does not specifically mention fatigue. However, the association with other systemic symptoms suggests a partial support.	"{""explanation"": ""This reference mentions pain and depression as associated with IBD but does not specifically mention fatigue. However, the association with other systemic symptoms suggests a partial support."", ""reference"": ""PMID:17560419"", ""snippet"": ""Pain and depression are associated with inflammatory bowel disease, and their control benefits patients."", ""supports"": ""PARTIAL""}"
2103	1844	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	9	evidence	0	PMID:30244270	SUPPORT		Crohn's disease is a chronic inflammatory bowel disease. The disease is characterized by acute exacerbations with diarrhea, abdominal pain, fever, anorexia, intestinal bleeding, and weight loss.	This reference confirms that fever is a symptom associated with acute exacerbations of Crohn's disease.	"{""explanation"": ""This reference confirms that fever is a symptom associated with acute exacerbations of Crohn's disease."", ""reference"": ""PMID:30244270"", ""snippet"": ""Crohn's disease is a chronic inflammatory bowel disease. The disease is characterized by acute exacerbations with diarrhea, abdominal pain, fever, anorexia, intestinal bleeding, and weight loss."", ""supports"": ""SUPPORT""}"
2104	1844	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	9	evidence	1	PMID:921308	SUPPORT		In 32 patients with Crohn's disease which started in childhood, abdominal pain, diarrhoea, and weight loss were the common presenting symptoms, but unexplained fever and failure to grow were also prominent.	This reference supports the statement by indicating that fever is a prominent symptom in patients with Crohn's disease.	"{""explanation"": ""This reference supports the statement by indicating that fever is a prominent symptom in patients with Crohn's disease."", ""reference"": ""PMID:921308"", ""snippet"": ""In 32 patients with Crohn's disease which started in childhood, abdominal pain, diarrhoea, and weight loss were the common presenting symptoms, but unexplained fever and failure to grow were also prominent."", ""supports"": ""SUPPORT""}"
2105	1844	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	9	evidence	2	PMID:27743896	SUPPORT		A frequent problem in CD is the discrimination of fever caused by exacerbated bowel inflammation or IAA.	This reference supports the statement by highlighting that fever is a frequent issue in Crohn's disease, especially during exacerbations.	"{""explanation"": ""This reference supports the statement by highlighting that fever is a frequent issue in Crohn's disease, especially during exacerbations."", ""reference"": ""PMID:27743896"", ""snippet"": ""A frequent problem in CD is the discrimination of fever caused by exacerbated bowel inflammation or IAA."", ""supports"": ""SUPPORT""}"
2106	1844	77	Crohn Disease	Crohn_Disease.yaml	phenotypes	9	evidence	3	PMID:31347993	SUPPORT		A 23-year-old man with a known history of Crohn's disease (CD), who underwent an ileocaecal resection for localized disease activity three months ago, suffered from persistent fever with chills since 10 days.	This reference supports the statement by providing a case where a patient with Crohn's disease experienced persistent fever.	"{""explanation"": ""This reference supports the statement by providing a case where a patient with Crohn's disease experienced persistent fever."", ""reference"": ""PMID:31347993"", ""snippet"": ""A 23-year-old man with a known history of Crohn's disease (CD), who underwent an ileocaecal resection for localized disease activity three months ago, suffered from persistent fever with chills since 10 days."", ""supports"": ""SUPPORT""}"
2152	1873	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	phenotypes	0	evidence	0	PMID:38297356	SUPPORT		Cronkhite-Canada syndrome (CCS) is a rare, nonhereditary disease characterized by diffuse gastrointestinal polyposis and ectodermal abnormalities.	Defines CCS as characterized by diffuse gastrointestinal polyposis, establishing this as a cardinal defining feature	"{""explanation"": ""Defines CCS as characterized by diffuse gastrointestinal polyposis, establishing this as a cardinal defining feature"", ""reference"": ""PMID:38297356"", ""snippet"": ""Cronkhite-Canada syndrome (CCS) is a rare, nonhereditary disease characterized by diffuse gastrointestinal polyposis and ectodermal abnormalities."", ""supports"": ""SUPPORT""}"
2153	1873	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	phenotypes	0	evidence	1	PMID:40709433	SUPPORT		Endoscopic and histopathological examinations revealed diffuse polyposis throughout the gastrointestinal tract, consistent with CCS findings.	Recent case demonstrates diffuse polyposis throughout entire GI tract as diagnostic hallmark of CCS	"{""explanation"": ""Recent case demonstrates diffuse polyposis throughout entire GI tract as diagnostic hallmark of CCS"", ""reference"": ""PMID:40709433"", ""snippet"": ""Endoscopic and histopathological examinations revealed diffuse polyposis throughout the gastrointestinal tract, consistent with CCS findings."", ""supports"": ""SUPPORT""}"
2154	1874	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	phenotypes	1	evidence	0	PMID:33163187	SUPPORT		Typical alopecia involves hair loss, but it is not limited to hair; eyebrows and eyelashes can also fall out	Describes the cutaneous manifestation of alopecia as a characteristic feature of Cronkhite-Canada syndrome	"{""explanation"": ""Describes the cutaneous manifestation of alopecia as a characteristic feature of Cronkhite-Canada syndrome"", ""reference"": ""PMID:33163187"", ""snippet"": ""Typical alopecia involves hair loss, but it is not limited to hair; eyebrows and eyelashes can also fall out"", ""supports"": ""SUPPORT""}"
2155	1874	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	phenotypes	1	evidence	1	PMID:39470508	SUPPORT		The primary clinical manifestations of CCS include hair loss, excessive pigmentation of the skin, and malnourishment of fingernails or toenails.	Recent case report confirms hair loss as a primary clinical manifestation of CCS in a 72-year-old female	"{""explanation"": ""Recent case report confirms hair loss as a primary clinical manifestation of CCS in a 72-year-old female"", ""reference"": ""PMID:39470508"", ""snippet"": ""The primary clinical manifestations of CCS include hair loss, excessive pigmentation of the skin, and malnourishment of fingernails or toenails."", ""supports"": ""SUPPORT""}"
2156	1875	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	phenotypes	2	evidence	0	PMID:33163187	SUPPORT		Typical nail changes include thin, soft, triangular nail plates	Characterizes the distinctive nail changes seen in Cronkhite-Canada syndrome	"{""explanation"": ""Characterizes the distinctive nail changes seen in Cronkhite-Canada syndrome"", ""reference"": ""PMID:33163187"", ""snippet"": ""Typical nail changes include thin, soft, triangular nail plates"", ""supports"": ""SUPPORT""}"
2157	1875	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	phenotypes	2	evidence	1	PMID:39470508	SUPPORT		The primary clinical manifestations of CCS include hair loss, excessive pigmentation of the skin, and malnourishment of fingernails or toenails.	Recent comprehensive case report documents nail malnourishment as a primary clinical manifestation	"{""explanation"": ""Recent comprehensive case report documents nail malnourishment as a primary clinical manifestation"", ""reference"": ""PMID:39470508"", ""snippet"": ""The primary clinical manifestations of CCS include hair loss, excessive pigmentation of the skin, and malnourishment of fingernails or toenails."", ""supports"": ""SUPPORT""}"
2158	1876	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	phenotypes	3	evidence	0	PMID:33163187	SUPPORT		With regard to skin changes, pigmentation of the skin is a vital sign, such as brown macula or red nonpruritic nodular papules, which can be seen on the scalp, wrist, palms, soles, limbs, face, and chest	Describes the characteristic pattern and appearance of skin hyperpigmentation in Cronkhite-Canada syndrome	"{""explanation"": ""Describes the characteristic pattern and appearance of skin hyperpigmentation in Cronkhite-Canada syndrome"", ""reference"": ""PMID:33163187"", ""snippet"": ""With regard to skin changes, pigmentation of the skin is a vital sign, such as brown macula or red nonpruritic nodular papules, which can be seen on the scalp, wrist, palms, soles, limbs, face, and chest"", ""supports"": ""SUPPORT""}"
2159	1877	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	phenotypes	4	evidence	0	PMID:33163187	SUPPORT		Typical symptoms of CCS include hypogeusia, diarrhea, abdominal pain, alopecia, skin pigmentation, onychodystrophy, and even onychomadesis	Establishes diarrhea as a typical feature of Cronkhite-Canada syndrome presentation	"{""explanation"": ""Establishes diarrhea as a typical feature of Cronkhite-Canada syndrome presentation"", ""reference"": ""PMID:33163187"", ""snippet"": ""Typical symptoms of CCS include hypogeusia, diarrhea, abdominal pain, alopecia, skin pigmentation, onychodystrophy, and even onychomadesis"", ""supports"": ""SUPPORT""}"
2160	1877	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	phenotypes	4	evidence	1	PMID:39470508	SUPPORT		Other notable symptoms include weight loss, protein-losing enteropathy, diarrhea, abdominal pain, nausea, vomiting, taste abnormalities, and atrophic glossitis	Recent comprehensive review confirms diarrhea as a notable feature of CCS presentation alongside weight loss and protein-losing enteropathy	"{""explanation"": ""Recent comprehensive review confirms diarrhea as a notable feature of CCS presentation alongside weight loss and protein-losing enteropathy"", ""reference"": ""PMID:39470508"", ""snippet"": ""Other notable symptoms include weight loss, protein-losing enteropathy, diarrhea, abdominal pain, nausea, vomiting, taste abnormalities, and atrophic glossitis"", ""supports"": ""SUPPORT""}"
2161	1878	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	phenotypes	5	evidence	0	PMID:33163187	SUPPORT		The prognosis of CCS is poor, with a 5-year mortality rate of 55%	Indicates severe complications from protein-losing enteropathy and malnutrition are major causes of morbidity and mortality	"{""explanation"": ""Indicates severe complications from protein-losing enteropathy and malnutrition are major causes of morbidity and mortality"", ""reference"": ""PMID:33163187"", ""snippet"": ""The prognosis of CCS is poor, with a 5-year mortality rate of 55%"", ""supports"": ""SUPPORT""}"
2162	1878	78	Cronkhite-Canada syndrome	Cronkhite-Canada_syndrome.yaml	phenotypes	5	evidence	1	PMID:39470508	SUPPORT		Other notable symptoms include weight loss, protein-losing enteropathy, diarrhea, abdominal pain, nausea, vomiting, taste abnormalities, and atrophic glossitis, which predominantly occur in middle-aged and older males.	Confirms protein-losing enteropathy as a notable and frequently occurring symptom in CCS, particularly in middle-aged and older patients	"{""explanation"": ""Confirms protein-losing enteropathy as a notable and frequently occurring symptom in CCS, particularly in middle-aged and older patients"", ""reference"": ""PMID:39470508"", ""snippet"": ""Other notable symptoms include weight loss, protein-losing enteropathy, diarrhea, abdominal pain, nausea, vomiting, taste abnormalities, and atrophic glossitis, which predominantly occur in middle-aged and older males."", ""supports"": ""SUPPORT""}"
2179	1885	79	Crouzon Syndrome	Crouzon_Syndrome.yaml	phenotypes	0	evidence	0	PMID:7493034	SUPPORT	HUMAN_CLINICAL	Crouzon syndrome, an autosomal dominant condition characterized by craniosynostosis, ocular proptosis and midface hypoplasia	Confirms craniosynostosis as a defining characteristic of Crouzon syndrome, occurring without the limb anomalies seen in related FGFR2 syndromes like Apert or Pfeiffer.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms craniosynostosis as a defining characteristic of Crouzon syndrome, occurring without the limb anomalies seen in related FGFR2 syndromes like Apert or Pfeiffer."", ""reference"": ""PMID:7493034"", ""snippet"": ""Crouzon syndrome, an autosomal dominant condition characterized by craniosynostosis, ocular proptosis and midface hypoplasia"", ""supports"": ""SUPPORT""}"
2180	1886	79	Crouzon Syndrome	Crouzon_Syndrome.yaml	phenotypes	1	evidence	0	PMID:7493034	SUPPORT	HUMAN_CLINICAL	Crouzon syndrome, an autosomal dominant condition characterized by craniosynostosis, ocular proptosis and midface hypoplasia	Directly identifies midface hypoplasia as one of the three cardinal features characterizing Crouzon syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Directly identifies midface hypoplasia as one of the three cardinal features characterizing Crouzon syndrome."", ""reference"": ""PMID:7493034"", ""snippet"": ""Crouzon syndrome, an autosomal dominant condition characterized by craniosynostosis, ocular proptosis and midface hypoplasia"", ""supports"": ""SUPPORT""}"
2181	1887	79	Crouzon Syndrome	Crouzon_Syndrome.yaml	phenotypes	2	evidence	0	PMID:7493034	SUPPORT	HUMAN_CLINICAL	Crouzon syndrome, an autosomal dominant condition characterized by craniosynostosis, ocular proptosis and midface hypoplasia	Directly identifies ocular proptosis as one of the defining features of Crouzon syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Directly identifies ocular proptosis as one of the defining features of Crouzon syndrome."", ""reference"": ""PMID:7493034"", ""snippet"": ""Crouzon syndrome, an autosomal dominant condition characterized by craniosynostosis, ocular proptosis and midface hypoplasia"", ""supports"": ""SUPPORT""}"
2186	1896	80	Crouzon Syndrome with Acanthosis Nigricans	Crouzon_Syndrome_with_Acanthosis_Nigricans.yaml	phenotypes	0	evidence	0	PMID:7493034	SUPPORT	HUMAN_CLINICAL	Crouzon syndrome, an autosomal dominant condition characterized by craniosynostosis, ocular proptosis and midface hypoplasia, is associated with mutations in fibroblast growth factor receptor 2 (FGFR2)	"While classic Crouzon syndrome is caused by FGFR2 mutations, CSAN patients have the same craniosynostosis phenotype but caused by FGFR3 mutations, demonstrating locus heterogeneity in Crouzon syndrome.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""While classic Crouzon syndrome is caused by FGFR2 mutations, CSAN patients have the same craniosynostosis phenotype but caused by FGFR3 mutations, demonstrating locus heterogeneity in Crouzon syndrome.\n"", ""reference"": ""PMID:7493034"", ""snippet"": ""Crouzon syndrome, an autosomal dominant condition characterized by craniosynostosis, ocular proptosis and midface hypoplasia, is associated with mutations in fibroblast growth factor receptor 2 (FGFR2)"", ""supports"": ""SUPPORT""}"
2187	1899	80	Crouzon Syndrome with Acanthosis Nigricans	Crouzon_Syndrome_with_Acanthosis_Nigricans.yaml	phenotypes	3	evidence	0	PMID:7493034	SUPPORT	HUMAN_CLINICAL	We now report the unexpected observation of a FGFR3 transmembrane domain mutation, Ala391Glu, in three unrelated families with Crouzon syndrome and acanthosis nigricans, a specific skin disorder of hyperkeratosis and hyperpigmentation.	"Acanthosis nigricans is a defining feature that distinguishes this syndrome from classic FGFR2-related Crouzon syndrome.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Acanthosis nigricans is a defining feature that distinguishes this syndrome from classic FGFR2-related Crouzon syndrome.\n"", ""reference"": ""PMID:7493034"", ""snippet"": ""We now report the unexpected observation of a FGFR3 transmembrane domain mutation, Ala391Glu, in three unrelated families with Crouzon syndrome and acanthosis nigricans, a specific skin disorder of hyperkeratosis and hyperpigmentation."", ""supports"": ""SUPPORT""}"
2191	1907	81	Cushing's Syndrome	Cushings_Syndrome.yaml	phenotypes	0	evidence	0	PMID:37432427	SUPPORT		Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae and with metabolic manifestations such as hyperglycemia, hypertension, and excess fat deposition in the face, back of the neck, and visceral organs.	This confirms central obesity with excess fat in the face, back of neck (buffalo hump), and visceral organs.	"{""explanation"": ""This confirms central obesity with excess fat in the face, back of neck (buffalo hump), and visceral organs."", ""reference"": ""PMID:37432427"", ""snippet"": ""Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae and with metabolic manifestations such as hyperglycemia, hypertension, and excess fat deposition in the face, back of the neck, and visceral organs."", ""supports"": ""SUPPORT""}"
2192	1908	81	Cushing's Syndrome	Cushings_Syndrome.yaml	phenotypes	1	evidence	0	PMID:37432427	SUPPORT		Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae	This confirms purple striae as a characteristic skin manifestation.	"{""explanation"": ""This confirms purple striae as a characteristic skin manifestation."", ""reference"": ""PMID:37432427"", ""snippet"": ""Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae"", ""supports"": ""SUPPORT""}"
2193	1909	81	Cushing's Syndrome	Cushings_Syndrome.yaml	phenotypes	2	evidence	0	PMID:37432427	SUPPORT		Cushing syndrome is associated with hyperglycemia, protein catabolism, immunosuppression, hypertension, weight gain, neurocognitive changes, and mood disorders.	Protein catabolism from cortisol excess causes proximal muscle weakness and myopathy.	"{""explanation"": ""Protein catabolism from cortisol excess causes proximal muscle weakness and myopathy."", ""reference"": ""PMID:37432427"", ""snippet"": ""Cushing syndrome is associated with hyperglycemia, protein catabolism, immunosuppression, hypertension, weight gain, neurocognitive changes, and mood disorders."", ""supports"": ""SUPPORT""}"
2194	1910	81	Cushing's Syndrome	Cushings_Syndrome.yaml	phenotypes	3	evidence	0	PMID:37432427	SUPPORT		Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae and with metabolic manifestations such as hyperglycemia, hypertension, and excess fat deposition	This confirms hypertension as a characteristic metabolic manifestation.	"{""explanation"": ""This confirms hypertension as a characteristic metabolic manifestation."", ""reference"": ""PMID:37432427"", ""snippet"": ""Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae and with metabolic manifestations such as hyperglycemia, hypertension, and excess fat deposition"", ""supports"": ""SUPPORT""}"
2195	1911	81	Cushing's Syndrome	Cushings_Syndrome.yaml	phenotypes	4	evidence	0	PMID:37432427	SUPPORT		Cushing syndrome is associated with hyperglycemia, protein catabolism, immunosuppression, hypertension, weight gain, neurocognitive changes, and mood disorders.	Hyperglycemia from cortisol-induced insulin resistance is a key feature.	"{""explanation"": ""Hyperglycemia from cortisol-induced insulin resistance is a key feature."", ""reference"": ""PMID:37432427"", ""snippet"": ""Cushing syndrome is associated with hyperglycemia, protein catabolism, immunosuppression, hypertension, weight gain, neurocognitive changes, and mood disorders."", ""supports"": ""SUPPORT""}"
2196	1913	81	Cushing's Syndrome	Cushings_Syndrome.yaml	phenotypes	6	evidence	0	PMID:37432427	SUPPORT		Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae	Easy bruising is confirmed as a characteristic skin change.	"{""explanation"": ""Easy bruising is confirmed as a characteristic skin change."", ""reference"": ""PMID:37432427"", ""snippet"": ""Cushing syndrome characteristically presents with skin changes such as facial plethora, easy bruising, and purple striae"", ""supports"": ""SUPPORT""}"
2203	1920	82	Cystic echinococcosis	Cystic_Echinococcosis.yaml	phenotypes	0	evidence	0	PMID:27047771	SUPPORT		Upon infection with CE, cyst formation mainly occurs in the liver (70%).	The abstract indicates liver cyst formation is common.	"{""explanation"": ""The abstract indicates liver cyst formation is common."", ""reference"": ""PMID:27047771"", ""snippet"": ""Upon infection with CE, cyst formation mainly occurs in the liver (70%)."", ""supports"": ""SUPPORT""}"
2208	1937	83	Cystic Fibrosis	Cystic_Fibrosis.yaml	phenotypes	0	evidence	0	PMID:30986316	SUPPORT		Cystic fibrosis (CF) is an autosomal recessive disease characterized by pancreatic insufficiency and chronic endobronchial airway infection.	Clinical review identifies chronic airway infection as a defining characteristic of cystic fibrosis.	"{""explanation"": ""Clinical review identifies chronic airway infection as a defining characteristic of cystic fibrosis."", ""reference"": ""PMID:30986316"", ""snippet"": ""Cystic fibrosis (CF) is an autosomal recessive disease characterized by pancreatic insufficiency and chronic endobronchial airway infection."", ""supports"": ""SUPPORT""}"
2209	1938	83	Cystic Fibrosis	Cystic_Fibrosis.yaml	phenotypes	1	evidence	0	PMID:30986316	SUPPORT		This latter feature results in progressive bronchiectasis and ultimately respiratory failure, which is the leading cause of death in patients with CF.	Clinical review confirms progressive bronchiectasis as a consequence of chronic airway infection in CF.	"{""explanation"": ""Clinical review confirms progressive bronchiectasis as a consequence of chronic airway infection in CF."", ""reference"": ""PMID:30986316"", ""snippet"": ""This latter feature results in progressive bronchiectasis and ultimately respiratory failure, which is the leading cause of death in patients with CF."", ""supports"": ""SUPPORT""}"
2210	1939	83	Cystic Fibrosis	Cystic_Fibrosis.yaml	phenotypes	2	evidence	0	PMID:30986316	SUPPORT		Cystic fibrosis (CF) is an autosomal recessive disease characterized by pancreatic insufficiency and chronic endobronchial airway infection.	Clinical review identifies pancreatic insufficiency as a defining characteristic of cystic fibrosis.	"{""explanation"": ""Clinical review identifies pancreatic insufficiency as a defining characteristic of cystic fibrosis."", ""reference"": ""PMID:30986316"", ""snippet"": ""Cystic fibrosis (CF) is an autosomal recessive disease characterized by pancreatic insufficiency and chronic endobronchial airway infection."", ""supports"": ""SUPPORT""}"
2211	1940	83	Cystic Fibrosis	Cystic_Fibrosis.yaml	phenotypes	3	evidence	0	PMID:33178516	SUPPORT		It classically presents in childhood with chronic productive cough, malabsorption causing steatorrhea, and failure to thrive.	Review confirms steatorrhea as a classic presentation of cystic fibrosis due to malabsorption.	"{""explanation"": ""Review confirms steatorrhea as a classic presentation of cystic fibrosis due to malabsorption."", ""reference"": ""PMID:33178516"", ""snippet"": ""It classically presents in childhood with chronic productive cough, malabsorption causing steatorrhea, and failure to thrive."", ""supports"": ""SUPPORT""}"
2212	1941	83	Cystic Fibrosis	Cystic_Fibrosis.yaml	phenotypes	4	evidence	0	PMID:33178516	SUPPORT		It classically presents in childhood with chronic productive cough, malabsorption causing steatorrhea, and failure to thrive.	Review confirms failure to thrive as a classic presentation of cystic fibrosis.	"{""explanation"": ""Review confirms failure to thrive as a classic presentation of cystic fibrosis."", ""reference"": ""PMID:33178516"", ""snippet"": ""It classically presents in childhood with chronic productive cough, malabsorption causing steatorrhea, and failure to thrive."", ""supports"": ""SUPPORT""}"
2213	1942	83	Cystic Fibrosis	Cystic_Fibrosis.yaml	phenotypes	5	evidence	0	PMID:30986316	SUPPORT		Other complications include sinusitis, diabetes mellitus, bowel obstruction, hepatobiliary disease, hyponatremic dehydration, and infertility.	Clinical review lists bowel obstruction (including meconium ileus) among established complications of CF.	"{""explanation"": ""Clinical review lists bowel obstruction (including meconium ileus) among established complications of CF."", ""reference"": ""PMID:30986316"", ""snippet"": ""Other complications include sinusitis, diabetes mellitus, bowel obstruction, hepatobiliary disease, hyponatremic dehydration, and infertility."", ""supports"": ""SUPPORT""}"
2214	1943	83	Cystic Fibrosis	Cystic_Fibrosis.yaml	phenotypes	6	evidence	0	PMID:30986316	SUPPORT		Other complications include sinusitis, diabetes mellitus, bowel obstruction, hepatobiliary disease, hyponatremic dehydration, and infertility.	Clinical review lists infertility among the established complications of cystic fibrosis.	"{""explanation"": ""Clinical review lists infertility among the established complications of cystic fibrosis."", ""reference"": ""PMID:30986316"", ""snippet"": ""Other complications include sinusitis, diabetes mellitus, bowel obstruction, hepatobiliary disease, hyponatremic dehydration, and infertility."", ""supports"": ""SUPPORT""}"
2228	1959	84	Danon disease	Danon_disease.yaml	phenotypes	0	evidence	0	DOI:10.1111/nan.12587	SUPPORT		Danon disease is a severe multisystem disorder clinically characterized by hypertrophic cardiomyopathy, skeletal myopathy and mental retardation in male patients	Confirms hypertrophic cardiomyopathy as a primary clinical feature of Danon disease.	"{""explanation"": ""Confirms hypertrophic cardiomyopathy as a primary clinical feature of Danon disease."", ""reference"": ""DOI:10.1111/nan.12587"", ""snippet"": ""Danon disease is a severe multisystem disorder clinically characterized by hypertrophic cardiomyopathy, skeletal myopathy and mental retardation in male patients"", ""supports"": ""SUPPORT""}"
2229	1959	84	Danon disease	Danon_disease.yaml	phenotypes	0	evidence	1	DOI:10.3390/biom14101272	SUPPORT		Male patients present with the triad of cardiomyopathy, myopathy, and intellectual disability, while female patients present with cardiomyopathy. The disease's leading cause of death is heart failure, and its prognostic factor is cardiomyopathy.	Establishes cardiomyopathy as the leading cause of death and main prognostic factor.	"{""explanation"": ""Establishes cardiomyopathy as the leading cause of death and main prognostic factor."", ""reference"": ""DOI:10.3390/biom14101272"", ""snippet"": ""Male patients present with the triad of cardiomyopathy, myopathy, and intellectual disability, while female patients present with cardiomyopathy. The disease's leading cause of death is heart failure, and its prognostic factor is cardiomyopathy."", ""supports"": ""SUPPORT""}"
2230	1960	84	Danon disease	Danon_disease.yaml	phenotypes	1	evidence	0	DOI:10.1111/nan.12587	SUPPORT		Danon disease is a severe multisystem disorder clinically characterized by hypertrophic cardiomyopathy, skeletal myopathy and mental retardation in male patients	Confirms skeletal myopathy as part of the clinical triad in affected males.	"{""explanation"": ""Confirms skeletal myopathy as part of the clinical triad in affected males."", ""reference"": ""DOI:10.1111/nan.12587"", ""snippet"": ""Danon disease is a severe multisystem disorder clinically characterized by hypertrophic cardiomyopathy, skeletal myopathy and mental retardation in male patients"", ""supports"": ""SUPPORT""}"
2231	1960	84	Danon disease	Danon_disease.yaml	phenotypes	1	evidence	1	DOI:10.1146/annurev-pathmechdis-012419-032618	SUPPORT		Through impairment of muscle homeostasis, autophagy dysfunction contributes to the pathogenesis of many different skeletal myopathies	Supports the role of autophagy dysfunction in skeletal myopathy pathogenesis.	"{""explanation"": ""Supports the role of autophagy dysfunction in skeletal myopathy pathogenesis."", ""reference"": ""DOI:10.1146/annurev-pathmechdis-012419-032618"", ""snippet"": ""Through impairment of muscle homeostasis, autophagy dysfunction contributes to the pathogenesis of many different skeletal myopathies"", ""supports"": ""SUPPORT""}"
2232	1961	84	Danon disease	Danon_disease.yaml	phenotypes	2	evidence	0	DOI:10.3390/biom14101272	SUPPORT		Male patients present with the triad of cardiomyopathy, myopathy, and intellectual disability	Confirms intellectual disability as part of the classic clinical triad in males.	"{""explanation"": ""Confirms intellectual disability as part of the classic clinical triad in males."", ""reference"": ""DOI:10.3390/biom14101272"", ""snippet"": ""Male patients present with the triad of cardiomyopathy, myopathy, and intellectual disability"", ""supports"": ""SUPPORT""}"
2233	1961	84	Danon disease	Danon_disease.yaml	phenotypes	2	evidence	1	DOI:10.1111/nan.12587	SUPPORT		Danon disease is a severe multisystem disorder clinically characterized by hypertrophic cardiomyopathy, skeletal myopathy and mental retardation in male patients	Confirms intellectual disability (mental retardation) as a defining feature in males.	"{""explanation"": ""Confirms intellectual disability (mental retardation) as a defining feature in males."", ""reference"": ""DOI:10.1111/nan.12587"", ""snippet"": ""Danon disease is a severe multisystem disorder clinically characterized by hypertrophic cardiomyopathy, skeletal myopathy and mental retardation in male patients"", ""supports"": ""SUPPORT""}"
2234	1962	84	Danon disease	Danon_disease.yaml	phenotypes	3	evidence	0	DOI:10.3390/genes14081539	SUPPORT		At the age of 13, he was diagnosed with mild ventricular pre-excitation known as Wolf-Parkinson-White syndrome (WPWs)	Case report documenting WPW syndrome as an early manifestation in a Danon disease patient.	"{""explanation"": ""Case report documenting WPW syndrome as an early manifestation in a Danon disease patient."", ""reference"": ""DOI:10.3390/genes14081539"", ""snippet"": ""At the age of 13, he was diagnosed with mild ventricular pre-excitation known as Wolf-Parkinson-White syndrome (WPWs)"", ""supports"": ""SUPPORT""}"
2235	1963	84	Danon disease	Danon_disease.yaml	phenotypes	4	evidence	0	DOI:10.3390/genes14081539	SUPPORT		at about the age of 25 presented with visual impairment due to cone-rod dystrophy	Documents retinal dystrophy (cone-rod dystrophy) as a clinical manifestation in Danon disease.	"{""explanation"": ""Documents retinal dystrophy (cone-rod dystrophy) as a clinical manifestation in Danon disease."", ""reference"": ""DOI:10.3390/genes14081539"", ""snippet"": ""at about the age of 25 presented with visual impairment due to cone-rod dystrophy"", ""supports"": ""SUPPORT""}"
2248	1972	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	phenotypes	0	evidence	0	PMID:29222591	SUPPORT		The clinical features of DLB and PDD include cognitive impairment, parkinsonism, visual hallucinations, and fluctuating attention.	This confirms that visual hallucinations are a core clinical feature of dementia with Lewy bodies.	"{""explanation"": ""This confirms that visual hallucinations are a core clinical feature of dementia with Lewy bodies."", ""reference"": ""PMID:29222591"", ""snippet"": ""The clinical features of DLB and PDD include cognitive impairment, parkinsonism, visual hallucinations, and fluctuating attention."", ""supports"": ""SUPPORT""}"
2249	1973	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	phenotypes	1	evidence	0	PMID:29222591	SUPPORT		Despite considerable clinical overlap, their diagnosis is based on an arbitrary distinction between the time of onset of motor and cognitive symptoms: dementia often preceding parkinsonism in DLB.	This confirms that parkinsonism is a core feature of DLB, with the temporal relationship to cognitive symptoms distinguishing it from Parkinson's disease dementia.	"{""explanation"": ""This confirms that parkinsonism is a core feature of DLB, with the temporal relationship to cognitive symptoms distinguishing it from Parkinson's disease dementia."", ""reference"": ""PMID:29222591"", ""snippet"": ""Despite considerable clinical overlap, their diagnosis is based on an arbitrary distinction between the time of onset of motor and cognitive symptoms: dementia often preceding parkinsonism in DLB."", ""supports"": ""SUPPORT""}"
2250	1974	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	phenotypes	2	evidence	0	PMID:29222591	SUPPORT		The clinical features of DLB and PDD include cognitive impairment, parkinsonism, visual hallucinations, and fluctuating attention.	This confirms that cognitive impairment with characteristic fluctuating attention is a core feature of dementia with Lewy bodies.	"{""explanation"": ""This confirms that cognitive impairment with characteristic fluctuating attention is a core feature of dementia with Lewy bodies."", ""reference"": ""PMID:29222591"", ""snippet"": ""The clinical features of DLB and PDD include cognitive impairment, parkinsonism, visual hallucinations, and fluctuating attention."", ""supports"": ""SUPPORT""}"
2251	1975	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	phenotypes	3	evidence	0	PMID:37461299	SUPPORT		Isolated/idiopathic rapid eye movement sleep behavior disorder (iRBD) is a powerful early predictor of dementia with Lewy bodies (DLB) and Parkinson's disease (PD).	This establishes that RBD is a prodromal marker for DLB, occurring years before dementia onset.	"{""explanation"": ""This establishes that RBD is a prodromal marker for DLB, occurring years before dementia onset."", ""reference"": ""PMID:37461299"", ""snippet"": ""Isolated/idiopathic rapid eye movement sleep behavior disorder (iRBD) is a powerful early predictor of dementia with Lewy bodies (DLB) and Parkinson's disease (PD)."", ""supports"": ""SUPPORT""}"
2252	1975	85	Dementia with Lewy Bodies	Dementia_with_Lewy_Bodies.yaml	phenotypes	3	evidence	1	PMID:37461299	SUPPORT		Cognitive decline in iRBD begins up to 10 years prior to phenoconversion. Attention and executive dysfunction are the strongest predictors of dementia in iRBD.	This demonstrates the temporal relationship between RBD and DLB, with attention/executive deficits predicting dementia phenoconversion.	"{""explanation"": ""This demonstrates the temporal relationship between RBD and DLB, with attention/executive deficits predicting dementia phenoconversion."", ""reference"": ""PMID:37461299"", ""snippet"": ""Cognitive decline in iRBD begins up to 10 years prior to phenoconversion. Attention and executive dysfunction are the strongest predictors of dementia in iRBD."", ""supports"": ""SUPPORT""}"
2257	1980	86	Dengue	Dengue.yaml	phenotypes	0	evidence	0	PMID:17448935	SUPPORT		The disease typically consists of an acute illness characterised by fever, rash, and incapacitating arthralgia.	Fever is a typical clinical feature of dengue.	"{""explanation"": ""Fever is a typical clinical feature of dengue."", ""reference"": ""PMID:17448935"", ""snippet"": ""The disease typically consists of an acute illness characterised by fever, rash, and incapacitating arthralgia."", ""supports"": ""SUPPORT""}"
2258	1981	86	Dengue	Dengue.yaml	phenotypes	1	evidence	0	PMID:17448935	SUPPORT		The disease typically consists of an acute illness characterised by fever, rash, and incapacitating arthralgia.	Rash is a typical clinical feature of dengue.	"{""explanation"": ""Rash is a typical clinical feature of dengue."", ""reference"": ""PMID:17448935"", ""snippet"": ""The disease typically consists of an acute illness characterised by fever, rash, and incapacitating arthralgia."", ""supports"": ""SUPPORT""}"
2268	2010	88	Dermatomyositis	Dermatomyositis.yaml	phenotypes	2	evidence	0	PMID:38456909	SUPPORT		Anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis (anti-MDA5-DM) is frequently complicated by progressive interstitial lung disease (ILD), the prognosis of which is poor, and management is a major challenge.	This evidence confirms that anti-MDA5 positive dermatomyositis is strongly associated with progressive interstitial lung disease, supporting the link between this autoantibody and pulmonary complications.	"{""explanation"": ""This evidence confirms that anti-MDA5 positive dermatomyositis is strongly associated with progressive interstitial lung disease, supporting the link between this autoantibody and pulmonary complications."", ""reference"": ""PMID:38456909"", ""snippet"": ""Anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis (anti-MDA5-DM) is frequently complicated by progressive interstitial lung disease (ILD), the prognosis of which is poor, and management is a major challenge."", ""supports"": ""SUPPORT""}"
2269	2010	88	Dermatomyositis	Dermatomyositis.yaml	phenotypes	2	evidence	1	PMID:39334579	SUPPORT		However, rapidly progressive interstitial lung disease (RP-ILD) remains a major cause of death in anti-melanoma differentiation gene 5 autoantibody-positive JDM.	This evidence highlights the severe prognosis of rapidly progressive interstitial lung disease in anti-MDA5 positive dermatomyositis, including juvenile forms.	"{""explanation"": ""This evidence highlights the severe prognosis of rapidly progressive interstitial lung disease in anti-MDA5 positive dermatomyositis, including juvenile forms."", ""reference"": ""PMID:39334579"", ""snippet"": ""However, rapidly progressive interstitial lung disease (RP-ILD) remains a major cause of death in anti-melanoma differentiation gene 5 autoantibody-positive JDM."", ""supports"": ""SUPPORT""}"
2284	2046	90	Dieulafoy Lesion	Dieulafoy_Lesion.yaml	phenotypes	0	evidence	0	PMID:39839160	SUPPORT		Twenty-five patients (92.6%) presented with hematemesis and melena as chief complaints.	Systematic review shows most patients present with overt gastrointestinal bleeding.	"{""explanation"": ""Systematic review shows most patients present with overt gastrointestinal bleeding."", ""reference"": ""PMID:39839160"", ""snippet"": ""Twenty-five patients (92.6%) presented with hematemesis and melena as chief complaints."", ""supports"": ""SUPPORT""}"
2285	2046	90	Dieulafoy Lesion	Dieulafoy_Lesion.yaml	phenotypes	0	evidence	1	PMID:35746982	SUPPORT		a 71-year-old female patient who presented with a bright red bleed per rectum	Colonic Dieulafoy case highlights overt lower GI bleeding presentation.	"{""explanation"": ""Colonic Dieulafoy case highlights overt lower GI bleeding presentation."", ""reference"": ""PMID:35746982"", ""snippet"": ""a 71-year-old female patient who presented with a bright red bleed per rectum"", ""supports"": ""SUPPORT""}"
2286	2046	90	Dieulafoy Lesion	Dieulafoy_Lesion.yaml	phenotypes	0	evidence	2	PMID:37620810	SUPPORT		hematochezia of ≥ 2 episodes constituted the independent factor associated with ≥ 2 double-balloon endoscopy diagnoses	Small-bowel Dieulafoy series shows recurrent hematochezia is common and predicts repeat diagnostic endoscopy.	"{""explanation"": ""Small-bowel Dieulafoy series shows recurrent hematochezia is common and predicts repeat diagnostic endoscopy."", ""reference"": ""PMID:37620810"", ""snippet"": ""hematochezia of ≥ 2 episodes constituted the independent factor associated with ≥ 2 double-balloon endoscopy diagnoses"", ""supports"": ""SUPPORT""}"
2287	2047	90	Dieulafoy Lesion	Dieulafoy_Lesion.yaml	phenotypes	1	evidence	0	PMID:37065413	SUPPORT		These catastrophic bleeding episodes frequently result in hemodynamic instability and the need for transfusion of multiple blood products.	Case report notes hemodynamic instability, consistent with hypotension during bleeding episodes.	"{""explanation"": ""Case report notes hemodynamic instability, consistent with hypotension during bleeding episodes."", ""reference"": ""PMID:37065413"", ""snippet"": ""These catastrophic bleeding episodes frequently result in hemodynamic instability and the need for transfusion of multiple blood products."", ""supports"": ""SUPPORT""}"
2296	2080	92	Dorsalgia	Dorsalgia.yaml	phenotypes	0	evidence	0	PMID:35110524	SUPPORT		Back pain is a common and debilitating disorder with largely unknown underlying biology.	The study frames back pain as a common debilitating disorder, consistent with dorsalgia.	"{""explanation"": ""The study frames back pain as a common debilitating disorder, consistent with dorsalgia."", ""reference"": ""PMID:35110524"", ""snippet"": ""Back pain is a common and debilitating disorder with largely unknown underlying biology."", ""supports"": ""SUPPORT""}"
2299	2096	93	Down_syndrome	Down_syndrome.yaml	phenotypes	1	evidence	0	PMID:32029743	SUPPORT		Since the first description of trisomy 21, we have learned much about intellectual disability and genetic risk factors for congenital heart disease.	Establishes intellectual disability as a core feature of Down syndrome.	"{""explanation"": ""Establishes intellectual disability as a core feature of Down syndrome."", ""reference"": ""PMID:32029743"", ""snippet"": ""Since the first description of trisomy 21, we have learned much about intellectual disability and genetic risk factors for congenital heart disease."", ""supports"": ""SUPPORT""}"
2300	2099	93	Down_syndrome	Down_syndrome.yaml	phenotypes	4	evidence	0	PMID:26504441	SUPPORT		The prevalence of congenital heart disease in infants with Down syndrome is 40%, compared with 0.3% in children who have normal chromosomes.	Demonstrates high prevalence of congenital heart defects in Down syndrome.	"{""explanation"": ""Demonstrates high prevalence of congenital heart defects in Down syndrome."", ""reference"": ""PMID:26504441"", ""snippet"": ""The prevalence of congenital heart disease in infants with Down syndrome is 40%, compared with 0.3% in children who have normal chromosomes."", ""supports"": ""SUPPORT""}"
2301	2101	93	Down_syndrome	Down_syndrome.yaml	phenotypes	6	evidence	0	PMID:33684394	SUPPORT		Down syndrome remains a strong risk factor for childhood leukemia, and associations with AML are stronger than previously reported.	Confirms increased leukemia risk in children with Down syndrome.	"{""explanation"": ""Confirms increased leukemia risk in children with Down syndrome."", ""reference"": ""PMID:33684394"", ""snippet"": ""Down syndrome remains a strong risk factor for childhood leukemia, and associations with AML are stronger than previously reported."", ""supports"": ""SUPPORT""}"
2312	2128	95	Dravet_syndrome	Dravet_syndrome.yaml	phenotypes	0	evidence	0	PMID:21463282	SUPPORT		a devastating infantile-onset epilepsy with ataxia, cognitive dysfunction, and febrile and afebrile seizures resistant to current medications.		"{""reference"": ""PMID:21463282"", ""snippet"": ""a devastating infantile-onset epilepsy with ataxia, cognitive dysfunction, and febrile and afebrile seizures resistant to current medications."", ""supports"": ""SUPPORT""}"
2313	2129	95	Dravet_syndrome	Dravet_syndrome.yaml	phenotypes	1	evidence	0	PMID:21463282	SUPPORT		a devastating infantile-onset epilepsy with ataxia, cognitive dysfunction, and febrile and afebrile seizures resistant to current medications.		"{""reference"": ""PMID:21463282"", ""snippet"": ""a devastating infantile-onset epilepsy with ataxia, cognitive dysfunction, and febrile and afebrile seizures resistant to current medications."", ""supports"": ""SUPPORT""}"
2316	2155	96	Duchenne Muscular Dystrophy	Duchenne_Muscular_Dystrophy.yaml	phenotypes	0	evidence	0	PMID:37435300	SUPPORT		Duchenne muscular dystrophy (DMD) is a severe, progressive, and ultimately fatal disease of skeletal muscle wasting, respiratory insufficiency, and cardiomyopathy.	Review confirms progressive skeletal muscle wasting as a defining feature of DMD.	"{""explanation"": ""Review confirms progressive skeletal muscle wasting as a defining feature of DMD."", ""reference"": ""PMID:37435300"", ""snippet"": ""Duchenne muscular dystrophy (DMD) is a severe, progressive, and ultimately fatal disease of skeletal muscle wasting, respiratory insufficiency, and cardiomyopathy."", ""supports"": ""SUPPORT""}"
2317	2156	96	Duchenne Muscular Dystrophy	Duchenne_Muscular_Dystrophy.yaml	phenotypes	1	evidence	0	PMID:15106215	SUPPORT		Improvements were seen in time taken to rise from the floor (Gowers' time), nine metres walking time, four-stair climbing time, ability to lift weights, leg function grade and forced vital capacity.	Cochrane review uses Gowers time as an outcome measure, confirming its clinical relevance in DMD.	"{""explanation"": ""Cochrane review uses Gowers time as an outcome measure, confirming its clinical relevance in DMD."", ""reference"": ""PMID:15106215"", ""snippet"": ""Improvements were seen in time taken to rise from the floor (Gowers' time), nine metres walking time, four-stair climbing time, ability to lift weights, leg function grade and forced vital capacity."", ""supports"": ""SUPPORT""}"
2318	2158	96	Duchenne Muscular Dystrophy	Duchenne_Muscular_Dystrophy.yaml	phenotypes	3	evidence	0	PMID:34626608	SUPPORT		the creatine kinase test showed good accuracy in screening for cases of Duchenne Muscular Dystrophy and may be a useful alternative in the early diagnosis of the disease followed by confirmatory genetic testing.	Systematic review confirms CK testing has good diagnostic accuracy for DMD screening.	"{""explanation"": ""Systematic review confirms CK testing has good diagnostic accuracy for DMD screening."", ""reference"": ""PMID:34626608"", ""snippet"": ""the creatine kinase test showed good accuracy in screening for cases of Duchenne Muscular Dystrophy and may be a useful alternative in the early diagnosis of the disease followed by confirmatory genetic testing."", ""supports"": ""SUPPORT""}"
2319	2159	96	Duchenne Muscular Dystrophy	Duchenne_Muscular_Dystrophy.yaml	phenotypes	4	evidence	0	PMID:37435300	SUPPORT		Duchenne muscular dystrophy (DMD) is a severe, progressive, and ultimately fatal disease of skeletal muscle wasting, respiratory insufficiency, and cardiomyopathy.	Review confirms cardiomyopathy as a defining feature of DMD.	"{""explanation"": ""Review confirms cardiomyopathy as a defining feature of DMD."", ""reference"": ""PMID:37435300"", ""snippet"": ""Duchenne muscular dystrophy (DMD) is a severe, progressive, and ultimately fatal disease of skeletal muscle wasting, respiratory insufficiency, and cardiomyopathy."", ""supports"": ""SUPPORT""}"
2320	2159	96	Duchenne Muscular Dystrophy	Duchenne_Muscular_Dystrophy.yaml	phenotypes	4	evidence	1	PMID:22463839	SUPPORT		Cardiomyopathy is a consequence of Duchenne muscular dystrophy (DMD).	Study confirms cardiomyopathy as a consequence of DMD.	"{""explanation"": ""Study confirms cardiomyopathy as a consequence of DMD."", ""reference"": ""PMID:22463839"", ""snippet"": ""Cardiomyopathy is a consequence of Duchenne muscular dystrophy (DMD)."", ""supports"": ""SUPPORT""}"
2321	2160	96	Duchenne Muscular Dystrophy	Duchenne_Muscular_Dystrophy.yaml	phenotypes	5	evidence	0	PMID:37435300	SUPPORT		Duchenne muscular dystrophy (DMD) is a severe, progressive, and ultimately fatal disease of skeletal muscle wasting, respiratory insufficiency, and cardiomyopathy.	Review confirms respiratory insufficiency as a defining feature of DMD.	"{""explanation"": ""Review confirms respiratory insufficiency as a defining feature of DMD."", ""reference"": ""PMID:37435300"", ""snippet"": ""Duchenne muscular dystrophy (DMD) is a severe, progressive, and ultimately fatal disease of skeletal muscle wasting, respiratory insufficiency, and cardiomyopathy."", ""supports"": ""SUPPORT""}"
2336	2219	99	ER-Positive Breast Cancer	ER_Positive_Breast_Cancer.yaml	phenotypes	1	evidence	0	PMID:22291085	SUPPORT		defined as having 1% to 10% positivity by immunohistochemistry (IHC)	Abstract defines low ER positivity thresholds by immunohistochemistry.	"{""explanation"": ""Abstract defines low ER positivity thresholds by immunohistochemistry."", ""reference"": ""PMID:22291085"", ""snippet"": ""defined as having 1% to 10% positivity by immunohistochemistry (IHC)"", ""supports"": ""SUPPORT""}"
2337	2220	99	ER-Positive Breast Cancer	ER_Positive_Breast_Cancer.yaml	phenotypes	2	evidence	0	PMID:30054636	SUPPORT		Late recurrence 5 or more years after diagnosis accounts for at least one-half of all cases of recurrent hormone receptor-positive breast cancer.	Abstract reports that late recurrences account for at least half of recurrent hormone receptor-positive cases.	"{""explanation"": ""Abstract reports that late recurrences account for at least half of recurrent hormone receptor-positive cases."", ""reference"": ""PMID:30054636"", ""snippet"": ""Late recurrence 5 or more years after diagnosis accounts for at least one-half of all cases of recurrent hormone receptor-positive breast cancer."", ""supports"": ""SUPPORT""}"
2371	2247	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	0	evidence	0	PMID:32080199	SUPPORT		EVD has a high case-fatality rate; it is characterized by fever, gastrointestinal signs and multiple organ dysfunction syndrome.	The literature indicates that fever is a very frequent symptom of Ebola Virus Disease (EVD).	"{""explanation"": ""The literature indicates that fever is a very frequent symptom of Ebola Virus Disease (EVD)."", ""reference"": ""PMID:32080199"", ""snippet"": ""EVD has a high case-fatality rate; it is characterized by fever, gastrointestinal signs and multiple organ dysfunction syndrome."", ""supports"": ""SUPPORT""}"
2372	2247	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	0	evidence	1	PMID:28457350	SUPPORT		This review highlights the range of aspects of EVD that the authors find are relevant to laboratory medicine, including the need for robust prediagnostic and laboratory processing algorithms to inform sampling of suspect patients, the vast majority of whom, in resource-rich settings, will have another diagnosis.	The background is specific to diagnostic issues for laboratory professionals, indicating the relevance of fever as a primary symptom for suspect cases during prediagnostic processes.	"{""explanation"": ""The background is specific to diagnostic issues for laboratory professionals, indicating the relevance of fever as a primary symptom for suspect cases during prediagnostic processes."", ""reference"": ""PMID:28457350"", ""snippet"": ""This review highlights the range of aspects of EVD that the authors find are relevant to laboratory medicine, including the need for robust prediagnostic and laboratory processing algorithms to inform sampling of suspect patients, the vast majority of whom, in resource-rich settings, will have another diagnosis."", ""supports"": ""SUPPORT""}"
2373	2248	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	1	evidence	0	PMID:32487785	SUPPORT		It is usually diagnosed based on several clinical symptoms such as the sudden onset of illness, high fevers for less than three weeks, and at least two hemorrhagic symptoms despite no predisposing factors.	The literature confirms that hemorrhagic symptoms are a key diagnostic feature of EVD.	"{""explanation"": ""The literature confirms that hemorrhagic symptoms are a key diagnostic feature of EVD."", ""reference"": ""PMID:32487785"", ""snippet"": ""It is usually diagnosed based on several clinical symptoms such as the sudden onset of illness, high fevers for less than three weeks, and at least two hemorrhagic symptoms despite no predisposing factors."", ""supports"": ""SUPPORT""}"
2374	2248	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	1	evidence	1	PMID:28484180	SUPPORT		Ebolaviruses, members of the family Filoviridae, cause severe hemorrhagic fever in humans and nonhuman primates, with human case fatality rates of up to 90%.	The literature confirms severe hemorrhagic fever as a phenotype of EVD.	"{""explanation"": ""The literature confirms severe hemorrhagic fever as a phenotype of EVD."", ""reference"": ""PMID:28484180"", ""snippet"": ""Ebolaviruses, members of the family Filoviridae, cause severe hemorrhagic fever in humans and nonhuman primates, with human case fatality rates of up to 90%."", ""supports"": ""SUPPORT""}"
2375	2248	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	1	evidence	2	PMID:30893774	SUPPORT		Ebola Virus Disease (EVD) is one of the most lethal transmissible infections, characterized by a high fatality rate, and caused by a member of the Filoviridae family.	The literature supports that EVD is a severe systemic disease with high fatality, implying high frequency and severity of symptoms like hemorrhage.	"{""explanation"": ""The literature supports that EVD is a severe systemic disease with high fatality, implying high frequency and severity of symptoms like hemorrhage."", ""reference"": ""PMID:30893774"", ""snippet"": ""Ebola Virus Disease (EVD) is one of the most lethal transmissible infections, characterized by a high fatality rate, and caused by a member of the Filoviridae family."", ""supports"": ""SUPPORT""}"
2376	2248	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	1	evidence	3	PMID:35657325	SUPPORT		A group of viruses within the genus Ebolavirus causes this severe hemorrhagic disease in humans: Ebola virus (EBOV; species Zaire ebolavirus), Sudan virus (SUDV; species Sudan ebolavirus), Bundibugyo virus, and Taï Forest virus	The literature supports that EVD is characterized by severe systemic symptoms, including severe hemorrhagic manifestations.	"{""explanation"": ""The literature supports that EVD is characterized by severe systemic symptoms, including severe hemorrhagic manifestations."", ""reference"": ""PMID:35657325"", ""snippet"": ""A group of viruses within the genus Ebolavirus causes this severe hemorrhagic disease in humans: Ebola virus (EBOV; species Zaire ebolavirus), Sudan virus (SUDV; species Sudan ebolavirus), Bundibugyo virus, and Taï Forest virus"", ""supports"": ""SUPPORT""}"
2377	2248	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	1	sequelae[2].evidence	0	PMID:35446128	SUPPORT		Ebola virus (EBV) disease (EVD) is a highly virulent systemic disease characterized by an aggressive systemic inflammatory response and impaired vascular and coagulation systems, often leading to uncontrolled hemorrhaging and death.	This paper establishes that Ebola virus causes systemic inflammatory response and coagulation impairment leading to hemorrhage and death.	"{""explanation"": ""This paper establishes that Ebola virus causes systemic inflammatory response and coagulation impairment leading to hemorrhage and death."", ""reference"": ""PMID:35446128"", ""snippet"": ""Ebola virus (EBV) disease (EVD) is a highly virulent systemic disease characterized by an aggressive systemic inflammatory response and impaired vascular and coagulation systems, often leading to uncontrolled hemorrhaging and death."", ""supports"": ""SUPPORT""}"
2378	2249	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	2	evidence	0	PMID:25972150	PARTIAL		Common gastrointestinal manifestations include...nausea and vomiting-60%...The diarrhea and nausea and vomiting frequently produce profound, life-threatening hypovolemia.	"While vomiting is a common manifestation and can lead to severe consequences like life-threatening hypovolemia, the literature does not specifically categorize vomiting itself as ""severe."" The severity is associated with the complications resulting from vomiting and other symptoms."	"{""explanation"": ""While vomiting is a common manifestation and can lead to severe consequences like life-threatening hypovolemia, the literature does not specifically categorize vomiting itself as \""severe.\"" The severity is associated with the complications resulting from vomiting and other symptoms."", ""reference"": ""PMID:25972150"", ""snippet"": ""Common gastrointestinal manifestations include...nausea and vomiting-60%...The diarrhea and nausea and vomiting frequently produce profound, life-threatening hypovolemia."", ""supports"": ""PARTIAL""}"
2379	2249	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	2	evidence	1	PMID:32080199	PARTIAL		EVD outbreaks typically start from a single case of probable zoonotic transmission, followed by human-to-human transmission via direct contact or contact with infected bodily fluids or contaminated fomites. EVD has a high case-fatality rate; it is characterized by fever, gastrointestinal signs and multiple organ dysfunction syndrome.	This reference indicates the inclusion of gastrointestinal signs in EVD, which can imply vomiting, but does not specifically mention the frequency or severity of vomiting.	"{""explanation"": ""This reference indicates the inclusion of gastrointestinal signs in EVD, which can imply vomiting, but does not specifically mention the frequency or severity of vomiting."", ""reference"": ""PMID:32080199"", ""snippet"": ""EVD outbreaks typically start from a single case of probable zoonotic transmission, followed by human-to-human transmission via direct contact or contact with infected bodily fluids or contaminated fomites. EVD has a high case-fatality rate; it is characterized by fever, gastrointestinal signs and multiple organ dysfunction syndrome."", ""supports"": ""PARTIAL""}"
2380	2249	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	2	evidence	2	PMID:27717513	PARTIAL		The clinical spectrum of Ebola virus disease (EVD) ranges from very serious forms with organ failure and death within days to paucisymptomatic forms and perhaps even asymptomatic.	This suggests variability in EVD presentation, acknowledging severe forms, but it does not specify the severity or frequency of vomiting in particular.	"{""explanation"": ""This suggests variability in EVD presentation, acknowledging severe forms, but it does not specify the severity or frequency of vomiting in particular."", ""reference"": ""PMID:27717513"", ""snippet"": ""The clinical spectrum of Ebola virus disease (EVD) ranges from very serious forms with organ failure and death within days to paucisymptomatic forms and perhaps even asymptomatic."", ""supports"": ""PARTIAL""}"
2381	2250	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	3	evidence	0	PMID:32080199	SUPPORT		EVD has a high case-fatality rate; it is characterized by fever, gastrointestinal signs and multiple organ dysfunction syndrome.	The reference mentions that EVD is characterized by gastrointestinal signs, indicating the relevance of diarrhea as a symptom.	"{""explanation"": ""The reference mentions that EVD is characterized by gastrointestinal signs, indicating the relevance of diarrhea as a symptom."", ""reference"": ""PMID:32080199"", ""snippet"": ""EVD has a high case-fatality rate; it is characterized by fever, gastrointestinal signs and multiple organ dysfunction syndrome."", ""supports"": ""SUPPORT""}"
2382	2250	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	3	evidence	1	PMID:25972150	SUPPORT		Common gastrointestinal manifestations include diarrhea-70 %.	This directly supports the statement by noting that diarrhea is a common (70% frequency) gastrointestinal manifestation.	"{""explanation"": ""This directly supports the statement by noting that diarrhea is a common (70% frequency) gastrointestinal manifestation."", ""reference"": ""PMID:25972150"", ""snippet"": ""Common gastrointestinal manifestations include diarrhea-70 %."", ""supports"": ""SUPPORT""}"
2383	2250	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	3	evidence	2	PMID:34986351	SUPPORT		During the 2013-2016 West African (WA) Ebola virus (EBOV) outbreak, severe gastrointestinal symptoms were common in patients and associated with poor outcome.	The reference highlights that severe gastrointestinal symptoms, including diarrhea, were common and associated with poor outcomes.	"{""explanation"": ""The reference highlights that severe gastrointestinal symptoms, including diarrhea, were common and associated with poor outcomes."", ""reference"": ""PMID:34986351"", ""snippet"": ""During the 2013-2016 West African (WA) Ebola virus (EBOV) outbreak, severe gastrointestinal symptoms were common in patients and associated with poor outcome."", ""supports"": ""SUPPORT""}"
2384	2251	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	4	evidence	0	PMID:25780982	SUPPORT		The main cutaneous finding of Ebola is a nonspecific maculopapular rash that appears between day four and six of disease.	The statement is supported as the primary dermatologic phenotype associated with Ebola Virus Disease (EVD) is a nonspecific maculopapular rash, and it is noted as a main cutaneous finding.	"{""explanation"": ""The statement is supported as the primary dermatologic phenotype associated with Ebola Virus Disease (EVD) is a nonspecific maculopapular rash, and it is noted as a main cutaneous finding."", ""reference"": ""PMID:25780982"", ""snippet"": ""The main cutaneous finding of Ebola is a nonspecific maculopapular rash that appears between day four and six of disease."", ""supports"": ""SUPPORT""}"
2385	2252	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	5	evidence	0	PMID:38840082	PARTIAL		The pooled prevalence was... fatigue 25% (95% CI: 19%-31%)	Fatigue is reported as a symptom in 25% of EVD survivors, which indicates it is relatively common but not 'very frequent' as the statement suggests.	"{""explanation"": ""Fatigue is reported as a symptom in 25% of EVD survivors, which indicates it is relatively common but not 'very frequent' as the statement suggests."", ""reference"": ""PMID:38840082"", ""snippet"": ""The pooled prevalence was... fatigue 25% (95% CI: 19%-31%)"", ""supports"": ""PARTIAL""}"
2386	2253	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	6	evidence	0	PMID:38840082	SUPPORT		The pooled prevalence was: arthralgia 50% (95% CI: 41%-59%); headache 44% (95% CI: 36%-52%); myalgia 32% (95% CI: 26%-38%)	The meta-analysis shows that myalgia has a pooled prevalence of 32% among Ebola Virus Disease (EVD) survivors, indicating it is a frequent musculoskeletal symptom.	"{""explanation"": ""The meta-analysis shows that myalgia has a pooled prevalence of 32% among Ebola Virus Disease (EVD) survivors, indicating it is a frequent musculoskeletal symptom."", ""reference"": ""PMID:38840082"", ""snippet"": ""The pooled prevalence was: arthralgia 50% (95% CI: 41%-59%); headache 44% (95% CI: 36%-52%); myalgia 32% (95% CI: 26%-38%)"", ""supports"": ""SUPPORT""}"
2387	2254	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	7	evidence	0	PMID:31874716	SUPPORT		The main clinical signs were asthenia (78.8%), fever (75.3%), anorexia (53.4%), headache (45.9%)...	This study lists headache as one of the main clinical signs in children with EVD, supporting the statement that headache is an occasional neurologic symptom of EVD.	"{""explanation"": ""This study lists headache as one of the main clinical signs in children with EVD, supporting the statement that headache is an occasional neurologic symptom of EVD."", ""reference"": ""PMID:31874716"", ""snippet"": ""The main clinical signs were asthenia (78.8%), fever (75.3%), anorexia (53.4%), headache (45.9%)..."", ""supports"": ""SUPPORT""}"
2388	2254	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	7	evidence	1	PMID:33493959	SUPPORT		In patients with EVD, neurologic manifestations range from mild symptoms such as confusion to severe neurologic diseases such as meningitis and encephalitis. Altered mental status, from mild confusion to delirium with hallucinations, may also occur.	While this reference does not explicitly mention headache, it discusses a range of neurologic symptoms in EVD patients, suggesting that neurologic symptoms, including headache, can occur occasionally.	"{""explanation"": ""While this reference does not explicitly mention headache, it discusses a range of neurologic symptoms in EVD patients, suggesting that neurologic symptoms, including headache, can occur occasionally."", ""reference"": ""PMID:33493959"", ""snippet"": ""In patients with EVD, neurologic manifestations range from mild symptoms such as confusion to severe neurologic diseases such as meningitis and encephalitis. Altered mental status, from mild confusion to delirium with hallucinations, may also occur."", ""supports"": ""SUPPORT""}"
2389	2254	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	7	evidence	2	PMID:26983037	SUPPORT		Survivors reported musculoskeletal pain (70%), headache (48%), and ocular problems (14%).	This study reports that 48% of EVD survivors experienced headaches, supporting the statement that headache is an occasional neurologic symptom of EVD.	"{""explanation"": ""This study reports that 48% of EVD survivors experienced headaches, supporting the statement that headache is an occasional neurologic symptom of EVD."", ""reference"": ""PMID:26983037"", ""snippet"": ""Survivors reported musculoskeletal pain (70%), headache (48%), and ocular problems (14%)."", ""supports"": ""SUPPORT""}"
2390	2255	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	8	evidence	0	PMID:25972150	SUPPORT		Common gastrointestinal manifestations include diarrhea-70 %, nausea and vomiting-60 %, and abdominal pain-45 %.	The literature indicates that abdominal pain occurs in 45% of EVD cases, supporting the claim that it is a frequent gastrointestinal manifestation.	"{""explanation"": ""The literature indicates that abdominal pain occurs in 45% of EVD cases, supporting the claim that it is a frequent gastrointestinal manifestation."", ""reference"": ""PMID:25972150"", ""snippet"": ""Common gastrointestinal manifestations include diarrhea-70 %, nausea and vomiting-60 %, and abdominal pain-45 %."", ""supports"": ""SUPPORT""}"
2391	2255	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	8	evidence	1	PMID:31874716	SUPPORT		The main clinical signs were asthenia (78.8%), fever (75.3%), anorexia (53.4%), headache (45.9%), vomiting (41.8%), abdominal pain (29.5%), and diarrhea (28.8%).	The study shows that abdominal pain was observed in 29.5% of children with EVD, supporting the statement that it is a frequent gastrointestinal symptom.	"{""explanation"": ""The study shows that abdominal pain was observed in 29.5% of children with EVD, supporting the statement that it is a frequent gastrointestinal symptom."", ""reference"": ""PMID:31874716"", ""snippet"": ""The main clinical signs were asthenia (78.8%), fever (75.3%), anorexia (53.4%), headache (45.9%), vomiting (41.8%), abdominal pain (29.5%), and diarrhea (28.8%)."", ""supports"": ""SUPPORT""}"
2392	2256	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	9	evidence	0	PMID:32487785	PARTIAL		Transmission of EBoV has been reported in various ways, including human to human transmission through close contact with blood and bodily fluids... It is usually diagnosed based on several clinical symptoms such as the sudden onset of illness, high fevers for less than three weeks, and at least two hemorrhagic symptoms despite no predisposing factors.	The literature mentions hemorrhagic symptoms but does not specifically mention thrombocytopenia or its frequency.	"{""explanation"": ""The literature mentions hemorrhagic symptoms but does not specifically mention thrombocytopenia or its frequency."", ""reference"": ""PMID:32487785"", ""snippet"": ""Transmission of EBoV has been reported in various ways, including human to human transmission through close contact with blood and bodily fluids... It is usually diagnosed based on several clinical symptoms such as the sudden onset of illness, high fevers for less than three weeks, and at least two hemorrhagic symptoms despite no predisposing factors."", ""supports"": ""PARTIAL""}"
2393	2256	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	9	evidence	1	PMID:25679971	PARTIAL		Understanding bleeding in Ebola virus disease.	The reference discusses bleeding in Ebola virus disease but does not specifically mention thrombocytopenia or its frequency.	"{""explanation"": ""The reference discusses bleeding in Ebola virus disease but does not specifically mention thrombocytopenia or its frequency."", ""reference"": ""PMID:25679971"", ""snippet"": ""Understanding bleeding in Ebola virus disease."", ""supports"": ""PARTIAL""}"
2394	2256	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	9	evidence	2	PMID:35446128	PARTIAL		Ebola virus (EBV) disease (EVD) is a highly virulent systemic disease characterized by an aggressive systemic inflammatory response and impaired vascular and coagulation systems, often leading to uncontrolled hemorrhaging and death.	The literature discusses impaired vascular and coagulation systems, which can be related to thrombocytopenia, but does not specifically mention its frequency.	"{""explanation"": ""The literature discusses impaired vascular and coagulation systems, which can be related to thrombocytopenia, but does not specifically mention its frequency."", ""reference"": ""PMID:35446128"", ""snippet"": ""Ebola virus (EBV) disease (EVD) is a highly virulent systemic disease characterized by an aggressive systemic inflammatory response and impaired vascular and coagulation systems, often leading to uncontrolled hemorrhaging and death."", ""supports"": ""PARTIAL""}"
2395	2257	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	10	evidence	0	PMID:2822180	PARTIAL		Even though HAV, HBV and HNANB viruses are responsible for most of the viral hepatitis cases, many other viruses have been reported to cause hepatic injury. These viruses may involve the liver, either as part of a systemic illness (e.g. EBV, CMV, HSV) or as the primary target organ (e.g. yellow fever virus, Lassa fever virus, Ebola virus). Clinically overt hepatocellular dysfunction is rare in such viral infections.	The reference indicates that Ebola virus can cause hepatic injury, but clinically overt hepatocellular dysfunction is rare. This partially supports the statement as it acknowledges hepatic involvement but suggests that severe liver dysfunction is not frequent.	"{""explanation"": ""The reference indicates that Ebola virus can cause hepatic injury, but clinically overt hepatocellular dysfunction is rare. This partially supports the statement as it acknowledges hepatic involvement but suggests that severe liver dysfunction is not frequent."", ""reference"": ""PMID:2822180"", ""snippet"": ""Even though HAV, HBV and HNANB viruses are responsible for most of the viral hepatitis cases, many other viruses have been reported to cause hepatic injury. These viruses may involve the liver, either as part of a systemic illness (e.g. EBV, CMV, HSV) or as the primary target organ (e.g. yellow fever virus, Lassa fever virus, Ebola virus). Clinically overt hepatocellular dysfunction is rare in such viral infections."", ""supports"": ""PARTIAL""}"
2396	2257	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	10	evidence	1	PMID:25972150	PARTIAL		The mean serum AST and ALT levels are each about 200/UL, with an unusual pattern for viral hepatitis of AST > ALT.	The reference indicates elevated liver enzymes (AST and ALT) in Ebola virus infection, which supports the part of the statement regarding elevated liver enzymes. However, it does not confirm frequent impaired liver function or hepatitis as a common sequela.	"{""explanation"": ""The reference indicates elevated liver enzymes (AST and ALT) in Ebola virus infection, which supports the part of the statement regarding elevated liver enzymes. However, it does not confirm frequent impaired liver function or hepatitis as a common sequela."", ""reference"": ""PMID:25972150"", ""snippet"": ""The mean serum AST and ALT levels are each about 200/UL, with an unusual pattern for viral hepatitis of AST > ALT."", ""supports"": ""PARTIAL""}"
2397	2257	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	10	evidence	2	PMID:37170900	PARTIAL		Results illustrate that EBOV causes macrophage phenotype alterations as well as neutrophil influx and prominent activation of interferon host responses in the liver.	The reference provides evidence of liver involvement and immune response alterations in Ebola virus infection, which can be associated with hepatic dysfunction. However, it does not explicitly state that hepatitis or impaired liver function is frequent.	"{""explanation"": ""The reference provides evidence of liver involvement and immune response alterations in Ebola virus infection, which can be associated with hepatic dysfunction. However, it does not explicitly state that hepatitis or impaired liver function is frequent."", ""reference"": ""PMID:37170900"", ""snippet"": ""Results illustrate that EBOV causes macrophage phenotype alterations as well as neutrophil influx and prominent activation of interferon host responses in the liver."", ""supports"": ""PARTIAL""}"
2398	2257	100	Ebola Virus Disease (EVD)	Ebola_Virus_Disease_EVD.yaml	phenotypes	10	evidence	3	PMID:29020340	NO_EVIDENCE		The role of the virus in liver damage remains unclear, but our evidence suggests that acute severe liver injury is not a typical feature of Ebola virus disease.	The reference suggests that acute severe liver injury is not typical in Ebola virus disease, which refutes the statement that impaired liver function is frequent.	"{""explanation"": ""The reference suggests that acute severe liver injury is not typical in Ebola virus disease, which refutes the statement that impaired liver function is frequent."", ""reference"": ""PMID:29020340"", ""snippet"": ""The role of the virus in liver damage remains unclear, but our evidence suggests that acute severe liver injury is not a typical feature of Ebola virus disease."", ""supports"": ""NO_EVIDENCE""}"
2464	2296	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	0	evidence	0	PMID:34807421	SUPPORT		Currently, musculoskeletal manifestations related to joint hypermobility are perceived as the most prevalent determinants of the quality of life of affected individuals.	This reference confirms that musculoskeletal manifestations, including joint hypermobility, are highly prevalent in individuals with Ehlers-Danlos Syndrome (EDS).	"{""explanation"": ""This reference confirms that musculoskeletal manifestations, including joint hypermobility, are highly prevalent in individuals with Ehlers-Danlos Syndrome (EDS)."", ""reference"": ""PMID:34807421"", ""snippet"": ""Currently, musculoskeletal manifestations related to joint hypermobility are perceived as the most prevalent determinants of the quality of life of affected individuals."", ""supports"": ""SUPPORT""}"
2465	2296	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	0	evidence	1	PMID:29915965	SUPPORT		Increasing data demonstrate that pain is a major disability determinator in JH and EDS. Recent findings confirm a complex pathogenesis for pain in JH and EDS and suggest a potential role for joint instability, central sensitization and small fiber neuropathy.	This reference supports the statement by highlighting the high frequency and significant impact of joint hypermobility (JH) and associated chronic joint pain and instabilities in EDS.	"{""explanation"": ""This reference supports the statement by highlighting the high frequency and significant impact of joint hypermobility (JH) and associated chronic joint pain and instabilities in EDS."", ""reference"": ""PMID:29915965"", ""snippet"": ""Increasing data demonstrate that pain is a major disability determinator in JH and EDS. Recent findings confirm a complex pathogenesis for pain in JH and EDS and suggest a potential role for joint instability, central sensitization and small fiber neuropathy."", ""supports"": ""SUPPORT""}"
2466	2296	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	0	evidence	2	PMID:37726791	SUPPORT		The Ehlers-Danlos syndromes are a group of clinically and genetically heterogeneous hereditary diseases affecting the connective tissue. They are characterized by hypermobility of the joints, hyperextensible skin and friable tissue.	This reference supports the statement by acknowledging hypermobility of the joints as a characteristic of EDS, along with chronic pain and other musculoskeletal features.	"{""explanation"": ""This reference supports the statement by acknowledging hypermobility of the joints as a characteristic of EDS, along with chronic pain and other musculoskeletal features."", ""reference"": ""PMID:37726791"", ""snippet"": ""The Ehlers-Danlos syndromes are a group of clinically and genetically heterogeneous hereditary diseases affecting the connective tissue. They are characterized by hypermobility of the joints, hyperextensible skin and friable tissue."", ""supports"": ""SUPPORT""}"
2467	2297	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	1	evidence	0	PMID:358109	SUPPORT		The cardinal features are cutaneous hyperextensibility, joint hypermobility, bleeding diathesis, and tissue fragility...	The reference clearly states that cutaneous (skin) hyperextensibility is one of the cardinal features of Ehlers-Danlos Syndrome (EDS). This aligns with the statement indicating a high frequency dermatologic phenotype of skin hyperextensibility in EDS.	"{""explanation"": ""The reference clearly states that cutaneous (skin) hyperextensibility is one of the cardinal features of Ehlers-Danlos Syndrome (EDS). This aligns with the statement indicating a high frequency dermatologic phenotype of skin hyperextensibility in EDS."", ""reference"": ""PMID:358109"", ""snippet"": ""The cardinal features are cutaneous hyperextensibility, joint hypermobility, bleeding diathesis, and tissue fragility..."", ""supports"": ""SUPPORT""}"
2468	2297	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	1	evidence	1	PMID:30837697	SUPPORT		All individuals with these atypical variants exhibited skin hyperextensibility as seen in individuals with classical EDS and classical-like EDS...	The reference shows that skin hyperextensibility is a consistent clinical feature across different EDS subtypes, which supports the statement about its high prevalence as a dermatologic phenotype.	"{""explanation"": ""The reference shows that skin hyperextensibility is a consistent clinical feature across different EDS subtypes, which supports the statement about its high prevalence as a dermatologic phenotype."", ""reference"": ""PMID:30837697"", ""snippet"": ""All individuals with these atypical variants exhibited skin hyperextensibility as seen in individuals with classical EDS and classical-like EDS..."", ""supports"": ""SUPPORT""}"
2469	2297	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	1	evidence	2	PMID:434850	SUPPORT		Hyperextensibility of the skin in this region developed within the subsequent five years...	Although this case was localized, it still confirms the presence of skin hyperextensibility in a patient with EDS, reinforcing its association with EDS.	"{""explanation"": ""Although this case was localized, it still confirms the presence of skin hyperextensibility in a patient with EDS, reinforcing its association with EDS."", ""reference"": ""PMID:434850"", ""snippet"": ""Hyperextensibility of the skin in this region developed within the subsequent five years..."", ""supports"": ""SUPPORT""}"
2470	2297	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	1	evidence	3	PMID:31904772	SUPPORT		Of the 13 subtypes of Ehlers-Danlos Syndromes (EDSs)...the authors provide an overview of hEDS symptoms and... current treatment options.	The overview and symptoms of various EDS subtypes include skin manifestations such as hyperextensibility, supporting the statement about its high prevalence.	"{""explanation"": ""The overview and symptoms of various EDS subtypes include skin manifestations such as hyperextensibility, supporting the statement about its high prevalence."", ""reference"": ""PMID:31904772"", ""snippet"": ""Of the 13 subtypes of Ehlers-Danlos Syndromes (EDSs)...the authors provide an overview of hEDS symptoms and... current treatment options."", ""supports"": ""SUPPORT""}"
2471	2297	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	1	evidence	4	PMID:6733946	SUPPORT		Collagen fibrils showed a distorted arrangement... abnormal collagen fibrils in normal skin suggests one of eight types of Ehlers-Danlos syndrome.	This reference details abnormal collagen fibrils and associates them with EDS, indicating that skin hyperextensibility is a frequent manifestation.	"{""explanation"": ""This reference details abnormal collagen fibrils and associates them with EDS, indicating that skin hyperextensibility is a frequent manifestation."", ""reference"": ""PMID:6733946"", ""snippet"": ""Collagen fibrils showed a distorted arrangement... abnormal collagen fibrils in normal skin suggests one of eight types of Ehlers-Danlos syndrome."", ""supports"": ""SUPPORT""}"
2472	2298	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	2	evidence	0	PMID:19055167	SUPPORT		Ehlers-Danlos syndrome (EDS) is a heterogeneous group of connective tissue disorders characterized by hyperextensibility, delayed wound healing, joint hypermobility, thin skin, easy bruising, tissue fragility, 'cigarette-paper' scarring over bony prominences, mitral valve prolapse, and other findings.	This reference directly mentions delayed wound healing as a characteristic of Ehlers-Danlos syndrome.	"{""explanation"": ""This reference directly mentions delayed wound healing as a characteristic of Ehlers-Danlos syndrome."", ""reference"": ""PMID:19055167"", ""snippet"": ""Ehlers-Danlos syndrome (EDS) is a heterogeneous group of connective tissue disorders characterized by hyperextensibility, delayed wound healing, joint hypermobility, thin skin, easy bruising, tissue fragility, 'cigarette-paper' scarring over bony prominences, mitral valve prolapse, and other findings."", ""supports"": ""SUPPORT""}"
2473	2298	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	2	evidence	1	PMID:2728341	SUPPORT		Although delayed wound healing has been reported to be a complication of Ehlers-Danlos syndrome in humans, using clinical and histologic criteria, wound healing in dogs and cats with Ehlers-Danlos syndrome appears to be similar to nonaffected animals.	This reference acknowledges delayed wound healing in humans with Ehlers-Danlos syndrome, although the study was conducted on animals.	"{""explanation"": ""This reference acknowledges delayed wound healing in humans with Ehlers-Danlos syndrome, although the study was conducted on animals."", ""reference"": ""PMID:2728341"", ""snippet"": ""Although delayed wound healing has been reported to be a complication of Ehlers-Danlos syndrome in humans, using clinical and histologic criteria, wound healing in dogs and cats with Ehlers-Danlos syndrome appears to be similar to nonaffected animals."", ""supports"": ""SUPPORT""}"
2474	2298	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	2	evidence	2	PMID:20847697	SUPPORT		Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder characterized by skin hyperextensibility, fragile and soft skin, delayed wound healing with formation of atrophic scars, easy bruising, and generalized joint hypermobility.	This reference lists delayed wound healing as a characteristic feature of classic Ehlers-Danlos syndrome.	"{""explanation"": ""This reference lists delayed wound healing as a characteristic feature of classic Ehlers-Danlos syndrome."", ""reference"": ""PMID:20847697"", ""snippet"": ""Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder characterized by skin hyperextensibility, fragile and soft skin, delayed wound healing with formation of atrophic scars, easy bruising, and generalized joint hypermobility."", ""supports"": ""SUPPORT""}"
2475	2299	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	3	evidence	0	PMID:19462862	SUPPORT		The mutation of the COL3A1 gene which encodes type III collagen, is responsible of early vascular (spontaneous arterial rupture or dissection), digestive (perforation) and obstetrical events (uterine and arterial rupture)	The literature specifies that the COL3A1 mutation, causing vascular EDS, leads to early vascular events including spontaneous arterial rupture or dissection.	"{""explanation"": ""The literature specifies that the COL3A1 mutation, causing vascular EDS, leads to early vascular events including spontaneous arterial rupture or dissection."", ""reference"": ""PMID:19462862"", ""snippet"": ""The mutation of the COL3A1 gene which encodes type III collagen, is responsible of early vascular (spontaneous arterial rupture or dissection), digestive (perforation) and obstetrical events (uterine and arterial rupture)"", ""supports"": ""SUPPORT""}"
2476	2299	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	3	evidence	1	PMID:30999998	SUPPORT		The only published clinical trial to date demonstrated the benefit of celiprolol on arterial morbimortality.	The literature states that vascular EDS results in exceptional arterial fragility, justifying a high frequency of arterial dissection and rupture.	"{""explanation"": ""The literature states that vascular EDS results in exceptional arterial fragility, justifying a high frequency of arterial dissection and rupture."", ""reference"": ""PMID:30999998"", ""snippet"": ""The only published clinical trial to date demonstrated the benefit of celiprolol on arterial morbimortality."", ""supports"": ""SUPPORT""}"
2477	2300	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	4	evidence	0	PMID:36237549	SUPPORT		In addition to these commonly recognized phenotypes, recent studies have notably highlighted variable ophthalmic features in EDS.	The literature highlights that Ehlers-Danlos syndrome has variable ophthalmic features, which supports the assertion that ophthalmologic phenotypes, including keratoconus, are part of the syndrome.	"{""explanation"": ""The literature highlights that Ehlers-Danlos syndrome has variable ophthalmic features, which supports the assertion that ophthalmologic phenotypes, including keratoconus, are part of the syndrome."", ""reference"": ""PMID:36237549"", ""snippet"": ""In addition to these commonly recognized phenotypes, recent studies have notably highlighted variable ophthalmic features in EDS."", ""supports"": ""SUPPORT""}"
2478	2300	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	4	evidence	1	PMID:28757364	NO_EVIDENCE		As the two patients reported here illustrate, patients with kEDS-PLOD1 do not always have a kyphoscoliosis present at birth or in the first year of life, neither do they necessarily develop kyphoscoliosis later in infancy.	This reference talks mainly about kyphoscoliotic EDS and its genetic underpinnings, without specifically mentioning ophthalmologic features or keratoconus.	"{""explanation"": ""This reference talks mainly about kyphoscoliotic EDS and its genetic underpinnings, without specifically mentioning ophthalmologic features or keratoconus."", ""reference"": ""PMID:28757364"", ""snippet"": ""As the two patients reported here illustrate, patients with kEDS-PLOD1 do not always have a kyphoscoliosis present at birth or in the first year of life, neither do they necessarily develop kyphoscoliosis later in infancy."", ""supports"": ""NO_EVIDENCE""}"
2479	2300	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	4	evidence	2	PMID:9493273	NO_EVIDENCE		Keratoconus is most commonly an isolated disorder, although several reports describe an association with Down syndrome, Leber's congenital amaurosis, and mitral valve prolapse.	This reference discusses keratoconus but does not specifically link it to Ehlers-Danlos syndrome.	"{""explanation"": ""This reference discusses keratoconus but does not specifically link it to Ehlers-Danlos syndrome."", ""reference"": ""PMID:9493273"", ""snippet"": ""Keratoconus is most commonly an isolated disorder, although several reports describe an association with Down syndrome, Leber's congenital amaurosis, and mitral valve prolapse."", ""supports"": ""NO_EVIDENCE""}"
2480	2300	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	4	evidence	3	PMID:14679583	SUPPORT		The brittle cornea syndrome (BCS) is a generalized connective tissue disorder characterized by corneal rupture following only minor trauma, keratoconus or keratoglobus, blue sclerae, hyperelasticity of the skin without excessive fragility, and hypermobility of the joints.	The brittle cornea syndrome listed here shares ophthalmologic phenotypes, including keratoconus, similar to Ehlers-Danlos syndrome.	"{""explanation"": ""The brittle cornea syndrome listed here shares ophthalmologic phenotypes, including keratoconus, similar to Ehlers-Danlos syndrome."", ""reference"": ""PMID:14679583"", ""snippet"": ""The brittle cornea syndrome (BCS) is a generalized connective tissue disorder characterized by corneal rupture following only minor trauma, keratoconus or keratoglobus, blue sclerae, hyperelasticity of the skin without excessive fragility, and hypermobility of the joints."", ""supports"": ""SUPPORT""}"
2481	2300	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	4	evidence	4	PMID:37074408	NO_EVIDENCE		A high proportion of patients had tomographically suspect corneas when using keratoconus diagnostic indices	This reference discusses keratoconus in the context of osteogenesis imperfecta, not Ehlers-Danlos syndrome.	"{""explanation"": ""This reference discusses keratoconus in the context of osteogenesis imperfecta, not Ehlers-Danlos syndrome."", ""reference"": ""PMID:37074408"", ""snippet"": ""A high proportion of patients had tomographically suspect corneas when using keratoconus diagnostic indices"", ""supports"": ""NO_EVIDENCE""}"
2482	2301	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	5	evidence	0	PMID:35000503	SUPPORT		Mitral valve prolapse was present in 7.5% and thoracic aortic dilatation in 15.2%.	This study reports the presence of mitral valve prolapse in patients with hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorder (HSD).	"{""explanation"": ""This study reports the presence of mitral valve prolapse in patients with hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorder (HSD)."", ""reference"": ""PMID:35000503"", ""snippet"": ""Mitral valve prolapse was present in 7.5% and thoracic aortic dilatation in 15.2%."", ""supports"": ""SUPPORT""}"
2483	2301	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	5	evidence	1	PMID:6993166	SUPPORT		It appears to occur more frequently in females and occasionally it is familial... particularly Marfan's syndrome, rheumatic heart disease, coronary heart disease, congestive cardiomyopathy, ostium secundum atrial septal defect, Ehlers-Danlos syndrome or abnormalities of the thoracic cage.	This reference mentions the association of mitral valve prolapse with Ehlers-Danlos syndrome.	"{""explanation"": ""This reference mentions the association of mitral valve prolapse with Ehlers-Danlos syndrome."", ""reference"": ""PMID:6993166"", ""snippet"": ""It appears to occur more frequently in females and occasionally it is familial... particularly Marfan's syndrome, rheumatic heart disease, coronary heart disease, congestive cardiomyopathy, ostium secundum atrial septal defect, Ehlers-Danlos syndrome or abnormalities of the thoracic cage."", ""supports"": ""SUPPORT""}"
2484	2301	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	5	evidence	2	PMID:34776077	SUPPORT		There is substantial symptoms overlap between the EDS subtypes, and they are associated with an increased incidence of cardiovascular abnormalities, such as mitral valve prolapse and aortic dissection.	This study confirms the association of mitral valve prolapse with Ehlers-Danlos syndrome.	"{""explanation"": ""This study confirms the association of mitral valve prolapse with Ehlers-Danlos syndrome."", ""reference"": ""PMID:34776077"", ""snippet"": ""There is substantial symptoms overlap between the EDS subtypes, and they are associated with an increased incidence of cardiovascular abnormalities, such as mitral valve prolapse and aortic dissection."", ""supports"": ""SUPPORT""}"
2485	2301	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	5	evidence	3	PMID:31328377	SUPPORT		Mitral valve prolapse and bicuspid aortic valve occurred at the same incidence as the general population.	This study indicates that mitral valve prolapse occurs at the same incidence in Ehlers-Danlos syndrome patients as in the general population.	"{""explanation"": ""This study indicates that mitral valve prolapse occurs at the same incidence in Ehlers-Danlos syndrome patients as in the general population."", ""reference"": ""PMID:31328377"", ""snippet"": ""Mitral valve prolapse and bicuspid aortic valve occurred at the same incidence as the general population."", ""supports"": ""SUPPORT""}"
2486	2302	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	6	evidence	0	PMID:19462862	SUPPORT		The mutation of the COL3A1 gene which encodes type III collagen, is responsible of early vascular (spontaneous arterial rupture or dissection)...	The abstract explicitly mentions that spontaneous arterial rupture or dissection is a characteristic of vascular Ehlers-Danlos syndrome (vEDS).	"{""explanation"": ""The abstract explicitly mentions that spontaneous arterial rupture or dissection is a characteristic of vascular Ehlers-Danlos syndrome (vEDS)."", ""reference"": ""PMID:19462862"", ""snippet"": ""The mutation of the COL3A1 gene which encodes type III collagen, is responsible of early vascular (spontaneous arterial rupture or dissection)..."", ""supports"": ""SUPPORT""}"
2487	2302	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	6	evidence	1	PMID:23657781	SUPPORT		The indication of embolization was spontaneous arterial rupture or pseudoaneurysm with acute bleeding.	The study evaluates the treatment of life-threatening arterial rupture in vEDS patients, indicating that arterial rupture is a significant and frequent concern in this subtype.	"{""explanation"": ""The study evaluates the treatment of life-threatening arterial rupture in vEDS patients, indicating that arterial rupture is a significant and frequent concern in this subtype."", ""reference"": ""PMID:23657781"", ""snippet"": ""The indication of embolization was spontaneous arterial rupture or pseudoaneurysm with acute bleeding."", ""supports"": ""SUPPORT""}"
2488	2302	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	6	evidence	2	PMID:7455751	SUPPORT		Of the six subtypes of Ehlers-Danlos syndrome, which can usually be clinically differentiated, only types 1 and 4 appear to be associated with a substantial risk of arterial rupture.	This reference highlights that type IV Ehlers-Danlos syndrome (vascular EDS) has a substantial risk of arterial rupture.	"{""explanation"": ""This reference highlights that type IV Ehlers-Danlos syndrome (vascular EDS) has a substantial risk of arterial rupture."", ""reference"": ""PMID:7455751"", ""snippet"": ""Of the six subtypes of Ehlers-Danlos syndrome, which can usually be clinically differentiated, only types 1 and 4 appear to be associated with a substantial risk of arterial rupture."", ""supports"": ""SUPPORT""}"
2489	2302	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	6	evidence	3	PMID:30999998	SUPPORT		Vascular Ehlers-Danlos syndrome (vEDS) is a rare genetic connective tissue disorder secondary to pathogenic variants within the COL3A1 gene, resulting in exceptional arterial and organ fragility and premature death.	The abstract indicates that vEDS leads to exceptional arterial fragility, which supports the statement that arterial dissection and rupture are very frequent in this subtype.	"{""explanation"": ""The abstract indicates that vEDS leads to exceptional arterial fragility, which supports the statement that arterial dissection and rupture are very frequent in this subtype."", ""reference"": ""PMID:30999998"", ""snippet"": ""Vascular Ehlers-Danlos syndrome (vEDS) is a rare genetic connective tissue disorder secondary to pathogenic variants within the COL3A1 gene, resulting in exceptional arterial and organ fragility and premature death."", ""supports"": ""SUPPORT""}"
2490	2302	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	6	evidence	4	PMID:33641388	SUPPORT		Arterial complications can affect all anatomic areas and about 25% involve supra-aortic trunks (SATs)...Cumulative incidence of a first identification of a SAT lesion was 41.7% at 40 years old.	The study shows a high prevalence of arterial complications, including dissections, in patients with vEDS, supporting the statement.	"{""explanation"": ""The study shows a high prevalence of arterial complications, including dissections, in patients with vEDS, supporting the statement."", ""reference"": ""PMID:33641388"", ""snippet"": ""Arterial complications can affect all anatomic areas and about 25% involve supra-aortic trunks (SATs)...Cumulative incidence of a first identification of a SAT lesion was 41.7% at 40 years old."", ""supports"": ""SUPPORT""}"
2491	2303	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	7	evidence	0	PMID:26376608	NO_EVIDENCE		Commonest GI symptoms were: abdominal pain (56.1%), nausea (42.3%), constipation (38.6%), heartburn (37.6%), and irritable bowel syndrome-like symptoms (27.5%).	The literature mentions heartburn and various other gastrointestinal symptoms but does not specifically mention gastroesophageal reflux as an occasional manifestation.	"{""explanation"": ""The literature mentions heartburn and various other gastrointestinal symptoms but does not specifically mention gastroesophageal reflux as an occasional manifestation."", ""reference"": ""PMID:26376608"", ""snippet"": ""Commonest GI symptoms were: abdominal pain (56.1%), nausea (42.3%), constipation (38.6%), heartburn (37.6%), and irritable bowel syndrome-like symptoms (27.5%)."", ""supports"": ""NO_EVIDENCE""}"
2492	2303	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	7	evidence	1	PMID:36000988	NO_EVIDENCE		We report a significant enrichment of EDS cases in a set of patients with gastroparesis.	The literature focuses on gastroparesis in EDS patients but does not provide evidence for gastroesophageal reflux as an occasional manifestation.	"{""explanation"": ""The literature focuses on gastroparesis in EDS patients but does not provide evidence for gastroesophageal reflux as an occasional manifestation."", ""reference"": ""PMID:36000988"", ""snippet"": ""We report a significant enrichment of EDS cases in a set of patients with gastroparesis."", ""supports"": ""NO_EVIDENCE""}"
2493	2303	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	7	evidence	2	PMID:34811894	PARTIAL		Functional aerodigestive manifestations such as inducible laryngeal obstruction may be misdiagnosed as asthma, with gastro-esophageal dysmotility and reflux as common contributing factors.	The literature mentions gastro-esophageal dysmotility and reflux as contributing factors but does not specify the frequency as 'occasional.'	"{""explanation"": ""The literature mentions gastro-esophageal dysmotility and reflux as contributing factors but does not specify the frequency as 'occasional.'"", ""reference"": ""PMID:34811894"", ""snippet"": ""Functional aerodigestive manifestations such as inducible laryngeal obstruction may be misdiagnosed as asthma, with gastro-esophageal dysmotility and reflux as common contributing factors."", ""supports"": ""PARTIAL""}"
2494	2304	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	8	evidence	0	PMID:36237549	SUPPORT		In addition to these commonly recognized phenotypes, recent studies have notably highlighted variable ophthalmic features in EDS.	The literature mentions variable ophthalmic features in Ehlers-Danlos Syndrome, which includes conditions like keratoconus.	"{""explanation"": ""The literature mentions variable ophthalmic features in Ehlers-Danlos Syndrome, which includes conditions like keratoconus."", ""reference"": ""PMID:36237549"", ""snippet"": ""In addition to these commonly recognized phenotypes, recent studies have notably highlighted variable ophthalmic features in EDS."", ""supports"": ""SUPPORT""}"
2495	2304	101	Ehlers-Danlos Syndrome	Ehlers-Danlos_Syndrome.yaml	phenotypes	8	evidence	1	PMID:34501218	SUPPORT		Because many patients with HDCTs have ocular symptoms, commonly myopia, they will often present to the clinic seeking refractive surgery. Currently, corrective measures are limited, as the FDA contraindicates laser-assisted in-situ keratomileusis (LASIK) in EDS and discourages the procedure in OI and MFS due to a theoretically increased risk of post-LASIK ectasia, poor wound healing, poor refractive predictability, underlying keratoconus, and globe rupture.	The literature indicates that patients with Ehlers-Danlos Syndrome (EDS) may have underlying keratoconus, supporting the statement that keratoconus is an occasional ophthalmologic manifestation in EDS.	"{""explanation"": ""The literature indicates that patients with Ehlers-Danlos Syndrome (EDS) may have underlying keratoconus, supporting the statement that keratoconus is an occasional ophthalmologic manifestation in EDS."", ""reference"": ""PMID:34501218"", ""snippet"": ""Because many patients with HDCTs have ocular symptoms, commonly myopia, they will often present to the clinic seeking refractive surgery. Currently, corrective measures are limited, as the FDA contraindicates laser-assisted in-situ keratomileusis (LASIK) in EDS and discourages the procedure in OI and MFS due to a theoretically increased risk of post-LASIK ectasia, poor wound healing, poor refractive predictability, underlying keratoconus, and globe rupture."", ""supports"": ""SUPPORT""}"
2532	2322	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	0	evidence	0	PMID:34807421	SUPPORT		Currently, musculoskeletal manifestations related to joint hypermobility are perceived as the most prevalent determinants of the quality of life of affected individuals.	This reference supports the high frequency and significant impact of joint hypermobility in Ehlers-Danlos syndrome.	"{""explanation"": ""This reference supports the high frequency and significant impact of joint hypermobility in Ehlers-Danlos syndrome."", ""reference"": ""PMID:34807421"", ""snippet"": ""Currently, musculoskeletal manifestations related to joint hypermobility are perceived as the most prevalent determinants of the quality of life of affected individuals."", ""supports"": ""SUPPORT""}"
2533	2322	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	0	evidence	1	PMID:19370768	SUPPORT		Classical Ehlers-Danlos syndrome (EDS) is a heritable disorder characterized by joint hypermobility, skin hyperextensibility, and abnormal wound healing.	The reference supports the musculoskeletal phenotype involving joint hypermobility and associated symptoms like joint pain.	"{""explanation"": ""The reference supports the musculoskeletal phenotype involving joint hypermobility and associated symptoms like joint pain."", ""reference"": ""PMID:19370768"", ""snippet"": ""Classical Ehlers-Danlos syndrome (EDS) is a heritable disorder characterized by joint hypermobility, skin hyperextensibility, and abnormal wound healing."", ""supports"": ""SUPPORT""}"
2534	2322	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	0	evidence	2	PMID:35964930	SUPPORT		Classical (cEDS) and vascular type (vEDS) are the most prevalent subtypes and are caused by heterozygous pathogenic variants in COL5A1, COL5A2, COL1A1 or, respectively, in COL3A1.	This indicates a direct relationship between COL5A1 mutations and the classical EDS phenotype, which includes musculoskeletal manifestations such as joint hypermobility.	"{""explanation"": ""This indicates a direct relationship between COL5A1 mutations and the classical EDS phenotype, which includes musculoskeletal manifestations such as joint hypermobility."", ""reference"": ""PMID:35964930"", ""snippet"": ""Classical (cEDS) and vascular type (vEDS) are the most prevalent subtypes and are caused by heterozygous pathogenic variants in COL5A1, COL5A2, COL1A1 or, respectively, in COL3A1."", ""supports"": ""SUPPORT""}"
2535	2322	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	0	evidence	3	PMID:10906878	SUPPORT		Thirty patients with Type III Ehlers-Danlos syndrome reported joint pain more frequently than did patients with Types I, II, or IV.	This supports the involvement of recurrent joint dislocations and chronic joint pain in the EDS phenotype.	"{""explanation"": ""This supports the involvement of recurrent joint dislocations and chronic joint pain in the EDS phenotype."", ""reference"": ""PMID:10906878"", ""snippet"": ""Thirty patients with Type III Ehlers-Danlos syndrome reported joint pain more frequently than did patients with Types I, II, or IV."", ""supports"": ""SUPPORT""}"
2536	2323	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	1	evidence	0	PMID:20847697	SUPPORT		Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder characterized by skin hyperextensibility, fragile and soft skin...	The abstract clearly states that skin hyperextensibility is a primary feature of classic Ehlers-Danlos syndrome, which is often caused by COL5A1 mutations.	"{""explanation"": ""The abstract clearly states that skin hyperextensibility is a primary feature of classic Ehlers-Danlos syndrome, which is often caused by COL5A1 mutations."", ""reference"": ""PMID:20847697"", ""snippet"": ""Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder characterized by skin hyperextensibility, fragile and soft skin..."", ""supports"": ""SUPPORT""}"
2537	2323	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	1	evidence	1	PMID:36764582	SUPPORT		A high prevalence of skin hyperextensibility, bruising, and soft skin were noted.	Skin hyperextensibility is identified as a common feature in Ehlers-Danlos syndromes, supporting the statement.	"{""explanation"": ""Skin hyperextensibility is identified as a common feature in Ehlers-Danlos syndromes, supporting the statement."", ""reference"": ""PMID:36764582"", ""snippet"": ""A high prevalence of skin hyperextensibility, bruising, and soft skin were noted."", ""supports"": ""SUPPORT""}"
2538	2323	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	1	evidence	2	PMID:37594181	SUPPORT		The classic tragic facial expression was observed as well as chronic pruritus and mild hyperesthesia.	This reference supports the dermatologic phenotype of Ehlers-Danlos Syndrome, including traits commonly associated with COL5A1 mutations.	"{""explanation"": ""This reference supports the dermatologic phenotype of Ehlers-Danlos Syndrome, including traits commonly associated with COL5A1 mutations."", ""reference"": ""PMID:37594181"", ""snippet"": ""The classic tragic facial expression was observed as well as chronic pruritus and mild hyperesthesia."", ""supports"": ""SUPPORT""}"
2539	2324	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	2	evidence	0	PMID:20847697	SUPPORT		Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder characterized by skin hyperextensibility, fragile and soft skin, delayed wound healing with formation of atrophic scars.	The literature specifies that classic Ehlers-Danlos syndrome, which includes COL5A1-related cases, involves the formation of atrophic scars as a common dermatologic phenotype.	"{""explanation"": ""The literature specifies that classic Ehlers-Danlos syndrome, which includes COL5A1-related cases, involves the formation of atrophic scars as a common dermatologic phenotype."", ""reference"": ""PMID:20847697"", ""snippet"": ""Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder characterized by skin hyperextensibility, fragile and soft skin, delayed wound healing with formation of atrophic scars."", ""supports"": ""SUPPORT""}"
2540	2325	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	3	evidence	0	PMID:20847697	SUPPORT		Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder characterized by ... easy bruising.	This reference confirms the presence of easy bruising as a common phenotype of classic Ehlers-Danlos syndrome, which is often related to COL5A1 mutations.	"{""explanation"": ""This reference confirms the presence of easy bruising as a common phenotype of classic Ehlers-Danlos syndrome, which is often related to COL5A1 mutations."", ""reference"": ""PMID:20847697"", ""snippet"": ""Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder characterized by ... easy bruising."", ""supports"": ""SUPPORT""}"
2541	2325	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	3	evidence	1	PMID:36764582	SUPPORT		The Ehlers-Danlos syndromes (EDSs) comprise a group of connective tissue disorders that manifest with... easy bruising...	This source supports that easy bruising is a common dermatologic manifestation in Ehlers-Danlos syndromes, which includes types related to COL5A1 mutations.	"{""explanation"": ""This source supports that easy bruising is a common dermatologic manifestation in Ehlers-Danlos syndromes, which includes types related to COL5A1 mutations."", ""reference"": ""PMID:36764582"", ""snippet"": ""The Ehlers-Danlos syndromes (EDSs) comprise a group of connective tissue disorders that manifest with... easy bruising..."", ""supports"": ""SUPPORT""}"
2542	2325	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	3	evidence	2	PMID:15566352	SUPPORT		Easy bruising is, to a variable degree, present in all subtypes of EDS...	This excerpt indicates that easy bruising is a common feature across various subtypes of Ehlers-Danlos syndrome, which would include the COL5A1-related types.	"{""explanation"": ""This excerpt indicates that easy bruising is a common feature across various subtypes of Ehlers-Danlos syndrome, which would include the COL5A1-related types."", ""reference"": ""PMID:15566352"", ""snippet"": ""Easy bruising is, to a variable degree, present in all subtypes of EDS..."", ""supports"": ""SUPPORT""}"
2543	2326	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	4	evidence	0	PMID:21193204	PARTIAL		Fifteen of the 252 patients (6.0%) had mitral valve prolapse (MVP), although only one patient (0.4%) had MVP that was mild to moderate.	The literature shows an occasional incidence of mitral valve prolapse in Ehlers-Danlos Syndrome, and while the exact subtype related to COL5A1 is not specified, it partially supports the statement.	"{""explanation"": ""The literature shows an occasional incidence of mitral valve prolapse in Ehlers-Danlos Syndrome, and while the exact subtype related to COL5A1 is not specified, it partially supports the statement."", ""reference"": ""PMID:21193204"", ""snippet"": ""Fifteen of the 252 patients (6.0%) had mitral valve prolapse (MVP), although only one patient (0.4%) had MVP that was mild to moderate."", ""supports"": ""PARTIAL""}"
2544	2326	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	4	evidence	1	PMID:34776077	SUPPORT		The EDS are currently classified into thirteen subtypes. There is substantial symptoms overlap between the EDS subtypes, and they are associated with an increased incidence of cardiovascular abnormalities, such as mitral valve prolapse and aortic dissection.	This reference supports the association of Ehlers-Danlos Syndrome (a group including COL5A1-related subtypes) with mitral valve prolapse.	"{""explanation"": ""This reference supports the association of Ehlers-Danlos Syndrome (a group including COL5A1-related subtypes) with mitral valve prolapse."", ""reference"": ""PMID:34776077"", ""snippet"": ""The EDS are currently classified into thirteen subtypes. There is substantial symptoms overlap between the EDS subtypes, and they are associated with an increased incidence of cardiovascular abnormalities, such as mitral valve prolapse and aortic dissection."", ""supports"": ""SUPPORT""}"
2545	2327	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	5	evidence	0	PMID:26376608	PARTIAL		Commonest GI symptoms were: abdominal pain (56.1%), nausea (42.3%), constipation (38.6%), heartburn (37.6%), and irritable bowel syndrome-like symptoms (27.5%)... Among 37.8% of the 378 patients who underwent esophagogastroduodenoscopy, the commonest abnormalities were gastritis, hiatal hernia and reflux esophagitis.	The study indicates that reflux esophagitis, which is related to gastroesophageal reflux, is one of the common abnormalities observed in EDS patients. However, it does not explicitly distinguish the frequency of this phenotype for COL5A1-related EDS specifically.	"{""explanation"": ""The study indicates that reflux esophagitis, which is related to gastroesophageal reflux, is one of the common abnormalities observed in EDS patients. However, it does not explicitly distinguish the frequency of this phenotype for COL5A1-related EDS specifically."", ""reference"": ""PMID:26376608"", ""snippet"": ""Commonest GI symptoms were: abdominal pain (56.1%), nausea (42.3%), constipation (38.6%), heartburn (37.6%), and irritable bowel syndrome-like symptoms (27.5%)... Among 37.8% of the 378 patients who underwent esophagogastroduodenoscopy, the commonest abnormalities were gastritis, hiatal hernia and reflux esophagitis."", ""supports"": ""PARTIAL""}"
2546	2328	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	6	evidence	0	PMID:27905128	SUPPORT		Molluscoid pseudotumours are a characteristic finding in patients with the classic ED variant, but are rarely reported in other variants.	The literature confirms that molluscoid pseudotumors are characteristic of the classic variant of Ehlers-Danlos Syndrome, which can be COL5A1-related. This supports the statement that these dermatologic features can occur occasionally in such cases.	"{""explanation"": ""The literature confirms that molluscoid pseudotumors are characteristic of the classic variant of Ehlers-Danlos Syndrome, which can be COL5A1-related. This supports the statement that these dermatologic features can occur occasionally in such cases."", ""reference"": ""PMID:27905128"", ""snippet"": ""Molluscoid pseudotumours are a characteristic finding in patients with the classic ED variant, but are rarely reported in other variants."", ""supports"": ""SUPPORT""}"
2547	2329	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	7	evidence	0	PMID:36237549	PARTIAL		In addition to these commonly recognized phenotypes, recent studies have notably highlighted variable ophthalmic features in EDS.	The study mentions variable ophthalmic features in EDS but does not specifically mention myopia as an occasional feature related to COL5A1.	"{""explanation"": ""The study mentions variable ophthalmic features in EDS but does not specifically mention myopia as an occasional feature related to COL5A1."", ""reference"": ""PMID:36237549"", ""snippet"": ""In addition to these commonly recognized phenotypes, recent studies have notably highlighted variable ophthalmic features in EDS."", ""supports"": ""PARTIAL""}"
2548	2329	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	7	evidence	1	PMID:30246406	NO_EVIDENCE		The affected cat showed multiple recurrent skin tears, hyperextensibility of the skin and joint abnormalities.	The study on a cat with EDS caused by a COL5A1 mutation does not mention myopia.	"{""explanation"": ""The study on a cat with EDS caused by a COL5A1 mutation does not mention myopia."", ""reference"": ""PMID:30246406"", ""snippet"": ""The affected cat showed multiple recurrent skin tears, hyperextensibility of the skin and joint abnormalities."", ""supports"": ""NO_EVIDENCE""}"
2549	2330	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	8	evidence	0	PMID:20697718	SUPPORT		Ehlers-Danlos Syndrome is a term that comprises a variety of inherited connective tissue disorders characterized primarily by skin hyperextensibility, joints hypermobility and excessive dislocations, easy bruisability, generalized fragility.	The literature supports excessive dislocations as a characteristic feature of Ehlers-Danlos Syndrome.	"{""explanation"": ""The literature supports excessive dislocations as a characteristic feature of Ehlers-Danlos Syndrome."", ""reference"": ""PMID:20697718"", ""snippet"": ""Ehlers-Danlos Syndrome is a term that comprises a variety of inherited connective tissue disorders characterized primarily by skin hyperextensibility, joints hypermobility and excessive dislocations, easy bruisability, generalized fragility."", ""supports"": ""SUPPORT""}"
2550	2331	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	9	evidence	0	PMID:10906878	SUPPORT		Thirty patients with Type III Ehlers-Danlos syndrome reported joint pain more frequently than did patients with Types I, II, or IV.	The literature supports chronic joint pain as a frequent symptom in Ehlers-Danlos syndrome.	"{""explanation"": ""The literature supports chronic joint pain as a frequent symptom in Ehlers-Danlos syndrome."", ""reference"": ""PMID:10906878"", ""snippet"": ""Thirty patients with Type III Ehlers-Danlos syndrome reported joint pain more frequently than did patients with Types I, II, or IV."", ""supports"": ""SUPPORT""}"
2551	2332	102	Ehlers-Danlos Syndrome, COL5A1-related	Ehlers-Danlos_Syndrome_COL5A1-related.yaml	phenotypes	10	evidence	0	PMID:20847697	SUPPORT		Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder characterized by skin hyperextensibility, fragile and soft skin, delayed wound healing with formation of atrophic scars.	Delayed wound healing is a core feature of classic EDS due to defective collagen V.	"{""explanation"": ""Delayed wound healing is a core feature of classic EDS due to defective collagen V."", ""reference"": ""PMID:20847697"", ""snippet"": ""Classic Ehlers-Danlos syndrome is a heritable connective tissue disorder characterized by skin hyperextensibility, fragile and soft skin, delayed wound healing with formation of atrophic scars."", ""supports"": ""SUPPORT""}"
2582	2376	104	Endometriosis	Endometriosis.yaml	phenotypes	1	evidence	0	PMID:30074218	SUPPORT		The expression of all three proteins in both serum and endometrial tissues increased significantly with the R-AFS stage (P<0.05) and with dysmenorrheal severity (P<0.05).	VEGF and HIF-1alpha expression correlates with dysmenorrhea severity, linking hypoxia and angiogenesis to pain	"{""explanation"": ""VEGF and HIF-1alpha expression correlates with dysmenorrhea severity, linking hypoxia and angiogenesis to pain"", ""reference"": ""PMID:30074218"", ""snippet"": ""The expression of all three proteins in both serum and endometrial tissues increased significantly with the R-AFS stage (P<0.05) and with dysmenorrheal severity (P<0.05)."", ""supports"": ""SUPPORT""}"
2583	2378	104	Endometriosis	Endometriosis.yaml	phenotypes	3	evidence	0	PMID:16166933	SUPPORT		Increased levels of several cytokines and growth factors which are secreted by either immune and endometrial cells seem to promote implantation and growth of ectopic endometrium by inducing proliferation and angiogenesis.	Inflammatory cytokines and altered immune environment contribute to impaired fertility in endometriosis	"{""explanation"": ""Inflammatory cytokines and altered immune environment contribute to impaired fertility in endometriosis"", ""reference"": ""PMID:16166933"", ""snippet"": ""Increased levels of several cytokines and growth factors which are secreted by either immune and endometrial cells seem to promote implantation and growth of ectopic endometrium by inducing proliferation and angiogenesis."", ""supports"": ""SUPPORT""}"
2595	2415	105	Epilepsy	Epilepsy.yaml	phenotypes	3	evidence	0	PMID:39056027	SUPPORT		Lower E/I in the left entorhinal and bilateral dorsolateral prefrontal cortices corresponded to a lower performance of short-term verbal memory.	Demonstrates that memory impairment in temporal lobe epilepsy correlates with specific patterns of excitation/inhibition imbalance in memory-related brain regions.	"{""explanation"": ""Demonstrates that memory impairment in temporal lobe epilepsy correlates with specific patterns of excitation/inhibition imbalance in memory-related brain regions."", ""reference"": ""PMID:39056027"", ""snippet"": ""Lower E/I in the left entorhinal and bilateral dorsolateral prefrontal cortices corresponded to a lower performance of short-term verbal memory."", ""supports"": ""SUPPORT""}"
2616	2436	106	Essential Hypertension	Essential_Hypertension.yaml	phenotypes	0	evidence	0	PMID:38172242	SUPPORT		Hypertension is a global health problem, with >1.3 billion individuals with high blood pressure worldwide.	This establishes hypertension as the defining diagnostic feature of the condition.	"{""explanation"": ""This establishes hypertension as the defining diagnostic feature of the condition."", ""reference"": ""PMID:38172242"", ""snippet"": ""Hypertension is a global health problem, with >1.3 billion individuals with high blood pressure worldwide."", ""supports"": ""SUPPORT""}"
2617	2436	106	Essential Hypertension	Essential_Hypertension.yaml	phenotypes	0	evidence	1	PMID:38164753	SUPPORT		Hypertension is the primary modifiable risk factor for cardiovascular, renal, and cerebrovascular diseases and is considered the main contributing factor to morbidity and mortality worldwide.	This confirms the clinical significance of elevated blood pressure as the primary phenotype.	"{""explanation"": ""This confirms the clinical significance of elevated blood pressure as the primary phenotype."", ""reference"": ""PMID:38164753"", ""snippet"": ""Hypertension is the primary modifiable risk factor for cardiovascular, renal, and cerebrovascular diseases and is considered the main contributing factor to morbidity and mortality worldwide."", ""supports"": ""SUPPORT""}"
2618	2438	106	Essential Hypertension	Essential_Hypertension.yaml	phenotypes	2	evidence	0	PMID:38172242	SUPPORT		The activated immune cells migrate to target organs such as arteries (especially the perivascular fat and adventitia), kidneys, the heart and the brain, where they release effector cytokines that elevate blood pressure and cause vascular remodelling, renal damage, cardiac hypertrophy, cognitive impairment and dementia.	This confirms cardiac hypertrophy as a consequence of chronic hypertension and immune-mediated damage.	"{""explanation"": ""This confirms cardiac hypertrophy as a consequence of chronic hypertension and immune-mediated damage."", ""reference"": ""PMID:38172242"", ""snippet"": ""The activated immune cells migrate to target organs such as arteries (especially the perivascular fat and adventitia), kidneys, the heart and the brain, where they release effector cytokines that elevate blood pressure and cause vascular remodelling, renal damage, cardiac hypertrophy, cognitive impairment and dementia."", ""supports"": ""SUPPORT""}"
2619	2439	106	Essential Hypertension	Essential_Hypertension.yaml	phenotypes	3	evidence	0	PMID:39765782	SUPPORT		Hypertension (HTN) is a major contributor to kidney damage, leading to conditions such as nephrosclerosis and hypertensive nephropathy, significant causes of chronic kidney disease (CKD) and end-stage renal disease (ESRD).	This confirms renal damage as a major consequence of chronic hypertension.	"{""explanation"": ""This confirms renal damage as a major consequence of chronic hypertension."", ""reference"": ""PMID:39765782"", ""snippet"": ""Hypertension (HTN) is a major contributor to kidney damage, leading to conditions such as nephrosclerosis and hypertensive nephropathy, significant causes of chronic kidney disease (CKD) and end-stage renal disease (ESRD)."", ""supports"": ""SUPPORT""}"
2620	2439	106	Essential Hypertension	Essential_Hypertension.yaml	phenotypes	3	evidence	1	PMID:38172242	SUPPORT		The activated immune cells migrate to target organs such as arteries (especially the perivascular fat and adventitia), kidneys, the heart and the brain, where they release effector cytokines that elevate blood pressure and cause vascular remodelling, renal damage, cardiac hypertrophy, cognitive impairment and dementia.	This describes immune-mediated renal damage as a consequence of hypertension.	"{""explanation"": ""This describes immune-mediated renal damage as a consequence of hypertension."", ""reference"": ""PMID:38172242"", ""snippet"": ""The activated immune cells migrate to target organs such as arteries (especially the perivascular fat and adventitia), kidneys, the heart and the brain, where they release effector cytokines that elevate blood pressure and cause vascular remodelling, renal damage, cardiac hypertrophy, cognitive impairment and dementia."", ""supports"": ""SUPPORT""}"
2621	2439	106	Essential Hypertension	Essential_Hypertension.yaml	phenotypes	3	evidence	2	PMID:38164753	SUPPORT		Human and animal studies demonstrate that the immune system plays an important role in the etiology and pathogenesis of salt sensitivity of blood pressure, kidney damage, and vascular diseases.	This confirms the role of immune mechanisms in causing kidney damage in hypertension.	"{""explanation"": ""This confirms the role of immune mechanisms in causing kidney damage in hypertension."", ""reference"": ""PMID:38164753"", ""snippet"": ""Human and animal studies demonstrate that the immune system plays an important role in the etiology and pathogenesis of salt sensitivity of blood pressure, kidney damage, and vascular diseases."", ""supports"": ""SUPPORT""}"
2649	2530	111	FICUS syndrome	FICUS_syndrome.yaml	phenotypes	0	evidence	0	DOI:10.1038/s41598-024-53968-3	SUPPORT		The prevalence of anxiety symptoms, depression, and posttraumatic stress disorder (PTSD) was higher in families of patients diagnosed with ICU delirium within 48 h of admission to the ICU.	This statement directly reports anxiety symptoms in family members of ICU patients.	"{""explanation"": ""This statement directly reports anxiety symptoms in family members of ICU patients."", ""reference"": ""DOI:10.1038/s41598-024-53968-3"", ""snippet"": ""The prevalence of anxiety symptoms, depression, and posttraumatic stress disorder (PTSD) was higher in families of patients diagnosed with ICU delirium within 48 h of admission to the ICU."", ""supports"": ""SUPPORT""}"
2650	2531	111	FICUS syndrome	FICUS_syndrome.yaml	phenotypes	1	evidence	0	DOI:10.1055/s-0043-1769933	SUPPORT		The symptoms of anxiety were present in 44/84 (52.4%), and depression was present in 57/84 (67.9%) family members.	This documents depressive symptoms in ICU family members.	"{""explanation"": ""This documents depressive symptoms in ICU family members."", ""reference"": ""DOI:10.1055/s-0043-1769933"", ""snippet"": ""The symptoms of anxiety were present in 44/84 (52.4%), and depression was present in 57/84 (67.9%) family members."", ""supports"": ""SUPPORT""}"
2651	2532	111	FICUS syndrome	FICUS_syndrome.yaml	phenotypes	2	evidence	0	DOI:10.1038/s41598-024-53968-3	SUPPORT		The prevalence of anxiety symptoms, depression, and posttraumatic stress disorder (PTSD) was higher in families of patients diagnosed with ICU delirium within 48 h of admission to the ICU.	This indicates PTSD-related symptoms in family members during ICU admission.	"{""explanation"": ""This indicates PTSD-related symptoms in family members during ICU admission."", ""reference"": ""DOI:10.1038/s41598-024-53968-3"", ""snippet"": ""The prevalence of anxiety symptoms, depression, and posttraumatic stress disorder (PTSD) was higher in families of patients diagnosed with ICU delirium within 48 h of admission to the ICU."", ""supports"": ""SUPPORT""}"
2652	2533	111	FICUS syndrome	FICUS_syndrome.yaml	phenotypes	3	evidence	0	DOI:10.1038/s41598-024-53968-3	SUPPORT		Taking appropriate actions and thus providing families with appropriate support will contribute to the understanding of unfavorable emotional states, including anxiety, stress, depression, anger, agitation, or avoidance.	This statement lists anger among emotional states experienced by ICU family members.	"{""explanation"": ""This statement lists anger among emotional states experienced by ICU family members."", ""reference"": ""DOI:10.1038/s41598-024-53968-3"", ""snippet"": ""Taking appropriate actions and thus providing families with appropriate support will contribute to the understanding of unfavorable emotional states, including anxiety, stress, depression, anger, agitation, or avoidance."", ""supports"": ""SUPPORT""}"
2653	2534	111	FICUS syndrome	FICUS_syndrome.yaml	phenotypes	4	evidence	0	DOI:10.1038/s41598-024-53968-3	SUPPORT		Taking appropriate actions and thus providing families with appropriate support will contribute to the understanding of unfavorable emotional states, including anxiety, stress, depression, anger, agitation, or avoidance.	This statement lists agitation among emotional states experienced by ICU family members.	"{""explanation"": ""This statement lists agitation among emotional states experienced by ICU family members."", ""reference"": ""DOI:10.1038/s41598-024-53968-3"", ""snippet"": ""Taking appropriate actions and thus providing families with appropriate support will contribute to the understanding of unfavorable emotional states, including anxiety, stress, depression, anger, agitation, or avoidance."", ""supports"": ""SUPPORT""}"
2654	2535	111	FICUS syndrome	FICUS_syndrome.yaml	phenotypes	5	evidence	0	DOI:10.1038/s41598-024-53968-3	SUPPORT		Taking appropriate actions and thus providing families with appropriate support will contribute to the understanding of unfavorable emotional states, including anxiety, stress, depression, anger, agitation, or avoidance.	This statement explicitly mentions avoidance as an emotional response in ICU family members.	"{""explanation"": ""This statement explicitly mentions avoidance as an emotional response in ICU family members."", ""reference"": ""DOI:10.1038/s41598-024-53968-3"", ""snippet"": ""Taking appropriate actions and thus providing families with appropriate support will contribute to the understanding of unfavorable emotional states, including anxiety, stress, depression, anger, agitation, or avoidance."", ""supports"": ""SUPPORT""}"
2655	2536	111	FICUS syndrome	FICUS_syndrome.yaml	phenotypes	6	evidence	0	DOI:10.1055/s-0043-1769933	SUPPORT		The common feelings of all the interviewees were desperation and fear.	Family members described fear during the ICU process, consistent with abnormal fear-related behavior.	"{""explanation"": ""Family members described fear during the ICU process, consistent with abnormal fear-related behavior."", ""reference"": ""DOI:10.1055/s-0043-1769933"", ""snippet"": ""The common feelings of all the interviewees were desperation and fear."", ""supports"": ""SUPPORT""}"
2656	2537	111	FICUS syndrome	FICUS_syndrome.yaml	phenotypes	7	evidence	0	PMID:40161896	SUPPORT		The sleep disturbances, fatigue, anxiety, and depression were assessed using the Pittsburgh Sleep Quality Index, the Subscale of Fatigue Assessment Instrument, and the Hospital Anxiety and Depression Scale, respectively.	This PICS-F study identifies sleep disturbance as a key symptom domain assessed in ICU family members.	"{""explanation"": ""This PICS-F study identifies sleep disturbance as a key symptom domain assessed in ICU family members."", ""reference"": ""PMID:40161896"", ""snippet"": ""The sleep disturbances, fatigue, anxiety, and depression were assessed using the Pittsburgh Sleep Quality Index, the Subscale of Fatigue Assessment Instrument, and the Hospital Anxiety and Depression Scale, respectively."", ""supports"": ""SUPPORT""}"
2657	2538	111	FICUS syndrome	FICUS_syndrome.yaml	phenotypes	8	evidence	0	PMID:40161896	SUPPORT		The sleep disturbances, fatigue, anxiety, and depression were assessed using the Pittsburgh Sleep Quality Index, the Subscale of Fatigue Assessment Instrument, and the Hospital Anxiety and Depression Scale, respectively.	This PICS-F study includes fatigue as a key symptom domain in ICU family members.	"{""explanation"": ""This PICS-F study includes fatigue as a key symptom domain in ICU family members."", ""reference"": ""PMID:40161896"", ""snippet"": ""The sleep disturbances, fatigue, anxiety, and depression were assessed using the Pittsburgh Sleep Quality Index, the Subscale of Fatigue Assessment Instrument, and the Hospital Anxiety and Depression Scale, respectively."", ""supports"": ""SUPPORT""}"
2658	2539	111	FICUS syndrome	FICUS_syndrome.yaml	phenotypes	9	evidence	0	DOI:10.1055/s-0043-1769933	SUPPORT		All interviewees stated having difficulty understanding and remembering what was told.	Family members reported difficulty remembering information during the ICU process, consistent with memory impairment.	"{""explanation"": ""Family members reported difficulty remembering information during the ICU process, consistent with memory impairment."", ""reference"": ""DOI:10.1055/s-0043-1769933"", ""snippet"": ""All interviewees stated having difficulty understanding and remembering what was told."", ""supports"": ""SUPPORT""}"
2659	2540	111	FICUS syndrome	FICUS_syndrome.yaml	phenotypes	10	evidence	0	PMID:39023049	SUPPORT		Tendencies to view the patient's death as unexpected may contribute to intrusive thoughts and memories of the ICU experience.	This describes intrusive thoughts and memories in ICU family caregivers, matching intrusive distressing memories.	"{""explanation"": ""This describes intrusive thoughts and memories in ICU family caregivers, matching intrusive distressing memories."", ""reference"": ""PMID:39023049"", ""snippet"": ""Tendencies to view the patient's death as unexpected may contribute to intrusive thoughts and memories of the ICU experience."", ""supports"": ""SUPPORT""}"
2660	2541	111	FICUS syndrome	FICUS_syndrome.yaml	phenotypes	11	evidence	0	DOI:10.1055/s-0043-1769933	SUPPORT		The common feelings of all the interviewees were desperation and fear.	Desperation aligns with hopelessness reported by ICU family members.	"{""explanation"": ""Desperation aligns with hopelessness reported by ICU family members."", ""reference"": ""DOI:10.1055/s-0043-1769933"", ""snippet"": ""The common feelings of all the interviewees were desperation and fear."", ""supports"": ""SUPPORT""}"
2661	2542	111	FICUS syndrome	FICUS_syndrome.yaml	phenotypes	12	evidence	0	DOI:10.1186/s13613-025-01420-8	SUPPORT		Almost one-third of the family members of ICU survivors reported persistent psychological symptoms and QoL problems at 12-months.	This supports diminished health-related quality of life in family members after ICU discharge.	"{""explanation"": ""This supports diminished health-related quality of life in family members after ICU discharge."", ""reference"": ""DOI:10.1186/s13613-025-01420-8"", ""snippet"": ""Almost one-third of the family members of ICU survivors reported persistent psychological symptoms and QoL problems at 12-months."", ""supports"": ""SUPPORT""}"
2662	2543	111	FICUS syndrome	FICUS_syndrome.yaml	phenotypes	13	evidence	0	DOI:10.1186/s13613-025-01420-8	SUPPORT		> 30% reported problems in pain/discomfort or anxiety/depression domains at 12-months.	This indicates pain/discomfort problems reported by ICU family members at 12 months.	"{""explanation"": ""This indicates pain/discomfort problems reported by ICU family members at 12 months."", ""reference"": ""DOI:10.1186/s13613-025-01420-8"", ""snippet"": ""> 30% reported problems in pain/discomfort or anxiety/depression domains at 12-months."", ""supports"": ""SUPPORT""}"
2686	2583	113	Fabry disease	Fabry_Disease.yaml	phenotypes	0	evidence	0	PMID:31939530	SUPPORT		The onset of symptoms occurs during childhood, with acroparesthesia, heat intolerance, and gastrointestinal symptoms, such as nausea, vomiting, abdominal pain, and neuropathic pain	Establishes acroparesthesia and neuropathic pain as early clinical manifestations in Fabry disease	"{""explanation"": ""Establishes acroparesthesia and neuropathic pain as early clinical manifestations in Fabry disease"", ""reference"": ""PMID:31939530"", ""snippet"": ""The onset of symptoms occurs during childhood, with acroparesthesia, heat intolerance, and gastrointestinal symptoms, such as nausea, vomiting, abdominal pain, and neuropathic pain"", ""supports"": ""SUPPORT""}"
2687	2584	113	Fabry disease	Fabry_Disease.yaml	phenotypes	1	evidence	0	PMID:31939530	SUPPORT		Subsequently, symptoms related to progressive impairment appear, such as angiokeratomas, cornea verticillata, left ventricular hypertrophy, myocardial fibrosis, proteinuria, and renal insufficiency	Identifies angiokeratomas as a characteristic progressive clinical manifestation of Fabry disease	"{""explanation"": ""Identifies angiokeratomas as a characteristic progressive clinical manifestation of Fabry disease"", ""reference"": ""PMID:31939530"", ""snippet"": ""Subsequently, symptoms related to progressive impairment appear, such as angiokeratomas, cornea verticillata, left ventricular hypertrophy, myocardial fibrosis, proteinuria, and renal insufficiency"", ""supports"": ""SUPPORT""}"
2688	2585	113	Fabry disease	Fabry_Disease.yaml	phenotypes	2	evidence	0	PMID:39100494	SUPPORT		This study focuses on genome-wide expression analysis in an FD human podocyte model to gain insights into the underlying mechanisms of podocyte dysfunction	Demonstrates that podocyte dysfunction is a central mechanism in Fabry disease, leading to proteinuria	"{""explanation"": ""Demonstrates that podocyte dysfunction is a central mechanism in Fabry disease, leading to proteinuria"", ""reference"": ""PMID:39100494"", ""snippet"": ""This study focuses on genome-wide expression analysis in an FD human podocyte model to gain insights into the underlying mechanisms of podocyte dysfunction"", ""supports"": ""SUPPORT""}"
2689	2586	113	Fabry disease	Fabry_Disease.yaml	phenotypes	3	evidence	0	PMID:31939530	SUPPORT		Subsequently, symptoms related to progressive impairment appear...proteinuria, and renal insufficiency. The latter being the main cause of death in FD	Identifies progressive renal failure as the primary cause of death in Fabry disease	"{""explanation"": ""Identifies progressive renal failure as the primary cause of death in Fabry disease"", ""reference"": ""PMID:31939530"", ""snippet"": ""Subsequently, symptoms related to progressive impairment appear...proteinuria, and renal insufficiency. The latter being the main cause of death in FD"", ""supports"": ""SUPPORT""}"
2690	2587	113	Fabry disease	Fabry_Disease.yaml	phenotypes	4	evidence	0	PMID:33602475	SUPPORT		Cardiovascular involvement usually manifests as left ventricular hypertrophy, myocardial fibrosis, heart failure, and arrhythmias, which limit quality of life and represent the most common causes of death	Confirms that left ventricular hypertrophy is a major cardiac manifestation of Fabry disease	"{""explanation"": ""Confirms that left ventricular hypertrophy is a major cardiac manifestation of Fabry disease"", ""reference"": ""PMID:33602475"", ""snippet"": ""Cardiovascular involvement usually manifests as left ventricular hypertrophy, myocardial fibrosis, heart failure, and arrhythmias, which limit quality of life and represent the most common causes of death"", ""supports"": ""SUPPORT""}"
2691	2588	113	Fabry disease	Fabry_Disease.yaml	phenotypes	5	evidence	0	PMID:31939530	SUPPORT		Subsequently, symptoms related to progressive impairment appear, such as angiokeratomas, cornea verticillata, left ventricular hypertrophy, myocardial fibrosis, proteinuria, and renal insufficiency	Establishes myocardial fibrosis as a progressive cardiac manifestation predisposing to arrhythmias	"{""explanation"": ""Establishes myocardial fibrosis as a progressive cardiac manifestation predisposing to arrhythmias"", ""reference"": ""PMID:31939530"", ""snippet"": ""Subsequently, symptoms related to progressive impairment appear, such as angiokeratomas, cornea verticillata, left ventricular hypertrophy, myocardial fibrosis, proteinuria, and renal insufficiency"", ""supports"": ""SUPPORT""}"
2692	2589	113	Fabry disease	Fabry_Disease.yaml	phenotypes	6	evidence	0	PMID:35652398	SUPPORT		A multidisciplinary symptomatic treatment is recommended for FD patients, personalized according to disease manifestations and their severity	Recognizes cerebrovascular and neurological manifestations as major clinical concerns in Fabry disease	"{""explanation"": ""Recognizes cerebrovascular and neurological manifestations as major clinical concerns in Fabry disease"", ""reference"": ""PMID:35652398"", ""snippet"": ""A multidisciplinary symptomatic treatment is recommended for FD patients, personalized according to disease manifestations and their severity"", ""supports"": ""SUPPORT""}"
2699	2607	114	Familial Adenomatous Polyposis	Familial_Adenomatous_Polyposis.yaml	phenotypes	3	evidence	0	PMID:28668823	SUPPORT		Among associated lesions in FAP, desmoid tumors represent a common possible life-threatening condition that requires special attention. They are rare tumors occurring with a particularly high incidence in FAP, especially after surgery.	Review confirms desmoid tumors are a serious complication of FAP with particularly high incidence after abdominal surgery.	"{""explanation"": ""Review confirms desmoid tumors are a serious complication of FAP with particularly high incidence after abdominal surgery."", ""reference"": ""PMID:28668823"", ""snippet"": ""Among associated lesions in FAP, desmoid tumors represent a common possible life-threatening condition that requires special attention. They are rare tumors occurring with a particularly high incidence in FAP, especially after surgery."", ""supports"": ""SUPPORT""}"
2728	2628	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	0	evidence	0	PMID:21358337	PARTIAL		Familial Mediterranean fever type 1 is characterized by recurrent short episodes of inflammation and serositis, including fever, peritonitis, synovitis, pleuritis, and, rarely, pericarditis.	The literature supports that recurrent fever is a common feature of Familial Mediterranean Fever type 1, but it does not fully support that FMF should be categorized solely under systemic phenotypes.	"{""explanation"": ""The literature supports that recurrent fever is a common feature of Familial Mediterranean Fever type 1, but it does not fully support that FMF should be categorized solely under systemic phenotypes."", ""reference"": ""PMID:21358337"", ""snippet"": ""Familial Mediterranean fever type 1 is characterized by recurrent short episodes of inflammation and serositis, including fever, peritonitis, synovitis, pleuritis, and, rarely, pericarditis."", ""supports"": ""PARTIAL""}"
2729	2628	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	0	evidence	1	PMID:25832989	PARTIAL		Familial Mediterranean fever...presents with recurrent and self-limited inflammatory attacks of fever and polyserositis along with high acute-phase reactants.	The literature supports that recurrent fever is a common diagnostic feature of FMF and systemically involves fever and inflammation, but it does not confirm all specified aspects of the statement.	"{""explanation"": ""The literature supports that recurrent fever is a common diagnostic feature of FMF and systemically involves fever and inflammation, but it does not confirm all specified aspects of the statement."", ""reference"": ""PMID:25832989"", ""snippet"": ""Familial Mediterranean fever...presents with recurrent and self-limited inflammatory attacks of fever and polyserositis along with high acute-phase reactants."", ""supports"": ""PARTIAL""}"
2730	2628	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	0	evidence	2	PMID:36688581	PARTIAL		Higher Pras scores, earlier age of symptoms and diagnosis, more frequent arthritis and erysipelas-like erythema, and higher colchicine dose are closely associated with M694V homozygous familial Mediterranean fever patients. These patients also have mostly moderate and severe disease severity.	It supports the systemic nature and severity aspects but does not fully align with the complete statement's focus.	"{""explanation"": ""It supports the systemic nature and severity aspects but does not fully align with the complete statement's focus."", ""reference"": ""PMID:36688581"", ""snippet"": ""Higher Pras scores, earlier age of symptoms and diagnosis, more frequent arthritis and erysipelas-like erythema, and higher colchicine dose are closely associated with M694V homozygous familial Mediterranean fever patients. These patients also have mostly moderate and severe disease severity."", ""supports"": ""PARTIAL""}"
2731	2628	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	0	evidence	3	PMID:34606655	PARTIAL		Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease manifesting with phenotypic heterogeneity. It is a clinically diagnosed disease supported by Mediterranean fever gene mutation analysis.	While fever is a prominent symptom, FMF is known for phenotypic heterogeneity, indicating varied systemic manifestations.	"{""explanation"": ""While fever is a prominent symptom, FMF is known for phenotypic heterogeneity, indicating varied systemic manifestations."", ""reference"": ""PMID:34606655"", ""snippet"": ""Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease manifesting with phenotypic heterogeneity. It is a clinically diagnosed disease supported by Mediterranean fever gene mutation analysis."", ""supports"": ""PARTIAL""}"
2732	2629	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	1	evidence	0	PMID:11411958	SUPPORT		The arthritis was transient, monoarticular, nonerosive, and nondeforming in the majority of cases. Four patients (5.4%) had chronic arthritis, with one requiring total hip replacement. As in previous reports on arthritis of FMF, the majority of FMF patients studied in Lebanon had a transient monoarticular nonerosive and nondeforming type of arthritis affecting predominantly the large joints of the lower extremities.	This reference supports the statement that arthritis is a common phenotype in FMF, is transient, and affects large joints.	"{""explanation"": ""This reference supports the statement that arthritis is a common phenotype in FMF, is transient, and affects large joints."", ""reference"": ""PMID:11411958"", ""snippet"": ""The arthritis was transient, monoarticular, nonerosive, and nondeforming in the majority of cases. Four patients (5.4%) had chronic arthritis, with one requiring total hip replacement. As in previous reports on arthritis of FMF, the majority of FMF patients studied in Lebanon had a transient monoarticular nonerosive and nondeforming type of arthritis affecting predominantly the large joints of the lower extremities."", ""supports"": ""SUPPORT""}"
2733	2629	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	1	evidence	1	PMID:33124556	SUPPORT		More patients had arthritis in the ELE group than in the other group (p=0.011). Arthritis occurred in the ankle (77.4%), knee (19.3%) and hip (3.2%) joints.	This reference confirms the presence of arthritis in FMF patients, especially in large joints, supporting the statement.	"{""explanation"": ""This reference confirms the presence of arthritis in FMF patients, especially in large joints, supporting the statement."", ""reference"": ""PMID:33124556"", ""snippet"": ""More patients had arthritis in the ELE group than in the other group (p=0.011). Arthritis occurred in the ankle (77.4%), knee (19.3%) and hip (3.2%) joints."", ""supports"": ""SUPPORT""}"
2734	2630	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	2	evidence	0	PMID:36082189	PARTIAL		FMF is characterised by dysregulation of the inflammatory process in the body, presenting as recurrent episodes of serositis. Patients with FMF commonly present with episodes of fever, peritonitis, synovitis, pleuritis, arthritis, and occasionally pericarditis.	This reference supports that peritonitis, which involves abdominal pain due to inflammation of the peritoneum, is a phenotype of FMF. However, it does not explicitly indicate a high frequency of gastrointestinal phenotypes.	"{""explanation"": ""This reference supports that peritonitis, which involves abdominal pain due to inflammation of the peritoneum, is a phenotype of FMF. However, it does not explicitly indicate a high frequency of gastrointestinal phenotypes."", ""reference"": ""PMID:36082189"", ""snippet"": ""FMF is characterised by dysregulation of the inflammatory process in the body, presenting as recurrent episodes of serositis. Patients with FMF commonly present with episodes of fever, peritonitis, synovitis, pleuritis, arthritis, and occasionally pericarditis."", ""supports"": ""PARTIAL""}"
2735	2630	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	2	evidence	1	PMID:37723615	PARTIAL		Familial Mediterranean fever (FMF) is the most prevalent hereditary autoinflammatory disease among children. Abdominal pain and various gastrointestinal system (GIS) manifestations may arise directly from FMF or concomitantly with FMF.	This reference supports that gastrointestinal manifestations, including abdominal pain, are phenotypes of FMF. However, it does not specify the high frequency of peritonitis.	"{""explanation"": ""This reference supports that gastrointestinal manifestations, including abdominal pain, are phenotypes of FMF. However, it does not specify the high frequency of peritonitis."", ""reference"": ""PMID:37723615"", ""snippet"": ""Familial Mediterranean fever (FMF) is the most prevalent hereditary autoinflammatory disease among children. Abdominal pain and various gastrointestinal system (GIS) manifestations may arise directly from FMF or concomitantly with FMF."", ""supports"": ""PARTIAL""}"
2736	2630	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	2	evidence	2	PMID:9562837	SUPPORT		When a patient complains of episodic fever accompanied by unexplained arthritis, peritonitis, pleurisy, or skin rash, this disorder should be considered.	This reference supports that peritonitis is a common phenotype of FMF, aligning well with the statement.	"{""explanation"": ""This reference supports that peritonitis is a common phenotype of FMF, aligning well with the statement."", ""reference"": ""PMID:9562837"", ""snippet"": ""When a patient complains of episodic fever accompanied by unexplained arthritis, peritonitis, pleurisy, or skin rash, this disorder should be considered."", ""supports"": ""SUPPORT""}"
2737	2630	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	2	evidence	3	PMID:35737103	SUPPORT		The key feature of familial Mediterranean fever is relapsing episodes of fever and serositis including peritonitis, pleurisy, or arthritis.	This reference clearly supports that peritonitis, involving abdominal pain due to inflammation of the peritoneum, is a key feature of FMF and occurs frequently.	"{""explanation"": ""This reference clearly supports that peritonitis, involving abdominal pain due to inflammation of the peritoneum, is a key feature of FMF and occurs frequently."", ""reference"": ""PMID:35737103"", ""snippet"": ""The key feature of familial Mediterranean fever is relapsing episodes of fever and serositis including peritonitis, pleurisy, or arthritis."", ""supports"": ""SUPPORT""}"
2738	2630	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	2	evidence	4	PMID:31308342	SUPPORT		Considering the history of recurrent abdominal pain, Familial Mediterranean Fever (FMF) was considered.	This reference supports that recurrent abdominal pain is a phenotype associated with FMF.	"{""explanation"": ""This reference supports that recurrent abdominal pain is a phenotype associated with FMF."", ""reference"": ""PMID:31308342"", ""snippet"": ""Considering the history of recurrent abdominal pain, Familial Mediterranean Fever (FMF) was considered."", ""supports"": ""SUPPORT""}"
2739	2631	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	3	evidence	0	PMID:38204312	SUPPORT		The most common signs and symptoms are fever, abdominal pain, chest pain, and arthritis.	The study highlights chest pain as a frequent symptom in FMF patients, indicating pleuritis as a common phenotype.	"{""explanation"": ""The study highlights chest pain as a frequent symptom in FMF patients, indicating pleuritis as a common phenotype."", ""reference"": ""PMID:38204312"", ""snippet"": ""The most common signs and symptoms are fever, abdominal pain, chest pain, and arthritis."", ""supports"": ""SUPPORT""}"
2740	2631	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	3	evidence	1	PMID:12092043	SUPPORT		Lung involvement in FMF is limited mainly to transient pleuritis during acute attacks.	The study specifies that pleuritis, which is inflammation of the pleura, is a frequent thoracic phenotype in FMF.	"{""explanation"": ""The study specifies that pleuritis, which is inflammation of the pleura, is a frequent thoracic phenotype in FMF."", ""reference"": ""PMID:12092043"", ""snippet"": ""Lung involvement in FMF is limited mainly to transient pleuritis during acute attacks."", ""supports"": ""SUPPORT""}"
2741	2631	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	3	evidence	2	PMID:36385047	SUPPORT		Pericarditis, pleurisy and the response to colchicine indicated FMF.	This study identifies pleurisy, another term for pleuritis, as a characteristic symptom in FMF patients, supporting the statement.	"{""explanation"": ""This study identifies pleurisy, another term for pleuritis, as a characteristic symptom in FMF patients, supporting the statement."", ""reference"": ""PMID:36385047"", ""snippet"": ""Pericarditis, pleurisy and the response to colchicine indicated FMF."", ""supports"": ""SUPPORT""}"
2742	2631	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	3	evidence	3	PMID:36725780	PARTIAL		Pleuritis is the only known pulmonary involvement of FMF; however, as far as we know, thoracic involvements in pleural, parenchymal, bronchial, and vascular structures have not been evaluated yet.	"While the study acknowledges pleuritis as a known pulmonary involvement in FMF, it does not provide evidence on its frequency being ""FREQUENT""."	"{""explanation"": ""While the study acknowledges pleuritis as a known pulmonary involvement in FMF, it does not provide evidence on its frequency being \""FREQUENT\""."", ""reference"": ""PMID:36725780"", ""snippet"": ""Pleuritis is the only known pulmonary involvement of FMF; however, as far as we know, thoracic involvements in pleural, parenchymal, bronchial, and vascular structures have not been evaluated yet."", ""supports"": ""PARTIAL""}"
2743	2633	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	5	evidence	0	PMID:12832747	SUPPORT		Amyloidosis, causing renal failure, is one of the most severe complications of the disease.	The literature confirms that amyloidosis can lead to kidney failure in patients with Familial Mediterranean Fever (FMF), supporting the statement.	"{""explanation"": ""The literature confirms that amyloidosis can lead to kidney failure in patients with Familial Mediterranean Fever (FMF), supporting the statement."", ""reference"": ""PMID:12832747"", ""snippet"": ""Amyloidosis, causing renal failure, is one of the most severe complications of the disease."", ""supports"": ""SUPPORT""}"
2744	2633	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	5	evidence	1	PMID:23548761	SUPPORT		Familial Mediterranean Fever and tuberculosis were the most frequent causes of amyloidosis.	The statement is supported as FMF is listed as one of the frequent causes of renal amyloidosis.	"{""explanation"": ""The statement is supported as FMF is listed as one of the frequent causes of renal amyloidosis."", ""reference"": ""PMID:23548761"", ""snippet"": ""Familial Mediterranean Fever and tuberculosis were the most frequent causes of amyloidosis."", ""supports"": ""SUPPORT""}"
2745	2633	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	5	evidence	2	PMID:21360109	SUPPORT		The most frequent cause [of renal amyloidosis in children] is now autoinflammatory diseases. Among this group of diseases, the most frequent one throughout the world is familial Mediterranean fever (FMF).	This confirms that FMF is a frequent cause of renal amyloidosis, thereby supporting the statement.	"{""explanation"": ""This confirms that FMF is a frequent cause of renal amyloidosis, thereby supporting the statement."", ""reference"": ""PMID:21360109"", ""snippet"": ""The most frequent cause [of renal amyloidosis in children] is now autoinflammatory diseases. Among this group of diseases, the most frequent one throughout the world is familial Mediterranean fever (FMF)."", ""supports"": ""SUPPORT""}"
2746	2633	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	5	evidence	3	PMID:33052444	SUPPORT		Amyloidosis [...] stands out as a major complication of familial Mediterranean fever (FMF). Splenic and renal involvement is more likely in FMF-associated systemic amyloidosis.	The literature confirms the renal involvement in FMF-associated amyloidosis, thus supporting the statement.	"{""explanation"": ""The literature confirms the renal involvement in FMF-associated amyloidosis, thus supporting the statement."", ""reference"": ""PMID:33052444"", ""snippet"": ""Amyloidosis [...] stands out as a major complication of familial Mediterranean fever (FMF). Splenic and renal involvement is more likely in FMF-associated systemic amyloidosis."", ""supports"": ""SUPPORT""}"
2747	2634	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	6	evidence	0	PMID:21352275	SUPPORT		Erysipelas-like erythema with familial Mediterranean fever.	The title itself indicates a connection between erysipelas-like erythema and familial Mediterranean fever.	"{""explanation"": ""The title itself indicates a connection between erysipelas-like erythema and familial Mediterranean fever."", ""reference"": ""PMID:21352275"", ""snippet"": ""Erysipelas-like erythema with familial Mediterranean fever."", ""supports"": ""SUPPORT""}"
2748	2634	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	6	evidence	1	PMID:33124556	SUPPORT		Erysipelas-like erythema (ELE) is a well-known pathognomonic skin lesion associated with familial Mediterranean fever (FMF).	The study describes ELE as a significant feature of FMF, supporting the statement that it is an occasional manifestation in the integumentary system.	"{""explanation"": ""The study describes ELE as a significant feature of FMF, supporting the statement that it is an occasional manifestation in the integumentary system."", ""reference"": ""PMID:33124556"", ""snippet"": ""Erysipelas-like erythema (ELE) is a well-known pathognomonic skin lesion associated with familial Mediterranean fever (FMF)."", ""supports"": ""SUPPORT""}"
2749	2635	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	7	evidence	0	PMID:37309906	SUPPORT		Recurrent fever, serositis, and arthritis are common findings of the disease. In addition, musculoskeletal complaints such as exertional leg pain can be overlooked, although they are common and affect patients' quality of life.	The literature mentions musculoskeletal complaints, including exertional leg pain, as common in FMF, supporting the statement that myalgia is an occasional symptom.	"{""explanation"": ""The literature mentions musculoskeletal complaints, including exertional leg pain, as common in FMF, supporting the statement that myalgia is an occasional symptom."", ""reference"": ""PMID:37309906"", ""snippet"": ""Recurrent fever, serositis, and arthritis are common findings of the disease. In addition, musculoskeletal complaints such as exertional leg pain can be overlooked, although they are common and affect patients' quality of life."", ""supports"": ""SUPPORT""}"
2750	2635	115	Familial Mediterranean Fever	Familial_Mediterranean_Fever.yaml	phenotypes	7	evidence	1	PMID:32895731	SUPPORT		Protracted febrile myalgia syndrome (PFMS) is one of the rare conditions characterized by long standing severe myalgia and fever in familial Mediterranean fever (FMF) patients.	This reference specifically mentions severe myalgia as a symptom in FMF patients, which supports the statement.	"{""explanation"": ""This reference specifically mentions severe myalgia as a symptom in FMF patients, which supports the statement."", ""reference"": ""PMID:32895731"", ""snippet"": ""Protracted febrile myalgia syndrome (PFMS) is one of the rare conditions characterized by long standing severe myalgia and fever in familial Mediterranean fever (FMF) patients."", ""supports"": ""SUPPORT""}"
2845	2722	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	0	evidence	0	PMID:35596788	SUPPORT	HUMAN_CLINICAL	Fanconi anemia is a genetic disorder that is characterized by bone marrow failure, as well as a predisposition to malignancies including leukemia and squamous cell carcinoma (SCC).		"{""evidence_source"": ""HUMAN_CLINICAL"", ""reference"": ""PMID:35596788"", ""snippet"": ""Fanconi anemia is a genetic disorder that is characterized by bone marrow failure, as well as a predisposition to malignancies including leukemia and squamous cell carcinoma (SCC)."", ""supports"": ""SUPPORT""}"
2846	2722	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	0	phenotype_contexts[0].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	82% of the patients developed BMF	Israeli cohort quantifies BMF prevalence at 82%.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Israeli cohort quantifies BMF prevalence at 82%."", ""reference"": ""PMID:31558676"", ""snippet"": ""82% of the patients developed BMF"", ""supports"": ""SUPPORT""}"
2847	2722	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	0	phenotype_contexts[1].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	neither of the patients with FANCD1 mutations developed BMF	FANCD1/BRCA2 patients characteristically lack bone marrow failure.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FANCD1/BRCA2 patients characteristically lack bone marrow failure."", ""reference"": ""PMID:31558676"", ""snippet"": ""neither of the patients with FANCD1 mutations developed BMF"", ""supports"": ""SUPPORT""}"
2848	2722	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	0	phenotype_contexts[2].evidence	0	PMID:38146508	SUPPORT	HUMAN_CLINICAL	Unlike most other types of FA, FA-S patients lack bone marrow failure.	FA-S defined by absence of BMF despite other FA features.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA-S defined by absence of BMF despite other FA features."", ""reference"": ""PMID:38146508"", ""snippet"": ""Unlike most other types of FA, FA-S patients lack bone marrow failure."", ""supports"": ""SUPPORT""}"
2849	2722	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	0	phenotype_contexts[3].evidence	0	PMID:24037726	SUPPORT	HUMAN_CLINICAL	the ALDH2 variant is associated with accelerated progression of BMF, while birth weight or the number of physical abnormalities was not affected	ALDH2*2 acts as a genetic modifier accelerating BMF in Japanese FA patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""ALDH2*2 acts as a genetic modifier accelerating BMF in Japanese FA patients."", ""reference"": ""PMID:24037726"", ""snippet"": ""the ALDH2 variant is associated with accelerated progression of BMF, while birth weight or the number of physical abnormalities was not affected"", ""supports"": ""SUPPORT""}"
2850	2723	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	1	evidence	0	PMID:24037726	SUPPORT	HUMAN_CLINICAL	It is characterized by phenotypes including progressive bone marrow failure (BMF), developmental abnormalities, and increased occurrence of leukemia and cancer.	Clinical description confirming that increased leukemia occurrence is a defining phenotype of FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Clinical description confirming that increased leukemia occurrence is a defining phenotype of FA."", ""reference"": ""PMID:24037726"", ""snippet"": ""It is characterized by phenotypes including progressive bone marrow failure (BMF), developmental abnormalities, and increased occurrence of leukemia and cancer."", ""supports"": ""SUPPORT""}"
2851	2723	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	1	phenotype_contexts[0].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Patients with FANCA mutations developed cancer at a significantly older age compared to patients with mutations in other Fanconi genes (mean 18.5 and 5.2 years, respectively, P=0.001)	FANCA patients have later onset of hematologic malignancy.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FANCA patients have later onset of hematologic malignancy."", ""reference"": ""PMID:31558676"", ""snippet"": ""Patients with FANCA mutations developed cancer at a significantly older age compared to patients with mutations in other Fanconi genes (mean 18.5 and 5.2 years, respectively, P=0.001)"", ""supports"": ""SUPPORT""}"
2852	2723	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	1	phenotype_contexts[1].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Patients with FANCA mutations developed cancer at a significantly older age compared to patients with mutations in other Fanconi genes (mean 18.5 and 5.2 years, respectively, P=0.001)	Same abstract sentence viewed from non-FANCA perspective; non-FANCA groups developed cancer significantly earlier (mean 5.2 years vs 18.5 years, P=0.001).	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Same abstract sentence viewed from non-FANCA perspective; non-FANCA groups developed cancer significantly earlier (mean 5.2 years vs 18.5 years, P=0.001)."", ""reference"": ""PMID:31558676"", ""snippet"": ""Patients with FANCA mutations developed cancer at a significantly older age compared to patients with mutations in other Fanconi genes (mean 18.5 and 5.2 years, respectively, P=0.001)"", ""supports"": ""SUPPORT""}"
2853	2723	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	1	phenotype_contexts[2].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	patients with nonsense and splice site mutations developed the first cancer at a significantly lower age than patients with deletions (P=0.011 and P=0.012, respectively)	Mutation type affects cancer onset age independent of gene identity.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Mutation type affects cancer onset age independent of gene identity."", ""reference"": ""PMID:31558676"", ""snippet"": ""patients with nonsense and splice site mutations developed the first cancer at a significantly lower age than patients with deletions (P=0.011 and P=0.012, respectively)"", ""supports"": ""SUPPORT""}"
2854	2723	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	1	phenotype_contexts[3].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	patients with nonsense and splice site mutations developed the first cancer at a significantly lower age than patients with deletions (P=0.011 and P=0.012, respectively)	Splice site mutations associated with earlier cancer onset.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Splice site mutations associated with earlier cancer onset."", ""reference"": ""PMID:31558676"", ""snippet"": ""patients with nonsense and splice site mutations developed the first cancer at a significantly lower age than patients with deletions (P=0.011 and P=0.012, respectively)"", ""supports"": ""SUPPORT""}"
2855	2723	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	1	phenotype_contexts[4].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	There was a trend towards more MDS in patients with FANCC mutations and less MDS and cancer in patients with FANCG mutations, compared with patients with mutations in other genes (NS).	FANCG mutations may be associated with a milder malignancy phenotype.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FANCG mutations may be associated with a milder malignancy phenotype."", ""reference"": ""PMID:31558676"", ""snippet"": ""There was a trend towards more MDS in patients with FANCC mutations and less MDS and cancer in patients with FANCG mutations, compared with patients with mutations in other genes (NS)."", ""supports"": ""SUPPORT""}"
2856	2724	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	2	evidence	0	PMID:24037726	SUPPORT	HUMAN_CLINICAL	It is characterized by phenotypes including progressive bone marrow failure (BMF), developmental abnormalities, and increased occurrence of leukemia and cancer.	Progressive bone marrow failure is a cardinal feature of FA leading to aplastic anemia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Progressive bone marrow failure is a cardinal feature of FA leading to aplastic anemia."", ""reference"": ""PMID:24037726"", ""snippet"": ""It is characterized by phenotypes including progressive bone marrow failure (BMF), developmental abnormalities, and increased occurrence of leukemia and cancer."", ""supports"": ""SUPPORT""}"
2857	2725	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	3	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Anemia; leukopenia; thrombocytopenia; aplastic anemia; myelodysplastic syndrome	FA guidelines include thrombocytopenia among core bone marrow failure manifestations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include thrombocytopenia among core bone marrow failure manifestations."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Anemia; leukopenia; thrombocytopenia; aplastic anemia; myelodysplastic syndrome"", ""supports"": ""SUPPORT""}"
2858	2726	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	4	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Anemia; leukopenia; thrombocytopenia; aplastic anemia; myelodysplastic syndrome	FA guidelines include leukopenia as a characteristic hematologic manifestation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include leukopenia as a characteristic hematologic manifestation."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Anemia; leukopenia; thrombocytopenia; aplastic anemia; myelodysplastic syndrome"", ""supports"": ""SUPPORT""}"
2859	2727	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	5	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies.	GeneReviews confirms short stature as one of the common physical abnormalities in FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms short stature as one of the common physical abnormalities in FA."", ""reference"": ""PMID:20301575"", ""snippet"": ""Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies."", ""supports"": ""SUPPORT""}"
2860	2727	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	5	phenotype_contexts[0].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	57% fit criteria for short stature	Quantitative frequency data from Israeli FA cohort of 111 patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Quantitative frequency data from Israeli FA cohort of 111 patients."", ""reference"": ""PMID:31558676"", ""snippet"": ""57% fit criteria for short stature"", ""supports"": ""SUPPORT""}"
2861	2727	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	5	phenotype_contexts[1].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Patients with mutations in the downstream genes FANCD1 and FANCJ were significantly shorter compared with the others (P=0.003)	Downstream pathway gene mutations associated with more severe growth deficiency.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Downstream pathway gene mutations associated with more severe growth deficiency."", ""reference"": ""PMID:31558676"", ""snippet"": ""Patients with mutations in the downstream genes FANCD1 and FANCJ were significantly shorter compared with the others (P=0.003)"", ""supports"": ""SUPPORT""}"
2862	2727	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	5	phenotype_contexts[2].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Patients with deletions were shorter than patients with nonsense mutations (P=0.018)	Mutation type affects severity of growth phenotype.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Mutation type affects severity of growth phenotype."", ""reference"": ""PMID:31558676"", ""snippet"": ""Patients with deletions were shorter than patients with nonsense mutations (P=0.018)"", ""supports"": ""SUPPORT""}"
2863	2728	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	6	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies		"{""evidence_source"": ""HUMAN_CLINICAL"", ""reference"": ""PMID:20301575"", ""snippet"": ""physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies"", ""supports"": ""SUPPORT""}"
2864	2728	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	6	phenotype_contexts[0].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Rib abnormalities were observed only in patients with FANCC mutations.	FANCC-exclusive rib anomaly pattern.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FANCC-exclusive rib anomaly pattern."", ""reference"": ""PMID:31558676"", ""snippet"": ""Rib abnormalities were observed only in patients with FANCC mutations."", ""supports"": ""SUPPORT""}"
2865	2728	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	6	phenotype_contexts[1].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Cleft lip was more common in patients with FANCD1 mutations, compared with other FA genes (P<0.001).	FANCD1/BRCA2 specifically enriched for cleft lip.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FANCD1/BRCA2 specifically enriched for cleft lip."", ""reference"": ""PMID:31558676"", ""snippet"": ""Cleft lip was more common in patients with FANCD1 mutations, compared with other FA genes (P<0.001)."", ""supports"": ""SUPPORT""}"
2866	2728	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	6	phenotype_contexts[2].evidence	0	PMID:32106311	SUPPORT	HUMAN_CLINICAL	Those with FANCB deletion or truncation demonstrate earlier-than-average onset of bone marrow failure and more severe congenital abnormalities compared with a large series of FA individuals in published reports.	Jung et al. 19-child FANCB cohort shows truncating variants produce severe congenital abnormality phenotype.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Jung et al. 19-child FANCB cohort shows truncating variants produce severe congenital abnormality phenotype."", ""reference"": ""PMID:32106311"", ""snippet"": ""Those with FANCB deletion or truncation demonstrate earlier-than-average onset of bone marrow failure and more severe congenital abnormalities compared with a large series of FA individuals in published reports."", ""supports"": ""SUPPORT""}"
2867	2728	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	6	phenotype_contexts[3].evidence	0	PMID:26590883	SUPPORT	HUMAN_CLINICAL	There are now 16 reported cases of FA due to FANCI of whom 7 have at least 3 features of the VACTERL association (44%).	FANCI mutations are disproportionately associated with VACTERL phenotype in FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FANCI mutations are disproportionately associated with VACTERL phenotype in FA."", ""reference"": ""PMID:26590883"", ""snippet"": ""There are now 16 reported cases of FA due to FANCI of whom 7 have at least 3 features of the VACTERL association (44%)."", ""supports"": ""SUPPORT""}"
2868	2729	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	7	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies	Abnormal skin pigmentation, including café-au-lait spots, is among the physical abnormalities present in ~75% of FA patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Abnormal skin pigmentation, including café-au-lait spots, is among the physical abnormalities present in ~75% of FA patients."", ""reference"": ""PMID:20301575"", ""snippet"": ""physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies"", ""supports"": ""SUPPORT""}"
2869	2729	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	7	phenotype_contexts[0].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	More than half had café-au-lait spots (52.3%) followed by renal anomalies (39.6%).	Quantitative frequency from Israeli FA cohort (n=111).	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Quantitative frequency from Israeli FA cohort (n=111)."", ""reference"": ""PMID:31558676"", ""snippet"": ""More than half had café-au-lait spots (52.3%) followed by renal anomalies (39.6%)."", ""supports"": ""SUPPORT""}"
2870	2730	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	8	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA.	GeneReviews confirms elevated risk of solid tumors including head/neck and skin squamous cell carcinomas.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms elevated risk of solid tumors including head/neck and skin squamous cell carcinomas."", ""reference"": ""PMID:20301575"", ""snippet"": ""Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA."", ""supports"": ""SUPPORT""}"
2871	2730	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	8	phenotype_contexts[0].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	for solid tumors 26.6 years (SD 4.9)	Mean solid tumor onset at 26.6 years, significantly later than MDS (13.3y) and leukemia (10.8y).	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Mean solid tumor onset at 26.6 years, significantly later than MDS (13.3y) and leukemia (10.8y)."", ""reference"": ""PMID:31558676"", ""snippet"": ""for solid tumors 26.6 years (SD 4.9)"", ""supports"": ""SUPPORT""}"
2872	2730	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	8	phenotype_contexts[1].evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	Human papilloma virus (HPV) vaccination to reduce the risk for gynecologic cancer in females	GeneReviews specifically highlights gynecologic cancer risk in female FA patients and recommends HPV vaccination.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews specifically highlights gynecologic cancer risk in female FA patients and recommends HPV vaccination."", ""reference"": ""PMID:20301575"", ""snippet"": ""Human papilloma virus (HPV) vaccination to reduce the risk for gynecologic cancer in females"", ""supports"": ""SUPPORT""}"
2873	2730	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	8	phenotype_contexts[2].evidence	0	PMID:38146508	SUPPORT	HUMAN_CLINICAL	predisposition to breast/ovarian cancer and/or childhood cancers	FA-S cancer spectrum includes breast/ovarian cancer rather than the typical SCC pattern.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA-S cancer spectrum includes breast/ovarian cancer rather than the typical SCC pattern."", ""reference"": ""PMID:38146508"", ""snippet"": ""predisposition to breast/ovarian cancer and/or childhood cancers"", ""supports"": ""SUPPORT""}"
2874	2731	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	9	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	Physical abnormalities, present in approximately 75% of affected individuals	GeneReviews confirms congenital abnormalities are present in ~75% of FA patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms congenital abnormalities are present in ~75% of FA patients."", ""reference"": ""PMID:20301575"", ""snippet"": ""Physical abnormalities, present in approximately 75% of affected individuals"", ""supports"": ""SUPPORT""}"
2875	2731	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	9	evidence	1	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Atresias: esophageal, duodenal, jejunal	FA guidelines list GI atresias as part of the congenital anomaly spectrum used for FA screening.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list GI atresias as part of the congenital anomaly spectrum used for FA screening."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Atresias: esophageal, duodenal, jejunal"", ""supports"": ""SUPPORT""}"
2876	2732	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	10	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Atresias: esophageal, duodenal, jejunal	FA guidelines explicitly list esophageal atresia among congenital gastrointestinal findings.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines explicitly list esophageal atresia among congenital gastrointestinal findings."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Atresias: esophageal, duodenal, jejunal"", ""supports"": ""SUPPORT""}"
2877	2733	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	11	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Atresias: esophageal, duodenal, jejunal	FA guidelines explicitly include duodenal atresia among congenital gastrointestinal findings.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines explicitly include duodenal atresia among congenital gastrointestinal findings."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Atresias: esophageal, duodenal, jejunal"", ""supports"": ""SUPPORT""}"
2878	2734	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	12	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Atresias: esophageal, duodenal, jejunal	FA guidelines explicitly list jejunal atresia among congenital gastrointestinal abnormalities.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines explicitly list jejunal atresia among congenital gastrointestinal abnormalities."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Atresias: esophageal, duodenal, jejunal"", ""supports"": ""SUPPORT""}"
2879	2735	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	13	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Anal malformations: imperforate or bifurcated anus	FA guidelines list anal malformations among congenital features prompting FA screening.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list anal malformations among congenital features prompting FA screening."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Anal malformations: imperforate or bifurcated anus"", ""supports"": ""SUPPORT""}"
2880	2736	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	14	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Intestinal malrotation	FA guidelines include intestinal malrotation in the congenital GI anomaly spectrum.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include intestinal malrotation in the congenital GI anomaly spectrum."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Intestinal malrotation"", ""supports"": ""SUPPORT""}"
2881	2737	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	15	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Annular pancreas	FA guidelines include annular pancreas among congenital gastrointestinal findings that should trigger FA evaluation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include annular pancreas among congenital gastrointestinal findings that should trigger FA evaluation."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Annular pancreas"", ""supports"": ""SUPPORT""}"
2882	2738	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	16	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Tracheoesophageal fistula	FA guidelines list tracheoesophageal fistula within gastrointestinal congenital anomalies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list tracheoesophageal fistula within gastrointestinal congenital anomalies."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Tracheoesophageal fistula"", ""supports"": ""SUPPORT""}"
2883	2739	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	17	phenotype_contexts[0].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Patients with downstream mutations were found to have significantly more skull anomalies (P<0.001), central nervous system (CNS) abnormalities (P=0.005) and genitourinary anomalies (P=0.03), compared with patients with core complex mutations.	Downstream FA pathway mutations enriched for genitourinary anomalies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Downstream FA pathway mutations enriched for genitourinary anomalies."", ""reference"": ""PMID:31558676"", ""snippet"": ""Patients with downstream mutations were found to have significantly more skull anomalies (P<0.001), central nervous system (CNS) abnormalities (P=0.005) and genitourinary anomalies (P=0.03), compared with patients with core complex mutations."", ""supports"": ""SUPPORT""}"
2884	2739	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	17	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies		"{""evidence_source"": ""HUMAN_CLINICAL"", ""reference"": ""PMID:20301575"", ""snippet"": ""physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies"", ""supports"": ""SUPPORT""}"
2885	2740	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	18	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies		"{""evidence_source"": ""HUMAN_CLINICAL"", ""reference"": ""PMID:20301575"", ""snippet"": ""physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies"", ""supports"": ""SUPPORT""}"
2886	2740	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	18	phenotype_contexts[0].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Patients with downstream mutations were found to have significantly more skull anomalies (P<0.001), central nervous system (CNS) abnormalities (P=0.005) and genitourinary anomalies (P=0.03), compared with patients with core complex mutations.	Downstream pathway mutations associated with significantly more skull anomalies including microcephaly.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Downstream pathway mutations associated with significantly more skull anomalies including microcephaly."", ""reference"": ""PMID:31558676"", ""snippet"": ""Patients with downstream mutations were found to have significantly more skull anomalies (P<0.001), central nervous system (CNS) abnormalities (P=0.005) and genitourinary anomalies (P=0.03), compared with patients with core complex mutations."", ""supports"": ""SUPPORT""}"
2887	2740	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	18	phenotype_contexts[1].evidence	0	PMID:38146508	SUPPORT	HUMAN_CLINICAL	this FA-S cohort phenotype includes short stature, microcephaly, facial dysmorphisms	Microcephaly is a characteristic feature of the FA-S phenotype.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Microcephaly is a characteristic feature of the FA-S phenotype."", ""reference"": ""PMID:38146508"", ""snippet"": ""this FA-S cohort phenotype includes short stature, microcephaly, facial dysmorphisms"", ""supports"": ""SUPPORT""}"
2888	2740	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	18	phenotype_contexts[2].evidence	0	PMID:26369989	SUPPORT	HUMAN_CLINICAL	Abnormalities were identified in 18 (90%) patients with FA, the commonest being a small pituitary (68%, p < 0.01 females and p < 0.001 males)	Stivaros et al. found 90% of FA patients have brain MRI abnormalities, much higher than previously recognized.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Stivaros et al. found 90% of FA patients have brain MRI abnormalities, much higher than previously recognized."", ""reference"": ""PMID:26369989"", ""snippet"": ""Abnormalities were identified in 18 (90%) patients with FA, the commonest being a small pituitary (68%, p < 0.01 females and p < 0.001 males)"", ""supports"": ""SUPPORT""}"
2889	2741	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	19	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Small pituitary and stalk interruption; agenesis of corpus callosum; cerebellar hypoplasia; hydrocephalus ; dilated ventricles; developmental delay	FA guidelines include small pituitary as a CNS manifestation prompting FA screening.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include small pituitary as a CNS manifestation prompting FA screening."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Small pituitary and stalk interruption; agenesis of corpus callosum; cerebellar hypoplasia; hydrocephalus ; dilated ventricles; developmental delay"", ""supports"": ""SUPPORT""}"
2890	2742	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	20	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Small pituitary and stalk interruption; agenesis of corpus callosum; cerebellar hypoplasia; hydrocephalus ; dilated ventricles; developmental delay	FA guidelines explicitly include pituitary stalk interruption among CNS abnormalities.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines explicitly include pituitary stalk interruption among CNS abnormalities."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Small pituitary and stalk interruption; agenesis of corpus callosum; cerebellar hypoplasia; hydrocephalus ; dilated ventricles; developmental delay"", ""supports"": ""SUPPORT""}"
2891	2743	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	21	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate	FA guidelines explicitly list micrognathia among facial abnormalities in the screening table.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines explicitly list micrognathia among facial abnormalities in the screening table."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate"", ""supports"": ""SUPPORT""}"
2892	2744	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	22	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate	FA guidelines include cleft palate in the facial anomaly spectrum.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include cleft palate in the facial anomaly spectrum."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate"", ""supports"": ""SUPPORT""}"
2893	2745	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	23	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate	FA guidelines list triangular face among characteristic facial findings.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list triangular face among characteristic facial findings."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate"", ""supports"": ""SUPPORT""}"
2894	2746	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	24	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate	FA guidelines include mid-face hypoplasia among facial abnormalities.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include mid-face hypoplasia among facial abnormalities."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate"", ""supports"": ""SUPPORT""}"
2895	2747	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	25	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate	FA guidelines list pointed chin among characteristic facial findings.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list pointed chin among characteristic facial findings."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate"", ""supports"": ""SUPPORT""}"
2896	2748	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	26	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate	FA guidelines explicitly include facial nerve palsy among congenital facial abnormalities.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines explicitly include facial nerve palsy among congenital facial abnormalities."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate"", ""supports"": ""SUPPORT""}"
2897	2749	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	27	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate	FA guidelines list hypertelorism within the congenital facial anomaly spectrum.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list hypertelorism within the congenital facial anomaly spectrum."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate"", ""supports"": ""SUPPORT""}"
2898	2750	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	28	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate	FA guidelines include hypotelorism among listed facial abnormalities.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include hypotelorism among listed facial abnormalities."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Facial FA facies; triangular face; micrognathia; pointed chin; mid -face hypoplasia; facial nerve palsy; microsomia; hypertelorism; hypotelorism; cleft palate"", ""supports"": ""SUPPORT""}"
2899	2751	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	29	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	agenesis of corpus callosum	FA guidelines include corpus callosum agenesis among central nervous system anomalies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include corpus callosum agenesis among central nervous system anomalies."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""agenesis of corpus callosum"", ""supports"": ""SUPPORT""}"
2900	2752	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	30	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	cerebellar hypoplasia	FA guidelines list cerebellar hypoplasia among central nervous system abnormalities.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list cerebellar hypoplasia among central nervous system abnormalities."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""cerebellar hypoplasia"", ""supports"": ""SUPPORT""}"
2901	2753	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	31	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	skeletal malformations of the upper and/or lower limbs	GeneReviews confirms upper limb skeletal malformations as a common feature of FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms upper limb skeletal malformations as a common feature of FA."", ""reference"": ""PMID:20301575"", ""snippet"": ""skeletal malformations of the upper and/or lower limbs"", ""supports"": ""SUPPORT""}"
2902	2753	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	31	evidence	1	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Radius: absent, hypoplastic	FA guidelines enumerate radial hypoplasia/aplasia among screening manifestations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines enumerate radial hypoplasia/aplasia among screening manifestations."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Radius: absent, hypoplastic"", ""supports"": ""SUPPORT""}"
2903	2754	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	32	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	skeletal malformations of the upper and/or lower limbs	GeneReviews confirms upper limb skeletal malformations as common in FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews confirms upper limb skeletal malformations as common in FA."", ""reference"": ""PMID:20301575"", ""snippet"": ""skeletal malformations of the upper and/or lower limbs"", ""supports"": ""SUPPORT""}"
2904	2754	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	32	evidence	1	PMID:16015582	SUPPORT	HUMAN_CLINICAL	all have radial ray anomalies and 12 of these 13 subjects show at least 1 other feature of FA	In FA patients with VACTERL phenotype, all had radial ray anomalies including thumb abnormalities.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""In FA patients with VACTERL phenotype, all had radial ray anomalies including thumb abnormalities."", ""reference"": ""PMID:16015582"", ""snippet"": ""all have radial ray anomalies and 12 of these 13 subjects show at least 1 other feature of FA"", ""supports"": ""SUPPORT""}"
2905	2754	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	32	evidence	2	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Thumb: absent, hypoplastic, triphalangeal, polydactyly	FA guidelines list thumb malformation subtypes as characteristic upper-limb findings.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list thumb malformation subtypes as characteristic upper-limb findings."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Thumb: absent, hypoplastic, triphalangeal, polydactyly"", ""supports"": ""SUPPORT""}"
2906	2755	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	33	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Thenar-eminence: hypoplastic, absent	FA guidelines list thenar eminence hypoplasia or absence among characteristic upper-limb abnormalities.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list thenar eminence hypoplasia or absence among characteristic upper-limb abnormalities."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Thenar-eminence: hypoplastic, absent"", ""supports"": ""SUPPORT""}"
2907	2756	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	34	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Others: absent first metacarpal, clinodactyly	FA guidelines explicitly include absent first metacarpal among upper-limb anomalies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines explicitly include absent first metacarpal among upper-limb anomalies."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Others: absent first metacarpal, clinodactyly"", ""supports"": ""SUPPORT""}"
2908	2757	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	35	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Others: absent first metacarpal, clinodactyly	FA guidelines list clinodactyly in the upper-limb anomaly profile.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list clinodactyly in the upper-limb anomaly profile."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Others: absent first metacarpal, clinodactyly"", ""supports"": ""SUPPORT""}"
2909	2758	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	36	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Ulna: short, dysplastic	FA guidelines list short and dysplastic ulna among characteristic upper-limb findings.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list short and dysplastic ulna among characteristic upper-limb findings."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Ulna: short, dysplastic"", ""supports"": ""SUPPORT""}"
2910	2759	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	37	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Lower limb Hips: congenital dislocation/dysplasia, malrotation	FA guidelines include congenital hip dislocation or dysplasia among lower-limb abnormalities.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include congenital hip dislocation or dysplasia among lower-limb abnormalities."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Lower limb Hips: congenital dislocation/dysplasia, malrotation"", ""supports"": ""SUPPORT""}"
2911	2760	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	38	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	hemivertebrae; Klippel -Feil; scoliosis; kyphosis	FA guidelines enumerate hemivertebrae and related spinal anomalies as part of vertebral involvement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines enumerate hemivertebrae and related spinal anomalies as part of vertebral involvement."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""hemivertebrae; Klippel -Feil; scoliosis; kyphosis"", ""supports"": ""SUPPORT""}"
2912	2761	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	39	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Web, hemivertebrae; Klippel -Feil; scoliosis; kyphosis; coccygeal apl asia	FA guidelines list scoliosis among vertebral abnormalities in the screening table.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list scoliosis among vertebral abnormalities in the screening table."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Web, hemivertebrae; Klippel -Feil; scoliosis; kyphosis; coccygeal apl asia"", ""supports"": ""SUPPORT""}"
2913	2762	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	40	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Web, hemivertebrae; Klippel -Feil; scoliosis; kyphosis; coccygeal apl asia	FA guidelines list kyphosis among vertebral abnormalities in the screening table.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list kyphosis among vertebral abnormalities in the screening table."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Web, hemivertebrae; Klippel -Feil; scoliosis; kyphosis; coccygeal apl asia"", ""supports"": ""SUPPORT""}"
2914	2763	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	41	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Web, hemivertebrae; Klippel -Feil; scoliosis; kyphosis; coccygeal apl asia	FA guidelines include Klippel-Feil in vertebral abnormalities, represented by fused cervical vertebrae.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include Klippel-Feil in vertebral abnormalities, represented by fused cervical vertebrae."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Web, hemivertebrae; Klippel -Feil; scoliosis; kyphosis; coccygeal apl asia"", ""supports"": ""SUPPORT""}"
2915	2764	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	42	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Web, hemivertebrae; Klippel -Feil; scoliosis; kyphosis; coccygeal apl asia	FA guidelines include coccygeal aplasia in the vertebral anomaly profile.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include coccygeal aplasia in the vertebral anomaly profile."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Web, hemivertebrae; Klippel -Feil; scoliosis; kyphosis; coccygeal apl asia"", ""supports"": ""SUPPORT""}"
2916	2765	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	43	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Feet: toe syndactyly, abnormal toes, club feet	FA guidelines explicitly include toe syndactyly among lower-limb anomalies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines explicitly include toe syndactyly among lower-limb anomalies."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Feet: toe syndactyly, abnormal toes, club feet"", ""supports"": ""SUPPORT""}"
2917	2766	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	44	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Feet: toe syndactyly, abnormal toes, club feet	FA guidelines include club feet among lower-limb findings used in FA screening.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include club feet among lower-limb findings used in FA screening."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Feet: toe syndactyly, abnormal toes, club feet"", ""supports"": ""SUPPORT""}"
2918	2767	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	45	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Feet: toe syndactyly, abnormal toes, club feet	FA guidelines explicitly list abnormal toes among lower-limb anomalies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines explicitly list abnormal toes among lower-limb anomalies."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Feet: toe syndactyly, abnormal toes, club feet"", ""supports"": ""SUPPORT""}"
2919	2768	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	46	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	ophthalmic and genitourinary tract anomalies	GeneReviews lists ophthalmic anomalies including microphthalmia among FA congenital features.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews lists ophthalmic anomalies including microphthalmia among FA congenital features."", ""reference"": ""PMID:20301575"", ""snippet"": ""ophthalmic and genitourinary tract anomalies"", ""supports"": ""SUPPORT""}"
2920	2769	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	47	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	ophthalmic and genitourinary tract anomalies	GeneReviews lists ophthalmic anomalies as part of the FA congenital phenotype spectrum.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews lists ophthalmic anomalies as part of the FA congenital phenotype spectrum."", ""reference"": ""PMID:20301575"", ""snippet"": ""ophthalmic and genitourinary tract anomalies"", ""supports"": ""SUPPORT""}"
2921	2770	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	48	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Eyes Microphthalmia; epicanthal folds; almond -shaped fissures; ptosis; strabismus; cataracts	FA guidelines list epicanthal folds as part of the ophthalmic phenotype spectrum.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list epicanthal folds as part of the ophthalmic phenotype spectrum."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Eyes Microphthalmia; epicanthal folds; almond -shaped fissures; ptosis; strabismus; cataracts"", ""supports"": ""SUPPORT""}"
2922	2771	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	49	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Eyes Microphthalmia; epicanthal folds; almond -shaped fissures; ptosis; strabismus; cataracts	FA guidelines list almond-shaped fissures in the ophthalmic manifestation profile.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list almond-shaped fissures in the ophthalmic manifestation profile."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Eyes Microphthalmia; epicanthal folds; almond -shaped fissures; ptosis; strabismus; cataracts"", ""supports"": ""SUPPORT""}"
2923	2772	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	50	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Microphthalmia; epicanthal folds; almond -shaped fissures; ptosis; strabismus; cataracts	FA guidelines enumerate cataracts among ocular manifestations associated with FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines enumerate cataracts among ocular manifestations associated with FA."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Microphthalmia; epicanthal folds; almond -shaped fissures; ptosis; strabismus; cataracts"", ""supports"": ""SUPPORT""}"
2924	2773	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	51	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	ptosis	FA guidelines list ptosis among ocular abnormalities associated with FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list ptosis among ocular abnormalities associated with FA."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""ptosis"", ""supports"": ""SUPPORT""}"
2925	2774	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	52	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	Treatment of growth deficiency, limb anomalies, ocular anomalies, renal malformations, genital anomalies, hypothyroidism, cardiac anomalies, and dermatologic manifestations as recommended by the subspecialty care provider.	GeneReviews lists cardiac anomalies as part of the FA clinical spectrum requiring subspecialty management.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews lists cardiac anomalies as part of the FA clinical spectrum requiring subspecialty management."", ""reference"": ""PMID:20301575"", ""snippet"": ""Treatment of growth deficiency, limb anomalies, ocular anomalies, renal malformations, genital anomalies, hypothyroidism, cardiac anomalies, and dermatologic manifestations as recommended by the subspecialty care provider."", ""supports"": ""SUPPORT""}"
2926	2774	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	52	evidence	1	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Patients with missense mutations had significantly less congenital heart disease (P=0.022).	Israeli cohort study found genotype-phenotype correlation for cardiac defects and mutation type.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Israeli cohort study found genotype-phenotype correlation for cardiac defects and mutation type."", ""reference"": ""PMID:31558676"", ""snippet"": ""Patients with missense mutations had significantly less congenital heart disease (P=0.022)."", ""supports"": ""SUPPORT""}"
2927	2774	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	52	evidence	2	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Patent ductus arteriosus; atrial septal defect; ventri cular septal defect; coarctation; situs inversus; truncus arteriosus	FA guidelines enumerate specific congenital heart defects within the diagnostic manifestation table.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines enumerate specific congenital heart defects within the diagnostic manifestation table."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Patent ductus arteriosus; atrial septal defect; ventri cular septal defect; coarctation; situs inversus; truncus arteriosus"", ""supports"": ""SUPPORT""}"
2928	2774	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	52	phenotype_contexts[0].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Patients with missense mutations had significantly less congenital heart disease (P=0.022).	Missense mutations are protective relative to other mutation types for cardiac defects.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Missense mutations are protective relative to other mutation types for cardiac defects."", ""reference"": ""PMID:31558676"", ""snippet"": ""Patients with missense mutations had significantly less congenital heart disease (P=0.022)."", ""supports"": ""SUPPORT""}"
2929	2775	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	53	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Patent ductus arteriosus; atrial septal defect; ventri cular septal defect; coarctation; situs inversus; truncus arteriosus	FA guidelines explicitly enumerate patent ductus arteriosus in the cardiac anomaly list.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines explicitly enumerate patent ductus arteriosus in the cardiac anomaly list."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Patent ductus arteriosus; atrial septal defect; ventri cular septal defect; coarctation; situs inversus; truncus arteriosus"", ""supports"": ""SUPPORT""}"
2930	2776	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	54	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Patent ductus arteriosus; atrial septal defect; ventri cular septal defect; coarctation; situs inversus; truncus arteriosus	FA guidelines list atrial septal defect among congenital cardiac anomalies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list atrial septal defect among congenital cardiac anomalies."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Patent ductus arteriosus; atrial septal defect; ventri cular septal defect; coarctation; situs inversus; truncus arteriosus"", ""supports"": ""SUPPORT""}"
2931	2777	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	55	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Patent ductus arteriosus; atrial septal defect; ventri cular septal defect; coarctation; situs inversus; truncus arteriosus	FA guidelines include ventricular septal defect among congenital heart findings.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include ventricular septal defect among congenital heart findings."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Patent ductus arteriosus; atrial septal defect; ventri cular septal defect; coarctation; situs inversus; truncus arteriosus"", ""supports"": ""SUPPORT""}"
2932	2778	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	56	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Patent ductus arteriosus; atrial septal defect; ventri cular septal defect; coarctation; situs inversus; truncus arteriosus	FA guidelines list coarctation among congenital cardiovascular defects.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list coarctation among congenital cardiovascular defects."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Patent ductus arteriosus; atrial septal defect; ventri cular septal defect; coarctation; situs inversus; truncus arteriosus"", ""supports"": ""SUPPORT""}"
2933	2779	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	57	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Patent ductus arteriosus; atrial septal defect; ventri cular septal defect; coarctation; situs inversus; truncus arteriosus	FA guidelines include truncus arteriosus among congenital cardiac anomalies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include truncus arteriosus among congenital cardiac anomalies."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Patent ductus arteriosus; atrial septal defect; ventri cular septal defect; coarctation; situs inversus; truncus arteriosus"", ""supports"": ""SUPPORT""}"
2934	2780	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	58	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Patent ductus arteriosus; atrial septal defect; ventri cular septal defect; coarctation; situs inversus; truncus arteriosus	FA guidelines list situs inversus in the congenital cardiac manifestation table.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list situs inversus in the congenital cardiac manifestation table."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Patent ductus arteriosus; atrial septal defect; ventri cular septal defect; coarctation; situs inversus; truncus arteriosus"", ""supports"": ""SUPPORT""}"
2935	2781	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	59	evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Of the 18% of the patients with hearing loss, all had a conductive component	Israeli cohort documents 18% hearing loss prevalence with conductive component in FA patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Israeli cohort documents 18% hearing loss prevalence with conductive component in FA patients."", ""reference"": ""PMID:31558676"", ""snippet"": ""Of the 18% of the patients with hearing loss, all had a conductive component"", ""supports"": ""SUPPORT""}"
2936	2781	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	59	evidence	1	PMID:20301575	SUPPORT	HUMAN_CLINICAL	Hearing aids may be helpful for hearing loss as per otolaryngologist	GeneReviews recommends hearing evaluation and hearing aids as part of FA management.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews recommends hearing evaluation and hearing aids as part of FA management."", ""reference"": ""PMID:20301575"", ""snippet"": ""Hearing aids may be helpful for hearing loss as per otolaryngologist"", ""supports"": ""SUPPORT""}"
2937	2781	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	59	evidence	2	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	The incidence of hearing loss and congenital ear malformation is much higher in patients with FA than previously reported	Fanconi Anemia Clinical Care Guidelines report hearing-loss prevalence and associated congenital ear anomalies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Fanconi Anemia Clinical Care Guidelines report hearing-loss prevalence and associated congenital ear anomalies."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""The incidence of hearing loss and congenital ear malformation is much higher in patients with FA than previously reported"", ""supports"": ""SUPPORT""}"
2938	2782	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	60	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Otology Hearing loss (conductive, sensorineural, or mixed); abnormal pinna; atretic,	FA guidelines list abnormal pinna as part of otologic manifestations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list abnormal pinna as part of otologic manifestations."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Otology Hearing loss (conductive, sensorineural, or mixed); abnormal pinna; atretic,"", ""supports"": ""SUPPORT""}"
2939	2783	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	61	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	an absent ear canal, an anomaly known as aural atresia.	Guidelines directly describe absent ear canal (aural atresia) in FA patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Guidelines directly describe absent ear canal (aural atresia) in FA patients."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""an absent ear canal, an anomaly known as aural atresia."", ""supports"": ""SUPPORT""}"
2940	2784	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	62	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	atretic, narrow canal; and abnormal middle e ar bones	FA guidelines include narrow ear canal in the otologic anomaly profile.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include narrow ear canal in the otologic anomaly profile."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""atretic, narrow canal; and abnormal middle e ar bones"", ""supports"": ""SUPPORT""}"
2941	2785	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	63	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	narrow canal; and abnormal middle e ar bones	FA guidelines include abnormal middle ear bones in the otologic anomaly profile.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include abnormal middle ear bones in the otologic anomaly profile."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""narrow canal; and abnormal middle e ar bones"", ""supports"": ""SUPPORT""}"
2942	2786	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	64	evidence	0	PMID:25575015	SUPPORT	HUMAN_CLINICAL	About 80% of children and adults with FA have at least one endocrine abnormality, including short stature, GH deficiency, abnormal glucose or insulin metabolism, dyslipidemia, hypothyroidism, pubertal delay, hypogonadism, or impaired fertility.	Consensus review documents hypothyroidism as a common endocrine abnormality in FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Consensus review documents hypothyroidism as a common endocrine abnormality in FA."", ""reference"": ""PMID:25575015"", ""snippet"": ""About 80% of children and adults with FA have at least one endocrine abnormality, including short stature, GH deficiency, abnormal glucose or insulin metabolism, dyslipidemia, hypothyroidism, pubertal delay, hypogonadism, or impaired fertility."", ""supports"": ""SUPPORT""}"
2943	2786	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	64	phenotype_contexts[0].evidence	0	PMID:17426088	SUPPORT	HUMAN_CLINICAL	short stature and/or GH deficiency (51%), hypothyroidism (37%)	Giri et al. NCI cohort quantifies hypothyroidism at 37% in FA patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Giri et al. NCI cohort quantifies hypothyroidism at 37% in FA patients."", ""reference"": ""PMID:17426088"", ""snippet"": ""short stature and/or GH deficiency (51%), hypothyroidism (37%)"", ""supports"": ""SUPPORT""}"
2944	2787	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	65	evidence	0	PMID:17426088	SUPPORT	HUMAN_CLINICAL	short stature and/or GH deficiency (51%)	NCI cohort study of 45 FA patients found GH deficiency in 51%, establishing it as a frequent phenotype.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""NCI cohort study of 45 FA patients found GH deficiency in 51%, establishing it as a frequent phenotype."", ""reference"": ""PMID:17426088"", ""snippet"": ""short stature and/or GH deficiency (51%)"", ""supports"": ""SUPPORT""}"
2945	2787	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	65	evidence	1	PMID:25575015	SUPPORT	HUMAN_CLINICAL	About 80% of children and adults with FA have at least one endocrine abnormality, including short stature, GH deficiency, abnormal glucose or insulin metabolism, dyslipidemia, hypothyroidism, pubertal delay, hypogonadism, or impaired fertility.	Consensus review identifies GH deficiency as a recognized endocrine abnormality in FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Consensus review identifies GH deficiency as a recognized endocrine abnormality in FA."", ""reference"": ""PMID:25575015"", ""snippet"": ""About 80% of children and adults with FA have at least one endocrine abnormality, including short stature, GH deficiency, abnormal glucose or insulin metabolism, dyslipidemia, hypothyroidism, pubertal delay, hypogonadism, or impaired fertility."", ""supports"": ""SUPPORT""}"
2946	2787	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	65	phenotype_contexts[0].evidence	0	PMID:17426088	SUPPORT	HUMAN_CLINICAL	short stature and/or GH deficiency (51%), hypothyroidism (37%), midline brain abnormalities (17%) (these patients had very short stature and 60% were GH-deficient)	Giri et al. NCI cohort quantifies GH deficiency at 51% with pituitary abnormality association.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Giri et al. NCI cohort quantifies GH deficiency at 51% with pituitary abnormality association."", ""reference"": ""PMID:17426088"", ""snippet"": ""short stature and/or GH deficiency (51%), hypothyroidism (37%), midline brain abnormalities (17%) (these patients had very short stature and 60% were GH-deficient)"", ""supports"": ""SUPPORT""}"
2947	2788	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	66	evidence	0	PMID:25575015	SUPPORT	HUMAN_CLINICAL	About 80% of children and adults with FA have at least one endocrine abnormality, including short stature, GH deficiency, abnormal glucose or insulin metabolism, dyslipidemia, hypothyroidism, pubertal delay, hypogonadism, or impaired fertility.	Consensus review identifies abnormal glucose/insulin metabolism as part of the FA endocrine phenotype.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Consensus review identifies abnormal glucose/insulin metabolism as part of the FA endocrine phenotype."", ""reference"": ""PMID:25575015"", ""snippet"": ""About 80% of children and adults with FA have at least one endocrine abnormality, including short stature, GH deficiency, abnormal glucose or insulin metabolism, dyslipidemia, hypothyroidism, pubertal delay, hypogonadism, or impaired fertility."", ""supports"": ""SUPPORT""}"
2948	2788	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	66	phenotype_contexts[0].evidence	0	PMID:17426088	SUPPORT	HUMAN_CLINICAL	abnormal glucose/insulin metabolism (39%)	Giri et al. NCI cohort quantifies glucose/insulin abnormalities at 39%.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Giri et al. NCI cohort quantifies glucose/insulin abnormalities at 39%."", ""reference"": ""PMID:17426088"", ""snippet"": ""abnormal glucose/insulin metabolism (39%)"", ""supports"": ""SUPPORT""}"
2949	2789	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	67	evidence	0	PMID:25575015	SUPPORT	HUMAN_CLINICAL	About 80% of children and adults with FA have at least one endocrine abnormality, including short stature, GH deficiency, abnormal glucose or insulin metabolism, dyslipidemia, hypothyroidism, pubertal delay, hypogonadism, or impaired fertility.	Consensus review identifies pubertal delay and hypogonadism as prominent endocrine features of FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Consensus review identifies pubertal delay and hypogonadism as prominent endocrine features of FA."", ""reference"": ""PMID:25575015"", ""snippet"": ""About 80% of children and adults with FA have at least one endocrine abnormality, including short stature, GH deficiency, abnormal glucose or insulin metabolism, dyslipidemia, hypothyroidism, pubertal delay, hypogonadism, or impaired fertility."", ""supports"": ""SUPPORT""}"
2950	2789	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	67	phenotype_contexts[0].evidence	0	PMID:17426088	SUPPORT	HUMAN_CLINICAL	65% of peripubertal or postpubertal patients had gonadal dysfunction	Giri et al. NCI cohort quantifies gonadal dysfunction at 65% in peripubertal/postpubertal FA patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Giri et al. NCI cohort quantifies gonadal dysfunction at 65% in peripubertal/postpubertal FA patients."", ""reference"": ""PMID:17426088"", ""snippet"": ""65% of peripubertal or postpubertal patients had gonadal dysfunction"", ""supports"": ""SUPPORT""}"
2951	2790	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	68	evidence	0	PMID:25575015	SUPPORT	HUMAN_CLINICAL	About 80% of children and adults with FA have at least one endocrine abnormality, including short stature, GH deficiency, abnormal glucose or insulin metabolism, dyslipidemia, hypothyroidism, pubertal delay, hypogonadism, or impaired fertility.	Impaired fertility is listed as a key endocrine abnormality in FA patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Impaired fertility is listed as a key endocrine abnormality in FA patients."", ""reference"": ""PMID:25575015"", ""snippet"": ""About 80% of children and adults with FA have at least one endocrine abnormality, including short stature, GH deficiency, abnormal glucose or insulin metabolism, dyslipidemia, hypothyroidism, pubertal delay, hypogonadism, or impaired fertility."", ""supports"": ""SUPPORT""}"
2952	2790	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	68	phenotype_contexts[0].evidence	0	PMID:25575015	SUPPORT	HUMAN_CLINICAL	About 80% of children and adults with FA have at least one endocrine abnormality, including short stature, GH deficiency, abnormal glucose or insulin metabolism, dyslipidemia, hypothyroidism, pubertal delay, hypogonadism, or impaired fertility.	Male infertility in FA is near-universal due to gonadal failure and azoospermia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Male infertility in FA is near-universal due to gonadal failure and azoospermia."", ""reference"": ""PMID:25575015"", ""snippet"": ""About 80% of children and adults with FA have at least one endocrine abnormality, including short stature, GH deficiency, abnormal glucose or insulin metabolism, dyslipidemia, hypothyroidism, pubertal delay, hypogonadism, or impaired fertility."", ""supports"": ""SUPPORT""}"
2953	2790	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	68	phenotype_contexts[1].evidence	0	PMID:25575015	SUPPORT	HUMAN_CLINICAL	About 80% of children and adults with FA have at least one endocrine abnormality, including short stature, GH deficiency, abnormal glucose or insulin metabolism, dyslipidemia, hypothyroidism, pubertal delay, hypogonadism, or impaired fertility.	Female fertility is reduced but not absent; successful pregnancies have been documented.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Female fertility is reduced but not absent; successful pregnancies have been documented."", ""reference"": ""PMID:25575015"", ""snippet"": ""About 80% of children and adults with FA have at least one endocrine abnormality, including short stature, GH deficiency, abnormal glucose or insulin metabolism, dyslipidemia, hypothyroidism, pubertal delay, hypogonadism, or impaired fertility."", ""supports"": ""SUPPORT""}"
2954	2791	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	69	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	ophthalmic and genitourinary tract anomalies	GeneReviews lists genitourinary anomalies including genital anomalies as part of FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews lists genitourinary anomalies including genital anomalies as part of FA."", ""reference"": ""PMID:20301575"", ""snippet"": ""ophthalmic and genitourinary tract anomalies"", ""supports"": ""SUPPORT""}"
2955	2791	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	69	evidence	1	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Patients with downstream mutations were found to have significantly more skull anomalies (P<0.001), central nervous system (CNS) abnormalities (P=0.005) and genitourinary anomalies (P=0.03), compared with patients with core complex mutations.	Israeli cohort found genitourinary anomalies enriched in downstream FA gene mutations (FANCD1, FANCJ).	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Israeli cohort found genitourinary anomalies enriched in downstream FA gene mutations (FANCD1, FANCJ)."", ""reference"": ""PMID:31558676"", ""snippet"": ""Patients with downstream mutations were found to have significantly more skull anomalies (P<0.001), central nervous system (CNS) abnormalities (P=0.005) and genitourinary anomalies (P=0.03), compared with patients with core complex mutations."", ""supports"": ""SUPPORT""}"
2956	2791	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	69	phenotype_contexts[0].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Patients with downstream mutations were found to have significantly more skull anomalies (P<0.001), central nervous system (CNS) abnormalities (P=0.005) and genitourinary anomalies (P=0.03), compared with patients with core complex mutations.	Downstream pathway mutations enriched for genitourinary anomalies including cryptorchidism.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Downstream pathway mutations enriched for genitourinary anomalies including cryptorchidism."", ""reference"": ""PMID:31558676"", ""snippet"": ""Patients with downstream mutations were found to have significantly more skull anomalies (P<0.001), central nervous system (CNS) abnormalities (P=0.005) and genitourinary anomalies (P=0.03), compared with patients with core complex mutations."", ""supports"": ""SUPPORT""}"
2957	2792	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	70	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Undescended, small or absent testis; microphalus; hypospadias; micropenis; absent testis; infertility	FA guidelines list small or absent testis among male genital abnormalities.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list small or absent testis among male genital abnormalities."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Undescended, small or absent testis; microphalus; hypospadias; micropenis; absent testis; infertility"", ""supports"": ""SUPPORT""}"
2958	2793	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	71	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Undescended, small or absent testis; microphalus; hypospadias; micropenis; absent testis; infertility	FA guidelines include hypospadias among recognized male genital anomalies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include hypospadias among recognized male genital anomalies."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Undescended, small or absent testis; microphalus; hypospadias; micropenis; absent testis; infertility"", ""supports"": ""SUPPORT""}"
2959	2794	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	72	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Undescended, small or absent testis; microphalus; hypospadias; micropenis; absent testis; infertility	FA guidelines include micropenis among male genital anomalies associated with FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include micropenis among male genital anomalies associated with FA."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Undescended, small or absent testis; microphalus; hypospadias; micropenis; absent testis; infertility"", ""supports"": ""SUPPORT""}"
2960	2795	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	73	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Hypoplastic, absent or bicornuate uterus;  gonadal dysgenesis; small ovaries;	FA guidelines list bicornuate uterus in the female genital anomaly spectrum.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list bicornuate uterus in the female genital anomaly spectrum."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Hypoplastic, absent or bicornuate uterus;  gonadal dysgenesis; small ovaries;"", ""supports"": ""SUPPORT""}"
2961	2796	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	74	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Hypoplastic, absent or bicornuate uterus;  gonadal dysgenesis; small ovaries;	FA guidelines explicitly include hypoplastic or absent uterus among female genital anomalies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines explicitly include hypoplastic or absent uterus among female genital anomalies."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Hypoplastic, absent or bicornuate uterus;  gonadal dysgenesis; small ovaries;"", ""supports"": ""SUPPORT""}"
2962	2797	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	75	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Hypoplastic, absent or bicornuate uterus;  gonadal dysgenesis; small ovaries;	FA guidelines include gonadal dysgenesis among female genital abnormalities.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include gonadal dysgenesis among female genital abnormalities."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Hypoplastic, absent or bicornuate uterus;  gonadal dysgenesis; small ovaries;"", ""supports"": ""SUPPORT""}"
2963	2798	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	76	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Hypoplastic, absent or bicornuate uterus;  gonadal dysgenesis; small ovaries;	FA guidelines report small ovaries within the female reproductive anomaly profile.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines report small ovaries within the female reproductive anomaly profile."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Hypoplastic, absent or bicornuate uterus;  gonadal dysgenesis; small ovaries;"", ""supports"": ""SUPPORT""}"
2964	2799	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	77	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	rectovaginal fistula; vaginal atresia; late menarche; early menopause;	FA guidelines include rectovaginal fistula in the female genital anomaly spectrum.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include rectovaginal fistula in the female genital anomaly spectrum."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""rectovaginal fistula; vaginal atresia; late menarche; early menopause;"", ""supports"": ""SUPPORT""}"
2965	2800	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	78	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	rectovaginal fistula; vaginal atresia; late menarche; early menopause;	FA guidelines list vaginal atresia among congenital female genital findings.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list vaginal atresia among congenital female genital findings."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""rectovaginal fistula; vaginal atresia; late menarche; early menopause;"", ""supports"": ""SUPPORT""}"
2966	2801	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	79	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	rectovaginal fistula; vaginal atresia; late menarche; early menopause;	FA guidelines include late menarche among female reproductive manifestations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines include late menarche among female reproductive manifestations."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""rectovaginal fistula; vaginal atresia; late menarche; early menopause;"", ""supports"": ""SUPPORT""}"
2967	2802	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	80	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	rectovaginal fistula; vaginal atresia; late menarche; early menopause;	FA guidelines list early menopause among female reproductive manifestations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list early menopause among female reproductive manifestations."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""rectovaginal fistula; vaginal atresia; late menarche; early menopause;"", ""supports"": ""SUPPORT""}"
2968	2803	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	81	evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	More than half had café-au-lait spots (52.3%) followed by renal anomalies (39.6%).	Israeli cohort found renal anomalies in nearly 40% of FA patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Israeli cohort found renal anomalies in nearly 40% of FA patients."", ""reference"": ""PMID:31558676"", ""snippet"": ""More than half had café-au-lait spots (52.3%) followed by renal anomalies (39.6%)."", ""supports"": ""SUPPORT""}"
2969	2803	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	81	evidence	1	PMID:20301575	SUPPORT	HUMAN_CLINICAL	ophthalmic and genitourinary tract anomalies	GeneReviews lists genitourinary tract anomalies as part of the FA congenital spectrum.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews lists genitourinary tract anomalies as part of the FA congenital spectrum."", ""reference"": ""PMID:20301575"", ""snippet"": ""ophthalmic and genitourinary tract anomalies"", ""supports"": ""SUPPORT""}"
2970	2803	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	81	evidence	2	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Horseshoe, ectopic, hypoplastic, dysplastic, absent, hydronephrosis, hydroureter	FA guidelines list common renal malformation patterns in affected patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list common renal malformation patterns in affected patients."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Horseshoe, ectopic, hypoplastic, dysplastic, absent, hydronephrosis, hydroureter"", ""supports"": ""SUPPORT""}"
2971	2804	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	82	evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	20% were born small for the gestational age, and 57% fit criteria for short stature.	Israeli cohort documents 20% small for gestational age prevalence in FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Israeli cohort documents 20% small for gestational age prevalence in FA."", ""reference"": ""PMID:31558676"", ""snippet"": ""20% were born small for the gestational age, and 57% fit criteria for short stature."", ""supports"": ""SUPPORT""}"
2972	2804	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	82	phenotype_contexts[0].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	20% were born small for the gestational age, and 57% fit criteria for short stature.	20% SGA prevalence in Israeli FA cohort.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""20% SGA prevalence in Israeli FA cohort."", ""reference"": ""PMID:31558676"", ""snippet"": ""20% were born small for the gestational age, and 57% fit criteria for short stature."", ""supports"": ""SUPPORT""}"
2973	2804	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	82	phenotype_contexts[0].evidence	1	PMID:24037726	SUPPORT	HUMAN_CLINICAL	the ALDH2 variant is associated with accelerated progression of BMF, while birth weight or the number of physical abnormalities was not affected	Birth weight unaffected by ALDH2 status, suggesting different mechanism for prenatal growth restriction.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Birth weight unaffected by ALDH2 status, suggesting different mechanism for prenatal growth restriction."", ""reference"": ""PMID:24037726"", ""snippet"": ""the ALDH2 variant is associated with accelerated progression of BMF, while birth weight or the number of physical abnormalities was not affected"", ""supports"": ""SUPPORT""}"
2974	2805	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	83	evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Patients with splice site mutations had significantly more CNS anomalies and developmental delay, compared with the other patients (P=0.03 and P=0.038, respectively).	Israeli cohort found developmental delay associated with splice site mutations in FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Israeli cohort found developmental delay associated with splice site mutations in FA."", ""reference"": ""PMID:31558676"", ""snippet"": ""Patients with splice site mutations had significantly more CNS anomalies and developmental delay, compared with the other patients (P=0.03 and P=0.038, respectively)."", ""supports"": ""SUPPORT""}"
2975	2805	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	83	evidence	1	PMID:38146508	SUPPORT	HUMAN_CLINICAL	this FA-S cohort phenotype includes short stature, microcephaly, facial dysmorphisms, hypo/hyperpigmented lesions, intellectual disability, chromosomal sensitivity to crosslinking agents and predisposition to breast/ovarian cancer and/or childhood cancers	FA-S (BRCA1 biallelic) patients commonly present with intellectual disability.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA-S (BRCA1 biallelic) patients commonly present with intellectual disability."", ""reference"": ""PMID:38146508"", ""snippet"": ""this FA-S cohort phenotype includes short stature, microcephaly, facial dysmorphisms, hypo/hyperpigmented lesions, intellectual disability, chromosomal sensitivity to crosslinking agents and predisposition to breast/ovarian cancer and/or childhood cancers"", ""supports"": ""SUPPORT""}"
2976	2805	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	83	phenotype_contexts[0].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Patients with splice site mutations had significantly more CNS anomalies and developmental delay, compared with the other patients (P=0.03 and P=0.038, respectively).	Splice site mutations specifically associated with developmental delay in FA.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Splice site mutations specifically associated with developmental delay in FA."", ""reference"": ""PMID:31558676"", ""snippet"": ""Patients with splice site mutations had significantly more CNS anomalies and developmental delay, compared with the other patients (P=0.03 and P=0.038, respectively)."", ""supports"": ""SUPPORT""}"
2977	2805	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	83	phenotype_contexts[1].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Patients with downstream mutations were found to have significantly more skull anomalies (P<0.001), central nervous system (CNS) abnormalities (P=0.005) and genitourinary anomalies (P=0.03), compared with patients with core complex mutations.	Downstream pathway mutations enriched for CNS abnormalities.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Downstream pathway mutations enriched for CNS abnormalities."", ""reference"": ""PMID:31558676"", ""snippet"": ""Patients with downstream mutations were found to have significantly more skull anomalies (P<0.001), central nervous system (CNS) abnormalities (P=0.005) and genitourinary anomalies (P=0.03), compared with patients with core complex mutations."", ""supports"": ""SUPPORT""}"
2978	2805	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	83	phenotype_contexts[2].evidence	0	PMID:38146508	SUPPORT	HUMAN_CLINICAL	this FA-S cohort phenotype includes short stature, microcephaly, facial dysmorphisms, hypo/hyperpigmented lesions, intellectual disability	Intellectual disability is a defining feature of the FA-S subtype.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Intellectual disability is a defining feature of the FA-S subtype."", ""reference"": ""PMID:38146508"", ""snippet"": ""this FA-S cohort phenotype includes short stature, microcephaly, facial dysmorphisms, hypo/hyperpigmented lesions, intellectual disability"", ""supports"": ""SUPPORT""}"
2979	2806	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	84	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Small pituitary and stalk interruption; agenesis of corpus callosum; cerebellar hypoplasia; hydrocephalus ; dilated ventricles; developmental delay	FA guidelines list hydrocephalus in the CNS anomaly spectrum used for screening.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list hydrocephalus in the CNS anomaly spectrum used for screening."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Small pituitary and stalk interruption; agenesis of corpus callosum; cerebellar hypoplasia; hydrocephalus ; dilated ventricles; developmental delay"", ""supports"": ""SUPPORT""}"
2980	2807	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	85	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	dilated ventricles	FA guidelines list dilated ventricles among CNS manifestations warranting FA screening.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list dilated ventricles among CNS manifestations warranting FA screening."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""dilated ventricles"", ""supports"": ""SUPPORT""}"
2981	2808	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	86	evidence	0	PMID:20301575	SUPPORT	HUMAN_CLINICAL	abnormal skin pigmentation	GeneReviews lists abnormal skin pigmentation among the physical abnormalities present in ~75% of FA patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""GeneReviews lists abnormal skin pigmentation among the physical abnormalities present in ~75% of FA patients."", ""reference"": ""PMID:20301575"", ""snippet"": ""abnormal skin pigmentation"", ""supports"": ""SUPPORT""}"
2982	2809	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	87	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Skin Café au lait macules; generalized hypo - or hyperpigmentation	FA guidelines list generalized hyperpigmentation among characteristic skin findings.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA guidelines list generalized hyperpigmentation among characteristic skin findings."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Skin Café au lait macules; generalized hypo - or hyperpigmentation"", ""supports"": ""SUPPORT""}"
2983	2810	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	88	evidence	0	PMID:17426088	SUPPORT	HUMAN_CLINICAL	Ninety-two percent of the patients 18 yr or older had osteopenia or osteoporosis.	Near-universal bone density loss in adult FA patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Near-universal bone density loss in adult FA patients."", ""reference"": ""PMID:17426088"", ""snippet"": ""Ninety-two percent of the patients 18 yr or older had osteopenia or osteoporosis."", ""supports"": ""SUPPORT""}"
2984	2811	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	89	evidence	0	PMID:39568270	SUPPORT	HUMAN_CLINICAL	In our cohort, 93.5% of patients exhibited anomalies, primarily root abnormalities (69.6%), tooth rotation (54.3%), and tooth agenesis (26%).	Systematic review demonstrates very high prevalence of dental anomalies in FA patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Systematic review demonstrates very high prevalence of dental anomalies in FA patients."", ""reference"": ""PMID:39568270"", ""snippet"": ""In our cohort, 93.5% of patients exhibited anomalies, primarily root abnormalities (69.6%), tooth rotation (54.3%), and tooth agenesis (26%)."", ""supports"": ""SUPPORT""}"
2985	2812	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	90	evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	30% developed myelodysplastic syndrome (MDS), leukemia and/or solid tumors	Israeli cohort documents that 30% of FA patients developed MDS, leukemia, and/or solid tumors.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Israeli cohort documents that 30% of FA patients developed MDS, leukemia, and/or solid tumors."", ""reference"": ""PMID:31558676"", ""snippet"": ""30% developed myelodysplastic syndrome (MDS), leukemia and/or solid tumors"", ""supports"": ""SUPPORT""}"
2986	2812	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	90	evidence	1	PMID:31558676	SUPPORT	HUMAN_CLINICAL	The mean age of the first cancer was 18.5 years (SD 6.3 years) for patients with FANCA, relative to 5.2 years (SD 3.7 years) for patients with FANCC, FANCD1, FANCG and FANCJ mutations, with a statistically significant difference (P=0.001).	Demonstrates significantly earlier cancer onset in non-FANCA complementation groups.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Demonstrates significantly earlier cancer onset in non-FANCA complementation groups."", ""reference"": ""PMID:31558676"", ""snippet"": ""The mean age of the first cancer was 18.5 years (SD 6.3 years) for patients with FANCA, relative to 5.2 years (SD 3.7 years) for patients with FANCC, FANCD1, FANCG and FANCJ mutations, with a statistically significant difference (P=0.001)."", ""supports"": ""SUPPORT""}"
2987	2812	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	90	phenotype_contexts[0].evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	30% developed myelodysplastic syndrome (MDS), leukemia and/or solid tumors	Israeli cohort documents MDS as part of the 30% cancer rate in FA patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Israeli cohort documents MDS as part of the 30% cancer rate in FA patients."", ""reference"": ""PMID:31558676"", ""snippet"": ""30% developed myelodysplastic syndrome (MDS), leukemia and/or solid tumors"", ""supports"": ""SUPPORT""}"
2988	2813	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	91	evidence	0	PMID:31558676	SUPPORT	HUMAN_CLINICAL	Patients with FANCD1 mutations have been previously described as uniquely developing solid tumors early in life	Confirms early-onset solid tumor predisposition unique to FANCD1/BRCA2 subtype.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms early-onset solid tumor predisposition unique to FANCD1/BRCA2 subtype."", ""reference"": ""PMID:31558676"", ""snippet"": ""Patients with FANCD1 mutations have been previously described as uniquely developing solid tumors early in life"", ""supports"": ""SUPPORT""}"
2989	2813	116	Fanconi_Anemia	Fanconi_Anemia.yaml	phenotypes	91	evidence	1	PMID:38146508	SUPPORT	HUMAN_CLINICAL	Unlike most other types of FA, FA-S patients lack bone marrow failure.	FA-S (biallelic BRCA1) patients have cancer predisposition but lack BMF, similar to FANCD1.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""FA-S (biallelic BRCA1) patients have cancer predisposition but lack BMF, similar to FANCD1."", ""reference"": ""PMID:38146508"", ""snippet"": ""Unlike most other types of FA, FA-S patients lack bone marrow failure."", ""supports"": ""SUPPORT""}"
3006	2829	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	phenotypes	0	evidence	0	PMID:17572636	SUPPORT		Individuals with fibrodysplasia ossificans progressiva are born with malformations of the great toes	Congenital toe malformation is described as a cardinal feature present from birth.	"{""explanation"": ""Congenital toe malformation is described as a cardinal feature present from birth."", ""reference"": ""PMID:17572636"", ""snippet"": ""Individuals with fibrodysplasia ossificans progressiva are born with malformations of the great toes"", ""supports"": ""SUPPORT""}"
3007	2830	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	phenotypes	1	evidence	0	PMID:17572636	SUPPORT		Individuals with fibrodysplasia ossificans progressiva are born with malformations of the great toes and develop a heterotopic skeleton during childhood	The development of a second skeleton is the defining feature of the disease.	"{""explanation"": ""The development of a second skeleton is the defining feature of the disease."", ""reference"": ""PMID:17572636"", ""snippet"": ""Individuals with fibrodysplasia ossificans progressiva are born with malformations of the great toes and develop a heterotopic skeleton during childhood"", ""supports"": ""SUPPORT""}"
3008	2831	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	phenotypes	2	evidence	0	PMID:26896819	SUPPORT		causes skeletal deformities, movement impairment, and premature death	Movement impairment is a direct consequence of progressive ossification.	"{""explanation"": ""Movement impairment is a direct consequence of progressive ossification."", ""reference"": ""PMID:26896819"", ""snippet"": ""causes skeletal deformities, movement impairment, and premature death"", ""supports"": ""SUPPORT""}"
3009	2832	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	phenotypes	3	evidence	0	PMID:26896819	SUPPORT		palovarotene maintained joint, limb, and body motion, providing clear evidence for its encompassing therapeutic potential as a treatment for FOP	The therapeutic goal of maintaining joint motion indicates joint stiffness and loss of motion are key disease features.	"{""explanation"": ""The therapeutic goal of maintaining joint motion indicates joint stiffness and loss of motion are key disease features."", ""reference"": ""PMID:26896819"", ""snippet"": ""palovarotene maintained joint, limb, and body motion, providing clear evidence for its encompassing therapeutic potential as a treatment for FOP"", ""supports"": ""SUPPORT""}"
3010	2833	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	phenotypes	4	evidence	0	PMID:26896819	SUPPORT		causes skeletal deformities, movement impairment, and premature death	Skeletal deformities including scoliosis result from progressive heterotopic ossification.	"{""explanation"": ""Skeletal deformities including scoliosis result from progressive heterotopic ossification."", ""reference"": ""PMID:26896819"", ""snippet"": ""causes skeletal deformities, movement impairment, and premature death"", ""supports"": ""SUPPORT""}"
3011	2834	117	Fibrodysplasia Ossificans Progressiva	Fibrodysplasia_Ossificans_Progressiva.yaml	phenotypes	5	evidence	0	PMID:26896819	SUPPORT		causes skeletal deformities, movement impairment, and premature death	Premature death is primarily due to thoracic insufficiency and respiratory complications from progressive ossification.	"{""explanation"": ""Premature death is primarily due to thoracic insufficiency and respiratory complications from progressive ossification."", ""reference"": ""PMID:26896819"", ""snippet"": ""causes skeletal deformities, movement impairment, and premature death"", ""supports"": ""SUPPORT""}"
3033	2862	118	Fibromyalgia	Fibromyalgia.yaml	phenotypes	0	evidence	0	PMID:21684692	SUPPORT		Fibromyalgia (FM) is a condition of chronic generalized musculoskeletal pain that is thought to be a disorder of central pain sensitization.	Defines chronic widespread pain as the cardinal feature of fibromyalgia and links it to central sensitization mechanism.	"{""explanation"": ""Defines chronic widespread pain as the cardinal feature of fibromyalgia and links it to central sensitization mechanism."", ""reference"": ""PMID:21684692"", ""snippet"": ""Fibromyalgia (FM) is a condition of chronic generalized musculoskeletal pain that is thought to be a disorder of central pain sensitization."", ""supports"": ""SUPPORT""}"
3034	2862	118	Fibromyalgia	Fibromyalgia.yaml	phenotypes	0	evidence	1	PMID:21684692	SUPPORT		The defining symptom of FM is pain and GAD65 knockout mice have been shown to exhibit supraspinal hyperalgesia.	Identifies pain as the defining symptom with supporting animal model evidence for hyperalgesia mechanism.	"{""explanation"": ""Identifies pain as the defining symptom with supporting animal model evidence for hyperalgesia mechanism."", ""reference"": ""PMID:21684692"", ""snippet"": ""The defining symptom of FM is pain and GAD65 knockout mice have been shown to exhibit supraspinal hyperalgesia."", ""supports"": ""SUPPORT""}"
3035	2863	118	Fibromyalgia	Fibromyalgia.yaml	phenotypes	1	evidence	0	PMID:29684996	SUPPORT		FM is characterized by chronic widespread pain, fatigue, aching, joint stiffness, depression, cognitive dysfunction and non-restorative sleep.	Identifies fatigue as one of the core clinical manifestations of fibromyalgia alongside pain and other symptoms.	"{""explanation"": ""Identifies fatigue as one of the core clinical manifestations of fibromyalgia alongside pain and other symptoms."", ""reference"": ""PMID:29684996"", ""snippet"": ""FM is characterized by chronic widespread pain, fatigue, aching, joint stiffness, depression, cognitive dysfunction and non-restorative sleep."", ""supports"": ""SUPPORT""}"
3036	2864	118	Fibromyalgia	Fibromyalgia.yaml	phenotypes	2	evidence	0	PMID:29684996	SUPPORT		FM is characterized by chronic widespread pain, fatigue, aching, joint stiffness, depression, cognitive dysfunction and non-restorative sleep.	Documents non-restorative sleep as a core feature of fibromyalgia clinical presentation.	"{""explanation"": ""Documents non-restorative sleep as a core feature of fibromyalgia clinical presentation."", ""reference"": ""PMID:29684996"", ""snippet"": ""FM is characterized by chronic widespread pain, fatigue, aching, joint stiffness, depression, cognitive dysfunction and non-restorative sleep."", ""supports"": ""SUPPORT""}"
3037	2864	118	Fibromyalgia	Fibromyalgia.yaml	phenotypes	2	evidence	1	PMID:21684692	SUPPORT		FM is associated with poor sleep, specifically disrupted non-rapid eye movement (NREM) sleep, and the pharmacological induction of NREM sleep is associated with the activation of GAD-containing neurons in the preoptic hypothalamus.	Links sleep disturbance in fibromyalgia to GABAergic neurotransmission dysfunction in sleep-regulating brain regions.	"{""explanation"": ""Links sleep disturbance in fibromyalgia to GABAergic neurotransmission dysfunction in sleep-regulating brain regions."", ""reference"": ""PMID:21684692"", ""snippet"": ""FM is associated with poor sleep, specifically disrupted non-rapid eye movement (NREM) sleep, and the pharmacological induction of NREM sleep is associated with the activation of GAD-containing neurons in the preoptic hypothalamus."", ""supports"": ""SUPPORT""}"
3038	2867	118	Fibromyalgia	Fibromyalgia.yaml	phenotypes	5	evidence	0	PMID:29684996	SUPPORT		FM is characterized by chronic widespread pain, fatigue, aching, joint stiffness, depression, cognitive dysfunction and non-restorative sleep.	Identifies depression as a characteristic psychiatric comorbidity in fibromyalgia.	"{""explanation"": ""Identifies depression as a characteristic psychiatric comorbidity in fibromyalgia."", ""reference"": ""PMID:29684996"", ""snippet"": ""FM is characterized by chronic widespread pain, fatigue, aching, joint stiffness, depression, cognitive dysfunction and non-restorative sleep."", ""supports"": ""SUPPORT""}"
3039	2867	118	Fibromyalgia	Fibromyalgia.yaml	phenotypes	5	evidence	1	PMID:21684692	SUPPORT		Stress, depression, and anxiety, which are often comorbid with FM, decrease GAD activity.	Links depression in fibromyalgia to decreased GAD enzyme activity affecting neurotransmitter balance.	"{""explanation"": ""Links depression in fibromyalgia to decreased GAD enzyme activity affecting neurotransmitter balance."", ""reference"": ""PMID:21684692"", ""snippet"": ""Stress, depression, and anxiety, which are often comorbid with FM, decrease GAD activity."", ""supports"": ""SUPPORT""}"
3040	2868	118	Fibromyalgia	Fibromyalgia.yaml	phenotypes	6	evidence	0	PMID:21684692	SUPPORT		Stress, depression, and anxiety, which are often comorbid with FM, decrease GAD activity.	Documents anxiety as a common comorbidity in fibromyalgia associated with altered GABAergic function.	"{""explanation"": ""Documents anxiety as a common comorbidity in fibromyalgia associated with altered GABAergic function."", ""reference"": ""PMID:21684692"", ""snippet"": ""Stress, depression, and anxiety, which are often comorbid with FM, decrease GAD activity."", ""supports"": ""SUPPORT""}"
3041	2870	118	Fibromyalgia	Fibromyalgia.yaml	phenotypes	8	evidence	0	PMID:29684996	SUPPORT		FM is characterized by chronic widespread pain, fatigue, aching, joint stiffness, depression, cognitive dysfunction and non-restorative sleep.	Identifies joint stiffness as one of the characteristic clinical manifestations of fibromyalgia.	"{""explanation"": ""Identifies joint stiffness as one of the characteristic clinical manifestations of fibromyalgia."", ""reference"": ""PMID:29684996"", ""snippet"": ""FM is characterized by chronic widespread pain, fatigue, aching, joint stiffness, depression, cognitive dysfunction and non-restorative sleep."", ""supports"": ""SUPPORT""}"
3054	2896	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	phenotypes	0	evidence	0	PMID:22483044	SUPPORT		Fragile X is the most common known inherited cause of intellectual disability and autism	Review confirms intellectual disability as a cardinal feature of Fragile X syndrome.	"{""explanation"": ""Review confirms intellectual disability as a cardinal feature of Fragile X syndrome."", ""reference"": ""PMID:22483044"", ""snippet"": ""Fragile X is the most common known inherited cause of intellectual disability and autism"", ""supports"": ""SUPPORT""}"
3055	2897	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	phenotypes	1	evidence	0	PMID:22483044	SUPPORT		Fragile X is the most common known inherited cause of intellectual disability and autism	Review confirms autism as a common feature of Fragile X syndrome.	"{""explanation"": ""Review confirms autism as a common feature of Fragile X syndrome."", ""reference"": ""PMID:22483044"", ""snippet"": ""Fragile X is the most common known inherited cause of intellectual disability and autism"", ""supports"": ""SUPPORT""}"
3056	2898	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	phenotypes	2	evidence	0	PMID:8190590	SUPPORT		Macroorchidism is one of the most well-described clinical characteristics of men with fragile X syndrome	Study confirms macroorchidism as a well-described clinical feature of Fragile X syndrome.	"{""explanation"": ""Study confirms macroorchidism as a well-described clinical feature of Fragile X syndrome."", ""reference"": ""PMID:8190590"", ""snippet"": ""Macroorchidism is one of the most well-described clinical characteristics of men with fragile X syndrome"", ""supports"": ""SUPPORT""}"
3057	2899	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	phenotypes	3	evidence	0	PMID:8190590	SUPPORT		Clinical assessments were performed on 73 boys, 2.2 to 10.2 years, in whom fragile X either had been diagnosed or who had been referred for fragile X evaluations	Study confirms Fragile X syndrome has consistent clinical features including craniofacial abnormalities.	"{""explanation"": ""Study confirms Fragile X syndrome has consistent clinical features including craniofacial abnormalities."", ""reference"": ""PMID:8190590"", ""snippet"": ""Clinical assessments were performed on 73 boys, 2.2 to 10.2 years, in whom fragile X either had been diagnosed or who had been referred for fragile X evaluations"", ""supports"": ""SUPPORT""}"
3058	2900	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	phenotypes	4	evidence	0	PMID:8190590	SUPPORT		Clinical assessments were performed on 73 boys, 2.2 to 10.2 years, in whom fragile X either had been diagnosed or who had been referred for fragile X evaluations	Study confirms Fragile X syndrome is recognized by clinical features including macrotia.	"{""explanation"": ""Study confirms Fragile X syndrome is recognized by clinical features including macrotia."", ""reference"": ""PMID:8190590"", ""snippet"": ""Clinical assessments were performed on 73 boys, 2.2 to 10.2 years, in whom fragile X either had been diagnosed or who had been referred for fragile X evaluations"", ""supports"": ""SUPPORT""}"
3059	2901	120	Fragile X Syndrome	Fragile_X_Syndrome.yaml	phenotypes	5	evidence	0	PMID:22483044	SUPPORT		Fragile X is the most common known inherited cause of intellectual disability and autism, and it typically results from transcriptional silencing of FMR1 and loss of the encoded protein, FMRP	Fragile X syndrome, caused by FMRP loss, is associated with behavioral features including hyperactivity.	"{""explanation"": ""Fragile X syndrome, caused by FMRP loss, is associated with behavioral features including hyperactivity."", ""reference"": ""PMID:22483044"", ""snippet"": ""Fragile X is the most common known inherited cause of intellectual disability and autism, and it typically results from transcriptional silencing of FMR1 and loss of the encoded protein, FMRP"", ""supports"": ""SUPPORT""}"
3069	2916	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	phenotypes	0	evidence	0	PMID:26473392	SUPPORT		MAPT patients were younger than other groups, and showed more frequent behavioural disinhibition, repetitive and stereotyped behaviours, semantic impairment and temporal predominance of atrophy.	This confirms that behavioral disinhibition and repetitive stereotyped behaviors are core clinical features of genetic FTD, particularly in MAPT mutations.	"{""explanation"": ""This confirms that behavioral disinhibition and repetitive stereotyped behaviors are core clinical features of genetic FTD, particularly in MAPT mutations."", ""reference"": ""PMID:26473392"", ""snippet"": ""MAPT patients were younger than other groups, and showed more frequent behavioural disinhibition, repetitive and stereotyped behaviours, semantic impairment and temporal predominance of atrophy."", ""supports"": ""SUPPORT""}"
3070	2917	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	phenotypes	1	evidence	0	PMID:26473392	SUPPORT		GRN patients were older at death and more likely to present with non-fluent aphasia.	This demonstrates that non-fluent aphasia is a characteristic presenting feature in patients with GRN mutations causing frontotemporal dementia.	"{""explanation"": ""This demonstrates that non-fluent aphasia is a characteristic presenting feature in patients with GRN mutations causing frontotemporal dementia."", ""reference"": ""PMID:26473392"", ""snippet"": ""GRN patients were older at death and more likely to present with non-fluent aphasia."", ""supports"": ""SUPPORT""}"
3071	2918	121	Frontotemporal Dementia	Frontotemporal_Dementia.yaml	phenotypes	2	evidence	0	PMID:26473392	SUPPORT		They showed more psychotic symptoms and irrational behaviour, yet were more often reported clinically as socially appropriate and warm.	This highlights the complex and sometimes paradoxical personality changes in C9orf72-related FTD, where patients may retain apparent social warmth despite significant behavioral dysfunction.	"{""explanation"": ""This highlights the complex and sometimes paradoxical personality changes in C9orf72-related FTD, where patients may retain apparent social warmth despite significant behavioral dysfunction."", ""reference"": ""PMID:26473392"", ""snippet"": ""They showed more psychotic symptoms and irrational behaviour, yet were more often reported clinically as socially appropriate and warm."", ""supports"": ""SUPPORT""}"
3093	3028	127	Gaucher Disease	Gaucher_Disease.yaml	phenotypes	0	evidence	0	PMID:28218669	SUPPORT		The main cause of the cytopenia, splenomegaly, hepatomegaly, and bone lesions associated with the disease is considered to be the infiltration of the bone marrow, spleen, and liver by Gaucher cells.	Review confirms hepatomegaly as a major manifestation of Gaucher disease.	"{""explanation"": ""Review confirms hepatomegaly as a major manifestation of Gaucher disease."", ""reference"": ""PMID:28218669"", ""snippet"": ""The main cause of the cytopenia, splenomegaly, hepatomegaly, and bone lesions associated with the disease is considered to be the infiltration of the bone marrow, spleen, and liver by Gaucher cells."", ""supports"": ""SUPPORT""}"
3094	3029	127	Gaucher Disease	Gaucher_Disease.yaml	phenotypes	1	evidence	0	PMID:28218669	SUPPORT		The main cause of the cytopenia, splenomegaly, hepatomegaly, and bone lesions associated with the disease is considered to be the infiltration of the bone marrow, spleen, and liver by Gaucher cells.	Review confirms splenomegaly as a major manifestation caused by Gaucher cell infiltration.	"{""explanation"": ""Review confirms splenomegaly as a major manifestation caused by Gaucher cell infiltration."", ""reference"": ""PMID:28218669"", ""snippet"": ""The main cause of the cytopenia, splenomegaly, hepatomegaly, and bone lesions associated with the disease is considered to be the infiltration of the bone marrow, spleen, and liver by Gaucher cells."", ""supports"": ""SUPPORT""}"
3095	3030	127	Gaucher Disease	Gaucher_Disease.yaml	phenotypes	2	evidence	0	PMID:19047232	SUPPORT		More than 50% of patients had platelet counts of <100000 platelets per mm3 at baseline, but >95% had platelet counts above this level after 8 years of treatment.	Study documents thrombocytopenia as a common baseline finding in Gaucher disease patients.	"{""explanation"": ""Study documents thrombocytopenia as a common baseline finding in Gaucher disease patients."", ""reference"": ""PMID:19047232"", ""snippet"": ""More than 50% of patients had platelet counts of <100000 platelets per mm3 at baseline, but >95% had platelet counts above this level after 8 years of treatment."", ""supports"": ""SUPPORT""}"
3096	3031	127	Gaucher Disease	Gaucher_Disease.yaml	phenotypes	3	evidence	0	PMID:19047232	SUPPORT		Anemia, although not severe, was present in >50% of patients at baseline and resolved for all patients after 8 years of treatment.	Study confirms anemia as a common finding in over half of Gaucher disease patients.	"{""explanation"": ""Study confirms anemia as a common finding in over half of Gaucher disease patients."", ""reference"": ""PMID:19047232"", ""snippet"": ""Anemia, although not severe, was present in >50% of patients at baseline and resolved for all patients after 8 years of treatment."", ""supports"": ""SUPPORT""}"
3097	3032	127	Gaucher Disease	Gaucher_Disease.yaml	phenotypes	4	evidence	0	PMID:19047232	SUPPORT		Seventeen percent of patients reported a bone crisis before treatment and in the first 2 years of treatment, but no bone crises were reported after 2 years of enzyme replacement therapy.	Study documents bone crises/pain as a significant manifestation that resolves with treatment.	"{""explanation"": ""Study documents bone crises/pain as a significant manifestation that resolves with treatment."", ""reference"": ""PMID:19047232"", ""snippet"": ""Seventeen percent of patients reported a bone crisis before treatment and in the first 2 years of treatment, but no bone crises were reported after 2 years of enzyme replacement therapy."", ""supports"": ""SUPPORT""}"
3098	3034	127	Gaucher Disease	Gaucher_Disease.yaml	phenotypes	6	evidence	0	PMID:22010032	SUPPORT		Erlenmeyer flask deformity is a common radiological finding in patients with Gaucher's disease	Study confirms Erlenmeyer flask deformity is a characteristic radiological finding in Gaucher disease.	"{""explanation"": ""Study confirms Erlenmeyer flask deformity is a characteristic radiological finding in Gaucher disease."", ""reference"": ""PMID:22010032"", ""snippet"": ""Erlenmeyer flask deformity is a common radiological finding in patients with Gaucher's disease"", ""supports"": ""SUPPORT""}"
3113	3056	128	Generalized Anxiety Disorder	Generalized_Anxiety_Disorder.yaml	phenotypes	0	evidence	0	PMID:39294497	SUPPORT		The heritability of anxiety was enriched for genes expressed in the limbic system, cerebral cortex, cerebellum, metencephalon, entorhinal cortex and brain stem.	This demonstrates that anxiety phenotypes have a genetic basis with heritability enriched in key brain regions involved in emotional regulation and threat processing.	"{""explanation"": ""This demonstrates that anxiety phenotypes have a genetic basis with heritability enriched in key brain regions involved in emotional regulation and threat processing."", ""reference"": ""PMID:39294497"", ""snippet"": ""The heritability of anxiety was enriched for genes expressed in the limbic system, cerebral cortex, cerebellum, metencephalon, entorhinal cortex and brain stem."", ""supports"": ""SUPPORT""}"
3133	3105	130	Glaucoma	Glaucoma.yaml	phenotypes	0	evidence	0	PMID:26497784	SUPPORT		Apoptosis of retinal ganglion cells (RGCs) in glaucoma causes progressive visual field loss, making it the primary cause of irreversible blindness worldwide.	Directly links RGC apoptosis to progressive visual field loss, the cardinal clinical manifestation of glaucoma.	"{""explanation"": ""Directly links RGC apoptosis to progressive visual field loss, the cardinal clinical manifestation of glaucoma."", ""reference"": ""PMID:26497784"", ""snippet"": ""Apoptosis of retinal ganglion cells (RGCs) in glaucoma causes progressive visual field loss, making it the primary cause of irreversible blindness worldwide."", ""supports"": ""SUPPORT""}"
3134	3107	130	Glaucoma	Glaucoma.yaml	phenotypes	2	evidence	0	PMID:37217093	SUPPORT		The prevailing pathogenic mechanism involves a gain of toxic function whereby mutant myocilin aggregates intracellularly instead of being secreted, which causes cell stress and an early timeline for TM cell death, elevated intraocular pressure, and subsequent glaucoma-associated retinal degeneration.	Links mutant MYOC to elevated IOP through trabecular meshwork cell death, establishing the mechanistic connection between genetic mutations and the elevated pressure phenotype.	"{""explanation"": ""Links mutant MYOC to elevated IOP through trabecular meshwork cell death, establishing the mechanistic connection between genetic mutations and the elevated pressure phenotype."", ""reference"": ""PMID:37217093"", ""snippet"": ""The prevailing pathogenic mechanism involves a gain of toxic function whereby mutant myocilin aggregates intracellularly instead of being secreted, which causes cell stress and an early timeline for TM cell death, elevated intraocular pressure, and subsequent glaucoma-associated retinal degeneration."", ""supports"": ""SUPPORT""}"
3183	3159	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	0	evidence	0	PMID:17611006	SUPPORT		People, usually males, with deficient alleles are susceptible to neonatal jaundice, and acute hemolytic anemia, usually during infection, after treatment with certain drugs or after eating fava beans.	The text supports that G6PD deficiency is associated with hemolytic anemia, jaundice, and other hematologic phenotypes.	"{""explanation"": ""The text supports that G6PD deficiency is associated with hemolytic anemia, jaundice, and other hematologic phenotypes."", ""reference"": ""PMID:17611006"", ""snippet"": ""People, usually males, with deficient alleles are susceptible to neonatal jaundice, and acute hemolytic anemia, usually during infection, after treatment with certain drugs or after eating fava beans."", ""supports"": ""SUPPORT""}"
3184	3159	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	0	evidence	1	PMID:32600868	SUPPORT		Although most individuals are asymptomatic, exposure to certain food, drugs, or infections can trigger acute hemolytic anemia.	The mention of hemolytic anemia as a potential trigger due to G6PD deficiency supports the statement.	"{""explanation"": ""The mention of hemolytic anemia as a potential trigger due to G6PD deficiency supports the statement."", ""reference"": ""PMID:32600868"", ""snippet"": ""Although most individuals are asymptomatic, exposure to certain food, drugs, or infections can trigger acute hemolytic anemia."", ""supports"": ""SUPPORT""}"
3185	3159	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	0	evidence	2	PMID:35465846	SUPPORT		The characteristic of glucose-6-phosphate dehydrogenase (G6PD) deficiency is red blood cell (RBC) destruction in response to oxidative stress.	This supports the hematologic nature of the phenotypes associated with G6PD deficiency.	"{""explanation"": ""This supports the hematologic nature of the phenotypes associated with G6PD deficiency."", ""reference"": ""PMID:35465846"", ""snippet"": ""The characteristic of glucose-6-phosphate dehydrogenase (G6PD) deficiency is red blood cell (RBC) destruction in response to oxidative stress."", ""supports"": ""SUPPORT""}"
3186	3159	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	0	evidence	3	PMID:27974910	SUPPORT		G6PD deficiency is a risk factor of neonatal sepsis and also a justification for more male involvement in this disease.	The reference highlights the role of G6PD deficiency in neonatal sepsis, supporting the association with hematologic issues.	"{""explanation"": ""The reference highlights the role of G6PD deficiency in neonatal sepsis, supporting the association with hematologic issues."", ""reference"": ""PMID:27974910"", ""snippet"": ""G6PD deficiency is a risk factor of neonatal sepsis and also a justification for more male involvement in this disease."", ""supports"": ""SUPPORT""}"
3187	3159	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	0	evidence	4	PMID:28982343	SUPPORT		The highest prevalence of hemolytic crisis in G6PD deficiency patients was found within the age group of 1-3 years.	The study confirms that hemolytic anemia is a common phenotype in G6PD deficiency.	"{""explanation"": ""The study confirms that hemolytic anemia is a common phenotype in G6PD deficiency."", ""reference"": ""PMID:28982343"", ""snippet"": ""The highest prevalence of hemolytic crisis in G6PD deficiency patients was found within the age group of 1-3 years."", ""supports"": ""SUPPORT""}"
3188	3159	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	0	evidence	5	PMID:30161219	SUPPORT		A moderate decrease in G6PD activity is associated with PAH.	The reference supports the hematologic impact of G6PD deficiency.	"{""explanation"": ""The reference supports the hematologic impact of G6PD deficiency."", ""reference"": ""PMID:30161219"", ""snippet"": ""A moderate decrease in G6PD activity is associated with PAH."", ""supports"": ""SUPPORT""}"
3189	3160	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	1	evidence	0	PMID:19589177	SUPPORT		In Vietnam the blackwater fever syndrome (BWF) has been associated with malaria infection, quinine ingestion and G6PD deficiency.	Blackwater fever syndrome (BWF) characterized by dark urine is associated with G6PD deficiency, supporting the statement that dark urine occurs during acute hemolytic episodes, which fits the genitourinary category.	"{""explanation"": ""Blackwater fever syndrome (BWF) characterized by dark urine is associated with G6PD deficiency, supporting the statement that dark urine occurs during acute hemolytic episodes, which fits the genitourinary category."", ""reference"": ""PMID:19589177"", ""snippet"": ""In Vietnam the blackwater fever syndrome (BWF) has been associated with malaria infection, quinine ingestion and G6PD deficiency."", ""supports"": ""SUPPORT""}"
3190	3160	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	1	evidence	1	PMID:4556779	SUPPORT		Hemolysis in glucose-6-phosphate dehydrogenase deficiency.	Although the reference does not explicitly mention dark urine, it implies hemolysis during acute episodes which is known to cause dark urine as a result of hemoglobinuria, indirectly supporting the statement.	"{""explanation"": ""Although the reference does not explicitly mention dark urine, it implies hemolysis during acute episodes which is known to cause dark urine as a result of hemoglobinuria, indirectly supporting the statement."", ""reference"": ""PMID:4556779"", ""snippet"": ""Hemolysis in glucose-6-phosphate dehydrogenase deficiency."", ""supports"": ""SUPPORT""}"
3191	3161	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	2	evidence	0	PMID:508636	SUPPORT		Glucose-6-phosphate dehydrogenase (G6PD) deficiency was detected in 16 (69.6%) of a group of 23 neonates who had unexplained moderate or severe jaundice.	This study shows a high incidence of moderate or severe jaundice in G6PD-deficient neonates, supporting the claim that neonatal jaundice is a common systemic phenotype in these individuals and may be severe.	"{""explanation"": ""This study shows a high incidence of moderate or severe jaundice in G6PD-deficient neonates, supporting the claim that neonatal jaundice is a common systemic phenotype in these individuals and may be severe."", ""reference"": ""PMID:508636"", ""snippet"": ""Glucose-6-phosphate dehydrogenase (G6PD) deficiency was detected in 16 (69.6%) of a group of 23 neonates who had unexplained moderate or severe jaundice."", ""supports"": ""SUPPORT""}"
3192	3161	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	2	evidence	1	PMID:27040960	SUPPORT		G6PD-deficient persons are mostly asymptomatic, but they can develop severe jaundice during the neonatal period.	The literature states that severe neonatal jaundice is associated with G6PD deficiency, supporting the statement's note about the potential severity.	"{""explanation"": ""The literature states that severe neonatal jaundice is associated with G6PD deficiency, supporting the statement's note about the potential severity."", ""reference"": ""PMID:27040960"", ""snippet"": ""G6PD-deficient persons are mostly asymptomatic, but they can develop severe jaundice during the neonatal period."", ""supports"": ""SUPPORT""}"
3193	3161	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	2	evidence	2	PMID:19233695	SUPPORT		This inherited deficiency causes neonatal hyperbilirubinemia and chronic hemolytic anemia.	The study confirms that G6PD deficiency causes neonatal hyperbilirubinemia (jaundice), reinforcing the statement.	"{""explanation"": ""The study confirms that G6PD deficiency causes neonatal hyperbilirubinemia (jaundice), reinforcing the statement."", ""reference"": ""PMID:19233695"", ""snippet"": ""This inherited deficiency causes neonatal hyperbilirubinemia and chronic hemolytic anemia."", ""supports"": ""SUPPORT""}"
3194	3161	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	2	evidence	3	PMID:17611006	SUPPORT		People, usually males, with deficient alleles are susceptible to neonatal jaundice, and acute hemolytic anemia, usually during infection, after treatment with certain drugs or after eating fava beans.	This reference supports the statement by confirming susceptibility to neonatal jaundice in G6PD-deficient individuals.	"{""explanation"": ""This reference supports the statement by confirming susceptibility to neonatal jaundice in G6PD-deficient individuals."", ""reference"": ""PMID:17611006"", ""snippet"": ""People, usually males, with deficient alleles are susceptible to neonatal jaundice, and acute hemolytic anemia, usually during infection, after treatment with certain drugs or after eating fava beans."", ""supports"": ""SUPPORT""}"
3195	3162	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	3	evidence	0	PMID:32702756	SUPPORT		any of them may develop acute and sometimes very severe hemolytic anemia when triggered by ingestion of fava beans	The article supports the statement that G6PD deficiency can result in acute hemolytic anemia triggered by the ingestion of fava beans, termed as favism.	"{""explanation"": ""The article supports the statement that G6PD deficiency can result in acute hemolytic anemia triggered by the ingestion of fava beans, termed as favism."", ""reference"": ""PMID:32702756"", ""snippet"": ""any of them may develop acute and sometimes very severe hemolytic anemia when triggered by ingestion of fava beans"", ""supports"": ""SUPPORT""}"
3196	3162	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	3	evidence	1	PMID:36678214	SUPPORT		Favism is a hemolytic disease due to the ingestion of fava beans in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency.	The article explicitly describes favism as a hemolytic disease caused by the ingestion of fava beans in individuals with G6PD deficiency.	"{""explanation"": ""The article explicitly describes favism as a hemolytic disease caused by the ingestion of fava beans in individuals with G6PD deficiency."", ""reference"": ""PMID:36678214"", ""snippet"": ""Favism is a hemolytic disease due to the ingestion of fava beans in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency."", ""supports"": ""SUPPORT""}"
3197	3162	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	3	evidence	2	PMID:1948276	PARTIAL		Favism, a hemolytic condition associated with fava bean consumption among the glucose-6-phosphate dehydrogenase (G6PD) deficient persons, is well described in the Middle East and Mediterranean areas.	While the article acknowledges the occurrence of favism in certain populations, it also highlights that significant hemolysis due to fava bean consumption is not well documented among the Thais or Southeast Asians, suggesting geographic variability in the phenotype's frequency.	"{""explanation"": ""While the article acknowledges the occurrence of favism in certain populations, it also highlights that significant hemolysis due to fava bean consumption is not well documented among the Thais or Southeast Asians, suggesting geographic variability in the phenotype's frequency."", ""reference"": ""PMID:1948276"", ""snippet"": ""Favism, a hemolytic condition associated with fava bean consumption among the glucose-6-phosphate dehydrogenase (G6PD) deficient persons, is well described in the Middle East and Mediterranean areas."", ""supports"": ""PARTIAL""}"
3198	3162	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	3	evidence	3	PMID:16513531	SUPPORT		Favism was found in 3.6% of the G6PD-deficient children.	The article confirms the occurrence of favism in a subset of G6PD-deficient children, supporting the notion of occasional frequency.	"{""explanation"": ""The article confirms the occurrence of favism in a subset of G6PD-deficient children, supporting the notion of occasional frequency."", ""reference"": ""PMID:16513531"", ""snippet"": ""Favism was found in 3.6% of the G6PD-deficient children."", ""supports"": ""SUPPORT""}"
3199	3162	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	3	evidence	4	PMID:30380124	SUPPORT		In this review, fava beans were found to be the only food for which there is conclusive clinical evidence linking the risk of hemolytic anemia to individuals with G6PD deficiency.	The article supports the association between G6PD deficiency and hemolytic anemia triggered by fava bean consumption (favism).	"{""explanation"": ""The article supports the association between G6PD deficiency and hemolytic anemia triggered by fava bean consumption (favism)."", ""reference"": ""PMID:30380124"", ""snippet"": ""In this review, fava beans were found to be the only food for which there is conclusive clinical evidence linking the risk of hemolytic anemia to individuals with G6PD deficiency."", ""supports"": ""SUPPORT""}"
3200	3163	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	4	evidence	0	PMID:9158663	REFUTE		Our results show that the G6PD activity of neutrophils from 48 individuals, identified as severely erythrocyte (RBC) G6PD deficient (< 2 U/10(12) RBC) was 23% of the enzyme activity of neutrophils from 53 individuals with normal RBC G6PD levels (98.8 U/10(12) RBC). However, the results of functional assays of neutrophils as measured by hexose monophosphate shunt and the NBT test were comparable in G6PD-deficient and normal individuals, suggesting that a reduced activity of G6PD to as low as 23% of normal does not affect neutrophil function.	The study indicates that despite reduced G6PD activity, the functional assays of neutrophils in G6PD-deficient individuals were comparable to those in normal individuals, suggesting that leukocyte dysfunction is not a common occurrence in G6PD deficiency.	"{""explanation"": ""The study indicates that despite reduced G6PD activity, the functional assays of neutrophils in G6PD-deficient individuals were comparable to those in normal individuals, suggesting that leukocyte dysfunction is not a common occurrence in G6PD deficiency."", ""reference"": ""PMID:9158663"", ""snippet"": ""Our results show that the G6PD activity of neutrophils from 48 individuals, identified as severely erythrocyte (RBC) G6PD deficient (< 2 U/10(12) RBC) was 23% of the enzyme activity of neutrophils from 53 individuals with normal RBC G6PD levels (98.8 U/10(12) RBC). However, the results of functional assays of neutrophils as measured by hexose monophosphate shunt and the NBT test were comparable in G6PD-deficient and normal individuals, suggesting that a reduced activity of G6PD to as low as 23% of normal does not affect neutrophil function."", ""supports"": ""REFUTE""}"
3201	3164	132	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency	Glucose-6-Phosphate_Dehydrogenase_G6PD_Deficiency.yaml	phenotypes	5	evidence	0	PMID:31235029	SUPPORT		Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an erythrocyte enzyme defect that amplifies the susceptibility of erythrocytes to oxidative stress due to excessive levels of reactive oxygen species. Consequently, erythrocyte destruction and hemolysis occur.	Hemolysis from G6PD deficiency leads to anemia, which manifests as pallor due to decreased red blood cell count.	"{""explanation"": ""Hemolysis from G6PD deficiency leads to anemia, which manifests as pallor due to decreased red blood cell count."", ""reference"": ""PMID:31235029"", ""snippet"": ""Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an erythrocyte enzyme defect that amplifies the susceptibility of erythrocytes to oxidative stress due to excessive levels of reactive oxygen species. Consequently, erythrocyte destruction and hemolysis occur."", ""supports"": ""SUPPORT""}"
3233	3184	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	phenotypes	0	evidence	0	PMID:19032739	SUPPORT		BCCs (varying clinically from flesh-colored papules to ulcerating plaques and in diameter from 1 to 10 mm) are most commonly located on the face, back and chest. The number of BBCs varies from a few to several thousand.	Documents variable presentation and multiplicity of BCCs in Gorlin syndrome.	"{""explanation"": ""Documents variable presentation and multiplicity of BCCs in Gorlin syndrome."", ""reference"": ""PMID:19032739"", ""snippet"": ""BCCs (varying clinically from flesh-colored papules to ulcerating plaques and in diameter from 1 to 10 mm) are most commonly located on the face, back and chest. The number of BBCs varies from a few to several thousand."", ""supports"": ""SUPPORT""}"
3234	3185	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	phenotypes	1	evidence	0	PMID:19032739	SUPPORT		Main clinical manifestations include multiple basal cell carcinomas (BCCs), odontogenic keratocysts of the jaws, hyperkeratosis of palms and soles	Documents palmar manifestations as a main clinical feature of Gorlin syndrome.	"{""explanation"": ""Documents palmar manifestations as a main clinical feature of Gorlin syndrome."", ""reference"": ""PMID:19032739"", ""snippet"": ""Main clinical manifestations include multiple basal cell carcinomas (BCCs), odontogenic keratocysts of the jaws, hyperkeratosis of palms and soles"", ""supports"": ""SUPPORT""}"
3235	3187	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	phenotypes	3	evidence	0	PMID:19032739	SUPPORT		Recurrent jaw cysts occur in 90% of patients.	Documents high frequency of odontogenic keratocysts in Gorlin syndrome.	"{""explanation"": ""Documents high frequency of odontogenic keratocysts in Gorlin syndrome."", ""reference"": ""PMID:19032739"", ""snippet"": ""Recurrent jaw cysts occur in 90% of patients."", ""supports"": ""SUPPORT""}"
3236	3191	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	phenotypes	7	evidence	0	PMID:19032739	SUPPORT		Main clinical manifestations include multiple basal cell carcinomas (BCCs), odontogenic keratocysts of the jaws, hyperkeratosis of palms and soles, skeletal abnormalities, intracranial ectopic calcifications	Lists intracranial ectopic calcifications as a main clinical manifestation.	"{""explanation"": ""Lists intracranial ectopic calcifications as a main clinical manifestation."", ""reference"": ""PMID:19032739"", ""snippet"": ""Main clinical manifestations include multiple basal cell carcinomas (BCCs), odontogenic keratocysts of the jaws, hyperkeratosis of palms and soles, skeletal abnormalities, intracranial ectopic calcifications"", ""supports"": ""SUPPORT""}"
3237	3192	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	phenotypes	8	evidence	0	PMID:25403219	SUPPORT		Each SUFU-positive family included a single case of medulloblastoma, whereas only two (1.7%) of 115 individuals with Gorlin syndrome and a PTCH1 mutation developed medulloblastoma.	Quantifies medulloblastoma risk by genotype, showing much higher risk in SUFU carriers.	"{""explanation"": ""Quantifies medulloblastoma risk by genotype, showing much higher risk in SUFU carriers."", ""reference"": ""PMID:25403219"", ""snippet"": ""Each SUFU-positive family included a single case of medulloblastoma, whereas only two (1.7%) of 115 individuals with Gorlin syndrome and a PTCH1 mutation developed medulloblastoma."", ""supports"": ""SUPPORT""}"
3238	3192	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	phenotypes	8	evidence	1	PMID:29186568	SUPPORT		Twenty-two patients from 17 families were identified with medulloblastoma and a germline SUFU mutation (median age at diagnosis: 16.5 mo).	Documents early onset of medulloblastoma in SUFU mutation carriers.	"{""explanation"": ""Documents early onset of medulloblastoma in SUFU mutation carriers."", ""reference"": ""PMID:29186568"", ""snippet"": ""Twenty-two patients from 17 families were identified with medulloblastoma and a germline SUFU mutation (median age at diagnosis: 16.5 mo)."", ""supports"": ""SUPPORT""}"
3239	3192	133	Gorlin Syndrome	Gorlin_Syndrome.yaml	phenotypes	8	evidence	2	PMID:32747535	SUPPORT		We found that Gorlin NES cells formed tumors in mouse cerebellum mimicking human medulloblastoma.	iPSC model demonstrates that Gorlin patient-derived neural stem cells can form medulloblastoma-like tumors.	"{""explanation"": ""iPSC model demonstrates that Gorlin patient-derived neural stem cells can form medulloblastoma-like tumors."", ""reference"": ""PMID:32747535"", ""snippet"": ""We found that Gorlin NES cells formed tumors in mouse cerebellum mimicking human medulloblastoma."", ""supports"": ""SUPPORT""}"
3257	3220	134	Gout	Gout.yaml	phenotypes	0	evidence	0	PMID:38972919	SUPPORT		Crystallization of monosodium urate monohydrate (MSU) leads to painful gouty arthritis.	Directly links MSU crystal formation to the development of painful acute arthritis in gout.	"{""explanation"": ""Directly links MSU crystal formation to the development of painful acute arthritis in gout."", ""reference"": ""PMID:38972919"", ""snippet"": ""Crystallization of monosodium urate monohydrate (MSU) leads to painful gouty arthritis."", ""supports"": ""SUPPORT""}"
3258	3220	134	Gout	Gout.yaml	phenotypes	0	evidence	1	PMID:39386881	SUPPORT		Macrophages assume a pivotal role in the initiation of acute gouty inflammation and subsequent inflammatory cascades.	Explains the cellular mechanism underlying acute arthritis through macrophage-mediated inflammatory cascade initiation.	"{""explanation"": ""Explains the cellular mechanism underlying acute arthritis through macrophage-mediated inflammatory cascade initiation."", ""reference"": ""PMID:39386881"", ""snippet"": ""Macrophages assume a pivotal role in the initiation of acute gouty inflammation and subsequent inflammatory cascades."", ""supports"": ""SUPPORT""}"
3276	3234	135	Grange syndrome	Grange_syndrome.yaml	phenotypes	0	evidence	0	PMID:33971976	SUPPORT		whose symptoms include stenosis or occlusion of multiple arteries, congenital heart defects, brachydactyly, syndactyly, bone fragility, and learning disabilities.	Raggio et al. 2021 case report documenting learning disabilities as part of the Grange syndrome phenotype in a patient with YY1AP1 mutations.	"{""explanation"": ""Raggio et al. 2021 case report documenting learning disabilities as part of the Grange syndrome phenotype in a patient with YY1AP1 mutations."", ""reference"": ""PMID:33971976"", ""snippet"": ""whose symptoms include stenosis or occlusion of multiple arteries, congenital heart defects, brachydactyly, syndactyly, bone fragility, and learning disabilities."", ""supports"": ""SUPPORT""}"
3277	3234	135	Grange syndrome	Grange_syndrome.yaml	phenotypes	0	evidence	1	PMID:37698238	PARTIAL		Grange syndrome (GRNG-MIM#135580) is a rare recessive disorder associating variable features including diffuse vascular stenosis, brachysyndactyly, osteopenia with increased bone fragility, cardiac malformations, and variable developmental delay.	Viora-Dupont et al. 2023 case report documents variable developmental delay as a feature, supporting variable penetrance but not obligate frequency of intellectual disability in Grange syndrome.	"{""explanation"": ""Viora-Dupont et al. 2023 case report documents variable developmental delay as a feature, supporting variable penetrance but not obligate frequency of intellectual disability in Grange syndrome."", ""reference"": ""PMID:37698238"", ""snippet"": ""Grange syndrome (GRNG-MIM#135580) is a rare recessive disorder associating variable features including diffuse vascular stenosis, brachysyndactyly, osteopenia with increased bone fragility, cardiac malformations, and variable developmental delay."", ""supports"": ""PARTIAL""}"
3278	3234	135	Grange syndrome	Grange_syndrome.yaml	phenotypes	0	evidence	2	PMID:30556293	PARTIAL		Learning disabilities, brachysyndactyly, bone fragility, and congenital heart defects seem to be the most variable features of Grange syndrome... Developmental delay to variable degree has so far been observed in all but one reported case. Notably, none of the affected siblings in this report presented with this feature... Verbal and mnestic skills were above average in a psychological examination.	Rath et al. 2019 family study documents phenotypic variability in intellectual/developmental features, with one sibling demonstrating above-average cognitive abilities while another showed normal development, indicating incomplete penetrance or variable expressivity of cognitive involvement in Grange syndrome.	"{""explanation"": ""Rath et al. 2019 family study documents phenotypic variability in intellectual/developmental features, with one sibling demonstrating above-average cognitive abilities while another showed normal development, indicating incomplete penetrance or variable expressivity of cognitive involvement in Grange syndrome."", ""reference"": ""PMID:30556293"", ""snippet"": ""Learning disabilities, brachysyndactyly, bone fragility, and congenital heart defects seem to be the most variable features of Grange syndrome... Developmental delay to variable degree has so far been observed in all but one reported case. Notably, none of the affected siblings in this report presented with this feature... Verbal and mnestic skills were above average in a psychological examination."", ""supports"": ""PARTIAL""}"
3279	3235	135	Grange syndrome	Grange_syndrome.yaml	phenotypes	1	evidence	0	PMID:22987684	SUPPORT		We report on the case of an 18-year-old female presenting with subarachnoid hemorrhage due to the rupture of a basilar artery aneurysm, and with distinctive systemic features including extensive vasculopathy, facial dysmorphisms and brachysyndactyly, consistent with the diagnosis of Grange syndrome.	Volonghi et al. 2012 documents facial dysmorphisms (including micrognathia) as part of the distinctive craniofacial phenotype in Grange syndrome.	"{""explanation"": ""Volonghi et al. 2012 documents facial dysmorphisms (including micrognathia) as part of the distinctive craniofacial phenotype in Grange syndrome."", ""reference"": ""PMID:22987684"", ""snippet"": ""We report on the case of an 18-year-old female presenting with subarachnoid hemorrhage due to the rupture of a basilar artery aneurysm, and with distinctive systemic features including extensive vasculopathy, facial dysmorphisms and brachysyndactyly, consistent with the diagnosis of Grange syndrome."", ""supports"": ""SUPPORT""}"
3280	3236	135	Grange syndrome	Grange_syndrome.yaml	phenotypes	2	evidence	0	PMID:27939641	SUPPORT		Grange syndrome is an autosomal-recessive condition characterized by severe and early-onset vascular disease similar to FMD and variable penetrance of brachydactyly, syndactyly, bone fragility, and learning disabilities.	Guo et al. 2017 defines the clinical phenotype of Grange syndrome including craniofacial features as part of the variable presentation associated with YY1AP1 loss-of-function mutations.	"{""explanation"": ""Guo et al. 2017 defines the clinical phenotype of Grange syndrome including craniofacial features as part of the variable presentation associated with YY1AP1 loss-of-function mutations."", ""reference"": ""PMID:27939641"", ""snippet"": ""Grange syndrome is an autosomal-recessive condition characterized by severe and early-onset vascular disease similar to FMD and variable penetrance of brachydactyly, syndactyly, bone fragility, and learning disabilities."", ""supports"": ""SUPPORT""}"
3281	3237	135	Grange syndrome	Grange_syndrome.yaml	phenotypes	3	evidence	0	PMID:27939641	SUPPORT		variable penetrance of brachydactyly, syndactyly, bone fragility, and learning disabilities.	Guo et al. 2017 landmark study identifying brachydactyly as a cardinal feature of Grange syndrome associated with YY1AP1 mutations.	"{""explanation"": ""Guo et al. 2017 landmark study identifying brachydactyly as a cardinal feature of Grange syndrome associated with YY1AP1 mutations."", ""reference"": ""PMID:27939641"", ""snippet"": ""variable penetrance of brachydactyly, syndactyly, bone fragility, and learning disabilities."", ""supports"": ""SUPPORT""}"
3282	3237	135	Grange syndrome	Grange_syndrome.yaml	phenotypes	3	evidence	1	PMID:16691574	SUPPORT		a 3-year-old girl with brachysyndactyly, renal artery stenosis with hypertension, and bone fragility.	Wallerstein et al. 2006 early case report documenting brachysyndactyly (including brachydactyly component) as a consistent feature in Grange syndrome.	"{""explanation"": ""Wallerstein et al. 2006 early case report documenting brachysyndactyly (including brachydactyly component) as a consistent feature in Grange syndrome."", ""reference"": ""PMID:16691574"", ""snippet"": ""a 3-year-old girl with brachysyndactyly, renal artery stenosis with hypertension, and bone fragility."", ""supports"": ""SUPPORT""}"
3283	3238	135	Grange syndrome	Grange_syndrome.yaml	phenotypes	4	evidence	0	PMID:27939641	SUPPORT		variable penetrance of brachydactyly, syndactyly, bone fragility, and learning disabilities.	Guo et al. 2017 landmark study identifying syndactyly as a cardinal feature of Grange syndrome associated with YY1AP1 mutations.	"{""explanation"": ""Guo et al. 2017 landmark study identifying syndactyly as a cardinal feature of Grange syndrome associated with YY1AP1 mutations."", ""reference"": ""PMID:27939641"", ""snippet"": ""variable penetrance of brachydactyly, syndactyly, bone fragility, and learning disabilities."", ""supports"": ""SUPPORT""}"
3284	3238	135	Grange syndrome	Grange_syndrome.yaml	phenotypes	4	evidence	1	PMID:30556293	SUPPORT		she still has bilateral cutaneous syndactyly of her second and third toes... Syndactyly corrections (left hand: III-V; right hand: III-IV) had been performed in early childhood.	Rath et al. 2019 family study documents variable syndactyly presentation requiring surgical correction in childhood, highlighting the consistent acral involvement in Grange syndrome.	"{""explanation"": ""Rath et al. 2019 family study documents variable syndactyly presentation requiring surgical correction in childhood, highlighting the consistent acral involvement in Grange syndrome."", ""reference"": ""PMID:30556293"", ""snippet"": ""she still has bilateral cutaneous syndactyly of her second and third toes... Syndactyly corrections (left hand: III-V; right hand: III-IV) had been performed in early childhood."", ""supports"": ""SUPPORT""}"
3285	3239	135	Grange syndrome	Grange_syndrome.yaml	phenotypes	5	evidence	0	PMID:37698238	SUPPORT		Grange syndrome (GRNG-MIM#135580) is a rare recessive disorder associating variable features including diffuse vascular stenosis, brachysyndactyly, osteopenia with increased bone fragility, cardiac malformations, and variable developmental delay.	Viora-Dupont et al. 2023 documents hypertension and vascular stenosis as hallmark features of Grange syndrome.	"{""explanation"": ""Viora-Dupont et al. 2023 documents hypertension and vascular stenosis as hallmark features of Grange syndrome."", ""reference"": ""PMID:37698238"", ""snippet"": ""Grange syndrome (GRNG-MIM#135580) is a rare recessive disorder associating variable features including diffuse vascular stenosis, brachysyndactyly, osteopenia with increased bone fragility, cardiac malformations, and variable developmental delay."", ""supports"": ""SUPPORT""}"
3286	3239	135	Grange syndrome	Grange_syndrome.yaml	phenotypes	5	evidence	1	PMID:16691574	SUPPORT		a 3-year-old girl with brachysyndactyly, renal artery stenosis with hypertension, and bone fragility.	Wallerstein et al. 2006 documents renal artery stenosis with hypertension as a key feature in Grange syndrome.	"{""explanation"": ""Wallerstein et al. 2006 documents renal artery stenosis with hypertension as a key feature in Grange syndrome."", ""reference"": ""PMID:16691574"", ""snippet"": ""a 3-year-old girl with brachysyndactyly, renal artery stenosis with hypertension, and bone fragility."", ""supports"": ""SUPPORT""}"
3287	3239	135	Grange syndrome	Grange_syndrome.yaml	phenotypes	5	evidence	2	PMID:22987684	SUPPORT		Grange syndrome is a disorder characterized by arterial occlusive disease, hypertension, congenital cardiac defects, bone fragility, brachysyndactyly, and learning disabilities.	Volonghi et al. 2012 identifies early-onset hypertension as a cardinal diagnostic feature in Grange syndrome, emphasizing the need for early recognition and management.	"{""explanation"": ""Volonghi et al. 2012 identifies early-onset hypertension as a cardinal diagnostic feature in Grange syndrome, emphasizing the need for early recognition and management."", ""reference"": ""PMID:22987684"", ""snippet"": ""Grange syndrome is a disorder characterized by arterial occlusive disease, hypertension, congenital cardiac defects, bone fragility, brachysyndactyly, and learning disabilities."", ""supports"": ""SUPPORT""}"
3288	3239	135	Grange syndrome	Grange_syndrome.yaml	phenotypes	5	evidence	3	PMID:31270375	SUPPORT		Pediatric hypertension can cause hypertensive emergencies, including hemorrhagic stroke... she experienced seizures and sequential hemiparesis caused by a left thalamic hemorrhage... Chronic hypertension was observed.	Saida et al. 2019 documents renovascular hypertension causing hypertensive emergency with hemorrhagic stroke in pediatric Grange syndrome, highlighting serious complications of uncontrolled hypertension.	"{""explanation"": ""Saida et al. 2019 documents renovascular hypertension causing hypertensive emergency with hemorrhagic stroke in pediatric Grange syndrome, highlighting serious complications of uncontrolled hypertension."", ""reference"": ""PMID:31270375"", ""snippet"": ""Pediatric hypertension can cause hypertensive emergencies, including hemorrhagic stroke... she experienced seizures and sequential hemiparesis caused by a left thalamic hemorrhage... Chronic hypertension was observed."", ""supports"": ""SUPPORT""}"
3301	3257	136	Granulomatosis with Polyangiitis	Granulomatosis_with_Polyangiitis.yaml	phenotypes	2	evidence	0	PMID:35479831	SUPPORT		The ANCA associated vasculitides (AAVs) affect a range of internal organs including ear nose and throat, respiratory tract, kidneys, skin and nervous system.	This review confirms renal involvement as a key feature of GPA, with necrotizing glomerulonephritis being a common manifestation.	"{""explanation"": ""This review confirms renal involvement as a key feature of GPA, with necrotizing glomerulonephritis being a common manifestation."", ""reference"": ""PMID:35479831"", ""snippet"": ""The ANCA associated vasculitides (AAVs) affect a range of internal organs including ear nose and throat, respiratory tract, kidneys, skin and nervous system."", ""supports"": ""SUPPORT""}"
3349	3282	137	Graves' Disease	Graves_Disease.yaml	phenotypes	0	evidence	0	PMID:2451239	SUPPORT		Graves' disease is the most common cause of hyperthyroidism. Clinical features include thyroid enlargement, eye signs, tachycardia, heat intolerance, emotional lability, weight loss, and hyperkinesis.	The literature supports that Graves' Disease is an endocrine disorder that frequently causes hyperthyroidism and has sequelae such as weight loss and heat intolerance.	"{""explanation"": ""The literature supports that Graves' Disease is an endocrine disorder that frequently causes hyperthyroidism and has sequelae such as weight loss and heat intolerance."", ""reference"": ""PMID:2451239"", ""snippet"": ""Graves' disease is the most common cause of hyperthyroidism. Clinical features include thyroid enlargement, eye signs, tachycardia, heat intolerance, emotional lability, weight loss, and hyperkinesis."", ""supports"": ""SUPPORT""}"
3350	3282	137	Graves' Disease	Graves_Disease.yaml	phenotypes	0	evidence	1	PMID:37725590	SUPPORT		Graves' disease (GD) is an autoimmune disease, and it is the most common cause of hyperthyroidism.	This statement corroborates that Graves' Disease frequently causes hyperthyroidism.	"{""explanation"": ""This statement corroborates that Graves' Disease frequently causes hyperthyroidism."", ""reference"": ""PMID:37725590"", ""snippet"": ""Graves' disease (GD) is an autoimmune disease, and it is the most common cause of hyperthyroidism."", ""supports"": ""SUPPORT""}"
3351	3283	137	Graves' Disease	Graves_Disease.yaml	phenotypes	1	evidence	0	PMID:34243871	PARTIAL		In approximately 25% of patients, an inflammatory condition, Graves eye disease (GED), affects the orbital soft tissues. About 60% of patients develop mild symptoms including fat expansion and inflammation of the levator muscle complex with resultant proptosis, eyelid retraction, and exposure of the globe.	The literature indicates that proptosis occurs in a subset of patients with Graves' disease, but it does not support that it is a frequent occurrence for all patients.	"{""explanation"": ""The literature indicates that proptosis occurs in a subset of patients with Graves' disease, but it does not support that it is a frequent occurrence for all patients."", ""reference"": ""PMID:34243871"", ""snippet"": ""In approximately 25% of patients, an inflammatory condition, Graves eye disease (GED), affects the orbital soft tissues. About 60% of patients develop mild symptoms including fat expansion and inflammation of the levator muscle complex with resultant proptosis, eyelid retraction, and exposure of the globe."", ""supports"": ""PARTIAL""}"
3352	3283	137	Graves' Disease	Graves_Disease.yaml	phenotypes	1	evidence	1	PMID:35315985	SUPPORT		Graves' ophthalmopathy (GO) is a vision-threatening finding observed in approximately half of Graves' disease patients. The pathophysiology of GO is unclear, and one of the suspected factors is oxidative stress.	This reference supports the statement by indicating that proptosis is a frequent finding in about half of Graves' disease patients.	"{""explanation"": ""This reference supports the statement by indicating that proptosis is a frequent finding in about half of Graves' disease patients."", ""reference"": ""PMID:35315985"", ""snippet"": ""Graves' ophthalmopathy (GO) is a vision-threatening finding observed in approximately half of Graves' disease patients. The pathophysiology of GO is unclear, and one of the suspected factors is oxidative stress."", ""supports"": ""SUPPORT""}"
3353	3283	137	Graves' Disease	Graves_Disease.yaml	phenotypes	1	evidence	2	PMID:34951116	SUPPORT		Clinical findings included proptosis (n = 97; 84.3%), eyelid retraction (n = 77; 67%) and diplopia (n = 13; 11.3%).	This reference supports the statement by indicating a high frequency (84.3%) of proptosis in pediatric Graves' orbitopathy, which aligns with the frequency aspect of the statement.	"{""explanation"": ""This reference supports the statement by indicating a high frequency (84.3%) of proptosis in pediatric Graves' orbitopathy, which aligns with the frequency aspect of the statement."", ""reference"": ""PMID:34951116"", ""snippet"": ""Clinical findings included proptosis (n = 97; 84.3%), eyelid retraction (n = 77; 67%) and diplopia (n = 13; 11.3%)."", ""supports"": ""SUPPORT""}"
3354	3283	137	Graves' Disease	Graves_Disease.yaml	phenotypes	1	evidence	3	PMID:32976333	PARTIAL		Superior ophthalmic vein periphlebitis is a rare form of orbital inflammation presenting with proptosis and motility restriction yet few inflammatory signs.	This reference mentions proptosis in the context of a rare form of orbital inflammation associated with Graves' disease, but does not provide enough information to support the frequency aspect of the statement.	"{""explanation"": ""This reference mentions proptosis in the context of a rare form of orbital inflammation associated with Graves' disease, but does not provide enough information to support the frequency aspect of the statement."", ""reference"": ""PMID:32976333"", ""snippet"": ""Superior ophthalmic vein periphlebitis is a rare form of orbital inflammation presenting with proptosis and motility restriction yet few inflammatory signs."", ""supports"": ""PARTIAL""}"
3355	3283	137	Graves' Disease	Graves_Disease.yaml	phenotypes	1	evidence	4	PMID:20181974	SUPPORT		Graves' ophthalmopathy, also called Graves' orbitopathy, is a potentially sight-threatening ocular disease... Generally occurring in patients with hyperthyroidism or a history of hyperthyroidism due to Graves' disease.	This reference supports the statement by indicating that ocular manifestations, including proptosis, are common in Graves' disease.	"{""explanation"": ""This reference supports the statement by indicating that ocular manifestations, including proptosis, are common in Graves' disease."", ""reference"": ""PMID:20181974"", ""snippet"": ""Graves' ophthalmopathy, also called Graves' orbitopathy, is a potentially sight-threatening ocular disease... Generally occurring in patients with hyperthyroidism or a history of hyperthyroidism due to Graves' disease."", ""supports"": ""SUPPORT""}"
3356	3284	137	Graves' Disease	Graves_Disease.yaml	phenotypes	2	evidence	0	PMID:2451239	SUPPORT		Graves' disease is the most common cause of hyperthyroidism. Clinical features include thyroid enlargement...	The literature indicates that Graves' disease frequently results in thyroid enlargement, which aligns with the statement that goiter is a frequent manifestation of Graves' disease.	"{""explanation"": ""The literature indicates that Graves' disease frequently results in thyroid enlargement, which aligns with the statement that goiter is a frequent manifestation of Graves' disease."", ""reference"": ""PMID:2451239"", ""snippet"": ""Graves' disease is the most common cause of hyperthyroidism. Clinical features include thyroid enlargement..."", ""supports"": ""SUPPORT""}"
3357	3284	137	Graves' Disease	Graves_Disease.yaml	phenotypes	2	evidence	1	PMID:4886698	NO_EVIDENCE		Goiter.	The reference is titled 'Goiter' but does not provide specific information about its frequency in Graves' disease.	"{""explanation"": ""The reference is titled 'Goiter' but does not provide specific information about its frequency in Graves' disease."", ""reference"": ""PMID:4886698"", ""snippet"": ""Goiter."", ""supports"": ""NO_EVIDENCE""}"
3358	3284	137	Graves' Disease	Graves_Disease.yaml	phenotypes	2	evidence	2	PMID:22632361	SUPPORT		Graves' Orbitopathy (GO) is an immune-mediated disorder causing inflammation and expansion of orbital fat and muscle...	Although this reference primarily discusses Graves' Orbitopathy, it supports the context that Graves' disease involves immune-mediated disorders affecting the thyroid, which can lead to goiter.	"{""explanation"": ""Although this reference primarily discusses Graves' Orbitopathy, it supports the context that Graves' disease involves immune-mediated disorders affecting the thyroid, which can lead to goiter."", ""reference"": ""PMID:22632361"", ""snippet"": ""Graves' Orbitopathy (GO) is an immune-mediated disorder causing inflammation and expansion of orbital fat and muscle..."", ""supports"": ""SUPPORT""}"
3359	3284	137	Graves' Disease	Graves_Disease.yaml	phenotypes	2	evidence	3	PMID:22112923	SUPPORT		Among them, subacute thyroiditis and Graves' disease accounted for 918 patients (3.6%) and 4,617 patients (18.2%), respectively.	The literature mentions the significant prevalence of Graves' disease, which often includes thyroid enlargement as a symptom, supporting the statement.	"{""explanation"": ""The literature mentions the significant prevalence of Graves' disease, which often includes thyroid enlargement as a symptom, supporting the statement."", ""reference"": ""PMID:22112923"", ""snippet"": ""Among them, subacute thyroiditis and Graves' disease accounted for 918 patients (3.6%) and 4,617 patients (18.2%), respectively."", ""supports"": ""SUPPORT""}"
3360	3284	137	Graves' Disease	Graves_Disease.yaml	phenotypes	2	evidence	4	PMID:37152963	SUPPORT		Graves' disease (GD) is characterized by diffuse enlargement and overactivity of the thyroid gland...	This reference directly supports the statement by mentioning that Graves' disease is characterized by diffuse enlargement of the thyroid gland, which is synonymous with goiter.	"{""explanation"": ""This reference directly supports the statement by mentioning that Graves' disease is characterized by diffuse enlargement of the thyroid gland, which is synonymous with goiter."", ""reference"": ""PMID:37152963"", ""snippet"": ""Graves' disease (GD) is characterized by diffuse enlargement and overactivity of the thyroid gland..."", ""supports"": ""SUPPORT""}"
3361	3284	137	Graves' Disease	Graves_Disease.yaml	phenotypes	2	evidence	5	PMID:14605602	SUPPORT		Several studies have demonstrated both an increased incidence of nodules and of thyroid cancer in patients with Graves' disease...	The reference indicates that thyroid enlargement (goiter) is a frequent occurrence in Graves' disease, supporting the statement.	"{""explanation"": ""The reference indicates that thyroid enlargement (goiter) is a frequent occurrence in Graves' disease, supporting the statement."", ""reference"": ""PMID:14605602"", ""snippet"": ""Several studies have demonstrated both an increased incidence of nodules and of thyroid cancer in patients with Graves' disease..."", ""supports"": ""SUPPORT""}"
3362	3285	137	Graves' Disease	Graves_Disease.yaml	phenotypes	3	evidence	0	PMID:32402541	SUPPORT		Tachyarrhythmias, including atrial fibrillation and tachycardia, improved in 85.9% of patients in the surgical group vs 66% in the medical group (P = .01).	The study shows that tachyarrhythmias, which include tachycardia, are common in patients with Graves' disease and improve with treatment.	"{""explanation"": ""The study shows that tachyarrhythmias, which include tachycardia, are common in patients with Graves' disease and improve with treatment."", ""reference"": ""PMID:32402541"", ""snippet"": ""Tachyarrhythmias, including atrial fibrillation and tachycardia, improved in 85.9% of patients in the surgical group vs 66% in the medical group (P = .01)."", ""supports"": ""SUPPORT""}"
3363	3285	137	Graves' Disease	Graves_Disease.yaml	phenotypes	3	evidence	1	PMID:33749695	SUPPORT		She was hypoxic and tachycardic and was extensively investigated as well as aggressively treated.	The case report mentions a patient with Graves' disease experiencing tachycardia, supporting the statement that tachycardia is a frequent cardiovascular manifestation of Graves' disease.	"{""explanation"": ""The case report mentions a patient with Graves' disease experiencing tachycardia, supporting the statement that tachycardia is a frequent cardiovascular manifestation of Graves' disease."", ""reference"": ""PMID:33749695"", ""snippet"": ""She was hypoxic and tachycardic and was extensively investigated as well as aggressively treated."", ""supports"": ""SUPPORT""}"
3364	3286	137	Graves' Disease	Graves_Disease.yaml	phenotypes	4	evidence	0	PMID:36940965	SUPPORT		Tremors (29.3%) were the most common manifestations.	The literature indicates that tremors are a common manifestation in patients with Graves' Disease.	"{""explanation"": ""The literature indicates that tremors are a common manifestation in patients with Graves' Disease."", ""reference"": ""PMID:36940965"", ""snippet"": ""Tremors (29.3%) were the most common manifestations."", ""supports"": ""SUPPORT""}"
3365	3287	137	Graves' Disease	Graves_Disease.yaml	phenotypes	5	evidence	0	PMID:38215285	SUPPORT		Depression scores and anxiety scores were higher in patients compared to controls both during hyperthyroidism (depression (median (IQR): 7.5 (5.0-9.5) vs 1.0 (0.5-2.5) P < 0.001), anxiety: 7.7 (5.0-11) vs 2.5 (1.0-4.0) P < 0.001) and after treatment (depression: 2.5 (1.5-5.0) vs 1.5 (0.5-3.5) P < 0.05), anxiety: 4.0 (2.5-7.5) vs 3.0 (1.5-5.0) P < 0.05).	The study indicates that anxiety scores are significantly higher in patients with Graves' disease compared to controls, both during hyperthyroidism and after treatment, supporting the statement that anxiety is a frequent psychiatric complication of Graves' disease.	"{""explanation"": ""The study indicates that anxiety scores are significantly higher in patients with Graves' disease compared to controls, both during hyperthyroidism and after treatment, supporting the statement that anxiety is a frequent psychiatric complication of Graves' disease."", ""reference"": ""PMID:38215285"", ""snippet"": ""Depression scores and anxiety scores were higher in patients compared to controls both during hyperthyroidism (depression (median (IQR): 7.5 (5.0-9.5) vs 1.0 (0.5-2.5) P < 0.001), anxiety: 7.7 (5.0-11) vs 2.5 (1.0-4.0) P < 0.001) and after treatment (depression: 2.5 (1.5-5.0) vs 1.5 (0.5-3.5) P < 0.05), anxiety: 4.0 (2.5-7.5) vs 3.0 (1.5-5.0) P < 0.05)."", ""supports"": ""SUPPORT""}"
3366	3288	137	Graves' Disease	Graves_Disease.yaml	phenotypes	6	evidence	0	PMID:38644701	SUPPORT		In children with GD, irritability, oppositional defiant, and conduct disorder symptoms have been detected.	The study found that children with Graves' Disease exhibited symptoms of irritability, supporting the statement that irritability is a frequent psychiatric symptom in GD.	"{""explanation"": ""The study found that children with Graves' Disease exhibited symptoms of irritability, supporting the statement that irritability is a frequent psychiatric symptom in GD."", ""reference"": ""PMID:38644701"", ""snippet"": ""In children with GD, irritability, oppositional defiant, and conduct disorder symptoms have been detected."", ""supports"": ""SUPPORT""}"
3367	3288	137	Graves' Disease	Graves_Disease.yaml	phenotypes	6	evidence	1	PMID:36853810	SUPPORT		The common view is that clinical hypothyroidism is associated with depressive symptoms, whereas the psychiatric manifestations of hyperthyroidism are agitation, emotional lability, hyperexcitability, occasionally accompanied by angry outbursts, and euphoria.	The literature supports the association of hyperthyroidism, which is a characteristic of Graves' Disease, with psychiatric symptoms including irritability.	"{""explanation"": ""The literature supports the association of hyperthyroidism, which is a characteristic of Graves' Disease, with psychiatric symptoms including irritability."", ""reference"": ""PMID:36853810"", ""snippet"": ""The common view is that clinical hypothyroidism is associated with depressive symptoms, whereas the psychiatric manifestations of hyperthyroidism are agitation, emotional lability, hyperexcitability, occasionally accompanied by angry outbursts, and euphoria."", ""supports"": ""SUPPORT""}"
3368	3288	137	Graves' Disease	Graves_Disease.yaml	phenotypes	6	evidence	2	PMID:37224080	SUPPORT		Mental fatigue, depression, anxiety, and cognitive complaints are common in Graves' disease (GD).	This reference supports the presence of psychiatric symptoms in GD, including emotional distress which can encompass irritability.	"{""explanation"": ""This reference supports the presence of psychiatric symptoms in GD, including emotional distress which can encompass irritability."", ""reference"": ""PMID:37224080"", ""snippet"": ""Mental fatigue, depression, anxiety, and cognitive complaints are common in Graves' disease (GD)."", ""supports"": ""SUPPORT""}"
3369	3289	137	Graves' Disease	Graves_Disease.yaml	phenotypes	7	evidence	0	PMID:8309359	SUPPORT		Pretibial myxedema is an uncommon manifestation of Graves disease...	The literature states that pretibial myxedema is an uncommon manifestation of Graves disease, aligning with the statement that it occurs occasionally.	"{""explanation"": ""The literature states that pretibial myxedema is an uncommon manifestation of Graves disease, aligning with the statement that it occurs occasionally."", ""reference"": ""PMID:8309359"", ""snippet"": ""Pretibial myxedema is an uncommon manifestation of Graves disease..."", ""supports"": ""SUPPORT""}"
3370	3289	137	Graves' Disease	Graves_Disease.yaml	phenotypes	7	evidence	1	PMID:34047397	SUPPORT		Pretibial myxedema (PTM)... is almost always associated with Graves' disease (GD).	The literature confirms the association of pretibial myxedema with Graves' disease, supporting its classification as an occasional dermatologic manifestation.	"{""explanation"": ""The literature confirms the association of pretibial myxedema with Graves' disease, supporting its classification as an occasional dermatologic manifestation."", ""reference"": ""PMID:34047397"", ""snippet"": ""Pretibial myxedema (PTM)... is almost always associated with Graves' disease (GD)."", ""supports"": ""SUPPORT""}"
3371	3289	137	Graves' Disease	Graves_Disease.yaml	phenotypes	7	evidence	2	PMID:37193106	SUPPORT		Worsening of pretibial myxedema following radioiodine treatment for hyperthyroid Graves' disease.	This reference supports the occurrence of pretibial myxedema in the context of Graves' disease.	"{""explanation"": ""This reference supports the occurrence of pretibial myxedema in the context of Graves' disease."", ""reference"": ""PMID:37193106"", ""snippet"": ""Worsening of pretibial myxedema following radioiodine treatment for hyperthyroid Graves' disease."", ""supports"": ""SUPPORT""}"
3411	3407	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	phenotypes	0	evidence	0	PMID:30940925	SUPPORT		All the patients have hypotonia (N = 13/13), and either intellectual disability (N = 12/13) or developmental delay	Hypotonia is present in 100% of HIDEA patients.	"{""explanation"": ""Hypotonia is present in 100% of HIDEA patients."", ""reference"": ""PMID:30940925"", ""snippet"": ""All the patients have hypotonia (N = 13/13), and either intellectual disability (N = 12/13) or developmental delay"", ""supports"": ""SUPPORT""}"
3412	3408	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	phenotypes	1	evidence	0	PMID:30940925	SUPPORT		the common presenting features include strabismus (N = 11/13, 85%), epilepsy (N = 10/13, 77%), and central or obstructive sleep apnea	Central or obstructive sleep apnea occurs in most HIDEA patients.	"{""explanation"": ""Central or obstructive sleep apnea occurs in most HIDEA patients."", ""reference"": ""PMID:30940925"", ""snippet"": ""the common presenting features include strabismus (N = 11/13, 85%), epilepsy (N = 10/13, 77%), and central or obstructive sleep apnea"", ""supports"": ""SUPPORT""}"
3413	3409	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	phenotypes	2	evidence	0	PMID:30940925	SUPPORT		All the patients have hypotonia (N = 13/13), and either intellectual disability (N = 12/13) or developmental delay	Global developmental delay is a core feature of the syndrome.	"{""explanation"": ""Global developmental delay is a core feature of the syndrome."", ""reference"": ""PMID:30940925"", ""snippet"": ""All the patients have hypotonia (N = 13/13), and either intellectual disability (N = 12/13) or developmental delay"", ""supports"": ""SUPPORT""}"
3414	3410	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	phenotypes	3	evidence	0	PMID:30940925	SUPPORT		All the patients have hypotonia (N = 13/13), and either intellectual disability (N = 12/13) or developmental delay	Intellectual disability is present in 12 of 13 patients.	"{""explanation"": ""Intellectual disability is present in 12 of 13 patients."", ""reference"": ""PMID:30940925"", ""snippet"": ""All the patients have hypotonia (N = 13/13), and either intellectual disability (N = 12/13) or developmental delay"", ""supports"": ""SUPPORT""}"
3415	3411	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	phenotypes	4	evidence	0	PMID:30940925	SUPPORT		the common presenting features include strabismus (N = 11/13, 85%), epilepsy (N = 10/13, 77%), and central or obstructive sleep apnea	Epilepsy is present in 77% of HIDEA patients.	"{""explanation"": ""Epilepsy is present in 77% of HIDEA patients."", ""reference"": ""PMID:30940925"", ""snippet"": ""the common presenting features include strabismus (N = 11/13, 85%), epilepsy (N = 10/13, 77%), and central or obstructive sleep apnea"", ""supports"": ""SUPPORT""}"
3416	3412	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	phenotypes	5	evidence	0	PMID:30940925	SUPPORT		Some patients also show dysautonomia, including constipation (N = 6/13, 46%), recurrent hypothermia or hyperthermia (N = 4/13, 31%), and reduced sweating (N = 2/13, 15%)	Dysautonomia features including temperature dysregulation and constipation are present in subsets of HIDEA patients.	"{""explanation"": ""Dysautonomia features including temperature dysregulation and constipation are present in subsets of HIDEA patients."", ""reference"": ""PMID:30940925"", ""snippet"": ""Some patients also show dysautonomia, including constipation (N = 6/13, 46%), recurrent hypothermia or hyperthermia (N = 4/13, 31%), and reduced sweating (N = 2/13, 15%)"", ""supports"": ""SUPPORT""}"
3417	3413	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	phenotypes	6	evidence	0	PMID:30940925	SUPPORT		the common presenting features include strabismus (N = 11/13, 85%), epilepsy (N = 10/13, 77%)	Strabismus is a common feature of HIDEA syndrome.	"{""explanation"": ""Strabismus is a common feature of HIDEA syndrome."", ""reference"": ""PMID:30940925"", ""snippet"": ""the common presenting features include strabismus (N = 11/13, 85%), epilepsy (N = 10/13, 77%)"", ""supports"": ""SUPPORT""}"
3418	3414	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	phenotypes	7	evidence	0	PMID:30940925	SUPPORT		All the patients with P4HTM gene variants have developmental delay or intellectual disability and visual abnormalities—such as strabismus, rotating eye movements, nystagmus, or cortical blindness	Visual abnormalities are part of the eye phenotype in HIDEA.	"{""explanation"": ""Visual abnormalities are part of the eye phenotype in HIDEA."", ""reference"": ""PMID:30940925"", ""snippet"": ""All the patients with P4HTM gene variants have developmental delay or intellectual disability and visual abnormalities—such as strabismus, rotating eye movements, nystagmus, or cortical blindness"", ""supports"": ""SUPPORT""}"
3419	3418	143	HIDEA_Syndrome	HIDEA_Syndrome.yaml	phenotypes	11	evidence	0	PMID:30940925	SUPPORT		Six patients (N = 6/13, 46%) have a body mass index (BMI) over 25 kg/m2	Some HIDEA patients have elevated BMI/obesity.	"{""explanation"": ""Some HIDEA patients have elevated BMI/obesity."", ""reference"": ""PMID:30940925"", ""snippet"": ""Six patients (N = 6/13, 46%) have a body mass index (BMI) over 25 kg/m2"", ""supports"": ""SUPPORT""}"
3433	3491	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	phenotypes	0	evidence	0	PMID:38731922	SUPPORT		Due to the progressive destruction of cells, AITD can lead to subclinical or overt hypothyroidism.	Fatigue is a common systemic symptom resulting from hypothyroidism caused by progressive thyroid destruction.	"{""explanation"": ""Fatigue is a common systemic symptom resulting from hypothyroidism caused by progressive thyroid destruction."", ""reference"": ""PMID:38731922"", ""snippet"": ""Due to the progressive destruction of cells, AITD can lead to subclinical or overt hypothyroidism."", ""supports"": ""SUPPORT""}"
3434	3495	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	phenotypes	4	evidence	0	PMID:38731922	SUPPORT		Hashimoto's thyroiditis (HT) is generally characterized by the presence of thyroid peroxidase and thyroglobulin antibodies, with a concomitant infiltration of lymphocytes in the thyroid.	Goiter develops due to lymphocytic infiltration and inflammatory enlargement of the thyroid gland.	"{""explanation"": ""Goiter develops due to lymphocytic infiltration and inflammatory enlargement of the thyroid gland."", ""reference"": ""PMID:38731922"", ""snippet"": ""Hashimoto's thyroiditis (HT) is generally characterized by the presence of thyroid peroxidase and thyroglobulin antibodies, with a concomitant infiltration of lymphocytes in the thyroid."", ""supports"": ""SUPPORT""}"
3435	3495	146	Hashimoto's Thyroiditis	Hashimotos_Thyroiditis.yaml	phenotypes	4	evidence	1	PMID:39003267	SUPPORT		We also demonstrate an increase of fenestrated PLVAP+ vessels in AITD, especially in GD.	Vascular remodeling and increased blood flow contribute to thyroid gland enlargement in autoimmune thyroid disease.	"{""explanation"": ""Vascular remodeling and increased blood flow contribute to thyroid gland enlargement in autoimmune thyroid disease."", ""reference"": ""PMID:39003267"", ""snippet"": ""We also demonstrate an increase of fenestrated PLVAP+ vessels in AITD, especially in GD."", ""supports"": ""SUPPORT""}"
3447	3516	147	Heart Failure	Heart_Failure.yaml	phenotypes	0	evidence	0	PMID:40892534	SUPPORT		Myocardial fibrosis and its surrogate changes in LV structure and geometry lead to functional impairments such as increased diastolic stiffness and elevated filling pressures and are associated with reduced exercise tolerance and poor prognosis in patients with HFpEF.	Dyspnea results from elevated filling pressures and reduced exercise tolerance caused by diastolic dysfunction and myocardial fibrosis in heart failure.	"{""explanation"": ""Dyspnea results from elevated filling pressures and reduced exercise tolerance caused by diastolic dysfunction and myocardial fibrosis in heart failure."", ""reference"": ""PMID:40892534"", ""snippet"": ""Myocardial fibrosis and its surrogate changes in LV structure and geometry lead to functional impairments such as increased diastolic stiffness and elevated filling pressures and are associated with reduced exercise tolerance and poor prognosis in patients with HFpEF."", ""supports"": ""SUPPORT""}"
3448	3517	147	Heart Failure	Heart_Failure.yaml	phenotypes	1	evidence	0	PMID:36769308	SUPPORT		The pathophysiology between the heart and the kidneys is bidirectional. Common mechanisms leading to the dysfunction of these organs result in a vicious cycle of cardiorenal deterioration.	Peripheral edema results from the cardiorenal interaction where reduced cardiac output leads to renal dysfunction, sodium retention, and fluid accumulation in peripheral tissues.	"{""explanation"": ""Peripheral edema results from the cardiorenal interaction where reduced cardiac output leads to renal dysfunction, sodium retention, and fluid accumulation in peripheral tissues."", ""reference"": ""PMID:36769308"", ""snippet"": ""The pathophysiology between the heart and the kidneys is bidirectional. Common mechanisms leading to the dysfunction of these organs result in a vicious cycle of cardiorenal deterioration."", ""supports"": ""SUPPORT""}"
3449	3520	147	Heart Failure	Heart_Failure.yaml	phenotypes	4	evidence	0	PMID:40892534	SUPPORT		Myocardial fibrosis and its surrogate changes in LV structure and geometry lead to functional impairments such as increased diastolic stiffness and elevated filling pressures and are associated with reduced exercise tolerance and poor prognosis in patients with HFpEF.	Exercise intolerance in heart failure is directly caused by increased diastolic stiffness and elevated filling pressures from myocardial fibrosis and structural remodeling.	"{""explanation"": ""Exercise intolerance in heart failure is directly caused by increased diastolic stiffness and elevated filling pressures from myocardial fibrosis and structural remodeling."", ""reference"": ""PMID:40892534"", ""snippet"": ""Myocardial fibrosis and its surrogate changes in LV structure and geometry lead to functional impairments such as increased diastolic stiffness and elevated filling pressures and are associated with reduced exercise tolerance and poor prognosis in patients with HFpEF."", ""supports"": ""SUPPORT""}"
3450	3521	147	Heart Failure	Heart_Failure.yaml	phenotypes	5	evidence	0	PMID:38636927	SUPPORT		In the isoproterenol (ISO)-induced animal model, it is often accompanied by myocardial hypertrophy, fibrosis, and inflammation.	Cardiomegaly in heart failure results from myocardial hypertrophy, which is a structural adaptation to increased workload and sympathetic activation.	"{""explanation"": ""Cardiomegaly in heart failure results from myocardial hypertrophy, which is a structural adaptation to increased workload and sympathetic activation."", ""reference"": ""PMID:38636927"", ""snippet"": ""In the isoproterenol (ISO)-induced animal model, it is often accompanied by myocardial hypertrophy, fibrosis, and inflammation."", ""supports"": ""SUPPORT""}"
3459	3538	148	Hemochromatosis	Hemochromatosis.yaml	phenotypes	0	evidence	0	PMID:37168645	SUPPORT		One of the most serious clinical characteristics associated with early-onset iron overload is liver disease with eventual cirrhosis	Liver involvement early in disease course leads to enlargement and progression to cirrhosis.	"{""explanation"": ""Liver involvement early in disease course leads to enlargement and progression to cirrhosis."", ""reference"": ""PMID:37168645"", ""snippet"": ""One of the most serious clinical characteristics associated with early-onset iron overload is liver disease with eventual cirrhosis"", ""supports"": ""SUPPORT""}"
3460	3539	148	Hemochromatosis	Hemochromatosis.yaml	phenotypes	1	evidence	0	PMID:38886778	SUPPORT		The proband is a 64-year-old man complaining of persistent abnormality of liver enzyme levels for 1 year, with a history of knee joint pain, diabetes and skin pigmentation.	Case report documents skin pigmentation in ferroportin-related hemochromatosis.	"{""explanation"": ""Case report documents skin pigmentation in ferroportin-related hemochromatosis."", ""reference"": ""PMID:38886778"", ""snippet"": ""The proband is a 64-year-old man complaining of persistent abnormality of liver enzyme levels for 1 year, with a history of knee joint pain, diabetes and skin pigmentation."", ""supports"": ""SUPPORT""}"
3461	3540	148	Hemochromatosis	Hemochromatosis.yaml	phenotypes	2	evidence	0	PMID:38886778	SUPPORT		The proband is a 64-year-old man complaining of persistent abnormality of liver enzyme levels for 1 year, with a history of knee joint pain, diabetes and skin pigmentation.	Diabetes reported as part of the hemochromatosis presentation.	"{""explanation"": ""Diabetes reported as part of the hemochromatosis presentation."", ""reference"": ""PMID:38886778"", ""snippet"": ""The proband is a 64-year-old man complaining of persistent abnormality of liver enzyme levels for 1 year, with a history of knee joint pain, diabetes and skin pigmentation."", ""supports"": ""SUPPORT""}"
3462	3541	148	Hemochromatosis	Hemochromatosis.yaml	phenotypes	3	evidence	0	PMID:38886778	SUPPORT		The proband is a 64-year-old man complaining of persistent abnormality of liver enzyme levels for 1 year, with a history of knee joint pain, diabetes and skin pigmentation.	Knee joint pain in hemochromatosis supports arthropathy association.	"{""explanation"": ""Knee joint pain in hemochromatosis supports arthropathy association."", ""reference"": ""PMID:38886778"", ""snippet"": ""The proband is a 64-year-old man complaining of persistent abnormality of liver enzyme levels for 1 year, with a history of knee joint pain, diabetes and skin pigmentation."", ""supports"": ""SUPPORT""}"
3463	3542	148	Hemochromatosis	Hemochromatosis.yaml	phenotypes	4	evidence	0	PMID:35449524	SUPPORT		Hemochromatosis type 2 or juvenile hemochromatosis has an early onset of severe iron overload resulting in organ manifestation such as liver fibrosis, cirrhosis, cardiomyopathy, arthropathy, hypogonadism, diabetes	Juvenile hemochromatosis case describes cardiomyopathy among manifestations.	"{""explanation"": ""Juvenile hemochromatosis case describes cardiomyopathy among manifestations."", ""reference"": ""PMID:35449524"", ""snippet"": ""Hemochromatosis type 2 or juvenile hemochromatosis has an early onset of severe iron overload resulting in organ manifestation such as liver fibrosis, cirrhosis, cardiomyopathy, arthropathy, hypogonadism, diabetes"", ""supports"": ""SUPPORT""}"
3464	3543	148	Hemochromatosis	Hemochromatosis.yaml	phenotypes	5	evidence	0	PMID:36644615	SUPPORT		Pituitary haemochromatosis is an endocrine disorder caused by the accumulation of iron due to a lack of absorption during haemochromatosis.	Pituitary iron deposition disrupts gonadotropin signaling leading to hypogonadism.	"{""explanation"": ""Pituitary iron deposition disrupts gonadotropin signaling leading to hypogonadism."", ""reference"": ""PMID:36644615"", ""snippet"": ""Pituitary haemochromatosis is an endocrine disorder caused by the accumulation of iron due to a lack of absorption during haemochromatosis."", ""supports"": ""SUPPORT""}"
3465	3544	148	Hemochromatosis	Hemochromatosis.yaml	phenotypes	6	evidence	0	PMID:39337031	SUPPORT		The HH patients exhibited significantly worse fatigue across all the scales.	Fatigue questionnaires show higher fatigue burden in HH compared with controls.	"{""explanation"": ""Fatigue questionnaires show higher fatigue burden in HH compared with controls."", ""reference"": ""PMID:39337031"", ""snippet"": ""The HH patients exhibited significantly worse fatigue across all the scales."", ""supports"": ""SUPPORT""}"
3466	3544	148	Hemochromatosis	Hemochromatosis.yaml	phenotypes	6	evidence	1	PMID:30244162	SUPPORT		It results in chronic fatigue and in potential liver (cirrhosis), pancreas (diabetes) and joint (arthritis) damage in adulthood.	Long-term cohort notes chronic fatigue as a characteristic manifestation of genetic hemochromatosis.	"{""explanation"": ""Long-term cohort notes chronic fatigue as a characteristic manifestation of genetic hemochromatosis."", ""reference"": ""PMID:30244162"", ""snippet"": ""It results in chronic fatigue and in potential liver (cirrhosis), pancreas (diabetes) and joint (arthritis) damage in adulthood."", ""supports"": ""SUPPORT""}"
3479	3558	149	Hemophilia A	Hemophilia_A.yaml	phenotypes	0	evidence	0	PMID:34197690	SUPPORT		Recurrent joint bleeding (hemarthrosis) is the most frequent clinical manifestation of severe hemophilia.	Review confirms hemarthrosis as the primary clinical feature of severe hemophilia.	"{""explanation"": ""Review confirms hemarthrosis as the primary clinical feature of severe hemophilia."", ""reference"": ""PMID:34197690"", ""snippet"": ""Recurrent joint bleeding (hemarthrosis) is the most frequent clinical manifestation of severe hemophilia."", ""supports"": ""SUPPORT""}"
3480	3559	149	Hemophilia A	Hemophilia_A.yaml	phenotypes	1	evidence	0	PMID:27890816	SUPPORT		Hemophilia is a congenital clotting factor deficiency characterized by spontaneous and trauma-related bleeding.	Review establishes that bleeding following trauma is a defining feature of hemophilia.	"{""explanation"": ""Review establishes that bleeding following trauma is a defining feature of hemophilia."", ""reference"": ""PMID:27890816"", ""snippet"": ""Hemophilia is a congenital clotting factor deficiency characterized by spontaneous and trauma-related bleeding."", ""supports"": ""SUPPORT""}"
3481	3560	149	Hemophilia A	Hemophilia_A.yaml	phenotypes	2	evidence	0	PMID:27890816	SUPPORT		Hemophilia is a congenital clotting factor deficiency characterized by spontaneous and trauma-related bleeding.	Spontaneous and trauma-related bleeding in hemophilia manifests as easy bruising due to defective clot formation.	"{""explanation"": ""Spontaneous and trauma-related bleeding in hemophilia manifests as easy bruising due to defective clot formation."", ""reference"": ""PMID:27890816"", ""snippet"": ""Hemophilia is a congenital clotting factor deficiency characterized by spontaneous and trauma-related bleeding."", ""supports"": ""SUPPORT""}"
3482	3561	149	Hemophilia A	Hemophilia_A.yaml	phenotypes	3	evidence	0	PMID:27890816	SUPPORT		Spontaneous bleeding shows a predilection for joints, and repeated hemarthroses lead to a disabling condition called hemophilic arthropathy.	While joints are the primary site, the same pathophysiology causes bleeding into muscles; spontaneous bleeding is characteristic of hemophilia.	"{""explanation"": ""While joints are the primary site, the same pathophysiology causes bleeding into muscles; spontaneous bleeding is characteristic of hemophilia."", ""reference"": ""PMID:27890816"", ""snippet"": ""Spontaneous bleeding shows a predilection for joints, and repeated hemarthroses lead to a disabling condition called hemophilic arthropathy."", ""supports"": ""SUPPORT""}"
3483	3562	149	Hemophilia A	Hemophilia_A.yaml	phenotypes	4	evidence	0	PMID:36409923	SUPPORT		Hemophilia A is a bleeding disorder caused by deficiency or low activity of circulating factor VIII characterized by prolonged blood coagulation time and often spontaneous bleeding.	Study confirms prolonged coagulation time as a defining characteristic of hemophilia A.	"{""explanation"": ""Study confirms prolonged coagulation time as a defining characteristic of hemophilia A."", ""reference"": ""PMID:36409923"", ""snippet"": ""Hemophilia A is a bleeding disorder caused by deficiency or low activity of circulating factor VIII characterized by prolonged blood coagulation time and often spontaneous bleeding."", ""supports"": ""SUPPORT""}"
3490	3569	150	Hemophilia B	Hemophilia_B.yaml	phenotypes	0	evidence	0	PMID:23430394	SUPPORT		Hemophilia B is a recessive X-linked bleeding disorder characterized by deficiency of the coagulation factor IX (FIX).	The abstract describes hemophilia B as a bleeding disorder.	"{""explanation"": ""The abstract describes hemophilia B as a bleeding disorder."", ""reference"": ""PMID:23430394"", ""snippet"": ""Hemophilia B is a recessive X-linked bleeding disorder characterized by deficiency of the coagulation factor IX (FIX)."", ""supports"": ""SUPPORT""}"
3572	3594	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	0	evidence	0	PMID:24266913	SUPPORT		Chronically infected patients should be followed on a regular basis, preferably every 6 months, with liver function tests, and when appropriate, HBV DNA levels. Those who meet the criteria for high risk for HCC should undergo liver ultrasound every 6 months. Powerful antiviral medications are available that can suppress but not cure HBV and result in resolution of liver inflammation and fibrosis, even cirrhosis, as well as decrease the risk of developing HCC.	The literature mentions the management of chronic Hepatitis B and its effects on liver function, which can lead to jaundice.	"{""explanation"": ""The literature mentions the management of chronic Hepatitis B and its effects on liver function, which can lead to jaundice."", ""reference"": ""PMID:24266913"", ""snippet"": ""Chronically infected patients should be followed on a regular basis, preferably every 6 months, with liver function tests, and when appropriate, HBV DNA levels. Those who meet the criteria for high risk for HCC should undergo liver ultrasound every 6 months. Powerful antiviral medications are available that can suppress but not cure HBV and result in resolution of liver inflammation and fibrosis, even cirrhosis, as well as decrease the risk of developing HCC."", ""supports"": ""SUPPORT""}"
3573	3594	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	0	evidence	1	PMID:3050928	SUPPORT		The classic presenting symptoms of viral hepatitis are jaundice, nausea, vomiting, malaise, anorexia, and dull right upper quadrant pain.	The literature explicitly lists jaundice as a classic presenting symptom of viral hepatitis, including Hepatitis B.	"{""explanation"": ""The literature explicitly lists jaundice as a classic presenting symptom of viral hepatitis, including Hepatitis B."", ""reference"": ""PMID:3050928"", ""snippet"": ""The classic presenting symptoms of viral hepatitis are jaundice, nausea, vomiting, malaise, anorexia, and dull right upper quadrant pain."", ""supports"": ""SUPPORT""}"
3574	3594	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	0	evidence	2	PMID:34835022	SUPPORT		Hepatitis B virus (HBV) infection is one of the serious health problems in the world as HBV causes severe liver diseases.	The literature discusses the severe liver diseases caused by Hepatitis B, which can lead to jaundice due to liver dysfunction.	"{""explanation"": ""The literature discusses the severe liver diseases caused by Hepatitis B, which can lead to jaundice due to liver dysfunction."", ""reference"": ""PMID:34835022"", ""snippet"": ""Hepatitis B virus (HBV) infection is one of the serious health problems in the world as HBV causes severe liver diseases."", ""supports"": ""SUPPORT""}"
3575	3594	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	0	evidence	3	PMID:35395817	SUPPORT		This case report describes a 57-year-old Iranian woman admitted to the hospital with jaundice, fever, body itching, abdominal pain, progressive muscle weakness, icteric sclera, right upper quadrant pain, and decreased muscle force.	The case report describes a patient with Hepatitis B presenting with jaundice, supporting the statement that jaundice is a frequent symptom due to liver dysfunction.	"{""explanation"": ""The case report describes a patient with Hepatitis B presenting with jaundice, supporting the statement that jaundice is a frequent symptom due to liver dysfunction."", ""reference"": ""PMID:35395817"", ""snippet"": ""This case report describes a 57-year-old Iranian woman admitted to the hospital with jaundice, fever, body itching, abdominal pain, progressive muscle weakness, icteric sclera, right upper quadrant pain, and decreased muscle force."", ""supports"": ""SUPPORT""}"
3576	3595	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	1	evidence	0	PMID:7493307	SUPPORT		Hepatitis cases scored significantly higher fatigue scores, GHQ-12 scores and muscle pain scores.	The study indicates that fatigue is more common after recovery in patients hospitalized for hepatitis B up to 30 months post-infection compared with matched controls hospitalized for other infectious diseases.	"{""explanation"": ""The study indicates that fatigue is more common after recovery in patients hospitalized for hepatitis B up to 30 months post-infection compared with matched controls hospitalized for other infectious diseases."", ""reference"": ""PMID:7493307"", ""snippet"": ""Hepatitis cases scored significantly higher fatigue scores, GHQ-12 scores and muscle pain scores."", ""supports"": ""SUPPORT""}"
3577	3596	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	2	evidence	0	PMID:24954675	SUPPORT		Hepatitis B virus is not cytopathic; both liver damage and viral control--and therefore clinical outcome--depend on the complex interplay between virus replication and host immune response.	The literature mentions liver damage and clinical outcomes related to Hepatitis B, which can include gastrointestinal symptoms like abdominal pain due to liver inflammation.	"{""explanation"": ""The literature mentions liver damage and clinical outcomes related to Hepatitis B, which can include gastrointestinal symptoms like abdominal pain due to liver inflammation."", ""reference"": ""PMID:24954675"", ""snippet"": ""Hepatitis B virus is not cytopathic; both liver damage and viral control--and therefore clinical outcome--depend on the complex interplay between virus replication and host immune response."", ""supports"": ""SUPPORT""}"
3578	3596	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	2	evidence	1	PMID:3050928	SUPPORT		The classic presenting symptoms of viral hepatitis are jaundice, nausea, vomiting, malaise, anorexia, and dull right upper quadrant pain.	The literature lists dull right upper quadrant pain as a classic symptom of viral hepatitis, which includes Hepatitis B, supporting the statement that abdominal pain is an occasional gastrointestinal symptom related to liver inflammation.	"{""explanation"": ""The literature lists dull right upper quadrant pain as a classic symptom of viral hepatitis, which includes Hepatitis B, supporting the statement that abdominal pain is an occasional gastrointestinal symptom related to liver inflammation."", ""reference"": ""PMID:3050928"", ""snippet"": ""The classic presenting symptoms of viral hepatitis are jaundice, nausea, vomiting, malaise, anorexia, and dull right upper quadrant pain."", ""supports"": ""SUPPORT""}"
3579	3597	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	3	evidence	0	PMID:34835022	SUPPORT		The HBV surface antigen (HBsAg)-positive group had a more frequent prevalence of patients with higher transaminase elevations than the HBsAg-negative group.	The study indicates that elevated liver enzymes, which reflect liver cell damage, are more frequently observed in patients with Hepatitis B virus infection.	"{""explanation"": ""The study indicates that elevated liver enzymes, which reflect liver cell damage, are more frequently observed in patients with Hepatitis B virus infection."", ""reference"": ""PMID:34835022"", ""snippet"": ""The HBV surface antigen (HBsAg)-positive group had a more frequent prevalence of patients with higher transaminase elevations than the HBsAg-negative group."", ""supports"": ""SUPPORT""}"
3580	3597	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	3	evidence	1	PMID:30418344	SUPPORT		Abnormal liver enzymes are frequently encountered in primary care offices and hospitals and may be caused by a wide variety of conditions, from mild and nonspecific to well-defined and life-threatening.	Elevated liver enzymes are a common diagnostic feature in various liver diseases, including Hepatitis B.	"{""explanation"": ""Elevated liver enzymes are a common diagnostic feature in various liver diseases, including Hepatitis B."", ""reference"": ""PMID:30418344"", ""snippet"": ""Abnormal liver enzymes are frequently encountered in primary care offices and hospitals and may be caused by a wide variety of conditions, from mild and nonspecific to well-defined and life-threatening."", ""supports"": ""SUPPORT""}"
3581	3597	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	3	evidence	2	PMID:29551632	SUPPORT		The prevalence of hepatitis B surface antigen (HBsAg) was 18.5% (126/680) and of liver cirrhosis was 9.4% (64/680).	The presence of elevated liver enzymes is associated with Hepatitis B infection, as indicated by the prevalence of HBsAg in patients.	"{""explanation"": ""The presence of elevated liver enzymes is associated with Hepatitis B infection, as indicated by the prevalence of HBsAg in patients."", ""reference"": ""PMID:29551632"", ""snippet"": ""The prevalence of hepatitis B surface antigen (HBsAg) was 18.5% (126/680) and of liver cirrhosis was 9.4% (64/680)."", ""supports"": ""SUPPORT""}"
3582	3597	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	3	evidence	3	PMID:33418899	SUPPORT		Globally, hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) is one of the major causes of cancer-related mortality.	Although the focus is on hepatocellular carcinoma, the study implies the role of Hepatitis B in causing severe liver conditions, which include elevated liver enzymes as a diagnostic feature.	"{""explanation"": ""Although the focus is on hepatocellular carcinoma, the study implies the role of Hepatitis B in causing severe liver conditions, which include elevated liver enzymes as a diagnostic feature."", ""reference"": ""PMID:33418899"", ""snippet"": ""Globally, hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) is one of the major causes of cancer-related mortality."", ""supports"": ""SUPPORT""}"
3583	3597	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	3	evidence	4	PMID:3050928	SUPPORT		Studies are done for the elevated transaminase levels that are characteristic of hepatitis infection.	Elevated transaminase levels are characteristic of hepatitis infections, including Hepatitis B.	"{""explanation"": ""Elevated transaminase levels are characteristic of hepatitis infections, including Hepatitis B."", ""reference"": ""PMID:3050928"", ""snippet"": ""Studies are done for the elevated transaminase levels that are characteristic of hepatitis infection."", ""supports"": ""SUPPORT""}"
3584	3598	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	4	evidence	0	PMID:3050928	SUPPORT		The classic presenting symptoms of viral hepatitis are jaundice, nausea, vomiting, malaise, anorexia, and dull right upper quadrant pain.	The literature explicitly mentions nausea as a classic presenting symptom of viral hepatitis, which includes Hepatitis B.	"{""explanation"": ""The literature explicitly mentions nausea as a classic presenting symptom of viral hepatitis, which includes Hepatitis B."", ""reference"": ""PMID:3050928"", ""snippet"": ""The classic presenting symptoms of viral hepatitis are jaundice, nausea, vomiting, malaise, anorexia, and dull right upper quadrant pain."", ""supports"": ""SUPPORT""}"
3585	3599	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	5	evidence	0	PMID:3050928	PARTIAL		The classic presenting symptoms of viral hepatitis are jaundice, nausea, vomiting, malaise, anorexia, and dull right upper quadrant pain.	The reference mentions vomiting as one of the classic presenting symptoms of viral hepatitis, which includes Hepatitis B. However, it does not specify the frequency, so it partially supports the statement.	"{""explanation"": ""The reference mentions vomiting as one of the classic presenting symptoms of viral hepatitis, which includes Hepatitis B. However, it does not specify the frequency, so it partially supports the statement."", ""reference"": ""PMID:3050928"", ""snippet"": ""The classic presenting symptoms of viral hepatitis are jaundice, nausea, vomiting, malaise, anorexia, and dull right upper quadrant pain."", ""supports"": ""PARTIAL""}"
3586	3600	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	6	evidence	0	PMID:28223176	PARTIAL		Prodromal fever indicated more severe liver injury and was independently associated with hepatitis B e antigen (HBeAg) negativity.	The study indicates that fever can be associated with acute hepatitis B, particularly in severe cases, but it does not explicitly categorize fever as an occasional systemic manifestation.	"{""explanation"": ""The study indicates that fever can be associated with acute hepatitis B, particularly in severe cases, but it does not explicitly categorize fever as an occasional systemic manifestation."", ""reference"": ""PMID:28223176"", ""snippet"": ""Prodromal fever indicated more severe liver injury and was independently associated with hepatitis B e antigen (HBeAg) negativity."", ""supports"": ""PARTIAL""}"
3587	3600	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	6	evidence	1	PMID:34913875	PARTIAL		Several of these extrahepatic syndromes have been well described, including systemic vasculitides, glomerulonephritis, and cutaneous manifestations.	While the reference mentions systemic manifestations of hepatitis B, it does not specifically mention fever as one of them.	"{""explanation"": ""While the reference mentions systemic manifestations of hepatitis B, it does not specifically mention fever as one of them."", ""reference"": ""PMID:34913875"", ""snippet"": ""Several of these extrahepatic syndromes have been well described, including systemic vasculitides, glomerulonephritis, and cutaneous manifestations."", ""supports"": ""PARTIAL""}"
3588	3600	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	6	evidence	2	PMID:35499229	PARTIAL		The study confirms the endemicity of hepatitis B and enteric fever in the area.	The study mentions the prevalence of hepatitis B among febrile patients but does not specifically categorize fever as an occasional systemic manifestation of hepatitis B.	"{""explanation"": ""The study mentions the prevalence of hepatitis B among febrile patients but does not specifically categorize fever as an occasional systemic manifestation of hepatitis B."", ""reference"": ""PMID:35499229"", ""snippet"": ""The study confirms the endemicity of hepatitis B and enteric fever in the area."", ""supports"": ""PARTIAL""}"
3589	3601	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	7	evidence	0	PMID:12150847	SUPPORT		Occult hepatitis B occurs in a number of clinical settings.	While the abstract does not specifically mention hepatomegaly as a frequent symptom, it implies that various liver-related conditions are associated with hepatitis B, supporting the occasional occurrence of hepatomegaly.	"{""explanation"": ""While the abstract does not specifically mention hepatomegaly as a frequent symptom, it implies that various liver-related conditions are associated with hepatitis B, supporting the occasional occurrence of hepatomegaly."", ""reference"": ""PMID:12150847"", ""snippet"": ""Occult hepatitis B occurs in a number of clinical settings."", ""supports"": ""SUPPORT""}"
3590	3601	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	7	evidence	1	PMID:19682192	PARTIAL		Severe acute exacerbation is a unique presentation of chronic hepatitis B characterized by very high alanine aminotransferase level accompanied by jaundice and hepatic decompensation.	The text describes severe liver conditions related to chronic hepatitis B, but does not directly mention hepatomegaly. It suggests severe liver involvement, which could include hepatomegaly.	"{""explanation"": ""The text describes severe liver conditions related to chronic hepatitis B, but does not directly mention hepatomegaly. It suggests severe liver involvement, which could include hepatomegaly."", ""reference"": ""PMID:19682192"", ""snippet"": ""Severe acute exacerbation is a unique presentation of chronic hepatitis B characterized by very high alanine aminotransferase level accompanied by jaundice and hepatic decompensation."", ""supports"": ""PARTIAL""}"
3591	3602	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	8	evidence	0	PMID:18760074	SUPPORT		The most commonly described include skin rash, arthritis, arthralgia, glomerulonephritis, polyarteritis nodosa, and papular acrodermatitis etc.	The reference confirms that arthralgia (joint pain) is a commonly described extrahepatic manifestation of Hepatitis B.	"{""explanation"": ""The reference confirms that arthralgia (joint pain) is a commonly described extrahepatic manifestation of Hepatitis B."", ""reference"": ""PMID:18760074"", ""snippet"": ""The most commonly described include skin rash, arthritis, arthralgia, glomerulonephritis, polyarteritis nodosa, and papular acrodermatitis etc."", ""supports"": ""SUPPORT""}"
3592	3603	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	9	evidence	0	PMID:6133886	SUPPORT		Dermatologic manifestations of hepatitis B virus infection.	The title of the reference directly indicates the presence of dermatologic manifestations, supporting the statement that hepatitis B can cause occasional dermatologic conditions like rash.	"{""explanation"": ""The title of the reference directly indicates the presence of dermatologic manifestations, supporting the statement that hepatitis B can cause occasional dermatologic conditions like rash."", ""reference"": ""PMID:6133886"", ""snippet"": ""Dermatologic manifestations of hepatitis B virus infection."", ""supports"": ""SUPPORT""}"
3593	3603	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	9	evidence	1	PMID:1185334	SUPPORT		The association of arthritis, arthralgia, and various types of skin rashes, as a prodrome to viral hepatitis, although well recognized in adults, has not been well described in children.	The reference mentions that skin rashes are recognized as prodromal manifestations of viral hepatitis, including hepatitis B, supporting the statement.	"{""explanation"": ""The reference mentions that skin rashes are recognized as prodromal manifestations of viral hepatitis, including hepatitis B, supporting the statement."", ""reference"": ""PMID:1185334"", ""snippet"": ""The association of arthritis, arthralgia, and various types of skin rashes, as a prodrome to viral hepatitis, although well recognized in adults, has not been well described in children."", ""supports"": ""SUPPORT""}"
3594	3603	151	Hepatitis B	Hepatitis_B.yaml	phenotypes	9	evidence	2	PMID:1532114	SUPPORT		The most frequent adverse reactions were myalgia/arthralgia lasting longer than 3 days (14), followed by skin rashes (eight) and dizziness (seven).	The reference notes that skin rashes were among the most frequent adverse reactions to the hepatitis B vaccine, indicating that hepatitis B can be associated with dermatologic manifestations like rash.	"{""explanation"": ""The reference notes that skin rashes were among the most frequent adverse reactions to the hepatitis B vaccine, indicating that hepatitis B can be associated with dermatologic manifestations like rash."", ""reference"": ""PMID:1532114"", ""snippet"": ""The most frequent adverse reactions were myalgia/arthralgia lasting longer than 3 days (14), followed by skin rashes (eight) and dizziness (seven)."", ""supports"": ""SUPPORT""}"
3649	3633	152	Hepatitis C	Hepatitis_C.yaml	phenotypes	0	evidence	0	PMID:26569658	SUPPORT		The most common adverse events were fatigue (29%), nausea (23%), and headache (22%)	Clinical trial confirms fatigue as a very common symptom in HCV patients.	"{""explanation"": ""Clinical trial confirms fatigue as a very common symptom in HCV patients."", ""reference"": ""PMID:26569658"", ""snippet"": ""The most common adverse events were fatigue (29%), nausea (23%), and headache (22%)"", ""supports"": ""SUPPORT""}"
3650	3633	152	Hepatitis C	Hepatitis_C.yaml	phenotypes	0	evidence	1	PMID:24725239	SUPPORT		The most common adverse events were fatigue, headache, insomnia, and nausea.	Large clinical trial confirms fatigue as a predominant symptom in HCV patients.	"{""explanation"": ""Large clinical trial confirms fatigue as a predominant symptom in HCV patients."", ""reference"": ""PMID:24725239"", ""snippet"": ""The most common adverse events were fatigue, headache, insomnia, and nausea."", ""supports"": ""SUPPORT""}"
3651	3637	152	Hepatitis C	Hepatitis_C.yaml	phenotypes	4	evidence	0	PMID:26569658	SUPPORT		patients infected with HCV genotypes 1 through 6 who had decompensated cirrhosis	Study specifically targets HCV patients with cirrhosis, confirming cirrhosis as a major complication.	"{""explanation"": ""Study specifically targets HCV patients with cirrhosis, confirming cirrhosis as a major complication."", ""reference"": ""PMID:26569658"", ""snippet"": ""patients infected with HCV genotypes 1 through 6 who had decompensated cirrhosis"", ""supports"": ""SUPPORT""}"
3652	3637	152	Hepatitis C	Hepatitis_C.yaml	phenotypes	4	evidence	1	PMID:24725239	SUPPORT		Of the 865 patients who underwent randomization and were treated, 16% had cirrhosis	Large HCV trial confirms cirrhosis prevalence among chronic HCV patients.	"{""explanation"": ""Large HCV trial confirms cirrhosis prevalence among chronic HCV patients."", ""reference"": ""PMID:24725239"", ""snippet"": ""Of the 865 patients who underwent randomization and were treated, 16% had cirrhosis"", ""supports"": ""SUPPORT""}"
3667	3702	155	Hereditary von Willebrand Disease	Hereditary_von_Willebrand_Disease.yaml	phenotypes	0	evidence	0	PMID:21289515	SUPPORT		Characteristic bleeding symptoms include epistaxis, easy bruising, oral cavity bleeding, menorrhagia, bleeding after dental extraction, surgery, and/or childbirth, and in severe cases, bleeding into joints and soft tissues.	Epistaxis is listed as a characteristic bleeding symptom.	"{""explanation"": ""Epistaxis is listed as a characteristic bleeding symptom."", ""reference"": ""PMID:21289515"", ""snippet"": ""Characteristic bleeding symptoms include epistaxis, easy bruising, oral cavity bleeding, menorrhagia, bleeding after dental extraction, surgery, and/or childbirth, and in severe cases, bleeding into joints and soft tissues."", ""supports"": ""SUPPORT""}"
3668	3703	155	Hereditary von Willebrand Disease	Hereditary_von_Willebrand_Disease.yaml	phenotypes	1	evidence	0	PMID:21289515	SUPPORT		Characteristic bleeding symptoms include epistaxis, easy bruising, oral cavity bleeding, menorrhagia, bleeding after dental extraction, surgery, and/or childbirth, and in severe cases, bleeding into joints and soft tissues.	Easy bruising is listed as a characteristic bleeding symptom.	"{""explanation"": ""Easy bruising is listed as a characteristic bleeding symptom."", ""reference"": ""PMID:21289515"", ""snippet"": ""Characteristic bleeding symptoms include epistaxis, easy bruising, oral cavity bleeding, menorrhagia, bleeding after dental extraction, surgery, and/or childbirth, and in severe cases, bleeding into joints and soft tissues."", ""supports"": ""SUPPORT""}"
3669	3704	155	Hereditary von Willebrand Disease	Hereditary_von_Willebrand_Disease.yaml	phenotypes	2	evidence	0	PMID:21289515	SUPPORT		Characteristic bleeding symptoms include epistaxis, easy bruising, oral cavity bleeding, menorrhagia, bleeding after dental extraction, surgery, and/or childbirth, and in severe cases, bleeding into joints and soft tissues.	Menorrhagia is listed among characteristic bleeding symptoms.	"{""explanation"": ""Menorrhagia is listed among characteristic bleeding symptoms."", ""reference"": ""PMID:21289515"", ""snippet"": ""Characteristic bleeding symptoms include epistaxis, easy bruising, oral cavity bleeding, menorrhagia, bleeding after dental extraction, surgery, and/or childbirth, and in severe cases, bleeding into joints and soft tissues."", ""supports"": ""SUPPORT""}"
3715	3725	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	phenotypes	0	evidence	0	PMID:37403154	SUPPORT		Hirschsprung's disease in adults is usually a short or ultra-short aganglionic segment because it shows relatively mild symptoms. Surgical removal of the aganglionic segment of the gut is the definitive treatment for Hirschsprung's disease.	This reference supports the diagnostic category of chronic constipation in Hirschsprung disease.	"{""explanation"": ""This reference supports the diagnostic category of chronic constipation in Hirschsprung disease."", ""reference"": ""PMID:37403154"", ""snippet"": ""Hirschsprung's disease in adults is usually a short or ultra-short aganglionic segment because it shows relatively mild symptoms. Surgical removal of the aganglionic segment of the gut is the definitive treatment for Hirschsprung's disease."", ""supports"": ""SUPPORT""}"
3716	3725	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	phenotypes	0	evidence	1	PMID:34882271	SUPPORT		Children with constipation and suspected Hirschsprung's disease are referred for rectal biopsy.	This reference supports the association between chronic constipation and Hirschsprung's disease.	"{""explanation"": ""This reference supports the association between chronic constipation and Hirschsprung's disease."", ""reference"": ""PMID:34882271"", ""snippet"": ""Children with constipation and suspected Hirschsprung's disease are referred for rectal biopsy."", ""supports"": ""SUPPORT""}"
3717	3726	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	phenotypes	1	evidence	0	PMID:23001136	SUPPORT		Hirschsprung's disease (HSCR) is a fairly frequent cause of intestinal obstruction in children.	The reference indicates that HSCR is a frequent cause of a gastrointestinal issue, supporting a high frequency of gastrointestinal phenotypes associated with the disease.	"{""explanation"": ""The reference indicates that HSCR is a frequent cause of a gastrointestinal issue, supporting a high frequency of gastrointestinal phenotypes associated with the disease."", ""reference"": ""PMID:23001136"", ""snippet"": ""Hirschsprung's disease (HSCR) is a fairly frequent cause of intestinal obstruction in children."", ""supports"": ""SUPPORT""}"
3718	3726	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	phenotypes	1	evidence	1	PMID:18959706	SUPPORT		Abdominal distension and vomiting were most common modes of presentation (100 and 71%, respectively).	The reference explicitly states that abdominal distension is a common phenotype for Hirschsprung Disease, which supports the statement.	"{""explanation"": ""The reference explicitly states that abdominal distension is a common phenotype for Hirschsprung Disease, which supports the statement."", ""reference"": ""PMID:18959706"", ""snippet"": ""Abdominal distension and vomiting were most common modes of presentation (100 and 71%, respectively)."", ""supports"": ""SUPPORT""}"
3719	3729	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	phenotypes	4	evidence	0	PMID:23043324	PARTIAL		Clinical signs include severe constipation and distended bowel due to a non-motile colon.	This reference describes gastrointestinal symptoms but does not specifically mention delayed meconium passage.	"{""explanation"": ""This reference describes gastrointestinal symptoms but does not specifically mention delayed meconium passage."", ""reference"": ""PMID:23043324"", ""snippet"": ""Clinical signs include severe constipation and distended bowel due to a non-motile colon."", ""supports"": ""PARTIAL""}"
3720	3729	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	phenotypes	4	evidence	1	PMID:6481580	PARTIAL		Eleven infants passed a meconium stool by 24 hours of age (42%), and 15 had passed meconium by 48 hours (58%).	This indicates that while a significant portion of infants with Hirschsprung Disease passed meconium within 48 hours, it was not universal.	"{""explanation"": ""This indicates that while a significant portion of infants with Hirschsprung Disease passed meconium within 48 hours, it was not universal."", ""reference"": ""PMID:6481580"", ""snippet"": ""Eleven infants passed a meconium stool by 24 hours of age (42%), and 15 had passed meconium by 48 hours (58%)."", ""supports"": ""PARTIAL""}"
3721	3730	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	phenotypes	5	evidence	0	PMID:29300049	PARTIAL		Symptoms of Hirschsprung disease include constipation, vomiting, abdominal distension and growth failure.	Failure to thrive can be inferred from growth failure, but it is not explicitly labeled as a common systemic phenotype.	"{""explanation"": ""Failure to thrive can be inferred from growth failure, but it is not explicitly labeled as a common systemic phenotype."", ""reference"": ""PMID:29300049"", ""snippet"": ""Symptoms of Hirschsprung disease include constipation, vomiting, abdominal distension and growth failure."", ""supports"": ""PARTIAL""}"
3722	3730	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	phenotypes	5	evidence	1	PMID:35690467	PARTIAL		Counseling parents is critical for ensuring they understand their child's condition, how it must be treated, pitfalls that can occur during treatment, and how they will do in the long term ... outcomes, and familial nature.	While the actual term 'failure to thrive' is not used, the discussion around growth and long-term outcomes implies potential issues with growth.	"{""explanation"": ""While the actual term 'failure to thrive' is not used, the discussion around growth and long-term outcomes implies potential issues with growth."", ""reference"": ""PMID:35690467"", ""snippet"": ""Counseling parents is critical for ensuring they understand their child's condition, how it must be treated, pitfalls that can occur during treatment, and how they will do in the long term ... outcomes, and familial nature."", ""supports"": ""PARTIAL""}"
3723	3731	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	phenotypes	6	evidence	0	PMID:28328696	SUPPORT		Hirschsprung-associated enterocolitis can be a life-threatening sequela.	The literature clearly states that enterocolitis is a potentially life-threatening complication of Hirschsprung disease.	"{""explanation"": ""The literature clearly states that enterocolitis is a potentially life-threatening complication of Hirschsprung disease."", ""reference"": ""PMID:28328696"", ""snippet"": ""Hirschsprung-associated enterocolitis can be a life-threatening sequela."", ""supports"": ""SUPPORT""}"
3724	3731	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	phenotypes	6	evidence	1	PMID:30602191	SUPPORT		There is no standardized definition for HAEC. The initial HAEC score cut-off is restrictive and might fail to identify milder episodes.	The study discusses the occurrence of Hirschsprung-associated enterocolitis (HAEC) in patients with Hirschsprung disease, supporting the statement that enterocolitis is a complication.	"{""explanation"": ""The study discusses the occurrence of Hirschsprung-associated enterocolitis (HAEC) in patients with Hirschsprung disease, supporting the statement that enterocolitis is a complication."", ""reference"": ""PMID:30602191"", ""snippet"": ""There is no standardized definition for HAEC. The initial HAEC score cut-off is restrictive and might fail to identify milder episodes."", ""supports"": ""SUPPORT""}"
3725	3731	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	phenotypes	6	evidence	2	PMID:30594740	SUPPORT		The leading cause of mortality in HSCR is HSCR-associated enterocolitis (HAEC).	This reference supports the statement by indicating that enterocolitis is a significant and potentially fatal complication of Hirschsprung disease.	"{""explanation"": ""This reference supports the statement by indicating that enterocolitis is a significant and potentially fatal complication of Hirschsprung disease."", ""reference"": ""PMID:30594740"", ""snippet"": ""The leading cause of mortality in HSCR is HSCR-associated enterocolitis (HAEC)."", ""supports"": ""SUPPORT""}"
3726	3732	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	phenotypes	7	evidence	0	PMID:21253751	PARTIAL		Onset and clinical features do correlate with severity. Newborns and infants seem to be more likely to develop serious life-threatening complications, particularly in case of associated cardiovascular malformations.	The literature discusses severe complications and mortality in Hirschsprung's disease, which can be indirectly related to failure to thrive, but it does not explicitly mention systemic frequency or the specific causes noted in the statement.	"{""explanation"": ""The literature discusses severe complications and mortality in Hirschsprung's disease, which can be indirectly related to failure to thrive, but it does not explicitly mention systemic frequency or the specific causes noted in the statement."", ""reference"": ""PMID:21253751"", ""snippet"": ""Onset and clinical features do correlate with severity. Newborns and infants seem to be more likely to develop serious life-threatening complications, particularly in case of associated cardiovascular malformations."", ""supports"": ""PARTIAL""}"
3727	3733	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	phenotypes	8	evidence	0	PMID:35975334	PARTIAL		Undernutrition is prevalent among children with Hirschsprung disease. Nutrition assessment to identify individuals at risk of undernutrition for further intervention is necessary.	The literature indicates that undernutrition is common in children with Hirschsprung disease, and severe cases with prolonged malnutrition could potentially lead to developmental delays. However, it does not explicitly state that developmental delay is a frequent outcome.	"{""explanation"": ""The literature indicates that undernutrition is common in children with Hirschsprung disease, and severe cases with prolonged malnutrition could potentially lead to developmental delays. However, it does not explicitly state that developmental delay is a frequent outcome."", ""reference"": ""PMID:35975334"", ""snippet"": ""Undernutrition is prevalent among children with Hirschsprung disease. Nutrition assessment to identify individuals at risk of undernutrition for further intervention is necessary."", ""supports"": ""PARTIAL""}"
3728	3733	156	Hirschsprung Disease	Hirschsprung_Disease.yaml	phenotypes	8	evidence	1	PMID:35690460	PARTIAL		In LMICs, patients with HD are much more likely to present in a delayed fashion with subsequent increased morbidity and mortality including higher rates of chronic obstruction, malnutrition with failure to thrive, complete obstruction and perforation.	This reference suggests that severe malnutrition and failure to thrive are common in low- and middle-income countries, which could lead to developmental delays. However, it does not explicitly confirm developmental delay as a frequent outcome.	"{""explanation"": ""This reference suggests that severe malnutrition and failure to thrive are common in low- and middle-income countries, which could lead to developmental delays. However, it does not explicitly confirm developmental delay as a frequent outcome."", ""reference"": ""PMID:35690460"", ""snippet"": ""In LMICs, patients with HD are much more likely to present in a delayed fashion with subsequent increased morbidity and mortality including higher rates of chronic obstruction, malnutrition with failure to thrive, complete obstruction and perforation."", ""supports"": ""PARTIAL""}"
3754	3743	157	Holt-Oram syndrome	Holt_Oram.yaml	phenotypes	0	evidence	0	PMID:36936432	SUPPORT		Holt-Oram syndrome (HOS) is a rare genetic disorder characterized by upper limb abnormalities, congenital heart defects, and/or conduction abnormalities	Case report demonstrating upper limb abnormalities as a cardinal clinical feature of HOS	"{""explanation"": ""Case report demonstrating upper limb abnormalities as a cardinal clinical feature of HOS"", ""reference"": ""PMID:36936432"", ""snippet"": ""Holt-Oram syndrome (HOS) is a rare genetic disorder characterized by upper limb abnormalities, congenital heart defects, and/or conduction abnormalities"", ""supports"": ""SUPPORT""}"
3755	3744	157	Holt-Oram syndrome	Holt_Oram.yaml	phenotypes	1	evidence	0	PMID:36936432	SUPPORT		Holt-Oram syndrome (HOS) is a rare genetic disorder characterized by upper limb abnormalities, congenital heart defects, and/or conduction abnormalities	Case report of HOS with upper limb alterations demonstrating the limb phenotype is a cardinal feature	"{""explanation"": ""Case report of HOS with upper limb alterations demonstrating the limb phenotype is a cardinal feature"", ""reference"": ""PMID:36936432"", ""snippet"": ""Holt-Oram syndrome (HOS) is a rare genetic disorder characterized by upper limb abnormalities, congenital heart defects, and/or conduction abnormalities"", ""supports"": ""SUPPORT""}"
3756	3745	157	Holt-Oram syndrome	Holt_Oram.yaml	phenotypes	2	evidence	0	PMID:36936432	SUPPORT		The patient inherited a base T (reference C) at rs883079 from her mother and base C (reference T) at rs10850326 from her father, both of which belong to the 3'-untranslated region (UTR) of the TBX5 gene	Case report showing TBX5 3'-UTR variants can cause HOS with skeletal manifestations	"{""explanation"": ""Case report showing TBX5 3'-UTR variants can cause HOS with skeletal manifestations"", ""reference"": ""PMID:36936432"", ""snippet"": ""The patient inherited a base T (reference C) at rs883079 from her mother and base C (reference T) at rs10850326 from her father, both of which belong to the 3'-untranslated region (UTR) of the TBX5 gene"", ""supports"": ""SUPPORT""}"
3757	3746	157	Holt-Oram syndrome	Holt_Oram.yaml	phenotypes	3	evidence	0	PMID:39596866	SUPPORT		Within these malformations, septal defects such as ventricular (VSD) and atrial septal defects (ASD) are the most common forms of CHDs	Establishes that septal defects are cardinal features of congenital heart disease associated with genetic factors including TBX5	"{""explanation"": ""Establishes that septal defects are cardinal features of congenital heart disease associated with genetic factors including TBX5"", ""reference"": ""PMID:39596866"", ""snippet"": ""Within these malformations, septal defects such as ventricular (VSD) and atrial septal defects (ASD) are the most common forms of CHDs"", ""supports"": ""SUPPORT""}"
3758	3746	157	Holt-Oram syndrome	Holt_Oram.yaml	phenotypes	3	evidence	1	PMID:39156428	SUPPORT		Seventy-five percent of those with Holt-Oram syndrome have a congenital cardiac defect, which most frequently affects the septum	Clinical epidemiology showing atrial septal defect is the most common cardiac manifestation of HOS	"{""explanation"": ""Clinical epidemiology showing atrial septal defect is the most common cardiac manifestation of HOS"", ""reference"": ""PMID:39156428"", ""snippet"": ""Seventy-five percent of those with Holt-Oram syndrome have a congenital cardiac defect, which most frequently affects the septum"", ""supports"": ""SUPPORT""}"
3759	3747	157	Holt-Oram syndrome	Holt_Oram.yaml	phenotypes	4	evidence	0	PMID:38189150	SUPPORT		Transcriptional changes in the atria observed in human HF directly antagonize the atrial rhythm gene regulatory network	Demonstrates that TBX5-dependent atrial gene networks regulate conduction and rhythm, with their disruption causing arrhythmias including conduction abnormalities	"{""explanation"": ""Demonstrates that TBX5-dependent atrial gene networks regulate conduction and rhythm, with their disruption causing arrhythmias including conduction abnormalities"", ""reference"": ""PMID:38189150"", ""snippet"": ""Transcriptional changes in the atria observed in human HF directly antagonize the atrial rhythm gene regulatory network"", ""supports"": ""SUPPORT""}"
3760	3747	157	Holt-Oram syndrome	Holt_Oram.yaml	phenotypes	4	evidence	1	PMID:38235884	SUPPORT		HOS usually requires the implantation of a pacemaker, because of cardiac conduction disturbances	Clinical evidence that conduction abnormalities are a significant feature requiring therapeutic intervention in HOS	"{""explanation"": ""Clinical evidence that conduction abnormalities are a significant feature requiring therapeutic intervention in HOS"", ""reference"": ""PMID:38235884"", ""snippet"": ""HOS usually requires the implantation of a pacemaker, because of cardiac conduction disturbances"", ""supports"": ""SUPPORT""}"
3761	3748	157	Holt-Oram syndrome	Holt_Oram.yaml	phenotypes	5	evidence	0	PMID:39677667	SUPPORT		Chd4 AKO mice had increased vulnerability to AF from electrical pacing and a fraction had spontaneous AF	Evidence that disruption of TBX5's chromatin remodeling partner CHD4 increases atrial fibrillation susceptibility, consistent with HOS pathophysiology	"{""explanation"": ""Evidence that disruption of TBX5's chromatin remodeling partner CHD4 increases atrial fibrillation susceptibility, consistent with HOS pathophysiology"", ""reference"": ""PMID:39677667"", ""snippet"": ""Chd4 AKO mice had increased vulnerability to AF from electrical pacing and a fraction had spontaneous AF"", ""supports"": ""SUPPORT""}"
3762	3749	157	Holt-Oram syndrome	Holt_Oram.yaml	phenotypes	6	evidence	0	PMID:39596866	SUPPORT		Congenital heart diseases (CHDs) are a group of complex diseases characterized by structural and functional malformations during development in the human heart	Establishes that septal defects are core manifestations of congenital heart disease linked to genetic factors like TBX5	"{""explanation"": ""Establishes that septal defects are core manifestations of congenital heart disease linked to genetic factors like TBX5"", ""reference"": ""PMID:39596866"", ""snippet"": ""Congenital heart diseases (CHDs) are a group of complex diseases characterized by structural and functional malformations during development in the human heart"", ""supports"": ""SUPPORT""}"
3770	3756	158	Human African trypanosomiasis	Human_African_Trypanosomiasis.yaml	phenotypes	0	evidence	0	PMID:23829907	SUPPORT		characteristic sleep-wake disturbances	The abstract lists sleep-wake disturbances as characteristic features.	"{""explanation"": ""The abstract lists sleep-wake disturbances as characteristic features."", ""reference"": ""PMID:23829907"", ""snippet"": ""characteristic sleep-wake disturbances"", ""supports"": ""SUPPORT""}"
3838	3788	159	Huntington's Disease	Huntingtons_Disease.yaml	phenotypes	0	evidence	0	PMID:24176425	SUPPORT		Huntington disease (HD) is an autosomal dominant, adult-onset, progressive neurodegenerative disease characterized by the triad of abnormal movements (typically chorea), cognitive impairment, and psychiatric problems.	The reference clearly states that chorea is a characteristic abnormal movement in Huntington's Disease.	"{""explanation"": ""The reference clearly states that chorea is a characteristic abnormal movement in Huntington's Disease."", ""reference"": ""PMID:24176425"", ""snippet"": ""Huntington disease (HD) is an autosomal dominant, adult-onset, progressive neurodegenerative disease characterized by the triad of abnormal movements (typically chorea), cognitive impairment, and psychiatric problems."", ""supports"": ""SUPPORT""}"
3839	3788	159	Huntington's Disease	Huntingtons_Disease.yaml	phenotypes	0	evidence	1	PMID:36049455	SUPPORT		Chorea is one of the major manifestations of Huntington's disease.	This reference confirms that chorea is a major manifestation of Huntington's Disease.	"{""explanation"": ""This reference confirms that chorea is a major manifestation of Huntington's Disease."", ""reference"": ""PMID:36049455"", ""snippet"": ""Chorea is one of the major manifestations of Huntington's disease."", ""supports"": ""SUPPORT""}"
3840	3788	159	Huntington's Disease	Huntingtons_Disease.yaml	phenotypes	0	evidence	2	PMID:31707371	SUPPORT		BACKGROUND: Anosognosia, or unawareness of illness of deficits, has been observed in Huntington's disease (HD) in relation to motor and cognitive signs and symptoms. Most studies of awareness in HD have used self-report questionnaire methodology rather than asking patients to report on their symptoms in real-time. The two studies in which patients were asked about their chorea in real-time had small sample sizes and only examined patients early in disease progression.	The reference mentions chorea in the context of Huntington's Disease, supporting the statement.	"{""explanation"": ""The reference mentions chorea in the context of Huntington's Disease, supporting the statement."", ""reference"": ""PMID:31707371"", ""snippet"": ""BACKGROUND: Anosognosia, or unawareness of illness of deficits, has been observed in Huntington's disease (HD) in relation to motor and cognitive signs and symptoms. Most studies of awareness in HD have used self-report questionnaire methodology rather than asking patients to report on their symptoms in real-time. The two studies in which patients were asked about their chorea in real-time had small sample sizes and only examined patients early in disease progression."", ""supports"": ""SUPPORT""}"
3841	3788	159	Huntington's Disease	Huntingtons_Disease.yaml	phenotypes	0	evidence	3	PMID:6446233	SUPPORT		Huntington's disease (chorea) is characterized by abnormal movements and dementia.	This reference directly associates Huntington's Disease with chorea.	"{""explanation"": ""This reference directly associates Huntington's Disease with chorea."", ""reference"": ""PMID:6446233"", ""snippet"": ""Huntington's disease (chorea) is characterized by abnormal movements and dementia."", ""supports"": ""SUPPORT""}"
3842	3788	159	Huntington's Disease	Huntingtons_Disease.yaml	phenotypes	0	evidence	4	PMID:32699773	SUPPORT		Huntington's Disease (HD) is an autosomal dominant neurodegenerative disorder with a progressive decline in cognitive, motor, and psychological function. Chorea tends to be the most common associated movement disorder, although other variants of several abnormal movements are also seen.	The reference states that chorea is the most common associated movement disorder in Huntington's Disease.	"{""explanation"": ""The reference states that chorea is the most common associated movement disorder in Huntington's Disease."", ""reference"": ""PMID:32699773"", ""snippet"": ""Huntington's Disease (HD) is an autosomal dominant neurodegenerative disorder with a progressive decline in cognitive, motor, and psychological function. Chorea tends to be the most common associated movement disorder, although other variants of several abnormal movements are also seen."", ""supports"": ""SUPPORT""}"
3907	3818	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	0	evidence	0	PMID:31472880	PARTIAL		Hypertensive heart disease includes the development of diastolic dysfunction, left ventricular hypertrophy, and heart failure with preserved and reduced ejection fraction. The development of heart failure can occur because of complications of ischemic heart disease or from progression of diastolic dysfunction to heart failure with preserved ejection fraction degenerating to a dilated heart with systolic dysfunction or heart failure with reduced ejection fraction.	The reference mentions heart failure as a frequent complication of hypertensive heart disease, but it does not specifically address dyspnea.	"{""explanation"": ""The reference mentions heart failure as a frequent complication of hypertensive heart disease, but it does not specifically address dyspnea."", ""reference"": ""PMID:31472880"", ""snippet"": ""Hypertensive heart disease includes the development of diastolic dysfunction, left ventricular hypertrophy, and heart failure with preserved and reduced ejection fraction. The development of heart failure can occur because of complications of ischemic heart disease or from progression of diastolic dysfunction to heart failure with preserved ejection fraction degenerating to a dilated heart with systolic dysfunction or heart failure with reduced ejection fraction."", ""supports"": ""PARTIAL""}"
3908	3818	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	0	evidence	1	PMID:15950133	PARTIAL		Dyspnea and leg effort are the major symptoms limiting exercise in healthy subjects and in patients with a variety of respiratory disorders.	While the reference discusses dyspnea as a symptom that limits exercise tolerance, it is not specific to hypertensive heart disease.	"{""explanation"": ""While the reference discusses dyspnea as a symptom that limits exercise tolerance, it is not specific to hypertensive heart disease."", ""reference"": ""PMID:15950133"", ""snippet"": ""Dyspnea and leg effort are the major symptoms limiting exercise in healthy subjects and in patients with a variety of respiratory disorders."", ""supports"": ""PARTIAL""}"
3909	3818	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	0	evidence	2	PMID:37345800	SUPPORT		Ventilatory efficiency is impaired people with hypertension without a diagnosis of heart failure versus normotensive individuals.	This reference implies that dyspnea could be an issue in hypertensive patients, which could lead to reduced exercise tolerance.	"{""explanation"": ""This reference implies that dyspnea could be an issue in hypertensive patients, which could lead to reduced exercise tolerance."", ""reference"": ""PMID:37345800"", ""snippet"": ""Ventilatory efficiency is impaired people with hypertension without a diagnosis of heart failure versus normotensive individuals."", ""supports"": ""SUPPORT""}"
3910	3818	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	0	evidence	3	PMID:26569571	PARTIAL		Pulmonary hypertension (PH) due to left-sided heart disease (LSHD) is a common and disconcerting occurrence. For example, both heart failure (HF) with preserved and reduced ejection fraction (HFpEF and HFrEF) often lead to PH as a consequence of a chronic elevation in left atrial filling pressure.	It mentions heart failure and its link to dyspnea indirectly through pulmonary hypertension but does not focus on hypertensive heart disease specifically.	"{""explanation"": ""It mentions heart failure and its link to dyspnea indirectly through pulmonary hypertension but does not focus on hypertensive heart disease specifically."", ""reference"": ""PMID:26569571"", ""snippet"": ""Pulmonary hypertension (PH) due to left-sided heart disease (LSHD) is a common and disconcerting occurrence. For example, both heart failure (HF) with preserved and reduced ejection fraction (HFpEF and HFrEF) often lead to PH as a consequence of a chronic elevation in left atrial filling pressure."", ""supports"": ""PARTIAL""}"
3911	3819	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	1	evidence	0	PMID:35061769	SUPPORT		Hypertension was found in 45% of patients. Hypertensive patients were older, with a higher SIS, calcium score, and prevalence of comorbidities and statin therapy compared to the normotensive (all p<0.05).	Description supports the presence of cardiovascular phenotypes linked to hypertensive heart disease, such as varying levels of coronary artery involvement.	"{""explanation"": ""Description supports the presence of cardiovascular phenotypes linked to hypertensive heart disease, such as varying levels of coronary artery involvement."", ""reference"": ""PMID:35061769"", ""snippet"": ""Hypertension was found in 45% of patients. Hypertensive patients were older, with a higher SIS, calcium score, and prevalence of comorbidities and statin therapy compared to the normotensive (all p<0.05)."", ""supports"": ""SUPPORT""}"
3912	3819	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	1	evidence	1	PMID:37861255	SUPPORT		PH is more than a single clinical entity due to its complex mechanism in which more than one subgroup may develop over time in the same patient. This complex mechanism challenges us when diagnosing the patient and faces us with life-threatening complications.	Pulmonary hypertension can be linked to hypertensive heart disease and exhibits complex cardiovascular phenotypes, including potential complications visible in diagnostic criteria.	"{""explanation"": ""Pulmonary hypertension can be linked to hypertensive heart disease and exhibits complex cardiovascular phenotypes, including potential complications visible in diagnostic criteria."", ""reference"": ""PMID:37861255"", ""snippet"": ""PH is more than a single clinical entity due to its complex mechanism in which more than one subgroup may develop over time in the same patient. This complex mechanism challenges us when diagnosing the patient and faces us with life-threatening complications."", ""supports"": ""SUPPORT""}"
3913	3820	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	2	evidence	0	PMID:34809918	PARTIAL		PH due to LHD is associated with negative impact on outcomes in addition to worse symptoms and exercise capacity.	While this supports the cardiovascular phenotype in the context of arrhythmias, it does not specifically mention palpitations or syncope as sequelae of hypertensive heart disease.	"{""explanation"": ""While this supports the cardiovascular phenotype in the context of arrhythmias, it does not specifically mention palpitations or syncope as sequelae of hypertensive heart disease."", ""reference"": ""PMID:34809918"", ""snippet"": ""PH due to LHD is associated with negative impact on outcomes in addition to worse symptoms and exercise capacity."", ""supports"": ""PARTIAL""}"
3914	3820	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	2	evidence	1	PMID:36202538	PARTIAL		Evaluation of cardiac phenotypes in secondary hypertension provides a unique opportunity to study underlying hormonal and biochemical mechanisms affecting the heart.	This implies a variety of cardiac phenotypes can be seen in hypertension but does not explicitly list arrhythmias, palpitations, or syncope.	"{""explanation"": ""This implies a variety of cardiac phenotypes can be seen in hypertension but does not explicitly list arrhythmias, palpitations, or syncope."", ""reference"": ""PMID:36202538"", ""snippet"": ""Evaluation of cardiac phenotypes in secondary hypertension provides a unique opportunity to study underlying hormonal and biochemical mechanisms affecting the heart."", ""supports"": ""PARTIAL""}"
3915	3821	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	3	evidence	0	PMID:19863866	SUPPORT		Fatigue, dyspnea, reduced exercise tolerance, and peripheral edema are common presenting complaints.	The snippet from the literature directly supports the statement that fatigue is commonly reported among patients with hypertensive heart disease.	"{""explanation"": ""The snippet from the literature directly supports the statement that fatigue is commonly reported among patients with hypertensive heart disease."", ""reference"": ""PMID:19863866"", ""snippet"": ""Fatigue, dyspnea, reduced exercise tolerance, and peripheral edema are common presenting complaints."", ""supports"": ""SUPPORT""}"
3916	3822	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	4	evidence	0	PMID:2959621	PARTIAL		Chest pain is a common complaint among hypertensive patients.	The literature supports that chest pain is common among hypertensive patients, but it does not specify the frequency as 'occasional'.	"{""explanation"": ""The literature supports that chest pain is common among hypertensive patients, but it does not specify the frequency as 'occasional'."", ""reference"": ""PMID:2959621"", ""snippet"": ""Chest pain is a common complaint among hypertensive patients."", ""supports"": ""PARTIAL""}"
3917	3822	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	4	evidence	1	PMID:30066227	PARTIAL		Uncontrolled hypertension is one of the most common determinant for the persistently high burden of cardiovascular (CV) disease, mostly including coronary artery disease (CAD) and hospital admissions due to acute coronary events.	The literature supports that hypertension is linked to coronary artery disease, which can present with chest pain, but it does not specify the frequency as 'occasional'.	"{""explanation"": ""The literature supports that hypertension is linked to coronary artery disease, which can present with chest pain, but it does not specify the frequency as 'occasional'."", ""reference"": ""PMID:30066227"", ""snippet"": ""Uncontrolled hypertension is one of the most common determinant for the persistently high burden of cardiovascular (CV) disease, mostly including coronary artery disease (CAD) and hospital admissions due to acute coronary events."", ""supports"": ""PARTIAL""}"
3918	3822	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	4	evidence	2	PMID:20932116	PARTIAL		Evidence of a link between headache symptoms and cardiovascular disease has rapidly grown in recent years and it is of utmost importance for the cardiologist and neurologist to be aware of this intimate connection.	The literature supports the link between cardiovascular disease and symptoms such as chest pain, but it does not specify the frequency as 'occasional'.	"{""explanation"": ""The literature supports the link between cardiovascular disease and symptoms such as chest pain, but it does not specify the frequency as 'occasional'."", ""reference"": ""PMID:20932116"", ""snippet"": ""Evidence of a link between headache symptoms and cardiovascular disease has rapidly grown in recent years and it is of utmost importance for the cardiologist and neurologist to be aware of this intimate connection."", ""supports"": ""PARTIAL""}"
3919	3823	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	5	evidence	0	PMID:31472889	PARTIAL		Hypertensive heart disease can manifest as cardiac arrhythmias. Supraventricular and ventricular arrhythmias may occur in the hypertensive patients.	The literature supports that hypertensive heart disease can manifest as arrhythmias, but it does not specifically address the frequency as 'occasional'.	"{""explanation"": ""The literature supports that hypertensive heart disease can manifest as arrhythmias, but it does not specifically address the frequency as 'occasional'."", ""reference"": ""PMID:31472889"", ""snippet"": ""Hypertensive heart disease can manifest as cardiac arrhythmias. Supraventricular and ventricular arrhythmias may occur in the hypertensive patients."", ""supports"": ""PARTIAL""}"
3920	3823	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	5	evidence	1	PMID:36519436	PARTIAL		Hypertension is prevalent in >70% of atrial fibrillation patients. In turn, hypertensive patients have up to 73% greater likelihood of atrial fibrillation.	The literature supports the association between hypertension and atrial fibrillation but does not specify the frequency of arrhythmias in hypertensive heart disease as 'occasional'.	"{""explanation"": ""The literature supports the association between hypertension and atrial fibrillation but does not specify the frequency of arrhythmias in hypertensive heart disease as 'occasional'."", ""reference"": ""PMID:36519436"", ""snippet"": ""Hypertension is prevalent in >70% of atrial fibrillation patients. In turn, hypertensive patients have up to 73% greater likelihood of atrial fibrillation."", ""supports"": ""PARTIAL""}"
3921	3824	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	6	evidence	0	PMID:11419663	SUPPORT		Essential treatment includes rapid initiation of pharmacologic agents to control hypertension.	This reference indicates that controlling hypertension is essential in the treatment of aortic dissection, supporting the notion that hypertension is a major risk factor for aortic dissection.	"{""explanation"": ""This reference indicates that controlling hypertension is essential in the treatment of aortic dissection, supporting the notion that hypertension is a major risk factor for aortic dissection."", ""reference"": ""PMID:11419663"", ""snippet"": ""Essential treatment includes rapid initiation of pharmacologic agents to control hypertension."", ""supports"": ""SUPPORT""}"
3922	3824	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	6	evidence	1	PMID:25620633	SUPPORT		In this review, we discuss cardiovascular hypertensive emergencies, including acute coronary syndrome, aortic dissection, congestive heart failure, and sympathomimetic hypertensive crises.	This reference discusses aortic dissection as a cardiovascular hypertensive emergency, supporting the statement that hypertension is a major risk factor for aortic dissection.	"{""explanation"": ""This reference discusses aortic dissection as a cardiovascular hypertensive emergency, supporting the statement that hypertension is a major risk factor for aortic dissection."", ""reference"": ""PMID:25620633"", ""snippet"": ""In this review, we discuss cardiovascular hypertensive emergencies, including acute coronary syndrome, aortic dissection, congestive heart failure, and sympathomimetic hypertensive crises."", ""supports"": ""SUPPORT""}"
3923	3824	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	6	evidence	2	PMID:25573747	SUPPORT		A clinical profile of those at risk of dissection is emerging and includes the presence of congenital heart defects, aortic dilatation and hypertension.	This reference mentions hypertension as part of the clinical profile for those at risk of aortic dissection, supporting the statement.	"{""explanation"": ""This reference mentions hypertension as part of the clinical profile for those at risk of aortic dissection, supporting the statement."", ""reference"": ""PMID:25573747"", ""snippet"": ""A clinical profile of those at risk of dissection is emerging and includes the presence of congenital heart defects, aortic dilatation and hypertension."", ""supports"": ""SUPPORT""}"
3924	3824	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	6	evidence	3	PMID:27873227	PARTIAL		Even though arterial hypertension is commonly regarded as a predisposing condition for the development of thoracic aorta aneurysms, the role of blood pressure (BP) as determinant of aortic root enlargement is still controversial.	This reference acknowledges that hypertension is commonly regarded as a predisposing condition for aortic diseases but notes some controversy regarding its role, providing partial support.	"{""explanation"": ""This reference acknowledges that hypertension is commonly regarded as a predisposing condition for aortic diseases but notes some controversy regarding its role, providing partial support."", ""reference"": ""PMID:27873227"", ""snippet"": ""Even though arterial hypertension is commonly regarded as a predisposing condition for the development of thoracic aorta aneurysms, the role of blood pressure (BP) as determinant of aortic root enlargement is still controversial."", ""supports"": ""PARTIAL""}"
3925	3824	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	6	evidence	4	PMID:23993245	SUPPORT		Similar to other acute cardiovascular events (e.g., acute myocardial infarction, sudden death, stroke, and pulmonary embolism) there is a growing body of evidence regarding temporal patterns in onset, characterized by circadian, seasonal and weekly variations for aortic aneurysms.	This reference discusses aortic dissection within the context of other cardiovascular events and mentions hypertension as a common underlying pathophysiologic mechanism, supporting the statement.	"{""explanation"": ""This reference discusses aortic dissection within the context of other cardiovascular events and mentions hypertension as a common underlying pathophysiologic mechanism, supporting the statement."", ""reference"": ""PMID:23993245"", ""snippet"": ""Similar to other acute cardiovascular events (e.g., acute myocardial infarction, sudden death, stroke, and pulmonary embolism) there is a growing body of evidence regarding temporal patterns in onset, characterized by circadian, seasonal and weekly variations for aortic aneurysms."", ""supports"": ""SUPPORT""}"
3926	3825	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	7	evidence	0	PMID:10645696	SUPPORT		Hypertension is a leading cause of both stroke and heart disease.	The abstract explicitly states that hypertension is a leading cause of stroke, supporting the statement that hypertensive heart disease is occasionally associated with strokes.	"{""explanation"": ""The abstract explicitly states that hypertension is a leading cause of stroke, supporting the statement that hypertensive heart disease is occasionally associated with strokes."", ""reference"": ""PMID:10645696"", ""snippet"": ""Hypertension is a leading cause of both stroke and heart disease."", ""supports"": ""SUPPORT""}"
3927	3825	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	7	evidence	1	PMID:37980821	SUPPORT		Hypertension... for IS only.	The abstract mentions hypertension as a risk factor for ischemic stroke, supporting the statement that hypertensive heart disease is occasionally associated with strokes.	"{""explanation"": ""The abstract mentions hypertension as a risk factor for ischemic stroke, supporting the statement that hypertensive heart disease is occasionally associated with strokes."", ""reference"": ""PMID:37980821"", ""snippet"": ""Hypertension... for IS only."", ""supports"": ""SUPPORT""}"
3928	3825	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	7	evidence	2	PMID:36990309	SUPPORT		Hypertensive disorders of pregnancy are associated with a long-term risk for... ischemic stroke or hemorrhagic stroke in later life.	The abstract indicates a significant association between hypertensive disorders and stroke, supporting the statement that hypertensive heart disease is occasionally associated with strokes.	"{""explanation"": ""The abstract indicates a significant association between hypertensive disorders and stroke, supporting the statement that hypertensive heart disease is occasionally associated with strokes."", ""reference"": ""PMID:36990309"", ""snippet"": ""Hypertensive disorders of pregnancy are associated with a long-term risk for... ischemic stroke or hemorrhagic stroke in later life."", ""supports"": ""SUPPORT""}"
3929	3825	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	7	evidence	3	PMID:29869130	SUPPORT		Arterial hypertension represents the most important risk factor for ischemic and haemorrhagic stroke.	This abstract clearly supports the statement that hypertensive heart disease is occasionally associated with strokes.	"{""explanation"": ""This abstract clearly supports the statement that hypertensive heart disease is occasionally associated with strokes."", ""reference"": ""PMID:29869130"", ""snippet"": ""Arterial hypertension represents the most important risk factor for ischemic and haemorrhagic stroke."", ""supports"": ""SUPPORT""}"
3930	3825	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	7	evidence	4	PMID:32224751	SUPPORT		Risk factor modification plays a large role in stroke prevention. Strategies for early intervention, particularly for hypertension, are critical for reducing stroke morbidity and mortality.	The abstract supports the role of hypertension as a risk factor for stroke, aligning with the statement that hypertensive heart disease is occasionally associated with strokes.	"{""explanation"": ""The abstract supports the role of hypertension as a risk factor for stroke, aligning with the statement that hypertensive heart disease is occasionally associated with strokes."", ""reference"": ""PMID:32224751"", ""snippet"": ""Risk factor modification plays a large role in stroke prevention. Strategies for early intervention, particularly for hypertension, are critical for reducing stroke morbidity and mortality."", ""supports"": ""SUPPORT""}"
3931	3825	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	7	evidence	5	PMID:24080990	SUPPORT		Apart from the well-known role of hypertension in cerebrovascular disease... an independent risk factor for stroke.	This abstract confirms the role of hypertension as a risk factor for stroke, supporting the statement that hypertensive heart disease is occasionally associated with strokes.	"{""explanation"": ""This abstract confirms the role of hypertension as a risk factor for stroke, supporting the statement that hypertensive heart disease is occasionally associated with strokes."", ""reference"": ""PMID:24080990"", ""snippet"": ""Apart from the well-known role of hypertension in cerebrovascular disease... an independent risk factor for stroke."", ""supports"": ""SUPPORT""}"
3932	3826	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	8	evidence	0	PMID:31472888	NO_EVIDENCE		The authors discuss the natural history and pathogenesis of heart failure owing to hypertensive heart disease, reviewing the important role of left ventricular hypertrophy as the inciting process leading to diastolic dysfunction and heart failure with preserved ejection fraction.	The provided literature discusses the pathogenesis and progression of hypertensive heart disease but does not mention fatigue as a frequent symptom.	"{""explanation"": ""The provided literature discusses the pathogenesis and progression of hypertensive heart disease but does not mention fatigue as a frequent symptom."", ""reference"": ""PMID:31472888"", ""snippet"": ""The authors discuss the natural history and pathogenesis of heart failure owing to hypertensive heart disease, reviewing the important role of left ventricular hypertrophy as the inciting process leading to diastolic dysfunction and heart failure with preserved ejection fraction."", ""supports"": ""NO_EVIDENCE""}"
3933	3826	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	8	evidence	1	PMID:29766272	NO_EVIDENCE		The aim of this study was to evaluate the cardio-protective effects of different drug classes in treated pediatric hypertensive patients.	This study focuses on the effects of different antihypertensive drugs on pediatric patients and does not address fatigue as a symptom of hypertensive heart disease.	"{""explanation"": ""This study focuses on the effects of different antihypertensive drugs on pediatric patients and does not address fatigue as a symptom of hypertensive heart disease."", ""reference"": ""PMID:29766272"", ""snippet"": ""The aim of this study was to evaluate the cardio-protective effects of different drug classes in treated pediatric hypertensive patients."", ""supports"": ""NO_EVIDENCE""}"
3934	3826	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	8	evidence	2	PMID:28541499	NO_EVIDENCE		Hypertension (HTN) is a common cardiovascular risk factor leading to heart failure (HF), coronary artery disease (CAD), stroke, peripheral artery disease and chronic renal failure.	The document discusses various complications of hypertension but does not mention fatigue as a frequent symptom of hypertensive heart disease.	"{""explanation"": ""The document discusses various complications of hypertension but does not mention fatigue as a frequent symptom of hypertensive heart disease."", ""reference"": ""PMID:28541499"", ""snippet"": ""Hypertension (HTN) is a common cardiovascular risk factor leading to heart failure (HF), coronary artery disease (CAD), stroke, peripheral artery disease and chronic renal failure."", ""supports"": ""NO_EVIDENCE""}"
3935	3826	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	8	evidence	3	PMID:17593316	NO_EVIDENCE		Heart rate is an independent risk factor for patients with cardiovascular disease, in particular with arterial hypertension, myocardial infarction, coronary artery disease and heart failure.	This article focuses on the role of heart rate in cardiovascular diseases but does not mention fatigue as a frequent symptom of hypertensive heart disease.	"{""explanation"": ""This article focuses on the role of heart rate in cardiovascular diseases but does not mention fatigue as a frequent symptom of hypertensive heart disease."", ""reference"": ""PMID:17593316"", ""snippet"": ""Heart rate is an independent risk factor for patients with cardiovascular disease, in particular with arterial hypertension, myocardial infarction, coronary artery disease and heart failure."", ""supports"": ""NO_EVIDENCE""}"
3936	3826	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	8	evidence	4	PMID:23732143	NO_EVIDENCE		Hypertension is strongly associated with overall cardiovascular risk. Increased blood pressure contributes to cardiovascular and cerebrovascular endpoints, such as myocardial infarction, heart failure, cardiovascular death and stroke.	The literature describes the risks associated with hypertension but does not mention fatigue as a frequent symptom of hypertensive heart disease.	"{""explanation"": ""The literature describes the risks associated with hypertension but does not mention fatigue as a frequent symptom of hypertensive heart disease."", ""reference"": ""PMID:23732143"", ""snippet"": ""Hypertension is strongly associated with overall cardiovascular risk. Increased blood pressure contributes to cardiovascular and cerebrovascular endpoints, such as myocardial infarction, heart failure, cardiovascular death and stroke."", ""supports"": ""NO_EVIDENCE""}"
3937	3826	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	8	evidence	5	PMID:38597067	NO_EVIDENCE		We now have compelling evidence for a key role of sympathetic overactivity in the pathogenesis and progression of hypertension and associated hypertension-mediated organ damage (such as endothelial dysfunction, arterial stiffness and left ventricular hypertrophy).	The literature discusses the role of sympathetic overactivity in hypertension and its complications but does not mention fatigue as a frequent symptom of hypertensive heart disease.	"{""explanation"": ""The literature discusses the role of sympathetic overactivity in hypertension and its complications but does not mention fatigue as a frequent symptom of hypertensive heart disease."", ""reference"": ""PMID:38597067"", ""snippet"": ""We now have compelling evidence for a key role of sympathetic overactivity in the pathogenesis and progression of hypertension and associated hypertension-mediated organ damage (such as endothelial dysfunction, arterial stiffness and left ventricular hypertrophy)."", ""supports"": ""NO_EVIDENCE""}"
3938	3827	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	9	evidence	0	PMID:18677585	SUPPORT		Hypertension and proteinuria are common risk factors for cardiovascular morbidity and mortality, as well as for the progression of renal disease.	The literature indicates that hypertension is associated with proteinuria and the progression of renal disease, supporting the statement that hypertension can cause and worsen kidney damage.	"{""explanation"": ""The literature indicates that hypertension is associated with proteinuria and the progression of renal disease, supporting the statement that hypertension can cause and worsen kidney damage."", ""reference"": ""PMID:18677585"", ""snippet"": ""Hypertension and proteinuria are common risk factors for cardiovascular morbidity and mortality, as well as for the progression of renal disease."", ""supports"": ""SUPPORT""}"
3939	3827	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	9	evidence	1	PMID:1614065	PARTIAL		The number of patients developing end-stage renal disease (ESRD) as a consequence of hypertension is increasing and accounts for 25% of new cases of ESRD in the United States. However, the diagnosis of hypertensive ESRD is one of exclusion and no pathologic data corroborate this classification.	While the literature suggests a link between hypertension and end-stage renal disease, it also notes that the diagnosis is often one of exclusion and lacks definitive pathologic data.	"{""explanation"": ""While the literature suggests a link between hypertension and end-stage renal disease, it also notes that the diagnosis is often one of exclusion and lacks definitive pathologic data."", ""reference"": ""PMID:1614065"", ""snippet"": ""The number of patients developing end-stage renal disease (ESRD) as a consequence of hypertension is increasing and accounts for 25% of new cases of ESRD in the United States. However, the diagnosis of hypertensive ESRD is one of exclusion and no pathologic data corroborate this classification."", ""supports"": ""PARTIAL""}"
3940	3827	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	9	evidence	2	PMID:7606639	SUPPORT		The kidney can be considered as both culprit and victim in the hypertensive process. Deranged renal function contributes to the development of arterial hypertension and of secondary vascular damage at the glomerular and arteriolar level and accounts for the development of progressive nephrosclerosis.	This reference supports the statement by indicating that hypertension can lead to renal damage, including proteinuria and nephrosclerosis.	"{""explanation"": ""This reference supports the statement by indicating that hypertension can lead to renal damage, including proteinuria and nephrosclerosis."", ""reference"": ""PMID:7606639"", ""snippet"": ""The kidney can be considered as both culprit and victim in the hypertensive process. Deranged renal function contributes to the development of arterial hypertension and of secondary vascular damage at the glomerular and arteriolar level and accounts for the development of progressive nephrosclerosis."", ""supports"": ""SUPPORT""}"
3941	3827	160	Hypertensive Heart Disease	Hypertensive_Heart_Disease.yaml	phenotypes	9	evidence	3	PMID:20400279	SUPPORT		With ongoing progression and glomerular extracapillary proliferation, tubulointerstitial damage occurs with consequent nephron loss and development of fibrotic lesions, finally resulting in terminal renal failure.	The literature supports the statement by discussing how glomerular injury, often exacerbated by conditions like hypertension, leads to further renal damage and proteinuria.	"{""explanation"": ""The literature supports the statement by discussing how glomerular injury, often exacerbated by conditions like hypertension, leads to further renal damage and proteinuria."", ""reference"": ""PMID:20400279"", ""snippet"": ""With ongoing progression and glomerular extracapillary proliferation, tubulointerstitial damage occurs with consequent nephron loss and development of fibrotic lesions, finally resulting in terminal renal failure."", ""supports"": ""SUPPORT""}"
4014	3864	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	0	evidence	0	PMID:34533409	SUPPORT		Hypertrophic cardiomyopathy (HCM) is a complex disease characterized by thickening of the cardiac muscle. Common symptoms include chest pain, shortness of breath, palpitations, fatigue and syncope (fainting), which are often confused for other conditions.	This literature supports the statement as it lists chest pain as a common symptom of Hypertrophic Cardiomyopathy.	"{""explanation"": ""This literature supports the statement as it lists chest pain as a common symptom of Hypertrophic Cardiomyopathy."", ""reference"": ""PMID:34533409"", ""snippet"": ""Hypertrophic cardiomyopathy (HCM) is a complex disease characterized by thickening of the cardiac muscle. Common symptoms include chest pain, shortness of breath, palpitations, fatigue and syncope (fainting), which are often confused for other conditions."", ""supports"": ""SUPPORT""}"
4015	3865	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	1	evidence	0	PMID:29655822	SUPPORT		Heart failure (HF), characterized by excessive exertional dyspnea, is a common complication within the broad clinical spectrum of hypertrophic cardiomyopathy (HCM).	The literature provided mentions that exertional dyspnea is common in patients with hypertrophic cardiomyopathy, supporting the statement that dyspnea is a common phenotype of HCM.	"{""explanation"": ""The literature provided mentions that exertional dyspnea is common in patients with hypertrophic cardiomyopathy, supporting the statement that dyspnea is a common phenotype of HCM."", ""reference"": ""PMID:29655822"", ""snippet"": ""Heart failure (HF), characterized by excessive exertional dyspnea, is a common complication within the broad clinical spectrum of hypertrophic cardiomyopathy (HCM)."", ""supports"": ""SUPPORT""}"
4016	3866	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	2	evidence	0	PMID:29150126	SUPPORT		Clinical manifestations of Hypertrophic Cardiomyopathy include shortness of breath, chest pain, palpitations and syncope, which are related to the onset of diastolic dysfunction, left ventricular outflow tract obstruction, ischemia, atrial fibrillation and abnormal vascular responses.	The excerpt directly states that syncope is a clinical manifestation of hypertrophic cardiomyopathy.	"{""explanation"": ""The excerpt directly states that syncope is a clinical manifestation of hypertrophic cardiomyopathy."", ""reference"": ""PMID:29150126"", ""snippet"": ""Clinical manifestations of Hypertrophic Cardiomyopathy include shortness of breath, chest pain, palpitations and syncope, which are related to the onset of diastolic dysfunction, left ventricular outflow tract obstruction, ischemia, atrial fibrillation and abnormal vascular responses."", ""supports"": ""SUPPORT""}"
4017	3866	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	2	evidence	1	PMID:36442670	SUPPORT		Syncope in hypertrophic cardiomyopathy: Explaining the unexplained.	Syncope is highlighted as a phenomenon occurring in individuals with hypertrophic cardiomyopathy.	"{""explanation"": ""Syncope is highlighted as a phenomenon occurring in individuals with hypertrophic cardiomyopathy."", ""reference"": ""PMID:36442670"", ""snippet"": ""Syncope in hypertrophic cardiomyopathy: Explaining the unexplained."", ""supports"": ""SUPPORT""}"
4018	3866	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	2	evidence	2	PMID:29761339	SUPPORT		Syncope and presyncope-in addition to extremely variable cardiac symptoms (dyspnea and angina)-are common.	The text explicitly mentions syncope as a common symptom in hypertrophic cardiomyopathy patients.	"{""explanation"": ""The text explicitly mentions syncope as a common symptom in hypertrophic cardiomyopathy patients."", ""reference"": ""PMID:29761339"", ""snippet"": ""Syncope and presyncope-in addition to extremely variable cardiac symptoms (dyspnea and angina)-are common."", ""supports"": ""SUPPORT""}"
4019	3867	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	3	evidence	0	PMID:34969871	SUPPORT		Study aims were to estimate the population-diagnosed prevalence of cardiomyopathies and describe the temporal relationship between a diagnosis of cardiomyopathy with HF and arrhythmia... Between 2010 and 2018, prevalence increased for ARVC by 180% and HCM by 9%.	The study indicates a relationship between hypertrophic cardiomyopathy (HCM) and arrhythmias, supporting the statement that arrhythmias are a common cardiovascular phenotype of HCM.	"{""explanation"": ""The study indicates a relationship between hypertrophic cardiomyopathy (HCM) and arrhythmias, supporting the statement that arrhythmias are a common cardiovascular phenotype of HCM."", ""reference"": ""PMID:34969871"", ""snippet"": ""Study aims were to estimate the population-diagnosed prevalence of cardiomyopathies and describe the temporal relationship between a diagnosis of cardiomyopathy with HF and arrhythmia... Between 2010 and 2018, prevalence increased for ARVC by 180% and HCM by 9%."", ""supports"": ""SUPPORT""}"
4020	3867	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	3	evidence	1	PMID:7201843	SUPPORT		The patients with hypertrophic cardiomyopathy showed a significant increase in supraventricular extrasystoles/24 hours, supraventricular arrhythmias, high grade ventricular arrhythmia, and the number of patients with more than 10 ventricular extrasystoles every 24 hours when compared with the other groups.	This study directly assesses the prevalence and types of arrhythmias in patients with hypertrophic cardiomyopathy, confirming that arrhythmias are a common phenotype.	"{""explanation"": ""This study directly assesses the prevalence and types of arrhythmias in patients with hypertrophic cardiomyopathy, confirming that arrhythmias are a common phenotype."", ""reference"": ""PMID:7201843"", ""snippet"": ""The patients with hypertrophic cardiomyopathy showed a significant increase in supraventricular extrasystoles/24 hours, supraventricular arrhythmias, high grade ventricular arrhythmia, and the number of patients with more than 10 ventricular extrasystoles every 24 hours when compared with the other groups."", ""supports"": ""SUPPORT""}"
4021	3867	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	3	evidence	2	PMID:3158692	SUPPORT		Frequent ventricular premature complexes, complex ventricular ectopic activity and asymptomatic ventricular tachycardia are common to both hypertrophic and dilated cardiomyopathy; in both conditions, sudden death is a common occurrence.	This reference mentions common arrhythmic events in hypertrophic cardiomyopathy, supporting the idea that arrhythmias are a common cardiovascular phenotype in HCM.	"{""explanation"": ""This reference mentions common arrhythmic events in hypertrophic cardiomyopathy, supporting the idea that arrhythmias are a common cardiovascular phenotype in HCM."", ""reference"": ""PMID:3158692"", ""snippet"": ""Frequent ventricular premature complexes, complex ventricular ectopic activity and asymptomatic ventricular tachycardia are common to both hypertrophic and dilated cardiomyopathy; in both conditions, sudden death is a common occurrence."", ""supports"": ""SUPPORT""}"
4022	3868	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	4	evidence	0	PMID:23124402	SUPPORT		Hypertrophic cardiomyopathy is the most common genetic cardiovascular disorder and the leading cause of sudden cardiac death in the young. This article reviews the ventricular arrhythmias associated with hypertrophic cardiomyopathy.	The reference confirms that hypertrophic cardiomyopathy is associated with ventricular arrhythmias and is a leading cause of sudden cardiac death.	"{""explanation"": ""The reference confirms that hypertrophic cardiomyopathy is associated with ventricular arrhythmias and is a leading cause of sudden cardiac death."", ""reference"": ""PMID:23124402"", ""snippet"": ""Hypertrophic cardiomyopathy is the most common genetic cardiovascular disorder and the leading cause of sudden cardiac death in the young. This article reviews the ventricular arrhythmias associated with hypertrophic cardiomyopathy."", ""supports"": ""SUPPORT""}"
4023	3868	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	4	evidence	1	PMID:28602671	SUPPORT		Patients with HCM are predisposed to developing atrial fibrillation (AF) due primarily to advanced diastolic dysfunction and left atrial (LA) dilatation and remodelling.	The reference confirms that atrial fibrillation is common in patients with hypertrophic cardiomyopathy.	"{""explanation"": ""The reference confirms that atrial fibrillation is common in patients with hypertrophic cardiomyopathy."", ""reference"": ""PMID:28602671"", ""snippet"": ""Patients with HCM are predisposed to developing atrial fibrillation (AF) due primarily to advanced diastolic dysfunction and left atrial (LA) dilatation and remodelling."", ""supports"": ""SUPPORT""}"
4024	3868	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	4	evidence	2	PMID:29203161	SUPPORT		Cardiac arrhythmias refer to any abnormality or disturbance in the normal activation sequence of the myocardium and may be indicative of structural heart disease and the cause of significant cardiovascular complications and sudden cardiac death.	The reference discusses the role of arrhythmias in structural heart disease, including hypertrophic cardiomyopathy, and their association with significant cardiovascular complications and sudden cardiac death.	"{""explanation"": ""The reference discusses the role of arrhythmias in structural heart disease, including hypertrophic cardiomyopathy, and their association with significant cardiovascular complications and sudden cardiac death."", ""reference"": ""PMID:29203161"", ""snippet"": ""Cardiac arrhythmias refer to any abnormality or disturbance in the normal activation sequence of the myocardium and may be indicative of structural heart disease and the cause of significant cardiovascular complications and sudden cardiac death."", ""supports"": ""SUPPORT""}"
4025	3868	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	4	evidence	3	PMID:11174912	SUPPORT		Ventricular arrhythmias in the athlete generally occur in the setting of structural heart disease that is genetically determined (hypertrophic cardiomyopathy, arrhythmogenic right ventricular dysplasia, anomalous coronary arteries) or acquired (coronary artery disease, myocarditis, idiopathic dilated cardiomyopathies).	The reference confirms that ventricular arrhythmias are common in hypertrophic cardiomyopathy, particularly in athletes.	"{""explanation"": ""The reference confirms that ventricular arrhythmias are common in hypertrophic cardiomyopathy, particularly in athletes."", ""reference"": ""PMID:11174912"", ""snippet"": ""Ventricular arrhythmias in the athlete generally occur in the setting of structural heart disease that is genetically determined (hypertrophic cardiomyopathy, arrhythmogenic right ventricular dysplasia, anomalous coronary arteries) or acquired (coronary artery disease, myocarditis, idiopathic dilated cardiomyopathies)."", ""supports"": ""SUPPORT""}"
4026	3869	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	5	evidence	0	PMID:21909825	SUPPORT		Elongation and pathological thickening of the mitral valve (MV) is commonly seen in hypertrophic cardiomyopathy (HCM)... failure of either to optimally adapt in this setting can result in mitral regurgitation.	The reference discusses the common occurrence of mitral valve elongation and thickening in HCM, which can lead to mitral regurgitation.	"{""explanation"": ""The reference discusses the common occurrence of mitral valve elongation and thickening in HCM, which can lead to mitral regurgitation."", ""reference"": ""PMID:21909825"", ""snippet"": ""Elongation and pathological thickening of the mitral valve (MV) is commonly seen in hypertrophic cardiomyopathy (HCM)... failure of either to optimally adapt in this setting can result in mitral regurgitation."", ""supports"": ""SUPPORT""}"
4027	3869	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	5	evidence	1	PMID:35644869	SUPPORT		RESULTS: Significant (more than mild) MR was a significant univariate predictor of all the three LA strain values	This study shows that mitral regurgitation (MR) is a significant factor in patients with hypertrophic cardiomyopathy (HCM), supporting the statement that thickened heart muscle can affect mitral valve function, causing leakage.	"{""explanation"": ""This study shows that mitral regurgitation (MR) is a significant factor in patients with hypertrophic cardiomyopathy (HCM), supporting the statement that thickened heart muscle can affect mitral valve function, causing leakage."", ""reference"": ""PMID:35644869"", ""snippet"": ""RESULTS: Significant (more than mild) MR was a significant univariate predictor of all the three LA strain values"", ""supports"": ""SUPPORT""}"
4028	3869	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	5	evidence	2	PMID:37563454	SUPPORT		However, the interplay between these conditions is increasingly being recognized and they frequently coexist, as in the paradigmatic examples of dilated cardiomyopathy and hypertrophic cardiomyopathy, which are often complicated by the occurrence of mitral regurgitation.	The reference indicates that hypertrophic cardiomyopathy is often complicated by mitral regurgitation, supporting the statement.	"{""explanation"": ""The reference indicates that hypertrophic cardiomyopathy is often complicated by mitral regurgitation, supporting the statement."", ""reference"": ""PMID:37563454"", ""snippet"": ""However, the interplay between these conditions is increasingly being recognized and they frequently coexist, as in the paradigmatic examples of dilated cardiomyopathy and hypertrophic cardiomyopathy, which are often complicated by the occurrence of mitral regurgitation."", ""supports"": ""SUPPORT""}"
4029	3869	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	5	evidence	3	PMID:37574021	SUPPORT		OHCM patients with MAC had a worse prognosis and more recurrent mitral valve regurgitation than those without MAC after septal myectomy.	This study indicates that mitral valve regurgitation is a complication in hypertrophic obstructive cardiomyopathy (OHCM), supporting the statement.	"{""explanation"": ""This study indicates that mitral valve regurgitation is a complication in hypertrophic obstructive cardiomyopathy (OHCM), supporting the statement."", ""reference"": ""PMID:37574021"", ""snippet"": ""OHCM patients with MAC had a worse prognosis and more recurrent mitral valve regurgitation than those without MAC after septal myectomy."", ""supports"": ""SUPPORT""}"
4030	3870	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	6	evidence	0	PMID:34533409	SUPPORT		Common symptoms include chest pain, shortness of breath, palpitations, fatigue and syncope (fainting)...	The reference mentions fatigue as a common symptom of hypertrophic cardiomyopathy, supporting the statement that fatigue occurs occasionally in this condition.	"{""explanation"": ""The reference mentions fatigue as a common symptom of hypertrophic cardiomyopathy, supporting the statement that fatigue occurs occasionally in this condition."", ""reference"": ""PMID:34533409"", ""snippet"": ""Common symptoms include chest pain, shortness of breath, palpitations, fatigue and syncope (fainting)..."", ""supports"": ""SUPPORT""}"
4031	3870	161	Hypertrophic Cardiomyopathy	Hypertrophic_Cardiomyopathy.yaml	phenotypes	6	evidence	1	PMID:37715354	SUPPORT		A 59-year-old man was referred for SSM as dyspnoea and low threshold muscle fatigue associated to severe left ventricular outflow obstruction...	The reference describes a patient with hypertrophic obstructive cardiomyopathy experiencing muscle fatigue, aligning with the statement that fatigue is occasionally observed due to reduced cardiac output and efficiency.	"{""explanation"": ""The reference describes a patient with hypertrophic obstructive cardiomyopathy experiencing muscle fatigue, aligning with the statement that fatigue is occasionally observed due to reduced cardiac output and efficiency."", ""reference"": ""PMID:37715354"", ""snippet"": ""A 59-year-old man was referred for SSM as dyspnoea and low threshold muscle fatigue associated to severe left ventricular outflow obstruction..."", ""supports"": ""SUPPORT""}"
4066	3887	162	Hypochondrogenesis	Hypochondrogenesis.yaml	phenotypes	0	evidence	0	PMID:6641761	SUPPORT	HUMAN_CLINICAL	The roentgenological signs were less severe than those of type II achondrogenesis.	Confirms that hypochondrogenesis represents a less severe form of short-limbed dwarfism compared to achondrogenesis type II.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms that hypochondrogenesis represents a less severe form of short-limbed dwarfism compared to achondrogenesis type II."", ""reference"": ""PMID:6641761"", ""snippet"": ""The roentgenological signs were less severe than those of type II achondrogenesis."", ""supports"": ""SUPPORT""}"
4067	3888	162	Hypochondrogenesis	Hypochondrogenesis.yaml	phenotypes	1	evidence	0	PMID:6641761	SUPPORT	HUMAN_CLINICAL	The delay in vertebral ossification, the absence of all the epiphyseal nuclei and of the tarsal bones might suggest the diagnosis of hypochondrogenesis, rather than that of spondyloepiphyseal dysplasia.	Confirms delayed vertebral ossification as a diagnostic feature of hypochondrogenesis.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms delayed vertebral ossification as a diagnostic feature of hypochondrogenesis."", ""reference"": ""PMID:6641761"", ""snippet"": ""The delay in vertebral ossification, the absence of all the epiphyseal nuclei and of the tarsal bones might suggest the diagnosis of hypochondrogenesis, rather than that of spondyloepiphyseal dysplasia."", ""supports"": ""SUPPORT""}"
4093	4018	169	Immune Thrombocytopenia	Immune_Thrombocytopenia.yaml	phenotypes	0	evidence	0	PMID:38396839	SUPPORT		Although the pathogenesis of ITP is currently better known and its etiology has been extensively studied, up to 75% of adult patients with ITP may develop chronicity, which represents a significant burden on patients' quality of life. A major risk of ITP is bleeding, but knowledge on the exact relationship between the degree of thrombocytopenia and bleeding symptoms, especially at a lower platelet count, is lacking.	This review highlights that thrombocytopenia is the cardinal feature of ITP, with up to 75% of adult patients developing chronic thrombocytopenia, and bleeding risk correlates with platelet count severity.	"{""explanation"": ""This review highlights that thrombocytopenia is the cardinal feature of ITP, with up to 75% of adult patients developing chronic thrombocytopenia, and bleeding risk correlates with platelet count severity."", ""reference"": ""PMID:38396839"", ""snippet"": ""Although the pathogenesis of ITP is currently better known and its etiology has been extensively studied, up to 75% of adult patients with ITP may develop chronicity, which represents a significant burden on patients' quality of life. A major risk of ITP is bleeding, but knowledge on the exact relationship between the degree of thrombocytopenia and bleeding symptoms, especially at a lower platelet count, is lacking."", ""supports"": ""SUPPORT""}"
4114	4049	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	phenotypes	0	evidence	0	PMID:18252749	SUPPORT		Increased TRPV1 nerve fibres are observed in IBS, together with a low-grade inflammatory response. The increased TRPV1 nerve fibres may contribute to visceral hypersensitivity and pain in IBS, and provide a novel therapeutic target.	TRPV1-expressing nerve fibers are increased in IBS and directly linked to abdominal pain severity.	"{""explanation"": ""TRPV1-expressing nerve fibers are increased in IBS and directly linked to abdominal pain severity."", ""reference"": ""PMID:18252749"", ""snippet"": ""Increased TRPV1 nerve fibres are observed in IBS, together with a low-grade inflammatory response. The increased TRPV1 nerve fibres may contribute to visceral hypersensitivity and pain in IBS, and provide a novel therapeutic target."", ""supports"": ""SUPPORT""}"
4115	4049	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	phenotypes	0	evidence	1	PMID:17241857	SUPPORT		IBS-dependent excitation of dorsal root ganglia was inhibited by histamine H(1) receptor blockade and serine protease inactivation (inhibition of 51.7%; P < .05 and 74.5%; P < .05; respectively).	Mast cell mediators, particularly histamine and proteases, directly excite nociceptive neurons to produce abdominal pain in IBS.	"{""explanation"": ""Mast cell mediators, particularly histamine and proteases, directly excite nociceptive neurons to produce abdominal pain in IBS."", ""reference"": ""PMID:17241857"", ""snippet"": ""IBS-dependent excitation of dorsal root ganglia was inhibited by histamine H(1) receptor blockade and serine protease inactivation (inhibition of 51.7%; P < .05 and 74.5%; P < .05; respectively)."", ""supports"": ""SUPPORT""}"
4116	4053	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	phenotypes	4	evidence	0	PMID:19595511	SUPPORT		Approximately 39% of diarrhea-predominant IBS patients had increased intestinal membrane permeability as measured by the lactulose/mannitol ratio.	Increased intestinal permeability is present in a substantial proportion of IBS-D patients and may contribute to diarrheal symptoms.	"{""explanation"": ""Increased intestinal permeability is present in a substantial proportion of IBS-D patients and may contribute to diarrheal symptoms."", ""reference"": ""PMID:19595511"", ""snippet"": ""Approximately 39% of diarrhea-predominant IBS patients had increased intestinal membrane permeability as measured by the lactulose/mannitol ratio."", ""supports"": ""SUPPORT""}"
4117	4053	171	Irritable Bowel Syndrome	Irritable_Bowel_Syndrome.yaml	phenotypes	4	evidence	1	PMID:15100164	SUPPORT		5-HT directly and indirectly affects intestinal motor and secretory function and abnormalities may lead to either constipation or diarrhea.	Dysregulated serotonin signaling affects secretion and motility, contributing to diarrhea in IBS-D.	"{""explanation"": ""Dysregulated serotonin signaling affects secretion and motility, contributing to diarrhea in IBS-D."", ""reference"": ""PMID:15100164"", ""snippet"": ""5-HT directly and indirectly affects intestinal motor and secretory function and abnormalities may lead to either constipation or diarrhea."", ""supports"": ""SUPPORT""}"
4125	4067	172	Jackson-Weiss Syndrome	Jackson-Weiss_Syndrome.yaml	phenotypes	0	evidence	0	PMID:7874170	SUPPORT	HUMAN_CLINICAL	Jackson-Weiss syndrome is an autosomal dominant condition characterized by craniosynostosis, foot anomalies and great phenotypic variability.	Confirms craniosynostosis as a key feature of Jackson-Weiss syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms craniosynostosis as a key feature of Jackson-Weiss syndrome."", ""reference"": ""PMID:7874170"", ""snippet"": ""Jackson-Weiss syndrome is an autosomal dominant condition characterized by craniosynostosis, foot anomalies and great phenotypic variability."", ""supports"": ""SUPPORT""}"
4126	4068	172	Jackson-Weiss Syndrome	Jackson-Weiss_Syndrome.yaml	phenotypes	1	evidence	0	PMID:1271196	SUPPORT	HUMAN_CLINICAL	Craniosynostosis, midfacial hypoplasia and foot abnormalities: an autosomal dominant phenotype in a large Amish kindred.	The original description includes midfacial hypoplasia as a defining feature in the title.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The original description includes midfacial hypoplasia as a defining feature in the title."", ""reference"": ""PMID:1271196"", ""snippet"": ""Craniosynostosis, midfacial hypoplasia and foot abnormalities: an autosomal dominant phenotype in a large Amish kindred."", ""supports"": ""SUPPORT""}"
4127	4069	172	Jackson-Weiss Syndrome	Jackson-Weiss_Syndrome.yaml	phenotypes	2	evidence	0	PMID:1271196	SUPPORT	HUMAN_CLINICAL	All affected individuals had some clinical or radiologic abnormality of the feet.	Original description establishing foot abnormalities as universal in affected individuals.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Original description establishing foot abnormalities as universal in affected individuals."", ""reference"": ""PMID:1271196"", ""snippet"": ""All affected individuals had some clinical or radiologic abnormality of the feet."", ""supports"": ""SUPPORT""}"
4128	4070	172	Jackson-Weiss Syndrome	Jackson-Weiss_Syndrome.yaml	phenotypes	3	evidence	0	PMID:1271196	SUPPORT	HUMAN_CLINICAL	All affected individuals had some clinical or radiologic abnormality of the feet.	The original description noted characteristic foot abnormalities including tarsal/metatarsal involvement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The original description noted characteristic foot abnormalities including tarsal/metatarsal involvement."", ""reference"": ""PMID:1271196"", ""snippet"": ""All affected individuals had some clinical or radiologic abnormality of the feet."", ""supports"": ""SUPPORT""}"
4129	4072	172	Jackson-Weiss Syndrome	Jackson-Weiss_Syndrome.yaml	phenotypes	5	evidence	0	PMID:1271196	SUPPORT	HUMAN_CLINICAL	Enlarged great toes and craniofacial abnormalities suggested Pfeiffer acrocephalosynadactyly type V; however, thumb abnormalities were not present.	The original description explicitly notes absence of thumb/hand abnormalities, distinguishing JWS from Pfeiffer syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The original description explicitly notes absence of thumb/hand abnormalities, distinguishing JWS from Pfeiffer syndrome."", ""reference"": ""PMID:1271196"", ""snippet"": ""Enlarged great toes and craniofacial abnormalities suggested Pfeiffer acrocephalosynadactyly type V; however, thumb abnormalities were not present."", ""supports"": ""SUPPORT""}"
4156	4092	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	phenotypes	0	sequelae[0].evidence	0	PMID:8270934	PARTIAL		Brief, typical absences occur with rapid eyelid myoclonia associated with retropulsive movements of the eyeballs and occasionally of the head. The seizures are of shorter duration than in childhood absence epilepsy, and are accompanied by less profound impairment of consciousness.	While this reference describes the eyelid movements and consciousness impairment during episodes, it indirectly supports that rapid eyelid closure would impair visual function.	"{""explanation"": ""While this reference describes the eyelid movements and consciousness impairment during episodes, it indirectly supports that rapid eyelid closure would impair visual function."", ""reference"": ""PMID:8270934"", ""snippet"": ""Brief, typical absences occur with rapid eyelid myoclonia associated with retropulsive movements of the eyeballs and occasionally of the head. The seizures are of shorter duration than in childhood absence epilepsy, and are accompanied by less profound impairment of consciousness."", ""supports"": ""PARTIAL""}"
4157	4092	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	phenotypes	0	evidence	0	PMID:32554361	SUPPORT		Jeavons syndrome (JS) is mainly characterized by eyelid myoclonia with or without absences.	The literature supports the neurologic diagnostic of eyelid myoclonia as a high frequency phenotype of Jeavons Syndrome (JS).	"{""explanation"": ""The literature supports the neurologic diagnostic of eyelid myoclonia as a high frequency phenotype of Jeavons Syndrome (JS)."", ""reference"": ""PMID:32554361"", ""snippet"": ""Jeavons syndrome (JS) is mainly characterized by eyelid myoclonia with or without absences."", ""supports"": ""SUPPORT""}"
4158	4092	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	phenotypes	0	evidence	1	PMID:30685520	SUPPORT		Eyelid myoclonia, the most common seizure type in all 8 patients, were typically initiated by eating or other simple orofacial stimuli.	This study confirms that eyelid myoclonia is a common and significant phenotype of JS, reinforcing the diagnostic.	"{""explanation"": ""This study confirms that eyelid myoclonia is a common and significant phenotype of JS, reinforcing the diagnostic."", ""reference"": ""PMID:30685520"", ""snippet"": ""Eyelid myoclonia, the most common seizure type in all 8 patients, were typically initiated by eating or other simple orofacial stimuli."", ""supports"": ""SUPPORT""}"
4159	4092	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	phenotypes	0	evidence	2	PMID:36216271	SUPPORT		To the best of our knowledge, this is the first case of STAG2 encephalopathy fulfilling all electroclinical criteria for epilepsy with eyelid myoclonia and absences (EMA), formally named Jeavons syndrome (JS).	It confirms the diagnostic frequency of eyelid myoclonia as a defining characteristic of JS.	"{""explanation"": ""It confirms the diagnostic frequency of eyelid myoclonia as a defining characteristic of JS."", ""reference"": ""PMID:36216271"", ""snippet"": ""To the best of our knowledge, this is the first case of STAG2 encephalopathy fulfilling all electroclinical criteria for epilepsy with eyelid myoclonia and absences (EMA), formally named Jeavons syndrome (JS)."", ""supports"": ""SUPPORT""}"
4160	4092	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	phenotypes	0	evidence	3	PMID:14706039	PARTIAL		Seizures induced by photic (or visual) stimuli or photosensitive seizures can be observed in generalized or focal, idiopathic, or symptomatic epilepsies...	While photosensitivity is discussed, the specific association with eyelid myoclonia and its sequelae in JS is not the main focus.	"{""explanation"": ""While photosensitivity is discussed, the specific association with eyelid myoclonia and its sequelae in JS is not the main focus."", ""reference"": ""PMID:14706039"", ""snippet"": ""Seizures induced by photic (or visual) stimuli or photosensitive seizures can be observed in generalized or focal, idiopathic, or symptomatic epilepsies..."", ""supports"": ""PARTIAL""}"
4161	4093	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	phenotypes	1	evidence	0	PMID:15508923	SUPPORT		Eyelid myoclonia and absence.	The literature provides a title indicating a connection between eyelid myoclonia (a feature of Jeavons Syndrome) and absences, further supporting the statement.	"{""explanation"": ""The literature provides a title indicating a connection between eyelid myoclonia (a feature of Jeavons Syndrome) and absences, further supporting the statement."", ""reference"": ""PMID:15508923"", ""snippet"": ""Eyelid myoclonia and absence."", ""supports"": ""SUPPORT""}"
4162	4094	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	phenotypes	2	evidence	0	PMID:30082241	PARTIAL		After a median follow-up of two years, 80% of patients had drug-resistant epilepsy and 70% experienced generalized tonic-clonic seizures.	The statement is partially supported because generalized tonic-clonic seizures occur in 70% of patients, which suggests a high frequency rather than 'occasional'.	"{""explanation"": ""The statement is partially supported because generalized tonic-clonic seizures occur in 70% of patients, which suggests a high frequency rather than 'occasional'."", ""reference"": ""PMID:30082241"", ""snippet"": ""After a median follow-up of two years, 80% of patients had drug-resistant epilepsy and 70% experienced generalized tonic-clonic seizures."", ""supports"": ""PARTIAL""}"
4163	4095	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	phenotypes	3	evidence	0	PMID:26492104	PARTIAL		All participants completed neuropsychological evaluations. Statistical analyses revealed performance that was below average on measures of global IQ, processing speed and rote, verbal learning coupled with average nonverbal reasoning, and sustained attention. There was also evidence of impaired higher-level verbal reasoning. While global IQ ranged from low average to borderline impaired, no participant could be accurately described as impaired or having intellectual disability (ID) given the consistently average performance noted on some higher-order tasks including nonverbal reasoning.	The literature supports that there are cognitive impairments in Jeavons syndrome, but it does not explicitly classify these impairments as 'mild cognitive impairment' (MCI) nor does it mention the frequency as 'occasional'. The impairments are more specific and varied, making the statement partially correct but not completely accurate.	"{""explanation"": ""The literature supports that there are cognitive impairments in Jeavons syndrome, but it does not explicitly classify these impairments as 'mild cognitive impairment' (MCI) nor does it mention the frequency as 'occasional'. The impairments are more specific and varied, making the statement partially correct but not completely accurate."", ""reference"": ""PMID:26492104"", ""snippet"": ""All participants completed neuropsychological evaluations. Statistical analyses revealed performance that was below average on measures of global IQ, processing speed and rote, verbal learning coupled with average nonverbal reasoning, and sustained attention. There was also evidence of impaired higher-level verbal reasoning. While global IQ ranged from low average to borderline impaired, no participant could be accurately described as impaired or having intellectual disability (ID) given the consistently average performance noted on some higher-order tasks including nonverbal reasoning."", ""supports"": ""PARTIAL""}"
4164	4096	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	phenotypes	4	evidence	0	PMID:30082241	SUPPORT		Jeavons syndrome is an underreported epileptic syndrome characterized by eyelid myoclonia, eyelid closure-induced seizures or electroencephalography paroxysms, and photosensitivity.	The abstract clearly states that photosensitivity is a characteristic feature of Jeavons syndrome.	"{""explanation"": ""The abstract clearly states that photosensitivity is a characteristic feature of Jeavons syndrome."", ""reference"": ""PMID:30082241"", ""snippet"": ""Jeavons syndrome is an underreported epileptic syndrome characterized by eyelid myoclonia, eyelid closure-induced seizures or electroencephalography paroxysms, and photosensitivity."", ""supports"": ""SUPPORT""}"
4165	4097	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	phenotypes	5	evidence	0	PMID:30082241	NO_EVIDENCE		BACKGROUND: Jeavons syndrome is an underreported epileptic syndrome characterized by eyelid myoclonia, eyelid closure-induced seizures or electroencephalography paroxysms, and photosensitivity.	The abstract does not mention developmental delays or any developmental milestones in relation to Jeavons Syndrome.	"{""explanation"": ""The abstract does not mention developmental delays or any developmental milestones in relation to Jeavons Syndrome."", ""reference"": ""PMID:30082241"", ""snippet"": ""BACKGROUND: Jeavons syndrome is an underreported epileptic syndrome characterized by eyelid myoclonia, eyelid closure-induced seizures or electroencephalography paroxysms, and photosensitivity."", ""supports"": ""NO_EVIDENCE""}"
4166	4097	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	phenotypes	5	evidence	1	PMID:30683501	NO_EVIDENCE		Jeavons Syndrome: An Overlooked Epilepsy Syndrome.	The abstract does not provide information on developmental delays or milestones in Jeavons Syndrome.	"{""explanation"": ""The abstract does not provide information on developmental delays or milestones in Jeavons Syndrome."", ""reference"": ""PMID:30683501"", ""snippet"": ""Jeavons Syndrome: An Overlooked Epilepsy Syndrome."", ""supports"": ""NO_EVIDENCE""}"
4167	4098	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	phenotypes	6	evidence	0	PMID:8270934	SUPPORT		Brief, typical absences occur with rapid eyelid myoclonia associated with retropulsive movements of the eyeballs and occasionally of the head. The seizures are of shorter duration than in childhood absence epilepsy, and are accompanied by less profound impairment of consciousness.	The rapid eyelid movements and retropulsive eye movements during seizures directly impair visual function during episodes.	"{""explanation"": ""The rapid eyelid movements and retropulsive eye movements during seizures directly impair visual function during episodes."", ""reference"": ""PMID:8270934"", ""snippet"": ""Brief, typical absences occur with rapid eyelid myoclonia associated with retropulsive movements of the eyeballs and occasionally of the head. The seizures are of shorter duration than in childhood absence epilepsy, and are accompanied by less profound impairment of consciousness."", ""supports"": ""SUPPORT""}"
4168	4098	173	Jeavons Syndrome	Jeavons_Syndrome.yaml	phenotypes	6	evidence	1	PMID:32554361	SUPPORT		Jeavons syndrome (JS) is mainly characterized by eyelid myoclonia with or without absences.	The characteristic eyelid myoclonia inherently causes transient visual impairment during episodes due to involuntary eyelid closure.	"{""explanation"": ""The characteristic eyelid myoclonia inherently causes transient visual impairment during episodes due to involuntary eyelid closure."", ""reference"": ""PMID:32554361"", ""snippet"": ""Jeavons syndrome (JS) is mainly characterized by eyelid myoclonia with or without absences."", ""supports"": ""SUPPORT""}"
4221	4198	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	0	evidence	0	PMID:30029859	SUPPORT		Fever, abdominal pain, and vomiting were the most frequent symptoms observed and typical Kawasaki disease signs and symptoms appeared after intestinal complaints in all cases.	The literature mentions fever as one of the most frequent symptoms observed in Kawasaki disease, supporting the statement that fever is a very frequent systemic diagnostic symptom of Kawasaki disease.	"{""explanation"": ""The literature mentions fever as one of the most frequent symptoms observed in Kawasaki disease, supporting the statement that fever is a very frequent systemic diagnostic symptom of Kawasaki disease."", ""reference"": ""PMID:30029859"", ""snippet"": ""Fever, abdominal pain, and vomiting were the most frequent symptoms observed and typical Kawasaki disease signs and symptoms appeared after intestinal complaints in all cases."", ""supports"": ""SUPPORT""}"
4222	4198	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	0	evidence	1	PMID:31900257	SUPPORT		The conundrum for acute paediatricians is which clinical features best distinguish the febrile child with possible KD, needing intravenous immunoglobulin, from the many other children with febrile illnesses.	The literature highlights the challenge of distinguishing Kawasaki disease from other febrile illnesses, indicating that fever is a very frequent systemic diagnostic symptom in Kawasaki disease.	"{""explanation"": ""The literature highlights the challenge of distinguishing Kawasaki disease from other febrile illnesses, indicating that fever is a very frequent systemic diagnostic symptom in Kawasaki disease."", ""reference"": ""PMID:31900257"", ""snippet"": ""The conundrum for acute paediatricians is which clinical features best distinguish the febrile child with possible KD, needing intravenous immunoglobulin, from the many other children with febrile illnesses."", ""supports"": ""SUPPORT""}"
4223	4198	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	0	evidence	2	PMID:26631821	SUPPORT		The main symptoms were fever (100%), exanthema (98%), changes in the extremities (91%), conjunctivitis (77%), oral cavity changes (89%), cervical adenitis (55%) and cardiac abnormalities (45%).	The literature states that fever is present in 100% of the cases, supporting the statement that fever is a very frequent systemic diagnostic symptom of Kawasaki disease.	"{""explanation"": ""The literature states that fever is present in 100% of the cases, supporting the statement that fever is a very frequent systemic diagnostic symptom of Kawasaki disease."", ""reference"": ""PMID:26631821"", ""snippet"": ""The main symptoms were fever (100%), exanthema (98%), changes in the extremities (91%), conjunctivitis (77%), oral cavity changes (89%), cervical adenitis (55%) and cardiac abnormalities (45%)."", ""supports"": ""SUPPORT""}"
4224	4199	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	1	evidence	0	PMID:26631821	SUPPORT		The main symptoms were fever (100%), exanthema (98%)...	Exanthema, which refers to a widespread rash, was present in 98% of the adult patients with Kawasaki Disease.	"{""explanation"": ""Exanthema, which refers to a widespread rash, was present in 98% of the adult patients with Kawasaki Disease."", ""reference"": ""PMID:26631821"", ""snippet"": ""The main symptoms were fever (100%), exanthema (98%)..."", ""supports"": ""SUPPORT""}"
4225	4199	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	1	evidence	1	PMID:1440951	SUPPORT		We describe a four-year-old girl who presented with fever, a diffuse erythematous maculopapular rash...	The case description includes a diffuse erythematous maculopapular rash as one of the clinical features.	"{""explanation"": ""The case description includes a diffuse erythematous maculopapular rash as one of the clinical features."", ""reference"": ""PMID:1440951"", ""snippet"": ""We describe a four-year-old girl who presented with fever, a diffuse erythematous maculopapular rash..."", ""supports"": ""SUPPORT""}"
4226	4199	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	1	evidence	2	PMID:33453126	SUPPORT		All children with KD have fever accompanied by clinical signs, with four of the five classic criteria for complete KD being mucocutaneous...	The abstract emphasizes the mucocutaneous manifestations, which include skin rashes, as critical for diagnosing Kawasaki Disease.	"{""explanation"": ""The abstract emphasizes the mucocutaneous manifestations, which include skin rashes, as critical for diagnosing Kawasaki Disease."", ""reference"": ""PMID:33453126"", ""snippet"": ""All children with KD have fever accompanied by clinical signs, with four of the five classic criteria for complete KD being mucocutaneous..."", ""supports"": ""SUPPORT""}"
4227	4199	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	1	evidence	3	PMID:23481152	SUPPORT		This is a report of a 4-year-old Hispanic boy who presented with skin changes to the lips and oral cavity, a generalized rash...	The case report mentions a generalized rash as one of the symptoms of Kawasaki Disease.	"{""explanation"": ""The case report mentions a generalized rash as one of the symptoms of Kawasaki Disease."", ""reference"": ""PMID:23481152"", ""snippet"": ""This is a report of a 4-year-old Hispanic boy who presented with skin changes to the lips and oral cavity, a generalized rash..."", ""supports"": ""SUPPORT""}"
4228	4199	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	1	evidence	4	PMID:32843441	SUPPORT		Both patients presented with fever lasting >5 days and were found to have rash, conjunctival injection, and swollen lips.	The patients with COVID-19 inflammatory syndrome had clinical features resembling Kawasaki Disease, including a rash.	"{""explanation"": ""The patients with COVID-19 inflammatory syndrome had clinical features resembling Kawasaki Disease, including a rash."", ""reference"": ""PMID:32843441"", ""snippet"": ""Both patients presented with fever lasting >5 days and were found to have rash, conjunctival injection, and swollen lips."", ""supports"": ""SUPPORT""}"
4229	4200	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	2	evidence	0	PMID:34814144	SUPPORT		In cross-sectional studies, KD was associated with allergic rhinitis (n = 6; OR, 1.69; 95% CI, 1.52-1.87), asthma (n = 3; OR, 1.72; 95% CI, 1.38-2.14), allergic conjunctivitis (n = 2; OR, 1.95; 95% CI, 1.68-2.27), and atopic dermatitis (n = 3; OR, 1.35; 95% CI, 1.22-1.49).	The study shows that Kawasaki Disease is associated with allergic conjunctivitis, supporting the statement that conjunctivitis is very frequent in Kawasaki Disease.	"{""explanation"": ""The study shows that Kawasaki Disease is associated with allergic conjunctivitis, supporting the statement that conjunctivitis is very frequent in Kawasaki Disease."", ""reference"": ""PMID:34814144"", ""snippet"": ""In cross-sectional studies, KD was associated with allergic rhinitis (n = 6; OR, 1.69; 95% CI, 1.52-1.87), asthma (n = 3; OR, 1.72; 95% CI, 1.38-2.14), allergic conjunctivitis (n = 2; OR, 1.95; 95% CI, 1.68-2.27), and atopic dermatitis (n = 3; OR, 1.35; 95% CI, 1.22-1.49)."", ""supports"": ""SUPPORT""}"
4230	4200	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	2	evidence	1	PMID:32843441	SUPPORT		Both patients presented with fever lasting >5 days and were found to have rash, conjunctival injection, and swollen lips.	The description of conjunctival injection in patients with Kawasaki Disease supports the statement.	"{""explanation"": ""The description of conjunctival injection in patients with Kawasaki Disease supports the statement."", ""reference"": ""PMID:32843441"", ""snippet"": ""Both patients presented with fever lasting >5 days and were found to have rash, conjunctival injection, and swollen lips."", ""supports"": ""SUPPORT""}"
4231	4200	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	2	evidence	2	PMID:7299613	SUPPORT		In a prospective series, ophthalmologic examinations on 10 children with Kawasaki disease showed that eight had anterior uveitis during the acute phase of the illness.	Although the study focuses on anterior uveitis, it indicates significant ocular involvement in Kawasaki Disease, supporting the statement indirectly.	"{""explanation"": ""Although the study focuses on anterior uveitis, it indicates significant ocular involvement in Kawasaki Disease, supporting the statement indirectly."", ""reference"": ""PMID:7299613"", ""snippet"": ""In a prospective series, ophthalmologic examinations on 10 children with Kawasaki disease showed that eight had anterior uveitis during the acute phase of the illness."", ""supports"": ""SUPPORT""}"
4232	4201	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	3	evidence	0	PMID:1704148	SUPPORT		The six main clinical presentations of Kawasaki disease are: prolonged fever, conjunctivitis, lesions of the oral and pharyngeal mucosa, inflammatory reddening and swelling of the hands and feet, skin rash and cervical lymph node enlargement.	The literature explicitly mentions that swelling of the hands and feet is one of the six main clinical presentations of Kawasaki disease.	"{""explanation"": ""The literature explicitly mentions that swelling of the hands and feet is one of the six main clinical presentations of Kawasaki disease."", ""reference"": ""PMID:1704148"", ""snippet"": ""The six main clinical presentations of Kawasaki disease are: prolonged fever, conjunctivitis, lesions of the oral and pharyngeal mucosa, inflammatory reddening and swelling of the hands and feet, skin rash and cervical lymph node enlargement."", ""supports"": ""SUPPORT""}"
4233	4201	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	3	evidence	1	PMID:3333141	SUPPORT		Early clinical features include fever, rash, conjunctival injection, dry reddened lips, oropharyngeal reddening, enlarged cervical nodes, and swelling and redness of hands and feet.	The literature lists swelling and redness of hands and feet as early clinical features of Kawasaki disease.	"{""explanation"": ""The literature lists swelling and redness of hands and feet as early clinical features of Kawasaki disease."", ""reference"": ""PMID:3333141"", ""snippet"": ""Early clinical features include fever, rash, conjunctival injection, dry reddened lips, oropharyngeal reddening, enlarged cervical nodes, and swelling and redness of hands and feet."", ""supports"": ""SUPPORT""}"
4234	4202	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	4	evidence	0	PMID:6833960	SUPPORT		The second, subacute, phase begins with a decline of the acute findings and proceeds with desquamation of rash...	The term 'desquamation' refers to peeling of the skin, which supports the statement that peeling skin is a frequent dermatologic manifestation of Kawasaki Disease, particularly during the subacute phase.	"{""explanation"": ""The term 'desquamation' refers to peeling of the skin, which supports the statement that peeling skin is a frequent dermatologic manifestation of Kawasaki Disease, particularly during the subacute phase."", ""reference"": ""PMID:6833960"", ""snippet"": ""The second, subacute, phase begins with a decline of the acute findings and proceeds with desquamation of rash..."", ""supports"": ""SUPPORT""}"
4235	4202	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	4	evidence	1	PMID:3333141	SUPPORT		Peeling of skin of fingers and toes, arthralgia, and marked thrombocytosis are frequent 1-2 weeks after onset.	This reference explicitly mentions that peeling of the skin on the fingers and toes is a frequent occurrence 1-2 weeks after the onset of Kawasaki Disease.	"{""explanation"": ""This reference explicitly mentions that peeling of the skin on the fingers and toes is a frequent occurrence 1-2 weeks after the onset of Kawasaki Disease."", ""reference"": ""PMID:3333141"", ""snippet"": ""Peeling of skin of fingers and toes, arthralgia, and marked thrombocytosis are frequent 1-2 weeks after onset."", ""supports"": ""SUPPORT""}"
4236	4202	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	4	evidence	2	PMID:37065507	SUPPORT		Kawasaki disease's clinical manifestations range from oral skin disease to the blistering of the mucosa, symptoms involving the hands and the feet, skin disease of the palms and soles, a desquamative rash...	The term 'desquamative rash' indicates peeling skin, supporting the statement that this is a frequent dermatologic manifestation of Kawasaki Disease.	"{""explanation"": ""The term 'desquamative rash' indicates peeling skin, supporting the statement that this is a frequent dermatologic manifestation of Kawasaki Disease."", ""reference"": ""PMID:37065507"", ""snippet"": ""Kawasaki disease's clinical manifestations range from oral skin disease to the blistering of the mucosa, symptoms involving the hands and the feet, skin disease of the palms and soles, a desquamative rash..."", ""supports"": ""SUPPORT""}"
4237	4203	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	5	evidence	0	PMID:15835487	SUPPORT		The disease can present with protean clinical manifestations which include high grade fever (for at least 5 days), rash, redness of the lips and a typical strawberry tongue, cervical lymph node enlargement (often unilateral), swelling over the hands/feet and, later a characteristic peripheral desquamation over the fingers and toes.	The abstract mentions redness of the lips and a typical strawberry tongue as clinical manifestations of Kawasaki disease.	"{""explanation"": ""The abstract mentions redness of the lips and a typical strawberry tongue as clinical manifestations of Kawasaki disease."", ""reference"": ""PMID:15835487"", ""snippet"": ""The disease can present with protean clinical manifestations which include high grade fever (for at least 5 days), rash, redness of the lips and a typical strawberry tongue, cervical lymph node enlargement (often unilateral), swelling over the hands/feet and, later a characteristic peripheral desquamation over the fingers and toes."", ""supports"": ""SUPPORT""}"
4238	4203	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	5	evidence	1	PMID:30903929	SUPPORT		Kawasaki disease (KD) is a febrile multisystemic vasculitis of unknown etiology whose coronary prognosis is improved by early diagnosis and management. ... ENT manifestations are frequently at the forefront of KD and constitute a misleading clinical picture responsible for delayed diagnosis and potentially inappropriate medico-surgical management.	The study indicates that ENT (ear, nose, and throat) manifestations, which include oropharyngeal symptoms, are frequently at the forefront of KD.	"{""explanation"": ""The study indicates that ENT (ear, nose, and throat) manifestations, which include oropharyngeal symptoms, are frequently at the forefront of KD."", ""reference"": ""PMID:30903929"", ""snippet"": ""Kawasaki disease (KD) is a febrile multisystemic vasculitis of unknown etiology whose coronary prognosis is improved by early diagnosis and management. ... ENT manifestations are frequently at the forefront of KD and constitute a misleading clinical picture responsible for delayed diagnosis and potentially inappropriate medico-surgical management."", ""supports"": ""SUPPORT""}"
4239	4203	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	5	evidence	2	PMID:1440951	SUPPORT		We describe a four-year-old girl who presented with fever, a diffuse erythematous maculopapular rash, bilateral nonpurulent bulbar conjunctivitis, dry, red, fissured lips, a tongue with a strawberry 'appearance', an erythematous pharynx, indurative erythema, and edema and desquamation of the face, hands and feet.	The case description includes dry, red, fissured lips and a tongue with a strawberry 'appearance', supporting the statement.	"{""explanation"": ""The case description includes dry, red, fissured lips and a tongue with a strawberry 'appearance', supporting the statement."", ""reference"": ""PMID:1440951"", ""snippet"": ""We describe a four-year-old girl who presented with fever, a diffuse erythematous maculopapular rash, bilateral nonpurulent bulbar conjunctivitis, dry, red, fissured lips, a tongue with a strawberry 'appearance', an erythematous pharynx, indurative erythema, and edema and desquamation of the face, hands and feet."", ""supports"": ""SUPPORT""}"
4240	4203	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	5	evidence	3	PMID:23481152	SUPPORT		This is a report of a 4-year-old Hispanic boy who presented with skin changes to the lips and oral cavity, a generalized rash, edema of hands and feet, and peeling of the periungual areas of the fingers as well as to the groin and perianal areas.	The report includes skin changes to the lips and oral cavity, which supports the statement.	"{""explanation"": ""The report includes skin changes to the lips and oral cavity, which supports the statement."", ""reference"": ""PMID:23481152"", ""snippet"": ""This is a report of a 4-year-old Hispanic boy who presented with skin changes to the lips and oral cavity, a generalized rash, edema of hands and feet, and peeling of the periungual areas of the fingers as well as to the groin and perianal areas."", ""supports"": ""SUPPORT""}"
4241	4204	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	6	evidence	0	PMID:10512599	REFUTE		Coronary artery aneurysms or ectasia develop in approximately 15-25% of children with the disease.	The literature indicates that coronary artery aneurysms are a common complication of Kawasaki disease, occurring in 15-25% of cases, which is more frequent than 'occasional'.	"{""explanation"": ""The literature indicates that coronary artery aneurysms are a common complication of Kawasaki disease, occurring in 15-25% of cases, which is more frequent than 'occasional'."", ""reference"": ""PMID:10512599"", ""snippet"": ""Coronary artery aneurysms or ectasia develop in approximately 15-25% of children with the disease."", ""supports"": ""REFUTE""}"
4242	4204	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	6	evidence	1	PMID:31732547	REFUTE		Twenty-three patients had SAAs, demonstrating an incidence of 14.2% (23 of 162) in patients who were screened at 1 month after onset. The proportion of patients with SAAs was estimated to be 2% (23 of 1148) of all patients with KD.	The incidence of coronary artery aneurysms (CAAs) in Kawasaki disease is significant, with a notable percentage of patients developing CAAs, indicating that the frequency is more than 'occasional'.	"{""explanation"": ""The incidence of coronary artery aneurysms (CAAs) in Kawasaki disease is significant, with a notable percentage of patients developing CAAs, indicating that the frequency is more than 'occasional'."", ""reference"": ""PMID:31732547"", ""snippet"": ""Twenty-three patients had SAAs, demonstrating an incidence of 14.2% (23 of 162) in patients who were screened at 1 month after onset. The proportion of patients with SAAs was estimated to be 2% (23 of 1148) of all patients with KD."", ""supports"": ""REFUTE""}"
4243	4204	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	6	evidence	2	PMID:34651205	REFUTE		Among the 640 KD children, most were 1-5 years old (415/640, 64.8%). Children < 1 year old (31.6%) and > 5 years old (28.3%) were more likely to have cardiovascular complications.	The study shows a high incidence of cardiovascular complications in children with Kawasaki disease, indicating that coronary artery aneurysms and other heart complications are not just occasional.	"{""explanation"": ""The study shows a high incidence of cardiovascular complications in children with Kawasaki disease, indicating that coronary artery aneurysms and other heart complications are not just occasional."", ""reference"": ""PMID:34651205"", ""snippet"": ""Among the 640 KD children, most were 1-5 years old (415/640, 64.8%). Children < 1 year old (31.6%) and > 5 years old (28.3%) were more likely to have cardiovascular complications."", ""supports"": ""REFUTE""}"
4244	4204	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	6	evidence	3	PMID:23075819	REFUTE		Patients with persistent or remodeled coronary aneurysms after Kawasaki disease have a high rate of complications including thrombosis or stenosis leading to myocardial infarction.	The literature indicates a high rate of complications from coronary artery aneurysms in Kawasaki disease, suggesting that these complications are not occasional but rather significant.	"{""explanation"": ""The literature indicates a high rate of complications from coronary artery aneurysms in Kawasaki disease, suggesting that these complications are not occasional but rather significant."", ""reference"": ""PMID:23075819"", ""snippet"": ""Patients with persistent or remodeled coronary aneurysms after Kawasaki disease have a high rate of complications including thrombosis or stenosis leading to myocardial infarction."", ""supports"": ""REFUTE""}"
4245	4205	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	7	evidence	0	PMID:33527178	SUPPORT		In Kawasaki disease (KD), thrombocytosis is commonly found in the subacute phase.	Thrombocytosis is a common finding during the subacute phase of KD.	"{""explanation"": ""Thrombocytosis is a common finding during the subacute phase of KD."", ""reference"": ""PMID:33527178"", ""snippet"": ""In Kawasaki disease (KD), thrombocytosis is commonly found in the subacute phase."", ""supports"": ""SUPPORT""}"
4246	4205	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	7	evidence	1	PMID:6833960	SUPPORT		The second, subacute, phase begins with a decline of the acute findings and proceeds with desquamation of rash, joint manifestations, thrombocytosis, and cardiac disease.	Thrombocytosis occurs during the subacute phase of KD.	"{""explanation"": ""Thrombocytosis occurs during the subacute phase of KD."", ""reference"": ""PMID:6833960"", ""snippet"": ""The second, subacute, phase begins with a decline of the acute findings and proceeds with desquamation of rash, joint manifestations, thrombocytosis, and cardiac disease."", ""supports"": ""SUPPORT""}"
4247	4208	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	10	evidence	0	PMID:31599798	SUPPORT		Kawasaki disease is a childhood vasculitis of unknown origin, whose major complication is the development of coronary artery aneurysms (CAA).	This reference directly states that coronary artery aneurysm development is a major complication of Kawasaki disease.	"{""explanation"": ""This reference directly states that coronary artery aneurysm development is a major complication of Kawasaki disease."", ""reference"": ""PMID:31599798"", ""snippet"": ""Kawasaki disease is a childhood vasculitis of unknown origin, whose major complication is the development of coronary artery aneurysms (CAA)."", ""supports"": ""SUPPORT""}"
4248	4208	177	Kawasaki Disease	Kawasaki_Disease.yaml	phenotypes	10	evidence	1	PMID:21447126	SUPPORT		Histologically, coronary arteritis begins 6-8 days after the onset of KD, and leads immediately to inflammation of all layers of the artery. The inflammation spreads completely around the artery; as a result, structural components of the artery undergo intense damage; the artery then begins to dilate.	This reference describes the mechanism by which arterial inflammation leads to dilation and aneurysm formation in Kawasaki disease.	"{""explanation"": ""This reference describes the mechanism by which arterial inflammation leads to dilation and aneurysm formation in Kawasaki disease."", ""reference"": ""PMID:21447126"", ""snippet"": ""Histologically, coronary arteritis begins 6-8 days after the onset of KD, and leads immediately to inflammation of all layers of the artery. The inflammation spreads completely around the artery; as a result, structural components of the artery undergo intense damage; the artery then begins to dilate."", ""supports"": ""SUPPORT""}"
4297	4228	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	phenotypes	0	evidence	0	PMID:10369869	SUPPORT		"VS is characterized by papular and honeycomb keratoderma associated with constrictions of digits leading to autoamputation
"	Honeycomb keratoderma is a defining feature of the syndrome.	"{""explanation"": ""Honeycomb keratoderma is a defining feature of the syndrome."", ""reference"": ""PMID:10369869"", ""snippet"": ""VS is characterized by papular and honeycomb keratoderma associated with constrictions of digits leading to autoamputation\n"", ""supports"": ""SUPPORT""}"
4298	4229	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	phenotypes	1	evidence	0	PMID:10369869	SUPPORT		"VS is characterized by papular and honeycomb keratoderma
"	Honeycomb pattern is characteristic of the syndrome.	"{""explanation"": ""Honeycomb pattern is characteristic of the syndrome."", ""reference"": ""PMID:10369869"", ""snippet"": ""VS is characterized by papular and honeycomb keratoderma\n"", ""supports"": ""SUPPORT""}"
4299	4230	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	phenotypes	2	evidence	0	PMID:10369869	SUPPORT		"constrictions of digits leading to autoamputation
"	Pseudoainhum with potential autoamputation is a key feature.	"{""explanation"": ""Pseudoainhum with potential autoamputation is a key feature."", ""reference"": ""PMID:10369869"", ""snippet"": ""constrictions of digits leading to autoamputation\n"", ""supports"": ""SUPPORT""}"
4300	4230	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	phenotypes	2	evidence	1	PMID:12072018	SUPPORT		"the clinical manifestations of ichthyosis, keratoderma and pseudoainhum
"	Pseudoainhum is a feature of both genetic forms.	"{""explanation"": ""Pseudoainhum is a feature of both genetic forms."", ""reference"": ""PMID:12072018"", ""snippet"": ""the clinical manifestations of ichthyosis, keratoderma and pseudoainhum\n"", ""supports"": ""SUPPORT""}"
4301	4231	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	phenotypes	3	evidence	0	PMID:10369869	SUPPORT		"A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families.
"	Sensorineural deafness is part of the classic Vohwinkel phenotype.	"{""explanation"": ""Sensorineural deafness is part of the classic Vohwinkel phenotype."", ""reference"": ""PMID:10369869"", ""snippet"": ""A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families.\n"", ""supports"": ""SUPPORT""}"
4302	4231	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	phenotypes	3	evidence	1	PMID:20031451	SUPPORT		"Vohwinkel Syndrome (VS) is a type of diffuse hereditary palmoplantar keratodermas (DHPPK) accompanied by skeletal dimorphisms and sensorineural deafness.
"	Confirms sensorineural deafness as a component of the syndrome.	"{""explanation"": ""Confirms sensorineural deafness as a component of the syndrome."", ""reference"": ""PMID:20031451"", ""snippet"": ""Vohwinkel Syndrome (VS) is a type of diffuse hereditary palmoplantar keratodermas (DHPPK) accompanied by skeletal dimorphisms and sensorineural deafness.\n"", ""supports"": ""SUPPORT""}"
4303	4232	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	phenotypes	4	evidence	0	PMID:10369869	SUPPORT		"distinctive starfish-like acral keratoses
"	Starfish-like acral keratoses are a characteristic feature.	"{""explanation"": ""Starfish-like acral keratoses are a characteristic feature."", ""reference"": ""PMID:10369869"", ""snippet"": ""distinctive starfish-like acral keratoses\n"", ""supports"": ""SUPPORT""}"
4304	4233	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	phenotypes	5	evidence	0	PMID:6237617	SUPPORT		"keratotic structures taking the shape of a starfish and/or knuckle pads on the dorsal surfaces of the hands
"	Describes starfish-shaped keratoses and knuckle pads as characteristic features.	"{""explanation"": ""Describes starfish-shaped keratoses and knuckle pads as characteristic features."", ""reference"": ""PMID:6237617"", ""snippet"": ""keratotic structures taking the shape of a starfish and/or knuckle pads on the dorsal surfaces of the hands\n"", ""supports"": ""SUPPORT""}"
4305	4233	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	phenotypes	5	evidence	1	PMID:30335335	SUPPORT		"The classic Vohwinkel syndrome is a hereditary PPK associated with ""starfish"" keratoses on the knuckles
"	StatPearls review confirms starfish keratoses on knuckles are part of classic syndrome.	"{""explanation"": ""StatPearls review confirms starfish keratoses on knuckles are part of classic syndrome."", ""reference"": ""PMID:30335335"", ""snippet"": ""The classic Vohwinkel syndrome is a hereditary PPK associated with \""starfish\"" keratoses on the knuckles\n"", ""supports"": ""SUPPORT""}"
4306	4234	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	phenotypes	6	evidence	0	PMID:9326398	SUPPORT		"Our first family (VK1) also had ichthyosis but not deafness.
"	Ichthyosis is present in the loricrin variant but not classic form.	"{""explanation"": ""Ichthyosis is present in the loricrin variant but not classic form."", ""reference"": ""PMID:9326398"", ""snippet"": ""Our first family (VK1) also had ichthyosis but not deafness.\n"", ""supports"": ""SUPPORT""}"
4307	4234	178	Keratoderma Hereditarium Mutilans	Keratoderma_Hereditarium_Mutilans.yaml	phenotypes	6	evidence	1	PMID:11038186	SUPPORT	MODEL_ORGANISM	"At birth, transgenic mice (ML.VS) exhibited erythrokeratoderma with an epidermal barrier dysfunction. 4 d after birth, high-expressing transgenic animals showed a generalized scaling of the skin
"	Transgenic mice with mutant loricrin develop ichthyosis-like scaling.	"{""evidence_source"": ""MODEL_ORGANISM"", ""explanation"": ""Transgenic mice with mutant loricrin develop ichthyosis-like scaling."", ""reference"": ""PMID:11038186"", ""snippet"": ""At birth, transgenic mice (ML.VS) exhibited erythrokeratoderma with an epidermal barrier dysfunction. 4 d after birth, high-expressing transgenic animals showed a generalized scaling of the skin\n"", ""supports"": ""SUPPORT""}"
4334	4256	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	0	evidence	0	PMID:29382506	SUPPORT		Hypogonadism is usually not evident until early adulthood and progresses with ageing.	The reference indicates that hypogonadism, a reproductive phenotype, is commonly associated with Klinefelter Syndrome.	"{""explanation"": ""The reference indicates that hypogonadism, a reproductive phenotype, is commonly associated with Klinefelter Syndrome."", ""reference"": ""PMID:29382506"", ""snippet"": ""Hypogonadism is usually not evident until early adulthood and progresses with ageing."", ""supports"": ""SUPPORT""}"
4335	4256	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	0	evidence	1	PMID:26823086	SUPPORT		Klinefelter's syndrome, the most common sex disorder associated with chromosomal aberrations, is characterized by a plethora of clinical features.	The text mentions that hypogonadism is among the numerous clinical features of Klinefelter Syndrome, supporting its high frequency and inclusion in reproductive diagnostics.	"{""explanation"": ""The text mentions that hypogonadism is among the numerous clinical features of Klinefelter Syndrome, supporting its high frequency and inclusion in reproductive diagnostics."", ""reference"": ""PMID:26823086"", ""snippet"": ""Klinefelter's syndrome, the most common sex disorder associated with chromosomal aberrations, is characterized by a plethora of clinical features."", ""supports"": ""SUPPORT""}"
4336	4256	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	0	evidence	2	PMID:33107323	SUPPORT		presented with hypoglycemia due to isolated secondary adrenal insufficiency, who further had a decrease in testicular size with increased follicle-stimulating hormone level (hypergonadotropic hypogonadism) and diagnosed with Klinefelter syndrome.	This reference specifically mentions hypogonadism in the context of a Klinefelter Syndrome diagnosis, supporting the reproductive diagnostic frequency.	"{""explanation"": ""This reference specifically mentions hypogonadism in the context of a Klinefelter Syndrome diagnosis, supporting the reproductive diagnostic frequency."", ""reference"": ""PMID:33107323"", ""snippet"": ""presented with hypoglycemia due to isolated secondary adrenal insufficiency, who further had a decrease in testicular size with increased follicle-stimulating hormone level (hypergonadotropic hypogonadism) and diagnosed with Klinefelter syndrome."", ""supports"": ""SUPPORT""}"
4337	4257	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	1	evidence	0	PMID:35948402	PARTIAL		Although Klinefelter syndrome (KS) is common, it is rarely recognised in childhood, sometimes being identified with speech or developmental delay or incidental antenatal diagnosis... Around two-thirds require speech and language therapy or developmental support.	The literature indicates that around two-thirds of individuals with KS require speech and language therapy or developmental support, suggesting that delayed speech and language development is relatively common but not universally present.	"{""explanation"": ""The literature indicates that around two-thirds of individuals with KS require speech and language therapy or developmental support, suggesting that delayed speech and language development is relatively common but not universally present."", ""reference"": ""PMID:35948402"", ""snippet"": ""Although Klinefelter syndrome (KS) is common, it is rarely recognised in childhood, sometimes being identified with speech or developmental delay or incidental antenatal diagnosis... Around two-thirds require speech and language therapy or developmental support."", ""supports"": ""PARTIAL""}"
4338	4257	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	1	evidence	1	PMID:21217607	SUPPORT		The behavioral phenotype of 47,XXY (Klinefelter syndrome) includes increased risks for developmental delays, language-based learning disabilities...	This reference supports the statement that delayed speech and language development is a common phenotype among individuals with Klinefelter Syndrome, as part of broader developmental delays.	"{""explanation"": ""This reference supports the statement that delayed speech and language development is a common phenotype among individuals with Klinefelter Syndrome, as part of broader developmental delays."", ""reference"": ""PMID:21217607"", ""snippet"": ""The behavioral phenotype of 47,XXY (Klinefelter syndrome) includes increased risks for developmental delays, language-based learning disabilities..."", ""supports"": ""SUPPORT""}"
4339	4258	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	2	evidence	0	PMID:20014369	SUPPORT		Most studies support that males with KS have an increased risk of language disorders and reading disabilities.	The abstract indicates an increased risk of language disorders and reading disabilities, which fits under learning disabilities.	"{""explanation"": ""The abstract indicates an increased risk of language disorders and reading disabilities, which fits under learning disabilities."", ""reference"": ""PMID:20014369"", ""snippet"": ""Most studies support that males with KS have an increased risk of language disorders and reading disabilities."", ""supports"": ""SUPPORT""}"
4340	4258	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	2	evidence	1	PMID:21217607	SUPPORT		The behavioral phenotype of 47,XXY (Klinefelter syndrome) includes increased risks for developmental delays, language-based learning disabilities, executive dysfunction/ADHD, and socialemotional difficulties.	The abstract directly mentions the increased risk of language-based learning disabilities in individuals with Klinefelter syndrome.	"{""explanation"": ""The abstract directly mentions the increased risk of language-based learning disabilities in individuals with Klinefelter syndrome."", ""reference"": ""PMID:21217607"", ""snippet"": ""The behavioral phenotype of 47,XXY (Klinefelter syndrome) includes increased risks for developmental delays, language-based learning disabilities, executive dysfunction/ADHD, and socialemotional difficulties."", ""supports"": ""SUPPORT""}"
4341	4259	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	3	evidence	0	PMID:21540567	SUPPORT		The typical symptoms are a tall stature...	The literature explicitly mentions tall stature as a typical symptom in Klinefelter Syndrome patients.	"{""explanation"": ""The literature explicitly mentions tall stature as a typical symptom in Klinefelter Syndrome patients."", ""reference"": ""PMID:21540567"", ""snippet"": ""The typical symptoms are a tall stature..."", ""supports"": ""SUPPORT""}"
4342	4260	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	4	evidence	0	PMID:20843200	NO_EVIDENCE		The most specific clinical features which can be observed at adult age are small testes, gynecomastia, female distribution of fat and body hair, slightly increased body length due to an increased leg length and azoospermia.	The provided literature does not mention reduced muscle tone as a feature of Klinefelter Syndrome, whether in infancy, childhood, or adulthood.	"{""explanation"": ""The provided literature does not mention reduced muscle tone as a feature of Klinefelter Syndrome, whether in infancy, childhood, or adulthood."", ""reference"": ""PMID:20843200"", ""snippet"": ""The most specific clinical features which can be observed at adult age are small testes, gynecomastia, female distribution of fat and body hair, slightly increased body length due to an increased leg length and azoospermia."", ""supports"": ""NO_EVIDENCE""}"
4343	4261	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	5	evidence	0	PMID:20843200	REFUTE		The most specific clinical features which can be observed at adult age are small testes, gynecomastia, female distribution of fat and body hair, slightly increased body length due to an increased leg length and azoospermia.	The provided literature does not mention micropenis as a characteristic feature of Klinefelter syndrome.	"{""explanation"": ""The provided literature does not mention micropenis as a characteristic feature of Klinefelter syndrome."", ""reference"": ""PMID:20843200"", ""snippet"": ""The most specific clinical features which can be observed at adult age are small testes, gynecomastia, female distribution of fat and body hair, slightly increased body length due to an increased leg length and azoospermia."", ""supports"": ""REFUTE""}"
4344	4261	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	5	evidence	1	PMID:32835378	NO_EVIDENCE		BBS patients frequently presented with genitourinary malformations, such as cryptorchidism (5/11), short scrotum (5/8), and micropenis (5/8), but unexpectedly, with normal testis size (7/8).	This reference discusses micropenis in the context of Bardet-Biedl syndrome, not Klinefelter syndrome.	"{""explanation"": ""This reference discusses micropenis in the context of Bardet-Biedl syndrome, not Klinefelter syndrome."", ""reference"": ""PMID:32835378"", ""snippet"": ""BBS patients frequently presented with genitourinary malformations, such as cryptorchidism (5/11), short scrotum (5/8), and micropenis (5/8), but unexpectedly, with normal testis size (7/8)."", ""supports"": ""NO_EVIDENCE""}"
4345	4261	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	5	evidence	2	PMID:38684424	REFUTE		Subsequent examinations were conducted due to various symptoms, including delayed motor development, intellectual disability, facial dysmorphisms, forearm deformities, hip dysplasia, cryptorchidism, micropenis, primary hypogonadism, and essential tremor	While this case mentions micropenis, it is associated with the 49,XXXYY karyotype, not the typical 47,XXY Klinefelter syndrome.	"{""explanation"": ""While this case mentions micropenis, it is associated with the 49,XXXYY karyotype, not the typical 47,XXY Klinefelter syndrome."", ""reference"": ""PMID:38684424"", ""snippet"": ""Subsequent examinations were conducted due to various symptoms, including delayed motor development, intellectual disability, facial dysmorphisms, forearm deformities, hip dysplasia, cryptorchidism, micropenis, primary hypogonadism, and essential tremor"", ""supports"": ""REFUTE""}"
4346	4262	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	6	evidence	0	PMID:20843200	SUPPORT		Cognition is characterized by verbal deficits and psychosocial features include autistiform behavior.	The reference mentions psychosocial features including autistiform behavior, which aligns with the statement about occasional psychosocial difficulties.	"{""explanation"": ""The reference mentions psychosocial features including autistiform behavior, which aligns with the statement about occasional psychosocial difficulties."", ""reference"": ""PMID:20843200"", ""snippet"": ""Cognition is characterized by verbal deficits and psychosocial features include autistiform behavior."", ""supports"": ""SUPPORT""}"
4347	4262	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	6	evidence	1	PMID:21217607	SUPPORT		Tartaglia.nicole@tchden.org The behavioral phenotype of 47,XXY (Klinefelter syndrome) includes increased risks for developmental delays, language-based learning disabilities, executive dysfunction/ADHD, and socialemotional difficulties	The reference highlights social-emotional difficulties, which supports the statement about occasional psychosocial difficulties.	"{""explanation"": ""The reference highlights social-emotional difficulties, which supports the statement about occasional psychosocial difficulties."", ""reference"": ""PMID:21217607"", ""snippet"": ""Tartaglia.nicole@tchden.org The behavioral phenotype of 47,XXY (Klinefelter syndrome) includes increased risks for developmental delays, language-based learning disabilities, executive dysfunction/ADHD, and socialemotional difficulties"", ""supports"": ""SUPPORT""}"
4348	4262	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	6	evidence	2	PMID:27743676	SUPPORT		Social cognition disorders, predominantly on emotional recognition processes, have also been documented	The reference discusses social cognition disorders, which can be related to psychosocial difficulties as mentioned in the statement.	"{""explanation"": ""The reference discusses social cognition disorders, which can be related to psychosocial difficulties as mentioned in the statement."", ""reference"": ""PMID:27743676"", ""snippet"": ""Social cognition disorders, predominantly on emotional recognition processes, have also been documented"", ""supports"": ""SUPPORT""}"
4349	4263	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	7	evidence	0	PMID:20573461	SUPPORT		A high rate of Attention Deficit/Hyperactivity Disorder (ADHD)-like characteristics has been reported in a wide variety of disorders including syndromes with known genetic causes... and Klinefelter Syndrome.	The literature indicates that ADHD-like characteristics are indeed more common in individuals with Klinefelter Syndrome, supporting the statement.	"{""explanation"": ""The literature indicates that ADHD-like characteristics are indeed more common in individuals with Klinefelter Syndrome, supporting the statement."", ""reference"": ""PMID:20573461"", ""snippet"": ""A high rate of Attention Deficit/Hyperactivity Disorder (ADHD)-like characteristics has been reported in a wide variety of disorders including syndromes with known genetic causes... and Klinefelter Syndrome."", ""supports"": ""SUPPORT""}"
4350	4263	179	Klinefelter Syndrome	Klinefelter_Syndrome.yaml	phenotypes	7	evidence	1	PMID:34431088	SUPPORT		X chromosome excess was associated with weakness in working memory (p=0.018) and approached significance for attention problems (p=0.071)...	This study found an association between X chromosome excess (as seen in Klinefelter Syndrome) and attention problems, supporting the statement that ADD/ADHD is more common in this population.	"{""explanation"": ""This study found an association between X chromosome excess (as seen in Klinefelter Syndrome) and attention problems, supporting the statement that ADD/ADHD is more common in this population."", ""reference"": ""PMID:34431088"", ""snippet"": ""X chromosome excess was associated with weakness in working memory (p=0.018) and approached significance for attention problems (p=0.071)..."", ""supports"": ""SUPPORT""}"
4369	4280	180	Kniest Dysplasia	Kniest_Dysplasia.yaml	phenotypes	1	evidence	0	PMID:25592122	SUPPORT	HUMAN_CLINICAL	Kniest dysplasia is an inherited disorder associated with defects in type II collagen and characterised by short-trunked dwarfism, kyphoscoliosis, and enlarged joints with restricted mobility.	This study describes enlarged joints with restricted mobility as a characteristic feature of Kniest dysplasia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study describes enlarged joints with restricted mobility as a characteristic feature of Kniest dysplasia."", ""reference"": ""PMID:25592122"", ""snippet"": ""Kniest dysplasia is an inherited disorder associated with defects in type II collagen and characterised by short-trunked dwarfism, kyphoscoliosis, and enlarged joints with restricted mobility."", ""supports"": ""SUPPORT""}"
4370	4284	180	Kniest Dysplasia	Kniest_Dysplasia.yaml	phenotypes	5	evidence	0	PMID:25592122	SUPPORT	HUMAN_CLINICAL	Six of the seven patients tested were high myopes with one patient being an emmetrope.	This study documents that 6/7 patients with molecularly confirmed Kniest dysplasia had high myopia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study documents that 6/7 patients with molecularly confirmed Kniest dysplasia had high myopia."", ""reference"": ""PMID:25592122"", ""snippet"": ""Six of the seven patients tested were high myopes with one patient being an emmetrope."", ""supports"": ""SUPPORT""}"
4371	4285	180	Kniest Dysplasia	Kniest_Dysplasia.yaml	phenotypes	6	evidence	0	PMID:25592122	SUPPORT	HUMAN_CLINICAL	Other features include marked hand arthropathy, cleft palate, hearing loss, and ocular abnormalities (myopia, abnormal vitreous, and high risk of developing retinal detachment).	This study confirms that patients with Kniest dysplasia have ocular abnormalities including abnormal vitreous and high risk of retinal detachment.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study confirms that patients with Kniest dysplasia have ocular abnormalities including abnormal vitreous and high risk of retinal detachment."", ""reference"": ""PMID:25592122"", ""snippet"": ""Other features include marked hand arthropathy, cleft palate, hearing loss, and ocular abnormalities (myopia, abnormal vitreous, and high risk of developing retinal detachment)."", ""supports"": ""SUPPORT""}"
4372	4286	180	Kniest Dysplasia	Kniest_Dysplasia.yaml	phenotypes	7	evidence	0	PMID:25592122	SUPPORT	HUMAN_CLINICAL	Six of the seven patients had significant hearing impairment	This study documents that 6/7 patients with molecularly confirmed Kniest dysplasia had significant hearing impairment.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study documents that 6/7 patients with molecularly confirmed Kniest dysplasia had significant hearing impairment."", ""reference"": ""PMID:25592122"", ""snippet"": ""Six of the seven patients had significant hearing impairment"", ""supports"": ""SUPPORT""}"
4373	4288	180	Kniest Dysplasia	Kniest_Dysplasia.yaml	phenotypes	9	evidence	0	PMID:8723084	SUPPORT	HUMAN_CLINICAL	Radiological findings in a severe case include short bowed tubular bones with exaggerated metaphyseal flare	This study documents the characteristic radiological finding of exaggerated metaphyseal flare in Kniest dysplasia, which contributes to the dumbbell-shaped appearance of long bones.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study documents the characteristic radiological finding of exaggerated metaphyseal flare in Kniest dysplasia, which contributes to the dumbbell-shaped appearance of long bones."", ""reference"": ""PMID:8723084"", ""snippet"": ""Radiological findings in a severe case include short bowed tubular bones with exaggerated metaphyseal flare"", ""supports"": ""SUPPORT""}"
4394	4308	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	phenotypes	0	evidence	0	PMID:35475077	SUPPORT		Idiopathic pulmonary hemosiderosis (IPH) causes diffuse alveolar hemorrhage (DAH) by a yet unknown mechanism	Systematic review identifies diffuse alveolar hemorrhage as the core pulmonary manifestation	"{""explanation"": ""Systematic review identifies diffuse alveolar hemorrhage as the core pulmonary manifestation"", ""reference"": ""PMID:35475077"", ""snippet"": ""Idiopathic pulmonary hemosiderosis (IPH) causes diffuse alveolar hemorrhage (DAH) by a yet unknown mechanism"", ""supports"": ""SUPPORT""}"
4395	4309	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	phenotypes	1	evidence	0	DOI:10.5505/respircase.2024.73604	SUPPORT			Case report highlighting hemoptysis as a key clinical manifestation responsive to gluten-free diet	"{""explanation"": ""Case report highlighting hemoptysis as a key clinical manifestation responsive to gluten-free diet"", ""reference"": ""DOI:10.5505/respircase.2024.73604"", ""supports"": ""SUPPORT""}"
4396	4309	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	phenotypes	1	evidence	1	PMID:41356730	SUPPORT		Lane-Hamilton syndrome is a rare association between idiopathic pulmonary hemosiderosis (IPH) and celiac disease that can present with isolated hemoptysis	Case report describes hemoptysis as a presenting symptom in Lane-Hamilton syndrome	"{""explanation"": ""Case report describes hemoptysis as a presenting symptom in Lane-Hamilton syndrome"", ""reference"": ""PMID:41356730"", ""snippet"": ""Lane-Hamilton syndrome is a rare association between idiopathic pulmonary hemosiderosis (IPH) and celiac disease that can present with isolated hemoptysis"", ""supports"": ""SUPPORT""}"
4397	4310	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	phenotypes	2	evidence	0	PMID:35475077	SUPPORT		The coexistence of IPH and celiac disease (CD), also known as Lane-Hamilton syndrome (LHS), has been reported in both pediatric and adult patients	Systematic review documents iron-deficiency anemia as a consistent finding in Lane Hamilton Syndrome patients	"{""explanation"": ""Systematic review documents iron-deficiency anemia as a consistent finding in Lane Hamilton Syndrome patients"", ""reference"": ""PMID:35475077"", ""snippet"": ""The coexistence of IPH and celiac disease (CD), also known as Lane-Hamilton syndrome (LHS), has been reported in both pediatric and adult patients"", ""supports"": ""SUPPORT""}"
4398	4311	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	phenotypes	3	evidence	0	PMID:35475077	SUPPORT		The classic triad was more likely to be present in patients with LHS	Systematic review documents dyspnea as part of clinical presentation in Lane Hamilton Syndrome	"{""explanation"": ""Systematic review documents dyspnea as part of clinical presentation in Lane Hamilton Syndrome"", ""reference"": ""PMID:35475077"", ""snippet"": ""The classic triad was more likely to be present in patients with LHS"", ""supports"": ""SUPPORT""}"
4399	4312	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	phenotypes	4	evidence	0	PMID:35475077	SUPPORT			Systematic review documents radiological findings in Lane Hamilton Syndrome presenting as diffuse alveolar hemorrhage	"{""explanation"": ""Systematic review documents radiological findings in Lane Hamilton Syndrome presenting as diffuse alveolar hemorrhage"", ""reference"": ""PMID:35475077"", ""supports"": ""SUPPORT""}"
4400	4313	181	Lane Hamilton Syndrome	Lane_Hamilton_Syndrome.yaml	phenotypes	5	evidence	0	PMID:35475077	PARTIAL		Only 20% of patients in the LHS cohort had any significant gastrointestinal (GI) symptoms at the time of IPH diagnosis	Systematic review documents that GI symptoms are often absent despite underlying celiac disease	"{""explanation"": ""Systematic review documents that GI symptoms are often absent despite underlying celiac disease"", ""reference"": ""PMID:35475077"", ""snippet"": ""Only 20% of patients in the LHS cohort had any significant gastrointestinal (GI) symptoms at the time of IPH diagnosis"", ""supports"": ""PARTIAL""}"
4430	4341	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	0	evidence	0	DOI:10.1186/s40792-023-01650-7	SUPPORT	HUMAN_CLINICAL	The patient experienced frequent vomiting and aspiration pneumonia	Case report describes frequent vomiting in LTEC.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report describes frequent vomiting in LTEC."", ""reference"": ""DOI:10.1186/s40792-023-01650-7"", ""snippet"": ""The patient experienced frequent vomiting and aspiration pneumonia"", ""supports"": ""SUPPORT""}"
4431	4342	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	1	evidence	0	DOI:10.1186/s40792-023-01650-7	SUPPORT	HUMAN_CLINICAL	The patient experienced frequent vomiting and aspiration pneumonia	Case report documents aspiration pneumonia in LTEC.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report documents aspiration pneumonia in LTEC."", ""reference"": ""DOI:10.1186/s40792-023-01650-7"", ""snippet"": ""The patient experienced frequent vomiting and aspiration pneumonia"", ""supports"": ""SUPPORT""}"
4432	4342	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	1	evidence	1	PMID:32593610	SUPPORT	HUMAN_CLINICAL	He had chronic aspiration, recurrent pneumonia, and a hoarse voice for his entire life.	Adult case report documents recurrent pneumonia in a laryngeal cleft patient.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Adult case report documents recurrent pneumonia in a laryngeal cleft patient."", ""reference"": ""PMID:32593610"", ""snippet"": ""He had chronic aspiration, recurrent pneumonia, and a hoarse voice for his entire life."", ""supports"": ""SUPPORT""}"
4433	4342	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	1	evidence	2	PMID:40227884	SUPPORT	HUMAN_CLINICAL	nearly half (44%) had a history of pneumonia	Cohort study reports frequent pneumonia history in type 1 laryngeal cleft.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Cohort study reports frequent pneumonia history in type 1 laryngeal cleft."", ""reference"": ""PMID:40227884"", ""snippet"": ""nearly half (44%) had a history of pneumonia"", ""supports"": ""SUPPORT""}"
4434	4342	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	1	evidence	3	PMID:6873110	SUPPORT	HUMAN_CLINICAL	life-threatening disturbances in the form of asphyxia and aspiration pneumonia.	Review highlights aspiration pneumonia as a major clinical complication.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review highlights aspiration pneumonia as a major clinical complication."", ""reference"": ""PMID:6873110"", ""snippet"": ""life-threatening disturbances in the form of asphyxia and aspiration pneumonia."", ""supports"": ""SUPPORT""}"
4435	4343	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	2	evidence	0	PMID:6873110	SUPPORT	HUMAN_CLINICAL	life-threatening disturbances in the form of asphyxia and aspiration pneumonia.	Review describes aspiration pneumonia as a key clinical disturbance.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review describes aspiration pneumonia as a key clinical disturbance."", ""reference"": ""PMID:6873110"", ""snippet"": ""life-threatening disturbances in the form of asphyxia and aspiration pneumonia."", ""supports"": ""SUPPORT""}"
4436	4344	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	3	evidence	0	PMID:32593610	SUPPORT	HUMAN_CLINICAL	a 56-year-old male referred for hoarseness and chronic cough that was discovered to have a type 2 laryngeal cleft.	Adult case report documents chronic cough in laryngeal cleft.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Adult case report documents chronic cough in laryngeal cleft."", ""reference"": ""PMID:32593610"", ""snippet"": ""a 56-year-old male referred for hoarseness and chronic cough that was discovered to have a type 2 laryngeal cleft."", ""supports"": ""SUPPORT""}"
4437	4344	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	3	evidence	1	PMID:39543566	SUPPORT	HUMAN_CLINICAL	severe coughing	Case report describes severe coughing in a child with a posterior laryngeal cleft.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report describes severe coughing in a child with a posterior laryngeal cleft."", ""reference"": ""PMID:39543566"", ""snippet"": ""severe coughing"", ""supports"": ""SUPPORT""}"
4438	4344	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	3	evidence	2	PMID:40330935	SUPPORT	HUMAN_CLINICAL	All patients experienced cough and choking with feeding.	Case series reports cough as a common presenting symptom in type 1 laryngeal cleft.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case series reports cough as a common presenting symptom in type 1 laryngeal cleft."", ""reference"": ""PMID:40330935"", ""snippet"": ""All patients experienced cough and choking with feeding."", ""supports"": ""SUPPORT""}"
4439	4345	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	4	evidence	0	PMID:40330935	SUPPORT	HUMAN_CLINICAL	All patients experienced cough and choking with feeding.	Case series documents choking with feeding in type 1 laryngeal cleft.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case series documents choking with feeding in type 1 laryngeal cleft."", ""reference"": ""PMID:40330935"", ""snippet"": ""All patients experienced cough and choking with feeding."", ""supports"": ""SUPPORT""}"
4440	4346	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	5	evidence	0	PMID:37436152	SUPPORT	HUMAN_CLINICAL	the sole presenting feature may be airway obstruction.	Case report notes upper airway obstruction as the presenting feature in type III clefts without aspiration.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report notes upper airway obstruction as the presenting feature in type III clefts without aspiration."", ""reference"": ""PMID:37436152"", ""snippet"": ""the sole presenting feature may be airway obstruction."", ""supports"": ""SUPPORT""}"
4441	4347	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	6	evidence	0	PMID:37441989	SUPPORT	HUMAN_CLINICAL	children with dysphagia found to have a LC-1 or DIG on endoscopic exam	Study cohort with LC-1/DIG demonstrates dysphagia assessed by VFSS.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Study cohort with LC-1/DIG demonstrates dysphagia assessed by VFSS."", ""reference"": ""PMID:37441989"", ""snippet"": ""children with dysphagia found to have a LC-1 or DIG on endoscopic exam"", ""supports"": ""SUPPORT""}"
4442	4348	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	7	evidence	0	PMID:40330935	SUPPORT	HUMAN_CLINICAL	one had a stridor	Case series reports stridor in a subset of type 1 laryngeal cleft patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case series reports stridor in a subset of type 1 laryngeal cleft patients."", ""reference"": ""PMID:40330935"", ""snippet"": ""one had a stridor"", ""supports"": ""SUPPORT""}"
4443	4349	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	8	evidence	0	PMID:32593610	SUPPORT	HUMAN_CLINICAL	referred for hoarseness and chronic cough	Adult case report lists hoarseness as a presenting symptom.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Adult case report lists hoarseness as a presenting symptom."", ""reference"": ""PMID:32593610"", ""snippet"": ""referred for hoarseness and chronic cough"", ""supports"": ""SUPPORT""}"
4444	4349	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	8	evidence	1	PMID:39543566	SUPPORT	HUMAN_CLINICAL	He presented with hoarseness	Pediatric case report notes hoarseness with posterior laryngeal cleft.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Pediatric case report notes hoarseness with posterior laryngeal cleft."", ""reference"": ""PMID:39543566"", ""snippet"": ""He presented with hoarseness"", ""supports"": ""SUPPORT""}"
4445	4350	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	9	evidence	0	PMID:30783751	SUPPORT	HUMAN_CLINICAL	showed severe dyspnea and dysphagia	Case report documents severe dyspnea in type IV LTEC.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report documents severe dyspnea in type IV LTEC."", ""reference"": ""PMID:30783751"", ""snippet"": ""showed severe dyspnea and dysphagia"", ""supports"": ""SUPPORT""}"
4446	4350	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	9	evidence	1	PMID:39543566	SUPPORT	HUMAN_CLINICAL	shortness of breath	Case report describes shortness of breath in a child with posterior laryngeal cleft.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report describes shortness of breath in a child with posterior laryngeal cleft."", ""reference"": ""PMID:39543566"", ""snippet"": ""shortness of breath"", ""supports"": ""SUPPORT""}"
4447	4351	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	10	evidence	0	PMID:39543566	SUPPORT	HUMAN_CLINICAL	severe wheezing	Case report notes severe wheezing in a child with posterior laryngeal cleft.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report notes severe wheezing in a child with posterior laryngeal cleft."", ""reference"": ""PMID:39543566"", ""snippet"": ""severe wheezing"", ""supports"": ""SUPPORT""}"
4448	4352	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	11	evidence	0	PMID:40227884	SUPPORT	HUMAN_CLINICAL	can result in chronic microaspiration and subsequent lung disease	Cohort study highlights chronic microaspiration in type 1 laryngeal cleft.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Cohort study highlights chronic microaspiration in type 1 laryngeal cleft."", ""reference"": ""PMID:40227884"", ""snippet"": ""can result in chronic microaspiration and subsequent lung disease"", ""supports"": ""SUPPORT""}"
4449	4353	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	12	evidence	0	PMID:40227884	SUPPORT	HUMAN_CLINICAL	atelectasis (56%)	Cohort study reports atelectasis as a common radiographic finding in type 1 laryngeal cleft.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Cohort study reports atelectasis as a common radiographic finding in type 1 laryngeal cleft."", ""reference"": ""PMID:40227884"", ""snippet"": ""atelectasis (56%)"", ""supports"": ""SUPPORT""}"
4450	4354	182	Laryngotracheoesophageal Cleft	Laryngotracheoesophageal_Cleft.yaml	phenotypes	13	evidence	0	PMID:40227884	SUPPORT	HUMAN_CLINICAL	bronchial wall thickening (59%)	Cohort study reports bronchial wall thickening as a prevalent radiographic finding.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Cohort study reports bronchial wall thickening as a prevalent radiographic finding."", ""reference"": ""PMID:40227884"", ""snippet"": ""bronchial wall thickening (59%)"", ""supports"": ""SUPPORT""}"
4470	4367	183	Leishmaniasis	Leishmaniasis.yaml	phenotypes	0	evidence	0	PMID:19634705	SUPPORT		Cutaneous leishmaniasis usually has milder course and often results into a self-healing of ulcers.	The review notes self-healing ulcers in cutaneous leishmaniasis.	"{""explanation"": ""The review notes self-healing ulcers in cutaneous leishmaniasis."", ""reference"": ""PMID:19634705"", ""snippet"": ""Cutaneous leishmaniasis usually has milder course and often results into a self-healing of ulcers."", ""supports"": ""SUPPORT""}"
4476	4373	184	Leprosy	Leprosy.yaml	phenotypes	0	evidence	0	PMID:11791665	SUPPORT		The bacteria have affinity to the peripheral nerves and are likely to cause neuropathy.	The abstract links leprosy to neuropathy.	"{""explanation"": ""The abstract links leprosy to neuropathy."", ""reference"": ""PMID:11791665"", ""snippet"": ""The bacteria have affinity to the peripheral nerves and are likely to cause neuropathy."", ""supports"": ""SUPPORT""}"
4477	4374	184	Leprosy	Leprosy.yaml	phenotypes	1	evidence	0	PMID:28763601	SUPPORT		Apart from the various characteristic skin lesions, the condition is marked by damage to the peripheral nervous system.	The abstract notes characteristic skin lesions in leprosy.	"{""explanation"": ""The abstract notes characteristic skin lesions in leprosy."", ""reference"": ""PMID:28763601"", ""snippet"": ""Apart from the various characteristic skin lesions, the condition is marked by damage to the peripheral nervous system."", ""supports"": ""SUPPORT""}"
4481	4387	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	phenotypes	0	evidence	0	PMID:26014290	SUPPORT		In childhood, the LFS tumor spectrum was characterized by osteosarcomas, adrenocortical carcinomas (ACC), CNS tumors, and soft tissue sarcomas (STS) observed in 30%, 27%, 26%, and 23% of the patients, respectively. In adults, the tumor distribution was characterized by the predominance of breast carcinomas observed in 79% of the females, and STS observed in 27% of the patients.	French cohort study of 415 TP53 mutation carriers demonstrates soft tissue sarcomas are a core tumor type in LFS, occurring in 23% of children and 27% of adults.	"{""explanation"": ""French cohort study of 415 TP53 mutation carriers demonstrates soft tissue sarcomas are a core tumor type in LFS, occurring in 23% of children and 27% of adults."", ""reference"": ""PMID:26014290"", ""snippet"": ""In childhood, the LFS tumor spectrum was characterized by osteosarcomas, adrenocortical carcinomas (ACC), CNS tumors, and soft tissue sarcomas (STS) observed in 30%, 27%, 26%, and 23% of the patients, respectively. In adults, the tumor distribution was characterized by the predominance of breast carcinomas observed in 79% of the females, and STS observed in 27% of the patients."", ""supports"": ""SUPPORT""}"
4482	4389	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	phenotypes	2	evidence	0	PMID:26014290	SUPPORT		In adults, the tumor distribution was characterized by the predominance of breast carcinomas observed in 79% of the females, and STS observed in 27% of the patients.	French cohort study demonstrates breast cancer is the predominant tumor type in adult females with LFS, occurring in 79% of affected women.	"{""explanation"": ""French cohort study demonstrates breast cancer is the predominant tumor type in adult females with LFS, occurring in 79% of affected women."", ""reference"": ""PMID:26014290"", ""snippet"": ""In adults, the tumor distribution was characterized by the predominance of breast carcinomas observed in 79% of the females, and STS observed in 27% of the patients."", ""supports"": ""SUPPORT""}"
4483	4393	185	Li-Fraumeni Syndrome	Li-Fraumeni_Syndrome.yaml	phenotypes	6	evidence	0	PMID:26014290	SUPPORT		The 322 affected carriers developed 552 tumors, and 43% had developed multiple malignancies. The mean age of first tumor onset was 24.9 years, 41% having developed a tumor by age 18.	Large French cohort demonstrates that 43% of LFS patients develop multiple malignancies, with average 1.7 tumors per affected carrier.	"{""explanation"": ""Large French cohort demonstrates that 43% of LFS patients develop multiple malignancies, with average 1.7 tumors per affected carrier."", ""reference"": ""PMID:26014290"", ""snippet"": ""The 322 affected carriers developed 552 tumors, and 43% had developed multiple malignancies. The mean age of first tumor onset was 24.9 years, 41% having developed a tumor by age 18."", ""supports"": ""SUPPORT""}"
4486	4399	186	Lichen Simplex Chronicus	Lichen_Simplex_Chronicus.yaml	phenotypes	0	evidence	0	PMID:40855389	SUPPORT		Lichen simplex chronicus (LSC), also known as neurodermatitis, is a common chronic pruritic dermatosis defined by lichenified plaques resulting from persistent scratching.	The abstract defines LSC as a pruritic dermatosis with lichenified plaques from scratching.	"{""explanation"": ""The abstract defines LSC as a pruritic dermatosis with lichenified plaques from scratching."", ""reference"": ""PMID:40855389"", ""snippet"": ""Lichen simplex chronicus (LSC), also known as neurodermatitis, is a common chronic pruritic dermatosis defined by lichenified plaques resulting from persistent scratching."", ""supports"": ""SUPPORT""}"
4495	4421	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	phenotypes	0	evidence	0	PMID:38642564	SUPPORT		Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy.	This establishes ascites as one of the major life-threatening complications arising from portal hypertension in cirrhosis.	"{""explanation"": ""This establishes ascites as one of the major life-threatening complications arising from portal hypertension in cirrhosis."", ""reference"": ""PMID:38642564"", ""snippet"": ""Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy."", ""supports"": ""SUPPORT""}"
4496	4424	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	phenotypes	3	evidence	0	PMID:38642564	SUPPORT		Portal hypertension occurs due to increased resistance of the cirrhotic liver vasculature to portal blood flow and is further aggravated by the hyperdynamic circulatory syndrome.	Splenomegaly results from portal hypertension and the hyperdynamic circulatory changes in cirrhosis, leading to splenic congestion.	"{""explanation"": ""Splenomegaly results from portal hypertension and the hyperdynamic circulatory changes in cirrhosis, leading to splenic congestion."", ""reference"": ""PMID:38642564"", ""snippet"": ""Portal hypertension occurs due to increased resistance of the cirrhotic liver vasculature to portal blood flow and is further aggravated by the hyperdynamic circulatory syndrome."", ""supports"": ""SUPPORT""}"
4497	4426	187	Liver Cirrhosis	Liver_Cirrhosis.yaml	phenotypes	5	evidence	0	PMID:38642564	SUPPORT		Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy.	This establishes hepatic encephalopathy as one of the major life-threatening complications of portal hypertension in cirrhosis.	"{""explanation"": ""This establishes hepatic encephalopathy as one of the major life-threatening complications of portal hypertension in cirrhosis."", ""reference"": ""PMID:38642564"", ""snippet"": ""Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy."", ""supports"": ""SUPPORT""}"
4523	4456	188	Long COVID	Long_COVID.yaml	phenotypes	0	evidence	0	PMID:37342500	SUPPORT		They develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias, post-exertional malaise, orthostatic intolerance and other symptoms that greatly interfere with their ability to function	Documents fatigue as a prominent symptom that interferes with function in Long COVID.	"{""explanation"": ""Documents fatigue as a prominent symptom that interferes with function in Long COVID."", ""reference"": ""PMID:37342500"", ""snippet"": ""They develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias, post-exertional malaise, orthostatic intolerance and other symptoms that greatly interfere with their ability to function"", ""supports"": ""SUPPORT""}"
4524	4457	188	Long COVID	Long_COVID.yaml	phenotypes	1	evidence	0	PMID:37342500	SUPPORT		They develop persistent fatigue, cognitive problems, headaches, disrupted sleep	Documents cognitive problems as a core symptom of Long COVID.	"{""explanation"": ""Documents cognitive problems as a core symptom of Long COVID."", ""reference"": ""PMID:37342500"", ""snippet"": ""They develop persistent fatigue, cognitive problems, headaches, disrupted sleep"", ""supports"": ""SUPPORT""}"
4525	4457	188	Long COVID	Long_COVID.yaml	phenotypes	1	evidence	1	PMID:37848036	SUPPORT		Peripheral serotonin reduction, in turn, impedes the activity of the vagus nerve and thereby impairs hippocampal responses and memory.	Provides mechanistic explanation for memory impairment in Long COVID.	"{""explanation"": ""Provides mechanistic explanation for memory impairment in Long COVID."", ""reference"": ""PMID:37848036"", ""snippet"": ""Peripheral serotonin reduction, in turn, impedes the activity of the vagus nerve and thereby impairs hippocampal responses and memory."", ""supports"": ""SUPPORT""}"
4526	4458	188	Long COVID	Long_COVID.yaml	phenotypes	2	evidence	0	PMID:33243837	SUPPORT		It encompasses a plethora of debilitating symptoms (including breathlessness, chest pain, palpitations and orthostatic intolerance)	Lists breathlessness (dyspnea) among the debilitating symptoms of Long COVID.	"{""explanation"": ""Lists breathlessness (dyspnea) among the debilitating symptoms of Long COVID."", ""reference"": ""PMID:33243837"", ""snippet"": ""It encompasses a plethora of debilitating symptoms (including breathlessness, chest pain, palpitations and orthostatic intolerance)"", ""supports"": ""SUPPORT""}"
4527	4459	188	Long COVID	Long_COVID.yaml	phenotypes	3	evidence	0	PMID:37342500	SUPPORT		They develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias, post-exertional malaise, orthostatic intolerance	Explicitly identifies post-exertional malaise as a core Long COVID symptom.	"{""explanation"": ""Explicitly identifies post-exertional malaise as a core Long COVID symptom."", ""reference"": ""PMID:37342500"", ""snippet"": ""They develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias, post-exertional malaise, orthostatic intolerance"", ""supports"": ""SUPPORT""}"
4528	4459	188	Long COVID	Long_COVID.yaml	phenotypes	3	evidence	1	PMID:37342500	SUPPORT		The illness (Long COVID) is similar to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)	Notes the similarity between Long COVID and ME/CFS, which share post-exertional malaise.	"{""explanation"": ""Notes the similarity between Long COVID and ME/CFS, which share post-exertional malaise."", ""reference"": ""PMID:37342500"", ""snippet"": ""The illness (Long COVID) is similar to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)"", ""supports"": ""SUPPORT""}"
4529	4460	188	Long COVID	Long_COVID.yaml	phenotypes	4	evidence	0	PMID:33243837	SUPPORT		It encompasses a plethora of debilitating symptoms (including breathlessness, chest pain, palpitations and orthostatic intolerance)	Lists palpitations among the debilitating symptoms of Long COVID.	"{""explanation"": ""Lists palpitations among the debilitating symptoms of Long COVID."", ""reference"": ""PMID:33243837"", ""snippet"": ""It encompasses a plethora of debilitating symptoms (including breathlessness, chest pain, palpitations and orthostatic intolerance)"", ""supports"": ""SUPPORT""}"
4530	4460	188	Long COVID	Long_COVID.yaml	phenotypes	4	evidence	1	PMID:37529714	SUPPORT		Cardiovascular manifestations of long-COVID include high heart rate, postural tachycardia, and palpitations.	Confirms palpitations as a cardiovascular manifestation of Long COVID.	"{""explanation"": ""Confirms palpitations as a cardiovascular manifestation of Long COVID."", ""reference"": ""PMID:37529714"", ""snippet"": ""Cardiovascular manifestations of long-COVID include high heart rate, postural tachycardia, and palpitations."", ""supports"": ""SUPPORT""}"
4531	4461	188	Long COVID	Long_COVID.yaml	phenotypes	5	evidence	0	PMID:37529714	SUPPORT		Cardiovascular manifestations of long-COVID include high heart rate, postural tachycardia, and palpitations.	Documents high heart rate and postural tachycardia as Long COVID manifestations.	"{""explanation"": ""Documents high heart rate and postural tachycardia as Long COVID manifestations."", ""reference"": ""PMID:37529714"", ""snippet"": ""Cardiovascular manifestations of long-COVID include high heart rate, postural tachycardia, and palpitations."", ""supports"": ""SUPPORT""}"
4532	4462	188	Long COVID	Long_COVID.yaml	phenotypes	6	evidence	0	PMID:33243837	SUPPORT		It encompasses a plethora of debilitating symptoms (including breathlessness, chest pain, palpitations and orthostatic intolerance)	Lists chest pain among the debilitating symptoms of Long COVID.	"{""explanation"": ""Lists chest pain among the debilitating symptoms of Long COVID."", ""reference"": ""PMID:33243837"", ""snippet"": ""It encompasses a plethora of debilitating symptoms (including breathlessness, chest pain, palpitations and orthostatic intolerance)"", ""supports"": ""SUPPORT""}"
4533	4463	188	Long COVID	Long_COVID.yaml	phenotypes	7	evidence	0	PMID:37342500	SUPPORT		They develop persistent fatigue, cognitive problems, headaches, disrupted sleep	Lists headaches among the persistent symptoms following COVID-19.	"{""explanation"": ""Lists headaches among the persistent symptoms following COVID-19."", ""reference"": ""PMID:37342500"", ""snippet"": ""They develop persistent fatigue, cognitive problems, headaches, disrupted sleep"", ""supports"": ""SUPPORT""}"
4534	4464	188	Long COVID	Long_COVID.yaml	phenotypes	8	evidence	0	PMID:37342500	SUPPORT		They develop persistent fatigue, cognitive problems, headaches, disrupted sleep	Documents disrupted sleep as a symptom that interferes with function.	"{""explanation"": ""Documents disrupted sleep as a symptom that interferes with function."", ""reference"": ""PMID:37342500"", ""snippet"": ""They develop persistent fatigue, cognitive problems, headaches, disrupted sleep"", ""supports"": ""SUPPORT""}"
4535	4465	188	Long COVID	Long_COVID.yaml	phenotypes	9	evidence	0	PMID:38321404	SUPPORT		The pooled prevalence of depression and anxiety among patients coping with Post COVID-19 syndrome was estimated to be 23% (95% CI: 20%-26%; I2 = 99.9%) based on data from 143 studies with 7,782,124 participants and 132 studies with 9,320,687 participants, respectively.	Meta-analysis establishes 23% prevalence of anxiety in Long COVID patients.	"{""explanation"": ""Meta-analysis establishes 23% prevalence of anxiety in Long COVID patients."", ""reference"": ""PMID:38321404"", ""snippet"": ""The pooled prevalence of depression and anxiety among patients coping with Post COVID-19 syndrome was estimated to be 23% (95% CI: 20%-26%; I2 = 99.9%) based on data from 143 studies with 7,782,124 participants and 132 studies with 9,320,687 participants, respectively."", ""supports"": ""SUPPORT""}"
4536	4465	188	Long COVID	Long_COVID.yaml	phenotypes	9	evidence	1	PMID:38231397	SUPPORT		Patients suffering from post-acute sequelae of COVID-19 (PASC) have a higher prevalence of anxiety and depression than the general population.	Documents higher prevalence of anxiety in PASC patients compared to general population.	"{""explanation"": ""Documents higher prevalence of anxiety in PASC patients compared to general population."", ""reference"": ""PMID:38231397"", ""snippet"": ""Patients suffering from post-acute sequelae of COVID-19 (PASC) have a higher prevalence of anxiety and depression than the general population."", ""supports"": ""SUPPORT""}"
4537	4466	188	Long COVID	Long_COVID.yaml	phenotypes	10	evidence	0	PMID:38321404	SUPPORT		The pooled prevalence of depression and anxiety among patients coping with Post COVID-19 syndrome was estimated to be 23% (95% CI: 20%-26%; I2 = 99.9%) based on data from 143 studies with 7,782,124 participants	Meta-analysis establishes 23% prevalence of depression in Long COVID patients.	"{""explanation"": ""Meta-analysis establishes 23% prevalence of depression in Long COVID patients."", ""reference"": ""PMID:38321404"", ""snippet"": ""The pooled prevalence of depression and anxiety among patients coping with Post COVID-19 syndrome was estimated to be 23% (95% CI: 20%-26%; I2 = 99.9%) based on data from 143 studies with 7,782,124 participants"", ""supports"": ""SUPPORT""}"
4538	4466	188	Long COVID	Long_COVID.yaml	phenotypes	10	evidence	1	PMID:38231397	SUPPORT		Overall, patients with PASC may have experienced a heavier burden of newly manifest anxiety and depression symptoms compared to patients seen in the GIM clinic.	Documents higher burden of newly manifest depression in Long COVID patients.	"{""explanation"": ""Documents higher burden of newly manifest depression in Long COVID patients."", ""reference"": ""PMID:38231397"", ""snippet"": ""Overall, patients with PASC may have experienced a heavier burden of newly manifest anxiety and depression symptoms compared to patients seen in the GIM clinic."", ""supports"": ""SUPPORT""}"
4539	4467	188	Long COVID	Long_COVID.yaml	phenotypes	11	evidence	0	PMID:38976065	SUPPORT		During the acute-phase of COVID-19, 80% of patients reported anosmia, 15% hyposmia, 63% ageusia, and 33% hypogeusia. At two years' follow-up, 53% still experienced smell impairment	Documents persistent anosmia with 53% still affected at 2-year follow-up.	"{""explanation"": ""Documents persistent anosmia with 53% still affected at 2-year follow-up."", ""reference"": ""PMID:38976065"", ""snippet"": ""During the acute-phase of COVID-19, 80% of patients reported anosmia, 15% hyposmia, 63% ageusia, and 33% hypogeusia. At two years' follow-up, 53% still experienced smell impairment"", ""supports"": ""SUPPORT""}"
4540	4467	188	Long COVID	Long_COVID.yaml	phenotypes	11	evidence	1	PMID:38976065	SUPPORT		Most patients who initially suffered from smell and/or taste disturbance did not reach full recovery after 2 years follow-up.	Demonstrates long-term persistence of olfactory dysfunction in Long COVID.	"{""explanation"": ""Demonstrates long-term persistence of olfactory dysfunction in Long COVID."", ""reference"": ""PMID:38976065"", ""snippet"": ""Most patients who initially suffered from smell and/or taste disturbance did not reach full recovery after 2 years follow-up."", ""supports"": ""SUPPORT""}"
4541	4468	188	Long COVID	Long_COVID.yaml	phenotypes	12	evidence	0	PMID:38976065	SUPPORT		During the acute-phase of COVID-19, 80% of patients reported anosmia, 15% hyposmia, 63% ageusia, and 33% hypogeusia. At two years' follow-up, 53% still experienced smell impairment, and 42% suffered from taste impairment.	Documents persistent ageusia with 42% still affected at 2-year follow-up.	"{""explanation"": ""Documents persistent ageusia with 42% still affected at 2-year follow-up."", ""reference"": ""PMID:38976065"", ""snippet"": ""During the acute-phase of COVID-19, 80% of patients reported anosmia, 15% hyposmia, 63% ageusia, and 33% hypogeusia. At two years' follow-up, 53% still experienced smell impairment, and 42% suffered from taste impairment."", ""supports"": ""SUPPORT""}"
4542	4469	188	Long COVID	Long_COVID.yaml	phenotypes	13	evidence	0	PMID:37342500	SUPPORT		They develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias	Lists myalgias as a persistent symptom of Long COVID.	"{""explanation"": ""Lists myalgias as a persistent symptom of Long COVID."", ""reference"": ""PMID:37342500"", ""snippet"": ""They develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias"", ""supports"": ""SUPPORT""}"
4543	4470	188	Long COVID	Long_COVID.yaml	phenotypes	14	evidence	0	PMID:37342500	SUPPORT		They develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias	Lists arthralgias as a persistent symptom of Long COVID.	"{""explanation"": ""Lists arthralgias as a persistent symptom of Long COVID."", ""reference"": ""PMID:37342500"", ""snippet"": ""They develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias"", ""supports"": ""SUPPORT""}"
4544	4471	188	Long COVID	Long_COVID.yaml	phenotypes	15	evidence	0	PMID:37342500	SUPPORT		They develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias, post-exertional malaise, orthostatic intolerance	Documents orthostatic intolerance among Long COVID symptoms.	"{""explanation"": ""Documents orthostatic intolerance among Long COVID symptoms."", ""reference"": ""PMID:37342500"", ""snippet"": ""They develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias, post-exertional malaise, orthostatic intolerance"", ""supports"": ""SUPPORT""}"
4545	4471	188	Long COVID	Long_COVID.yaml	phenotypes	15	evidence	1	PMID:33243837	SUPPORT		It encompasses a plethora of debilitating symptoms (including breathlessness, chest pain, palpitations and orthostatic intolerance)	Documents orthostatic intolerance as a debilitating Long COVID symptom.	"{""explanation"": ""Documents orthostatic intolerance as a debilitating Long COVID symptom."", ""reference"": ""PMID:33243837"", ""snippet"": ""It encompasses a plethora of debilitating symptoms (including breathlessness, chest pain, palpitations and orthostatic intolerance)"", ""supports"": ""SUPPORT""}"
4546	4472	188	Long COVID	Long_COVID.yaml	phenotypes	16	evidence	0	PMID:34839263	SUPPORT		curated 59 relevant manuscripts that described clinical manifestations in 81 cohorts three weeks or more following acute COVID-19, and mapped 287 unique clinical findings to HPO terms	Systematic review identifying cough among the 287 clinical manifestations mapped to HPO terms in Long COVID.	"{""explanation"": ""Systematic review identifying cough among the 287 clinical manifestations mapped to HPO terms in Long COVID."", ""reference"": ""PMID:34839263"", ""snippet"": ""curated 59 relevant manuscripts that described clinical manifestations in 81 cohorts three weeks or more following acute COVID-19, and mapped 287 unique clinical findings to HPO terms"", ""supports"": ""SUPPORT""}"
4547	4473	188	Long COVID	Long_COVID.yaml	phenotypes	17	evidence	0	PMID:34839263	SUPPORT		curated 59 relevant manuscripts that described clinical manifestations in 81 cohorts three weeks or more following acute COVID-19, and mapped 287 unique clinical findings to HPO terms	Systematic review documenting pulmonary imaging findings including ground glass opacity in Long COVID.	"{""explanation"": ""Systematic review documenting pulmonary imaging findings including ground glass opacity in Long COVID."", ""reference"": ""PMID:34839263"", ""snippet"": ""curated 59 relevant manuscripts that described clinical manifestations in 81 cohorts three weeks or more following acute COVID-19, and mapped 287 unique clinical findings to HPO terms"", ""supports"": ""SUPPORT""}"
4548	4474	188	Long COVID	Long_COVID.yaml	phenotypes	18	evidence	0	PMID:34839263	SUPPORT		Across at least 10 cohorts, authors reported 31 unique clinical features corresponding to HPO terms; the most commonly reported feature was Fatigue (median 45.1%)	Insomnia was among the 31 most commonly reported clinical features across Long COVID cohorts.	"{""explanation"": ""Insomnia was among the 31 most commonly reported clinical features across Long COVID cohorts."", ""reference"": ""PMID:34839263"", ""snippet"": ""Across at least 10 cohorts, authors reported 31 unique clinical features corresponding to HPO terms; the most commonly reported feature was Fatigue (median 45.1%)"", ""supports"": ""SUPPORT""}"
4549	4475	188	Long COVID	Long_COVID.yaml	phenotypes	19	evidence	0	PMID:34839263	SUPPORT		curated 59 relevant manuscripts that described clinical manifestations in 81 cohorts three weeks or more following acute COVID-19, and mapped 287 unique clinical findings to HPO terms	Gastrointestinal symptoms including diarrhea were among the clinical manifestations mapped in Long COVID.	"{""explanation"": ""Gastrointestinal symptoms including diarrhea were among the clinical manifestations mapped in Long COVID."", ""reference"": ""PMID:34839263"", ""snippet"": ""curated 59 relevant manuscripts that described clinical manifestations in 81 cohorts three weeks or more following acute COVID-19, and mapped 287 unique clinical findings to HPO terms"", ""supports"": ""SUPPORT""}"
4550	4476	188	Long COVID	Long_COVID.yaml	phenotypes	20	evidence	0	PMID:34839263	SUPPORT		the most commonly reported feature was Fatigue (median 45.1%) and the least commonly reported was Nausea (median 3.9%)	Nausea was reported across multiple Long COVID cohorts with median prevalence of 3.9%.	"{""explanation"": ""Nausea was reported across multiple Long COVID cohorts with median prevalence of 3.9%."", ""reference"": ""PMID:34839263"", ""snippet"": ""the most commonly reported feature was Fatigue (median 45.1%) and the least commonly reported was Nausea (median 3.9%)"", ""supports"": ""SUPPORT""}"
4580	4499	189	Ludwig's Angina	Ludwigs_Angina.yaml	phenotypes	0	evidence	0	PMID:38445409	SUPPORT		resulted in an inspiratory dyspnea and a stridor.	Notes inspiratory stridor during airway obstruction.	"{""explanation"": ""Notes inspiratory stridor during airway obstruction."", ""reference"": ""PMID:38445409"", ""snippet"": ""resulted in an inspiratory dyspnea and a stridor."", ""supports"": ""SUPPORT""}"
4581	4500	189	Ludwig's Angina	Ludwigs_Angina.yaml	phenotypes	1	evidence	0	PMID:38445409	SUPPORT		obstruction of the airway and resulted in an inspiratory dyspnea	Highlights dyspnea resulting from airway obstruction.	"{""explanation"": ""Highlights dyspnea resulting from airway obstruction."", ""reference"": ""PMID:38445409"", ""snippet"": ""obstruction of the airway and resulted in an inspiratory dyspnea"", ""supports"": ""SUPPORT""}"
4582	4501	189	Ludwig's Angina	Ludwigs_Angina.yaml	phenotypes	2	evidence	0	PMID:33383265	SUPPORT		Trismus is a late finding.	Indicates trismus appears as disease progresses.	"{""explanation"": ""Indicates trismus appears as disease progresses."", ""reference"": ""PMID:33383265"", ""snippet"": ""Trismus is a late finding."", ""supports"": ""SUPPORT""}"
4583	4502	189	Ludwig's Angina	Ludwigs_Angina.yaml	phenotypes	3	evidence	0	PMID:35784784	SUPPORT		with fever, headache, nausea	Reports fever among presenting symptoms.	"{""explanation"": ""Reports fever among presenting symptoms."", ""reference"": ""PMID:35784784"", ""snippet"": ""with fever, headache, nausea"", ""supports"": ""SUPPORT""}"
4584	4503	189	Ludwig's Angina	Ludwigs_Angina.yaml	phenotypes	4	evidence	0	PMID:33383265	SUPPORT		Patients may have a woody or indurated floor of the mouth with submandibular swelling.	Describes characteristic submandibular/neck swelling.	"{""explanation"": ""Describes characteristic submandibular/neck swelling."", ""reference"": ""PMID:33383265"", ""snippet"": ""Patients may have a woody or indurated floor of the mouth with submandibular swelling."", ""supports"": ""SUPPORT""}"
4585	4504	189	Ludwig's Angina	Ludwigs_Angina.yaml	phenotypes	5	evidence	0	PMID:37178657	SUPPORT		A diagnosis of Ludwig's angina with unilateral facial nerve paralysis and treated with immediate incision and drainage.	Documents rare facial nerve palsy complicating Ludwig's angina.	"{""explanation"": ""Documents rare facial nerve palsy complicating Ludwig's angina."", ""reference"": ""PMID:37178657"", ""snippet"": ""A diagnosis of Ludwig's angina with unilateral facial nerve paralysis and treated with immediate incision and drainage."", ""supports"": ""SUPPORT""}"
4595	4514	190	Lung Carcinoma	Lung_Carcinoma.yaml	phenotypes	0	evidence	0	PMID:29666219	SUPPORT		Compared with the cough-alone symptom group, the risks of dying or HRs were significantly higher for the groups presenting with breathlessness (HR 1.86, 95% CI 1.54 to 2.24, n=359), systemic symptoms (HR 1.91, 95% CI 1.48 to 2.45, n=95), weight loss (HR 2.46, 95% CI 1.90 to 3.18, n=106), chest pain (HR 1.96, 95% CI 1.56 to 2.45, n=159), cough with breathlessness (HR 1.59 95% CI 1.28 to 1.98, n=177), neurological symptoms (HR 3.07, 95% CI 2.45 to 3.84, n=155) and other symptom combinations (HR 2.05, 95% CI 1.75 to 2.40, n=1963).	The abstract describes cough as a presenting symptom group in lung cancer.	"{""explanation"": ""The abstract describes cough as a presenting symptom group in lung cancer."", ""reference"": ""PMID:29666219"", ""snippet"": ""Compared with the cough-alone symptom group, the risks of dying or HRs were significantly higher for the groups presenting with breathlessness (HR 1.86, 95% CI 1.54 to 2.24, n=359), systemic symptoms (HR 1.91, 95% CI 1.48 to 2.45, n=95), weight loss (HR 2.46, 95% CI 1.90 to 3.18, n=106), chest pain (HR 1.96, 95% CI 1.56 to 2.45, n=159), cough with breathlessness (HR 1.59 95% CI 1.28 to 1.98, n=177), neurological symptoms (HR 3.07, 95% CI 2.45 to 3.84, n=155) and other symptom combinations (HR 2.05, 95% CI 1.75 to 2.40, n=1963)."", ""supports"": ""SUPPORT""}"
4596	4515	190	Lung Carcinoma	Lung_Carcinoma.yaml	phenotypes	1	evidence	0	PMID:29666219	SUPPORT		Compared with the cough-alone symptom group, the risks of dying or HRs were significantly higher for the groups presenting with breathlessness (HR 1.86, 95% CI 1.54 to 2.24, n=359), systemic symptoms (HR 1.91, 95% CI 1.48 to 2.45, n=95), weight loss (HR 2.46, 95% CI 1.90 to 3.18, n=106), chest pain (HR 1.96, 95% CI 1.56 to 2.45, n=159), cough with breathlessness (HR 1.59 95% CI 1.28 to 1.98, n=177), neurological symptoms (HR 3.07, 95% CI 2.45 to 3.84, n=155) and other symptom combinations (HR 2.05, 95% CI 1.75 to 2.40, n=1963).	Breathlessness is listed among presenting symptom groups in lung cancer.	"{""explanation"": ""Breathlessness is listed among presenting symptom groups in lung cancer."", ""reference"": ""PMID:29666219"", ""snippet"": ""Compared with the cough-alone symptom group, the risks of dying or HRs were significantly higher for the groups presenting with breathlessness (HR 1.86, 95% CI 1.54 to 2.24, n=359), systemic symptoms (HR 1.91, 95% CI 1.48 to 2.45, n=95), weight loss (HR 2.46, 95% CI 1.90 to 3.18, n=106), chest pain (HR 1.96, 95% CI 1.56 to 2.45, n=159), cough with breathlessness (HR 1.59 95% CI 1.28 to 1.98, n=177), neurological symptoms (HR 3.07, 95% CI 2.45 to 3.84, n=155) and other symptom combinations (HR 2.05, 95% CI 1.75 to 2.40, n=1963)."", ""supports"": ""SUPPORT""}"
4597	4516	190	Lung Carcinoma	Lung_Carcinoma.yaml	phenotypes	2	evidence	0	PMID:29666219	SUPPORT		Compared with the cough-alone symptom group, the risks of dying or HRs were significantly higher for the groups presenting with breathlessness (HR 1.86, 95% CI 1.54 to 2.24, n=359), systemic symptoms (HR 1.91, 95% CI 1.48 to 2.45, n=95), weight loss (HR 2.46, 95% CI 1.90 to 3.18, n=106), chest pain (HR 1.96, 95% CI 1.56 to 2.45, n=159), cough with breathlessness (HR 1.59 95% CI 1.28 to 1.98, n=177), neurological symptoms (HR 3.07, 95% CI 2.45 to 3.84, n=155) and other symptom combinations (HR 2.05, 95% CI 1.75 to 2.40, n=1963).	Weight loss is listed among presenting symptom groups in lung cancer.	"{""explanation"": ""Weight loss is listed among presenting symptom groups in lung cancer."", ""reference"": ""PMID:29666219"", ""snippet"": ""Compared with the cough-alone symptom group, the risks of dying or HRs were significantly higher for the groups presenting with breathlessness (HR 1.86, 95% CI 1.54 to 2.24, n=359), systemic symptoms (HR 1.91, 95% CI 1.48 to 2.45, n=95), weight loss (HR 2.46, 95% CI 1.90 to 3.18, n=106), chest pain (HR 1.96, 95% CI 1.56 to 2.45, n=159), cough with breathlessness (HR 1.59 95% CI 1.28 to 1.98, n=177), neurological symptoms (HR 3.07, 95% CI 2.45 to 3.84, n=155) and other symptom combinations (HR 2.05, 95% CI 1.75 to 2.40, n=1963)."", ""supports"": ""SUPPORT""}"
4598	4517	190	Lung Carcinoma	Lung_Carcinoma.yaml	phenotypes	3	evidence	0	PMID:29666219	SUPPORT		Compared with the cough-alone symptom group, the risks of dying or HRs were significantly higher for the groups presenting with breathlessness (HR 1.86, 95% CI 1.54 to 2.24, n=359), systemic symptoms (HR 1.91, 95% CI 1.48 to 2.45, n=95), weight loss (HR 2.46, 95% CI 1.90 to 3.18, n=106), chest pain (HR 1.96, 95% CI 1.56 to 2.45, n=159), cough with breathlessness (HR 1.59 95% CI 1.28 to 1.98, n=177), neurological symptoms (HR 3.07, 95% CI 2.45 to 3.84, n=155) and other symptom combinations (HR 2.05, 95% CI 1.75 to 2.40, n=1963).	Chest pain is listed among presenting symptom groups in lung cancer.	"{""explanation"": ""Chest pain is listed among presenting symptom groups in lung cancer."", ""reference"": ""PMID:29666219"", ""snippet"": ""Compared with the cough-alone symptom group, the risks of dying or HRs were significantly higher for the groups presenting with breathlessness (HR 1.86, 95% CI 1.54 to 2.24, n=359), systemic symptoms (HR 1.91, 95% CI 1.48 to 2.45, n=95), weight loss (HR 2.46, 95% CI 1.90 to 3.18, n=106), chest pain (HR 1.96, 95% CI 1.56 to 2.45, n=159), cough with breathlessness (HR 1.59 95% CI 1.28 to 1.98, n=177), neurological symptoms (HR 3.07, 95% CI 2.45 to 3.84, n=155) and other symptom combinations (HR 2.05, 95% CI 1.75 to 2.40, n=1963)."", ""supports"": ""SUPPORT""}"
4615	4546	191	Lyme Disease	Lyme_Disease.yaml	phenotypes	0	evidence	0	PMID:33669940	SUPPORT		Results: In total, 1005 patients were enrolled with the following prevalence of clinical syndromes: erythema migrans (EM), 945 (94.02%); Lyme arthritis, 32 (3.18%); neuroborreliosis, 23 (2.28%); Lyme carditis, 4 (0.39%); and acrodermatitis, 1 (0.09%).	Large Lithuanian cohort confirms erythema migrans as the dominant presentation.	"{""explanation"": ""Large Lithuanian cohort confirms erythema migrans as the dominant presentation."", ""reference"": ""PMID:33669940"", ""snippet"": ""Results: In total, 1005 patients were enrolled with the following prevalence of clinical syndromes: erythema migrans (EM), 945 (94.02%); Lyme arthritis, 32 (3.18%); neuroborreliosis, 23 (2.28%); Lyme carditis, 4 (0.39%); and acrodermatitis, 1 (0.09%)."", ""supports"": ""SUPPORT""}"
4616	4547	191	Lyme Disease	Lyme_Disease.yaml	phenotypes	1	evidence	0	PMID:33669940	SUPPORT		Clinical symptoms were as follows: arthralgia (33.2%), general weakness (19%), head pain (13.1%), myalgia (11.2%), fever (6.2%), joint swelling (5.9%), head dizziness (5.1%), nervus facialis neuropathy (2.4%), and radiculitis (2.0%).	Population data list general weakness among frequent symptoms of Lyme disease.	"{""explanation"": ""Population data list general weakness among frequent symptoms of Lyme disease."", ""reference"": ""PMID:33669940"", ""snippet"": ""Clinical symptoms were as follows: arthralgia (33.2%), general weakness (19%), head pain (13.1%), myalgia (11.2%), fever (6.2%), joint swelling (5.9%), head dizziness (5.1%), nervus facialis neuropathy (2.4%), and radiculitis (2.0%)."", ""supports"": ""SUPPORT""}"
4617	4548	191	Lyme Disease	Lyme_Disease.yaml	phenotypes	2	evidence	0	PMID:33669940	SUPPORT		Clinical symptoms were as follows: arthralgia (33.2%), general weakness (19%), head pain (13.1%), myalgia (11.2%), fever (6.2%), joint swelling (5.9%), head dizziness (5.1%), nervus facialis neuropathy (2.4%), and radiculitis (2.0%).	Arthralgia was reported in one-third of patients in a large endemic cohort.	"{""explanation"": ""Arthralgia was reported in one-third of patients in a large endemic cohort."", ""reference"": ""PMID:33669940"", ""snippet"": ""Clinical symptoms were as follows: arthralgia (33.2%), general weakness (19%), head pain (13.1%), myalgia (11.2%), fever (6.2%), joint swelling (5.9%), head dizziness (5.1%), nervus facialis neuropathy (2.4%), and radiculitis (2.0%)."", ""supports"": ""SUPPORT""}"
4618	4549	191	Lyme Disease	Lyme_Disease.yaml	phenotypes	3	evidence	0	PMID:33669940	SUPPORT		The main symptoms were the following: nervus facialis neuropathy (47.8%), myalgia (39%), head pain (26%), and radiculitis (21%).	Neuroborreliosis cases frequently manifested facial nerve palsy.	"{""explanation"": ""Neuroborreliosis cases frequently manifested facial nerve palsy."", ""reference"": ""PMID:33669940"", ""snippet"": ""The main symptoms were the following: nervus facialis neuropathy (47.8%), myalgia (39%), head pain (26%), and radiculitis (21%)."", ""supports"": ""SUPPORT""}"
4619	4550	191	Lyme Disease	Lyme_Disease.yaml	phenotypes	4	evidence	0	PMID:33669940	SUPPORT		Lyme arthritis mainly manifested among middle-aged women as an oligoarthritis, mostly affecting the knee joint.	Cohort study documents oligoarticular knee-predominant Lyme arthritis.	"{""explanation"": ""Cohort study documents oligoarticular knee-predominant Lyme arthritis."", ""reference"": ""PMID:33669940"", ""snippet"": ""Lyme arthritis mainly manifested among middle-aged women as an oligoarthritis, mostly affecting the knee joint."", ""supports"": ""SUPPORT""}"
4620	4551	191	Lyme Disease	Lyme_Disease.yaml	phenotypes	5	evidence	0	PMID:37234726	SUPPORT		the most common clinical manifestation is AV block, which can be acute in onset and can rapidly progress to complete heart block.	Case report and review emphasize AV block as the hallmark of Lyme carditis.	"{""explanation"": ""Case report and review emphasize AV block as the hallmark of Lyme carditis."", ""reference"": ""PMID:37234726"", ""snippet"": ""the most common clinical manifestation is AV block, which can be acute in onset and can rapidly progress to complete heart block."", ""supports"": ""SUPPORT""}"
4621	4552	191	Lyme Disease	Lyme_Disease.yaml	phenotypes	6	evidence	0	PMID:30046879	SUPPORT		Dementia-like syndromes are rare manifestations of Lyme neuroborreliosis... The response to 2-4 weeks of antibiotic treatment with ceftriaxone was excellent.	Review of definite neuroborreliosis cases shows dementia syndromes resolving after ceftriaxone.	"{""explanation"": ""Review of definite neuroborreliosis cases shows dementia syndromes resolving after ceftriaxone."", ""reference"": ""PMID:30046879"", ""snippet"": ""Dementia-like syndromes are rare manifestations of Lyme neuroborreliosis... The response to 2-4 weeks of antibiotic treatment with ceftriaxone was excellent."", ""supports"": ""SUPPORT""}"
4622	4552	191	Lyme Disease	Lyme_Disease.yaml	phenotypes	6	evidence	1	PMID:36740841	SUPPORT		Lyme disease is an uncommon cause of reversible dementia... the brilliant clinical improvement after the appropriate antimicrobial therapy is strongly suggestive for a diagnosis of neuroborreliosis.	Geriatric case of reversible dementia with marked improvement after antimicrobial therapy.	"{""explanation"": ""Geriatric case of reversible dementia with marked improvement after antimicrobial therapy."", ""reference"": ""PMID:36740841"", ""snippet"": ""Lyme disease is an uncommon cause of reversible dementia... the brilliant clinical improvement after the appropriate antimicrobial therapy is strongly suggestive for a diagnosis of neuroborreliosis."", ""supports"": ""SUPPORT""}"
4623	4553	191	Lyme Disease	Lyme_Disease.yaml	phenotypes	7	evidence	0	PMID:33082765	SUPPORT		We report a case of acute neuroborreliosis that manifested as extended isolated cervical myelitis.	Case report confirms Lyme-associated cervical myelitis with CSF pleocytosis and intrathecal Borrelia antibodies.	"{""explanation"": ""Case report confirms Lyme-associated cervical myelitis with CSF pleocytosis and intrathecal Borrelia antibodies."", ""reference"": ""PMID:33082765"", ""snippet"": ""We report a case of acute neuroborreliosis that manifested as extended isolated cervical myelitis."", ""supports"": ""SUPPORT""}"
4624	4554	191	Lyme Disease	Lyme_Disease.yaml	phenotypes	8	evidence	0	PMID:41133080	SUPPORT		developed acquired epidermolysis bullosa (EBA) following an LD diagnosis. Initially, the patient presented with atypical erythema migrans, which later evolved into multiple bullous lesions	Case report documents bullous lesions evolving after Lyme disease.	"{""explanation"": ""Case report documents bullous lesions evolving after Lyme disease."", ""reference"": ""PMID:41133080"", ""snippet"": ""developed acquired epidermolysis bullosa (EBA) following an LD diagnosis. Initially, the patient presented with atypical erythema migrans, which later evolved into multiple bullous lesions"", ""supports"": ""SUPPORT""}"
4633	4563	192	Lymphatic filariasis	Lymphatic_Filariasis.yaml	phenotypes	0	evidence	0	PMID:39739969	SUPPORT		Chronic infections can develop into severe clinical manifestations, primarily lymphedema, hydrocoele, and elephantiasis.	Lymphedema is listed as a primary clinical manifestation.	"{""explanation"": ""Lymphedema is listed as a primary clinical manifestation."", ""reference"": ""PMID:39739969"", ""snippet"": ""Chronic infections can develop into severe clinical manifestations, primarily lymphedema, hydrocoele, and elephantiasis."", ""supports"": ""SUPPORT""}"
4634	4564	192	Lymphatic filariasis	Lymphatic_Filariasis.yaml	phenotypes	1	evidence	0	PMID:39739969	SUPPORT		Chronic infections can develop into severe clinical manifestations, primarily lymphedema, hydrocoele, and elephantiasis.	Hydrocoele is listed as a primary clinical manifestation.	"{""explanation"": ""Hydrocoele is listed as a primary clinical manifestation."", ""reference"": ""PMID:39739969"", ""snippet"": ""Chronic infections can develop into severe clinical manifestations, primarily lymphedema, hydrocoele, and elephantiasis."", ""supports"": ""SUPPORT""}"
4635	4565	192	Lymphatic filariasis	Lymphatic_Filariasis.yaml	phenotypes	2	evidence	0	PMID:21413271	SUPPORT		Repeated, prolonged infection with these worms can lead to elephantiasis, a buildup of excess tissue in the affected area.	Elephantiasis represents severe chronic lymphedema driven by repeated infection.	"{""explanation"": ""Elephantiasis represents severe chronic lymphedema driven by repeated infection."", ""reference"": ""PMID:21413271"", ""snippet"": ""Repeated, prolonged infection with these worms can lead to elephantiasis, a buildup of excess tissue in the affected area."", ""supports"": ""SUPPORT""}"
4642	4573	193	Lymphoma	Lymphoma.yaml	phenotypes	0	evidence	0	PMID:32433447	SUPPORT		Hodgkin lymphoma classically presents as lymphadenopathy with contiguous spread with or without associated B symptoms including night sweats, weight loss, and fever.	Lymphadenopathy is a classic presenting feature of lymphoma.	"{""explanation"": ""Lymphadenopathy is a classic presenting feature of lymphoma."", ""reference"": ""PMID:32433447"", ""snippet"": ""Hodgkin lymphoma classically presents as lymphadenopathy with contiguous spread with or without associated B symptoms including night sweats, weight loss, and fever."", ""supports"": ""SUPPORT""}"
4643	4574	193	Lymphoma	Lymphoma.yaml	phenotypes	1	evidence	0	PMID:32433447	SUPPORT		Hodgkin lymphoma classically presents as lymphadenopathy with contiguous spread with or without associated B symptoms including night sweats, weight loss, and fever.	Fever is listed among B symptoms in lymphoma presentations.	"{""explanation"": ""Fever is listed among B symptoms in lymphoma presentations."", ""reference"": ""PMID:32433447"", ""snippet"": ""Hodgkin lymphoma classically presents as lymphadenopathy with contiguous spread with or without associated B symptoms including night sweats, weight loss, and fever."", ""supports"": ""SUPPORT""}"
4644	4575	193	Lymphoma	Lymphoma.yaml	phenotypes	2	evidence	0	PMID:32433447	SUPPORT		Hodgkin lymphoma classically presents as lymphadenopathy with contiguous spread with or without associated B symptoms including night sweats, weight loss, and fever.	Night sweats are listed among B symptoms in lymphoma presentations.	"{""explanation"": ""Night sweats are listed among B symptoms in lymphoma presentations."", ""reference"": ""PMID:32433447"", ""snippet"": ""Hodgkin lymphoma classically presents as lymphadenopathy with contiguous spread with or without associated B symptoms including night sweats, weight loss, and fever."", ""supports"": ""SUPPORT""}"
4645	4576	193	Lymphoma	Lymphoma.yaml	phenotypes	3	evidence	0	PMID:32433447	SUPPORT		Hodgkin lymphoma classically presents as lymphadenopathy with contiguous spread with or without associated B symptoms including night sweats, weight loss, and fever.	Weight loss is listed among B symptoms in lymphoma presentations.	"{""explanation"": ""Weight loss is listed among B symptoms in lymphoma presentations."", ""reference"": ""PMID:32433447"", ""snippet"": ""Hodgkin lymphoma classically presents as lymphadenopathy with contiguous spread with or without associated B symptoms including night sweats, weight loss, and fever."", ""supports"": ""SUPPORT""}"
4710	4602	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	0	sequelae[0].evidence	0	PMID:37262391	SUPPORT		60% (6 of 10) of MMR-P CRCs were metastatic compared with 13% (12 of 89) of MMR-D CRCs.	This study demonstrates that Lynch syndrome colorectal cancers can progress to metastatic disease.	"{""explanation"": ""This study demonstrates that Lynch syndrome colorectal cancers can progress to metastatic disease."", ""reference"": ""PMID:37262391"", ""snippet"": ""60% (6 of 10) of MMR-P CRCs were metastatic compared with 13% (12 of 89) of MMR-D CRCs."", ""supports"": ""SUPPORT""}"
4711	4602	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	0	sequelae[1].evidence	0	PMID:28722918	SUPPORT		In some cases, an obstruction is the first clinical sign of colorectal carcinoma, particularly left-sided carcinoma, and up to 25% of colorectal carcinomas present as large bowel obstruction.	This reference establishes that colorectal cancer causes bowel obstruction in up to 25% of cases.	"{""explanation"": ""This reference establishes that colorectal cancer causes bowel obstruction in up to 25% of cases."", ""reference"": ""PMID:28722918"", ""snippet"": ""In some cases, an obstruction is the first clinical sign of colorectal carcinoma, particularly left-sided carcinoma, and up to 25% of colorectal carcinomas present as large bowel obstruction."", ""supports"": ""SUPPORT""}"
4712	4602	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	0	evidence	0	PMID:37088804	PARTIAL		Some patients with Lynch syndrome (LS) have extreme phenotypes, i.e. cancer before the recommended screening age, or cancer for which there are no screening guidelines.	While this study mentions patients with Lynch syndrome having early-onset cancer, it does not specify whether it includes colorectal cancer or not. It partially supports the statement on phenotypes.	"{""explanation"": ""While this study mentions patients with Lynch syndrome having early-onset cancer, it does not specify whether it includes colorectal cancer or not. It partially supports the statement on phenotypes."", ""reference"": ""PMID:37088804"", ""snippet"": ""Some patients with Lynch syndrome (LS) have extreme phenotypes, i.e. cancer before the recommended screening age, or cancer for which there are no screening guidelines."", ""supports"": ""PARTIAL""}"
4713	4602	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	0	evidence	1	PMID:16136388	SUPPORT		The major aim of surveillance in Lynch syndrome is to diagnose malignant or premalignant lesions at the asymptomatic stage by regular checkups, particularly in the large bowel.	Supports the high frequency of colorectal cancer diagnosis in Lynch syndrome as a major phenotype.	"{""explanation"": ""Supports the high frequency of colorectal cancer diagnosis in Lynch syndrome as a major phenotype."", ""reference"": ""PMID:16136388"", ""snippet"": ""The major aim of surveillance in Lynch syndrome is to diagnose malignant or premalignant lesions at the asymptomatic stage by regular checkups, particularly in the large bowel."", ""supports"": ""SUPPORT""}"
4714	4602	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	0	evidence	2	PMID:29071502	SUPPORT		Lynch syndrome is the hereditary disorder that most frequently predisposes to colorectal cancer...	Affirms that Lynch syndrome frequently predisposes to colorectal cancer, supporting a high-frequency diagnostic.	"{""explanation"": ""Affirms that Lynch syndrome frequently predisposes to colorectal cancer, supporting a high-frequency diagnostic."", ""reference"": ""PMID:29071502"", ""snippet"": ""Lynch syndrome is the hereditary disorder that most frequently predisposes to colorectal cancer..."", ""supports"": ""SUPPORT""}"
4715	4602	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	0	evidence	3	PMID:23681793	SUPPORT		Lynch syndrome (LS), one of the most frequent forms of hereditary colorectal cancer (CRC)...	This supports the statement mentioning Lynch syndrome as frequently associated with hereditary colorectal cancer.	"{""explanation"": ""This supports the statement mentioning Lynch syndrome as frequently associated with hereditary colorectal cancer."", ""reference"": ""PMID:23681793"", ""snippet"": ""Lynch syndrome (LS), one of the most frequent forms of hereditary colorectal cancer (CRC)..."", ""supports"": ""SUPPORT""}"
4716	4602	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	0	evidence	4	PMID:34798988	SUPPORT		Lynch syndrome (LS) is a common form of inherited cancer susceptibility, which predisposes to colorectal cancer (CRC)...	This reference supports the common occurrence of colorectal cancer in individuals with Lynch syndrome.	"{""explanation"": ""This reference supports the common occurrence of colorectal cancer in individuals with Lynch syndrome."", ""reference"": ""PMID:34798988"", ""snippet"": ""Lynch syndrome (LS) is a common form of inherited cancer susceptibility, which predisposes to colorectal cancer (CRC)..."", ""supports"": ""SUPPORT""}"
4717	4602	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	0	evidence	5	PMID:36031446	SUPPORT		Lynch syndrome is associated with the most common form of heritable bowel cancer.	This supports that colorectal cancer is a common gastrointestinal phenotype in Lynch syndrome.	"{""explanation"": ""This supports that colorectal cancer is a common gastrointestinal phenotype in Lynch syndrome."", ""reference"": ""PMID:36031446"", ""snippet"": ""Lynch syndrome is associated with the most common form of heritable bowel cancer."", ""supports"": ""SUPPORT""}"
4718	4602	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	0	evidence	6	PMID:26974895	SUPPORT		Lynch syndrome accounts for roughly 1 of every 35 patients with colorectal carcinoma, making it the most common hereditary form of colorectal carcinoma.	This directly supports the statement that colorectal cancer is a frequent diagnostic and phenotype in Lynch syndrome.	"{""explanation"": ""This directly supports the statement that colorectal cancer is a frequent diagnostic and phenotype in Lynch syndrome."", ""reference"": ""PMID:26974895"", ""snippet"": ""Lynch syndrome accounts for roughly 1 of every 35 patients with colorectal carcinoma, making it the most common hereditary form of colorectal carcinoma."", ""supports"": ""SUPPORT""}"
4719	4602	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	0	evidence	7	PMID:21325953	SUPPORT		Individuals with Lynch syndrome have an increased risk for colorectal cancer...	Supports the high frequency of colorectal cancer in individuals with Lynch syndrome.	"{""explanation"": ""Supports the high frequency of colorectal cancer in individuals with Lynch syndrome."", ""reference"": ""PMID:21325953"", ""snippet"": ""Individuals with Lynch syndrome have an increased risk for colorectal cancer..."", ""supports"": ""SUPPORT""}"
4720	4602	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	0	evidence	8	PMID:35306248	SUPPORT		Lynch Syndrome carriers are at increased lifetime risk of developing certain cancers, such as colorectal and endometrial.	Supports the statement of colorectal cancer phenotype in Lynch syndrome as it emphasizes colorectal cancer risk.	"{""explanation"": ""Supports the statement of colorectal cancer phenotype in Lynch syndrome as it emphasizes colorectal cancer risk."", ""reference"": ""PMID:35306248"", ""snippet"": ""Lynch Syndrome carriers are at increased lifetime risk of developing certain cancers, such as colorectal and endometrial."", ""supports"": ""SUPPORT""}"
4721	4603	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	1	evidence	0	PMID:28376523	SUPPORT		The clinical characteristics of Lynch-associated endometrial cancer and screening and risk-reducing strategies also are described.	The article discusses Lynch syndrome and its association with endometrial cancer, supporting the statement.	"{""explanation"": ""The article discusses Lynch syndrome and its association with endometrial cancer, supporting the statement."", ""reference"": ""PMID:28376523"", ""snippet"": ""The clinical characteristics of Lynch-associated endometrial cancer and screening and risk-reducing strategies also are described."", ""supports"": ""SUPPORT""}"
4722	4603	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	1	evidence	1	PMID:23681793	SUPPORT		Carriers of MMR defects have a strongly increased risk of developing CRC and endometrial cancer.	The article states that Lynch syndrome carriers have a strongly increased risk of developing endometrial cancer.	"{""explanation"": ""The article states that Lynch syndrome carriers have a strongly increased risk of developing endometrial cancer."", ""reference"": ""PMID:23681793"", ""snippet"": ""Carriers of MMR defects have a strongly increased risk of developing CRC and endometrial cancer."", ""supports"": ""SUPPORT""}"
4723	4603	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	1	evidence	2	PMID:29071502	SUPPORT		Lynch syndrome is the hereditary disorder that most frequently predisposes to colorectal cancer as well as predisposing to a number of extracolonic cancers, most prominently endometrial cancer.	The review confirms that Lynch syndrome prominently predisposes individuals to endometrial cancer.	"{""explanation"": ""The review confirms that Lynch syndrome prominently predisposes individuals to endometrial cancer."", ""reference"": ""PMID:29071502"", ""snippet"": ""Lynch syndrome is the hereditary disorder that most frequently predisposes to colorectal cancer as well as predisposing to a number of extracolonic cancers, most prominently endometrial cancer."", ""supports"": ""SUPPORT""}"
4724	4603	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	1	evidence	3	PMID:37728516	SUPPORT		Lynch syndrome (LS) markedly increases risks of colorectal and endometrial cancers.	This reference further supports the statement that Lynch syndrome is strongly associated with endometrial cancer.	"{""explanation"": ""This reference further supports the statement that Lynch syndrome is strongly associated with endometrial cancer."", ""reference"": ""PMID:37728516"", ""snippet"": ""Lynch syndrome (LS) markedly increases risks of colorectal and endometrial cancers."", ""supports"": ""SUPPORT""}"
4725	4604	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	2	evidence	0	PMID:31319185	SUPPORT		Lynch syndrome is the most common inherited cause of gastrointestinal cancer and increases risk for a variety of malignancies, including gastric cancer.	The reference supports the increased frequency of stomach (gastric) cancer as a phenotype of Lynch Syndrome.	"{""explanation"": ""The reference supports the increased frequency of stomach (gastric) cancer as a phenotype of Lynch Syndrome."", ""reference"": ""PMID:31319185"", ""snippet"": ""Lynch syndrome is the most common inherited cause of gastrointestinal cancer and increases risk for a variety of malignancies, including gastric cancer."", ""supports"": ""SUPPORT""}"
4726	4604	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	2	evidence	1	PMID:27546846	PARTIAL		Approximately 5% arise from germline mutations in genes associated with cancer predisposition.	While this provides general context about hereditary gastrointestinal cancers, it does not specify Lynch Syndrome or stomach cancer.	"{""explanation"": ""While this provides general context about hereditary gastrointestinal cancers, it does not specify Lynch Syndrome or stomach cancer."", ""reference"": ""PMID:27546846"", ""snippet"": ""Approximately 5% arise from germline mutations in genes associated with cancer predisposition."", ""supports"": ""PARTIAL""}"
4727	4605	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	3	evidence	0	PMID:31615790	SUPPORT		Lynch syndrome confers markedly increased risks of various malignancies, including urinary tract cancers (UTC; renal pelvis, ureter, bladder, and possibly kidney cancers).	This large cohort supports urinary tract cancer as a recognized Lynch-associated malignancy and informs clinical risk stratification.	"{""explanation"": ""This large cohort supports urinary tract cancer as a recognized Lynch-associated malignancy and informs clinical risk stratification."", ""reference"": ""PMID:31615790"", ""snippet"": ""Lynch syndrome confers markedly increased risks of various malignancies, including urinary tract cancers (UTC; renal pelvis, ureter, bladder, and possibly kidney cancers)."", ""supports"": ""SUPPORT""}"
4728	4605	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	3	evidence	1	PMID:21419447	SUPPORT		Patients with Lynch syndrome are much more likely to have generally rare upper urinary tract urothelial carcinoma but not bladder urothelial carcinoma.	The literature supports the occurrence of upper urinary tract cancer (urothelial carcinoma) in patients with Lynch syndrome, which includes transitional cell carcinoma of the ureter or renal pelvis.	"{""explanation"": ""The literature supports the occurrence of upper urinary tract cancer (urothelial carcinoma) in patients with Lynch syndrome, which includes transitional cell carcinoma of the ureter or renal pelvis."", ""reference"": ""PMID:21419447"", ""snippet"": ""Patients with Lynch syndrome are much more likely to have generally rare upper urinary tract urothelial carcinoma but not bladder urothelial carcinoma."", ""supports"": ""SUPPORT""}"
4729	4605	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	3	evidence	2	PMID:34798988	SUPPORT		Lynch syndrome (LS) is a common form of inherited cancer susceptibility, which predisposes to colorectal cancer (CRC) along with a wide array of other extracolonic malignancies, including other gastrointestinal cancers, cancers of the gynecologic and genitourinary tracts, and other organ sites.	The literature confirms that Lynch syndrome is associated with cancers of the genitourinary tract, which includes urinary tract cancer.	"{""explanation"": ""The literature confirms that Lynch syndrome is associated with cancers of the genitourinary tract, which includes urinary tract cancer."", ""reference"": ""PMID:34798988"", ""snippet"": ""Lynch syndrome (LS) is a common form of inherited cancer susceptibility, which predisposes to colorectal cancer (CRC) along with a wide array of other extracolonic malignancies, including other gastrointestinal cancers, cancers of the gynecologic and genitourinary tracts, and other organ sites."", ""supports"": ""SUPPORT""}"
4730	4605	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	3	evidence	3	PMID:23700068	SUPPORT		Urinary tract cancers (UTC) have in many studies been reported increased in LS and it has been discussed among researchers and clinicians whether or not screening for urological tumours should be included in the surveillance programme.	This review supports the elevated UTC burden and the relevance of LS-specific surveillance.	"{""explanation"": ""This review supports the elevated UTC burden and the relevance of LS-specific surveillance."", ""reference"": ""PMID:23700068"", ""snippet"": ""Urinary tract cancers (UTC) have in many studies been reported increased in LS and it has been discussed among researchers and clinicians whether or not screening for urological tumours should be included in the surveillance programme."", ""supports"": ""SUPPORT""}"
4731	4605	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	3	evidence	4	PMID:15962502	SUPPORT		Transitional cell carcinomas of the upper urinary tract (UUT-TCCs) are rare: they account for approximately 5% of all urothelial carcinomas. ... UUT-TCC occurs in 5% of patients with HNPCC.	The literature indicates that transitional cell carcinomas of the upper urinary tract are rare but occur in patients with Lynch syndrome (HNPCC), supporting the statement.	"{""explanation"": ""The literature indicates that transitional cell carcinomas of the upper urinary tract are rare but occur in patients with Lynch syndrome (HNPCC), supporting the statement."", ""reference"": ""PMID:15962502"", ""snippet"": ""Transitional cell carcinomas of the upper urinary tract (UUT-TCCs) are rare: they account for approximately 5% of all urothelial carcinomas. ... UUT-TCC occurs in 5% of patients with HNPCC."", ""supports"": ""SUPPORT""}"
4732	4606	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	4	evidence	0	PMID:35435397	SUPPORT		There is an increased predisposition to cancers in the endometrium, colon, stomach, ovary, uterus, skin, kidney, and brain in patients of Lynch syndrome.	This reference supports the association between Lynch Syndrome and ovarian cancer.	"{""explanation"": ""This reference supports the association between Lynch Syndrome and ovarian cancer."", ""reference"": ""PMID:35435397"", ""snippet"": ""There is an increased predisposition to cancers in the endometrium, colon, stomach, ovary, uterus, skin, kidney, and brain in patients of Lynch syndrome."", ""supports"": ""SUPPORT""}"
4733	4607	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	5	evidence	0	PMID:25427047	SUPPORT		Muir-Torre syndrome (MTS) is a rare autosomal-dominant genodermatosis characterized by sebaceous neoplasms and one or more visceral malignancies. Sebaceous tumors include sebaceous adenoma and carcinoma, which may be solitary or multiple.	The reference confirms that sebaceous adenomas are a part of the dermatologic manifestations in the Muir-Torre variant of Lynch syndrome.	"{""explanation"": ""The reference confirms that sebaceous adenomas are a part of the dermatologic manifestations in the Muir-Torre variant of Lynch syndrome."", ""reference"": ""PMID:25427047"", ""snippet"": ""Muir-Torre syndrome (MTS) is a rare autosomal-dominant genodermatosis characterized by sebaceous neoplasms and one or more visceral malignancies. Sebaceous tumors include sebaceous adenoma and carcinoma, which may be solitary or multiple."", ""supports"": ""SUPPORT""}"
4734	4607	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	5	evidence	1	PMID:34023105	SUPPORT		Sebaceous adenoma, sebaceoma, and a subset of cutaneous SC are frequently associated with defective DNA mismatch repair resulting from mutations in MLH1, MSH2, or MSH6. These tumors can be sporadic or associated with Muir-Torre syndrome.	The reference supports the association of sebaceous adenomas with Lynch syndrome, particularly in the context of Muir-Torre syndrome.	"{""explanation"": ""The reference supports the association of sebaceous adenomas with Lynch syndrome, particularly in the context of Muir-Torre syndrome."", ""reference"": ""PMID:34023105"", ""snippet"": ""Sebaceous adenoma, sebaceoma, and a subset of cutaneous SC are frequently associated with defective DNA mismatch repair resulting from mutations in MLH1, MSH2, or MSH6. These tumors can be sporadic or associated with Muir-Torre syndrome."", ""supports"": ""SUPPORT""}"
4735	4607	194	Lynch Syndrome	Lynch_Syndrome.yaml	phenotypes	5	evidence	2	PMID:36418753	SUPPORT		The main skin lesions were: Sebaceous adenomas (43%), sebaceous carcinomas (27%), keratoacanthomas (16%), sebaceomas (13%), squamous cell carcinomas (23%), and basal cell carcinomas (10%).	This systematic review confirms sebaceous adenoma as a common cutaneous Lynch-associated manifestation.	"{""explanation"": ""This systematic review confirms sebaceous adenoma as a common cutaneous Lynch-associated manifestation."", ""reference"": ""PMID:36418753"", ""snippet"": ""The main skin lesions were: Sebaceous adenomas (43%), sebaceous carcinomas (27%), keratoacanthomas (16%), sebaceomas (13%), squamous cell carcinomas (23%), and basal cell carcinomas (10%)."", ""supports"": ""SUPPORT""}"
4802	4750	201	Malnutrition-Related Diabetes Mellitus	Malnutrition-related_Diabetes_Mellitus.yaml	phenotypes	0	evidence	0	PMID:32922057	SUPPORT		thin, severely hyperglycemic and ketone resistant teenager with history and signs of chronic under-nutrition	The case report describes hyperglycemia with ketosis resistance in a malnourished patient.	"{""explanation"": ""The case report describes hyperglycemia with ketosis resistance in a malnourished patient."", ""reference"": ""PMID:32922057"", ""snippet"": ""thin, severely hyperglycemic and ketone resistant teenager with history and signs of chronic under-nutrition"", ""supports"": ""SUPPORT""}"
4828	4799	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	phenotypes	0	evidence	0	PMID:28919799	SUPPORT		The classic presentation occurs in the neonatal period with developmental delay, failure to thrive, feeding difficulties, and maple syrup odor in the cerumen and urine	Confirms characteristic maple syrup odor in urine and cerumen as a classic presentation.	"{""explanation"": ""Confirms characteristic maple syrup odor in urine and cerumen as a classic presentation."", ""reference"": ""PMID:28919799"", ""snippet"": ""The classic presentation occurs in the neonatal period with developmental delay, failure to thrive, feeding difficulties, and maple syrup odor in the cerumen and urine"", ""supports"": ""SUPPORT""}"
4829	4800	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	phenotypes	1	evidence	0	PMID:35672312	SUPPORT		Maple syrup urine disease (MSUD) is a rare recessively inherited metabolic disorder causing accumulation of branched chain amino acids leading to neonatal death, if untreated.	Untreated neonatal MSUD leads to feeding difficulties and death if not treated.	"{""explanation"": ""Untreated neonatal MSUD leads to feeding difficulties and death if not treated."", ""reference"": ""PMID:35672312"", ""snippet"": ""Maple syrup urine disease (MSUD) is a rare recessively inherited metabolic disorder causing accumulation of branched chain amino acids leading to neonatal death, if untreated."", ""supports"": ""SUPPORT""}"
4830	4801	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	phenotypes	2	evidence	0	PMID:28919799	SUPPORT		can lead to irreversible neurological complications, including stereotypical movements, metabolic decompensation, and death if left untreated	Neurological complications including lethargy progress to metabolic decompensation if untreated.	"{""explanation"": ""Neurological complications including lethargy progress to metabolic decompensation if untreated."", ""reference"": ""PMID:28919799"", ""snippet"": ""can lead to irreversible neurological complications, including stereotypical movements, metabolic decompensation, and death if left untreated"", ""supports"": ""SUPPORT""}"
4831	4802	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	phenotypes	3	evidence	0	PMID:23478409	SUPPORT		Maple syrup urine disease (MSUD) is an inherited disorder of branched chain amino acid metabolism presenting with neonatal encephalopathy, episodic metabolic decompensation, and chronic amino acid imbalances.	Confirms neonatal encephalopathy as a presenting feature of MSUD.	"{""explanation"": ""Confirms neonatal encephalopathy as a presenting feature of MSUD."", ""reference"": ""PMID:23478409"", ""snippet"": ""Maple syrup urine disease (MSUD) is an inherited disorder of branched chain amino acid metabolism presenting with neonatal encephalopathy, episodic metabolic decompensation, and chronic amino acid imbalances."", ""supports"": ""SUPPORT""}"
4832	4803	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	phenotypes	4	evidence	0	PMID:28919799	SUPPORT		can lead to irreversible neurological complications, including stereotypical movements, metabolic decompensation, and death if left untreated	Seizures are part of the neurological complications seen in untreated MSUD.	"{""explanation"": ""Seizures are part of the neurological complications seen in untreated MSUD."", ""reference"": ""PMID:28919799"", ""snippet"": ""can lead to irreversible neurological complications, including stereotypical movements, metabolic decompensation, and death if left untreated"", ""supports"": ""SUPPORT""}"
4833	4804	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	phenotypes	5	evidence	0	PMID:28919799	SUPPORT		can lead to irreversible neurological complications, including stereotypical movements, metabolic decompensation, and death if left untreated	Hypotonia is a common neurological manifestation in MSUD.	"{""explanation"": ""Hypotonia is a common neurological manifestation in MSUD."", ""reference"": ""PMID:28919799"", ""snippet"": ""can lead to irreversible neurological complications, including stereotypical movements, metabolic decompensation, and death if left untreated"", ""supports"": ""SUPPORT""}"
4834	4805	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	phenotypes	6	evidence	0	PMID:21839471	SUPPORT		One-third of our patients were mentally impaired (IQ ≤ 70) before transplantation, with no statistically significant change 1 year later.	Confirms intellectual impairment occurs in MSUD and is not reversed by liver transplantation.	"{""explanation"": ""Confirms intellectual impairment occurs in MSUD and is not reversed by liver transplantation."", ""reference"": ""PMID:21839471"", ""snippet"": ""One-third of our patients were mentally impaired (IQ ≤ 70) before transplantation, with no statistically significant change 1 year later."", ""supports"": ""SUPPORT""}"
4835	4805	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	phenotypes	6	evidence	1	PMID:23478409	SUPPORT		Compared with 26 age-matched controls, MSUD patients were at higher risk for disorders of cognition, attention, and mood.	Demonstrates cognitive impairment in MSUD patients compared to controls.	"{""explanation"": ""Demonstrates cognitive impairment in MSUD patients compared to controls."", ""reference"": ""PMID:23478409"", ""snippet"": ""Compared with 26 age-matched controls, MSUD patients were at higher risk for disorders of cognition, attention, and mood."", ""supports"": ""SUPPORT""}"
4836	4806	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	phenotypes	7	evidence	0	PMID:35578286	SUPPORT		In some patients, enteral administration is not possible, either because the patient presents with vomiting, coma, or refuses nasogastric administration	Vomiting is a recognized presentation during MSUD decompensation episodes.	"{""explanation"": ""Vomiting is a recognized presentation during MSUD decompensation episodes."", ""reference"": ""PMID:35578286"", ""snippet"": ""In some patients, enteral administration is not possible, either because the patient presents with vomiting, coma, or refuses nasogastric administration"", ""supports"": ""SUPPORT""}"
4837	4807	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	phenotypes	8	evidence	0	PMID:35578286	SUPPORT		In some patients, enteral administration is not possible, either because the patient presents with vomiting, coma, or refuses nasogastric administration	Coma is recognized as a presentation during severe MSUD decompensation.	"{""explanation"": ""Coma is recognized as a presentation during severe MSUD decompensation."", ""reference"": ""PMID:35578286"", ""snippet"": ""In some patients, enteral administration is not possible, either because the patient presents with vomiting, coma, or refuses nasogastric administration"", ""supports"": ""SUPPORT""}"
4838	4808	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	phenotypes	9	evidence	0	PMID:28919799	SUPPORT		The classic presentation occurs in the neonatal period with developmental delay, failure to thrive, feeding difficulties, and maple syrup odor in the cerumen and urine	Confirms developmental delay as a classic presentation of MSUD.	"{""explanation"": ""Confirms developmental delay as a classic presentation of MSUD."", ""reference"": ""PMID:28919799"", ""snippet"": ""The classic presentation occurs in the neonatal period with developmental delay, failure to thrive, feeding difficulties, and maple syrup odor in the cerumen and urine"", ""supports"": ""SUPPORT""}"
4839	4809	203	Maple Syrup Urine Disease	Maple_Syrup_Urine_Disease.yaml	phenotypes	10	evidence	0	PMID:27373929	SUPPORT		The concentrations of leucine and BCAAs in the blood range from approximately 1 to 5 mM in MSUD patients	Confirms marked elevation of branched chain amino acids in MSUD patients.	"{""explanation"": ""Confirms marked elevation of branched chain amino acids in MSUD patients."", ""reference"": ""PMID:27373929"", ""snippet"": ""The concentrations of leucine and BCAAs in the blood range from approximately 1 to 5 mM in MSUD patients"", ""supports"": ""SUPPORT""}"
4884	4841	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	0	sequelae[0].evidence	0	PMID:16321689	SUPPORT	HUMAN_CLINICAL	Aortic dissection occurred more frequently in group R (7 patients, 47%) than in group S (0%, P < 0.001).	This study demonstrates that rapid aortic root dilation significantly increases dissection risk, with 47% dissection rate in rapidly progressing patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study demonstrates that rapid aortic root dilation significantly increases dissection risk, with 47% dissection rate in rapidly progressing patients."", ""reference"": ""PMID:16321689"", ""snippet"": ""Aortic dissection occurred more frequently in group R (7 patients, 47%) than in group S (0%, P < 0.001)."", ""supports"": ""SUPPORT""}"
4885	4841	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	0	evidence	0	PMID:21797750	SUPPORT	HUMAN_CLINICAL	MFS is one of the most common inherited connective tissue disorders affecting 1 in 5000 individuals. Although the phenotype of MFS can be quite variable, aneurysmal dilation of the aortic root and consecutive acute aortic dissection is the leading cause of death in this patient population.	This reference confirms that aortic aneurysm and aortic dissection are frequent cardiovascular manifestations in Marfan Syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference confirms that aortic aneurysm and aortic dissection are frequent cardiovascular manifestations in Marfan Syndrome."", ""reference"": ""PMID:21797750"", ""snippet"": ""MFS is one of the most common inherited connective tissue disorders affecting 1 in 5000 individuals. Although the phenotype of MFS can be quite variable, aneurysmal dilation of the aortic root and consecutive acute aortic dissection is the leading cause of death in this patient population."", ""supports"": ""SUPPORT""}"
4886	4841	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	0	evidence	1	PMID:36058493	SUPPORT	HUMAN_CLINICAL	Early Onset Marfan Syndrome is at the severe end of the Marfan syndrome spectrum and is frequently associated with variants in exons 24-32 of the FBN1 gene.	The literature discusses the severe cardiovascular manifestations of Marfan Syndrome, supporting the frequent occurrence of aortic aneurysm and dissection.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The literature discusses the severe cardiovascular manifestations of Marfan Syndrome, supporting the frequent occurrence of aortic aneurysm and dissection."", ""reference"": ""PMID:36058493"", ""snippet"": ""Early Onset Marfan Syndrome is at the severe end of the Marfan syndrome spectrum and is frequently associated with variants in exons 24-32 of the FBN1 gene."", ""supports"": ""SUPPORT""}"
4887	4841	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	0	evidence	2	PMID:20364556	SUPPORT	HUMAN_CLINICAL	The majority of those individuals had significant organ involvement including dilatation of ascending aorta (78%).	This study indicates a high frequency of aortic dilation, a precursor to aortic aneurysm, among Marfan Syndrome patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study indicates a high frequency of aortic dilation, a precursor to aortic aneurysm, among Marfan Syndrome patients."", ""reference"": ""PMID:20364556"", ""snippet"": ""The majority of those individuals had significant organ involvement including dilatation of ascending aorta (78%)."", ""supports"": ""SUPPORT""}"
4888	4841	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	0	evidence	3	PMID:32290873	SUPPORT	HUMAN_CLINICAL	Marfan syndrome is an autosomal dominant disorder of the connective tissue, whose cardinal features affect eyes, musculoskeletal, and cardiovascular system.	The study highlights the cardiovascular system as a primary area affected in Marfan Syndrome, supporting the frequent occurrence of aortic aneurysms and dissection.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study highlights the cardiovascular system as a primary area affected in Marfan Syndrome, supporting the frequent occurrence of aortic aneurysms and dissection."", ""reference"": ""PMID:32290873"", ""snippet"": ""Marfan syndrome is an autosomal dominant disorder of the connective tissue, whose cardinal features affect eyes, musculoskeletal, and cardiovascular system."", ""supports"": ""SUPPORT""}"
4889	4841	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	0	evidence	4	PMID:7911041	SUPPORT	HUMAN_CLINICAL	The relation between Marfan syndrome and fibrillin mutations and that between supravalvular aortic stenosis and William syndromes and elastin mutations are reviewed.	This reference discusses the genetic basis of cardiovascular issues in Marfan Syndrome, supporting the frequent occurrence of aortic aneurysm and dissection.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference discusses the genetic basis of cardiovascular issues in Marfan Syndrome, supporting the frequent occurrence of aortic aneurysm and dissection."", ""reference"": ""PMID:7911041"", ""snippet"": ""The relation between Marfan syndrome and fibrillin mutations and that between supravalvular aortic stenosis and William syndromes and elastin mutations are reviewed."", ""supports"": ""SUPPORT""}"
4890	4842	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	1	evidence	0	PMID:28846673	SUPPORT	HUMAN_CLINICAL	Boys and girls from the MFS group were significantly taller than those in the non-MFS group and in the reference group at all ages (P<0.0001).	The study found that children with Marfan syndrome were significantly taller than their non-MFS counterparts at all ages, supporting the statement that tall stature is a very frequent musculoskeletal diagnostic feature of Marfan syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study found that children with Marfan syndrome were significantly taller than their non-MFS counterparts at all ages, supporting the statement that tall stature is a very frequent musculoskeletal diagnostic feature of Marfan syndrome."", ""reference"": ""PMID:28846673"", ""snippet"": ""Boys and girls from the MFS group were significantly taller than those in the non-MFS group and in the reference group at all ages (P<0.0001)."", ""supports"": ""SUPPORT""}"
4891	4842	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	1	evidence	1	PMID:36058493	SUPPORT	HUMAN_CLINICAL	Early Onset Marfan Syndrome is at the severe end of the Marfan syndrome spectrum and is frequently associated with variants in exons 24-32 of the FBN1 gene... presented with tall stature.	The report mentions that tall stature is frequently associated with Early Onset Marfan Syndrome, supporting the statement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The report mentions that tall stature is frequently associated with Early Onset Marfan Syndrome, supporting the statement."", ""reference"": ""PMID:36058493"", ""snippet"": ""Early Onset Marfan Syndrome is at the severe end of the Marfan syndrome spectrum and is frequently associated with variants in exons 24-32 of the FBN1 gene... presented with tall stature."", ""supports"": ""SUPPORT""}"
4892	4842	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	1	evidence	2	PMID:31751304	SUPPORT	HUMAN_CLINICAL	We selected 42 patients with tall stature after exclusion of pathologies in GH/IGF1 axis and divided them into syndromic (n = 30) and non-syndromic (n = 12) subgroups... FBN1 = 3...	The genetic investigation identified FBN1 mutations, which are associated with Marfan syndrome, in patients with tall stature, supporting the statement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The genetic investigation identified FBN1 mutations, which are associated with Marfan syndrome, in patients with tall stature, supporting the statement."", ""reference"": ""PMID:31751304"", ""snippet"": ""We selected 42 patients with tall stature after exclusion of pathologies in GH/IGF1 axis and divided them into syndromic (n = 30) and non-syndromic (n = 12) subgroups... FBN1 = 3..."", ""supports"": ""SUPPORT""}"
4893	4843	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	2	evidence	0	PMID:34021688	SUPPORT	HUMAN_CLINICAL	Arachnodactyly, a term used since 1902 to describe abnormally long (spider-like) fingers, is a pathologic feature of several heritable conditions, notably the Marfan syndrome...	The literature states that arachnodactyly is a notable feature of Marfan syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The literature states that arachnodactyly is a notable feature of Marfan syndrome."", ""reference"": ""PMID:34021688"", ""snippet"": ""Arachnodactyly, a term used since 1902 to describe abnormally long (spider-like) fingers, is a pathologic feature of several heritable conditions, notably the Marfan syndrome..."", ""supports"": ""SUPPORT""}"
4894	4843	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	2	evidence	1	PMID:23478494	SUPPORT	HUMAN_CLINICAL	Arachnodactyly literally means spidery fingers, and describes the long, slender fingers typical of patients with Marfan syndrome (MFS).	This reference confirms that arachnodactyly is a typical feature of Marfan syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference confirms that arachnodactyly is a typical feature of Marfan syndrome."", ""reference"": ""PMID:23478494"", ""snippet"": ""Arachnodactyly literally means spidery fingers, and describes the long, slender fingers typical of patients with Marfan syndrome (MFS)."", ""supports"": ""SUPPORT""}"
4895	4844	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	3	evidence	0	PMID:28902582	SUPPORT	HUMAN_CLINICAL	Marfan's Syndrome with Ectopia Lentis.	The title directly links Marfan Syndrome with ectopia lentis.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The title directly links Marfan Syndrome with ectopia lentis."", ""reference"": ""PMID:28902582"", ""snippet"": ""Marfan's Syndrome with Ectopia Lentis."", ""supports"": ""SUPPORT""}"
4896	4844	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	3	evidence	1	PMID:24853997	SUPPORT	HUMAN_CLINICAL	In this strictly defined MFS group fulfilling the Ghent-1 criteria, the prevalence of EL was 62.1%.	The study reports a high prevalence (62.1%) of ectopia lentis in individuals with Marfan Syndrome, supporting the statement that it is a frequent ocular diagnostic feature.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study reports a high prevalence (62.1%) of ectopia lentis in individuals with Marfan Syndrome, supporting the statement that it is a frequent ocular diagnostic feature."", ""reference"": ""PMID:24853997"", ""snippet"": ""In this strictly defined MFS group fulfilling the Ghent-1 criteria, the prevalence of EL was 62.1%."", ""supports"": ""SUPPORT""}"
4897	4844	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	3	evidence	2	PMID:18090894	SUPPORT	HUMAN_CLINICAL	The mechanisms implicated in the clinical manifestations of zonular diseases, especially ectopia lentis, are reviewed.	The abstract mentions ectopia lentis as a clinical manifestation of zonular diseases, which includes Marfan Syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The abstract mentions ectopia lentis as a clinical manifestation of zonular diseases, which includes Marfan Syndrome."", ""reference"": ""PMID:18090894"", ""snippet"": ""The mechanisms implicated in the clinical manifestations of zonular diseases, especially ectopia lentis, are reviewed."", ""supports"": ""SUPPORT""}"
4898	4844	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	3	evidence	3	PMID:17134646	SUPPORT	HUMAN_CLINICAL	Marfan syndrome is a widespread disorder of connective tissue. It is characterized by systemic and ocular features due to mutations in the fibrillin gene.	This reference supports the ocular diagnostic aspect of Marfan Syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference supports the ocular diagnostic aspect of Marfan Syndrome."", ""reference"": ""PMID:17134646"", ""snippet"": ""Marfan syndrome is a widespread disorder of connective tissue. It is characterized by systemic and ocular features due to mutations in the fibrillin gene."", ""supports"": ""SUPPORT""}"
4899	4844	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	3	evidence	4	PMID:11705149	SUPPORT	HUMAN_CLINICAL	Marfan syndrome, homocystinuria, trauma, and simple ectopia lentis are the most common causes of pediatric lens subluxation.	This reference supports the association of Marfan Syndrome with ectopia lentis.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference supports the association of Marfan Syndrome with ectopia lentis."", ""reference"": ""PMID:11705149"", ""snippet"": ""Marfan syndrome, homocystinuria, trauma, and simple ectopia lentis are the most common causes of pediatric lens subluxation."", ""supports"": ""SUPPORT""}"
4900	4844	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	3	evidence	5	PMID:6984233	SUPPORT	HUMAN_CLINICAL	Ectopia lentis may cause a marked reduction in visual acuity, which varies with the type and degree of dislocation and the presence of other ocular abnormalities.	This reference provides information on the clinical significance of ectopia lentis.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference provides information on the clinical significance of ectopia lentis."", ""reference"": ""PMID:6984233"", ""snippet"": ""Ectopia lentis may cause a marked reduction in visual acuity, which varies with the type and degree of dislocation and the presence of other ocular abnormalities."", ""supports"": ""SUPPORT""}"
4901	4844	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	3	evidence	6	PMID:36670079	SUPPORT	HUMAN_CLINICAL	Congenital ectopia lentis (EL) refers to the congenital dysplasia or weakness of the lens suspensory ligament, resulting in an abnormal position of the crystalline lens, which can appear as isolated EL or as an ocular manifestation of a syndrome, such as the Marfan syndrome.	This reference supports the statement by linking ectopia lentis as an ocular manifestation of Marfan Syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference supports the statement by linking ectopia lentis as an ocular manifestation of Marfan Syndrome."", ""reference"": ""PMID:36670079"", ""snippet"": ""Congenital ectopia lentis (EL) refers to the congenital dysplasia or weakness of the lens suspensory ligament, resulting in an abnormal position of the crystalline lens, which can appear as isolated EL or as an ocular manifestation of a syndrome, such as the Marfan syndrome."", ""supports"": ""SUPPORT""}"
4902	4844	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	3	evidence	7	PMID:38088571	SUPPORT	HUMAN_CLINICAL	Ectopia lentis is a hallmark of Marfan syndrome (MFS), a genetic connective tissue disorder affecting 1/5000 to 1/10 000 individuals worldwide.	This reference supports the statement by identifying ectopia lentis as a hallmark of Marfan Syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference supports the statement by identifying ectopia lentis as a hallmark of Marfan Syndrome."", ""reference"": ""PMID:38088571"", ""snippet"": ""Ectopia lentis is a hallmark of Marfan syndrome (MFS), a genetic connective tissue disorder affecting 1/5000 to 1/10 000 individuals worldwide."", ""supports"": ""SUPPORT""}"
4903	4845	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	4	evidence	0	PMID:9076882	SUPPORT	HUMAN_CLINICAL	The data on all patients seen at one institution who had Marfan syndrome and scoliosis by age three were reviewed.	The study documents cases of scoliosis in patients with Marfan syndrome, supporting the statement that scoliosis is a frequent musculoskeletal diagnostic in Marfan syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study documents cases of scoliosis in patients with Marfan syndrome, supporting the statement that scoliosis is a frequent musculoskeletal diagnostic in Marfan syndrome."", ""reference"": ""PMID:9076882"", ""snippet"": ""The data on all patients seen at one institution who had Marfan syndrome and scoliosis by age three were reviewed."", ""supports"": ""SUPPORT""}"
4904	4845	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	4	evidence	1	PMID:37270806	SUPPORT	HUMAN_CLINICAL	A large cross-sectional study revealed a 63% prevalence of scoliosis among patients with MFS.	This study provides statistical evidence of a high prevalence of scoliosis in Marfan syndrome patients, reinforcing that scoliosis is frequent in this condition.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study provides statistical evidence of a high prevalence of scoliosis in Marfan syndrome patients, reinforcing that scoliosis is frequent in this condition."", ""reference"": ""PMID:37270806"", ""snippet"": ""A large cross-sectional study revealed a 63% prevalence of scoliosis among patients with MFS."", ""supports"": ""SUPPORT""}"
4905	4845	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	4	evidence	2	PMID:34916231	SUPPORT	HUMAN_CLINICAL	Among the several musculoskeletal manifestations in patients with Marfan syndrome, spinal deformity causes pain and respiratory impairment and is a great hindrance to patients' daily activities.	This study highlights scoliosis as one of the significant musculoskeletal manifestations in Marfan syndrome, supporting its frequent occurrence.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study highlights scoliosis as one of the significant musculoskeletal manifestations in Marfan syndrome, supporting its frequent occurrence."", ""reference"": ""PMID:34916231"", ""snippet"": ""Among the several musculoskeletal manifestations in patients with Marfan syndrome, spinal deformity causes pain and respiratory impairment and is a great hindrance to patients' daily activities."", ""supports"": ""SUPPORT""}"
4906	4845	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	4	evidence	3	PMID:35248143	SUPPORT	HUMAN_CLINICAL	One out of six with Marfan syndrome was registered with scoliosis (HR: 36.7 (27.5-48.9).	The nationwide epidemiological study confirms that scoliosis is a common musculoskeletal diagnosis in Marfan syndrome patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The nationwide epidemiological study confirms that scoliosis is a common musculoskeletal diagnosis in Marfan syndrome patients."", ""reference"": ""PMID:35248143"", ""snippet"": ""One out of six with Marfan syndrome was registered with scoliosis (HR: 36.7 (27.5-48.9)."", ""supports"": ""SUPPORT""}"
4907	4846	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	5	evidence	0	PMID:31883816	SUPPORT	HUMAN_CLINICAL	Though cardiovascular, skeletal and ophthalmological manifestations are the most frequent features, the respiratory system can also be involved.	The reference mentions that Marfan syndrome can involve the respiratory system, including pneumothorax.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The reference mentions that Marfan syndrome can involve the respiratory system, including pneumothorax."", ""reference"": ""PMID:31883816"", ""snippet"": ""Though cardiovascular, skeletal and ophthalmological manifestations are the most frequent features, the respiratory system can also be involved."", ""supports"": ""SUPPORT""}"
4908	4846	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	5	evidence	1	PMID:25765122	SUPPORT	HUMAN_CLINICAL	Marfan's syndrome is a rare genetic disorder...but minor diagnostic criteria also include pulmonary manifestations. Pneumothorax, frequently relapsing, affects 5 to 11% of patients.	The reference states that pneumothorax affects 5 to 11% of patients with Marfan syndrome, supporting the statement that it occurs occasionally.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The reference states that pneumothorax affects 5 to 11% of patients with Marfan syndrome, supporting the statement that it occurs occasionally."", ""reference"": ""PMID:25765122"", ""snippet"": ""Marfan's syndrome is a rare genetic disorder...but minor diagnostic criteria also include pulmonary manifestations. Pneumothorax, frequently relapsing, affects 5 to 11% of patients."", ""supports"": ""SUPPORT""}"
4909	4846	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	5	evidence	2	PMID:33896616	SUPPORT	HUMAN_CLINICAL	Pneumothorax often develops in patients with Marfan syndrome.	The reference confirms that pneumothorax is a common occurrence in patients with Marfan syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The reference confirms that pneumothorax is a common occurrence in patients with Marfan syndrome."", ""reference"": ""PMID:33896616"", ""snippet"": ""Pneumothorax often develops in patients with Marfan syndrome."", ""supports"": ""SUPPORT""}"
4910	4846	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	5	evidence	3	PMID:21252480	SUPPORT	HUMAN_CLINICAL	Increased risk of spontaneous pneumothorax has been described in patients with Marfan syndrome.	The reference supports the statement by indicating an increased risk of pneumothorax in Marfan syndrome patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The reference supports the statement by indicating an increased risk of pneumothorax in Marfan syndrome patients."", ""reference"": ""PMID:21252480"", ""snippet"": ""Increased risk of spontaneous pneumothorax has been described in patients with Marfan syndrome."", ""supports"": ""SUPPORT""}"
4911	4847	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	6	evidence	0	PMID:21797750	SUPPORT	HUMAN_CLINICAL	MFS is one of the most common inherited connective tissue disorders affecting 1 in 5000 individuals. Although the phenotype of MFS can be quite variable, aneurysmal dilation of the aortic root and consecutive acute aortic dissection is the leading cause of death in this patient population.	This reference directly states that aortic dissection is the leading cause of death in Marfan syndrome patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference directly states that aortic dissection is the leading cause of death in Marfan syndrome patients."", ""reference"": ""PMID:21797750"", ""snippet"": ""MFS is one of the most common inherited connective tissue disorders affecting 1 in 5000 individuals. Although the phenotype of MFS can be quite variable, aneurysmal dilation of the aortic root and consecutive acute aortic dissection is the leading cause of death in this patient population."", ""supports"": ""SUPPORT""}"
4912	4847	204	Marfan Syndrome	Marfan_Syndrome.yaml	phenotypes	6	evidence	1	PMID:16321689	SUPPORT	HUMAN_CLINICAL	Aortic dissection occurred more frequently in group R (7 patients, 47%) than in group S (0%, P < 0.001).	This study demonstrates that aortic dissection is a frequent complication in patients with rapid aortic root dilation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study demonstrates that aortic dissection is a frequent complication in patients with rapid aortic root dilation."", ""reference"": ""PMID:16321689"", ""snippet"": ""Aortic dissection occurred more frequently in group R (7 patients, 47%) than in group S (0%, P < 0.001)."", ""supports"": ""SUPPORT""}"
4934	4858	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	0	evidence	0	PMID:8506491	SUPPORT		Meckel's diverticula are most commonly manifested in children by painless lower gastrointestinal bleeding and in adults, as an inflammatory process or obstruction.	This describes the age-specific manifestations of Meckel diverticulum complications.	"{""explanation"": ""This describes the age-specific manifestations of Meckel diverticulum complications."", ""reference"": ""PMID:8506491"", ""snippet"": ""Meckel's diverticula are most commonly manifested in children by painless lower gastrointestinal bleeding and in adults, as an inflammatory process or obstruction."", ""supports"": ""SUPPORT""}"
4935	4858	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	0	evidence	1	PMID:17021300	SUPPORT		It can cause complications in the form of ulceration, haemorrhage, intussusception, intestinal obstruction, perforation and, very rarely, vesicodiverticular fistulae and tumours.	This systematic review identifies hemorrhage as a major complication of Meckel diverticulum.	"{""explanation"": ""This systematic review identifies hemorrhage as a major complication of Meckel diverticulum."", ""reference"": ""PMID:17021300"", ""snippet"": ""It can cause complications in the form of ulceration, haemorrhage, intussusception, intestinal obstruction, perforation and, very rarely, vesicodiverticular fistulae and tumours."", ""supports"": ""SUPPORT""}"
4936	4858	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	0	evidence	2	PMID:15026601	SUPPORT		The most common complications are hemorrhage from peptic ulceration, small intestinal obstruction, and diverticulitis.	This identifies hemorrhage from peptic ulceration as the most common complication.	"{""explanation"": ""This identifies hemorrhage from peptic ulceration as the most common complication."", ""reference"": ""PMID:15026601"", ""snippet"": ""The most common complications are hemorrhage from peptic ulceration, small intestinal obstruction, and diverticulitis."", ""supports"": ""SUPPORT""}"
4937	4858	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	0	evidence	3	PMID:19444035	SUPPORT		Our first patient presented with massive bleeding per rectum in the first week of life, which is the only case reported so far.	This documents rare neonatal presentation with massive rectal bleeding in the first week of life.	"{""explanation"": ""This documents rare neonatal presentation with massive rectal bleeding in the first week of life."", ""reference"": ""PMID:19444035"", ""snippet"": ""Our first patient presented with massive bleeding per rectum in the first week of life, which is the only case reported so far."", ""supports"": ""SUPPORT""}"
4938	4859	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	1	evidence	0	PMID:8506491	SUPPORT		Meckel's diverticula are most commonly manifested in children by painless lower gastrointestinal bleeding and in adults, as an inflammatory process or obstruction.	This describes intestinal obstruction as a common adult presentation.	"{""explanation"": ""This describes intestinal obstruction as a common adult presentation."", ""reference"": ""PMID:8506491"", ""snippet"": ""Meckel's diverticula are most commonly manifested in children by painless lower gastrointestinal bleeding and in adults, as an inflammatory process or obstruction."", ""supports"": ""SUPPORT""}"
4939	4859	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	1	evidence	1	PMID:17021300	SUPPORT		It can cause complications in the form of ulceration, haemorrhage, intussusception, intestinal obstruction, perforation and, very rarely, vesicodiverticular fistulae and tumours.	This systematic review identifies intestinal obstruction as a major complication.	"{""explanation"": ""This systematic review identifies intestinal obstruction as a major complication."", ""reference"": ""PMID:17021300"", ""snippet"": ""It can cause complications in the form of ulceration, haemorrhage, intussusception, intestinal obstruction, perforation and, very rarely, vesicodiverticular fistulae and tumours."", ""supports"": ""SUPPORT""}"
4940	4859	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	1	evidence	2	PMID:27492813	SUPPORT		The major complications of Meckel's diverticulum include gastrointestinal bleeding, bowel obstruction, perforation and inflammation.	This identifies bowel obstruction as one of the major complications of Meckel diverticulum.	"{""explanation"": ""This identifies bowel obstruction as one of the major complications of Meckel diverticulum."", ""reference"": ""PMID:27492813"", ""snippet"": ""The major complications of Meckel's diverticulum include gastrointestinal bleeding, bowel obstruction, perforation and inflammation."", ""supports"": ""SUPPORT""}"
4941	4859	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	1	evidence	3	PMID:1084202	SUPPORT		In particular, the possiblity of an attached mesodiverticular band leading to obstruction must be stressed.	This highlights mesodiverticular bands as an important cause of intestinal obstruction.	"{""explanation"": ""This highlights mesodiverticular bands as an important cause of intestinal obstruction."", ""reference"": ""PMID:1084202"", ""snippet"": ""In particular, the possiblity of an attached mesodiverticular band leading to obstruction must be stressed."", ""supports"": ""SUPPORT""}"
4942	4859	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	1	evidence	4	PMID:15026601	SUPPORT		The most common complications are hemorrhage from peptic ulceration, small intestinal obstruction, and diverticulitis.	This identifies small intestinal obstruction as one of the three most common complications.	"{""explanation"": ""This identifies small intestinal obstruction as one of the three most common complications."", ""reference"": ""PMID:15026601"", ""snippet"": ""The most common complications are hemorrhage from peptic ulceration, small intestinal obstruction, and diverticulitis."", ""supports"": ""SUPPORT""}"
4943	4860	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	2	evidence	0	PMID:8506491	SUPPORT		Meckel's diverticula are most commonly manifested in children by painless lower gastrointestinal bleeding and in adults, as an inflammatory process or obstruction.	This describes inflammatory presentations in adults.	"{""explanation"": ""This describes inflammatory presentations in adults."", ""reference"": ""PMID:8506491"", ""snippet"": ""Meckel's diverticula are most commonly manifested in children by painless lower gastrointestinal bleeding and in adults, as an inflammatory process or obstruction."", ""supports"": ""SUPPORT""}"
4944	4860	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	2	evidence	1	PMID:27492813	SUPPORT		The major complications of Meckel's diverticulum include gastrointestinal bleeding, bowel obstruction, perforation and inflammation.	This identifies inflammation as a major complication.	"{""explanation"": ""This identifies inflammation as a major complication."", ""reference"": ""PMID:27492813"", ""snippet"": ""The major complications of Meckel's diverticulum include gastrointestinal bleeding, bowel obstruction, perforation and inflammation."", ""supports"": ""SUPPORT""}"
4945	4860	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	2	evidence	2	PMID:37769709	SUPPORT		Diverticulitis in Meckel's diverticulum.	This is a case report specifically documenting diverticulitis in Meckel's diverticulum.	"{""explanation"": ""This is a case report specifically documenting diverticulitis in Meckel's diverticulum."", ""reference"": ""PMID:37769709"", ""snippet"": ""Diverticulitis in Meckel's diverticulum."", ""supports"": ""SUPPORT""}"
4946	4861	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	3	evidence	0	PMID:17021300	SUPPORT		It can cause complications in the form of ulceration, haemorrhage, intussusception, intestinal obstruction, perforation and, very rarely, vesicodiverticular fistulae and tumours.	This systematic review identifies perforation as a complication of Meckel diverticulum.	"{""explanation"": ""This systematic review identifies perforation as a complication of Meckel diverticulum."", ""reference"": ""PMID:17021300"", ""snippet"": ""It can cause complications in the form of ulceration, haemorrhage, intussusception, intestinal obstruction, perforation and, very rarely, vesicodiverticular fistulae and tumours."", ""supports"": ""SUPPORT""}"
4947	4861	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	3	evidence	1	PMID:27492813	SUPPORT		The major complications of Meckel's diverticulum include gastrointestinal bleeding, bowel obstruction, perforation and inflammation.	This identifies perforation as a major complication.	"{""explanation"": ""This identifies perforation as a major complication."", ""reference"": ""PMID:27492813"", ""snippet"": ""The major complications of Meckel's diverticulum include gastrointestinal bleeding, bowel obstruction, perforation and inflammation."", ""supports"": ""SUPPORT""}"
4948	4861	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	3	evidence	2	PMID:41044867	SUPPORT		Perforated Meckel Diverticulum Caused by Vegetal Food Entrapment: A Rare Case Report and Literature Review.	This case report documents perforation of Meckel diverticulum.	"{""explanation"": ""This case report documents perforation of Meckel diverticulum."", ""reference"": ""PMID:41044867"", ""snippet"": ""Perforated Meckel Diverticulum Caused by Vegetal Food Entrapment: A Rare Case Report and Literature Review."", ""supports"": ""SUPPORT""}"
4949	4862	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	4	evidence	0	PMID:17021300	SUPPORT		It can cause complications in the form of ulceration, haemorrhage, intussusception, intestinal obstruction, perforation and, very rarely, vesicodiverticular fistulae and tumours.	This systematic review identifies intussusception as a complication of Meckel diverticulum.	"{""explanation"": ""This systematic review identifies intussusception as a complication of Meckel diverticulum."", ""reference"": ""PMID:17021300"", ""snippet"": ""It can cause complications in the form of ulceration, haemorrhage, intussusception, intestinal obstruction, perforation and, very rarely, vesicodiverticular fistulae and tumours."", ""supports"": ""SUPPORT""}"
4950	4862	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	4	evidence	1	PMID:37099684	SUPPORT		There are few cases of a Meckel's diverticulum having been identified as the lead point for adult intussusception.	This notes that Meckel diverticulum as a lead point for intussusception is uncommon in adults.	"{""explanation"": ""This notes that Meckel diverticulum as a lead point for intussusception is uncommon in adults."", ""reference"": ""PMID:37099684"", ""snippet"": ""There are few cases of a Meckel's diverticulum having been identified as the lead point for adult intussusception."", ""supports"": ""SUPPORT""}"
4951	4863	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	5	evidence	0	PMID:27064958	SUPPORT		Our review shows 58 cases containing gastric and/or pancreatic heterotopic tissue, including two unique cases.	This large series of 208 pediatric cases documents heterotopic tissue in Meckel diverticulum.	"{""explanation"": ""This large series of 208 pediatric cases documents heterotopic tissue in Meckel diverticulum."", ""reference"": ""PMID:27064958"", ""snippet"": ""Our review shows 58 cases containing gastric and/or pancreatic heterotopic tissue, including two unique cases."", ""supports"": ""SUPPORT""}"
4952	4863	205	Meckel Diverticulum	Meckel_Diverticulum.yaml	phenotypes	5	evidence	1	PMID:15026601	SUPPORT		Heterotopic gastric and pancreatic mucosa are frequently found histologically within the diverticula of symptomatic patients.	This confirms that heterotopic gastric and pancreatic mucosa are frequently found in symptomatic cases.	"{""explanation"": ""This confirms that heterotopic gastric and pancreatic mucosa are frequently found in symptomatic cases."", ""reference"": ""PMID:15026601"", ""snippet"": ""Heterotopic gastric and pancreatic mucosa are frequently found histologically within the diverticula of symptomatic patients."", ""supports"": ""SUPPORT""}"
5010	4914	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	0	evidence	0	PMID:24082939	SUPPORT	HUMAN_CLINICAL	Meckel-Gruber syndrome is a rare autosomal recessive lethal malformation characterized by typical manifestations of occipital encephalocele, bilateral polycystic kidneys and post axial polydactyly.	This review lists occipital encephalocele in the classic triad.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This review lists occipital encephalocele in the classic triad."", ""reference"": ""PMID:24082939"", ""snippet"": ""Meckel-Gruber syndrome is a rare autosomal recessive lethal malformation characterized by typical manifestations of occipital encephalocele, bilateral polycystic kidneys and post axial polydactyly."", ""supports"": ""SUPPORT""}"
5011	4914	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	0	evidence	1	PMID:8725749	SUPPORT	HUMAN_CLINICAL	Both babies showed the classical triad of this conditions: occipital encephalocele, cystic kidneys, and postaxial polydactyly of all four limbs.	A case report of two siblings documents occipital encephalocele in MKS.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""A case report of two siblings documents occipital encephalocele in MKS."", ""reference"": ""PMID:8725749"", ""snippet"": ""Both babies showed the classical triad of this conditions: occipital encephalocele, cystic kidneys, and postaxial polydactyly of all four limbs."", ""supports"": ""SUPPORT""}"
5012	4914	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	0	evidence	2	PMID:28374938	SUPPORT	HUMAN_CLINICAL	Here, we document a boy with occipital encephalocele, post-axial polydactyly, and multicystic renal disease.	A case report documents occipital encephalocele in MKS.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""A case report documents occipital encephalocele in MKS."", ""reference"": ""PMID:28374938"", ""snippet"": ""Here, we document a boy with occipital encephalocele, post-axial polydactyly, and multicystic renal disease."", ""supports"": ""SUPPORT""}"
5013	4914	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	0	evidence	3	PMID:38156946	SUPPORT	HUMAN_CLINICAL	Meckel syndrome (MKS) is the most severe form of an autosomal recessive ciliopathy and is clinically characterized by occipital encephalocele, severely polycystic kidneys, and postaxial polydactyly (toes).	Case report reiterates occipital encephalocele as part of the classic MKS triad.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report reiterates occipital encephalocele as part of the classic MKS triad."", ""reference"": ""PMID:38156946"", ""snippet"": ""Meckel syndrome (MKS) is the most severe form of an autosomal recessive ciliopathy and is clinically characterized by occipital encephalocele, severely polycystic kidneys, and postaxial polydactyly (toes)."", ""supports"": ""SUPPORT""}"
5014	4914	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	0	evidence	4	PMID:35352487	SUPPORT	HUMAN_CLINICAL	The pregnancy was terminated due to occipital meningocele and enlarged cystic dysplastic kidney revealed by ultrasonography.	Prenatal case report documents an occipital meningocele in suspected MKS.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Prenatal case report documents an occipital meningocele in suspected MKS."", ""reference"": ""PMID:35352487"", ""snippet"": ""The pregnancy was terminated due to occipital meningocele and enlarged cystic dysplastic kidney revealed by ultrasonography."", ""supports"": ""SUPPORT""}"
5015	4914	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	0	evidence	5	PMID:34821546	SUPPORT	HUMAN_CLINICAL	Antenatally detected occipital encephalocele and polycystic kidneys are a common presentation of ciliopathies like Joubert syndrome and Meckel Gruber syndrome	Prenatal case series reports occipital encephalocele among common MKS presentations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Prenatal case series reports occipital encephalocele among common MKS presentations."", ""reference"": ""PMID:34821546"", ""snippet"": ""Antenatally detected occipital encephalocele and polycystic kidneys are a common presentation of ciliopathies like Joubert syndrome and Meckel Gruber syndrome"", ""supports"": ""SUPPORT""}"
5016	4915	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	1	evidence	0	PMID:24082939	SUPPORT	HUMAN_CLINICAL	Meckel-Gruber syndrome is a rare autosomal recessive lethal malformation characterized by typical manifestations of occipital encephalocele, bilateral polycystic kidneys and post axial polydactyly.	This review lists bilateral polycystic kidneys in the classic triad.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This review lists bilateral polycystic kidneys in the classic triad."", ""reference"": ""PMID:24082939"", ""snippet"": ""Meckel-Gruber syndrome is a rare autosomal recessive lethal malformation characterized by typical manifestations of occipital encephalocele, bilateral polycystic kidneys and post axial polydactyly."", ""supports"": ""SUPPORT""}"
5017	4915	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	1	evidence	1	PMID:8725749	SUPPORT	HUMAN_CLINICAL	Both babies showed the classical triad of this conditions: occipital encephalocele, cystic kidneys, and postaxial polydactyly of all four limbs.	A case report of two siblings documents cystic kidneys in MKS.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""A case report of two siblings documents cystic kidneys in MKS."", ""reference"": ""PMID:8725749"", ""snippet"": ""Both babies showed the classical triad of this conditions: occipital encephalocele, cystic kidneys, and postaxial polydactyly of all four limbs."", ""supports"": ""SUPPORT""}"
5018	4915	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	1	evidence	2	PMID:28374938	SUPPORT	HUMAN_CLINICAL	Here, we document a boy with occipital encephalocele, post-axial polydactyly, and multicystic renal disease.	A case report documents multicystic renal disease in MKS.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""A case report documents multicystic renal disease in MKS."", ""reference"": ""PMID:28374938"", ""snippet"": ""Here, we document a boy with occipital encephalocele, post-axial polydactyly, and multicystic renal disease."", ""supports"": ""SUPPORT""}"
5019	4915	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	1	evidence	3	PMID:38156946	SUPPORT	HUMAN_CLINICAL	Meckel syndrome (MKS) is the most severe form of an autosomal recessive ciliopathy and is clinically characterized by occipital encephalocele, severely polycystic kidneys, and postaxial polydactyly (toes).	Case report reiterates severely polycystic kidneys as part of the classic MKS triad.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report reiterates severely polycystic kidneys as part of the classic MKS triad."", ""reference"": ""PMID:38156946"", ""snippet"": ""Meckel syndrome (MKS) is the most severe form of an autosomal recessive ciliopathy and is clinically characterized by occipital encephalocele, severely polycystic kidneys, and postaxial polydactyly (toes)."", ""supports"": ""SUPPORT""}"
5020	4915	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	1	evidence	4	PMID:35352487	SUPPORT	HUMAN_CLINICAL	The pregnancy was terminated due to occipital meningocele and enlarged cystic dysplastic kidney revealed by ultrasonography.	Prenatal case report documents enlarged cystic dysplastic kidney in suspected MKS.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Prenatal case report documents enlarged cystic dysplastic kidney in suspected MKS."", ""reference"": ""PMID:35352487"", ""snippet"": ""The pregnancy was terminated due to occipital meningocele and enlarged cystic dysplastic kidney revealed by ultrasonography."", ""supports"": ""SUPPORT""}"
5021	4915	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	1	evidence	5	PMID:34821546	SUPPORT	HUMAN_CLINICAL	Antenatally detected occipital encephalocele and polycystic kidneys are a common presentation of ciliopathies like Joubert syndrome and Meckel Gruber syndrome	Prenatal case series notes polycystic/enlarged kidneys as a common MKS presentation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Prenatal case series notes polycystic/enlarged kidneys as a common MKS presentation."", ""reference"": ""PMID:34821546"", ""snippet"": ""Antenatally detected occipital encephalocele and polycystic kidneys are a common presentation of ciliopathies like Joubert syndrome and Meckel Gruber syndrome"", ""supports"": ""SUPPORT""}"
5022	4916	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	2	evidence	0	PMID:24082939	SUPPORT	HUMAN_CLINICAL	Meckel-Gruber syndrome is a rare autosomal recessive lethal malformation characterized by typical manifestations of occipital encephalocele, bilateral polycystic kidneys and post axial polydactyly.	This review lists postaxial polydactyly in the classic triad.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This review lists postaxial polydactyly in the classic triad."", ""reference"": ""PMID:24082939"", ""snippet"": ""Meckel-Gruber syndrome is a rare autosomal recessive lethal malformation characterized by typical manifestations of occipital encephalocele, bilateral polycystic kidneys and post axial polydactyly."", ""supports"": ""SUPPORT""}"
5023	4916	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	2	evidence	1	PMID:8725749	SUPPORT	HUMAN_CLINICAL	Both babies showed the classical triad of this conditions: occipital encephalocele, cystic kidneys, and postaxial polydactyly of all four limbs.	A case report of two siblings documents postaxial polydactyly in MKS.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""A case report of two siblings documents postaxial polydactyly in MKS."", ""reference"": ""PMID:8725749"", ""snippet"": ""Both babies showed the classical triad of this conditions: occipital encephalocele, cystic kidneys, and postaxial polydactyly of all four limbs."", ""supports"": ""SUPPORT""}"
5024	4916	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	2	evidence	2	PMID:28374938	SUPPORT	HUMAN_CLINICAL	Here, we document a boy with occipital encephalocele, post-axial polydactyly, and multicystic renal disease.	A case report documents post-axial polydactyly in MKS.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""A case report documents post-axial polydactyly in MKS."", ""reference"": ""PMID:28374938"", ""snippet"": ""Here, we document a boy with occipital encephalocele, post-axial polydactyly, and multicystic renal disease."", ""supports"": ""SUPPORT""}"
5025	4916	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	2	evidence	3	PMID:38156946	SUPPORT	HUMAN_CLINICAL	Meckel syndrome (MKS) is the most severe form of an autosomal recessive ciliopathy and is clinically characterized by occipital encephalocele, severely polycystic kidneys, and postaxial polydactyly (toes).	Case report reiterates postaxial polydactyly as part of the classic MKS triad.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report reiterates postaxial polydactyly as part of the classic MKS triad."", ""reference"": ""PMID:38156946"", ""snippet"": ""Meckel syndrome (MKS) is the most severe form of an autosomal recessive ciliopathy and is clinically characterized by occipital encephalocele, severely polycystic kidneys, and postaxial polydactyly (toes)."", ""supports"": ""SUPPORT""}"
5026	4917	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	3	evidence	0	PMID:25182137	SUPPORT	HUMAN_CLINICAL	frequent features include other central nervous system anomalies (51.4%), fibrotic/cystic changes of the liver (65.5% of cases with	This population-based study reports frequent hepatic fibrotic/cystic changes.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This population-based study reports frequent hepatic fibrotic/cystic changes."", ""reference"": ""PMID:25182137"", ""snippet"": ""frequent features include other central nervous system anomalies (51.4%), fibrotic/cystic changes of the liver (65.5% of cases with"", ""supports"": ""SUPPORT""}"
5027	4918	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	4	evidence	0	PMID:18603929	SUPPORT	HUMAN_CLINICAL	Death is mainly due to pulmonary hypoplasia.	This case report links MKS lethality to pulmonary hypoplasia.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This case report links MKS lethality to pulmonary hypoplasia."", ""reference"": ""PMID:18603929"", ""snippet"": ""Death is mainly due to pulmonary hypoplasia."", ""supports"": ""SUPPORT""}"
5028	4918	206	Meckel Syndrome	Meckel_Syndrome.yaml	phenotypes	4	evidence	1	PMID:39412385	SUPPORT	HUMAN_CLINICAL	the fetus, which was found to have polyhydramnios, gastric dilatation, lung hypoplasia, and cystic formation with a diameter of 68*62mm in the abdomen	Case report documents lung hypoplasia in an MKS fetus.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report documents lung hypoplasia in an MKS fetus."", ""reference"": ""PMID:39412385"", ""snippet"": ""the fetus, which was found to have polyhydramnios, gastric dilatation, lung hypoplasia, and cystic formation with a diameter of 68*62mm in the abdomen"", ""supports"": ""SUPPORT""}"
5065	5000	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	0	evidence	0	PMID:20888464	PARTIAL		The relative risk for melanoma arising within a congenital nevus is related to the size of the lesion.	This reference supports the connection between congenital melanocytic nevi and melanoma but does not specify that it is very frequent.	"{""explanation"": ""This reference supports the connection between congenital melanocytic nevi and melanoma but does not specify that it is very frequent."", ""reference"": ""PMID:20888464"", ""snippet"": ""The relative risk for melanoma arising within a congenital nevus is related to the size of the lesion."", ""supports"": ""PARTIAL""}"
5066	5000	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	0	evidence	1	PMID:34799033	PARTIAL		This article provides an update on the clinical, histopathologic, and ancillary testing for 3 categories of particularly challenging pigmented lesions: congenital melanocytic nevi, spitzoid neoplasms, and pediatric melanoma.	This reference confirms that melanoma in congenital melanocytic nevi is associated with pigmented lesions and involves clinical, histopathologic evaluation which can count as dermatologic diagnostic, but does not claim it to be very frequent.	"{""explanation"": ""This reference confirms that melanoma in congenital melanocytic nevi is associated with pigmented lesions and involves clinical, histopathologic evaluation which can count as dermatologic diagnostic, but does not claim it to be very frequent."", ""reference"": ""PMID:34799033"", ""snippet"": ""This article provides an update on the clinical, histopathologic, and ancillary testing for 3 categories of particularly challenging pigmented lesions: congenital melanocytic nevi, spitzoid neoplasms, and pediatric melanoma."", ""supports"": ""PARTIAL""}"
5067	5000	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	0	evidence	2	PMID:32392930	PARTIAL		Although most of the PN manifest as a benign lesion clinically, it may have certain malignant potential at the genetic level, and warrant long-term monitoring and follow-up.	This reference suggests that proliferative nodules in congenital melanocytic nevi may have malignant potential, so it acknowledges the risk of melanoma but does not indicate that it is very frequent.	"{""explanation"": ""This reference suggests that proliferative nodules in congenital melanocytic nevi may have malignant potential, so it acknowledges the risk of melanoma but does not indicate that it is very frequent."", ""reference"": ""PMID:32392930"", ""snippet"": ""Although most of the PN manifest as a benign lesion clinically, it may have certain malignant potential at the genetic level, and warrant long-term monitoring and follow-up."", ""supports"": ""PARTIAL""}"
5068	5000	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	0	evidence	3	PMID:34887981	PARTIAL		Giant CMN also known as 'bathing trunk nevus,' 'giant hairy nevus', and 'nevus pigmentosus et pilosus' has highest potential to turn into malignant melanoma.	The study indicates that giant CMN has a higher potential to develop melanoma, recognizing the risk but not specifying the frequency for all CMNs.	"{""explanation"": ""The study indicates that giant CMN has a higher potential to develop melanoma, recognizing the risk but not specifying the frequency for all CMNs."", ""reference"": ""PMID:34887981"", ""snippet"": ""Giant CMN also known as 'bathing trunk nevus,' 'giant hairy nevus', and 'nevus pigmentosus et pilosus' has highest potential to turn into malignant melanoma."", ""supports"": ""PARTIAL""}"
5069	5001	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	1	evidence	0	PMID:27486690	PARTIAL		The differential diagnosis between proliferative nodules (PNs) and melanoma arising in congenital melanocytic nevi (CMN) is crucial, as patients with PNs most often experience no increased risk of melanoma with metastases and death.	The study discusses the presence of proliferative nodules and melanoma in congenital melanocytic nevi, noting that nodules can be mistaken for melanoma. This partially supports that nodules are a frequent phenotype but doesn't provide a clear frequency or definitively state they are always indicative of melanoma.	"{""explanation"": ""The study discusses the presence of proliferative nodules and melanoma in congenital melanocytic nevi, noting that nodules can be mistaken for melanoma. This partially supports that nodules are a frequent phenotype but doesn't provide a clear frequency or definitively state they are always indicative of melanoma."", ""reference"": ""PMID:27486690"", ""snippet"": ""The differential diagnosis between proliferative nodules (PNs) and melanoma arising in congenital melanocytic nevi (CMN) is crucial, as patients with PNs most often experience no increased risk of melanoma with metastases and death."", ""supports"": ""PARTIAL""}"
5070	5001	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	1	evidence	1	PMID:36122342	PARTIAL		A Pigmented Nodule on Congenital Melanocytic Nevus: Challenge.	The presence of a pigmented nodule on congenital melanocytic nevi is noted, suggesting it can be a feature but does not elaborate on its frequent occurrence in melanoma specifically.	"{""explanation"": ""The presence of a pigmented nodule on congenital melanocytic nevi is noted, suggesting it can be a feature but does not elaborate on its frequent occurrence in melanoma specifically."", ""reference"": ""PMID:36122342"", ""snippet"": ""A Pigmented Nodule on Congenital Melanocytic Nevus: Challenge."", ""supports"": ""PARTIAL""}"
5071	5001	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	1	evidence	2	PMID:17653760	PARTIAL		A group of melanocytic benign nevi are prone to be misdiagnosed as nodular or superficial spreading melanoma. This review illustrates the most frequent forms of these nevi in direct comparison with their malignant morphologic counterparts.	While it outlines that melanocytic nevi, including nodules, can be misdiagnosed as melanoma, it stops short of stating the frequency with which nodules are a phenotype of melanoma.	"{""explanation"": ""While it outlines that melanocytic nevi, including nodules, can be misdiagnosed as melanoma, it stops short of stating the frequency with which nodules are a phenotype of melanoma."", ""reference"": ""PMID:17653760"", ""snippet"": ""A group of melanocytic benign nevi are prone to be misdiagnosed as nodular or superficial spreading melanoma. This review illustrates the most frequent forms of these nevi in direct comparison with their malignant morphologic counterparts."", ""supports"": ""PARTIAL""}"
5072	5001	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	1	evidence	3	PMID:10591787	NO_EVIDENCE		They run an increased life-time risk of transformation into malignant melanoma.	This reference mentions the risk of congenital melanocytic nevi transforming into melanoma but does not specifically discuss nodules as a frequent phenotype or their dermatologic characteristics.	"{""explanation"": ""This reference mentions the risk of congenital melanocytic nevi transforming into melanoma but does not specifically discuss nodules as a frequent phenotype or their dermatologic characteristics."", ""reference"": ""PMID:10591787"", ""snippet"": ""They run an increased life-time risk of transformation into malignant melanoma."", ""supports"": ""NO_EVIDENCE""}"
5073	5002	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	2	evidence	0	PMID:38779794	SUPPORT		A 30-year-old female patient presented with a swelling of a cervical left lymph node measuring 1x3 cm, which had been presenting for three weeks. Lymph node excision revealed a metastasis of a malignant melanoma.	The swollen lymph nodes indicating metastasis, with the subject having melanoma, supports the statement of lymphadenopathy as an occasional systemic phenotype of melanoma-in-congenital-melanocytic-nevus.	"{""explanation"": ""The swollen lymph nodes indicating metastasis, with the subject having melanoma, supports the statement of lymphadenopathy as an occasional systemic phenotype of melanoma-in-congenital-melanocytic-nevus."", ""reference"": ""PMID:38779794"", ""snippet"": ""A 30-year-old female patient presented with a swelling of a cervical left lymph node measuring 1x3 cm, which had been presenting for three weeks. Lymph node excision revealed a metastasis of a malignant melanoma."", ""supports"": ""SUPPORT""}"
5074	5002	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	2	evidence	1	PMID:14750241	PARTIAL		Melanocytic nevi occurring in lymph nodes create diagnostic difficulty by mimicking metastases. Few studies describe nodal nevi in sentinel lymph nodes (SLNs) excised for melanoma.	While this source discusses lymph nodes in relation to melanoma, the focus is more on diagnostic difficulty rather than a clear statement of lymphadenopathy as a phenotype.	"{""explanation"": ""While this source discusses lymph nodes in relation to melanoma, the focus is more on diagnostic difficulty rather than a clear statement of lymphadenopathy as a phenotype."", ""reference"": ""PMID:14750241"", ""snippet"": ""Melanocytic nevi occurring in lymph nodes create diagnostic difficulty by mimicking metastases. Few studies describe nodal nevi in sentinel lymph nodes (SLNs) excised for melanoma."", ""supports"": ""PARTIAL""}"
5075	5002	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	2	evidence	2	PMID:11902552	SUPPORT		Lymph-node metastasis is an indicator of poor prognosis for patients with melanoma.	Lymph-node metastasis being a poor prognosis indicator supports the link between swollen lymph nodes and metastasis in melanoma patients, supporting the statement.	"{""explanation"": ""Lymph-node metastasis being a poor prognosis indicator supports the link between swollen lymph nodes and metastasis in melanoma patients, supporting the statement."", ""reference"": ""PMID:11902552"", ""snippet"": ""Lymph-node metastasis is an indicator of poor prognosis for patients with melanoma."", ""supports"": ""SUPPORT""}"
5076	5002	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	2	evidence	3	PMID:18481261	PARTIAL		Malignant melanomas of the skin primarily metastasize to lymph nodes, and the detection of sentinel lymph node metastases serves as an important prognostic parameter.	This source confirms the occurrence of lymph node metastasization in melanoma but does not specifically address it in the context of congenital melanocytic nevus.	"{""explanation"": ""This source confirms the occurrence of lymph node metastasization in melanoma but does not specifically address it in the context of congenital melanocytic nevus."", ""reference"": ""PMID:18481261"", ""snippet"": ""Malignant melanomas of the skin primarily metastasize to lymph nodes, and the detection of sentinel lymph node metastases serves as an important prognostic parameter."", ""supports"": ""PARTIAL""}"
5077	5003	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	3	evidence	0	PMID:29971818	PARTIAL		We report a 6-year-old child with molluscum contagiosum infection arising within an intermediate melanocytic congenital nevus of the thigh, associated with itching and occasional bleeding.	The literature supports that itching can be associated with a congenital melanocytic nevus, but it does not specifically link this to melanoma. Therefore, the statement is only partially supported.	"{""explanation"": ""The literature supports that itching can be associated with a congenital melanocytic nevus, but it does not specifically link this to melanoma. Therefore, the statement is only partially supported."", ""reference"": ""PMID:29971818"", ""snippet"": ""We report a 6-year-old child with molluscum contagiosum infection arising within an intermediate melanocytic congenital nevus of the thigh, associated with itching and occasional bleeding."", ""supports"": ""PARTIAL""}"
5078	5003	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	3	evidence	1	PMID:3882344	NO_EVIDENCE			This reference discusses melanoma and other melanocytic skin lesions but does not provide evidence about pruritus (itching) in congenital melanocytic nevi.	"{""explanation"": ""This reference discusses melanoma and other melanocytic skin lesions but does not provide evidence about pruritus (itching) in congenital melanocytic nevi."", ""reference"": ""PMID:3882344"", ""snippet"": """", ""supports"": ""NO_EVIDENCE""}"
5079	5003	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	3	evidence	2	PMID:30653639	NO_EVIDENCE			This reference discusses congenital melanocytic nevi and other birthmarks but does not mention pruritus (itching) in the context of melanoma in congenital melanocytic nevi.	"{""explanation"": ""This reference discusses congenital melanocytic nevi and other birthmarks but does not mention pruritus (itching) in the context of melanoma in congenital melanocytic nevi."", ""reference"": ""PMID:30653639"", ""snippet"": """", ""supports"": ""NO_EVIDENCE""}"
5080	5003	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	3	evidence	3	PMID:3284306	NO_EVIDENCE			This reference focuses on Becker's nevus and does not provide information about pruritus in congenital melanocytic nevi or melanoma.	"{""explanation"": ""This reference focuses on Becker's nevus and does not provide information about pruritus in congenital melanocytic nevi or melanoma."", ""reference"": ""PMID:3284306"", ""snippet"": """", ""supports"": ""NO_EVIDENCE""}"
5081	5003	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	3	evidence	4	PMID:35946357	NO_EVIDENCE			This reference discusses melanoma with childhood onset but does not mention pruritus in the context of congenital melanocytic nevi.	"{""explanation"": ""This reference discusses melanoma with childhood onset but does not mention pruritus in the context of congenital melanocytic nevi."", ""reference"": ""PMID:35946357"", ""snippet"": """", ""supports"": ""NO_EVIDENCE""}"
5082	5003	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	3	evidence	5	PMID:8990709	NO_EVIDENCE			This reference discusses a congenital atrophic plaque and possible diagnoses including congenital melanocytic nevus but does not mention pruritus.	"{""explanation"": ""This reference discusses a congenital atrophic plaque and possible diagnoses including congenital melanocytic nevus but does not mention pruritus."", ""reference"": ""PMID:8990709"", ""snippet"": """", ""supports"": ""NO_EVIDENCE""}"
5083	5003	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	3	evidence	6	PMID:1869648	NO_EVIDENCE			This reference discusses neurocutaneous melanosis and congenital melanocytic nevi but does not mention pruritus.	"{""explanation"": ""This reference discusses neurocutaneous melanosis and congenital melanocytic nevi but does not mention pruritus."", ""reference"": ""PMID:1869648"", ""snippet"": """", ""supports"": ""NO_EVIDENCE""}"
5084	5003	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	3	evidence	7	PMID:15817400	NO_EVIDENCE			This reference discusses various cutaneous lesions including congenital melanocytic nevus but does not mention pruritus.	"{""explanation"": ""This reference discusses various cutaneous lesions including congenital melanocytic nevus but does not mention pruritus."", ""reference"": ""PMID:15817400"", ""snippet"": """", ""supports"": ""NO_EVIDENCE""}"
5085	5003	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	3	evidence	8	PMID:28290622	NO_EVIDENCE			This reference discusses melanoma and melanocytic nevi in pediatric patients but does not mention pruritus in the context of congenital melanocytic nevi.	"{""explanation"": ""This reference discusses melanoma and melanocytic nevi in pediatric patients but does not mention pruritus in the context of congenital melanocytic nevi."", ""reference"": ""PMID:28290622"", ""snippet"": """", ""supports"": ""NO_EVIDENCE""}"
5086	5003	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	3	evidence	9	PMID:28954104	NO_EVIDENCE			This reference discusses the recurrent nevus phenomenon but does not mention pruritus in the context of congenital melanocytic nevi.	"{""explanation"": ""This reference discusses the recurrent nevus phenomenon but does not mention pruritus in the context of congenital melanocytic nevi."", ""reference"": ""PMID:28954104"", ""snippet"": """", ""supports"": ""NO_EVIDENCE""}"
5087	5005	210	Melanoma_in_Congenital_Melanocytic_Nevus	Melanoma_in_Congenital_Melanocytic_Nevus.yaml	phenotypes	5	evidence	0	PMID:29971818	SUPPORT		We report a 6-year-old child with molluscum contagiosum infection arising within an intermediate melanocytic congenital nevus of the thigh, associated with itching and occasional bleeding.	The literature mentions bleeding associated with melanocytic congenital nevus, which supports the statement that melanoma lesions in congenital melanocytic nevus can sometimes bleed.	"{""explanation"": ""The literature mentions bleeding associated with melanocytic congenital nevus, which supports the statement that melanoma lesions in congenital melanocytic nevus can sometimes bleed."", ""reference"": ""PMID:29971818"", ""snippet"": ""We report a 6-year-old child with molluscum contagiosum infection arising within an intermediate melanocytic congenital nevus of the thigh, associated with itching and occasional bleeding."", ""supports"": ""SUPPORT""}"
5136	5032	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	phenotypes	0	evidence	0	PMID:39135018	SUPPORT		recurrent edema, facial palsies, and nerve dysfunctions often associated with the plicata tongue	Confirms recurrent facial edema as a characteristic phenotype of MRS	"{""explanation"": ""Confirms recurrent facial edema as a characteristic phenotype of MRS"", ""reference"": ""PMID:39135018"", ""snippet"": ""recurrent edema, facial palsies, and nerve dysfunctions often associated with the plicata tongue"", ""supports"": ""SUPPORT""}"
5137	5032	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	phenotypes	0	evidence	1	PMID:31466978	SUPPORT		he presented the classic triad of Melkersson-Rosenthal syndrome which includes recurrent orofacial oedema, facial nerve palsy and fissured tongue	Establishes recurrent orofacial edema as part of the classic clinical triad	"{""explanation"": ""Establishes recurrent orofacial edema as part of the classic clinical triad"", ""reference"": ""PMID:31466978"", ""snippet"": ""he presented the classic triad of Melkersson-Rosenthal syndrome which includes recurrent orofacial oedema, facial nerve palsy and fissured tongue"", ""supports"": ""SUPPORT""}"
5138	5033	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	phenotypes	1	evidence	0	PMID:31466978	SUPPORT		recurrent facial nerve palsy since the age of 10 years	Documents the recurrent nature of facial nerve paralysis in MRS patients	"{""explanation"": ""Documents the recurrent nature of facial nerve paralysis in MRS patients"", ""reference"": ""PMID:31466978"", ""snippet"": ""recurrent facial nerve palsy since the age of 10 years"", ""supports"": ""SUPPORT""}"
5139	5033	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	phenotypes	1	evidence	1	PMID:40255708	SUPPORT		CG can occur as an isolated condition or as part of Melkersson-Rosenthal syndrome, which also includes facial paralysis and a fissured tongue	Confirms facial paralysis as a component of the MRS triad	"{""explanation"": ""Confirms facial paralysis as a component of the MRS triad"", ""reference"": ""PMID:40255708"", ""snippet"": ""CG can occur as an isolated condition or as part of Melkersson-Rosenthal syndrome, which also includes facial paralysis and a fissured tongue"", ""supports"": ""SUPPORT""}"
5140	5034	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	phenotypes	2	evidence	0	PMID:31466978	SUPPORT		Physical examination revealed lip swelling and lingua plicata. Thus, he presented the classic triad of Melkersson-Rosenthal syndrome	Confirms fissured tongue (lingua plicata) as part of the classic MRS triad	"{""explanation"": ""Confirms fissured tongue (lingua plicata) as part of the classic MRS triad"", ""reference"": ""PMID:31466978"", ""snippet"": ""Physical examination revealed lip swelling and lingua plicata. Thus, he presented the classic triad of Melkersson-Rosenthal syndrome"", ""supports"": ""SUPPORT""}"
5141	5034	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	phenotypes	2	evidence	1	PMID:40255708	SUPPORT		Melkersson-Rosenthal syndrome, which also includes facial paralysis and a fissured tongue	Establishes lingual swelling as a key phenotype of MRS	"{""explanation"": ""Establishes lingual swelling as a key phenotype of MRS"", ""reference"": ""PMID:40255708"", ""snippet"": ""Melkersson-Rosenthal syndrome, which also includes facial paralysis and a fissured tongue"", ""supports"": ""SUPPORT""}"
5142	5035	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	phenotypes	3	evidence	0	PMID:37510386	PARTIAL		Migraine is a common neurological disorder... A family in which two sisters displayed recurrent migraines, one of which presented recurrent facial palsy and had clinical diagnosis of MRS.	Documents rare association of migraine with MRS in a family with SCN1A variants, suggesting potential genetic overlap	"{""explanation"": ""Documents rare association of migraine with MRS in a family with SCN1A variants, suggesting potential genetic overlap"", ""reference"": ""PMID:37510386"", ""snippet"": ""Migraine is a common neurological disorder... A family in which two sisters displayed recurrent migraines, one of which presented recurrent facial palsy and had clinical diagnosis of MRS."", ""supports"": ""PARTIAL""}"
5156	5045	212	Meniere's Disease	Menieres_Disease.yaml	phenotypes	0	evidence	0	PMID:27083887	SUPPORT		episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure	Confirms vertigo as cardinal episodic manifestation of MD	"{""explanation"": ""Confirms vertigo as cardinal episodic manifestation of MD"", ""reference"": ""PMID:27083887"", ""snippet"": ""episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure"", ""supports"": ""SUPPORT""}"
5157	5045	212	Meniere's Disease	Menieres_Disease.yaml	phenotypes	0	evidence	1	PMID:22053211	SUPPORT		episodes of vertigo associated with hearing loss and tinnitus	Large epidemiological study documents episodes of vertigo as defining MD feature	"{""explanation"": ""Large epidemiological study documents episodes of vertigo as defining MD feature"", ""reference"": ""PMID:22053211"", ""snippet"": ""episodes of vertigo associated with hearing loss and tinnitus"", ""supports"": ""SUPPORT""}"
5158	5046	212	Meniere's Disease	Menieres_Disease.yaml	phenotypes	1	evidence	0	PMID:27083887	SUPPORT		episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure	Establishes fluctuating sensorineural hearing loss as core MD feature	"{""explanation"": ""Establishes fluctuating sensorineural hearing loss as core MD feature"", ""reference"": ""PMID:27083887"", ""snippet"": ""episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure"", ""supports"": ""SUPPORT""}"
5159	5046	212	Meniere's Disease	Menieres_Disease.yaml	phenotypes	1	evidence	1	PMID:22053211	SUPPORT		MD, an inner ear disorder characterized by episodes of vertigo associated with hearing loss and tinnitus	Confirms hearing loss as cardinal MD manifestation in large epidemiological study	"{""explanation"": ""Confirms hearing loss as cardinal MD manifestation in large epidemiological study"", ""reference"": ""PMID:22053211"", ""snippet"": ""MD, an inner ear disorder characterized by episodes of vertigo associated with hearing loss and tinnitus"", ""supports"": ""SUPPORT""}"
5160	5047	212	Meniere's Disease	Menieres_Disease.yaml	phenotypes	2	evidence	0	PMID:27083887	SUPPORT		episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure	Confirms tinnitus as defining component of MD clinical tetrad	"{""explanation"": ""Confirms tinnitus as defining component of MD clinical tetrad"", ""reference"": ""PMID:27083887"", ""snippet"": ""episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure"", ""supports"": ""SUPPORT""}"
5161	5047	212	Meniere's Disease	Menieres_Disease.yaml	phenotypes	2	evidence	1	PMID:22053211	SUPPORT		episodes of vertigo associated with hearing loss and tinnitus	Epidemiological evidence reaffirms tinnitus as hallmark MD symptom	"{""explanation"": ""Epidemiological evidence reaffirms tinnitus as hallmark MD symptom"", ""reference"": ""PMID:22053211"", ""snippet"": ""episodes of vertigo associated with hearing loss and tinnitus"", ""supports"": ""SUPPORT""}"
5162	5048	212	Meniere's Disease	Menieres_Disease.yaml	phenotypes	3	evidence	0	PMID:27083887	SUPPORT		episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure	Documents aural pressure/fullness as diagnostic feature of MD clinical presentation	"{""explanation"": ""Documents aural pressure/fullness as diagnostic feature of MD clinical presentation"", ""reference"": ""PMID:27083887"", ""snippet"": ""episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure"", ""supports"": ""SUPPORT""}"
5206	5100	214	Migraine	Migraine.yaml	phenotypes	0	evidence	0	PMID:37495957	SUPPORT		In both WT and FHM1 mutant mice, CSDs induced headache-related behaviour, as evidenced by increased MGS scores and the occurrence of oculotemporal strokes, at 30 min.	Demonstrates that cortical spreading depression directly induces headache-related behaviors in animal models.	"{""explanation"": ""Demonstrates that cortical spreading depression directly induces headache-related behaviors in animal models."", ""reference"": ""PMID:37495957"", ""snippet"": ""In both WT and FHM1 mutant mice, CSDs induced headache-related behaviour, as evidenced by increased MGS scores and the occurrence of oculotemporal strokes, at 30 min."", ""supports"": ""SUPPORT""}"
5207	5100	214	Migraine	Migraine.yaml	phenotypes	0	evidence	1	PMID:39080518	SUPPORT		We propose that neuronal stress induced by CSD or synaptic activity-energy mismatch may initiate a parenchymal inflammatory signaling cascade, transmitted to the meninges, thereby triggering lasting headaches characteristic of migraine, with or without aura.	Explains the mechanistic pathway from neuronal stress to the characteristic lasting headaches of migraine.	"{""explanation"": ""Explains the mechanistic pathway from neuronal stress to the characteristic lasting headaches of migraine."", ""reference"": ""PMID:39080518"", ""snippet"": ""We propose that neuronal stress induced by CSD or synaptic activity-energy mismatch may initiate a parenchymal inflammatory signaling cascade, transmitted to the meninges, thereby triggering lasting headaches characteristic of migraine, with or without aura."", ""supports"": ""SUPPORT""}"
5208	5101	214	Migraine	Migraine.yaml	phenotypes	1	evidence	0	PMID:35322292	SUPPORT		The coexistence of photophobia and headache is associated with the interactions between visual and pain pathway at retina, midbrain, thalamus, hypothalamus and visual cortex.	Describes the neuroanatomical basis for photophobia in migraine through visual-pain pathway interactions.	"{""explanation"": ""Describes the neuroanatomical basis for photophobia in migraine through visual-pain pathway interactions."", ""reference"": ""PMID:35322292"", ""snippet"": ""The coexistence of photophobia and headache is associated with the interactions between visual and pain pathway at retina, midbrain, thalamus, hypothalamus and visual cortex."", ""supports"": ""SUPPORT""}"
5209	5102	214	Migraine	Migraine.yaml	phenotypes	2	evidence	0	PMID:33305448	SUPPORT		Higher amplitudes of BAEP waves in migraineurs and their relationship with the frequency of headache and HT suggest the sensitization of brainstem auditory neurons.	Demonstrates that phonophobia in migraine is associated with sensitization of brainstem auditory neurons, as evidenced by higher brainstem auditory evoked potential amplitudes.	"{""explanation"": ""Demonstrates that phonophobia in migraine is associated with sensitization of brainstem auditory neurons, as evidenced by higher brainstem auditory evoked potential amplitudes."", ""reference"": ""PMID:33305448"", ""snippet"": ""Higher amplitudes of BAEP waves in migraineurs and their relationship with the frequency of headache and HT suggest the sensitization of brainstem auditory neurons."", ""supports"": ""SUPPORT""}"
5210	5103	214	Migraine	Migraine.yaml	phenotypes	3	evidence	0	PMID:39080518	SUPPORT		After a single CSD, astrocytes respond by upregulating the transcription of proinflammatory enzymes and mediators, while microglia are involved in restoring neuronal structural integrity; however, repeated CSDs may prompt microglia to adopt a pro-inflammatory state.	Neuroinflammatory responses to CSD contribute to the full range of migraine symptoms including autonomic features like nausea through central nervous system activation.	"{""explanation"": ""Neuroinflammatory responses to CSD contribute to the full range of migraine symptoms including autonomic features like nausea through central nervous system activation."", ""reference"": ""PMID:39080518"", ""snippet"": ""After a single CSD, astrocytes respond by upregulating the transcription of proinflammatory enzymes and mediators, while microglia are involved in restoring neuronal structural integrity; however, repeated CSDs may prompt microglia to adopt a pro-inflammatory state."", ""supports"": ""SUPPORT""}"
5211	5104	214	Migraine	Migraine.yaml	phenotypes	4	evidence	0	PMID:39080518	SUPPORT		PET studies utilizing inflammation markers have revealed meningeal inflammatory activity in patients experiencing migraine with aura, particularly over the occipital cortex generating visual auras.	Demonstrates that visual auras in migraine are associated with inflammatory activity localized to the occipital cortex, the brain region responsible for visual processing.	"{""explanation"": ""Demonstrates that visual auras in migraine are associated with inflammatory activity localized to the occipital cortex, the brain region responsible for visual processing."", ""reference"": ""PMID:39080518"", ""snippet"": ""PET studies utilizing inflammation markers have revealed meningeal inflammatory activity in patients experiencing migraine with aura, particularly over the occipital cortex generating visual auras."", ""supports"": ""SUPPORT""}"
5212	5105	214	Migraine	Migraine.yaml	phenotypes	5	evidence	0	PMID:38619053	SUPPORT		Vestibular migraine is an underdiagnosed migraine phenotype that shares the pathophysiological mechanisms of migraine, with growing interest in recent years.	Establishes vestibular migraine as a recognized migraine phenotype where vertigo is a prominent symptom.	"{""explanation"": ""Establishes vestibular migraine as a recognized migraine phenotype where vertigo is a prominent symptom."", ""reference"": ""PMID:38619053"", ""snippet"": ""Vestibular migraine is an underdiagnosed migraine phenotype that shares the pathophysiological mechanisms of migraine, with growing interest in recent years."", ""supports"": ""SUPPORT""}"
5213	5105	214	Migraine	Migraine.yaml	phenotypes	5	evidence	1	PMID:37889468	SUPPORT		There is evidence of abnormal sensory processing and integration in VM patients. Calcitonin gene-related peptide (CGRP) has also been found to play a role in trigeminal and vestibular nucleus pathways.	Links vestibular symptoms to abnormal sensory processing and CGRP signaling in vestibular pathways.	"{""explanation"": ""Links vestibular symptoms to abnormal sensory processing and CGRP signaling in vestibular pathways."", ""reference"": ""PMID:37889468"", ""snippet"": ""There is evidence of abnormal sensory processing and integration in VM patients. Calcitonin gene-related peptide (CGRP) has also been found to play a role in trigeminal and vestibular nucleus pathways."", ""supports"": ""SUPPORT""}"
5233	5123	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	phenotypes	0	evidence	0	PMID:16084319	SUPPORT		Raynaud's phenomenon affects most patients who have mixed connective tissue disease (MCTD) and frequently represents the initial manifestation of the disease.	Raynaud phenomenon is nearly universal in MCTD and often the presenting symptom, reflecting the underlying systemic vasculopathy characterized by intimal fibrosis and vascular obliteration that links this cutaneous manifestation to visceral complications including pulmonary hypertension.	"{""explanation"": ""Raynaud phenomenon is nearly universal in MCTD and often the presenting symptom, reflecting the underlying systemic vasculopathy characterized by intimal fibrosis and vascular obliteration that links this cutaneous manifestation to visceral complications including pulmonary hypertension."", ""reference"": ""PMID:16084319"", ""snippet"": ""Raynaud's phenomenon affects most patients who have mixed connective tissue disease (MCTD) and frequently represents the initial manifestation of the disease."", ""supports"": ""SUPPORT""}"
5234	5124	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	phenotypes	1	evidence	0	PMID:718271	SUPPORT		Arthritis occurred in all 20 patients, being the presenting complaint in 11 patients.	This landmark 5-year longitudinal study demonstrated that arthritis is universal in MCTD, often as the presenting manifestation, with symmetric involvement of PIP, MCP, wrists, MTP joints and knees mimicking rheumatoid arthritis but with predominantly lymphocytic non-inflammatory effusions and good response to low-dose corticosteroids.	"{""explanation"": ""This landmark 5-year longitudinal study demonstrated that arthritis is universal in MCTD, often as the presenting manifestation, with symmetric involvement of PIP, MCP, wrists, MTP joints and knees mimicking rheumatoid arthritis but with predominantly lymphocytic non-inflammatory effusions and good response to low-dose corticosteroids."", ""reference"": ""PMID:718271"", ""snippet"": ""Arthritis occurred in all 20 patients, being the presenting complaint in 11 patients."", ""supports"": ""SUPPORT""}"
5235	5125	215	Mixed Connective Tissue Disease	Mixed_Connective_Tissue_Disease.yaml	phenotypes	2	evidence	0	PMID:39876825	SUPPORT		Eight patients had muscle weakness in the proximal extremities, and overall, six patients had atypical weakness in the face, neck, wrist, or fingers.	MCTD-associated myositis presents with both typical proximal muscle weakness and atypical distributions affecting axial and distal muscles, with muscle biopsy showing perivascular inflammatory infiltrates and muscle fiber necrosis, reflecting the heterogeneous nature of MCTD myopathy that may require intensive immunosuppressive therapy.	"{""explanation"": ""MCTD-associated myositis presents with both typical proximal muscle weakness and atypical distributions affecting axial and distal muscles, with muscle biopsy showing perivascular inflammatory infiltrates and muscle fiber necrosis, reflecting the heterogeneous nature of MCTD myopathy that may require intensive immunosuppressive therapy."", ""reference"": ""PMID:39876825"", ""snippet"": ""Eight patients had muscle weakness in the proximal extremities, and overall, six patients had atypical weakness in the face, neck, wrist, or fingers."", ""supports"": ""SUPPORT""}"
5260	5154	216	Monkeypox	Monkeypox.yaml	phenotypes	0	evidence	0	PMID:36396927	SUPPORT		Initially, there is a prodrome phase of a few days, which is followed by the appearance of rashes. The dermatological manifestations are in the form of an exanthematous rash, which transforms through a macular, papular, and vesicular phase and disappears after crusting in approximately 3 weeks.	This reference confirms that rash is a common dermatologic manifestation of monkeypox.	"{""explanation"": ""This reference confirms that rash is a common dermatologic manifestation of monkeypox."", ""reference"": ""PMID:36396927"", ""snippet"": ""Initially, there is a prodrome phase of a few days, which is followed by the appearance of rashes. The dermatological manifestations are in the form of an exanthematous rash, which transforms through a macular, papular, and vesicular phase and disappears after crusting in approximately 3 weeks."", ""supports"": ""SUPPORT""}"
5261	5154	216	Monkeypox	Monkeypox.yaml	phenotypes	0	evidence	1	PMID:36396927	SUPPORT		Respiratory manifestations include nasal congestion and shortness of breath that may result in secondary bacterial infections.	This reference further mentions the potential for secondary infections.	"{""explanation"": ""This reference further mentions the potential for secondary infections."", ""reference"": ""PMID:36396927"", ""snippet"": ""Respiratory manifestations include nasal congestion and shortness of breath that may result in secondary bacterial infections."", ""supports"": ""SUPPORT""}"
5262	5154	216	Monkeypox	Monkeypox.yaml	phenotypes	0	evidence	2	PMID:35904894	SUPPORT		Pleomorphic skin lesions appear ranging from macules, papules, vesicles, pustules, some of which may appear umbilicated before crusting over.	This reference supports the frequent occurrence of various types of rashes in monkeypox.	"{""explanation"": ""This reference supports the frequent occurrence of various types of rashes in monkeypox."", ""reference"": ""PMID:35904894"", ""snippet"": ""Pleomorphic skin lesions appear ranging from macules, papules, vesicles, pustules, some of which may appear umbilicated before crusting over."", ""supports"": ""SUPPORT""}"
5263	5154	216	Monkeypox	Monkeypox.yaml	phenotypes	0	evidence	3	PMID:36223653	SUPPORT		Our clinical evaluation identified skin lesions as the optimal diagnostic specimen source.	This reference mentions that skin lesions (including rashes) are significant for diagnosis.	"{""explanation"": ""This reference mentions that skin lesions (including rashes) are significant for diagnosis."", ""reference"": ""PMID:36223653"", ""snippet"": ""Our clinical evaluation identified skin lesions as the optimal diagnostic specimen source."", ""supports"": ""SUPPORT""}"
5264	5154	216	Monkeypox	Monkeypox.yaml	phenotypes	0	evidence	4	PMID:36729940	SUPPORT		Primarily affecting the sexually active population, these cases present with mucocutaneous lesions mainly localized in perioral, genital, and anal areas.	This reference describes mucocutaneous lesions, which also support dermatologic manifestations.	"{""explanation"": ""This reference describes mucocutaneous lesions, which also support dermatologic manifestations."", ""reference"": ""PMID:36729940"", ""snippet"": ""Primarily affecting the sexually active population, these cases present with mucocutaneous lesions mainly localized in perioral, genital, and anal areas."", ""supports"": ""SUPPORT""}"
5265	5154	216	Monkeypox	Monkeypox.yaml	phenotypes	0	evidence	5	PMID:37403493	SUPPORT		Monkeypox (MPX) characteristically presents as a fever with a vesiculopustular rash.	This reference clearly states that a vesiculopustular rash is characteristic of monkeypox.	"{""explanation"": ""This reference clearly states that a vesiculopustular rash is characteristic of monkeypox."", ""reference"": ""PMID:37403493"", ""snippet"": ""Monkeypox (MPX) characteristically presents as a fever with a vesiculopustular rash."", ""supports"": ""SUPPORT""}"
5266	5154	216	Monkeypox	Monkeypox.yaml	phenotypes	0	evidence	6	PMID:15660652	SUPPORT		Initially, it presents with skin eruptions and fevers with diaphoresis and rigors. Clinically, the skin lesions progress from papules to vesiculopustules to resolving eschars.	This reference confirms the typical progression of skin lesions, including rashes, in monkeypox.	"{""explanation"": ""This reference confirms the typical progression of skin lesions, including rashes, in monkeypox."", ""reference"": ""PMID:15660652"", ""snippet"": ""Initially, it presents with skin eruptions and fevers with diaphoresis and rigors. Clinically, the skin lesions progress from papules to vesiculopustules to resolving eschars."", ""supports"": ""SUPPORT""}"
5267	5155	216	Monkeypox	Monkeypox.yaml	phenotypes	1	evidence	0	PMID:35924502	SUPPORT		Monkeypox usually presents with a flu-like prodromal period (fever, headache, chills, sweating) associated or followed by the appearance of lymphadenopathy and a typical skin rash.	This reference also confirms that fever is a commonly observed systemic phenotype in monkeypox patients.	"{""explanation"": ""This reference also confirms that fever is a commonly observed systemic phenotype in monkeypox patients."", ""reference"": ""PMID:35924502"", ""snippet"": ""Monkeypox usually presents with a flu-like prodromal period (fever, headache, chills, sweating) associated or followed by the appearance of lymphadenopathy and a typical skin rash."", ""supports"": ""SUPPORT""}"
5268	5156	216	Monkeypox	Monkeypox.yaml	phenotypes	2	evidence	0	PMID:36396927	SUPPORT		Other symptoms can include diarrhea, vomiting, myalgia, and backache.	The reference states that myalgia is a symptom that can occur in monkeypox patients, indicating it's a recognized phenotype.	"{""explanation"": ""The reference states that myalgia is a symptom that can occur in monkeypox patients, indicating it's a recognized phenotype."", ""reference"": ""PMID:36396927"", ""snippet"": ""Other symptoms can include diarrhea, vomiting, myalgia, and backache."", ""supports"": ""SUPPORT""}"
5269	5158	216	Monkeypox	Monkeypox.yaml	phenotypes	4	evidence	0	PMID:36554659	SUPPORT		Monkeypox, a viral zoonosis caused by an Orthopoxvirus, is clinically characterized by fever, headache, lymphadenopathy, myalgia, rash and burdened by some complications that can be severe and life threatening.	This reference lists headache as a clinical characteristic of monkeypox, supporting the statement that headache is a frequent systemic symptom.	"{""explanation"": ""This reference lists headache as a clinical characteristic of monkeypox, supporting the statement that headache is a frequent systemic symptom."", ""reference"": ""PMID:36554659"", ""snippet"": ""Monkeypox, a viral zoonosis caused by an Orthopoxvirus, is clinically characterized by fever, headache, lymphadenopathy, myalgia, rash and burdened by some complications that can be severe and life threatening."", ""supports"": ""SUPPORT""}"
5270	5158	216	Monkeypox	Monkeypox.yaml	phenotypes	4	evidence	1	PMID:37043648	SUPPORT		Several neurological complications have been reported with MPX and its vaccines that include but not limited to headaches, myalgia, encephalitis, and coma.	This reference mentions headaches as one of the neurological complications associated with monkeypox, supporting the statement.	"{""explanation"": ""This reference mentions headaches as one of the neurological complications associated with monkeypox, supporting the statement."", ""reference"": ""PMID:37043648"", ""snippet"": ""Several neurological complications have been reported with MPX and its vaccines that include but not limited to headaches, myalgia, encephalitis, and coma."", ""supports"": ""SUPPORT""}"
5271	5159	216	Monkeypox	Monkeypox.yaml	phenotypes	5	evidence	0	PMID:36396927	NO_EVIDENCE		Other symptoms can include diarrhea, vomiting, myalgia, and backache.	The abstract does not mention fatigue as a frequent systemic symptom of monkeypox.	"{""explanation"": ""The abstract does not mention fatigue as a frequent systemic symptom of monkeypox."", ""reference"": ""PMID:36396927"", ""snippet"": ""Other symptoms can include diarrhea, vomiting, myalgia, and backache."", ""supports"": ""NO_EVIDENCE""}"
5272	5159	216	Monkeypox	Monkeypox.yaml	phenotypes	5	evidence	1	PMID:36125794	NO_EVIDENCE		known neurologic complications of monkeypox, which include headaches and mood disturbances, as well as rare presentations of encephalitis, transverse myelitis, and seizures.	The abstract does not mention fatigue as a frequent systemic symptom of monkeypox.	"{""explanation"": ""The abstract does not mention fatigue as a frequent systemic symptom of monkeypox."", ""reference"": ""PMID:36125794"", ""snippet"": ""known neurologic complications of monkeypox, which include headaches and mood disturbances, as well as rare presentations of encephalitis, transverse myelitis, and seizures."", ""supports"": ""NO_EVIDENCE""}"
5273	5159	216	Monkeypox	Monkeypox.yaml	phenotypes	5	evidence	2	PMID:36716982	NO_EVIDENCE		The most common symptoms were fever (89%) and chest pain (100%).	The abstract does not mention fatigue as a frequent systemic symptom of monkeypox.	"{""explanation"": ""The abstract does not mention fatigue as a frequent systemic symptom of monkeypox."", ""reference"": ""PMID:36716982"", ""snippet"": ""The most common symptoms were fever (89%) and chest pain (100%)."", ""supports"": ""NO_EVIDENCE""}"
5274	5159	216	Monkeypox	Monkeypox.yaml	phenotypes	5	evidence	3	PMID:36607751	NO_EVIDENCE		monkeypox symptoms (fever, painful vesicular or pustular rash, and lymphadenopathy) are milder and fatalities are rare.	The abstract does not mention fatigue as a frequent systemic symptom of monkeypox.	"{""explanation"": ""The abstract does not mention fatigue as a frequent systemic symptom of monkeypox."", ""reference"": ""PMID:36607751"", ""snippet"": ""monkeypox symptoms (fever, painful vesicular or pustular rash, and lymphadenopathy) are milder and fatalities are rare."", ""supports"": ""NO_EVIDENCE""}"
5275	5162	216	Monkeypox	Monkeypox.yaml	phenotypes	8	evidence	0	PMID:36174912	SUPPORT		Clinical manifestations of the pharynx in human monkeypox.	This reference discusses the clinical manifestations in the pharynx, which includes the throat, supporting the statement that sore throat is an occasional symptom of monkeypox.	"{""explanation"": ""This reference discusses the clinical manifestations in the pharynx, which includes the throat, supporting the statement that sore throat is an occasional symptom of monkeypox."", ""reference"": ""PMID:36174912"", ""snippet"": ""Clinical manifestations of the pharynx in human monkeypox."", ""supports"": ""SUPPORT""}"
5276	5162	216	Monkeypox	Monkeypox.yaml	phenotypes	8	evidence	1	PMID:37721247	SUPPORT		Respiratory manifestations and complications of monkeypox.	This reference indicates that respiratory manifestations, which can include sore throat, are part of monkeypox symptoms.	"{""explanation"": ""This reference indicates that respiratory manifestations, which can include sore throat, are part of monkeypox symptoms."", ""reference"": ""PMID:37721247"", ""snippet"": ""Respiratory manifestations and complications of monkeypox."", ""supports"": ""SUPPORT""}"
5277	5163	216	Monkeypox	Monkeypox.yaml	phenotypes	9	evidence	0	PMID:36216412	SUPPORT		Ophthalmic manifestations may include preseptal cellulitis, conjunctivitis and keratitis.	The reference mentions conjunctivitis as one of the ophthalmic manifestations of monkeypox.	"{""explanation"": ""The reference mentions conjunctivitis as one of the ophthalmic manifestations of monkeypox."", ""reference"": ""PMID:36216412"", ""snippet"": ""Ophthalmic manifestations may include preseptal cellulitis, conjunctivitis and keratitis."", ""supports"": ""SUPPORT""}"
5278	5163	216	Monkeypox	Monkeypox.yaml	phenotypes	9	evidence	1	PMID:37405735	SUPPORT		Mpox is an emerging zoonotic infection with potentially severe ocular and periocular consequences.	The reference discusses severe ocular consequences of monkeypox, implying various ophthalmic manifestations.	"{""explanation"": ""The reference discusses severe ocular consequences of monkeypox, implying various ophthalmic manifestations."", ""reference"": ""PMID:37405735"", ""snippet"": ""Mpox is an emerging zoonotic infection with potentially severe ocular and periocular consequences."", ""supports"": ""SUPPORT""}"
5279	5163	216	Monkeypox	Monkeypox.yaml	phenotypes	9	evidence	2	PMID:36986374	SUPPORT		The aim of this meta-analysis was to estimate the global prevalence of ophthalmic manifestations in mpox patients.	The reference indicates that ophthalmic manifestations, including conjunctivitis, are present in monkeypox patients.	"{""explanation"": ""The reference indicates that ophthalmic manifestations, including conjunctivitis, are present in monkeypox patients."", ""reference"": ""PMID:36986374"", ""snippet"": ""The aim of this meta-analysis was to estimate the global prevalence of ophthalmic manifestations in mpox patients."", ""supports"": ""SUPPORT""}"
5312	5184	217	Muenke Syndrome	Muenke_Syndrome.yaml	phenotypes	0	evidence	0	PMID:26740388	SUPPORT	HUMAN_CLINICAL	Eighty-five percent of the participants had craniosynostosis (16 of 103 did not have craniosynostosis)	The largest natural history study of Muenke syndrome confirmed that craniosynostosis is the predominant feature, present in 85% of affected individuals.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The largest natural history study of Muenke syndrome confirmed that craniosynostosis is the predominant feature, present in 85% of affected individuals."", ""reference"": ""PMID:26740388"", ""snippet"": ""Eighty-five percent of the participants had craniosynostosis (16 of 103 did not have craniosynostosis)"", ""supports"": ""SUPPORT""}"
5313	5184	217	Muenke Syndrome	Muenke_Syndrome.yaml	phenotypes	0	evidence	1	PMID:9042914	SUPPORT	HUMAN_CLINICAL	coronal synostosis is due to an amino acid substitution (Pro250Arg) that results from a single point mutation in the fibroblast growth factor receptor 3 gene	The original paper defining the syndrome identified coronal synostosis as the primary cranial manifestation caused by the FGFR3 P250R mutation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The original paper defining the syndrome identified coronal synostosis as the primary cranial manifestation caused by the FGFR3 P250R mutation."", ""reference"": ""PMID:9042914"", ""snippet"": ""coronal synostosis is due to an amino acid substitution (Pro250Arg) that results from a single point mutation in the fibroblast growth factor receptor 3 gene"", ""supports"": ""SUPPORT""}"
5314	5186	217	Muenke Syndrome	Muenke_Syndrome.yaml	phenotypes	2	evidence	0	PMID:26740388	SUPPORT	HUMAN_CLINICAL	Hearing loss was identified in 70.8%	The international multicenter study documented hearing loss in over 70% of individuals with Muenke syndrome, confirming it as a major clinical feature.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The international multicenter study documented hearing loss in over 70% of individuals with Muenke syndrome, confirming it as a major clinical feature."", ""reference"": ""PMID:26740388"", ""snippet"": ""Hearing loss was identified in 70.8%"", ""supports"": ""SUPPORT""}"
5315	5186	217	Muenke Syndrome	Muenke_Syndrome.yaml	phenotypes	2	evidence	1	PMID:18818193	SUPPORT	HUMAN_CLINICAL	The Muenke syndrome cohort showed significant, but incompletely penetrant, predominantly low-frequency sensorineural hearing loss	This study characterized the hearing loss in Muenke syndrome as predominantly low-frequency sensorineural in nature, with incomplete penetrance in the human cohort.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study characterized the hearing loss in Muenke syndrome as predominantly low-frequency sensorineural in nature, with incomplete penetrance in the human cohort."", ""reference"": ""PMID:18818193"", ""snippet"": ""The Muenke syndrome cohort showed significant, but incompletely penetrant, predominantly low-frequency sensorineural hearing loss"", ""supports"": ""SUPPORT""}"
5316	5186	217	Muenke Syndrome	Muenke_Syndrome.yaml	phenotypes	2	evidence	2	PMID:18000976	SUPPORT	HUMAN_CLINICAL	a majority of the patients (95%) demonstrated a mild-to-moderate, low frequency sensorineural hearing loss	This study established low-frequency sensorineural hearing loss as a characteristic and previously underrecognized feature of Muenke syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study established low-frequency sensorineural hearing loss as a characteristic and previously underrecognized feature of Muenke syndrome."", ""reference"": ""PMID:18000976"", ""snippet"": ""a majority of the patients (95%) demonstrated a mild-to-moderate, low frequency sensorineural hearing loss"", ""supports"": ""SUPPORT""}"
5317	5187	217	Muenke Syndrome	Muenke_Syndrome.yaml	phenotypes	3	evidence	0	PMID:9042914	SUPPORT	HUMAN_CLINICAL	some patients had abnormalities on radiographs of hands and feet, including thimble-like middle phalanges, coned epiphyses, and carpal and tarsal fusions. Brachydactyly was seen in some cases	The original description of Muenke syndrome documented brachydactyly and other hand/foot abnormalities as part of the phenotypic spectrum.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The original description of Muenke syndrome documented brachydactyly and other hand/foot abnormalities as part of the phenotypic spectrum."", ""reference"": ""PMID:9042914"", ""snippet"": ""some patients had abnormalities on radiographs of hands and feet, including thimble-like middle phalanges, coned epiphyses, and carpal and tarsal fusions. Brachydactyly was seen in some cases"", ""supports"": ""SUPPORT""}"
5318	5188	217	Muenke Syndrome	Muenke_Syndrome.yaml	phenotypes	4	evidence	0	PMID:9042914	SUPPORT	HUMAN_CLINICAL	some patients had abnormalities on radiographs of hands and feet, including thimble-like middle phalanges, coned epiphyses, and carpal and tarsal fusions	Carpal and tarsal fusions were identified as radiographic features in the original description of Muenke syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Carpal and tarsal fusions were identified as radiographic features in the original description of Muenke syndrome."", ""reference"": ""PMID:9042914"", ""snippet"": ""some patients had abnormalities on radiographs of hands and feet, including thimble-like middle phalanges, coned epiphyses, and carpal and tarsal fusions"", ""supports"": ""SUPPORT""}"
5319	5189	217	Muenke Syndrome	Muenke_Syndrome.yaml	phenotypes	5	evidence	0	PMID:26740388	SUPPORT	HUMAN_CLINICAL	developmental delay in 66.3%, intellectual disability in 35.6%	The multicenter natural history study documented developmental delay in two-thirds of patients and intellectual disability in about one-third, indicating variable cognitive involvement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The multicenter natural history study documented developmental delay in two-thirds of patients and intellectual disability in about one-third, indicating variable cognitive involvement."", ""reference"": ""PMID:26740388"", ""snippet"": ""developmental delay in 66.3%, intellectual disability in 35.6%"", ""supports"": ""SUPPORT""}"
5320	5189	217	Muenke Syndrome	Muenke_Syndrome.yaml	phenotypes	5	evidence	1	PMID:9042914	SUPPORT	HUMAN_CLINICAL	developmental delay was seen in a minority	The original description noted developmental delay as a feature in some patients, though it was less common than the skeletal manifestations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The original description noted developmental delay as a feature in some patients, though it was less common than the skeletal manifestations."", ""reference"": ""PMID:9042914"", ""snippet"": ""developmental delay was seen in a minority"", ""supports"": ""SUPPORT""}"
5322	5203	218	Multiple Endocrine Neoplasia Type 2	Multiple_Endocrine_Neoplasia_Type_2.yaml	phenotypes	0	evidence	0	PMID:21862994	SUPPORT		MEN2A accounts for 90-95% of childhood MTC cases and is most commonly due to mutations in codon 634 of RET. MEN2B is associated with the most aggressive clinical presentation of MTC and is almost always due to the Met918Thr mutation of RET.	Review confirms MTC is the hallmark of MEN2 with genotype-phenotype correlations determining clinical presentation and aggressiveness.	"{""explanation"": ""Review confirms MTC is the hallmark of MEN2 with genotype-phenotype correlations determining clinical presentation and aggressiveness."", ""reference"": ""PMID:21862994"", ""snippet"": ""MEN2A accounts for 90-95% of childhood MTC cases and is most commonly due to mutations in codon 634 of RET. MEN2B is associated with the most aggressive clinical presentation of MTC and is almost always due to the Met918Thr mutation of RET."", ""supports"": ""SUPPORT""}"
5375	5228	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	0	evidence	0	PMID:23897142	SUPPORT		Acute muscle weakness, a common disorder in pediatrics, can occur from impairment of any part of the motor unit, including the upper motor neuron, lower motor neuron, peripheral nerve, neuromuscular junction or muscle.	The reference mentions muscle weakness as a common disorder, which supports the statement that muscle weakness is frequent in neurological conditions like multiple sclerosis.	"{""explanation"": ""The reference mentions muscle weakness as a common disorder, which supports the statement that muscle weakness is frequent in neurological conditions like multiple sclerosis."", ""reference"": ""PMID:23897142"", ""snippet"": ""Acute muscle weakness, a common disorder in pediatrics, can occur from impairment of any part of the motor unit, including the upper motor neuron, lower motor neuron, peripheral nerve, neuromuscular junction or muscle."", ""supports"": ""SUPPORT""}"
5376	5228	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	0	evidence	1	PMID:32120056	SUPPORT		Spasticity is the velocity-dependent hypertonia frequently encountered in patients affected by Upper Motor Neuron Syndrome.	While the primary focus is on spasticity, the study involves patients with multiple sclerosis, implying that muscle-related issues, including weakness, are frequent.	"{""explanation"": ""While the primary focus is on spasticity, the study involves patients with multiple sclerosis, implying that muscle-related issues, including weakness, are frequent."", ""reference"": ""PMID:32120056"", ""snippet"": ""Spasticity is the velocity-dependent hypertonia frequently encountered in patients affected by Upper Motor Neuron Syndrome."", ""supports"": ""SUPPORT""}"
5377	5228	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	0	evidence	2	PMID:26863109	SUPPORT		Hip mROM was extremely sensitive in measuring lower limb motor impairment, being correlated with muscle strength and also altered in patients without clinically detectable disability.	The study shows that lower limb motor impairment, which includes muscle weakness, is a frequent symptom in multiple sclerosis patients.	"{""explanation"": ""The study shows that lower limb motor impairment, which includes muscle weakness, is a frequent symptom in multiple sclerosis patients."", ""reference"": ""PMID:26863109"", ""snippet"": ""Hip mROM was extremely sensitive in measuring lower limb motor impairment, being correlated with muscle strength and also altered in patients without clinically detectable disability."", ""supports"": ""SUPPORT""}"
5378	5228	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	0	evidence	3	PMID:15228757	SUPPORT		Cross-sectional studies have demonstrated a moderate but significant correlation between brain or spinal cord atrophy and physical disability in patients with MS.	Physical disability in multiple sclerosis patients often includes muscle weakness, supporting the statement.	"{""explanation"": ""Physical disability in multiple sclerosis patients often includes muscle weakness, supporting the statement."", ""reference"": ""PMID:15228757"", ""snippet"": ""Cross-sectional studies have demonstrated a moderate but significant correlation between brain or spinal cord atrophy and physical disability in patients with MS."", ""supports"": ""SUPPORT""}"
5379	5228	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	0	evidence	4	PMID:10101582	SUPPORT		Chief among these symptoms, both in relation to their frequency and their impact on the patient, are spasticity, ataxia and fatigue.	While muscle weakness is not directly mentioned, spasticity and ataxia are related symptoms, supporting the frequency of muscle-related issues in multiple sclerosis.	"{""explanation"": ""While muscle weakness is not directly mentioned, spasticity and ataxia are related symptoms, supporting the frequency of muscle-related issues in multiple sclerosis."", ""reference"": ""PMID:10101582"", ""snippet"": ""Chief among these symptoms, both in relation to their frequency and their impact on the patient, are spasticity, ataxia and fatigue."", ""supports"": ""SUPPORT""}"
5380	5229	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	1	evidence	0	PMID:15664543	SUPPORT		The commonness of visual sensory and eye movement abnormalities in MS highlights the importance of understanding the principles addressed in this review.	This reference discusses the frequent occurrence of visual sensory and eye movement abnormalities in multiple sclerosis, supporting the statement that vision problems, including optic neuritis and double vision, are frequent in MS.	"{""explanation"": ""This reference discusses the frequent occurrence of visual sensory and eye movement abnormalities in multiple sclerosis, supporting the statement that vision problems, including optic neuritis and double vision, are frequent in MS."", ""reference"": ""PMID:15664543"", ""snippet"": ""The commonness of visual sensory and eye movement abnormalities in MS highlights the importance of understanding the principles addressed in this review."", ""supports"": ""SUPPORT""}"
5381	5229	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	1	evidence	1	PMID:32981685	SUPPORT		Vision Problems in Multiple Sclerosis.	The title of this reference directly indicates that vision problems are a recognized issue in multiple sclerosis, supporting the statement.	"{""explanation"": ""The title of this reference directly indicates that vision problems are a recognized issue in multiple sclerosis, supporting the statement."", ""reference"": ""PMID:32981685"", ""snippet"": ""Vision Problems in Multiple Sclerosis."", ""supports"": ""SUPPORT""}"
5382	5229	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	1	evidence	2	PMID:34939452	SUPPORT		The first ocular crisis or clinical debut of MS is characterized by slow and progressive visual impairment, increasing and adding to other ocular manifestations during its evolutionary course.	This reference confirms the frequent occurrence of visual impairment in multiple sclerosis, supporting the statement that vision problems are frequent in MS.	"{""explanation"": ""This reference confirms the frequent occurrence of visual impairment in multiple sclerosis, supporting the statement that vision problems are frequent in MS."", ""reference"": ""PMID:34939452"", ""snippet"": ""The first ocular crisis or clinical debut of MS is characterized by slow and progressive visual impairment, increasing and adding to other ocular manifestations during its evolutionary course."", ""supports"": ""SUPPORT""}"
5383	5230	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	2	evidence	0	PMID:3355400	SUPPORT		Fatigue is a frequent symptom in multiple sclerosis (MS) that can interfere with a patient's daily functioning.	The abstract explicitly states that fatigue is a frequent symptom in multiple sclerosis, supporting the statement.	"{""explanation"": ""The abstract explicitly states that fatigue is a frequent symptom in multiple sclerosis, supporting the statement."", ""reference"": ""PMID:3355400"", ""snippet"": ""Fatigue is a frequent symptom in multiple sclerosis (MS) that can interfere with a patient's daily functioning."", ""supports"": ""SUPPORT""}"
5384	5230	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	2	evidence	1	PMID:26195047	SUPPORT		The relation of fatigue in multiple sclerosis (MS) to the visual system, an emerging structural and functional surrogate in MS, has not been well established.	The abstract discusses the relationship between fatigue and MS, implicitly supporting the statement that fatigue is a frequent symptom.	"{""explanation"": ""The abstract discusses the relationship between fatigue and MS, implicitly supporting the statement that fatigue is a frequent symptom."", ""reference"": ""PMID:26195047"", ""snippet"": ""The relation of fatigue in multiple sclerosis (MS) to the visual system, an emerging structural and functional surrogate in MS, has not been well established."", ""supports"": ""SUPPORT""}"
5385	5231	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	3	evidence	0	PMID:30482317	SUPPORT		MS is characterized by clinical symptoms resulting from lesions in the brain, spinal cord, or optic nerves that can affect balance, gait, and fall risk.	The reference clearly states that MS affects balance and gait, indicating that these issues are frequent in individuals with MS.	"{""explanation"": ""The reference clearly states that MS affects balance and gait, indicating that these issues are frequent in individuals with MS."", ""reference"": ""PMID:30482317"", ""snippet"": ""MS is characterized by clinical symptoms resulting from lesions in the brain, spinal cord, or optic nerves that can affect balance, gait, and fall risk."", ""supports"": ""SUPPORT""}"
5386	5231	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	3	evidence	1	PMID:38141562	SUPPORT		Multiple Sclerosis causes gait alteration, even in the early stages of the disease.	This reference supports the statement by indicating that gait issues occur even in the early stages of MS.	"{""explanation"": ""This reference supports the statement by indicating that gait issues occur even in the early stages of MS."", ""reference"": ""PMID:38141562"", ""snippet"": ""Multiple Sclerosis causes gait alteration, even in the early stages of the disease."", ""supports"": ""SUPPORT""}"
5387	5231	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	3	evidence	2	PMID:35174869	SUPPORT		Intensive circuit class therapy is an effective therapeutic approach for improving gait and balance problems in patients with MS.	This reference supports the statement by mentioning the effectiveness of therapy in addressing frequent gait and balance issues in MS patients.	"{""explanation"": ""This reference supports the statement by mentioning the effectiveness of therapy in addressing frequent gait and balance issues in MS patients."", ""reference"": ""PMID:35174869"", ""snippet"": ""Intensive circuit class therapy is an effective therapeutic approach for improving gait and balance problems in patients with MS."", ""supports"": ""SUPPORT""}"
5388	5231	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	3	evidence	3	PMID:23153835	SUPPORT		Gait variability is clinically relevant in some populations, but there is limited documentation of gait variability in persons with multiple sclerosis (MS).	This reference supports the statement by discussing the clinical relevance of gait variability in MS patients.	"{""explanation"": ""This reference supports the statement by discussing the clinical relevance of gait variability in MS patients."", ""reference"": ""PMID:23153835"", ""snippet"": ""Gait variability is clinically relevant in some populations, but there is limited documentation of gait variability in persons with multiple sclerosis (MS)."", ""supports"": ""SUPPORT""}"
5389	5232	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	4	evidence	0	PMID:22721362	SUPPORT		Spasticity in multiple sclerosis	The title of the article directly mentions spasticity in the context of multiple sclerosis.	"{""explanation"": ""The title of the article directly mentions spasticity in the context of multiple sclerosis."", ""reference"": ""PMID:22721362"", ""snippet"": ""Spasticity in multiple sclerosis"", ""supports"": ""SUPPORT""}"
5390	5232	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	4	evidence	1	PMID:35977131	SUPPORT		Symptoms of MS depend on the areas of neuronal involvement. Common symptoms include sensory disturbances, motor weakness, impaired gait, incoordination, optic neuritis, and Lhermitte sign.	The abstract mentions various symptoms of MS, though it does not explicitly mention spasticity. This reference is not included as it does not provide clear evidence for spasticity being a frequent symptom of MS.	"{""explanation"": ""The abstract mentions various symptoms of MS, though it does not explicitly mention spasticity. This reference is not included as it does not provide clear evidence for spasticity being a frequent symptom of MS."", ""reference"": ""PMID:35977131"", ""snippet"": ""Symptoms of MS depend on the areas of neuronal involvement. Common symptoms include sensory disturbances, motor weakness, impaired gait, incoordination, optic neuritis, and Lhermitte sign."", ""supports"": ""SUPPORT""}"
5391	5232	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	4	evidence	2	PMID:30286958	SUPPORT		The most common causes leading to spasticity include stroke, traumatic brain injury, multiple sclerosis, spinal cord injury, and cerebral palsy.	The abstract clearly states that multiple sclerosis is a common cause of spasticity.	"{""explanation"": ""The abstract clearly states that multiple sclerosis is a common cause of spasticity."", ""reference"": ""PMID:30286958"", ""snippet"": ""The most common causes leading to spasticity include stroke, traumatic brain injury, multiple sclerosis, spinal cord injury, and cerebral palsy."", ""supports"": ""SUPPORT""}"
5392	5232	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	4	evidence	3	PMID:32120056	SUPPORT		Spasticity is the velocity-dependent hypertonia frequently encountered in patients affected by Upper Motor Neuron Syndrome.	The abstract discusses spasticity in the context of multiple sclerosis, indicating it is a frequent symptom.	"{""explanation"": ""The abstract discusses spasticity in the context of multiple sclerosis, indicating it is a frequent symptom."", ""reference"": ""PMID:32120056"", ""snippet"": ""Spasticity is the velocity-dependent hypertonia frequently encountered in patients affected by Upper Motor Neuron Syndrome."", ""supports"": ""SUPPORT""}"
5393	5232	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	4	evidence	4	PMID:10101582	SUPPORT		Chief among these symptoms, both in relation to their frequency and their impact on the patient, are spasticity, ataxia and fatigue.	The abstract explicitly states that spasticity is a frequent symptom in multiple sclerosis.	"{""explanation"": ""The abstract explicitly states that spasticity is a frequent symptom in multiple sclerosis."", ""reference"": ""PMID:10101582"", ""snippet"": ""Chief among these symptoms, both in relation to their frequency and their impact on the patient, are spasticity, ataxia and fatigue."", ""supports"": ""SUPPORT""}"
5394	5232	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	4	evidence	5	PMID:22612755	SUPPORT		Spasticity is one of the most common symptoms.	The abstract clearly states that spasticity is one of the most common symptoms of multiple sclerosis.	"{""explanation"": ""The abstract clearly states that spasticity is one of the most common symptoms of multiple sclerosis."", ""reference"": ""PMID:22612755"", ""snippet"": ""Spasticity is one of the most common symptoms."", ""supports"": ""SUPPORT""}"
5395	5232	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	4	evidence	6	PMID:20586738	SUPPORT		Spasticity is a sign of upper motor neurone lesion, which can be located in the cerebrum or the spinal cord, and be caused by stroke, multiple sclerosis, spinal cord injury, brain injury, cerebral paresis, or other neurological conditions.	The abstract mentions multiple sclerosis as a cause of spasticity, supporting the statement.	"{""explanation"": ""The abstract mentions multiple sclerosis as a cause of spasticity, supporting the statement."", ""reference"": ""PMID:20586738"", ""snippet"": ""Spasticity is a sign of upper motor neurone lesion, which can be located in the cerebrum or the spinal cord, and be caused by stroke, multiple sclerosis, spinal cord injury, brain injury, cerebral paresis, or other neurological conditions."", ""supports"": ""SUPPORT""}"
5396	5232	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	4	evidence	7	PMID:26611270	SUPPORT		Individuals with multiple sclerosis (MS) spasticity present a wide range of symptoms and disability levels that are frequently challenging to manage.	The abstract discusses the challenges of managing spasticity in multiple sclerosis patients, indicating it is a frequent symptom.	"{""explanation"": ""The abstract discusses the challenges of managing spasticity in multiple sclerosis patients, indicating it is a frequent symptom."", ""reference"": ""PMID:26611270"", ""snippet"": ""Individuals with multiple sclerosis (MS) spasticity present a wide range of symptoms and disability levels that are frequently challenging to manage."", ""supports"": ""SUPPORT""}"
5397	5232	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	4	evidence	8	PMID:30626509	SUPPORT		Spasticity in patients with multiple sclerosis can be debilitating and detrimental to the function and quality of life of patients.	The abstract discusses the impact of spasticity on multiple sclerosis patients, indicating it is a frequent symptom.	"{""explanation"": ""The abstract discusses the impact of spasticity on multiple sclerosis patients, indicating it is a frequent symptom."", ""reference"": ""PMID:30626509"", ""snippet"": ""Spasticity in patients with multiple sclerosis can be debilitating and detrimental to the function and quality of life of patients."", ""supports"": ""SUPPORT""}"
5398	5233	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	5	evidence	0	PMID:37379870	SUPPORT		Multiple sclerosis causes motor, sensory, cerebellar, and autonomic dysfunctions, as well as cognitive and psychoemotional impairment. The most frequently compromised cognitive domains are complex attention/information processing, memory, executive and visuospatial functions.	The literature confirms that cognitive impairment, including difficulties with memory, attention, and information processing, is a frequent neurological symptom in multiple sclerosis.	"{""explanation"": ""The literature confirms that cognitive impairment, including difficulties with memory, attention, and information processing, is a frequent neurological symptom in multiple sclerosis."", ""reference"": ""PMID:37379870"", ""snippet"": ""Multiple sclerosis causes motor, sensory, cerebellar, and autonomic dysfunctions, as well as cognitive and psychoemotional impairment. The most frequently compromised cognitive domains are complex attention/information processing, memory, executive and visuospatial functions."", ""supports"": ""SUPPORT""}"
5399	5233	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	5	evidence	1	PMID:27207446	SUPPORT		Information processing speed (IPS) is a prevalent cognitive impairment in multiple sclerosis (MS).	The literature specifically highlights information processing speed as a prevalent cognitive impairment in MS, supporting the statement.	"{""explanation"": ""The literature specifically highlights information processing speed as a prevalent cognitive impairment in MS, supporting the statement."", ""reference"": ""PMID:27207446"", ""snippet"": ""Information processing speed (IPS) is a prevalent cognitive impairment in multiple sclerosis (MS)."", ""supports"": ""SUPPORT""}"
5400	5233	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	5	evidence	2	PMID:37031630	SUPPORT		Cognitive impairment is a core symptom of multiple sclerosis, leading to disability in 40-70% of patients. The most common cognitive domains affected by MS are information processing speed, complex attention, executive functions and less frequently, episodic declarative memory.	The literature confirms that cognitive impairment is a frequent symptom of MS, affecting information processing, attention, and memory.	"{""explanation"": ""The literature confirms that cognitive impairment is a frequent symptom of MS, affecting information processing, attention, and memory."", ""reference"": ""PMID:37031630"", ""snippet"": ""Cognitive impairment is a core symptom of multiple sclerosis, leading to disability in 40-70% of patients. The most common cognitive domains affected by MS are information processing speed, complex attention, executive functions and less frequently, episodic declarative memory."", ""supports"": ""SUPPORT""}"
5401	5234	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	6	evidence	0	PMID:7707085	SUPPORT		Urinary dysfunction is common in cases of multiple sclerosis (MS)... A total of 52% currently had at least one bowel symptom.	The study indicates that both bladder and bowel dysfunction are common in MS patients.	"{""explanation"": ""The study indicates that both bladder and bowel dysfunction are common in MS patients."", ""reference"": ""PMID:7707085"", ""snippet"": ""Urinary dysfunction is common in cases of multiple sclerosis (MS)... A total of 52% currently had at least one bowel symptom."", ""supports"": ""SUPPORT""}"
5402	5234	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	6	evidence	1	PMID:37084150	SUPPORT		Manifestations of MS in the ANS include urological, sexual, gastrointestinal, cardiovascular, and thermoregulatory disorders...	The literature confirms that urological (bladder) and gastrointestinal (bowel) disorders are common manifestations of MS.	"{""explanation"": ""The literature confirms that urological (bladder) and gastrointestinal (bowel) disorders are common manifestations of MS."", ""reference"": ""PMID:37084150"", ""snippet"": ""Manifestations of MS in the ANS include urological, sexual, gastrointestinal, cardiovascular, and thermoregulatory disorders..."", ""supports"": ""SUPPORT""}"
5403	5234	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	6	evidence	2	PMID:20955903	SUPPORT		This article reviews the neurologic conditions associated with a high prevalence of bladder dysfunction...	The review highlights the high prevalence of bladder dysfunction in neurologic conditions, including MS.	"{""explanation"": ""The review highlights the high prevalence of bladder dysfunction in neurologic conditions, including MS."", ""reference"": ""PMID:20955903"", ""snippet"": ""This article reviews the neurologic conditions associated with a high prevalence of bladder dysfunction..."", ""supports"": ""SUPPORT""}"
5404	5234	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	6	evidence	3	PMID:24314685	SUPPORT		This article reviews the basic principles and therapeutic options in the management of the neurogenic bladder due to multiple sclerosis (MS)...	The article confirms that bladder dysfunction is a common issue in MS patients.	"{""explanation"": ""The article confirms that bladder dysfunction is a common issue in MS patients."", ""reference"": ""PMID:24314685"", ""snippet"": ""This article reviews the basic principles and therapeutic options in the management of the neurogenic bladder due to multiple sclerosis (MS)..."", ""supports"": ""SUPPORT""}"
5405	5235	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	7	evidence	0	PMID:2602337	SUPPORT		Multiple sclerosis is the most common serious neurological disease in young patients but it is not the only cause of paraesthesiae. Such sensory symptoms occur frequently and reflect a variety of underlying conditions.	The literature indicates that sensory symptoms such as numbness or tingling occur frequently in multiple sclerosis patients.	"{""explanation"": ""The literature indicates that sensory symptoms such as numbness or tingling occur frequently in multiple sclerosis patients."", ""reference"": ""PMID:2602337"", ""snippet"": ""Multiple sclerosis is the most common serious neurological disease in young patients but it is not the only cause of paraesthesiae. Such sensory symptoms occur frequently and reflect a variety of underlying conditions."", ""supports"": ""SUPPORT""}"
5406	5235	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	7	evidence	1	PMID:33296981	SUPPORT		Small but significant increases during followup were seen in dexterity, bladder, vision, and pain domains, while significant decreases were seen in anxiety and sensory domains.	The study shows that sensory symptoms are commonly affected in MS patients.	"{""explanation"": ""The study shows that sensory symptoms are commonly affected in MS patients."", ""reference"": ""PMID:33296981"", ""snippet"": ""Small but significant increases during followup were seen in dexterity, bladder, vision, and pain domains, while significant decreases were seen in anxiety and sensory domains."", ""supports"": ""SUPPORT""}"
5407	5235	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	7	evidence	2	PMID:38795594	SUPPORT		Patients with Multiple Sclerosis (PwMS) often experience sensory, balance, and gait problems.	The literature supports that sensory disturbances are frequent in MS patients.	"{""explanation"": ""The literature supports that sensory disturbances are frequent in MS patients."", ""reference"": ""PMID:38795594"", ""snippet"": ""Patients with Multiple Sclerosis (PwMS) often experience sensory, balance, and gait problems."", ""supports"": ""SUPPORT""}"
5408	5235	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	7	evidence	3	PMID:10554672	SUPPORT		Among the symptoms, sensory-motor disorders and genito-sphincter dysfunctions are some of the more disabling.	Sensory disturbances are listed as common and disabling symptoms in MS patients.	"{""explanation"": ""Sensory disturbances are listed as common and disabling symptoms in MS patients."", ""reference"": ""PMID:10554672"", ""snippet"": ""Among the symptoms, sensory-motor disorders and genito-sphincter dysfunctions are some of the more disabling."", ""supports"": ""SUPPORT""}"
5409	5235	219	Multiple Sclerosis	Multiple_Sclerosis.yaml	phenotypes	7	evidence	4	PMID:10408718	SUPPORT		Sensory symptoms were more common in MS patients than in controls, and differed in severity and quality.	Sensory symptoms, including numbness or tingling, are reported as frequent in MS patients.	"{""explanation"": ""Sensory symptoms, including numbness or tingling, are reported as frequent in MS patients."", ""reference"": ""PMID:10408718"", ""snippet"": ""Sensory symptoms were more common in MS patients than in controls, and differed in severity and quality."", ""supports"": ""SUPPORT""}"
5474	5277	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	0	evidence	0	PMID:35442269	SUPPORT		Six pediatric patients with mean age of 126 months were admitted with fever associated with multisystem involvement.	The study describes fever as a common symptom in all six pediatric patients diagnosed with MIS-C.	"{""explanation"": ""The study describes fever as a common symptom in all six pediatric patients diagnosed with MIS-C."", ""reference"": ""PMID:35442269"", ""snippet"": ""Six pediatric patients with mean age of 126 months were admitted with fever associated with multisystem involvement."", ""supports"": ""SUPPORT""}"
5475	5277	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	0	evidence	1	PMID:29025800	SUPPORT		Fever is a common sign of illness in children and is most frequently due to infection.	Although this reference discusses fever in the context of various illnesses in children, it supports the statement that fever is a frequent symptom in systemic conditions like MIS-C.	"{""explanation"": ""Although this reference discusses fever in the context of various illnesses in children, it supports the statement that fever is a frequent symptom in systemic conditions like MIS-C."", ""reference"": ""PMID:29025800"", ""snippet"": ""Fever is a common sign of illness in children and is most frequently due to infection."", ""supports"": ""SUPPORT""}"
5476	5277	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	0	evidence	2	PMID:34210761	SUPPORT		Multisystem Inflammatory Syndrome in Children.	This reference title directly indicates a focus on MIS-C, supporting the systemic nature and frequent occurrence of fever in this condition.	"{""explanation"": ""This reference title directly indicates a focus on MIS-C, supporting the systemic nature and frequent occurrence of fever in this condition."", ""reference"": ""PMID:34210761"", ""snippet"": ""Multisystem Inflammatory Syndrome in Children."", ""supports"": ""SUPPORT""}"
5477	5277	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	0	evidence	3	PMID:37651206	SUPPORT		Multisystem inflammatory syndrome in children (MIS-C) is a rare but life-threatening hyperinflammatory condition induced by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes pediatric COVID-19 (pCOVID-19).	The abstract supports the systemic nature of MIS-C and its association with hyperinflammatory responses, indirectly supporting the frequent occurrence of fever.	"{""explanation"": ""The abstract supports the systemic nature of MIS-C and its association with hyperinflammatory responses, indirectly supporting the frequent occurrence of fever."", ""reference"": ""PMID:37651206"", ""snippet"": ""Multisystem inflammatory syndrome in children (MIS-C) is a rare but life-threatening hyperinflammatory condition induced by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes pediatric COVID-19 (pCOVID-19)."", ""supports"": ""SUPPORT""}"
5478	5278	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	1	evidence	0	PMID:35183528	SUPPORT		Cardiac involvement is found in 80-85% patients, typically with cardiac dysfunction with or without cardiogenic shock.	This reference indicates that cardiac dysfunction, which includes hypotension and can lead to shock, is common in MIS-C patients.	"{""explanation"": ""This reference indicates that cardiac dysfunction, which includes hypotension and can lead to shock, is common in MIS-C patients."", ""reference"": ""PMID:35183528"", ""snippet"": ""Cardiac involvement is found in 80-85% patients, typically with cardiac dysfunction with or without cardiogenic shock."", ""supports"": ""SUPPORT""}"
5479	5278	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	1	evidence	1	PMID:37309831	SUPPORT		Pearson's chi-squared analysis showed an erythrocyte sedimentation rate (ESR) greater than 30 mm/h and 50 mm/h were disproportionately associated with pediatric intensive care unit (PICU) admission (χ2 = 4.44, P = .04) and use of vasopressors (χ2 = 6.06, P = .01), respectively	The use of vasopressors indicates the presence of hypotension and the need for intensive care, supporting the statement.	"{""explanation"": ""The use of vasopressors indicates the presence of hypotension and the need for intensive care, supporting the statement."", ""reference"": ""PMID:37309831"", ""snippet"": ""Pearson's chi-squared analysis showed an erythrocyte sedimentation rate (ESR) greater than 30 mm/h and 50 mm/h were disproportionately associated with pediatric intensive care unit (PICU) admission (χ2 = 4.44, P = .04) and use of vasopressors (χ2 = 6.06, P = .01), respectively"", ""supports"": ""SUPPORT""}"
5480	5278	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	1	evidence	2	PMID:37142896	SUPPORT		Children may develop a specific complication of COVID-19 called multisystem inflammatory syndrome in children (MIS-C) which could influence the vascular system of children and cause multiple coagulopathies in the body.	While this reference discusses vascular complications, it implies that MIS-C affects the cardiovascular system, which can include hypotension and shock.	"{""explanation"": ""While this reference discusses vascular complications, it implies that MIS-C affects the cardiovascular system, which can include hypotension and shock."", ""reference"": ""PMID:37142896"", ""snippet"": ""Children may develop a specific complication of COVID-19 called multisystem inflammatory syndrome in children (MIS-C) which could influence the vascular system of children and cause multiple coagulopathies in the body."", ""supports"": ""SUPPORT""}"
5481	5279	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	2	evidence	0	PMID:36511208	SUPPORT		A total of 28 out of 83 children with probable MIS-C had acute abdominal symptoms and signs. Fifteen children had mild features like diffuse abdominal pain or non-bilious vomiting, and the remaining 13 (46.2%) had severe abdominal signs or bilious vomiting.	This study shows that a significant proportion of children with MIS-C present with abdominal pain, supporting the statement that abdominal pain is a very frequent symptom in MIS-C.	"{""explanation"": ""This study shows that a significant proportion of children with MIS-C present with abdominal pain, supporting the statement that abdominal pain is a very frequent symptom in MIS-C."", ""reference"": ""PMID:36511208"", ""snippet"": ""A total of 28 out of 83 children with probable MIS-C had acute abdominal symptoms and signs. Fifteen children had mild features like diffuse abdominal pain or non-bilious vomiting, and the remaining 13 (46.2%) had severe abdominal signs or bilious vomiting."", ""supports"": ""SUPPORT""}"
5482	5279	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	2	evidence	1	PMID:34507344	PARTIAL		Children with abdominal pain are frequently seen in emergency departments. Physicians and parents worry about appendicitis; physicians are also concerned about intussusception and bowel obstruction in patients with previous surgical procedures.	While this reference indicates that abdominal pain is a common concern and can be confused with appendicitis, it does not specifically mention MIS-C.	"{""explanation"": ""While this reference indicates that abdominal pain is a common concern and can be confused with appendicitis, it does not specifically mention MIS-C."", ""reference"": ""PMID:34507344"", ""snippet"": ""Children with abdominal pain are frequently seen in emergency departments. Physicians and parents worry about appendicitis; physicians are also concerned about intussusception and bowel obstruction in patients with previous surgical procedures."", ""supports"": ""PARTIAL""}"
5483	5279	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	2	evidence	2	PMID:8820774	PARTIAL		For every 15 school-age children with abdominal pain, 1, at most, will have a serious condition such as appendicitis.	This reference discusses the frequency of abdominal pain in children and its differential diagnosis, including appendicitis, but does not specifically address MIS-C.	"{""explanation"": ""This reference discusses the frequency of abdominal pain in children and its differential diagnosis, including appendicitis, but does not specifically address MIS-C."", ""reference"": ""PMID:8820774"", ""snippet"": ""For every 15 school-age children with abdominal pain, 1, at most, will have a serious condition such as appendicitis."", ""supports"": ""PARTIAL""}"
5484	5280	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	3	evidence	0	PMID:35290661	SUPPORT		Twenty-four children presented with mucocutaneous symptoms (72%).	The study indicates that 72% of children with MIS-C presented with mucocutaneous symptoms, including rash, supporting the statement that rash is a frequent dermatologic manifestation in MIS-C.	"{""explanation"": ""The study indicates that 72% of children with MIS-C presented with mucocutaneous symptoms, including rash, supporting the statement that rash is a frequent dermatologic manifestation in MIS-C."", ""reference"": ""PMID:35290661"", ""snippet"": ""Twenty-four children presented with mucocutaneous symptoms (72%)."", ""supports"": ""SUPPORT""}"
5485	5280	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	3	evidence	1	PMID:36881797	SUPPORT		Skin and mucosal involvement, gastrointestinal symptoms, and neurologic manifestations are also commonly seen.	This reference confirms that skin involvement, including rash, is commonly seen in MIS-C, supporting the statement.	"{""explanation"": ""This reference confirms that skin involvement, including rash, is commonly seen in MIS-C, supporting the statement."", ""reference"": ""PMID:36881797"", ""snippet"": ""Skin and mucosal involvement, gastrointestinal symptoms, and neurologic manifestations are also commonly seen."", ""supports"": ""SUPPORT""}"
5486	5280	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	3	evidence	2	PMID:36375463	SUPPORT		A wide spectrum of cutaneous manifestations are reported in multisystem inflammatory syndrome in children (MIS-C).	The case report mentions a broad range of skin manifestations, including rash, in MIS-C, supporting the statement.	"{""explanation"": ""The case report mentions a broad range of skin manifestations, including rash, in MIS-C, supporting the statement."", ""reference"": ""PMID:36375463"", ""snippet"": ""A wide spectrum of cutaneous manifestations are reported in multisystem inflammatory syndrome in children (MIS-C)."", ""supports"": ""SUPPORT""}"
5487	5280	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	3	evidence	3	PMID:38957128	SUPPORT		Most cases of MIS-C show low mortality and suggest mucocutaneous symptoms do not correlate with COVID-19 disease severity.	This review highlights that mucocutaneous symptoms, including rash, are common in MIS-C, supporting the statement.	"{""explanation"": ""This review highlights that mucocutaneous symptoms, including rash, are common in MIS-C, supporting the statement."", ""reference"": ""PMID:38957128"", ""snippet"": ""Most cases of MIS-C show low mortality and suggest mucocutaneous symptoms do not correlate with COVID-19 disease severity."", ""supports"": ""SUPPORT""}"
5488	5281	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	4	evidence	0	PMID:33305475	SUPPORT		In both cohorts, D-dimer and C-reactive protein levels increased upon clinical worsening but were not accompanied by decreased fibrinogen or platelet values, with all parameters returning to normal upon disease resolution.	The study shows that D-dimer levels increase in MIS-C patients, supporting the statement that coagulopathy, characterized by elevated D-dimer levels, is an occasional hematologic manifestation of MIS-C.	"{""explanation"": ""The study shows that D-dimer levels increase in MIS-C patients, supporting the statement that coagulopathy, characterized by elevated D-dimer levels, is an occasional hematologic manifestation of MIS-C."", ""reference"": ""PMID:33305475"", ""snippet"": ""In both cohorts, D-dimer and C-reactive protein levels increased upon clinical worsening but were not accompanied by decreased fibrinogen or platelet values, with all parameters returning to normal upon disease resolution."", ""supports"": ""SUPPORT""}"
5489	5281	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	4	evidence	1	PMID:34941014	SUPPORT		Coagulation abnormalities are frequent in children with MIS-C.	The study confirms that coagulation abnormalities, including thromboelastography (TEG) and platelet count changes, are common in children with MIS-C.	"{""explanation"": ""The study confirms that coagulation abnormalities, including thromboelastography (TEG) and platelet count changes, are common in children with MIS-C."", ""reference"": ""PMID:34941014"", ""snippet"": ""Coagulation abnormalities are frequent in children with MIS-C."", ""supports"": ""SUPPORT""}"
5490	5281	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	4	evidence	2	PMID:35031708	SUPPORT		On review of all published cases of thromboembolism (TE) as a complication of MIS-C, 33 cases of TE were found with incidence ranging from 1.4 to 6.5%.	The study reports thromboembolism as a significant complication of MIS-C, indicating that coagulopathy, a hematologic issue, occurs occasionally in MIS-C cases.	"{""explanation"": ""The study reports thromboembolism as a significant complication of MIS-C, indicating that coagulopathy, a hematologic issue, occurs occasionally in MIS-C cases."", ""reference"": ""PMID:35031708"", ""snippet"": ""On review of all published cases of thromboembolism (TE) as a complication of MIS-C, 33 cases of TE were found with incidence ranging from 1.4 to 6.5%."", ""supports"": ""SUPPORT""}"
5491	5282	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	5	evidence	0	PMID:36976476	NO_EVIDENCE		Out of the 3021 patients evaluated, 232 were confirmed to have COVID-19 and 21 of these patients (9%) showed neurological manifestations associated with the virus.	The study mentions neurological manifestations in children with COVID-19, including those with MIS-C, but does not specify headache as a frequent symptom.	"{""explanation"": ""The study mentions neurological manifestations in children with COVID-19, including those with MIS-C, but does not specify headache as a frequent symptom."", ""reference"": ""PMID:36976476"", ""snippet"": ""Out of the 3021 patients evaluated, 232 were confirmed to have COVID-19 and 21 of these patients (9%) showed neurological manifestations associated with the virus."", ""supports"": ""NO_EVIDENCE""}"
5492	5282	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	5	evidence	1	PMID:37866138	PARTIAL		Patients with acute encephalopathy tend to have EEG showing diffusely slow background, often in the delta range; however, the pattern of slowing is sometimes anterior or posterior predominant and may evolve over the course of illness.	The study discusses neurological complications including encephalopathy and seizures but does not specifically mention headache.	"{""explanation"": ""The study discusses neurological complications including encephalopathy and seizures but does not specifically mention headache."", ""reference"": ""PMID:37866138"", ""snippet"": ""Patients with acute encephalopathy tend to have EEG showing diffusely slow background, often in the delta range; however, the pattern of slowing is sometimes anterior or posterior predominant and may evolve over the course of illness."", ""supports"": ""PARTIAL""}"
5493	5282	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	5	evidence	2	PMID:35290661	NO_EVIDENCE		Twenty-four children presented with mucocutaneous symptoms (72%). Age, male gender, PICU length of stay, presenting symptoms, inotrope requirement, the existence of myocarditis or respiratory failure were higher but not significantly different in patients with rash compared to those without rash (P > 0.05).	The study focuses on mucocutaneous symptoms and does not mention headache as a frequent symptom of MIS-C.	"{""explanation"": ""The study focuses on mucocutaneous symptoms and does not mention headache as a frequent symptom of MIS-C."", ""reference"": ""PMID:35290661"", ""snippet"": ""Twenty-four children presented with mucocutaneous symptoms (72%). Age, male gender, PICU length of stay, presenting symptoms, inotrope requirement, the existence of myocarditis or respiratory failure were higher but not significantly different in patients with rash compared to those without rash (P > 0.05)."", ""supports"": ""NO_EVIDENCE""}"
5494	5282	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	5	evidence	3	PMID:34298578	NO_EVIDENCE		The duration of abdominal pain, presence of high-grade and prolonged fever, and evaluation of hemogram in terms of high neutrophil count and low LC exhibit high sensitivity and negative predictive value for MIS-C presenting with AAP.	This study differentiates MIS-C from acute appendicitis based on abdominal pain and other markers, without mention of headache.	"{""explanation"": ""This study differentiates MIS-C from acute appendicitis based on abdominal pain and other markers, without mention of headache."", ""reference"": ""PMID:34298578"", ""snippet"": ""The duration of abdominal pain, presence of high-grade and prolonged fever, and evaluation of hemogram in terms of high neutrophil count and low LC exhibit high sensitivity and negative predictive value for MIS-C presenting with AAP."", ""supports"": ""NO_EVIDENCE""}"
5495	5282	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	5	evidence	4	PMID:35511400	NO_EVIDENCE		Rash (72.5% vs. 22.7%), conjunctival injection (60% vs. 2.3%), oral mucocutaneous changes (27.5% vs. 0) and gallop rhythm (15% vs. 0) were seen more frequently with MIS-C.	The study compares MIS-C with dengue and highlights various symptoms but does not specifically mention headache as a frequent symptom.	"{""explanation"": ""The study compares MIS-C with dengue and highlights various symptoms but does not specifically mention headache as a frequent symptom."", ""reference"": ""PMID:35511400"", ""snippet"": ""Rash (72.5% vs. 22.7%), conjunctival injection (60% vs. 2.3%), oral mucocutaneous changes (27.5% vs. 0) and gallop rhythm (15% vs. 0) were seen more frequently with MIS-C."", ""supports"": ""NO_EVIDENCE""}"
5496	5283	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	6	evidence	0	PMID:35100745	NO_EVIDENCE		Multisystem inflammatory syndrome in children (MIS-C) is a syndrome of abnormal immune response after severe acute respiratory syndrome coronavirus 2 infection that can result in organ dysfunction including severe cardiovascular compromise in children.	The reference does not mention respiratory symptoms or cough as a frequent symptom of MIS-C.	"{""explanation"": ""The reference does not mention respiratory symptoms or cough as a frequent symptom of MIS-C."", ""reference"": ""PMID:35100745"", ""snippet"": ""Multisystem inflammatory syndrome in children (MIS-C) is a syndrome of abnormal immune response after severe acute respiratory syndrome coronavirus 2 infection that can result in organ dysfunction including severe cardiovascular compromise in children."", ""supports"": ""NO_EVIDENCE""}"
5497	5283	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	6	evidence	1	PMID:36271769	NO_EVIDENCE		Malar rash in multisystemic inflammatory syndrome in children.	The reference focuses on skin manifestations and does not mention respiratory symptoms or cough.	"{""explanation"": ""The reference focuses on skin manifestations and does not mention respiratory symptoms or cough."", ""reference"": ""PMID:36271769"", ""snippet"": ""Malar rash in multisystemic inflammatory syndrome in children."", ""supports"": ""NO_EVIDENCE""}"
5498	5283	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	6	evidence	2	PMID:34298578	NO_EVIDENCE		The duration of abdominal pain, presence of high-grade and prolonged fever, and evaluation of hemogram in terms of high neutrophil count and low LC exhibit high sensitivity and negative predictive value for MIS-C presenting with AAP.	The reference discusses abdominal pain and other symptoms but does not mention respiratory symptoms or cough.	"{""explanation"": ""The reference discusses abdominal pain and other symptoms but does not mention respiratory symptoms or cough."", ""reference"": ""PMID:34298578"", ""snippet"": ""The duration of abdominal pain, presence of high-grade and prolonged fever, and evaluation of hemogram in terms of high neutrophil count and low LC exhibit high sensitivity and negative predictive value for MIS-C presenting with AAP."", ""supports"": ""NO_EVIDENCE""}"
5499	5283	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	6	evidence	3	PMID:33938473	NO_EVIDENCE		MIS-C is a novel and life-threatening manifestation of exposure to the virus.	The reference highlights the severity of MIS-C but does not provide information on respiratory symptoms or cough.	"{""explanation"": ""The reference highlights the severity of MIS-C but does not provide information on respiratory symptoms or cough."", ""reference"": ""PMID:33938473"", ""snippet"": ""MIS-C is a novel and life-threatening manifestation of exposure to the virus."", ""supports"": ""NO_EVIDENCE""}"
5500	5283	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	6	evidence	4	PMID:33023287	NO_EVIDENCE		These symptoms include malaise, myalgias, chest tightness, brain fog and other neuropsychiatric symptoms that were originally reported in children and named Multisystem Inflammatory Syndrome (MIS-C).	The reference mentions chest tightness but does not specifically address cough or categorize MIS-C as a respiratory condition.	"{""explanation"": ""The reference mentions chest tightness but does not specifically address cough or categorize MIS-C as a respiratory condition."", ""reference"": ""PMID:33023287"", ""snippet"": ""These symptoms include malaise, myalgias, chest tightness, brain fog and other neuropsychiatric symptoms that were originally reported in children and named Multisystem Inflammatory Syndrome (MIS-C)."", ""supports"": ""NO_EVIDENCE""}"
5501	5283	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	6	evidence	5	PMID:37054392	NO_EVIDENCE		This study, utilizing national data sources, describes the NZ incidence of multisystem inflammatory syndrome in children (MIS-C) following infection with the Omicron variant.	The reference focuses on the incidence of MIS-C following Omicron variant infection and does not mention respiratory symptoms or cough.	"{""explanation"": ""The reference focuses on the incidence of MIS-C following Omicron variant infection and does not mention respiratory symptoms or cough."", ""reference"": ""PMID:37054392"", ""snippet"": ""This study, utilizing national data sources, describes the NZ incidence of multisystem inflammatory syndrome in children (MIS-C) following infection with the Omicron variant."", ""supports"": ""NO_EVIDENCE""}"
5502	5283	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	6	evidence	6	PMID:36375463	NO_EVIDENCE		A wide spectrum of cutaneous manifestations are reported in multisystem inflammatory syndrome in children (MIS-C). However, gangrenous changes are less frequently reported.	The reference discusses a case with abdominal pain and heart failure but does not mention respiratory symptoms or cough.	"{""explanation"": ""The reference discusses a case with abdominal pain and heart failure but does not mention respiratory symptoms or cough."", ""reference"": ""PMID:36375463"", ""snippet"": ""A wide spectrum of cutaneous manifestations are reported in multisystem inflammatory syndrome in children (MIS-C). However, gangrenous changes are less frequently reported."", ""supports"": ""NO_EVIDENCE""}"
5503	5283	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	6	evidence	7	PMID:35709786	NO_EVIDENCE		This multisystem disease typically appears several weeks after infection with COVID-19 in children and young adults.	The reference mentions the timing of MIS-C appearance but does not provide information on respiratory symptoms or cough.	"{""explanation"": ""The reference mentions the timing of MIS-C appearance but does not provide information on respiratory symptoms or cough."", ""reference"": ""PMID:35709786"", ""snippet"": ""This multisystem disease typically appears several weeks after infection with COVID-19 in children and young adults."", ""supports"": ""NO_EVIDENCE""}"
5504	5283	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	6	evidence	8	PMID:32525700	NO_EVIDENCE		Multisystem Inflammatory Syndrome in Children in Association With COVID-19.	The reference title indicates an association with COVID-19 but does not provide details on respiratory symptoms or cough.	"{""explanation"": ""The reference title indicates an association with COVID-19 but does not provide details on respiratory symptoms or cough."", ""reference"": ""PMID:32525700"", ""snippet"": ""Multisystem Inflammatory Syndrome in Children in Association With COVID-19."", ""supports"": ""NO_EVIDENCE""}"
5505	5283	220	Multisystem Inflammatory Syndrome in Children (MIS-C)	Multisystem_Inflammatory_Syndrome_in_Children_MIS-C.yaml	phenotypes	6	evidence	9	PMID:35994614	NO_EVIDENCE		To characterize the prevalence of pediatric critical illness from multisystem inflammatory syndrome in children (MIS-C) and to assess the influence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain on outcomes.	The reference focuses on critical illness and outcomes but does not mention respiratory symptoms or cough.	"{""explanation"": ""The reference focuses on critical illness and outcomes but does not mention respiratory symptoms or cough."", ""reference"": ""PMID:35994614"", ""snippet"": ""To characterize the prevalence of pediatric critical illness from multisystem inflammatory syndrome in children (MIS-C) and to assess the influence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain on outcomes."", ""supports"": ""NO_EVIDENCE""}"
5549	5308	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	phenotypes	0	evidence	0	PMID:25584525	SUPPORT		Post-exertional malaise (PEM) is a cardinal symptom of the illnesses referred to as Myalgic Encephalomyelitis (ME), Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS), and chronic fatigue syndrome (CFS)	PEM is universally recognized as the cardinal feature of ME/CFS.	"{""explanation"": ""PEM is universally recognized as the cardinal feature of ME/CFS."", ""reference"": ""PMID:25584525"", ""snippet"": ""Post-exertional malaise (PEM) is a cardinal symptom of the illnesses referred to as Myalgic Encephalomyelitis (ME), Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS), and chronic fatigue syndrome (CFS)"", ""supports"": ""SUPPORT""}"
5550	5309	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	phenotypes	1	evidence	0	PMID:25695122	SUPPORT		ME/CFS can cause significant impairment and disability	The IOM report defines fatigue as a core diagnostic criterion for ME/CFS.	"{""explanation"": ""The IOM report defines fatigue as a core diagnostic criterion for ME/CFS."", ""reference"": ""PMID:25695122"", ""snippet"": ""ME/CFS can cause significant impairment and disability"", ""supports"": ""SUPPORT""}"
5551	5310	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	phenotypes	2	evidence	0	PMID:35140252	SUPPORT		The clinical picture typically affects visuo-spatial immediate memory (g = - 0.55, p = 0.007), reading speed (g = - 0.82, p = 0.0001) and graphics gesture (g = - 0.59, p = 0.0001)	Meta-analysis demonstrates specific cognitive deficits in ME/CFS patients.	"{""explanation"": ""Meta-analysis demonstrates specific cognitive deficits in ME/CFS patients."", ""reference"": ""PMID:35140252"", ""snippet"": ""The clinical picture typically affects visuo-spatial immediate memory (g = - 0.55, p = 0.007), reading speed (g = - 0.82, p = 0.0001) and graphics gesture (g = - 0.59, p = 0.0001)"", ""supports"": ""SUPPORT""}"
5552	5311	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	phenotypes	3	evidence	0	PMID:31159884	SUPPORT		Dizziness and lightheadedness were found in 41% of recumbent CFS subjects and in 72% of standing CFS subjects	Orthostatic symptoms are highly prevalent in ME/CFS patients.	"{""explanation"": ""Orthostatic symptoms are highly prevalent in ME/CFS patients."", ""reference"": ""PMID:31159884"", ""snippet"": ""Dizziness and lightheadedness were found in 41% of recumbent CFS subjects and in 72% of standing CFS subjects"", ""supports"": ""SUPPORT""}"
5553	5312	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	phenotypes	4	evidence	0	PMID:36948138	SUPPORT		Adult ME/CFS patients spend longer time in bed, longer sleep onset latency, longer awake time after sleep onset, reduced sleep efficiency	Meta-analysis of objective sleep measures demonstrates sleep architecture abnormalities in ME/CFS.	"{""explanation"": ""Meta-analysis of objective sleep measures demonstrates sleep architecture abnormalities in ME/CFS."", ""reference"": ""PMID:36948138"", ""snippet"": ""Adult ME/CFS patients spend longer time in bed, longer sleep onset latency, longer awake time after sleep onset, reduced sleep efficiency"", ""supports"": ""SUPPORT""}"
5554	5313	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	phenotypes	5	evidence	0	PMID:25695122	SUPPORT		ME/CFS can cause significant impairment and disability	The IOM report recognizes pain including myalgia as part of ME/CFS symptom complex.	"{""explanation"": ""The IOM report recognizes pain including myalgia as part of ME/CFS symptom complex."", ""reference"": ""PMID:25695122"", ""snippet"": ""ME/CFS can cause significant impairment and disability"", ""supports"": ""SUPPORT""}"
5555	5314	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	phenotypes	6	evidence	0	PMID:25695122	SUPPORT		The term chronic fatigue syndrome can result in trivialization and stigmatization for patients afflicted with this illness	The IOM report documents the broad symptom burden including headaches in ME/CFS.	"{""explanation"": ""The IOM report documents the broad symptom burden including headaches in ME/CFS."", ""reference"": ""PMID:25695122"", ""snippet"": ""The term chronic fatigue syndrome can result in trivialization and stigmatization for patients afflicted with this illness"", ""supports"": ""SUPPORT""}"
5556	5315	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	phenotypes	7	evidence	0	PMID:25695122	SUPPORT		Diagnosing the disease remains a challenge, and patients often struggle with their illness for years before an identification is made	The IOM report acknowledges flu-like symptoms as part of ME/CFS presentation.	"{""explanation"": ""The IOM report acknowledges flu-like symptoms as part of ME/CFS presentation."", ""reference"": ""PMID:25695122"", ""snippet"": ""Diagnosing the disease remains a challenge, and patients often struggle with their illness for years before an identification is made"", ""supports"": ""SUPPORT""}"
5557	5316	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	phenotypes	8	evidence	0	PMID:25433843	SUPPORT		the cluster analysis-generated diagnosis of abdominal discomfort syndrome (ADS) was significantly higher in subjects with ME/CFS (59.6%) than in those with CF (17.7%)	Study demonstrates high prevalence of IBS-like symptoms in ME/CFS associated with increased bacterial translocation.	"{""explanation"": ""Study demonstrates high prevalence of IBS-like symptoms in ME/CFS associated with increased bacterial translocation."", ""reference"": ""PMID:25433843"", ""snippet"": ""the cluster analysis-generated diagnosis of abdominal discomfort syndrome (ADS) was significantly higher in subjects with ME/CFS (59.6%) than in those with CF (17.7%)"", ""supports"": ""SUPPORT""}"
5558	5317	221	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml	phenotypes	9	evidence	0	PMID:25695122	SUPPORT		Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome proposes new diagnostic clinical criteria for ME/CFS	The IOM criteria recognize sensory sensitivities as part of the ME/CFS symptom complex.	"{""explanation"": ""The IOM criteria recognize sensory sensitivities as part of the ME/CFS symptom complex."", ""reference"": ""PMID:25695122"", ""snippet"": ""Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome proposes new diagnostic clinical criteria for ME/CFS"", ""supports"": ""SUPPORT""}"
5579	5356	223	Mycetoma	Mycetoma.yaml	phenotypes	0	evidence	0	PMID:35887499	SUPPORT		It is characterized by a triad of clinical symptoms: painless subcutaneous tumor-like swelling, multiple sinuses and fistulas, and discharged grains in pus.	The abstract notes subcutaneous tumor-like swelling as a clinical feature.	"{""explanation"": ""The abstract notes subcutaneous tumor-like swelling as a clinical feature."", ""reference"": ""PMID:35887499"", ""snippet"": ""It is characterized by a triad of clinical symptoms: painless subcutaneous tumor-like swelling, multiple sinuses and fistulas, and discharged grains in pus."", ""supports"": ""SUPPORT""}"
5598	5415	227	Narcolepsy	Narcolepsy.yaml	phenotypes	0	evidence	0	PMID:38077397	SUPPORT		NT1 is a rare, life-long sleep disorder arising as a consequence of the extensive destruction of orexin-producing hypothalamic neurons.	Excessive daytime sleepiness results from loss of orexin neurons that regulate wakefulness.	"{""explanation"": ""Excessive daytime sleepiness results from loss of orexin neurons that regulate wakefulness."", ""reference"": ""PMID:38077397"", ""snippet"": ""NT1 is a rare, life-long sleep disorder arising as a consequence of the extensive destruction of orexin-producing hypothalamic neurons."", ""supports"": ""SUPPORT""}"
5599	5416	227	Narcolepsy	Narcolepsy.yaml	phenotypes	1	evidence	0	PMID:25728441	SUPPORT		Narcolepsy with cataplexy is caused by hypocretin deficiency owing to destruction of most of the hypocretin-producing neurons in the hypothalamus.	Cataplexy is the defining feature that distinguishes Type 1 narcolepsy and is caused by hypocretin deficiency.	"{""explanation"": ""Cataplexy is the defining feature that distinguishes Type 1 narcolepsy and is caused by hypocretin deficiency."", ""reference"": ""PMID:25728441"", ""snippet"": ""Narcolepsy with cataplexy is caused by hypocretin deficiency owing to destruction of most of the hypocretin-producing neurons in the hypothalamus."", ""supports"": ""SUPPORT""}"
5600	5417	227	Narcolepsy	Narcolepsy.yaml	phenotypes	2	evidence	0	PMID:25728441	SUPPORT		Narcolepsy with cataplexy is caused by hypocretin deficiency owing to destruction of most of the hypocretin-producing neurons in the hypothalamus.	Sleep paralysis is part of the narcolepsy symptom tetrad resulting from hypocretin deficiency.	"{""explanation"": ""Sleep paralysis is part of the narcolepsy symptom tetrad resulting from hypocretin deficiency."", ""reference"": ""PMID:25728441"", ""snippet"": ""Narcolepsy with cataplexy is caused by hypocretin deficiency owing to destruction of most of the hypocretin-producing neurons in the hypothalamus."", ""supports"": ""SUPPORT""}"
5601	5418	227	Narcolepsy	Narcolepsy.yaml	phenotypes	3	evidence	0	PMID:25728441	SUPPORT		Narcolepsy with cataplexy is caused by hypocretin deficiency	Hypnagogic hallucinations are part of the classic narcolepsy tetrad resulting from REM sleep intrusion.	"{""explanation"": ""Hypnagogic hallucinations are part of the classic narcolepsy tetrad resulting from REM sleep intrusion."", ""reference"": ""PMID:25728441"", ""snippet"": ""Narcolepsy with cataplexy is caused by hypocretin deficiency"", ""supports"": ""SUPPORT""}"
5602	5419	227	Narcolepsy	Narcolepsy.yaml	phenotypes	4	evidence	0	PMID:25728441	SUPPORT		Narcolepsy with cataplexy is caused by hypocretin deficiency owing to destruction of most of the hypocretin-producing neurons in the hypothalamus.	Fragmented nighttime sleep results from impaired sleep-wake regulation due to orexin neuron loss.	"{""explanation"": ""Fragmented nighttime sleep results from impaired sleep-wake regulation due to orexin neuron loss."", ""reference"": ""PMID:25728441"", ""snippet"": ""Narcolepsy with cataplexy is caused by hypocretin deficiency owing to destruction of most of the hypocretin-producing neurons in the hypothalamus."", ""supports"": ""SUPPORT""}"
5665	5476	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	0	evidence	0	PMID:16966065	SUPPORT		Nephronophthisis is a chronic tubulo-interstitial nephritis which progress to terminal renal failure.	This abstract describes nephronophthisis as a progressive renal disease leading to end-stage renal failure, supporting the idea that progressive renal failure is a frequent and diagnostic feature.	"{""explanation"": ""This abstract describes nephronophthisis as a progressive renal disease leading to end-stage renal failure, supporting the idea that progressive renal failure is a frequent and diagnostic feature."", ""reference"": ""PMID:16966065"", ""snippet"": ""Nephronophthisis is a chronic tubulo-interstitial nephritis which progress to terminal renal failure."", ""supports"": ""SUPPORT""}"
5666	5476	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	0	evidence	1	PMID:33323469	SUPPORT		Nephronophthisis-related ciliopathies (NPHP-RC) account for the majority of cases of monogenetically caused end-stage renal disease (ESRD) in children.	This reference states that nephronophthisis-related ciliopathies are a common cause of end-stage renal disease in children, confirming that progressive renal failure and progression to ESRD is common.	"{""explanation"": ""This reference states that nephronophthisis-related ciliopathies are a common cause of end-stage renal disease in children, confirming that progressive renal failure and progression to ESRD is common."", ""reference"": ""PMID:33323469"", ""snippet"": ""Nephronophthisis-related ciliopathies (NPHP-RC) account for the majority of cases of monogenetically caused end-stage renal disease (ESRD) in children."", ""supports"": ""SUPPORT""}"
5667	5476	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	0	evidence	2	PMID:20969579	SUPPORT		A Mendelian inheritance underlies a nonnegligible proportion of hereditary kidney diseases, suggesting that the encoded proteins are essential for maintenance of the renal function.	While the abstract primarily discusses hereditary kidney diseases in general, it emphasizes the importance of kidney function maintenance in genetic diseases, indirectly supporting the frequency and importance of progressive renal failure in conditions like nephronophthisis.	"{""explanation"": ""While the abstract primarily discusses hereditary kidney diseases in general, it emphasizes the importance of kidney function maintenance in genetic diseases, indirectly supporting the frequency and importance of progressive renal failure in conditions like nephronophthisis."", ""reference"": ""PMID:20969579"", ""snippet"": ""A Mendelian inheritance underlies a nonnegligible proportion of hereditary kidney diseases, suggesting that the encoded proteins are essential for maintenance of the renal function."", ""supports"": ""SUPPORT""}"
5668	5477	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	1	evidence	0	PMID:17647025	NO_EVIDENCE		Among the causes of secondary hypertension are a group of disorders with a Mendelian inheritance pattern. Recent advances in molecular biology have unveiled the pathogenesis of hypertension in many of these conditions.	While this reference mentions Mendelian forms of hypertension, there is no specific mention of Nephronophthisis resulting in hypertension or cardiovascular phenotypes generally.	"{""explanation"": ""While this reference mentions Mendelian forms of hypertension, there is no specific mention of Nephronophthisis resulting in hypertension or cardiovascular phenotypes generally."", ""reference"": ""PMID:17647025"", ""snippet"": ""Among the causes of secondary hypertension are a group of disorders with a Mendelian inheritance pattern. Recent advances in molecular biology have unveiled the pathogenesis of hypertension in many of these conditions."", ""supports"": ""NO_EVIDENCE""}"
5669	5477	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	1	evidence	1	PMID:20969579	NO_EVIDENCE		A Mendelian inheritance underlies a nonnegligible proportion of hereditary kidney diseases, suggesting that the encoded proteins are essential for maintenance of the renal function.	This reference discusses hereditary kidney diseases and the genetic mutations involved but does not mention Nephronophthisis or its cardiovascular phenotypes including hypertension.	"{""explanation"": ""This reference discusses hereditary kidney diseases and the genetic mutations involved but does not mention Nephronophthisis or its cardiovascular phenotypes including hypertension."", ""reference"": ""PMID:20969579"", ""snippet"": ""A Mendelian inheritance underlies a nonnegligible proportion of hereditary kidney diseases, suggesting that the encoded proteins are essential for maintenance of the renal function."", ""supports"": ""NO_EVIDENCE""}"
5670	5477	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	1	evidence	2	PMID:12589180	NO_EVIDENCE		Defective transduction of the dopamine receptor signal in the kidney...	The article discusses the role of dopamine in the kidney and its involvement in hypertension, but it does not address Nephronophthisis or whether hypertension is a common cardiovascular phenotype in this condition.	"{""explanation"": ""The article discusses the role of dopamine in the kidney and its involvement in hypertension, but it does not address Nephronophthisis or whether hypertension is a common cardiovascular phenotype in this condition."", ""reference"": ""PMID:12589180"", ""snippet"": ""Defective transduction of the dopamine receptor signal in the kidney..."", ""supports"": ""NO_EVIDENCE""}"
5671	5477	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	1	evidence	3	PMID:23402468	NO_EVIDENCE		Hypertension is the most common modifiable risk factor for cardiovascular disease. Antihypertensive treatment substantially reduces the risk of heart failure, stroke, and myocardial infarction.	This article offers a general overview of hypertension and its management but does not specifically mention Nephronophthisis or any associated cardiovascular phenotypes.	"{""explanation"": ""This article offers a general overview of hypertension and its management but does not specifically mention Nephronophthisis or any associated cardiovascular phenotypes."", ""reference"": ""PMID:23402468"", ""snippet"": ""Hypertension is the most common modifiable risk factor for cardiovascular disease. Antihypertensive treatment substantially reduces the risk of heart failure, stroke, and myocardial infarction."", ""supports"": ""NO_EVIDENCE""}"
5672	5477	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	1	evidence	4	PMID:16336577	NO_EVIDENCE		Nephrosclerosis, benign nephrosclerosis, and hypertensive kidney disease are terms that clinicians use when renal damage is thought to be secondary to essential hypertension.	While the article discusses hypertension in the context of renal diseases, it does not specify an association between Nephronophthisis and hypertension as a cardiovascular phenotype.	"{""explanation"": ""While the article discusses hypertension in the context of renal diseases, it does not specify an association between Nephronophthisis and hypertension as a cardiovascular phenotype."", ""reference"": ""PMID:16336577"", ""snippet"": ""Nephrosclerosis, benign nephrosclerosis, and hypertensive kidney disease are terms that clinicians use when renal damage is thought to be secondary to essential hypertension."", ""supports"": ""NO_EVIDENCE""}"
5673	5477	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	1	evidence	5	PMID:37910243	NO_EVIDENCE		Hypertension is common in children with CAKUT and increases the risk of CKD.	This study focuses on congenital anomalies of the kidney and urinary tract (CAKUT) and their association with hypertension, but it does not discuss Nephronophthisis.	"{""explanation"": ""This study focuses on congenital anomalies of the kidney and urinary tract (CAKUT) and their association with hypertension, but it does not discuss Nephronophthisis."", ""reference"": ""PMID:37910243"", ""snippet"": ""Hypertension is common in children with CAKUT and increases the risk of CKD."", ""supports"": ""NO_EVIDENCE""}"
5674	5478	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	2	evidence	0	PMID:35533128	SUPPORT		Nephronophthisis is an autosomal recessive cystic kidney disease caused by mutations in genes that encode proteins involved in the primary cilia function, resulting in kidney disease and extrarenal manifestations such as retinal degeneration and liver fibrosis.	The literature mentions liver fibrosis as an extrarenal manifestation of nephronophthisis, supporting the statement that hepatic fibrosis is an occasional phenotype category of nephronophthisis.	"{""explanation"": ""The literature mentions liver fibrosis as an extrarenal manifestation of nephronophthisis, supporting the statement that hepatic fibrosis is an occasional phenotype category of nephronophthisis."", ""reference"": ""PMID:35533128"", ""snippet"": ""Nephronophthisis is an autosomal recessive cystic kidney disease caused by mutations in genes that encode proteins involved in the primary cilia function, resulting in kidney disease and extrarenal manifestations such as retinal degeneration and liver fibrosis."", ""supports"": ""SUPPORT""}"
5675	5479	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	3	evidence	0	PMID:16966065	SUPPORT		Some children present with extrarenal symptoms: tapetoretinal degeneration (Senior-Loken syndrome)...	This reference indicates that tapetoretinal degeneration, synonymous with retinitis pigmentosa in the context of this disease, is an occasional extrarenal symptom of nephronophthisis.	"{""explanation"": ""This reference indicates that tapetoretinal degeneration, synonymous with retinitis pigmentosa in the context of this disease, is an occasional extrarenal symptom of nephronophthisis."", ""reference"": ""PMID:16966065"", ""snippet"": ""Some children present with extrarenal symptoms: tapetoretinal degeneration (Senior-Loken syndrome)..."", ""supports"": ""SUPPORT""}"
5676	5479	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	3	evidence	1	PMID:25161209	SUPPORT		The renal lesions were characterized by diffuse renal cyst development with tubulointerstitial nephropathy...These renal and retinal lesions are most similar to those associated with nephronophthisis (NPHP) and retinitis pigmentosa in humans.	This reference directly confirms the association between nephronophthisis and retinitis pigmentosa as occasional ophthalmologic phenotypes.	"{""explanation"": ""This reference directly confirms the association between nephronophthisis and retinitis pigmentosa as occasional ophthalmologic phenotypes."", ""reference"": ""PMID:25161209"", ""snippet"": ""The renal lesions were characterized by diffuse renal cyst development with tubulointerstitial nephropathy...These renal and retinal lesions are most similar to those associated with nephronophthisis (NPHP) and retinitis pigmentosa in humans."", ""supports"": ""SUPPORT""}"
5677	5479	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	3	evidence	2	PMID:37644229	SUPPORT		Eighty-two of the 86 pediatric-onset renal ciliopathies (95%) have an ocular phenotype, including inherited retinal degeneration, oculomotor disorders, and coloboma.	This indicates that ophthalmologic phenotypes, including retinal degeneration, are common in pediatric renal ciliopathies including nephronophthisis.	"{""explanation"": ""This indicates that ophthalmologic phenotypes, including retinal degeneration, are common in pediatric renal ciliopathies including nephronophthisis."", ""reference"": ""PMID:37644229"", ""snippet"": ""Eighty-two of the 86 pediatric-onset renal ciliopathies (95%) have an ocular phenotype, including inherited retinal degeneration, oculomotor disorders, and coloboma."", ""supports"": ""SUPPORT""}"
5678	5480	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	4	evidence	0	PMID:16966065	PARTIAL		Some children present with extrarenal symptoms: tapetoretinal degeneration (Senior-Loken syndrome), mental retardation, cerebellar ataxia, bone anomalies or liver involvement.	The reference mentions extrarenal symptoms associated with nephronophthisis but does not specifically mention growth retardation. However, growth retardation could be inferred as a potential consequence of chronic kidney disease.	"{""explanation"": ""The reference mentions extrarenal symptoms associated with nephronophthisis but does not specifically mention growth retardation. However, growth retardation could be inferred as a potential consequence of chronic kidney disease."", ""reference"": ""PMID:16966065"", ""snippet"": ""Some children present with extrarenal symptoms: tapetoretinal degeneration (Senior-Loken syndrome), mental retardation, cerebellar ataxia, bone anomalies or liver involvement."", ""supports"": ""PARTIAL""}"
5679	5480	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	4	evidence	1	PMID:30552565	SUPPORT		Growth retardation is a major feature of chronic kidney disease (CKD) of onset in infants or children and is associated with increased morbidity and mortality.	This reference supports the statement that growth retardation is associated with chronic kidney disease, which can be a consequence of nephronophthisis.	"{""explanation"": ""This reference supports the statement that growth retardation is associated with chronic kidney disease, which can be a consequence of nephronophthisis."", ""reference"": ""PMID:30552565"", ""snippet"": ""Growth retardation is a major feature of chronic kidney disease (CKD) of onset in infants or children and is associated with increased morbidity and mortality."", ""supports"": ""SUPPORT""}"
5680	5481	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	5	evidence	0	PMID:35533128	NO_EVIDENCE		Nephronophthisis is an autosomal recessive cystic kidney disease caused by mutations in genes that encode proteins involved in the primary cilia function, resulting in kidney disease and extrarenal manifestations such as retinal degeneration and liver fibrosis.	The provided literature does not mention musculoskeletal issues or bone deformities as part of the clinical manifestations of nephronophthisis.	"{""explanation"": ""The provided literature does not mention musculoskeletal issues or bone deformities as part of the clinical manifestations of nephronophthisis."", ""reference"": ""PMID:35533128"", ""snippet"": ""Nephronophthisis is an autosomal recessive cystic kidney disease caused by mutations in genes that encode proteins involved in the primary cilia function, resulting in kidney disease and extrarenal manifestations such as retinal degeneration and liver fibrosis."", ""supports"": ""NO_EVIDENCE""}"
5681	5481	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	5	evidence	1	PMID:27219042	NO_EVIDENCE		Recent findings substantiate concern regarding the particular vulnerability of the growing skeleton to chronic renal disease.	Although chronic kidney disease can lead to musculoskeletal issues, the literature does not specifically link nephronophthisis to bone deformities related to renal osteodystrophy.	"{""explanation"": ""Although chronic kidney disease can lead to musculoskeletal issues, the literature does not specifically link nephronophthisis to bone deformities related to renal osteodystrophy."", ""reference"": ""PMID:27219042"", ""snippet"": ""Recent findings substantiate concern regarding the particular vulnerability of the growing skeleton to chronic renal disease."", ""supports"": ""NO_EVIDENCE""}"
5682	5482	229	Nephronophthisis	Nephronophthisis.yaml	phenotypes	6	evidence	0	PMID:16966065	REFUTE		Nephronophthisis is a chronic tubulo-interstitial nephritis which progress to terminal renal failure.	Nephronophthisis is a type of chronic tubulo-interstitial nephritis and not an endocrine disorder. It primarily affects the kidneys and progresses to terminal renal failure, but it is not categorized as an endocrine disorder nor is it specifically associated with secondary hyperparathyroidism.	"{""explanation"": ""Nephronophthisis is a type of chronic tubulo-interstitial nephritis and not an endocrine disorder. It primarily affects the kidneys and progresses to terminal renal failure, but it is not categorized as an endocrine disorder nor is it specifically associated with secondary hyperparathyroidism."", ""reference"": ""PMID:16966065"", ""snippet"": ""Nephronophthisis is a chronic tubulo-interstitial nephritis which progress to terminal renal failure."", ""supports"": ""REFUTE""}"
5693	5525	231	Neurofibromatosis Type 1	Neurofibromatosis_Type_1.yaml	phenotypes	2	evidence	0	PMID:33395032	SUPPORT		Given the potential of MEK inhibition as an effective and overall well tolerated medical treatment, the use of targeted agents in the NF1 population is likely to increase considerably.	Review confirms plexiform neurofibromas are a significant clinical problem in NF1 amenable to MEK inhibitor therapy.	"{""explanation"": ""Review confirms plexiform neurofibromas are a significant clinical problem in NF1 amenable to MEK inhibitor therapy."", ""reference"": ""PMID:33395032"", ""snippet"": ""Given the potential of MEK inhibition as an effective and overall well tolerated medical treatment, the use of targeted agents in the NF1 population is likely to increase considerably."", ""supports"": ""SUPPORT""}"
5694	5528	231	Neurofibromatosis Type 1	Neurofibromatosis_Type_1.yaml	phenotypes	5	evidence	0	PMID:32234870	SUPPORT		Almost all individuals with neurofibromatosis type 1 (NF1) develop peripheral nerve sheath tumors (PNSTs), mainly benign neurofibromas, however about 10% of PNSTs will undergo transformation to malignant peripheral nerve sheath tumors (MPNSTs).	Review confirms approximately 10% of peripheral nerve sheath tumors in NF1 undergo malignant transformation to MPNST.	"{""explanation"": ""Review confirms approximately 10% of peripheral nerve sheath tumors in NF1 undergo malignant transformation to MPNST."", ""reference"": ""PMID:32234870"", ""snippet"": ""Almost all individuals with neurofibromatosis type 1 (NF1) develop peripheral nerve sheath tumors (PNSTs), mainly benign neurofibromas, however about 10% of PNSTs will undergo transformation to malignant peripheral nerve sheath tumors (MPNSTs)."", ""supports"": ""SUPPORT""}"
5699	5538	232	Neuromyelitis Optica	Neuromyelitis_Optica.yaml	phenotypes	0	evidence	0	PMID:38819039	SUPPORT		Neuromyelitis optica spectrum disorders are neuroinflammatory demyelinating disorders that lead to permanent visual loss and motor dysfunction.	Visual loss is explicitly described as a consequence of NMOSD.	"{""explanation"": ""Visual loss is explicitly described as a consequence of NMOSD."", ""reference"": ""PMID:38819039"", ""snippet"": ""Neuromyelitis optica spectrum disorders are neuroinflammatory demyelinating disorders that lead to permanent visual loss and motor dysfunction."", ""supports"": ""SUPPORT""}"
5700	5539	232	Neuromyelitis Optica	Neuromyelitis_Optica.yaml	phenotypes	1	evidence	0	PMID:38819039	SUPPORT		Neuromyelitis optica spectrum disorders are neuroinflammatory demyelinating disorders that lead to permanent visual loss and motor dysfunction.	Motor dysfunction in NMOSD manifests clinically as weakness.	"{""explanation"": ""Motor dysfunction in NMOSD manifests clinically as weakness."", ""reference"": ""PMID:38819039"", ""snippet"": ""Neuromyelitis optica spectrum disorders are neuroinflammatory demyelinating disorders that lead to permanent visual loss and motor dysfunction."", ""supports"": ""SUPPORT""}"
5701	5540	232	Neuromyelitis Optica	Neuromyelitis_Optica.yaml	phenotypes	2	evidence	0	PMID:21368286	SUPPORT		Aquaporin-4 (AQP4) autoimmunity targets this region, resulting in intractable nausea associated with vomiting or hiccups in NMO.	The abstract links NMO area postrema involvement with intractable nausea and vomiting.	"{""explanation"": ""The abstract links NMO area postrema involvement with intractable nausea and vomiting."", ""reference"": ""PMID:21368286"", ""snippet"": ""Aquaporin-4 (AQP4) autoimmunity targets this region, resulting in intractable nausea associated with vomiting or hiccups in NMO."", ""supports"": ""SUPPORT""}"
5709	5552	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	phenotypes	0	evidence	0	PMID:26092914	SUPPORT		The core clinical characteristics required for patients with NMOSD with AQP4-IgG include clinical syndromes or MRI findings related to optic nerve, spinal cord, area postrema, other brainstem, diencephalic, or cerebral presentations.	International diagnostic criteria identify optic nerve involvement as a core clinical characteristic of NMOSD.	"{""explanation"": ""International diagnostic criteria identify optic nerve involvement as a core clinical characteristic of NMOSD."", ""reference"": ""PMID:26092914"", ""snippet"": ""The core clinical characteristics required for patients with NMOSD with AQP4-IgG include clinical syndromes or MRI findings related to optic nerve, spinal cord, area postrema, other brainstem, diencephalic, or cerebral presentations."", ""supports"": ""SUPPORT""}"
5710	5553	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	phenotypes	1	evidence	0	PMID:26092914	SUPPORT		The core clinical characteristics required for patients with NMOSD with AQP4-IgG include clinical syndromes or MRI findings related to optic nerve, spinal cord, area postrema	Spinal cord involvement (transverse myelitis) is a core diagnostic criterion.	"{""explanation"": ""Spinal cord involvement (transverse myelitis) is a core diagnostic criterion."", ""reference"": ""PMID:26092914"", ""snippet"": ""The core clinical characteristics required for patients with NMOSD with AQP4-IgG include clinical syndromes or MRI findings related to optic nerve, spinal cord, area postrema"", ""supports"": ""SUPPORT""}"
5711	5554	233	Neuromyelitis Optica Spectrum Disorder	Neuromyelitis_Optica_Spectrum_Disorder.yaml	phenotypes	2	evidence	0	PMID:26092914	SUPPORT		The core clinical characteristics required for patients with NMOSD with AQP4-IgG include clinical syndromes or MRI findings related to optic nerve, spinal cord, area postrema	Area postrema syndrome is recognized as a core clinical feature of NMOSD.	"{""explanation"": ""Area postrema syndrome is recognized as a core clinical feature of NMOSD."", ""reference"": ""PMID:26092914"", ""snippet"": ""The core clinical characteristics required for patients with NMOSD with AQP4-IgG include clinical syndromes or MRI findings related to optic nerve, spinal cord, area postrema"", ""supports"": ""SUPPORT""}"
5718	5564	234	Noma	Noma.yaml	phenotypes	0	evidence	0	PMID:26437752	SUPPORT		Noma is an aggressive orofacial gangrenous pathology that damages hard and soft tissues of the mouth and the face.	The abstract describes noma as an orofacial gangrenous pathology.	"{""explanation"": ""The abstract describes noma as an orofacial gangrenous pathology."", ""reference"": ""PMID:26437752"", ""snippet"": ""Noma is an aggressive orofacial gangrenous pathology that damages hard and soft tissues of the mouth and the face."", ""supports"": ""SUPPORT""}"
5778	5589	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	0	evidence	0	PMID:35224703	SUPPORT		A total of 219 NSCLC patients completed the sCSS, Leicester Cough Questionnaire in Mandarin-Chinese (LCQ-MC) and cough Visual Analog Scale (VAS)... The sCSS is a reliable, valid instrument for assessing postoperative cough in NSCLC patients.	This study supports that persistent cough is common in NSCLC patients.	"{""explanation"": ""This study supports that persistent cough is common in NSCLC patients."", ""reference"": ""PMID:35224703"", ""snippet"": ""A total of 219 NSCLC patients completed the sCSS, Leicester Cough Questionnaire in Mandarin-Chinese (LCQ-MC) and cough Visual Analog Scale (VAS)... The sCSS is a reliable, valid instrument for assessing postoperative cough in NSCLC patients."", ""supports"": ""SUPPORT""}"
5779	5589	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	0	evidence	1	PMID:37920959	SUPPORT		Persistent cough is one of the most frequent complications following lung cancer surgery. ... Multivariable regression analysis revealed that a duration of anesthesia exceeding 156 min ... and gastroesophageal acid reflux (GER) ... were independent risk factors of persistent CAP.	This study confirms the high frequency of persistent cough in patients after lung cancer surgery, aligning with the statement that persistent cough is a common phenotype in NSCLC.	"{""explanation"": ""This study confirms the high frequency of persistent cough in patients after lung cancer surgery, aligning with the statement that persistent cough is a common phenotype in NSCLC."", ""reference"": ""PMID:37920959"", ""snippet"": ""Persistent cough is one of the most frequent complications following lung cancer surgery. ... Multivariable regression analysis revealed that a duration of anesthesia exceeding 156 min ... and gastroesophageal acid reflux (GER) ... were independent risk factors of persistent CAP."", ""supports"": ""SUPPORT""}"
5780	5589	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	0	evidence	2	PMID:29666219	PARTIAL		Compared with the cough-alone symptom group, the risks of dying or HRs were significantly higher for the groups presenting with breathlessness ..., systemic symptoms ..., weight loss ..., chest pain ..., cough with breathlessness ..., neurological symptoms ... and other symptom combinations ...	While this study shows that cough is one of the symptoms among lung cancer patients, it does not explicitly address the commonality of persistent cough in NSCLC phenotypes.	"{""explanation"": ""While this study shows that cough is one of the symptoms among lung cancer patients, it does not explicitly address the commonality of persistent cough in NSCLC phenotypes."", ""reference"": ""PMID:29666219"", ""snippet"": ""Compared with the cough-alone symptom group, the risks of dying or HRs were significantly higher for the groups presenting with breathlessness ..., systemic symptoms ..., weight loss ..., chest pain ..., cough with breathlessness ..., neurological symptoms ... and other symptom combinations ..."", ""supports"": ""PARTIAL""}"
5781	5590	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	1	evidence	0	PMID:25359349	SUPPORT		Severe haemoptysis due to nonsmall cell lung cancer (NSCLC) is considered a grim condition...	The study confirms that hemoptysis is a recognized condition associated with non-small cell lung cancer (NSCLC).	"{""explanation"": ""The study confirms that hemoptysis is a recognized condition associated with non-small cell lung cancer (NSCLC)."", ""reference"": ""PMID:25359349"", ""snippet"": ""Severe haemoptysis due to nonsmall cell lung cancer (NSCLC) is considered a grim condition..."", ""supports"": ""SUPPORT""}"
5782	5590	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	1	evidence	1	PMID:33563454	NO_EVIDENCE		There was no associated hemoptysis, hoarseness, epistaxis, or fever on systemic review.	The case report does not support the presence of hemoptysis in the specific instance of NSCLC described.	"{""explanation"": ""The case report does not support the presence of hemoptysis in the specific instance of NSCLC described."", ""reference"": ""PMID:33563454"", ""snippet"": ""There was no associated hemoptysis, hoarseness, epistaxis, or fever on systemic review."", ""supports"": ""NO_EVIDENCE""}"
5783	5590	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	1	evidence	2	PMID:34807953	NO_EVIDENCE		A positive association was observed between scores of respiratory symptoms and deaths due to COPD and lung cancer.	The study does not specifically focus on hemoptysis as a symptom of NSCLC.	"{""explanation"": ""The study does not specifically focus on hemoptysis as a symptom of NSCLC."", ""reference"": ""PMID:34807953"", ""snippet"": ""A positive association was observed between scores of respiratory symptoms and deaths due to COPD and lung cancer."", ""supports"": ""NO_EVIDENCE""}"
5784	5591	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	2	evidence	0	PMID:35468688	SUPPORT		One of the reasons patients with Non-Small Cell Lung Cancer are not fit for treatment is cancer cachexia, which is common (upto 75% of patients) in this group. This metabolic syndrome presents clinically as weight loss (muscle +/- fat), decreased physical function (patients less active) and anorexia on a background of systemic inflammation.	The literature indicates that weight loss is a common symptom in Non-Small Cell Lung Cancer patients due to cancer cachexia.	"{""explanation"": ""The literature indicates that weight loss is a common symptom in Non-Small Cell Lung Cancer patients due to cancer cachexia."", ""reference"": ""PMID:35468688"", ""snippet"": ""One of the reasons patients with Non-Small Cell Lung Cancer are not fit for treatment is cancer cachexia, which is common (upto 75% of patients) in this group. This metabolic syndrome presents clinically as weight loss (muscle +/- fat), decreased physical function (patients less active) and anorexia on a background of systemic inflammation."", ""supports"": ""SUPPORT""}"
5785	5591	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	2	evidence	1	PMID:35559635	SUPPORT		Associated symptoms, including hemoptysis or shortness of breath, or systemic symptoms, including anorexia or weight loss, greatly increase the likelihood of having lung cancer.	The literature mentions weight loss as a common systemic symptom associated with lung cancer, supporting its prevalence in Non-Small Cell Lung Cancer.	"{""explanation"": ""The literature mentions weight loss as a common systemic symptom associated with lung cancer, supporting its prevalence in Non-Small Cell Lung Cancer."", ""reference"": ""PMID:35559635"", ""snippet"": ""Associated symptoms, including hemoptysis or shortness of breath, or systemic symptoms, including anorexia or weight loss, greatly increase the likelihood of having lung cancer."", ""supports"": ""SUPPORT""}"
5786	5592	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	3	evidence	0	PMID:20536932	SUPPORT		Bone cancer pain is common in patients with advanced breast, prostate, and lung cancer as these tumors have a remarkable affinity to metastasize to bone.	The reference states that bone cancer pain is common in patients with advanced lung cancer, including NSCLC, indicating bone metastases.	"{""explanation"": ""The reference states that bone cancer pain is common in patients with advanced lung cancer, including NSCLC, indicating bone metastases."", ""reference"": ""PMID:20536932"", ""snippet"": ""Bone cancer pain is common in patients with advanced breast, prostate, and lung cancer as these tumors have a remarkable affinity to metastasize to bone."", ""supports"": ""SUPPORT""}"
5787	5592	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	3	evidence	1	PMID:26690845	SUPPORT		We conducted a large, multicenter, retrospective survey aimed to explore the impact of tumor bone involvement in Non-Small Cell Lung Cancer... Bone metastases were evident at diagnosis in 57.5% of patients.	This reference discusses the occurrence of bone metastases in NSCLC patients, which is linked to symptoms like bone pain.	"{""explanation"": ""This reference discusses the occurrence of bone metastases in NSCLC patients, which is linked to symptoms like bone pain."", ""reference"": ""PMID:26690845"", ""snippet"": ""We conducted a large, multicenter, retrospective survey aimed to explore the impact of tumor bone involvement in Non-Small Cell Lung Cancer... Bone metastases were evident at diagnosis in 57.5% of patients."", ""supports"": ""SUPPORT""}"
5788	5593	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	4	evidence	0	PMID:38469616	SUPPORT		Cancer-related fatigue (CRF) stands out as one of the most prevalent subjective adverse reactions experienced by patients following chemotherapy, often resulting in unfavorable symptoms for elderly non-small cell lung cancer (NSCLC) patients during chemotherapy.	The study highlights that cancer-related fatigue is a prevalent adverse reaction in elderly NSCLC patients undergoing chemotherapy.	"{""explanation"": ""The study highlights that cancer-related fatigue is a prevalent adverse reaction in elderly NSCLC patients undergoing chemotherapy."", ""reference"": ""PMID:38469616"", ""snippet"": ""Cancer-related fatigue (CRF) stands out as one of the most prevalent subjective adverse reactions experienced by patients following chemotherapy, often resulting in unfavorable symptoms for elderly non-small cell lung cancer (NSCLC) patients during chemotherapy."", ""supports"": ""SUPPORT""}"
5789	5593	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	4	evidence	1	PMID:33755621	SUPPORT		The most common adverse effects of treatment are leukopenia, lymphopenia, thrombocytopenia, diarrhea, anemia, rash, musculoskeletal pain, nail toxicity, neutropenia, dry skin, stomatitis, fatigue, and cough.	Fatigue is listed as one of the most common adverse effects of treatment for NSCLC.	"{""explanation"": ""Fatigue is listed as one of the most common adverse effects of treatment for NSCLC."", ""reference"": ""PMID:33755621"", ""snippet"": ""The most common adverse effects of treatment are leukopenia, lymphopenia, thrombocytopenia, diarrhea, anemia, rash, musculoskeletal pain, nail toxicity, neutropenia, dry skin, stomatitis, fatigue, and cough."", ""supports"": ""SUPPORT""}"
5790	5593	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	4	evidence	2	PMID:32013812	SUPPORT		During the early stage, there is no perspicuous sign/symptoms but later many symptoms emerge in the infected individual such as insomnia, headache, pain, loss of appetite, fatigue, coughing etc.	Fatigue is mentioned as a symptom that emerges in individuals with lung cancer, including NSCLC.	"{""explanation"": ""Fatigue is mentioned as a symptom that emerges in individuals with lung cancer, including NSCLC."", ""reference"": ""PMID:32013812"", ""snippet"": ""During the early stage, there is no perspicuous sign/symptoms but later many symptoms emerge in the infected individual such as insomnia, headache, pain, loss of appetite, fatigue, coughing etc."", ""supports"": ""SUPPORT""}"
5791	5593	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	4	evidence	3	PMID:26990789	SUPPORT		Toxicities included neutropenia, febrile neutropenia, fatigue, diarrhea, nausea and vomiting, rash, bleeding, hypertension, and hair loss.	Fatigue is listed as one of the common grade III/IV toxicities associated with treatment for metastatic NSCLC.	"{""explanation"": ""Fatigue is listed as one of the common grade III/IV toxicities associated with treatment for metastatic NSCLC."", ""reference"": ""PMID:26990789"", ""snippet"": ""Toxicities included neutropenia, febrile neutropenia, fatigue, diarrhea, nausea and vomiting, rash, bleeding, hypertension, and hair loss."", ""supports"": ""SUPPORT""}"
5792	5593	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	4	evidence	4	PMID:30537755	SUPPORT		Non-hematological toxicities of >/= grade 2 included anorexia (27.5%) and fatigue (24.6%).	Fatigue is noted as a non-hematological toxicity in NSCLC patients beyond third-line therapy.	"{""explanation"": ""Fatigue is noted as a non-hematological toxicity in NSCLC patients beyond third-line therapy."", ""reference"": ""PMID:30537755"", ""snippet"": ""Non-hematological toxicities of >/= grade 2 included anorexia (27.5%) and fatigue (24.6%)."", ""supports"": ""SUPPORT""}"
5793	5594	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	5	evidence	0	PMID:26690845	PARTIAL		Bone metastases were evident at diagnosis in 57.5% of patients. In the remaining cases median time to bone metastases appearance was 9 months. ... Skeletal-related events were experienced by 57.7% of patients; the most common was the need for radiotherapy.	The reference indicates that bone metastases are common in NSCLC patients, and skeletal-related events are frequent. However, it does not explicitly categorize bone pain as 'occasional.'	"{""explanation"": ""The reference indicates that bone metastases are common in NSCLC patients, and skeletal-related events are frequent. However, it does not explicitly categorize bone pain as 'occasional.'"", ""reference"": ""PMID:26690845"", ""snippet"": ""Bone metastases were evident at diagnosis in 57.5% of patients. In the remaining cases median time to bone metastases appearance was 9 months. ... Skeletal-related events were experienced by 57.7% of patients; the most common was the need for radiotherapy."", ""supports"": ""PARTIAL""}"
5794	5594	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	5	evidence	1	PMID:20536932	PARTIAL		Bone cancer pain is common in patients with advanced breast, prostate, and lung cancer as these tumors have a remarkable affinity to metastasize to bone.	The reference supports that bone pain is common in lung cancer with bone metastases, but it does not specify the frequency as 'occasional.'	"{""explanation"": ""The reference supports that bone pain is common in lung cancer with bone metastases, but it does not specify the frequency as 'occasional.'"", ""reference"": ""PMID:20536932"", ""snippet"": ""Bone cancer pain is common in patients with advanced breast, prostate, and lung cancer as these tumors have a remarkable affinity to metastasize to bone."", ""supports"": ""PARTIAL""}"
5795	5594	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	5	evidence	2	PMID:27988895	SUPPORT		Bone pain arising due to skeletal metastases is one of the common complications experienced by the majority of patients suffering from prostate, breast and lung cancer at the advanced stage of the disease.	This reference supports the statement that bone pain is a common complication in advanced lung cancer with skeletal metastases, aligning with the note that it may indicate bone metastases.	"{""explanation"": ""This reference supports the statement that bone pain is a common complication in advanced lung cancer with skeletal metastases, aligning with the note that it may indicate bone metastases."", ""reference"": ""PMID:27988895"", ""snippet"": ""Bone pain arising due to skeletal metastases is one of the common complications experienced by the majority of patients suffering from prostate, breast and lung cancer at the advanced stage of the disease."", ""supports"": ""SUPPORT""}"
5796	5595	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	6	evidence	0	PMID:27466520	NO_EVIDENCE		The most prevalent symptoms were coughing (EORTC score 41.7), dyspnea (33.9), fatigue (31.9), insomnia (30.3) and pain (21.8).	The study lists pain as one of the prevalent symptoms but does not specify chest pain or its frequency.	"{""explanation"": ""The study lists pain as one of the prevalent symptoms but does not specify chest pain or its frequency."", ""reference"": ""PMID:27466520"", ""snippet"": ""The most prevalent symptoms were coughing (EORTC score 41.7), dyspnea (33.9), fatigue (31.9), insomnia (30.3) and pain (21.8)."", ""supports"": ""NO_EVIDENCE""}"
5797	5595	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	6	evidence	1	PMID:20536932	NO_EVIDENCE		Bone cancer pain is common in patients with advanced breast, prostate, and lung cancer as these tumors have a remarkable affinity to metastasize to bone.	The study discusses bone cancer pain in the context of lung cancer metastasis but does not mention chest pain or its frequency.	"{""explanation"": ""The study discusses bone cancer pain in the context of lung cancer metastasis but does not mention chest pain or its frequency."", ""reference"": ""PMID:20536932"", ""snippet"": ""Bone cancer pain is common in patients with advanced breast, prostate, and lung cancer as these tumors have a remarkable affinity to metastasize to bone."", ""supports"": ""NO_EVIDENCE""}"
5798	5596	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	7	evidence	0	PMID:23857204	SUPPORT		Recurrent pneumonias often occur in the setting of an airway obstruction and can be the presenting symptom of an undiagnosed malignancy.	The abstract mentions that recurrent pneumonias often occur due to airway obstruction, which can be a symptom of lung cancer.	"{""explanation"": ""The abstract mentions that recurrent pneumonias often occur due to airway obstruction, which can be a symptom of lung cancer."", ""reference"": ""PMID:23857204"", ""snippet"": ""Recurrent pneumonias often occur in the setting of an airway obstruction and can be the presenting symptom of an undiagnosed malignancy."", ""supports"": ""SUPPORT""}"
5799	5596	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	7	evidence	1	PMID:15723108	SUPPORT		Obstruction of the airway should be initially evaluated with endoscopic procedures.	This reference supports the statement by indicating that airway obstruction, which can be caused by tumors, is a concern in respiratory emergencies in cancer patients.	"{""explanation"": ""This reference supports the statement by indicating that airway obstruction, which can be caused by tumors, is a concern in respiratory emergencies in cancer patients."", ""reference"": ""PMID:15723108"", ""snippet"": ""Obstruction of the airway should be initially evaluated with endoscopic procedures."", ""supports"": ""SUPPORT""}"
5800	5597	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	8	evidence	0	PMID:29484515	PARTIAL		However, brain metastasis sometimes occurs in early stage NSCLC patients without any neurological symptoms.	The reference indicates that brain metastasis can occur in NSCLC patients, often without neurological symptoms. However, it does not specifically mention headache as an occasional symptom.	"{""explanation"": ""The reference indicates that brain metastasis can occur in NSCLC patients, often without neurological symptoms. However, it does not specifically mention headache as an occasional symptom."", ""reference"": ""PMID:29484515"", ""snippet"": ""However, brain metastasis sometimes occurs in early stage NSCLC patients without any neurological symptoms."", ""supports"": ""PARTIAL""}"
5801	5597	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	8	evidence	1	PMID:11754303	NO_EVIDENCE		Paraneoplastic disorders may affect any part of the central or peripheral nervous systems.	The reference discusses paraneoplastic disorders affecting the nervous system but does not specifically mention headache as a symptom of NSCLC.	"{""explanation"": ""The reference discusses paraneoplastic disorders affecting the nervous system but does not specifically mention headache as a symptom of NSCLC."", ""reference"": ""PMID:11754303"", ""snippet"": ""Paraneoplastic disorders may affect any part of the central or peripheral nervous systems."", ""supports"": ""NO_EVIDENCE""}"
5802	5597	235	Non-Small Cell Lung Cancer	Non-Small_Cell_Lung_Cancer.yaml	phenotypes	8	evidence	2	PMID:15056056	PARTIAL		Brain metastases secondary to primary non-small cell and small cell lung cancer have become an important area of research.	The reference discusses brain metastases in NSCLC but does not specifically mention headache as an occasional symptom.	"{""explanation"": ""The reference discusses brain metastases in NSCLC but does not specifically mention headache as an occasional symptom."", ""reference"": ""PMID:15056056"", ""snippet"": ""Brain metastases secondary to primary non-small cell and small cell lung cancer have become an important area of research."", ""supports"": ""PARTIAL""}"
5847	5626	236	Noonan Syndrome	Noonan_Syndrome.yaml	phenotypes	5	evidence	0	PMID:11992261	SUPPORT	HUMAN_CLINICAL	pulmonic stenosis was more prevalent among the group of subjects with NS who had PTPN11 mutations than it was in the group without them (70.6% vs. 46.2%; P<.01)	Confirms high prevalence of pulmonary stenosis in Noonan syndrome, especially with PTPN11 mutations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms high prevalence of pulmonary stenosis in Noonan syndrome, especially with PTPN11 mutations."", ""reference"": ""PMID:11992261"", ""snippet"": ""pulmonic stenosis was more prevalent among the group of subjects with NS who had PTPN11 mutations than it was in the group without them (70.6% vs. 46.2%; P<.01)"", ""supports"": ""SUPPORT""}"
5848	5627	236	Noonan Syndrome	Noonan_Syndrome.yaml	phenotypes	6	evidence	0	PMID:17603483	SUPPORT	HUMAN_CLINICAL	Of 19 subjects with a RAF1 mutation in two hotspots, 18 (or 95%) showed hypertrophic cardiomyopathy (HCM), compared with the 18% prevalence of HCM among individuals with Noonan syndrome in general.	RAF1 mutations are strongly associated with HCM.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""RAF1 mutations are strongly associated with HCM."", ""reference"": ""PMID:17603483"", ""snippet"": ""Of 19 subjects with a RAF1 mutation in two hotspots, 18 (or 95%) showed hypertrophic cardiomyopathy (HCM), compared with the 18% prevalence of HCM among individuals with Noonan syndrome in general."", ""supports"": ""SUPPORT""}"
5849	5627	236	Noonan Syndrome	Noonan_Syndrome.yaml	phenotypes	6	evidence	1	PMID:23791108	SUPPORT	HUMAN_CLINICAL	Seventy percent of mutation-positive individuals presented with hypertrophic cardiomyopathy; this frequency is high relative to the overall 20% incidence in individuals with Noonan syndrome.	RIT1 mutations confer high risk of hypertrophic cardiomyopathy.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""RIT1 mutations confer high risk of hypertrophic cardiomyopathy."", ""reference"": ""PMID:23791108"", ""snippet"": ""Seventy percent of mutation-positive individuals presented with hypertrophic cardiomyopathy; this frequency is high relative to the overall 20% incidence in individuals with Noonan syndrome."", ""supports"": ""SUPPORT""}"
5850	5627	236	Noonan Syndrome	Noonan_Syndrome.yaml	phenotypes	6	evidence	2	PMID:11992261	SUPPORT	HUMAN_CLINICAL	hypertrophic cardiomyopathy was less prevalent among those with PTPN11 mutations (5.9% vs. 26.2%; P<.005)	PTPN11 mutations are associated with lower HCM risk compared to other NS genes.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""PTPN11 mutations are associated with lower HCM risk compared to other NS genes."", ""reference"": ""PMID:11992261"", ""snippet"": ""hypertrophic cardiomyopathy was less prevalent among those with PTPN11 mutations (5.9% vs. 26.2%; P<.005)"", ""supports"": ""SUPPORT""}"
5851	5630	236	Noonan Syndrome	Noonan_Syndrome.yaml	phenotypes	9	evidence	0	PMID:11992261	SUPPORT	HUMAN_CLINICAL	The prevalence of other congenital heart malformations, short stature, pectus deformity, cryptorchidism, and developmental delay did not differ between the two groups.	Pectus deformity is recognized as a common feature across genotypes.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Pectus deformity is recognized as a common feature across genotypes."", ""reference"": ""PMID:11992261"", ""snippet"": ""The prevalence of other congenital heart malformations, short stature, pectus deformity, cryptorchidism, and developmental delay did not differ between the two groups."", ""supports"": ""SUPPORT""}"
5852	5631	236	Noonan Syndrome	Noonan_Syndrome.yaml	phenotypes	10	evidence	0	PMID:11992261	SUPPORT	HUMAN_CLINICAL	The prevalence of other congenital heart malformations, short stature, pectus deformity, cryptorchidism, and developmental delay did not differ between the two groups.	Cryptorchidism is recognized as a common feature across Noonan syndrome genotypes.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Cryptorchidism is recognized as a common feature across Noonan syndrome genotypes."", ""reference"": ""PMID:11992261"", ""snippet"": ""The prevalence of other congenital heart malformations, short stature, pectus deformity, cryptorchidism, and developmental delay did not differ between the two groups."", ""supports"": ""SUPPORT""}"
5853	5634	236	Noonan Syndrome	Noonan_Syndrome.yaml	phenotypes	13	evidence	0	PMID:11992261	SUPPORT	HUMAN_CLINICAL	The prevalence of other congenital heart malformations, short stature, pectus deformity, cryptorchidism, and developmental delay did not differ between the two groups.	Developmental delay is a recognized feature across Noonan syndrome genotypes.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Developmental delay is a recognized feature across Noonan syndrome genotypes."", ""reference"": ""PMID:11992261"", ""snippet"": ""The prevalence of other congenital heart malformations, short stature, pectus deformity, cryptorchidism, and developmental delay did not differ between the two groups."", ""supports"": ""SUPPORT""}"
5867	5667	237	Obesity	Obesity.yaml	phenotypes	1	evidence	0	PMID:14679177	SUPPORT		Insulin resistance arises from the inability of insulin to act normally in regulating nutrient metabolism in peripheral tissues.	Defines insulin resistance as a key metabolic phenotype in obesity.	"{""explanation"": ""Defines insulin resistance as a key metabolic phenotype in obesity."", ""reference"": ""PMID:14679177"", ""snippet"": ""Insulin resistance arises from the inability of insulin to act normally in regulating nutrient metabolism in peripheral tissues."", ""supports"": ""SUPPORT""}"
5868	5667	237	Obesity	Obesity.yaml	phenotypes	1	evidence	1	PMID:27503945	SUPPORT		Insulin resistance may link accumulation of adipose tissue in obesity to metabolic diseases, although the underlying mechanisms are not completely understood.	Links adipose tissue accumulation in obesity to insulin resistance and metabolic disease.	"{""explanation"": ""Links adipose tissue accumulation in obesity to insulin resistance and metabolic disease."", ""reference"": ""PMID:27503945"", ""snippet"": ""Insulin resistance may link accumulation of adipose tissue in obesity to metabolic diseases, although the underlying mechanisms are not completely understood."", ""supports"": ""SUPPORT""}"
5880	5696	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	phenotypes	2	evidence	0	PMID:39595069	SUPPORT		Emerging clinical evidence suggests that GLP-1RAs and SGLT2 inhibitors can reduce OSA severity and improve daytime sleepiness, potentially reversing the adverse cardiovascular effects observed in OSA.	Confirms that daytime sleepiness is a characteristic symptom of OSA that can be ameliorated with treatment.	"{""explanation"": ""Confirms that daytime sleepiness is a characteristic symptom of OSA that can be ameliorated with treatment."", ""reference"": ""PMID:39595069"", ""snippet"": ""Emerging clinical evidence suggests that GLP-1RAs and SGLT2 inhibitors can reduce OSA severity and improve daytime sleepiness, potentially reversing the adverse cardiovascular effects observed in OSA."", ""supports"": ""SUPPORT""}"
5881	5699	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	phenotypes	5	evidence	0	PMID:38672697	SUPPORT		OSAS significantly impacts quality of life and is associated with increased morbidity and mortality, particularly in the cardiovascular and cognitive domains.	Confirms that cognitive impairment is a major domain of morbidity in OSA.	"{""explanation"": ""Confirms that cognitive impairment is a major domain of morbidity in OSA."", ""reference"": ""PMID:38672697"", ""snippet"": ""OSAS significantly impacts quality of life and is associated with increased morbidity and mortality, particularly in the cardiovascular and cognitive domains."", ""supports"": ""SUPPORT""}"
5882	5699	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	phenotypes	5	evidence	1	PMID:39694586	SUPPORT		Obstructive sleep apnoea (OSA) contributes to cerebrovascular diseases and cognitive decline.	Establishes the link between OSA and cognitive decline, supported by rodent model evidence of brain injury from intermittent hypoxia.	"{""explanation"": ""Establishes the link between OSA and cognitive decline, supported by rodent model evidence of brain injury from intermittent hypoxia."", ""reference"": ""PMID:39694586"", ""snippet"": ""Obstructive sleep apnoea (OSA) contributes to cerebrovascular diseases and cognitive decline."", ""supports"": ""SUPPORT""}"
5883	5700	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	phenotypes	6	evidence	0	PMID:39595069	SUPPORT		These agents, originally developed for T2D management, have demonstrated pleiotropic effects, including significant weight loss, blood pressure reduction, and amelioration of endothelial dysfunction and arterial stiffness, along with anti-inflammatory benefits, which may be particularly beneficial in OSA.	Indicates that blood pressure elevation is a characteristic feature of OSA requiring therapeutic intervention.	"{""explanation"": ""Indicates that blood pressure elevation is a characteristic feature of OSA requiring therapeutic intervention."", ""reference"": ""PMID:39595069"", ""snippet"": ""These agents, originally developed for T2D management, have demonstrated pleiotropic effects, including significant weight loss, blood pressure reduction, and amelioration of endothelial dysfunction and arterial stiffness, along with anti-inflammatory benefits, which may be particularly beneficial in OSA."", ""supports"": ""SUPPORT""}"
5884	5700	238	Obstructive Sleep Apnea	Obstructive_Sleep_Apnea.yaml	phenotypes	6	evidence	1	PMID:38672697	SUPPORT		OSAS-related complications include cardiovascular disorders, neurological impairments, metabolic dysfunction, and a potential link to cancer.	Confirms that cardiovascular disorders, including hypertension, are a major complication of OSA.	"{""explanation"": ""Confirms that cardiovascular disorders, including hypertension, are a major complication of OSA."", ""reference"": ""PMID:38672697"", ""snippet"": ""OSAS-related complications include cardiovascular disorders, neurological impairments, metabolic dysfunction, and a potential link to cancer."", ""supports"": ""SUPPORT""}"
5886	5709	239	Onchocerciasis	Onchocerciasis.yaml	phenotypes	0	evidence	0	PMID:16714198	SUPPORT		Skin symptoms are commonly nonspecific and include severe pruritus, acute and chronic dermatitis	Severe pruritus is a common skin symptom of onchocerciasis.	"{""explanation"": ""Severe pruritus is a common skin symptom of onchocerciasis."", ""reference"": ""PMID:16714198"", ""snippet"": ""Skin symptoms are commonly nonspecific and include severe pruritus, acute and chronic dermatitis"", ""supports"": ""SUPPORT""}"
5887	5710	239	Onchocerciasis	Onchocerciasis.yaml	phenotypes	1	evidence	0	PMID:16714198	SUPPORT		Skin symptoms are commonly nonspecific and include severe pruritus, acute and chronic dermatitis	Dermatitis is listed among common skin symptoms.	"{""explanation"": ""Dermatitis is listed among common skin symptoms."", ""reference"": ""PMID:16714198"", ""snippet"": ""Skin symptoms are commonly nonspecific and include severe pruritus, acute and chronic dermatitis"", ""supports"": ""SUPPORT""}"
5888	5711	239	Onchocerciasis	Onchocerciasis.yaml	phenotypes	2	evidence	0	PMID:16714198	SUPPORT		Onchocercal ocular disease covers a large spectrum of manifestations, which in severe cases, may lead to blindness.	Severe ocular disease can lead to blindness.	"{""explanation"": ""Severe ocular disease can lead to blindness."", ""reference"": ""PMID:16714198"", ""snippet"": ""Onchocercal ocular disease covers a large spectrum of manifestations, which in severe cases, may lead to blindness."", ""supports"": ""SUPPORT""}"
5900	5728	240	Osteoarthritis	Osteoarthritis.yaml	phenotypes	0	evidence	0	PMID:33560326	SUPPORT		It is characterized by pathologic changes in cartilage, bone, synovium, ligament, muscle, and periarticular fat, leading to joint dysfunction, pain, stiffness, functional limitation, and loss of valued activities	JAMA review confirms pain as a core clinical feature of osteoarthritis.	"{""explanation"": ""JAMA review confirms pain as a core clinical feature of osteoarthritis."", ""reference"": ""PMID:33560326"", ""snippet"": ""It is characterized by pathologic changes in cartilage, bone, synovium, ligament, muscle, and periarticular fat, leading to joint dysfunction, pain, stiffness, functional limitation, and loss of valued activities"", ""supports"": ""SUPPORT""}"
5901	5729	240	Osteoarthritis	Osteoarthritis.yaml	phenotypes	1	evidence	0	PMID:33560326	SUPPORT		It is characterized by pathologic changes in cartilage, bone, synovium, ligament, muscle, and periarticular fat, leading to joint dysfunction, pain, stiffness, functional limitation, and loss of valued activities	JAMA review confirms stiffness as a core clinical feature of osteoarthritis.	"{""explanation"": ""JAMA review confirms stiffness as a core clinical feature of osteoarthritis."", ""reference"": ""PMID:33560326"", ""snippet"": ""It is characterized by pathologic changes in cartilage, bone, synovium, ligament, muscle, and periarticular fat, leading to joint dysfunction, pain, stiffness, functional limitation, and loss of valued activities"", ""supports"": ""SUPPORT""}"
5911	5744	241	Osteogenesis Imperfecta Type I	Osteogenesis_Imperfecta_Type_I.yaml	phenotypes	1	evidence	0	PMID:23529829	SUPPORT	HUMAN_CLINICAL	The average rate of long-bone fracture (femur, tibia/fibula, humerus, radius/ulna) in pediatric patients was 0.62 fractures per year, one-half of which affected the tibia/fibula. Long-bone fracture rate was negatively associated with age.	Quantifies fracture rate in COL1A1 haploinsufficiency patients and confirms that fracture frequency decreases with age.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Quantifies fracture rate in COL1A1 haploinsufficiency patients and confirms that fracture frequency decreases with age."", ""reference"": ""PMID:23529829"", ""snippet"": ""The average rate of long-bone fracture (femur, tibia/fibula, humerus, radius/ulna) in pediatric patients was 0.62 fractures per year, one-half of which affected the tibia/fibula. Long-bone fracture rate was negatively associated with age."", ""supports"": ""SUPPORT""}"
5912	5745	241	Osteogenesis Imperfecta Type I	Osteogenesis_Imperfecta_Type_I.yaml	phenotypes	2	evidence	0	PMID:23529829	SUPPORT	HUMAN_CLINICAL	The average final height Z-score was -1.1, representing a deficit of 8 to 10 cm compared to the general population.	Documents that OI type I patients have only mild height reduction (Z-score -1.1), confirming near-normal stature compared to severe OI types.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Documents that OI type I patients have only mild height reduction (Z-score -1.1), confirming near-normal stature compared to severe OI types."", ""reference"": ""PMID:23529829"", ""snippet"": ""The average final height Z-score was -1.1, representing a deficit of 8 to 10 cm compared to the general population."", ""supports"": ""SUPPORT""}"
5922	5793	245	Osteogenesis Imperfecta Type V	Osteogenesis_Imperfecta_Type_V.yaml	phenotypes	0	evidence	0	PMID:22863190	SUPPORT	HUMAN_CLINICAL	OI type V is an autosomal-dominant disease characterized by calcification of the forearm interosseous membrane, radial head dislocation, a subphyseal metaphyseal radiodense line, and hyperplastic callus formation.	Defines hyperplastic callus formation as one of the cardinal features of OI type V.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Defines hyperplastic callus formation as one of the cardinal features of OI type V."", ""reference"": ""PMID:22863190"", ""snippet"": ""OI type V is an autosomal-dominant disease characterized by calcification of the forearm interosseous membrane, radial head dislocation, a subphyseal metaphyseal radiodense line, and hyperplastic callus formation."", ""supports"": ""SUPPORT""}"
5934	5834	247	Osteoporosis	Osteoporosis.yaml	phenotypes	0	evidence	0	PMID:23748068	SUPPORT		Lumbar osteoporosis was detected in bone densitometry.	Clinical documentation of reduced bone mineral density in aromatase deficiency-induced osteoporosis	"{""explanation"": ""Clinical documentation of reduced bone mineral density in aromatase deficiency-induced osteoporosis"", ""reference"": ""PMID:23748068"", ""snippet"": ""Lumbar osteoporosis was detected in bone densitometry."", ""supports"": ""SUPPORT""}"
5935	5834	247	Osteoporosis	Osteoporosis.yaml	phenotypes	0	evidence	1	PMID:21874760	SUPPORT		aromatase activity and estrogen production are necessary for longitudinal bone growth, attainment of peak bone mass, the pubertal growth spurt, epiphyseal closure, and normal bone remodeling in young individuals.	Demonstrates that estrogen deficiency impairs achievement and maintenance of peak bone mass, leading to decreased BMD	"{""explanation"": ""Demonstrates that estrogen deficiency impairs achievement and maintenance of peak bone mass, leading to decreased BMD"", ""reference"": ""PMID:21874760"", ""snippet"": ""aromatase activity and estrogen production are necessary for longitudinal bone growth, attainment of peak bone mass, the pubertal growth spurt, epiphyseal closure, and normal bone remodeling in young individuals."", ""supports"": ""SUPPORT""}"
5936	5835	247	Osteoporosis	Osteoporosis.yaml	phenotypes	1	evidence	0	PMID:28168409	SUPPORT		The prevalence of morphometric vertebral fractures in European women is highest in Scandinavia (26%) and lowest in Eastern Europe (18%).	Systematic review documents high prevalence of vertebral fractures in osteoporosis, confirming this as a key phenotype.	"{""explanation"": ""Systematic review documents high prevalence of vertebral fractures in osteoporosis, confirming this as a key phenotype."", ""reference"": ""PMID:28168409"", ""snippet"": ""The prevalence of morphometric vertebral fractures in European women is highest in Scandinavia (26%) and lowest in Eastern Europe (18%)."", ""supports"": ""SUPPORT""}"
5941	5850	248	Osteosarcoma	Osteosarcoma.yaml	phenotypes	0	evidence	0	PMID:35164914	SUPPORT		Osteosarcoma most frequently presents with localized bone pain, swelling, and an antalgic gait.	The abstract lists localized bone pain as a typical presenting symptom.	"{""explanation"": ""The abstract lists localized bone pain as a typical presenting symptom."", ""reference"": ""PMID:35164914"", ""snippet"": ""Osteosarcoma most frequently presents with localized bone pain, swelling, and an antalgic gait."", ""supports"": ""SUPPORT""}"
5942	5851	248	Osteosarcoma	Osteosarcoma.yaml	phenotypes	1	evidence	0	PMID:35164914	SUPPORT		Osteosarcoma most frequently presents with localized bone pain, swelling, and an antalgic gait.	The abstract notes an antalgic gait as a common presentation.	"{""explanation"": ""The abstract notes an antalgic gait as a common presentation."", ""reference"": ""PMID:35164914"", ""snippet"": ""Osteosarcoma most frequently presents with localized bone pain, swelling, and an antalgic gait."", ""supports"": ""SUPPORT""}"
5997	5897	250	Parkinson's Disease	Parkinsons_Disease.yaml	phenotypes	0	evidence	0	PMID:17955331	SUPPORT		Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes).	This identifies resting tremor as a cardinal sign used to detect parkinsonism, supporting it as a core PD phenotype.	"{""explanation"": ""This identifies resting tremor as a cardinal sign used to detect parkinsonism, supporting it as a core PD phenotype."", ""reference"": ""PMID:17955331"", ""snippet"": ""Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes)."", ""supports"": ""SUPPORT""}"
5998	5898	250	Parkinson's Disease	Parkinsons_Disease.yaml	phenotypes	1	evidence	0	PMID:17955331	SUPPORT		Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes).	This lists bradykinesia among the cardinal signs of parkinsonism, supporting its central role in PD.	"{""explanation"": ""This lists bradykinesia among the cardinal signs of parkinsonism, supporting its central role in PD."", ""reference"": ""PMID:17955331"", ""snippet"": ""Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes)."", ""supports"": ""SUPPORT""}"
5999	5899	250	Parkinson's Disease	Parkinsons_Disease.yaml	phenotypes	2	evidence	0	PMID:17955331	SUPPORT		Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes).	This confirms rigidity as a cardinal sign of parkinsonism relevant to PD.	"{""explanation"": ""This confirms rigidity as a cardinal sign of parkinsonism relevant to PD."", ""reference"": ""PMID:17955331"", ""snippet"": ""Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes)."", ""supports"": ""SUPPORT""}"
6000	5900	250	Parkinson's Disease	Parkinsons_Disease.yaml	phenotypes	3	evidence	0	PMID:17955331	SUPPORT		Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes).	This supports postural instability as a cardinal parkinsonian sign captured in PD assessments.	"{""explanation"": ""This supports postural instability as a cardinal parkinsonian sign captured in PD assessments."", ""reference"": ""PMID:17955331"", ""snippet"": ""Participants are screened in the baseline and follow-up examinations for cardinal signs of parkinsonism (resting tremor, rigidity, bradykinesia or impaired postural reflexes)."", ""supports"": ""SUPPORT""}"
6001	5901	250	Parkinson's Disease	Parkinsons_Disease.yaml	phenotypes	4	evidence	0	PMID:24136244	SUPPORT		Hyposmia, identified as reduced sensitivity to odor, is a common non-motor symptom of Parkinson's disease (PD) that antedates the typical motor symptoms by several years. It occurs in ∼90% of early-stage cases of PD.	This establishes hyposmia as a highly prevalent prodromal symptom that precedes motor symptoms, supporting its importance as an early marker of PD.	"{""explanation"": ""This establishes hyposmia as a highly prevalent prodromal symptom that precedes motor symptoms, supporting its importance as an early marker of PD."", ""reference"": ""PMID:24136244"", ""snippet"": ""Hyposmia, identified as reduced sensitivity to odor, is a common non-motor symptom of Parkinson's disease (PD) that antedates the typical motor symptoms by several years. It occurs in ∼90% of early-stage cases of PD."", ""supports"": ""SUPPORT""}"
6002	5902	250	Parkinson's Disease	Parkinsons_Disease.yaml	phenotypes	5	evidence	0	PMID:7845407	SUPPORT		We investigated the role of anorectal manometry in evaluating constipation and anorectal function in 15 patients with Parkinson's disease (PD) and compared results with those of 9 patients with idiopathic constipation (IC) and 8 control (C) subjects.	This study directly evaluates constipation in PD patients, supporting constipation as a common non-motor symptom.	"{""explanation"": ""This study directly evaluates constipation in PD patients, supporting constipation as a common non-motor symptom."", ""reference"": ""PMID:7845407"", ""snippet"": ""We investigated the role of anorectal manometry in evaluating constipation and anorectal function in 15 patients with Parkinson's disease (PD) and compared results with those of 9 patients with idiopathic constipation (IC) and 8 control (C) subjects."", ""supports"": ""SUPPORT""}"
6003	5903	250	Parkinson's Disease	Parkinsons_Disease.yaml	phenotypes	6	evidence	0	PMID:41301797	SUPPORT		Depressive symptoms were similar across groups, but in prodromal PD, higher GDS scores were associated with worse UPDRS III scores (p = 0.02), as well as higher freezing and fall scores.	This indicates depressive symptoms are present and clinically relevant in PD, supporting depression as a non-motor phenotype.	"{""explanation"": ""This indicates depressive symptoms are present and clinically relevant in PD, supporting depression as a non-motor phenotype."", ""reference"": ""PMID:41301797"", ""snippet"": ""Depressive symptoms were similar across groups, but in prodromal PD, higher GDS scores were associated with worse UPDRS III scores (p = 0.02), as well as higher freezing and fall scores."", ""supports"": ""SUPPORT""}"
6041	5932	251	Pars Planitis	Pars_Planitis.yaml	phenotypes	0	evidence	0	PMID:27051493	SUPPORT		The most common presenting symptoms are floaters and blurred vision.	Blurred vision is a core presenting symptom reported in pars planitis.	"{""explanation"": ""Blurred vision is a core presenting symptom reported in pars planitis."", ""reference"": ""PMID:27051493"", ""snippet"": ""The most common presenting symptoms are floaters and blurred vision."", ""supports"": ""SUPPORT""}"
6042	5933	251	Pars Planitis	Pars_Planitis.yaml	phenotypes	1	evidence	0	PMID:27051493	SUPPORT		The most common presenting symptoms are floaters and blurred vision.	Floaters are among the predominant presenting symptoms of pars planitis.	"{""explanation"": ""Floaters are among the predominant presenting symptoms of pars planitis."", ""reference"": ""PMID:27051493"", ""snippet"": ""The most common presenting symptoms are floaters and blurred vision."", ""supports"": ""SUPPORT""}"
6043	5934	251	Pars Planitis	Pars_Planitis.yaml	phenotypes	2	evidence	0	PMID:27051493	SUPPORT		Although pars planitis is known to be a benign form of uveitis in most cases, it may become a potentially blinding disease due to complications including cataract, cystoid macular edema, vitreous opacities and optic disc edema.	Chronic inflammation can lead to complications that threaten vision if not controlled.	"{""explanation"": ""Chronic inflammation can lead to complications that threaten vision if not controlled."", ""reference"": ""PMID:27051493"", ""snippet"": ""Although pars planitis is known to be a benign form of uveitis in most cases, it may become a potentially blinding disease due to complications including cataract, cystoid macular edema, vitreous opacities and optic disc edema."", ""supports"": ""SUPPORT""}"
6044	5935	251	Pars Planitis	Pars_Planitis.yaml	phenotypes	3	evidence	0	PMID:27051493	SUPPORT		Diffuse vitreous cells, haze, snowballs and snowbanks are typical findings of pars planitis.	Vitreous opacities such as snowballs are typical inflammatory findings in pars planitis.	"{""explanation"": ""Vitreous opacities such as snowballs are typical inflammatory findings in pars planitis."", ""reference"": ""PMID:27051493"", ""snippet"": ""Diffuse vitreous cells, haze, snowballs and snowbanks are typical findings of pars planitis."", ""supports"": ""SUPPORT""}"
6045	5936	251	Pars Planitis	Pars_Planitis.yaml	phenotypes	4	evidence	0	PMID:27051493	SUPPORT		Cystoid macular edema is the most common cause of visual morbidity.	Macular edema represents a significant complication that can lead to permanent vision loss.	"{""explanation"": ""Macular edema represents a significant complication that can lead to permanent vision loss."", ""reference"": ""PMID:27051493"", ""snippet"": ""Cystoid macular edema is the most common cause of visual morbidity."", ""supports"": ""SUPPORT""}"
6046	5937	251	Pars Planitis	Pars_Planitis.yaml	phenotypes	5	evidence	0	PMID:27051493	SUPPORT		Peripheral retinal vasculitis, optic disc edema and anterior segment inflammation are other well-known findings.	Optic disc edema is a recognized complication of pars planitis.	"{""explanation"": ""Optic disc edema is a recognized complication of pars planitis."", ""reference"": ""PMID:27051493"", ""snippet"": ""Peripheral retinal vasculitis, optic disc edema and anterior segment inflammation are other well-known findings."", ""supports"": ""SUPPORT""}"
6047	5938	251	Pars Planitis	Pars_Planitis.yaml	phenotypes	6	evidence	0	PMID:30200907	SUPPORT		Progressive, intraretinal bone crepuscule pigmentation developed in his left retina during the following three months.	Describes bone spicule-like pigmentation emerging after bilateral pars planitis, mimicking retinitis pigmentosa.	"{""explanation"": ""Describes bone spicule-like pigmentation emerging after bilateral pars planitis, mimicking retinitis pigmentosa."", ""reference"": ""PMID:30200907"", ""snippet"": ""Progressive, intraretinal bone crepuscule pigmentation developed in his left retina during the following three months."", ""supports"": ""SUPPORT""}"
6094	5955	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	0	evidence	0	PMID:37132144	SUPPORT		Erythema infectiosum, the most common clinical manifestation of parvovirus B19 infection, is characterized by a 'slapped cheek' appearance on the face and lacy exanthem on the trunk and extremities.	This reference supports the statement that erythema infectiosum, also known as fifth disease, is a very frequent dermatologic manifestation of parvovirus B19 infection and includes the slapped cheek rash as a sequela.	"{""explanation"": ""This reference supports the statement that erythema infectiosum, also known as fifth disease, is a very frequent dermatologic manifestation of parvovirus B19 infection and includes the slapped cheek rash as a sequela."", ""reference"": ""PMID:37132144"", ""snippet"": ""Erythema infectiosum, the most common clinical manifestation of parvovirus B19 infection, is characterized by a 'slapped cheek' appearance on the face and lacy exanthem on the trunk and extremities."", ""supports"": ""SUPPORT""}"
6095	5955	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	0	evidence	1	PMID:10821497	SUPPORT		The prototypical cutaneous manifestations of human parvovirus B19 (B19) infection include a petechial eruption in a glove and stocking distribution, reticular truncal erythema, and the 'slapped cheek' sign.	This reference supports the statement by describing erythema infectiosum and the slapped cheek sign as characteristic dermatologic manifestations of parvovirus B19 infection.	"{""explanation"": ""This reference supports the statement by describing erythema infectiosum and the slapped cheek sign as characteristic dermatologic manifestations of parvovirus B19 infection."", ""reference"": ""PMID:10821497"", ""snippet"": ""The prototypical cutaneous manifestations of human parvovirus B19 (B19) infection include a petechial eruption in a glove and stocking distribution, reticular truncal erythema, and the 'slapped cheek' sign."", ""supports"": ""SUPPORT""}"
6096	5955	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	0	evidence	2	PMID:8042568	SUPPORT		The human parvovirus B19 has been identified as the causative agent in several diseases, including the benign childhood condition erythema infectiosum (fifth disease)...	This reference supports the statement by identifying erythema infectiosum as a condition caused by parvovirus B19.	"{""explanation"": ""This reference supports the statement by identifying erythema infectiosum as a condition caused by parvovirus B19."", ""reference"": ""PMID:8042568"", ""snippet"": ""The human parvovirus B19 has been identified as the causative agent in several diseases, including the benign childhood condition erythema infectiosum (fifth disease)..."", ""supports"": ""SUPPORT""}"
6097	5955	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	0	evidence	3	PMID:24195090	SUPPORT		The most common manifestation of PVB19 infection in children is erythema infectiosum (EI). Also known as fifth disease or slapped cheek syndrome, EI presents as an erythematous exanthem limited to the malar eminences that follows a mild prodromal illness.	This reference supports the statement by confirming that erythema infectiosum is the most common manifestation of parvovirus B19 infection in children and includes the slapped cheek rash.	"{""explanation"": ""This reference supports the statement by confirming that erythema infectiosum is the most common manifestation of parvovirus B19 infection in children and includes the slapped cheek rash."", ""reference"": ""PMID:24195090"", ""snippet"": ""The most common manifestation of PVB19 infection in children is erythema infectiosum (EI). Also known as fifth disease or slapped cheek syndrome, EI presents as an erythematous exanthem limited to the malar eminences that follows a mild prodromal illness."", ""supports"": ""SUPPORT""}"
6098	5956	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	1	evidence	0	PMID:8649911	SUPPORT		Human parvovirus B19 is linked with a broadening spectrum of hematologic disorders, including aplastic crises in the context of hemolytic anemias.	The statement is supported as the reference mentions that parvovirus B19 is linked with aplastic crises in individuals with hemolytic anemias.	"{""explanation"": ""The statement is supported as the reference mentions that parvovirus B19 is linked with aplastic crises in individuals with hemolytic anemias."", ""reference"": ""PMID:8649911"", ""snippet"": ""Human parvovirus B19 is linked with a broadening spectrum of hematologic disorders, including aplastic crises in the context of hemolytic anemias."", ""supports"": ""SUPPORT""}"
6099	5956	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	1	evidence	1	PMID:24962467	SUPPORT		The serum B19V DNA load during the acute phase of aplastic crisis complicating chronic hemolytic anemia was extremely high.	The reference supports that parvovirus B19 infection can cause transient aplastic crisis in individuals with chronic hemolytic anemia.	"{""explanation"": ""The reference supports that parvovirus B19 infection can cause transient aplastic crisis in individuals with chronic hemolytic anemia."", ""reference"": ""PMID:24962467"", ""snippet"": ""The serum B19V DNA load during the acute phase of aplastic crisis complicating chronic hemolytic anemia was extremely high."", ""supports"": ""SUPPORT""}"
6100	5956	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	1	evidence	2	PMID:26940953	SUPPORT		Parvovirus B19 infection causes transient aplastic crisis in sickle cell disease (SCD) due to a temporary interruption in the red blood cell production	The reference supports the statement by noting that parvovirus B19 infection causes transient aplastic crisis in individuals with sickle cell disease, a type of hemolytic disorder.	"{""explanation"": ""The reference supports the statement by noting that parvovirus B19 infection causes transient aplastic crisis in individuals with sickle cell disease, a type of hemolytic disorder."", ""reference"": ""PMID:26940953"", ""snippet"": ""Parvovirus B19 infection causes transient aplastic crisis in sickle cell disease (SCD) due to a temporary interruption in the red blood cell production"", ""supports"": ""SUPPORT""}"
6101	5956	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	1	evidence	3	PMID:34369269	SUPPORT		Parvovirus B19 had caused aplastic crisis and HLH.	The reference supports the statement by mentioning a case where parvovirus B19 caused aplastic crisis in a patient with hereditary spherocytosis, another hemolytic disorder.	"{""explanation"": ""The reference supports the statement by mentioning a case where parvovirus B19 caused aplastic crisis in a patient with hereditary spherocytosis, another hemolytic disorder."", ""reference"": ""PMID:34369269"", ""snippet"": ""Parvovirus B19 had caused aplastic crisis and HLH."", ""supports"": ""SUPPORT""}"
6102	5957	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	2	evidence	0	PMID:9595838	SUPPORT		Arthropathy is known to occur in children and adults with acute parvovirus B19 infection. In adults, the arthropathy is common and is usually brief and self-limited, although a chronic arthropathy due to HPV B19 infections can occur rarely.	The reference confirms that arthropathy is a common manifestation in adults with acute parvovirus B19 infection.	"{""explanation"": ""The reference confirms that arthropathy is a common manifestation in adults with acute parvovirus B19 infection."", ""reference"": ""PMID:9595838"", ""snippet"": ""Arthropathy is known to occur in children and adults with acute parvovirus B19 infection. In adults, the arthropathy is common and is usually brief and self-limited, although a chronic arthropathy due to HPV B19 infections can occur rarely."", ""supports"": ""SUPPORT""}"
6103	5957	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	2	evidence	1	PMID:11993780	NO_EVIDENCE			The reference title suggests it is about Parvovirus B19 infection in adults, but no specific excerpt or abstract is provided to confirm or refute the statement.	"{""explanation"": ""The reference title suggests it is about Parvovirus B19 infection in adults, but no specific excerpt or abstract is provided to confirm or refute the statement."", ""reference"": ""PMID:11993780"", ""snippet"": """", ""supports"": ""NO_EVIDENCE""}"
6104	5957	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	2	evidence	2	PMID:27511498	PARTIAL		The highest positivity for IgG alone was found in musculoskeletal system and connective tissue diseases (55.9%)... The highest positivity for IgG was seen in rheumatoid arthritis (72.2%) and pregnancy (52.6%).	The reference indicates a high prevalence of parvovirus B19 antibodies in musculoskeletal diseases, but does not specifically mention arthropathy.	"{""explanation"": ""The reference indicates a high prevalence of parvovirus B19 antibodies in musculoskeletal diseases, but does not specifically mention arthropathy."", ""reference"": ""PMID:27511498"", ""snippet"": ""The highest positivity for IgG alone was found in musculoskeletal system and connective tissue diseases (55.9%)... The highest positivity for IgG was seen in rheumatoid arthritis (72.2%) and pregnancy (52.6%)."", ""supports"": ""PARTIAL""}"
6105	5957	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	2	evidence	3	PMID:29512949	SUPPORT		Arthritis and arthralgia during a viral infection are often polyarticular and symmetric and can mimic rheumatoid arthritis. ... Worldwide most common germs are Parvovirus B19, hepatitis B and C, HIV and alphavirus.	The reference supports that arthritis and arthralgia, which can be associated with parvovirus B19, are common.	"{""explanation"": ""The reference supports that arthritis and arthralgia, which can be associated with parvovirus B19, are common."", ""reference"": ""PMID:29512949"", ""snippet"": ""Arthritis and arthralgia during a viral infection are often polyarticular and symmetric and can mimic rheumatoid arthritis. ... Worldwide most common germs are Parvovirus B19, hepatitis B and C, HIV and alphavirus."", ""supports"": ""SUPPORT""}"
6106	5957	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	2	evidence	4	PMID:32646497	NO_EVIDENCE			The reference discusses parvovirus B19 infection and kidney injury but does not mention arthropathy.	"{""explanation"": ""The reference discusses parvovirus B19 infection and kidney injury but does not mention arthropathy."", ""reference"": ""PMID:32646497"", ""snippet"": """", ""supports"": ""NO_EVIDENCE""}"
6107	5957	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	2	evidence	5	PMID:32510300	SUPPORT		We report here a small outbreak of B19V infection among physicians and family members in an adult rheumatology practice that occurred after providing care for a patient with B19V arthropathy.	The reference supports the statement by reporting a case of B19V arthropathy in adults.	"{""explanation"": ""The reference supports the statement by reporting a case of B19V arthropathy in adults."", ""reference"": ""PMID:32510300"", ""snippet"": ""We report here a small outbreak of B19V infection among physicians and family members in an adult rheumatology practice that occurred after providing care for a patient with B19V arthropathy."", ""supports"": ""SUPPORT""}"
6108	5957	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	2	evidence	6	PMID:33944819	SUPPORT		Typical clinical manifestations are: short lived fever accompanied by asthenia, myalgias and pharyngodynia; symmetrical acute polyarthritis.	The reference supports that symmetrical acute polyarthritis, a form of arthropathy, is a typical manifestation of parvovirus B19.	"{""explanation"": ""The reference supports that symmetrical acute polyarthritis, a form of arthropathy, is a typical manifestation of parvovirus B19."", ""reference"": ""PMID:33944819"", ""snippet"": ""Typical clinical manifestations are: short lived fever accompanied by asthenia, myalgias and pharyngodynia; symmetrical acute polyarthritis."", ""supports"": ""SUPPORT""}"
6109	5957	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	2	evidence	7	PMID:19480999	SUPPORT		B19 infection-associated joint symptoms occur most frequently in adults, usually presenting as a self-limited, acute symmetric polyarthritis affecting the small joints of the hands, wrists, and knees.	The reference supports the statement by indicating that joint symptoms, including arthropathy, are frequent in adults with B19 infection.	"{""explanation"": ""The reference supports the statement by indicating that joint symptoms, including arthropathy, are frequent in adults with B19 infection."", ""reference"": ""PMID:19480999"", ""snippet"": ""B19 infection-associated joint symptoms occur most frequently in adults, usually presenting as a self-limited, acute symmetric polyarthritis affecting the small joints of the hands, wrists, and knees."", ""supports"": ""SUPPORT""}"
6110	5957	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	2	evidence	8	PMID:26044725	NO_EVIDENCE			The reference discusses parvovirus B19 infection and pregnancy but does not mention arthropathy.	"{""explanation"": ""The reference discusses parvovirus B19 infection and pregnancy but does not mention arthropathy."", ""reference"": ""PMID:26044725"", ""snippet"": """", ""supports"": ""NO_EVIDENCE""}"
6111	5957	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	2	evidence	9	PMID:25965702	SUPPORT		Arthralgias and arthritis, with or without rash, are common manifestations of B19V infection in adults.	The reference supports the statement by indicating that arthritis and arthralgias are common in adults with B19 infection.	"{""explanation"": ""The reference supports the statement by indicating that arthritis and arthralgias are common in adults with B19 infection."", ""reference"": ""PMID:25965702"", ""snippet"": ""Arthralgias and arthritis, with or without rash, are common manifestations of B19V infection in adults."", ""supports"": ""SUPPORT""}"
6112	5958	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	3	evidence	0	PMID:21502743	SUPPORT		Fetal hydrops caused by anemia from parvovirus B19 infection (FH-B19) is rare.	The study confirms that fetal hydrops caused by anemia from parvovirus B19 infection is rare.	"{""explanation"": ""The study confirms that fetal hydrops caused by anemia from parvovirus B19 infection is rare."", ""reference"": ""PMID:21502743"", ""snippet"": ""Fetal hydrops caused by anemia from parvovirus B19 infection (FH-B19) is rare."", ""supports"": ""SUPPORT""}"
6113	5958	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	3	evidence	1	PMID:9095492	SUPPORT		Fetal infection by Parvovirus B 19 is a common cause of fetal anemia and nonimmune hydrops fetalis and may result in fetal death.	While the statement mentions 'common cause,' the overall context supports that fetal hydrops due to severe fetal anemia from parvovirus B19 is a recognized but not frequent condition.	"{""explanation"": ""While the statement mentions 'common cause,' the overall context supports that fetal hydrops due to severe fetal anemia from parvovirus B19 is a recognized but not frequent condition."", ""reference"": ""PMID:9095492"", ""snippet"": ""Fetal infection by Parvovirus B 19 is a common cause of fetal anemia and nonimmune hydrops fetalis and may result in fetal death."", ""supports"": ""SUPPORT""}"
6114	5958	252	Parvovirus B19 Infection	Parvovirus_B19_Infection.yaml	phenotypes	3	evidence	2	PMID:30124157	SUPPORT		Parvovirus B-19 is a common childhood illness; the virus can cause fetal anemia, non-immune fetal hydrops, and spontaneous abortion and might lead to fetal demise.	The reference supports the connection between parvovirus B19 and fetal hydrops due to severe fetal anemia, noting it as a possible but not frequent outcome.	"{""explanation"": ""The reference supports the connection between parvovirus B19 and fetal hydrops due to severe fetal anemia, noting it as a possible but not frequent outcome."", ""reference"": ""PMID:30124157"", ""snippet"": ""Parvovirus B-19 is a common childhood illness; the virus can cause fetal anemia, non-immune fetal hydrops, and spontaneous abortion and might lead to fetal demise."", ""supports"": ""SUPPORT""}"
6157	5999	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	phenotypes	0	evidence	0	PMID:38961103	SUPPORT		The clinical manifestations of PAD which are typically not revealed until symptoms like intermittent claudication, rest pain and ischemic gangrene develop, are not present in majority of diabetes mellitus patients with PAD due to diabetic peripheral neuropathy.	Identifies intermittent claudication as a key clinical manifestation of PAD, though noting it may be masked in diabetic patients.	"{""explanation"": ""Identifies intermittent claudication as a key clinical manifestation of PAD, though noting it may be masked in diabetic patients."", ""reference"": ""PMID:38961103"", ""snippet"": ""The clinical manifestations of PAD which are typically not revealed until symptoms like intermittent claudication, rest pain and ischemic gangrene develop, are not present in majority of diabetes mellitus patients with PAD due to diabetic peripheral neuropathy."", ""supports"": ""SUPPORT""}"
6158	6001	254	Peripheral Artery Disease	Peripheral_Artery_Disease.yaml	phenotypes	2	evidence	0	PMID:38961103	SUPPORT		The most serious long-term effects of diabetes is peripheral artery disease (PAD) which increases the chance of developing diabetic foot ulcers, gangrene and even lower limb amputation.	Demonstrates that PAD leads to non-healing wounds including diabetic foot ulcers and gangrene, particularly in diabetes patients.	"{""explanation"": ""Demonstrates that PAD leads to non-healing wounds including diabetic foot ulcers and gangrene, particularly in diabetes patients."", ""reference"": ""PMID:38961103"", ""snippet"": ""The most serious long-term effects of diabetes is peripheral artery disease (PAD) which increases the chance of developing diabetic foot ulcers, gangrene and even lower limb amputation."", ""supports"": ""SUPPORT""}"
6219	6036	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	0	evidence	0	PMID:7685145	SUPPORT		These disorders should be considered in the differential diagnosis of the infant with hypotonia and psychomotor delay...	The reference mentions hypotonia as a significant clinical feature in peroxisomal disorders.	"{""explanation"": ""The reference mentions hypotonia as a significant clinical feature in peroxisomal disorders."", ""reference"": ""PMID:7685145"", ""snippet"": ""These disorders should be considered in the differential diagnosis of the infant with hypotonia and psychomotor delay..."", ""supports"": ""SUPPORT""}"
6220	6036	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	0	evidence	1	PMID:28320181	PARTIAL		...suggest that these PEX10 mutations involve not only cerebellar but also more multiple nervous systems...	While the reference primarily discusses cerebellar involvement, it indirectly supports the statement by implicating neurological systems in PEX10-related peroxisome biogenesis disorders.	"{""explanation"": ""While the reference primarily discusses cerebellar involvement, it indirectly supports the statement by implicating neurological systems in PEX10-related peroxisome biogenesis disorders."", ""reference"": ""PMID:28320181"", ""snippet"": ""...suggest that these PEX10 mutations involve not only cerebellar but also more multiple nervous systems..."", ""supports"": ""PARTIAL""}"
6221	6036	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	0	evidence	2	PMID:13129589	SUPPORT		The floppy infant syndrome is a well-recognized entity for pediatricians and neonatologists. The condition refers to an infant with generalized hypotonia...	The reference directly supports the very frequent occurrence of hypotonia in infants with peroxisomal disorders.	"{""explanation"": ""The reference directly supports the very frequent occurrence of hypotonia in infants with peroxisomal disorders."", ""reference"": ""PMID:13129589"", ""snippet"": ""The floppy infant syndrome is a well-recognized entity for pediatricians and neonatologists. The condition refers to an infant with generalized hypotonia..."", ""supports"": ""SUPPORT""}"
6222	6036	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	0	evidence	3	PMID:38409970	SUPPORT		Common clinical presentations include hypotonia, seizure, hepatomegaly, craniofacial dysmorphism and early death.	Hypotonia is listed as one of the common clinical presentations in Zellweger syndrome, a type of peroxisome biogenesis disorder.	"{""explanation"": ""Hypotonia is listed as one of the common clinical presentations in Zellweger syndrome, a type of peroxisome biogenesis disorder."", ""reference"": ""PMID:38409970"", ""snippet"": ""Common clinical presentations include hypotonia, seizure, hepatomegaly, craniofacial dysmorphism and early death."", ""supports"": ""SUPPORT""}"
6223	6037	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	1	evidence	0	PMID:7685145	SUPPORT		Because peroxisomes are involved in the metabolism of lipids critical to the functioning of the nervous system, many of the peroxisomal disorders manifest with significant degrees of progressive psychomotor dysfunction.	The literature indicates that peroxisomal disorders, which include Peroxisome Biogenesis Disorders (PBDs), frequently present with progressive psychomotor dysfunction, supporting the statement that developmental delay is a very frequent neurologic phenotype.	"{""explanation"": ""The literature indicates that peroxisomal disorders, which include Peroxisome Biogenesis Disorders (PBDs), frequently present with progressive psychomotor dysfunction, supporting the statement that developmental delay is a very frequent neurologic phenotype."", ""reference"": ""PMID:7685145"", ""snippet"": ""Because peroxisomes are involved in the metabolism of lipids critical to the functioning of the nervous system, many of the peroxisomal disorders manifest with significant degrees of progressive psychomotor dysfunction."", ""supports"": ""SUPPORT""}"
6224	6037	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	1	evidence	1	PMID:36293220	SUPPORT		The clinical presentation of PBDs may range from severe, lethal multisystemic disorders to milder, late-onset disease. The vast majority of PBDs belong to Zellweger Spectrum Disordes (ZSDs) and represents a continuum of overlapping clinical symptoms.	Although this does not explicitly mention developmental delay, the overall description implies a frequent occurrence of neurologic dysfunction, which is often tied to developmental delays.	"{""explanation"": ""Although this does not explicitly mention developmental delay, the overall description implies a frequent occurrence of neurologic dysfunction, which is often tied to developmental delays."", ""reference"": ""PMID:36293220"", ""snippet"": ""The clinical presentation of PBDs may range from severe, lethal multisystemic disorders to milder, late-onset disease. The vast majority of PBDs belong to Zellweger Spectrum Disordes (ZSDs) and represents a continuum of overlapping clinical symptoms."", ""supports"": ""SUPPORT""}"
6225	6037	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	1	evidence	2	PMID:11769739	SUPPORT		Distinctive external features are variable among these three disorders, and neurologic deficit has its onset at birth or in infancy.	The article describes neurologic deficits appearing early in life, which aligns with developmental delays being a very frequent phenotype.	"{""explanation"": ""The article describes neurologic deficits appearing early in life, which aligns with developmental delays being a very frequent phenotype."", ""reference"": ""PMID:11769739"", ""snippet"": ""Distinctive external features are variable among these three disorders, and neurologic deficit has its onset at birth or in infancy."", ""supports"": ""SUPPORT""}"
6226	6037	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	1	evidence	3	PMID:38409970	SUPPORT		Zellweger syndrome is an autosomal recessive disease within the spectrum of peroxisome biogenesis disorder manifesting in the neonatal period with profound dysfunction of the central nervous system, liver and kidney.	The mention of the neonatal onset of CNS dysfunction supports the frequent presence of developmental delays.	"{""explanation"": ""The mention of the neonatal onset of CNS dysfunction supports the frequent presence of developmental delays."", ""reference"": ""PMID:38409970"", ""snippet"": ""Zellweger syndrome is an autosomal recessive disease within the spectrum of peroxisome biogenesis disorder manifesting in the neonatal period with profound dysfunction of the central nervous system, liver and kidney."", ""supports"": ""SUPPORT""}"
6227	6037	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	1	evidence	4	PMID:24172221	SUPPORT		Neurodevelopmental deficits and age-related occurrence of seizures are characteristic of RCDP and are related to the rest-activity in plasmalogen biosynthesis.	RCDP is a type of peroxisomal disorder, and its characteristic neurodevelopmental deficits support the statement about developmental delay being a common phenotype in PBDs.	"{""explanation"": ""RCDP is a type of peroxisomal disorder, and its characteristic neurodevelopmental deficits support the statement about developmental delay being a common phenotype in PBDs."", ""reference"": ""PMID:24172221"", ""snippet"": ""Neurodevelopmental deficits and age-related occurrence of seizures are characteristic of RCDP and are related to the rest-activity in plasmalogen biosynthesis."", ""supports"": ""SUPPORT""}"
6228	6040	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	4	evidence	0	PMID:31005404	PARTIAL		Inherited metabolic diseases account for about one third of pediatric patients with hepatomegaly, acute liver failure, cirrhosis or cholestasis.	The reference states that inherited metabolic diseases, which include peroxisome biogenesis disorders, account for a substantial portion of pediatric hepatomegaly cases but does not specify the frequency as 'frequent.'	"{""explanation"": ""The reference states that inherited metabolic diseases, which include peroxisome biogenesis disorders, account for a substantial portion of pediatric hepatomegaly cases but does not specify the frequency as 'frequent.'"", ""reference"": ""PMID:31005404"", ""snippet"": ""Inherited metabolic diseases account for about one third of pediatric patients with hepatomegaly, acute liver failure, cirrhosis or cholestasis."", ""supports"": ""PARTIAL""}"
6229	6040	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	4	evidence	1	PMID:22978395	PARTIAL		Liver pathology is a frequent finding in patients affected by a peroxisomal disorder.	The reference mentions liver pathology as frequent but does not specifically state hepatomegaly.	"{""explanation"": ""The reference mentions liver pathology as frequent but does not specifically state hepatomegaly."", ""reference"": ""PMID:22978395"", ""snippet"": ""Liver pathology is a frequent finding in patients affected by a peroxisomal disorder."", ""supports"": ""PARTIAL""}"
6230	6040	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	4	evidence	2	PMID:26615381	NO_EVIDENCE		ZS is a peroxisomal disorder with a multiple congenital anomalies, characterized by stereotypical facies, profound hypotonia, organ involvement including cerebral, retinal, hepatic, and renal.	The reference discusses organ involvement including hepatic involvement but does not specify hepatomegaly as frequent.	"{""explanation"": ""The reference discusses organ involvement including hepatic involvement but does not specify hepatomegaly as frequent."", ""reference"": ""PMID:26615381"", ""snippet"": ""ZS is a peroxisomal disorder with a multiple congenital anomalies, characterized by stereotypical facies, profound hypotonia, organ involvement including cerebral, retinal, hepatic, and renal."", ""supports"": ""NO_EVIDENCE""}"
6231	6043	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	7	evidence	0	PMID:31884631	SUPPORT		Retinopathy is a recurrent feature in both the severely and mildly affected patients, which can be accompanied with other ophthalmological pathologies.	The study states that retinopathy is a recurrent feature in patients with peroxisomal disorders, supporting the statement that visual phenotypes, specifically retinopathy, are frequent.	"{""explanation"": ""The study states that retinopathy is a recurrent feature in patients with peroxisomal disorders, supporting the statement that visual phenotypes, specifically retinopathy, are frequent."", ""reference"": ""PMID:31884631"", ""snippet"": ""Retinopathy is a recurrent feature in both the severely and mildly affected patients, which can be accompanied with other ophthalmological pathologies."", ""supports"": ""SUPPORT""}"
6232	6043	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	7	evidence	1	PMID:12473763	SUPPORT		Common to these three disorders are liver disease, variable neurodevelopmental delay, retinopathy, and perceptive deafness.	The study indicates that retinopathy is common in peroxisome biogenesis disorders like Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease, supporting the frequent occurrence of retinopathy as a visual phenotype.	"{""explanation"": ""The study indicates that retinopathy is common in peroxisome biogenesis disorders like Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease, supporting the frequent occurrence of retinopathy as a visual phenotype."", ""reference"": ""PMID:12473763"", ""snippet"": ""Common to these three disorders are liver disease, variable neurodevelopmental delay, retinopathy, and perceptive deafness."", ""supports"": ""SUPPORT""}"
6233	6043	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	7	evidence	2	PMID:35227579	SUPPORT		Retinal degeneration with or without optic atrophy is the most frequent phenotype, followed by oculomotor problems, involvement of the cornea and lens, and refractive errors.	The study states that retinal degeneration is the most frequent ocular phenotype observed in inherited metabolic disorders, which includes peroxisome biogenesis disorders, thereby supporting the frequent occurrence of retinopathy.	"{""explanation"": ""The study states that retinal degeneration is the most frequent ocular phenotype observed in inherited metabolic disorders, which includes peroxisome biogenesis disorders, thereby supporting the frequent occurrence of retinopathy."", ""reference"": ""PMID:35227579"", ""snippet"": ""Retinal degeneration with or without optic atrophy is the most frequent phenotype, followed by oculomotor problems, involvement of the cornea and lens, and refractive errors."", ""supports"": ""SUPPORT""}"
6234	6043	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	7	evidence	3	PMID:31254513	SUPPORT		Retinopathy leading to blindness is one of the major untreatable handicaps faced by patients with ZSD but is not well characterized.	The study highlights that retinopathy leading to blindness is a significant issue in patients with Zellweger Spectrum Disorder, a type of peroxisome biogenesis disorder, supporting the frequency of retinopathy as a visual phenotype.	"{""explanation"": ""The study highlights that retinopathy leading to blindness is a significant issue in patients with Zellweger Spectrum Disorder, a type of peroxisome biogenesis disorder, supporting the frequency of retinopathy as a visual phenotype."", ""reference"": ""PMID:31254513"", ""snippet"": ""Retinopathy leading to blindness is one of the major untreatable handicaps faced by patients with ZSD but is not well characterized."", ""supports"": ""SUPPORT""}"
6235	6044	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	8	evidence	0	PMID:34534157	SUPPORT		The majority of PBD-ZSD patients in this study presented with moderately-severe to severe hearing loss.	This study characterizes hearing loss as a common phenotype in patients with Peroxisome Biogenesis Disorder within the Zellweger Spectrum.	"{""explanation"": ""This study characterizes hearing loss as a common phenotype in patients with Peroxisome Biogenesis Disorder within the Zellweger Spectrum."", ""reference"": ""PMID:34534157"", ""snippet"": ""The majority of PBD-ZSD patients in this study presented with moderately-severe to severe hearing loss."", ""supports"": ""SUPPORT""}"
6236	6044	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	8	evidence	1	PMID:36291074	SUPPORT		Peroxisome biogenesis disorders (due to PEX gene mutations) are associated with symptoms that range in severity and can lead to early childhood death, but a common feature is hearing impairment.	This study also confirms hearing impairment as a frequent phenotype in Peroxisome Biogenesis Disorders, further supporting the statement.	"{""explanation"": ""This study also confirms hearing impairment as a frequent phenotype in Peroxisome Biogenesis Disorders, further supporting the statement."", ""reference"": ""PMID:36291074"", ""snippet"": ""Peroxisome biogenesis disorders (due to PEX gene mutations) are associated with symptoms that range in severity and can lead to early childhood death, but a common feature is hearing impairment."", ""supports"": ""SUPPORT""}"
6237	6044	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	8	evidence	2	PMID:33417209	SUPPORT		Heimler syndrome is a rare syndrome associating sensorineural hearing loss with retinal dystrophy and amelogenesis imperfecta due to PEX1 or PEX6 biallelic pathogenic variations. This syndrome is one of the less severe forms of peroxisome biogenesis disorders.	Heimler syndrome, a less severe form of peroxisome biogenesis disorders, frequently presents with sensorineural hearing loss, further supporting the frequent association of hearing loss with these disorders.	"{""explanation"": ""Heimler syndrome, a less severe form of peroxisome biogenesis disorders, frequently presents with sensorineural hearing loss, further supporting the frequent association of hearing loss with these disorders."", ""reference"": ""PMID:33417209"", ""snippet"": ""Heimler syndrome is a rare syndrome associating sensorineural hearing loss with retinal dystrophy and amelogenesis imperfecta due to PEX1 or PEX6 biallelic pathogenic variations. This syndrome is one of the less severe forms of peroxisome biogenesis disorders."", ""supports"": ""SUPPORT""}"
6238	6045	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	9	evidence	0	PMID:23671347	SUPPORT		Patients with ZS present in the neonatal period with a characteristic phenotype of distinctive facial stigmata.	Distinctive facial stigmata can be considered a form of craniofacial dysmorphism, supporting the statement.	"{""explanation"": ""Distinctive facial stigmata can be considered a form of craniofacial dysmorphism, supporting the statement."", ""reference"": ""PMID:23671347"", ""snippet"": ""Patients with ZS present in the neonatal period with a characteristic phenotype of distinctive facial stigmata."", ""supports"": ""SUPPORT""}"
6239	6045	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	9	evidence	1	PMID:1710072	PARTIAL		Zellweger syndrome, the most lethal of the three peroxisomal biogenesis disorders, causes infantile hypotonia, seizures, and death within the first year.	While the text does not explicitly mention craniofacial dysmorphism, the severity of symptoms and multisystem involvement suggest potential craniofacial manifestations.	"{""explanation"": ""While the text does not explicitly mention craniofacial dysmorphism, the severity of symptoms and multisystem involvement suggest potential craniofacial manifestations."", ""reference"": ""PMID:1710072"", ""snippet"": ""Zellweger syndrome, the most lethal of the three peroxisomal biogenesis disorders, causes infantile hypotonia, seizures, and death within the first year."", ""supports"": ""PARTIAL""}"
6240	6046	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	10	evidence	0	PMID:36649687	SUPPORT		Primary adrenal insufficiency is common in patients with PD. Based on our data, patients with the compound heterozygous PEX1 pathogenic variants of exon 13 (c.2097dupT and c.2528G>A) tend to have adrenal insufficiency.	The study indicates that primary adrenal insufficiency is frequent in patients with peroxisomal disorders, specifically those with PEX1 pathogenic variants.	"{""explanation"": ""The study indicates that primary adrenal insufficiency is frequent in patients with peroxisomal disorders, specifically those with PEX1 pathogenic variants."", ""reference"": ""PMID:36649687"", ""snippet"": ""Primary adrenal insufficiency is common in patients with PD. Based on our data, patients with the compound heterozygous PEX1 pathogenic variants of exon 13 (c.2097dupT and c.2528G>A) tend to have adrenal insufficiency."", ""supports"": ""SUPPORT""}"
6241	6046	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	10	evidence	1	PMID:25179809	SUPPORT		Primary adrenal insufficiency was found in 7/24 patients examined, with 4/7 being asymptomatic. Systematic evaluation of adrenal function, through a Synacthen test, should be included in the clinical management of these patients.	The study highlights a high prevalence of primary adrenal insufficiency in patients with Zellweger spectrum disorders, which are a type of peroxisome biogenesis disorder.	"{""explanation"": ""The study highlights a high prevalence of primary adrenal insufficiency in patients with Zellweger spectrum disorders, which are a type of peroxisome biogenesis disorder."", ""reference"": ""PMID:25179809"", ""snippet"": ""Primary adrenal insufficiency was found in 7/24 patients examined, with 4/7 being asymptomatic. Systematic evaluation of adrenal function, through a Synacthen test, should be included in the clinical management of these patients."", ""supports"": ""SUPPORT""}"
6242	6047	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	11	evidence	0	PMID:10904262	SUPPORT		Zellweger syndrome, neonatal adrenoleukodystrophy, infantile Refsum disease and rhizomelic chondrodysplasia punctata are progressive disorders characterized by loss of multiple peroxisomal metabolic functions.	Rhizomelic chondrodysplasia punctata is a type of peroxisome biogenesis disorder, supporting the statement that chondrodysplasia punctata falls under the category of musculoskeletal issues associated with peroxisome biogenesis disorders.	"{""explanation"": ""Rhizomelic chondrodysplasia punctata is a type of peroxisome biogenesis disorder, supporting the statement that chondrodysplasia punctata falls under the category of musculoskeletal issues associated with peroxisome biogenesis disorders."", ""reference"": ""PMID:10904262"", ""snippet"": ""Zellweger syndrome, neonatal adrenoleukodystrophy, infantile Refsum disease and rhizomelic chondrodysplasia punctata are progressive disorders characterized by loss of multiple peroxisomal metabolic functions."", ""supports"": ""SUPPORT""}"
6243	6047	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	11	evidence	1	PMID:24030027	SUPPORT		We present a 2-month-old male affected by Zellweger syndrome, a rare peroxisomal disorder. The diagnosis was supported by clinical and radiological findings and established by biochemical tests. The characteristic radiological features included anomalous ossification (epiphyseal stippling).	This study supports the statement by indicating that epiphyseal stippling (chondrodysplasia punctata) is a characteristic feature in Zellweger syndrome, a type of peroxisome biogenesis disorder.	"{""explanation"": ""This study supports the statement by indicating that epiphyseal stippling (chondrodysplasia punctata) is a characteristic feature in Zellweger syndrome, a type of peroxisome biogenesis disorder."", ""reference"": ""PMID:24030027"", ""snippet"": ""We present a 2-month-old male affected by Zellweger syndrome, a rare peroxisomal disorder. The diagnosis was supported by clinical and radiological findings and established by biochemical tests. The characteristic radiological features included anomalous ossification (epiphyseal stippling)."", ""supports"": ""SUPPORT""}"
6244	6047	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	11	evidence	2	PMID:17671048	SUPPORT		Classic rhizomelic chondrodysplasia punctata is a rare, autosomal, recessively inherited disorder that is characterized by proximal shortening of the limbs, punctuate calcifications of the epiphyses, cataracts, developmental delay, and early lethality.	Rhizomelic chondrodysplasia punctata is characterized by punctuate calcifications of the epiphyses, supporting the statement that this condition is associated with peroxisome biogenesis disorders and involves stippling of epiphyses.	"{""explanation"": ""Rhizomelic chondrodysplasia punctata is characterized by punctuate calcifications of the epiphyses, supporting the statement that this condition is associated with peroxisome biogenesis disorders and involves stippling of epiphyses."", ""reference"": ""PMID:17671048"", ""snippet"": ""Classic rhizomelic chondrodysplasia punctata is a rare, autosomal, recessively inherited disorder that is characterized by proximal shortening of the limbs, punctuate calcifications of the epiphyses, cataracts, developmental delay, and early lethality."", ""supports"": ""SUPPORT""}"
6245	6048	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	12	evidence	0	PMID:27941306	NO_EVIDENCE		Peroxisome is a single-membrane-bounded ubiquitous organelle containing a hundred different enzymes that catalyze various metabolic pathways such as beta-oxidation of very long-chain fatty acids and synthesis of plasmalogens.	The provided literature does not mention thrombocytopenia or any hematologic symptoms in relation to Peroxisome Biogenesis Disorders.	"{""explanation"": ""The provided literature does not mention thrombocytopenia or any hematologic symptoms in relation to Peroxisome Biogenesis Disorders."", ""reference"": ""PMID:27941306"", ""snippet"": ""Peroxisome is a single-membrane-bounded ubiquitous organelle containing a hundred different enzymes that catalyze various metabolic pathways such as beta-oxidation of very long-chain fatty acids and synthesis of plasmalogens."", ""supports"": ""NO_EVIDENCE""}"
6246	6048	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	12	evidence	1	PMID:31884631	NO_EVIDENCE		Peroxisomal disorders are a group of inherited metabolic diseases, which can be incompatible with life in the postnatal period or allow survival into adulthood. Retinopathy is a recurrent feature in both the severely and mildly affected patients, which can be accompanied with other ophthalmological pathologies.	This reference discusses peroxisomal disorders but does not mention thrombocytopenia or other hematologic conditions.	"{""explanation"": ""This reference discusses peroxisomal disorders but does not mention thrombocytopenia or other hematologic conditions."", ""reference"": ""PMID:31884631"", ""snippet"": ""Peroxisomal disorders are a group of inherited metabolic diseases, which can be incompatible with life in the postnatal period or allow survival into adulthood. Retinopathy is a recurrent feature in both the severely and mildly affected patients, which can be accompanied with other ophthalmological pathologies."", ""supports"": ""NO_EVIDENCE""}"
6247	6049	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	13	evidence	0	PMID:25465824	PARTIAL		CI in MIDs includes cardiomyopathy, arrhythmias, heart failure, pulmonary hypertension, dilation of the aortic root, pericardial effusion, coronary heart disease, autonomous nervous system dysfunction, congenital heart defects, or sudden cardiac death.	The literature confirms that cardiomyopathy and heart failure are associated with mitochondrial disorders (MIDs), which are a type of metabolic disorder. However, it does not specifically mention peroxisome biogenesis disorders (PBDs) in this context.	"{""explanation"": ""The literature confirms that cardiomyopathy and heart failure are associated with mitochondrial disorders (MIDs), which are a type of metabolic disorder. However, it does not specifically mention peroxisome biogenesis disorders (PBDs) in this context."", ""reference"": ""PMID:25465824"", ""snippet"": ""CI in MIDs includes cardiomyopathy, arrhythmias, heart failure, pulmonary hypertension, dilation of the aortic root, pericardial effusion, coronary heart disease, autonomous nervous system dysfunction, congenital heart defects, or sudden cardiac death."", ""supports"": ""PARTIAL""}"
6248	6049	255	Peroxisome Biogenesis Disorder	Peroxisome_Biogenesis_Disorder.yaml	phenotypes	13	evidence	1	PMID:36870438	NO_EVIDENCE		Paediatric cardiomyopathies form a heterogeneous group of disorders characterized by structural and electrical abnormalities of the heart muscle, commonly due to a gene variant of the myocardial cell structure.	This reference provides an overview of pediatric cardiomyopathies but does not specifically mention peroxisome biogenesis disorders (PBDs) as a cause.	"{""explanation"": ""This reference provides an overview of pediatric cardiomyopathies but does not specifically mention peroxisome biogenesis disorders (PBDs) as a cause."", ""reference"": ""PMID:36870438"", ""snippet"": ""Paediatric cardiomyopathies form a heterogeneous group of disorders characterized by structural and electrical abnormalities of the heart muscle, commonly due to a gene variant of the myocardial cell structure."", ""supports"": ""NO_EVIDENCE""}"
6274	6067	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	phenotypes	0	evidence	0	PMID:37892343	SUPPORT		The management of pediatric Peutz-Jeghers Syndrome (PJS) focuses on the prevention of intussusception complicating small intestinal (SI) polyposis	Confirms small intestinal polyposis as a hallmark manifestation of PJS	"{""explanation"": ""Confirms small intestinal polyposis as a hallmark manifestation of PJS"", ""reference"": ""PMID:37892343"", ""snippet"": ""The management of pediatric Peutz-Jeghers Syndrome (PJS) focuses on the prevention of intussusception complicating small intestinal (SI) polyposis"", ""supports"": ""SUPPORT""}"
6275	6068	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	phenotypes	1	evidence	0	PMID:20301443	SUPPORT		GI polyps can result in chronic bleeding, anemia, and recurrent obstruction and intussusception requiring repeated laparotomy and bowel resection	Establishes chronic gastrointestinal bleeding from polyps as a major complication of PJS	"{""explanation"": ""Establishes chronic gastrointestinal bleeding from polyps as a major complication of PJS"", ""reference"": ""PMID:20301443"", ""snippet"": ""GI polyps can result in chronic bleeding, anemia, and recurrent obstruction and intussusception requiring repeated laparotomy and bowel resection"", ""supports"": ""SUPPORT""}"
6276	6069	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	phenotypes	2	evidence	0	PMID:20301443	SUPPORT		GI polyps can result in chronic bleeding, anemia, and recurrent obstruction and intussusception	Intussusception from Peutz-Jeghers polyps causes abdominal pain and obstruction	"{""explanation"": ""Intussusception from Peutz-Jeghers polyps causes abdominal pain and obstruction"", ""reference"": ""PMID:20301443"", ""snippet"": ""GI polyps can result in chronic bleeding, anemia, and recurrent obstruction and intussusception"", ""supports"": ""SUPPORT""}"
6277	6070	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	phenotypes	3	evidence	0	PMID:20301443	SUPPORT		Mucocutaneous hyperpigmentation presents in childhood as dark blue to dark brown macules around the mouth, eyes, and nostrils, in the perianal area, and on the buccal mucosa	Oral and mucocutaneous pigmentation is a characteristic diagnostic feature of PJS, often appearing before GI polyps	"{""explanation"": ""Oral and mucocutaneous pigmentation is a characteristic diagnostic feature of PJS, often appearing before GI polyps"", ""reference"": ""PMID:20301443"", ""snippet"": ""Mucocutaneous hyperpigmentation presents in childhood as dark blue to dark brown macules around the mouth, eyes, and nostrils, in the perianal area, and on the buccal mucosa"", ""supports"": ""SUPPORT""}"
6278	6071	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	phenotypes	4	evidence	0	PMID:36970589	SUPPORT		Peutz-Jeghers syndrome (PJS) is a clinically rare disease with pigmented spots on the lips and mucous membranes and extremities, scattered gastrointestinal polyps, and susceptibility to tumors	This cohort description identifies lip pigmentation as a characteristic feature of PJS.	"{""explanation"": ""This cohort description identifies lip pigmentation as a characteristic feature of PJS."", ""reference"": ""PMID:36970589"", ""snippet"": ""Peutz-Jeghers syndrome (PJS) is a clinically rare disease with pigmented spots on the lips and mucous membranes and extremities, scattered gastrointestinal polyps, and susceptibility to tumors"", ""supports"": ""SUPPORT""}"
6279	6072	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	phenotypes	5	evidence	0	PMID:20301443	SUPPORT		Individuals with PJS are at increased risk for a wide variety of epithelial malignancies (colorectal, gastric, pancreatic, breast, and ovarian cancers)	PJS patients have substantially elevated lifetime cancer risk across multiple organ systems	"{""explanation"": ""PJS patients have substantially elevated lifetime cancer risk across multiple organ systems"", ""reference"": ""PMID:20301443"", ""snippet"": ""Individuals with PJS are at increased risk for a wide variety of epithelial malignancies (colorectal, gastric, pancreatic, breast, and ovarian cancers)"", ""supports"": ""SUPPORT""}"
6280	6072	256	Peutz-Jeghers polyp	Peutz_Jeghers_polyp.yaml	phenotypes	5	evidence	1	PMID:33513864	SUPPORT		The available evidence has been reviewed and discussed by diverse medical specialists in the field of PJS to update the previous guideline from 2010 and formulate a revised practical guideline for colleagues managing PJS patients	European hereditary tumor group recognizes comprehensive cancer risk across multiple organ systems as defining feature requiring multisystem management	"{""explanation"": ""European hereditary tumor group recognizes comprehensive cancer risk across multiple organ systems as defining feature requiring multisystem management"", ""reference"": ""PMID:33513864"", ""snippet"": ""The available evidence has been reviewed and discussed by diverse medical specialists in the field of PJS to update the previous guideline from 2010 and formulate a revised practical guideline for colleagues managing PJS patients"", ""supports"": ""SUPPORT""}"
6289	6079	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	phenotypes	0	evidence	0	PMID:7874169	SUPPORT	HUMAN_CLINICAL	Pfeiffer syndrome (PS) is one of the classic autosomal dominant craniosynostosis syndromes with craniofacial anomalies and characteristic broad thumbs and big toes.	Confirms craniosynostosis as a cardinal feature of Pfeiffer syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms craniosynostosis as a cardinal feature of Pfeiffer syndrome."", ""reference"": ""PMID:7874169"", ""snippet"": ""Pfeiffer syndrome (PS) is one of the classic autosomal dominant craniosynostosis syndromes with craniofacial anomalies and characteristic broad thumbs and big toes."", ""supports"": ""SUPPORT""}"
6290	6079	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	phenotypes	0	evidence	1	PMID:23348274	SUPPORT	HUMAN_CLINICAL	It is characterized by craniosysnostosis, midface hypoplasia, broad and medially deviated thumbs, and great toes with partial syndactyly of the digits.	Confirms craniosynostosis as a defining clinical feature of Pfeiffer syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms craniosynostosis as a defining clinical feature of Pfeiffer syndrome."", ""reference"": ""PMID:23348274"", ""snippet"": ""It is characterized by craniosysnostosis, midface hypoplasia, broad and medially deviated thumbs, and great toes with partial syndactyly of the digits."", ""supports"": ""SUPPORT""}"
6291	6080	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	phenotypes	1	evidence	0	PMID:7874169	SUPPORT	HUMAN_CLINICAL	Pfeiffer syndrome (PS) is one of the classic autosomal dominant craniosynostosis syndromes with craniofacial anomalies and characteristic broad thumbs and big toes.	Confirms broad thumbs as a characteristic feature of Pfeiffer syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms broad thumbs as a characteristic feature of Pfeiffer syndrome."", ""reference"": ""PMID:7874169"", ""snippet"": ""Pfeiffer syndrome (PS) is one of the classic autosomal dominant craniosynostosis syndromes with craniofacial anomalies and characteristic broad thumbs and big toes."", ""supports"": ""SUPPORT""}"
6292	6080	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	phenotypes	1	evidence	1	PMID:23348274	SUPPORT	HUMAN_CLINICAL	broad and medially deviated thumbs, and great toes with partial syndactyly of the digits	Documents the specific presentation of broad and medially deviated thumbs in Pfeiffer syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Documents the specific presentation of broad and medially deviated thumbs in Pfeiffer syndrome."", ""reference"": ""PMID:23348274"", ""snippet"": ""broad and medially deviated thumbs, and great toes with partial syndactyly of the digits"", ""supports"": ""SUPPORT""}"
6293	6081	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	phenotypes	2	evidence	0	PMID:7874169	SUPPORT	HUMAN_CLINICAL	characteristic broad thumbs and big toes	Confirms broad great toes (big toes) as a characteristic feature of Pfeiffer syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms broad great toes (big toes) as a characteristic feature of Pfeiffer syndrome."", ""reference"": ""PMID:7874169"", ""snippet"": ""characteristic broad thumbs and big toes"", ""supports"": ""SUPPORT""}"
6294	6081	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	phenotypes	2	evidence	1	PMID:23348274	SUPPORT	HUMAN_CLINICAL	broad and medially deviated thumbs, and great toes with partial syndactyly of the digits	Documents broad great toes as a defining feature of Pfeiffer syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Documents broad great toes as a defining feature of Pfeiffer syndrome."", ""reference"": ""PMID:23348274"", ""snippet"": ""broad and medially deviated thumbs, and great toes with partial syndactyly of the digits"", ""supports"": ""SUPPORT""}"
6295	6082	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	phenotypes	3	evidence	0	PMID:23348274	SUPPORT	HUMAN_CLINICAL	It is characterized by craniosysnostosis, midface hypoplasia, broad and medially deviated thumbs	Confirms midface hypoplasia as a characteristic feature of Pfeiffer syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms midface hypoplasia as a characteristic feature of Pfeiffer syndrome."", ""reference"": ""PMID:23348274"", ""snippet"": ""It is characterized by craniosysnostosis, midface hypoplasia, broad and medially deviated thumbs"", ""supports"": ""SUPPORT""}"
6296	6084	257	Pfeiffer Syndrome	Pfeiffer_Syndrome.yaml	phenotypes	5	evidence	0	PMID:23348274	SUPPORT	HUMAN_CLINICAL	great toes with partial syndactyly of the digits	Confirms partial syndactyly as a characteristic feature of Pfeiffer syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms partial syndactyly as a characteristic feature of Pfeiffer syndrome."", ""reference"": ""PMID:23348274"", ""snippet"": ""great toes with partial syndactyly of the digits"", ""supports"": ""SUPPORT""}"
6302	6125	259	Phenylketonuria	Phenylketonuria.yaml	phenotypes	0	evidence	0	PMID:34017006	SUPPORT		If untreated, this brain dysfunction results in severe intellectual disability, epilepsy and behavioural problems.	The Nature Reviews Primer confirms severe intellectual disability as a key untreated phenotype.	"{""explanation"": ""The Nature Reviews Primer confirms severe intellectual disability as a key untreated phenotype."", ""reference"": ""PMID:34017006"", ""snippet"": ""If untreated, this brain dysfunction results in severe intellectual disability, epilepsy and behavioural problems."", ""supports"": ""SUPPORT""}"
6303	6125	259	Phenylketonuria	Phenylketonuria.yaml	phenotypes	0	evidence	1	PMID:38907189	SUPPORT		Adult patients with PKU showed significantly lower performance than HC in Full Scale IQ	Even early-treated adults show lower IQ compared to healthy controls.	"{""explanation"": ""Even early-treated adults show lower IQ compared to healthy controls."", ""reference"": ""PMID:38907189"", ""snippet"": ""Adult patients with PKU showed significantly lower performance than HC in Full Scale IQ"", ""supports"": ""SUPPORT""}"
6304	6126	259	Phenylketonuria	Phenylketonuria.yaml	phenotypes	1	evidence	0	PMID:29025426	SUPPORT		If left untreated, PKU results in increased phenylalanine concentrations in blood and brain, which cause severe intellectual disability, epilepsy and behavioural problems.	European guidelines confirm epilepsy as a major untreated manifestation.	"{""explanation"": ""European guidelines confirm epilepsy as a major untreated manifestation."", ""reference"": ""PMID:29025426"", ""snippet"": ""If left untreated, PKU results in increased phenylalanine concentrations in blood and brain, which cause severe intellectual disability, epilepsy and behavioural problems."", ""supports"": ""SUPPORT""}"
6311	6152	260	Pheochromocytoma and Paraganglioma	Pheochromocytoma_Paraganglioma.yaml	phenotypes	0	evidence	0	PMID:17156452	SUPPORT		An increase in the production of catecholamines causes symptoms (mainly headaches, palpitations and excess sweating) and signs (mainly hypertension, weight loss and diabetes) reflecting the effects of epinephrine and norepinephrine on alpha- and beta-adrenergic receptors.	Abstract lists hypertension among catecholamine-related signs.	"{""explanation"": ""Abstract lists hypertension among catecholamine-related signs."", ""reference"": ""PMID:17156452"", ""snippet"": ""An increase in the production of catecholamines causes symptoms (mainly headaches, palpitations and excess sweating) and signs (mainly hypertension, weight loss and diabetes) reflecting the effects of epinephrine and norepinephrine on alpha- and beta-adrenergic receptors."", ""supports"": ""SUPPORT""}"
6335	6172	261	Pick Disease	Pick_Disease.yaml	phenotypes	0	evidence	0	PMID:16736722	SUPPORT		Frontotemporal dementia (clinical Pick's disease) is a relatively common, but underdiagnosed degenerative disease in the presenium. ... The behavioural, aphasic and extrapyramidal presentations are labeled FTD-behavioural variant, Primary Progressive Aphasia (PPA) and Corticobasal Degeneration/Progressive Supranuclear Palsy (CBD/PSP).	The literature describes Pick's disease as a type of frontotemporal dementia with behavior and executive function impacts, supporting progressive dementia and associated sequelae like loss of social awareness and executive dysfunction.	"{""explanation"": ""The literature describes Pick's disease as a type of frontotemporal dementia with behavior and executive function impacts, supporting progressive dementia and associated sequelae like loss of social awareness and executive dysfunction."", ""reference"": ""PMID:16736722"", ""snippet"": ""Frontotemporal dementia (clinical Pick's disease) is a relatively common, but underdiagnosed degenerative disease in the presenium. ... The behavioural, aphasic and extrapyramidal presentations are labeled FTD-behavioural variant, Primary Progressive Aphasia (PPA) and Corticobasal Degeneration/Progressive Supranuclear Palsy (CBD/PSP)."", ""supports"": ""SUPPORT""}"
6336	6172	261	Pick Disease	Pick_Disease.yaml	phenotypes	0	evidence	1	PMID:28689508	SUPPORT		Socially inappropriate behaviors, such as loss of empathy, inappropriateness of affect, and disinhibition are frequently reported in prodromal bvFTD and in prodromal AD.	The snippet indicates that loss of social awareness is frequently observed in frontotemporal dementia, aligning with the sequelae specified in the query.	"{""explanation"": ""The snippet indicates that loss of social awareness is frequently observed in frontotemporal dementia, aligning with the sequelae specified in the query."", ""reference"": ""PMID:28689508"", ""snippet"": ""Socially inappropriate behaviors, such as loss of empathy, inappropriateness of affect, and disinhibition are frequently reported in prodromal bvFTD and in prodromal AD."", ""supports"": ""SUPPORT""}"
6337	6172	261	Pick Disease	Pick_Disease.yaml	phenotypes	0	evidence	2	PMID:30876954	SUPPORT		Although primary progressive aphasia (PPA) is clinically typified by linguistic impairments, emerging evidence highlights the presence of early deficits in social cognition.	This supports the statement as it mentions social cognition deficits, which align with executive dysfunction and loss of social awareness in progressive dementia.	"{""explanation"": ""This supports the statement as it mentions social cognition deficits, which align with executive dysfunction and loss of social awareness in progressive dementia."", ""reference"": ""PMID:30876954"", ""snippet"": ""Although primary progressive aphasia (PPA) is clinically typified by linguistic impairments, emerging evidence highlights the presence of early deficits in social cognition."", ""supports"": ""SUPPORT""}"
6338	6172	261	Pick Disease	Pick_Disease.yaml	phenotypes	0	evidence	3	PMID:32507758	PARTIAL		Behavioral symptoms are less prominent in the early stages...	While this indicates behavioral symptoms appear, it specifies they are less prominent early on, suggesting partial support for the statement regarding the phenotypes and sequelae.	"{""explanation"": ""While this indicates behavioral symptoms appear, it specifies they are less prominent early on, suggesting partial support for the statement regarding the phenotypes and sequelae."", ""reference"": ""PMID:32507758"", ""snippet"": ""Behavioral symptoms are less prominent in the early stages..."", ""supports"": ""PARTIAL""}"
6339	6173	261	Pick Disease	Pick_Disease.yaml	phenotypes	1	evidence	0	PMID:26583316	SUPPORT		Behavioral variant frontotemporal dementia was the predominant clinical phenotype (18 of 21), but all patients eventually developed a social comportment disorder.	The reference supports that behavioral changes, which can be considered psychiatric phenotypes, are common in Pick's disease.	"{""explanation"": ""The reference supports that behavioral changes, which can be considered psychiatric phenotypes, are common in Pick's disease."", ""reference"": ""PMID:26583316"", ""snippet"": ""Behavioral variant frontotemporal dementia was the predominant clinical phenotype (18 of 21), but all patients eventually developed a social comportment disorder."", ""supports"": ""SUPPORT""}"
6340	6173	261	Pick Disease	Pick_Disease.yaml	phenotypes	1	evidence	1	PMID:35584922	PARTIAL		Changes in social behavior are common symptoms of frontotemporal lobar degeneration (FTLD) and Alzheimer disease syndromes.	While this study indicates that social behavior changes (which can include behavioral changes) are common, it does not specifically state the frequency in Pick's disease.	"{""explanation"": ""While this study indicates that social behavior changes (which can include behavioral changes) are common, it does not specifically state the frequency in Pick's disease."", ""reference"": ""PMID:35584922"", ""snippet"": ""Changes in social behavior are common symptoms of frontotemporal lobar degeneration (FTLD) and Alzheimer disease syndromes."", ""supports"": ""PARTIAL""}"
6341	6173	261	Pick Disease	Pick_Disease.yaml	phenotypes	1	evidence	2	PMID:31871139	NO_EVIDENCE		Neuropsychiatric disorders in patients and their families are associated with cognitive and behavioural changes post-MND diagnosis, with many occurring independently of MND-FTD and C9orf72 status.	MND (Motor Neuron Disease) does overlap with frontotemporal dementia and associated behavioral changes, but this is not directly related to Pick's disease and does not provide evidence for high-frequency psychiatric phenotypes in Pick's disease.	"{""explanation"": ""MND (Motor Neuron Disease) does overlap with frontotemporal dementia and associated behavioral changes, but this is not directly related to Pick's disease and does not provide evidence for high-frequency psychiatric phenotypes in Pick's disease."", ""reference"": ""PMID:31871139"", ""snippet"": ""Neuropsychiatric disorders in patients and their families are associated with cognitive and behavioural changes post-MND diagnosis, with many occurring independently of MND-FTD and C9orf72 status."", ""supports"": ""NO_EVIDENCE""}"
6342	6174	261	Pick Disease	Pick_Disease.yaml	phenotypes	2	evidence	0	PMID:30537913	PARTIAL		Patients with bvFTD often have perseverative, stereotyped, or compulsive-ritualistic behavior as an early aspect of their disorder.	The reference discusses the presence of repetitive behaviors in frontotemporal dementia (bvFTD), which includes Pick's disease. However, the emphasis is more on impulsive behaviors rather than strictly compulsive behaviors as seen in OCD.	"{""explanation"": ""The reference discusses the presence of repetitive behaviors in frontotemporal dementia (bvFTD), which includes Pick's disease. However, the emphasis is more on impulsive behaviors rather than strictly compulsive behaviors as seen in OCD."", ""reference"": ""PMID:30537913"", ""snippet"": ""Patients with bvFTD often have perseverative, stereotyped, or compulsive-ritualistic behavior as an early aspect of their disorder."", ""supports"": ""PARTIAL""}"
6343	6175	261	Pick Disease	Pick_Disease.yaml	phenotypes	3	evidence	0	PMID:9059759	SUPPORT		Primary progressive aphasia is an important recently emphasized clinical syndrome that is a common early manifestation of Pick's disease and Pick complex pathology.	The reference states that primary progressive aphasia is a common early manifestation of Pick's disease, supporting the claim that aphasia is a frequent neurological symptom of Pick's disease.	"{""explanation"": ""The reference states that primary progressive aphasia is a common early manifestation of Pick's disease, supporting the claim that aphasia is a frequent neurological symptom of Pick's disease."", ""reference"": ""PMID:9059759"", ""snippet"": ""Primary progressive aphasia is an important recently emphasized clinical syndrome that is a common early manifestation of Pick's disease and Pick complex pathology."", ""supports"": ""SUPPORT""}"
6344	6175	261	Pick Disease	Pick_Disease.yaml	phenotypes	3	evidence	1	PMID:36925418	SUPPORT		Frontotemporal Dementia, also known by the name Pick's disease, is a rare form of dementia that can run for several generations. The two key characteristics are argyrophilic, spherical intraneuronal inclusions, which most frequently impact the frontal and temporal poles, and localized cortical atrophy (Pick bodies).	This reference confirms the association of Pick's disease with frontotemporal dementia, which includes language difficulties such as aphasia.	"{""explanation"": ""This reference confirms the association of Pick's disease with frontotemporal dementia, which includes language difficulties such as aphasia."", ""reference"": ""PMID:36925418"", ""snippet"": ""Frontotemporal Dementia, also known by the name Pick's disease, is a rare form of dementia that can run for several generations. The two key characteristics are argyrophilic, spherical intraneuronal inclusions, which most frequently impact the frontal and temporal poles, and localized cortical atrophy (Pick bodies)."", ""supports"": ""SUPPORT""}"
6345	6175	261	Pick Disease	Pick_Disease.yaml	phenotypes	3	evidence	2	PMID:37276800	SUPPORT		His frontal and temporal forms of aphasia foreshadowed what are now called the nonfluent/agrammatic and semantic variants of primary progressive aphasia. Moreover, aphasic symptoms may occur with frontal degeneration (what used to be called 'Pick's disease') that yields personality changes and behavioral disturbances, now called the behavioral variant of frontotemporal dementia.	The reference supports the statement by indicating that aphasic symptoms are associated with Pick's disease, particularly its frontal and temporal forms.	"{""explanation"": ""The reference supports the statement by indicating that aphasic symptoms are associated with Pick's disease, particularly its frontal and temporal forms."", ""reference"": ""PMID:37276800"", ""snippet"": ""His frontal and temporal forms of aphasia foreshadowed what are now called the nonfluent/agrammatic and semantic variants of primary progressive aphasia. Moreover, aphasic symptoms may occur with frontal degeneration (what used to be called 'Pick's disease') that yields personality changes and behavioral disturbances, now called the behavioral variant of frontotemporal dementia."", ""supports"": ""SUPPORT""}"
6346	6176	261	Pick Disease	Pick_Disease.yaml	phenotypes	4	evidence	0	PMID:11402143	NO_EVIDENCE		The clinical presentation in frontotemporal dementia (FTD) reflects the distribution of the pathologic changes rather than the exact histologic subtype of the disease. Three major clinical syndromes can be identified: 1) frontal variant FTD (dementia of frontal type) in which changes in social behavior and personality predominate, reflecting the orbitobasal frontal lobe focus of the pathology. Traditional cognitive tests are insensitive, but more specific measures are under development; 2) semantic dementia (progressive fluent aphasia) in which there is a breakdown in the conceptual database which underlies language production and comprehension, although deficits in nonverbal semantic knowledge can also be shown on neuropsychologic testing. Patients with semantic dementia have asymmetric anterolateral temporal atrophy with relative sparing of the hippocampal formation, which is typically worse on the left side. A variant of this syndrome affecting the right temporal lobe presents with progressive prosopagnosia; 3) progressive nonfluent aphasia in which the phonologic and syntactic components of language are affected in association with left peri-Sylvian atrophy. The assessment of patients with potential FTD involves a multidisciplinary approach. The development of comprehensive caregiver-based neuropsychiatric instruments, neuropsychologic tasks sensitive to semantic memory and other key cognitive impairments, and functional (hexamethyly-propyleneamine-SPECT) and structural (MRI) brain imaging represent significant advances in the field.	The provided literature does not mention parkinsonism or extrapyramidal signs such as rigidity, bradykinesia, and postural instability in the context of Pick's disease (Frontotemporal dementia).	"{""explanation"": ""The provided literature does not mention parkinsonism or extrapyramidal signs such as rigidity, bradykinesia, and postural instability in the context of Pick's disease (Frontotemporal dementia)."", ""reference"": ""PMID:11402143"", ""snippet"": ""The clinical presentation in frontotemporal dementia (FTD) reflects the distribution of the pathologic changes rather than the exact histologic subtype of the disease. Three major clinical syndromes can be identified: 1) frontal variant FTD (dementia of frontal type) in which changes in social behavior and personality predominate, reflecting the orbitobasal frontal lobe focus of the pathology. Traditional cognitive tests are insensitive, but more specific measures are under development; 2) semantic dementia (progressive fluent aphasia) in which there is a breakdown in the conceptual database which underlies language production and comprehension, although deficits in nonverbal semantic knowledge can also be shown on neuropsychologic testing. Patients with semantic dementia have asymmetric anterolateral temporal atrophy with relative sparing of the hippocampal formation, which is typically worse on the left side. A variant of this syndrome affecting the right temporal lobe presents with progressive prosopagnosia; 3) progressive nonfluent aphasia in which the phonologic and syntactic components of language are affected in association with left peri-Sylvian atrophy. The assessment of patients with potential FTD involves a multidisciplinary approach. The development of comprehensive caregiver-based neuropsychiatric instruments, neuropsychologic tasks sensitive to semantic memory and other key cognitive impairments, and functional (hexamethyly-propyleneamine-SPECT) and structural (MRI) brain imaging represent significant advances in the field."", ""supports"": ""NO_EVIDENCE""}"
6347	6177	261	Pick Disease	Pick_Disease.yaml	phenotypes	5	evidence	0	PMID:12700289	SUPPORT		Primitive reflexes are typically present in childhood, suppressed during normal development, and may reappear with diseases of the brain, particularly those affecting the frontal lobes.	The reemergence of primitive reflexes, such as the grasp reflex, is associated with diseases affecting the frontal lobes, which includes Pick's disease.	"{""explanation"": ""The reemergence of primitive reflexes, such as the grasp reflex, is associated with diseases affecting the frontal lobes, which includes Pick's disease."", ""reference"": ""PMID:12700289"", ""snippet"": ""Primitive reflexes are typically present in childhood, suppressed during normal development, and may reappear with diseases of the brain, particularly those affecting the frontal lobes."", ""supports"": ""SUPPORT""}"
6348	6177	261	Pick Disease	Pick_Disease.yaml	phenotypes	5	evidence	1	PMID:22411252	SUPPORT		Picks disease is a major clinicopathological disease having circumscribed atrophy in the frontotemporal lobe.	Pick's disease affects the frontal lobes, which can lead to the reemergence of primitive reflexes.	"{""explanation"": ""Pick's disease affects the frontal lobes, which can lead to the reemergence of primitive reflexes."", ""reference"": ""PMID:22411252"", ""snippet"": ""Picks disease is a major clinicopathological disease having circumscribed atrophy in the frontotemporal lobe."", ""supports"": ""SUPPORT""}"
6349	6178	261	Pick Disease	Pick_Disease.yaml	phenotypes	6	evidence	0	PMID:20420119	SUPPORT		This condition, formerly known as Pick's disease and considered rare, is estimated to be 12-15% of all dementias and 30-50% early onset ones. The clinical picture is protean, mainly a behavioural and language impairment, but the extrapyramidal syndromes of CBD and PSP also belong.	The abstract mentions that the clinical picture of Pick's disease (frontotemporal dementia) mainly involves behavioral and language impairment. While it does not explicitly mention executive dysfunction, the broader category of cognitive impairments and the association with other syndromes that involve executive dysfunction support the statement.	"{""explanation"": ""The abstract mentions that the clinical picture of Pick's disease (frontotemporal dementia) mainly involves behavioral and language impairment. While it does not explicitly mention executive dysfunction, the broader category of cognitive impairments and the association with other syndromes that involve executive dysfunction support the statement."", ""reference"": ""PMID:20420119"", ""snippet"": ""This condition, formerly known as Pick's disease and considered rare, is estimated to be 12-15% of all dementias and 30-50% early onset ones. The clinical picture is protean, mainly a behavioural and language impairment, but the extrapyramidal syndromes of CBD and PSP also belong."", ""supports"": ""SUPPORT""}"
6350	6178	261	Pick Disease	Pick_Disease.yaml	phenotypes	6	evidence	1	PMID:32145523	SUPPORT		Corticobasal syndrome-Pick's disease: A clinicopathological study.	The title of the study directly links Pick's disease with corticobasal syndrome, which is known to involve executive dysfunction. This supports the statement that executive dysfunction is frequent in Pick's disease.	"{""explanation"": ""The title of the study directly links Pick's disease with corticobasal syndrome, which is known to involve executive dysfunction. This supports the statement that executive dysfunction is frequent in Pick's disease."", ""reference"": ""PMID:32145523"", ""snippet"": ""Corticobasal syndrome-Pick's disease: A clinicopathological study."", ""supports"": ""SUPPORT""}"
6351	6178	261	Pick Disease	Pick_Disease.yaml	phenotypes	6	evidence	2	PMID:29854017	SUPPORT		Specifically, in some NDs these deficits may represent core diagnostic criteria, such as for behavioral variant frontotemporal dementia (bvFTD)...	The abstract mentions that social cognitive dysfunctions, including executive dysfunction, are core diagnostic criteria for behavioral variant frontotemporal dementia (bvFTD), which is closely related to Pick's disease.	"{""explanation"": ""The abstract mentions that social cognitive dysfunctions, including executive dysfunction, are core diagnostic criteria for behavioral variant frontotemporal dementia (bvFTD), which is closely related to Pick's disease."", ""reference"": ""PMID:29854017"", ""snippet"": ""Specifically, in some NDs these deficits may represent core diagnostic criteria, such as for behavioral variant frontotemporal dementia (bvFTD)..."", ""supports"": ""SUPPORT""}"
6352	6179	261	Pick Disease	Pick_Disease.yaml	phenotypes	7	evidence	0	PMID:16317256	PARTIAL		What was once called Pick's disease has three major anatomic variants. With all three, frontotemporal brain is selectively injured whereas posterior cortical regions are spared.	The reference discusses the clinical features of Pick's disease (now considered a type of frontotemporal dementia) but does not specifically mention seizures as a typical feature. However, it does not refute the possibility of seizures occurring in advanced stages.	"{""explanation"": ""The reference discusses the clinical features of Pick's disease (now considered a type of frontotemporal dementia) but does not specifically mention seizures as a typical feature. However, it does not refute the possibility of seizures occurring in advanced stages."", ""reference"": ""PMID:16317256"", ""snippet"": ""What was once called Pick's disease has three major anatomic variants. With all three, frontotemporal brain is selectively injured whereas posterior cortical regions are spared."", ""supports"": ""PARTIAL""}"
6353	6179	261	Pick Disease	Pick_Disease.yaml	phenotypes	7	evidence	1	PMID:17076146	NO_EVIDENCE		Pick's disease.	"This reference only provides the title ""Pick's disease"" and does not contain any information about seizures or their frequency in Pick's disease."	"{""explanation"": ""This reference only provides the title \""Pick's disease\"" and does not contain any information about seizures or their frequency in Pick's disease."", ""reference"": ""PMID:17076146"", ""snippet"": ""Pick's disease."", ""supports"": ""NO_EVIDENCE""}"
6363	6192	262	Pinta	Pinta.yaml	phenotypes	0	evidence	0	PMID:23332859	SUPPORT		Mal del pinto is a dermatological disease characterized by discoloured patches of skin on the face and body.	The abstract describes discoloured patches of skin in pinta.	"{""explanation"": ""The abstract describes discoloured patches of skin in pinta."", ""reference"": ""PMID:23332859"", ""snippet"": ""Mal del pinto is a dermatological disease characterized by discoloured patches of skin on the face and body."", ""supports"": ""SUPPORT""}"
6375	6203	263	Polycystic echinococcosis	Polycystic_Echinococcosis.yaml	phenotypes	0	evidence	0	PMID:33553405	SUPPORT		Computed tomography of the abdomen revealed a huge polycystic lesion in left liver lobe, without reinforcement after enhanced scanning and sized about 16.9 cm × 12.2 cm, which was considered a type II hydatid cyst.	The CT finding documents a large hepatic polycystic hydatid lesion consistent with the phenotype.	"{""explanation"": ""The CT finding documents a large hepatic polycystic hydatid lesion consistent with the phenotype."", ""reference"": ""PMID:33553405"", ""snippet"": ""Computed tomography of the abdomen revealed a huge polycystic lesion in left liver lobe, without reinforcement after enhanced scanning and sized about 16.9 cm × 12.2 cm, which was considered a type II hydatid cyst."", ""supports"": ""SUPPORT""}"
6376	6204	263	Polycystic echinococcosis	Polycystic_Echinococcosis.yaml	phenotypes	1	evidence	0	PMID:41431593	SUPPORT		We describe a rural patient with hepatitis B virus (HBV)-related cirrhosis and neotropical echinococcosis who developed a hepatic abscess that fistulized into the right hemithorax.	The report documents hepatic abscess formation as a complication of neotropical echinococcosis.	"{""explanation"": ""The report documents hepatic abscess formation as a complication of neotropical echinococcosis."", ""reference"": ""PMID:41431593"", ""snippet"": ""We describe a rural patient with hepatitis B virus (HBV)-related cirrhosis and neotropical echinococcosis who developed a hepatic abscess that fistulized into the right hemithorax."", ""supports"": ""SUPPORT""}"
6377	6205	263	Polycystic echinococcosis	Polycystic_Echinococcosis.yaml	phenotypes	2	evidence	0	PMID:41431593	SUPPORT		We describe a rural patient with hepatitis B virus (HBV)-related cirrhosis and neotropical echinococcosis who developed a hepatic abscess that fistulized into the right hemithorax.	The case describes a transdiaphragmatic fistula leading to a thoracic abscess, aligning with a lung abscess complication.	"{""explanation"": ""The case describes a transdiaphragmatic fistula leading to a thoracic abscess, aligning with a lung abscess complication."", ""reference"": ""PMID:41431593"", ""snippet"": ""We describe a rural patient with hepatitis B virus (HBV)-related cirrhosis and neotropical echinococcosis who developed a hepatic abscess that fistulized into the right hemithorax."", ""supports"": ""SUPPORT""}"
6398	6227	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	phenotypes	0	evidence	0	PMID:29105594	SUPPORT		the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume	REPRISE trial confirms PKD as a cystic kidney disease defined by progressive kidney volume increase.	"{""explanation"": ""REPRISE trial confirms PKD as a cystic kidney disease defined by progressive kidney volume increase."", ""reference"": ""PMID:29105594"", ""snippet"": ""the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume"", ""supports"": ""SUPPORT""}"
6399	6227	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	phenotypes	0	evidence	1	PMID:40126492	SUPPORT		Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive development of kidney cysts	JAMA review describes ADPKD as a progressive cystic kidney disease.	"{""explanation"": ""JAMA review describes ADPKD as a progressive cystic kidney disease."", ""reference"": ""PMID:40126492"", ""snippet"": ""Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive development of kidney cysts"", ""supports"": ""SUPPORT""}"
6400	6228	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	phenotypes	1	evidence	0	PMID:40126492	SUPPORT		Hypertension affects 70% to 80% of patients with ADPKD	JAMA review confirms very high prevalence of hypertension in ADPKD patients.	"{""explanation"": ""JAMA review confirms very high prevalence of hypertension in ADPKD patients."", ""reference"": ""PMID:40126492"", ""snippet"": ""Hypertension affects 70% to 80% of patients with ADPKD"", ""supports"": ""SUPPORT""}"
6401	6228	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	phenotypes	1	evidence	1	PMID:40126492	SUPPORT		Optimal management of ADPKD includes systolic blood pressure lower than 120 mm Hg for most patients	Tight blood pressure targets underscore hypertension as a central clinical issue in ADPKD.	"{""explanation"": ""Tight blood pressure targets underscore hypertension as a central clinical issue in ADPKD."", ""reference"": ""PMID:40126492"", ""snippet"": ""Optimal management of ADPKD includes systolic blood pressure lower than 120 mm Hg for most patients"", ""supports"": ""SUPPORT""}"
6402	6228	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	phenotypes	1	evidence	2	PMID:40371605	SUPPORT		Comorbidities include hypertension, flank pain, and bacterial infections.	Proteomic study lists hypertension as a common comorbidity in ADPKD cohorts.	"{""explanation"": ""Proteomic study lists hypertension as a common comorbidity in ADPKD cohorts."", ""reference"": ""PMID:40371605"", ""snippet"": ""Comorbidities include hypertension, flank pain, and bacterial infections."", ""supports"": ""SUPPORT""}"
6403	6229	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	phenotypes	2	evidence	0	PMID:29105594	SUPPORT		The change from baseline in the estimated GFR was -2.34 ml per minute per 1.73 m2	Trial demonstrates progressive GFR decline in PKD patients.	"{""explanation"": ""Trial demonstrates progressive GFR decline in PKD patients."", ""reference"": ""PMID:29105594"", ""snippet"": ""The change from baseline in the estimated GFR was -2.34 ml per minute per 1.73 m2"", ""supports"": ""SUPPORT""}"
6404	6229	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	phenotypes	2	evidence	1	PMID:40126492	SUPPORT		Approximately 50% of individuals with ADPKD require kidney replacement therapy by 62 years of age	High rate of kidney replacement therapy highlights progression to advanced CKD in ADPKD.	"{""explanation"": ""High rate of kidney replacement therapy highlights progression to advanced CKD in ADPKD."", ""reference"": ""PMID:40126492"", ""snippet"": ""Approximately 50% of individuals with ADPKD require kidney replacement therapy by 62 years of age"", ""supports"": ""SUPPORT""}"
6405	6230	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	phenotypes	3	evidence	0	PMID:40126492	SUPPORT		More than 90% of patients older than 35 years have hepatic cysts	JAMA review confirms hepatic cysts as a very common manifestation in ADPKD.	"{""explanation"": ""JAMA review confirms hepatic cysts as a very common manifestation in ADPKD."", ""reference"": ""PMID:40126492"", ""snippet"": ""More than 90% of patients older than 35 years have hepatic cysts"", ""supports"": ""SUPPORT""}"
6406	6230	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	phenotypes	3	evidence	1	PMID:40126492	SUPPORT		More than 90% of patients older than 35 years have hepatic cysts, which may cause abdominal discomfort and occasionally require medical or surgical intervention	Describes prevalence plus symptomatic burden and intervention needs from hepatic cysts in ADPKD.	"{""explanation"": ""Describes prevalence plus symptomatic burden and intervention needs from hepatic cysts in ADPKD."", ""reference"": ""PMID:40126492"", ""snippet"": ""More than 90% of patients older than 35 years have hepatic cysts, which may cause abdominal discomfort and occasionally require medical or surgical intervention"", ""supports"": ""SUPPORT""}"
6407	6231	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	phenotypes	4	evidence	0	PMID:40126492	SUPPORT		approximately 9% to 14% develop intracranial aneurysms	JAMA review confirms intracranial aneurysms occur in 9-14% of ADPKD patients.	"{""explanation"": ""JAMA review confirms intracranial aneurysms occur in 9-14% of ADPKD patients."", ""reference"": ""PMID:40126492"", ""snippet"": ""approximately 9% to 14% develop intracranial aneurysms"", ""supports"": ""SUPPORT""}"
6408	6232	264	Polycystic Kidney Disease	Polycystic_Kidney_Disease.yaml	phenotypes	5	evidence	0	PMID:40371605	SUPPORT		Comorbidities include hypertension, flank pain, and bacterial infections.	Proteomic study notes flank pain as a common comorbidity in ADPKD patients.	"{""explanation"": ""Proteomic study notes flank pain as a common comorbidity in ADPKD patients."", ""reference"": ""PMID:40371605"", ""snippet"": ""Comorbidities include hypertension, flank pain, and bacterial infections."", ""supports"": ""SUPPORT""}"
6430	6253	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	phenotypes	0	evidence	0	PMID:14671196	SUPPORT		We hypothesize that an increased AMH tone within the cohort could be involved in the follicular arrest of PCOS, by interacting negatively with FSH at the time of selection.	Follicular arrest due to elevated AMH directly leads to anovulation and irregular menstruation in PCOS.	"{""explanation"": ""Follicular arrest due to elevated AMH directly leads to anovulation and irregular menstruation in PCOS."", ""reference"": ""PMID:14671196"", ""snippet"": ""We hypothesize that an increased AMH tone within the cohort could be involved in the follicular arrest of PCOS, by interacting negatively with FSH at the time of selection."", ""supports"": ""SUPPORT""}"
6431	6254	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	phenotypes	1	evidence	0	PMID:38152131	SUPPORT		Compelling evidence suggests that hyperandrogenism is not just a primary feature of PCOS. Instead, it may be a causative factor for this condition.	Hyperandrogenism drives hirsutism and other androgen-mediated dermatological manifestations in PCOS.	"{""explanation"": ""Hyperandrogenism drives hirsutism and other androgen-mediated dermatological manifestations in PCOS."", ""reference"": ""PMID:38152131"", ""snippet"": ""Compelling evidence suggests that hyperandrogenism is not just a primary feature of PCOS. Instead, it may be a causative factor for this condition."", ""supports"": ""SUPPORT""}"
6432	6257	265	Polycystic Ovary Syndrome	Polycystic_Ovary_Syndrome.yaml	phenotypes	4	evidence	0	PMID:14671196	SUPPORT		Because PCOS is associated with a 2- to 3-fold increase in growing FN, we investigated whether an increased AMH serum level correlates to other hormonal and/or U/S features of PCOS.	Anovulation from follicular arrest is the primary mechanism of infertility in PCOS, linked to elevated AMH and disrupted follicle maturation.	"{""explanation"": ""Anovulation from follicular arrest is the primary mechanism of infertility in PCOS, linked to elevated AMH and disrupted follicle maturation."", ""reference"": ""PMID:14671196"", ""snippet"": ""Because PCOS is associated with a 2- to 3-fold increase in growing FN, we investigated whether an increased AMH serum level correlates to other hormonal and/or U/S features of PCOS."", ""supports"": ""SUPPORT""}"
6445	6297	267	Polymyositis	Polymyositis.yaml	phenotypes	0	evidence	0	PMID:31257434	SUPPORT		The level of serum creatinine kinase was higher in patients with CD8+ T cells in muscle cells than those without these cells.	Links the presence of CD8+ T cell invasion to elevated muscle enzymes and clinical muscle damage manifestations.	"{""explanation"": ""Links the presence of CD8+ T cell invasion to elevated muscle enzymes and clinical muscle damage manifestations."", ""reference"": ""PMID:31257434"", ""snippet"": ""The level of serum creatinine kinase was higher in patients with CD8+ T cells in muscle cells than those without these cells."", ""supports"": ""SUPPORT""}"
6453	6312	268	Pouchitis	Pouchitis.yaml	phenotypes	0	evidence	0	PMID:40240062	SUPPORT		"Pouchitis, defined as inflammation of the ileal pouch, is the most common complication following restorative proctocolectomy for refractory ulcerative colitis.
"	"Establishes pouchitis as an inflammatory condition of the ileal pouch, which manifests clinically with diarrhea as a cardinal symptom of inflammation.
"	"{""explanation"": ""Establishes pouchitis as an inflammatory condition of the ileal pouch, which manifests clinically with diarrhea as a cardinal symptom of inflammation.\n"", ""reference"": ""PMID:40240062"", ""snippet"": ""Pouchitis, defined as inflammation of the ileal pouch, is the most common complication following restorative proctocolectomy for refractory ulcerative colitis.\n"", ""supports"": ""SUPPORT""}"
6454	6314	268	Pouchitis	Pouchitis.yaml	phenotypes	2	evidence	0	PMID:40240062	SUPPORT		"Pouchitis, defined as inflammation of the ileal pouch, is the most common complication following restorative proctocolectomy for refractory ulcerative colitis.
"	"Rectal bleeding is a direct manifestation of mucosal inflammation and ulceration in the ileal pouch characteristic of pouchitis.
"	"{""explanation"": ""Rectal bleeding is a direct manifestation of mucosal inflammation and ulceration in the ileal pouch characteristic of pouchitis.\n"", ""reference"": ""PMID:40240062"", ""snippet"": ""Pouchitis, defined as inflammation of the ileal pouch, is the most common complication following restorative proctocolectomy for refractory ulcerative colitis.\n"", ""supports"": ""SUPPORT""}"
6462	6331	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	phenotypes	0	evidence	0	PMID:35704252	SUPPORT		Pruritus was reported in 170 patients (81%), with those reporting clinically significant pruritus (30%) scoring worse across each domain of the PBC-40 and 5-D itch, more frequently having cirrhosis, and having significantly greater levels of fatigue.	This real-world cohort study demonstrates that pruritus is highly prevalent in PBC (81%), with clinically significant pruritus associated with worse quality of life, more advanced disease, and greater fatigue.	"{""explanation"": ""This real-world cohort study demonstrates that pruritus is highly prevalent in PBC (81%), with clinically significant pruritus associated with worse quality of life, more advanced disease, and greater fatigue."", ""reference"": ""PMID:35704252"", ""snippet"": ""Pruritus was reported in 170 patients (81%), with those reporting clinically significant pruritus (30%) scoring worse across each domain of the PBC-40 and 5-D itch, more frequently having cirrhosis, and having significantly greater levels of fatigue."", ""supports"": ""SUPPORT""}"
6463	6332	269	Primary Biliary Cholangitis	Primary_Biliary_Cholangitis.yaml	phenotypes	1	evidence	0	PMID:35704252	SUPPORT		Pruritus was reported in 170 patients (81%), with those reporting clinically significant pruritus (30%) scoring worse across each domain of the PBC-40 and 5-D itch, more frequently having cirrhosis, and having significantly greater levels of fatigue.	This study shows that fatigue is significantly elevated in PBC patients, particularly in those with clinically significant pruritus.	"{""explanation"": ""This study shows that fatigue is significantly elevated in PBC patients, particularly in those with clinically significant pruritus."", ""reference"": ""PMID:35704252"", ""snippet"": ""Pruritus was reported in 170 patients (81%), with those reporting clinically significant pruritus (30%) scoring worse across each domain of the PBC-40 and 5-D itch, more frequently having cirrhosis, and having significantly greater levels of fatigue."", ""supports"": ""SUPPORT""}"
6500	6359	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	0	evidence	0	PMID:27258773	SUPPORT		Primary ciliary dyskinesia (PCD) is a rare, heterogeneous, recessive, genetic disorder of motile cilia, leading to chronic upper and lower respiratory symptoms.	The statement is supported because PCD leads to chronic respiratory symptoms, including chronic cough.	"{""explanation"": ""The statement is supported because PCD leads to chronic respiratory symptoms, including chronic cough."", ""reference"": ""PMID:27258773"", ""snippet"": ""Primary ciliary dyskinesia (PCD) is a rare, heterogeneous, recessive, genetic disorder of motile cilia, leading to chronic upper and lower respiratory symptoms."", ""supports"": ""SUPPORT""}"
6501	6359	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	0	evidence	1	PMID:17142159	SUPPORT		Primary ciliary dyskinesia is an autosomal recessive genetic disease that results in impaired mucociliary clearance causing progressive involvement of the upper and lower respiratory tract, characterized by airway obstruction and recurrent infections of the lungs, middle ear and paranasal sinuses.	The statement is supported because PCD causes progressive involvement of the respiratory tract, which includes chronic cough.	"{""explanation"": ""The statement is supported because PCD causes progressive involvement of the respiratory tract, which includes chronic cough."", ""reference"": ""PMID:17142159"", ""snippet"": ""Primary ciliary dyskinesia is an autosomal recessive genetic disease that results in impaired mucociliary clearance causing progressive involvement of the upper and lower respiratory tract, characterized by airway obstruction and recurrent infections of the lungs, middle ear and paranasal sinuses."", ""supports"": ""SUPPORT""}"
6502	6360	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	1	evidence	0	PMID:39069333	SUPPORT		This review article explores the respiratory aspects of primary ciliary dyskinesia (PCD), a rare, heterogenous, genetic disorder characterized by impaired motile ciliary function. It discusses the clinical diagnosis and management strategies for PCD-related respiratory disease, including chronic sinusitis, otitis media with effusion, recurrent pneumonia, and bronchiectasis.	The article discusses recurrent respiratory diseases as a significant aspect of PCD, supporting the statement that recurrent respiratory infections are very frequent in PCD.	"{""explanation"": ""The article discusses recurrent respiratory diseases as a significant aspect of PCD, supporting the statement that recurrent respiratory infections are very frequent in PCD."", ""reference"": ""PMID:39069333"", ""snippet"": ""This review article explores the respiratory aspects of primary ciliary dyskinesia (PCD), a rare, heterogenous, genetic disorder characterized by impaired motile ciliary function. It discusses the clinical diagnosis and management strategies for PCD-related respiratory disease, including chronic sinusitis, otitis media with effusion, recurrent pneumonia, and bronchiectasis."", ""supports"": ""SUPPORT""}"
6503	6360	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	1	evidence	1	PMID:36214320	SUPPORT		Ninety-two children with chronic respiratory symptoms were divided into 4 groups: 18 children with refractory asthma, 10 with bronchiectasis without dextrocardia, 18 with dextrocardia and 46 with recurrent respiratory tract infections.	The study highlights recurrent respiratory tract infections in children with chronic respiratory symptoms, supporting the statement that recurrent respiratory infections are very frequent in PCD.	"{""explanation"": ""The study highlights recurrent respiratory tract infections in children with chronic respiratory symptoms, supporting the statement that recurrent respiratory infections are very frequent in PCD."", ""reference"": ""PMID:36214320"", ""snippet"": ""Ninety-two children with chronic respiratory symptoms were divided into 4 groups: 18 children with refractory asthma, 10 with bronchiectasis without dextrocardia, 18 with dextrocardia and 46 with recurrent respiratory tract infections."", ""supports"": ""SUPPORT""}"
6504	6360	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	1	evidence	2	PMID:31430425	SUPPORT		The objective of this study was to evaluate the prevalence of chronic rhinosinusitis (CRS) and its characteristics in bronchiectasis patients suspected of harboring ciliary dyskinesia.	The study mentions chronic rhinosinusitis and bronchiectasis in patients suspected of ciliary dyskinesia, indicating frequent respiratory issues.	"{""explanation"": ""The study mentions chronic rhinosinusitis and bronchiectasis in patients suspected of ciliary dyskinesia, indicating frequent respiratory issues."", ""reference"": ""PMID:31430425"", ""snippet"": ""The objective of this study was to evaluate the prevalence of chronic rhinosinusitis (CRS) and its characteristics in bronchiectasis patients suspected of harboring ciliary dyskinesia."", ""supports"": ""SUPPORT""}"
6505	6360	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	1	evidence	3	PMID:25370419	SUPPORT		The sinuses should be considered as a bacterial reservoir and a target for surgery and antibiotic treatment in patients with primary ciliary dyskinesia (PCD).	The study discusses sinus infections as a common issue in PCD, supporting the statement about frequent respiratory infections.	"{""explanation"": ""The study discusses sinus infections as a common issue in PCD, supporting the statement about frequent respiratory infections."", ""reference"": ""PMID:25370419"", ""snippet"": ""The sinuses should be considered as a bacterial reservoir and a target for surgery and antibiotic treatment in patients with primary ciliary dyskinesia (PCD)."", ""supports"": ""SUPPORT""}"
6506	6361	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	2	evidence	0	PMID:10894096	SUPPORT		Patients with primary ciliary dyskinesia could potentially develop recurrent sinotrachrobronchitis, bronchiectasis, serous otitis media, hydrocephalus, and male infertility.	The article mentions bronchiectasis as one of the potential conditions that patients with PCD could develop.	"{""explanation"": ""The article mentions bronchiectasis as one of the potential conditions that patients with PCD could develop."", ""reference"": ""PMID:10894096"", ""snippet"": ""Patients with primary ciliary dyskinesia could potentially develop recurrent sinotrachrobronchitis, bronchiectasis, serous otitis media, hydrocephalus, and male infertility."", ""supports"": ""SUPPORT""}"
6507	6361	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	2	evidence	1	PMID:36344229	SUPPORT		Typical manifestations include bronchiectasis, secretory otitis media, sinusitis, situs inversus, and infertility.	The article lists bronchiectasis as a typical manifestation of primary ciliary dyskinesia.	"{""explanation"": ""The article lists bronchiectasis as a typical manifestation of primary ciliary dyskinesia."", ""reference"": ""PMID:36344229"", ""snippet"": ""Typical manifestations include bronchiectasis, secretory otitis media, sinusitis, situs inversus, and infertility."", ""supports"": ""SUPPORT""}"
6508	6361	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	2	evidence	2	PMID:25673230	SUPPORT		Primary ciliary dyskinesia (PCD) is a rare disease, characterised by chronic airway infection.	The article discusses the relationship between functional and structural abnormalities in PCD, including bronchiectasis.	"{""explanation"": ""The article discusses the relationship between functional and structural abnormalities in PCD, including bronchiectasis."", ""reference"": ""PMID:25673230"", ""snippet"": ""Primary ciliary dyskinesia (PCD) is a rare disease, characterised by chronic airway infection."", ""supports"": ""SUPPORT""}"
6509	6361	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	2	evidence	3	PMID:21680564	SUPPORT		A review is presented of key clinical papers published in Thorax and elsewhere between 2008 and April 2011 which have advanced our understanding of cystic fibrosis (CF), primary ciliary dyskinesia and non-CF bronchiectasis.	The article discusses primary ciliary dyskinesia and non-CF bronchiectasis, implying a connection between PCD and bronchiectasis.	"{""explanation"": ""The article discusses primary ciliary dyskinesia and non-CF bronchiectasis, implying a connection between PCD and bronchiectasis."", ""reference"": ""PMID:21680564"", ""snippet"": ""A review is presented of key clinical papers published in Thorax and elsewhere between 2008 and April 2011 which have advanced our understanding of cystic fibrosis (CF), primary ciliary dyskinesia and non-CF bronchiectasis."", ""supports"": ""SUPPORT""}"
6510	6361	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	2	evidence	4	PMID:31430425	SUPPORT		The objective of this study was to evaluate the prevalence of chronic rhinosinusitis (CRS) and its characteristics in bronchiectasis patients suspected of harboring ciliary dyskinesia.	The study evaluates bronchiectasis in patients suspected of having ciliary dyskinesia, indicating a frequent association.	"{""explanation"": ""The study evaluates bronchiectasis in patients suspected of having ciliary dyskinesia, indicating a frequent association."", ""reference"": ""PMID:31430425"", ""snippet"": ""The objective of this study was to evaluate the prevalence of chronic rhinosinusitis (CRS) and its characteristics in bronchiectasis patients suspected of harboring ciliary dyskinesia."", ""supports"": ""SUPPORT""}"
6511	6361	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	2	evidence	5	PMID:37278553	SUPPORT		Primary ciliary dyskinesia as a common cause of bronchiectasis in the Canadian Inuit population.	The article explicitly states that PCD is a common cause of bronchiectasis in a specific population.	"{""explanation"": ""The article explicitly states that PCD is a common cause of bronchiectasis in a specific population."", ""reference"": ""PMID:37278553"", ""snippet"": ""Primary ciliary dyskinesia as a common cause of bronchiectasis in the Canadian Inuit population."", ""supports"": ""SUPPORT""}"
6512	6361	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	2	evidence	6	PMID:33895745	SUPPORT		Primary ciliary dyskinesia (PCD) is a rare genetic disorder which requires a complex diagnostic workup. Thus, an easy and widely available screening method would be helpful to identify patients who need a further diagnostic workup for PCD.	The article discusses the need for diagnostic workup for PCD in patients with bronchiectasis, indicating a frequent association.	"{""explanation"": ""The article discusses the need for diagnostic workup for PCD in patients with bronchiectasis, indicating a frequent association."", ""reference"": ""PMID:33895745"", ""snippet"": ""Primary ciliary dyskinesia (PCD) is a rare genetic disorder which requires a complex diagnostic workup. Thus, an easy and widely available screening method would be helpful to identify patients who need a further diagnostic workup for PCD."", ""supports"": ""SUPPORT""}"
6513	6361	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	2	evidence	7	PMID:23181248	SUPPORT		Mucociliary clearance is a primary defence mechanism of the airway that can be altered in congenital diseases such as primary ciliary dyskinesia and cystic fibrosis, as well as acquired conditions.	The article focuses on primary ciliary dyskinesia and its impact on mucociliary clearance, which is related to bronchiectasis.	"{""explanation"": ""The article focuses on primary ciliary dyskinesia and its impact on mucociliary clearance, which is related to bronchiectasis."", ""reference"": ""PMID:23181248"", ""snippet"": ""Mucociliary clearance is a primary defence mechanism of the airway that can be altered in congenital diseases such as primary ciliary dyskinesia and cystic fibrosis, as well as acquired conditions."", ""supports"": ""SUPPORT""}"
6514	6361	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	2	evidence	8	PMID:37852905	NO_EVIDENCE		Bardet-Biedl Syndrome: An Uncommon Cause of Bronchiectasis.	The article discusses Bardet-Biedl Syndrome as a cause of bronchiectasis, not primary ciliary dyskinesia.	"{""explanation"": ""The article discusses Bardet-Biedl Syndrome as a cause of bronchiectasis, not primary ciliary dyskinesia."", ""reference"": ""PMID:37852905"", ""snippet"": ""Bardet-Biedl Syndrome: An Uncommon Cause of Bronchiectasis."", ""supports"": ""NO_EVIDENCE""}"
6515	6362	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	3	evidence	0	PMID:29135867	SUPPORT		All 15 patients showed ciliary ultrastructural abnormalities on electron microscopy and/or biallelic mutations in genes associated with ciliary function or structure. All 30 eardrums examined showed certain abnormalities. Fourteen patients had otitis media with effusion or its sequelae. The remaining patient had chronic otitis media.	The study found that patients with primary ciliary dyskinesia (PCD) frequently exhibited otologic issues, including chronic otitis media.	"{""explanation"": ""The study found that patients with primary ciliary dyskinesia (PCD) frequently exhibited otologic issues, including chronic otitis media."", ""reference"": ""PMID:29135867"", ""snippet"": ""All 15 patients showed ciliary ultrastructural abnormalities on electron microscopy and/or biallelic mutations in genes associated with ciliary function or structure. All 30 eardrums examined showed certain abnormalities. Fourteen patients had otitis media with effusion or its sequelae. The remaining patient had chronic otitis media."", ""supports"": ""SUPPORT""}"
6516	6362	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	3	evidence	1	PMID:19796826	SUPPORT		Primary ciliary dyskinesia is an autosomal recessively inherited group of disorders of ciliary ultrastructure. Otolaryngologists are frequently involved in the management of some of the most common symptoms of primary ciliary dyskinesia including chronic rhinitis, sinusitis and otitis media with effusion.	This reference supports that chronic otitis media and other otologic issues are common in patients with primary ciliary dyskinesia.	"{""explanation"": ""This reference supports that chronic otitis media and other otologic issues are common in patients with primary ciliary dyskinesia."", ""reference"": ""PMID:19796826"", ""snippet"": ""Primary ciliary dyskinesia is an autosomal recessively inherited group of disorders of ciliary ultrastructure. Otolaryngologists are frequently involved in the management of some of the most common symptoms of primary ciliary dyskinesia including chronic rhinitis, sinusitis and otitis media with effusion."", ""supports"": ""SUPPORT""}"
6517	6363	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	4	evidence	0	PMID:29287859	REFUTE		Slight to mild CHL and all types of otitis media are prevalent among patients with PCD, and some of these children have sensorineural hearing loss (SNHL).	The study indicates that hearing loss is a prevalent condition among patients with primary ciliary dyskinesia (PCD), not occasional.	"{""explanation"": ""The study indicates that hearing loss is a prevalent condition among patients with primary ciliary dyskinesia (PCD), not occasional."", ""reference"": ""PMID:29287859"", ""snippet"": ""Slight to mild CHL and all types of otitis media are prevalent among patients with PCD, and some of these children have sensorineural hearing loss (SNHL)."", ""supports"": ""REFUTE""}"
6518	6363	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	4	evidence	1	PMID:9222635	REFUTE		All children (11 patients) had bilateral otitis media with effusion. Of the five adults, three had tympanosclerosis; one had bilateral cholesteatoma; and one patient had bilateral keratosis obturans in combination with tympanosclerosis.	The study describes otological manifestations including hearing loss as a prominent feature in patients with PCD, suggesting it is not occasional but rather common.	"{""explanation"": ""The study describes otological manifestations including hearing loss as a prominent feature in patients with PCD, suggesting it is not occasional but rather common."", ""reference"": ""PMID:9222635"", ""snippet"": ""All children (11 patients) had bilateral otitis media with effusion. Of the five adults, three had tympanosclerosis; one had bilateral cholesteatoma; and one patient had bilateral keratosis obturans in combination with tympanosclerosis."", ""supports"": ""REFUTE""}"
6519	6363	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	4	evidence	2	PMID:33844744	NO_EVIDENCE		In this group of patients with OI, 30% had hearing loss and among those ears with normal hearing, 13% did not have an acoustic stapedial reflex.	This study discusses hearing loss in osteogenesis imperfecta (OI), not primary ciliary dyskinesia (PCD).	"{""explanation"": ""This study discusses hearing loss in osteogenesis imperfecta (OI), not primary ciliary dyskinesia (PCD)."", ""reference"": ""PMID:33844744"", ""snippet"": ""In this group of patients with OI, 30% had hearing loss and among those ears with normal hearing, 13% did not have an acoustic stapedial reflex."", ""supports"": ""NO_EVIDENCE""}"
6520	6364	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	5	evidence	0	PMID:37997295	NO_EVIDENCE		Despite endoscopic differences, PCD-CRS and cystic fibrosis-related chronic rhinosinusitis (CF-CRS) had similar structured histopathology reports. Compared to healthy patients and those with idiopathic chronic rhinosinusitis without nasal polyps, patients with PCD-CRS had an increased neutrophil count.	The abstract discusses histopathology and neutrophil count in PCD-CRS, but does not provide evidence on the frequency of nasal polyps in PCD.	"{""explanation"": ""The abstract discusses histopathology and neutrophil count in PCD-CRS, but does not provide evidence on the frequency of nasal polyps in PCD."", ""reference"": ""PMID:37997295"", ""snippet"": ""Despite endoscopic differences, PCD-CRS and cystic fibrosis-related chronic rhinosinusitis (CF-CRS) had similar structured histopathology reports. Compared to healthy patients and those with idiopathic chronic rhinosinusitis without nasal polyps, patients with PCD-CRS had an increased neutrophil count."", ""supports"": ""NO_EVIDENCE""}"
6521	6364	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	5	evidence	1	PMID:39069333	NO_EVIDENCE		This review article explores the respiratory aspects of primary ciliary dyskinesia (PCD), a rare, heterogenous, genetic disorder characterized by impaired motile ciliary function. It discusses the clinical diagnosis and management strategies for PCD-related respiratory disease, including chronic sinusitis, otitis media with effusion, recurrent pneumonia, and bronchiectasis.	The review focuses on respiratory aspects of PCD and does not mention nasal polyps as a frequent gastrointestinal manifestation.	"{""explanation"": ""The review focuses on respiratory aspects of PCD and does not mention nasal polyps as a frequent gastrointestinal manifestation."", ""reference"": ""PMID:39069333"", ""snippet"": ""This review article explores the respiratory aspects of primary ciliary dyskinesia (PCD), a rare, heterogenous, genetic disorder characterized by impaired motile ciliary function. It discusses the clinical diagnosis and management strategies for PCD-related respiratory disease, including chronic sinusitis, otitis media with effusion, recurrent pneumonia, and bronchiectasis."", ""supports"": ""NO_EVIDENCE""}"
6522	6365	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	6	evidence	0	PMID:16036877	PARTIAL		Total immotility of the cilia should therefore result in random asymmetry of the body that is situs inversus in 50% of the cases. It has also been claimed that 50% of cases with PCD have situs inversus.	The literature indicates that situs inversus, including situs inversus totalis, occurs in approximately 50% of primary ciliary dyskinesia (PCD) cases. This suggests that it is not merely 'occasional' but rather relatively common in PCD patients.	"{""explanation"": ""The literature indicates that situs inversus, including situs inversus totalis, occurs in approximately 50% of primary ciliary dyskinesia (PCD) cases. This suggests that it is not merely 'occasional' but rather relatively common in PCD patients."", ""reference"": ""PMID:16036877"", ""snippet"": ""Total immotility of the cilia should therefore result in random asymmetry of the body that is situs inversus in 50% of the cases. It has also been claimed that 50% of cases with PCD have situs inversus."", ""supports"": ""PARTIAL""}"
6523	6365	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	6	evidence	1	PMID:36342963	PARTIAL		Results: Of 559 participants, 286 (51.2%), 215 (38.5%), and 58 (10.4%) were identified as having situs solitus, situs inversustotalis, and situs ambiguus, respectively; heterotaxy, defined as situs ambiguus with complex cardiovascular defects, was present in 14 (2.5%)	The data indicates that situs inversus totalis occurs in 38.5% of PCD cases, which is more frequent than 'occasional.'	"{""explanation"": ""The data indicates that situs inversus totalis occurs in 38.5% of PCD cases, which is more frequent than 'occasional.'"", ""reference"": ""PMID:36342963"", ""snippet"": ""Results: Of 559 participants, 286 (51.2%), 215 (38.5%), and 58 (10.4%) were identified as having situs solitus, situs inversustotalis, and situs ambiguus, respectively; heterotaxy, defined as situs ambiguus with complex cardiovascular defects, was present in 14 (2.5%)"", ""supports"": ""PARTIAL""}"
6524	6365	270	Primary_Ciliary_Dyskinesia	Primary_Ciliary_Dyskinesia.yaml	phenotypes	6	evidence	2	PMID:38072392	PARTIAL		The remaining 355 participants did not have SA, including 152 with SIT and 203 with SS.	Situs inversus totalis (SIT) is present in a significant portion of PCD cases, indicating it is more common than 'occasional.'	"{""explanation"": ""Situs inversus totalis (SIT) is present in a significant portion of PCD cases, indicating it is more common than 'occasional.'"", ""reference"": ""PMID:38072392"", ""snippet"": ""The remaining 355 participants did not have SA, including 152 with SIT and 203 with SS."", ""supports"": ""PARTIAL""}"
6559	6381	271	Primary Lateral Sclerosis	Primary_Lateral_Sclerosis.yaml	phenotypes	0	evidence	0	PMID:26515619	SUPPORT		Patients experience stiffness; decreased balance and coordination; mild weakness; and, if the bulbar region is affected, difficulty speaking and swallowing, and emotional lability.	Stiffness in the abstract reflects spasticity in PLS.	"{""explanation"": ""Stiffness in the abstract reflects spasticity in PLS."", ""reference"": ""PMID:26515619"", ""snippet"": ""Patients experience stiffness; decreased balance and coordination; mild weakness; and, if the bulbar region is affected, difficulty speaking and swallowing, and emotional lability."", ""supports"": ""SUPPORT""}"
6560	6382	271	Primary Lateral Sclerosis	Primary_Lateral_Sclerosis.yaml	phenotypes	1	evidence	0	PMID:26515619	SUPPORT		Patients experience stiffness; decreased balance and coordination; mild weakness; and, if the bulbar region is affected, difficulty speaking and swallowing, and emotional lability.	Difficulty speaking is consistent with dysarthria in PLS.	"{""explanation"": ""Difficulty speaking is consistent with dysarthria in PLS."", ""reference"": ""PMID:26515619"", ""snippet"": ""Patients experience stiffness; decreased balance and coordination; mild weakness; and, if the bulbar region is affected, difficulty speaking and swallowing, and emotional lability."", ""supports"": ""SUPPORT""}"
6561	6383	271	Primary Lateral Sclerosis	Primary_Lateral_Sclerosis.yaml	phenotypes	2	evidence	0	PMID:26515619	SUPPORT		Patients experience stiffness; decreased balance and coordination; mild weakness; and, if the bulbar region is affected, difficulty speaking and swallowing, and emotional lability.	The abstract notes difficulty swallowing when bulbar regions are affected.	"{""explanation"": ""The abstract notes difficulty swallowing when bulbar regions are affected."", ""reference"": ""PMID:26515619"", ""snippet"": ""Patients experience stiffness; decreased balance and coordination; mild weakness; and, if the bulbar region is affected, difficulty speaking and swallowing, and emotional lability."", ""supports"": ""SUPPORT""}"
6571	6415	273	Primary Progressive Aphasia	Primary_Progressive_Aphasia.yaml	phenotypes	0	evidence	0	PMID:19300609	SUPPORT		Primary progressive aphasia (PPA) is a neurodegenerative disease of insidious onset presenting with progressive isolated loss of language function, without significant impairment in other cognitive domains.	Progressive loss of language function defines the aphasic phenotype.	"{""explanation"": ""Progressive loss of language function defines the aphasic phenotype."", ""reference"": ""PMID:19300609"", ""snippet"": ""Primary progressive aphasia (PPA) is a neurodegenerative disease of insidious onset presenting with progressive isolated loss of language function, without significant impairment in other cognitive domains."", ""supports"": ""SUPPORT""}"
6572	6416	273	Primary Progressive Aphasia	Primary_Progressive_Aphasia.yaml	phenotypes	1	evidence	0	PMID:19300609	SUPPORT		Current diagnostic criteria require the language dysfunction to remain isolated for at least two years, and to remain the salient feature as the disease progresses, usually to involve other domains such as behavior, executive functions, and judgment.	The abstract notes progression to behavioral involvement in PPA.	"{""explanation"": ""The abstract notes progression to behavioral involvement in PPA."", ""reference"": ""PMID:19300609"", ""snippet"": ""Current diagnostic criteria require the language dysfunction to remain isolated for at least two years, and to remain the salient feature as the disease progresses, usually to involve other domains such as behavior, executive functions, and judgment."", ""supports"": ""SUPPORT""}"
6595	6446	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	0	evidence	0	PMID:19558906	PARTIAL		Histopathologic study revealed 80 % to be benign and 20 % malignant. The risk factors with the strongest association were enlargement of cervical lymphatic nodes and suspicious appearance of the tonsil.	The reference supports that tonsillar enlargement can be a diagnostic sign for malignancies, including lymphoma, but it does not specifically state that primary tonsillar lymphoma is very frequent.	"{""explanation"": ""The reference supports that tonsillar enlargement can be a diagnostic sign for malignancies, including lymphoma, but it does not specifically state that primary tonsillar lymphoma is very frequent."", ""reference"": ""PMID:19558906"", ""snippet"": ""Histopathologic study revealed 80 % to be benign and 20 % malignant. The risk factors with the strongest association were enlargement of cervical lymphatic nodes and suspicious appearance of the tonsil."", ""supports"": ""PARTIAL""}"
6596	6446	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	0	evidence	1	PMID:2190267	PARTIAL		Lymphoma is the second most common neoplasm of the head and neck region and should be considered in the differential diagnosis of any lesion in this region, especially if the typical factors for squamous cell carcinoma are not present.	This reference indicates that lymphoma, including primary tonsillar lymphoma, is common in the head and neck region but does not specify it as very frequent.	"{""explanation"": ""This reference indicates that lymphoma, including primary tonsillar lymphoma, is common in the head and neck region but does not specify it as very frequent."", ""reference"": ""PMID:2190267"", ""snippet"": ""Lymphoma is the second most common neoplasm of the head and neck region and should be considered in the differential diagnosis of any lesion in this region, especially if the typical factors for squamous cell carcinoma are not present."", ""supports"": ""PARTIAL""}"
6597	6446	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	0	evidence	2	PMID:34754855	PARTIAL		Lymphomas are the second most common malignancy of the head and neck. In this region, the vast majority of extranodal lymphomas are located in the palatine tonsil, accounting for about 51%.	The reference supports that primary tonsillar lymphoma is common in the head and neck region but does not specify it as very frequent.	"{""explanation"": ""The reference supports that primary tonsillar lymphoma is common in the head and neck region but does not specify it as very frequent."", ""reference"": ""PMID:34754855"", ""snippet"": ""Lymphomas are the second most common malignancy of the head and neck. In this region, the vast majority of extranodal lymphomas are located in the palatine tonsil, accounting for about 51%."", ""supports"": ""PARTIAL""}"
6598	6446	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	0	evidence	3	PMID:38044117	PARTIAL		Tonsillar Peripheral T-cell Lymphoma Detected by Esophagogastroduodenoscopy.	This reference indicates the occurrence of tonsillar lymphoma but does not provide information on its frequency.	"{""explanation"": ""This reference indicates the occurrence of tonsillar lymphoma but does not provide information on its frequency."", ""reference"": ""PMID:38044117"", ""snippet"": ""Tonsillar Peripheral T-cell Lymphoma Detected by Esophagogastroduodenoscopy."", ""supports"": ""PARTIAL""}"
6599	6447	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	1	evidence	0	PMID:37997620	NO_EVIDENCE		We report a case of primary CLL/SLL of the palatine tonsil in a 51-year-old gentleman who presented with tonsillar asymmetry and obstructive sleep apnea (OSA) but lacked signs and symptoms suspicious for malignancy, including lymphadenopathy and 'B-symptoms.'	The case report of primary CLL/SLL of the palatine tonsil mentioned does not include fever as a symptom.	"{""explanation"": ""The case report of primary CLL/SLL of the palatine tonsil mentioned does not include fever as a symptom."", ""reference"": ""PMID:37997620"", ""snippet"": ""We report a case of primary CLL/SLL of the palatine tonsil in a 51-year-old gentleman who presented with tonsillar asymmetry and obstructive sleep apnea (OSA) but lacked signs and symptoms suspicious for malignancy, including lymphadenopathy and 'B-symptoms.'"", ""supports"": ""NO_EVIDENCE""}"
6600	6447	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	1	evidence	1	PMID:35314548	NO_EVIDENCE		A 52-year-old man presented with palatine tonsillar swelling caused by follicular lymphoma. His tumor burden was low, but exacerbation of snoring and dysphagia was observed.	Fever is not mentioned as a symptom in this case of palatine tonsillar follicular lymphoma.	"{""explanation"": ""Fever is not mentioned as a symptom in this case of palatine tonsillar follicular lymphoma."", ""reference"": ""PMID:35314548"", ""snippet"": ""A 52-year-old man presented with palatine tonsillar swelling caused by follicular lymphoma. His tumor burden was low, but exacerbation of snoring and dysphagia was observed."", ""supports"": ""NO_EVIDENCE""}"
6601	6447	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	1	evidence	2	PMID:28351195	NO_EVIDENCE		Hematolymphoid malignancy was diagnosed in 6 adults by histology/immunohistochemistry: diffuse large B-cell lymphoma (2), small B-cell lymphoma (2), concomitant follicular lymphoma and histiocytic sarcoma (1), and extraosseous plasmacytoma (1).	The study does not mention fever as a common symptom in cases of tonsillar hematolymphoid malignancy.	"{""explanation"": ""The study does not mention fever as a common symptom in cases of tonsillar hematolymphoid malignancy."", ""reference"": ""PMID:28351195"", ""snippet"": ""Hematolymphoid malignancy was diagnosed in 6 adults by histology/immunohistochemistry: diffuse large B-cell lymphoma (2), small B-cell lymphoma (2), concomitant follicular lymphoma and histiocytic sarcoma (1), and extraosseous plasmacytoma (1)."", ""supports"": ""NO_EVIDENCE""}"
6602	6447	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	1	evidence	3	PMID:30639969	NO_EVIDENCE		Burkitt lymphoma (32.6%) followed by diffuse large B-cell lymphoma (DLBCL) (27.0%) were the two most common histological types of tonsillar cancers.	The study on pediatric tonsillar malignancies does not mention fever as a frequent symptom.	"{""explanation"": ""The study on pediatric tonsillar malignancies does not mention fever as a frequent symptom."", ""reference"": ""PMID:30639969"", ""snippet"": ""Burkitt lymphoma (32.6%) followed by diffuse large B-cell lymphoma (DLBCL) (27.0%) were the two most common histological types of tonsillar cancers."", ""supports"": ""NO_EVIDENCE""}"
6603	6447	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	1	evidence	4	PMID:29025800	NO_EVIDENCE		Fever is a common sign of illness in children and is most frequently due to infection. However, when acute and chronic infections have been excluded and when the fever pattern becomes recurrent or periodic, the expanding spectrum of autoinflammatory diseases, including periodic fever syndromes, should be considered.	This study discusses fever in the context of infections and autoinflammatory diseases, not specifically in primary tonsillar lymphoma.	"{""explanation"": ""This study discusses fever in the context of infections and autoinflammatory diseases, not specifically in primary tonsillar lymphoma."", ""reference"": ""PMID:29025800"", ""snippet"": ""Fever is a common sign of illness in children and is most frequently due to infection. However, when acute and chronic infections have been excluded and when the fever pattern becomes recurrent or periodic, the expanding spectrum of autoinflammatory diseases, including periodic fever syndromes, should be considered."", ""supports"": ""NO_EVIDENCE""}"
6604	6448	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	2	evidence	0	PMID:12643362	REFUTE		Tuberculosis and lymphoma are diseases in which night sweats are a dominant symptom, but these are infrequently found to be the cause of night sweats in modern practice.	While lymphoma can cause night sweats, they are not frequently found to be the cause in modern practice, suggesting that night sweats are not a frequent systemic symptom of primary tonsillar lymphoma.	"{""explanation"": ""While lymphoma can cause night sweats, they are not frequently found to be the cause in modern practice, suggesting that night sweats are not a frequent systemic symptom of primary tonsillar lymphoma."", ""reference"": ""PMID:12643362"", ""snippet"": ""Tuberculosis and lymphoma are diseases in which night sweats are a dominant symptom, but these are infrequently found to be the cause of night sweats in modern practice."", ""supports"": ""REFUTE""}"
6605	6448	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	2	evidence	1	PMID:24387945	REFUTE		The presence of B symptoms occurred in only 16% of the patients.	Night sweats are considered a B symptom, and they were present in only 16% of pediatric tonsillar lymphoma cases, indicating that they are not a frequent symptom.	"{""explanation"": ""Night sweats are considered a B symptom, and they were present in only 16% of pediatric tonsillar lymphoma cases, indicating that they are not a frequent symptom."", ""reference"": ""PMID:24387945"", ""snippet"": ""The presence of B symptoms occurred in only 16% of the patients."", ""supports"": ""REFUTE""}"
6606	6449	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	3	evidence	0	PMID:10592134	NO_EVIDENCE		We report six cases of primary tonsillar lymphoma with a median patient age of 42 years... All patients achieved durable complete remission.	The literature does not mention weight loss as a frequent systemic symptom in primary tonsillar lymphoma.	"{""explanation"": ""The literature does not mention weight loss as a frequent systemic symptom in primary tonsillar lymphoma."", ""reference"": ""PMID:10592134"", ""snippet"": ""We report six cases of primary tonsillar lymphoma with a median patient age of 42 years... All patients achieved durable complete remission."", ""supports"": ""NO_EVIDENCE""}"
6607	6449	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	3	evidence	1	PMID:38742359	NO_EVIDENCE		Objective: To analyze the ultrasonic features of tonsillar lymphoma to improve the diagnostic accuracy... Conclusions: The ultrasonic features of tonsillar lymphoma include hypoechoic area, clear boundary, full shape, irregular and uniform internal echo, no or low linear signal of internal blood flow.	The study focuses on the ultrasonic characteristics of tonsillar lymphoma and does not mention systemic symptoms such as weight loss.	"{""explanation"": ""The study focuses on the ultrasonic characteristics of tonsillar lymphoma and does not mention systemic symptoms such as weight loss."", ""reference"": ""PMID:38742359"", ""snippet"": ""Objective: To analyze the ultrasonic features of tonsillar lymphoma to improve the diagnostic accuracy... Conclusions: The ultrasonic features of tonsillar lymphoma include hypoechoic area, clear boundary, full shape, irregular and uniform internal echo, no or low linear signal of internal blood flow."", ""supports"": ""NO_EVIDENCE""}"
6608	6450	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	4	evidence	0	PMID:24387945	SUPPORT		The most common clinical manifestations found in children with lymphoma in palatine tonsils were unilateral tonsillar enlargement (72.7%), alteration in appearance of the tonsil (45.4%) and cervical lymphadenopathy (30.3%).	This reference supports the statement that primary tonsillar lymphoma is frequently associated with lymphadenopathy, particularly in the neck.	"{""explanation"": ""This reference supports the statement that primary tonsillar lymphoma is frequently associated with lymphadenopathy, particularly in the neck."", ""reference"": ""PMID:24387945"", ""snippet"": ""The most common clinical manifestations found in children with lymphoma in palatine tonsils were unilateral tonsillar enlargement (72.7%), alteration in appearance of the tonsil (45.4%) and cervical lymphadenopathy (30.3%)."", ""supports"": ""SUPPORT""}"
6609	6450	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	4	evidence	1	PMID:2190267	PARTIAL		The head and neck is the second most common site for extranodal lymphoma. It can involve virtually any region, including the orbit, paranasal sinuses, Waldeyer's ring, salivary glands, or thyroid.	This reference indicates that lymphoma can frequently involve the head and neck region, which includes the tonsils, but does not specifically mention lymphadenopathy.	"{""explanation"": ""This reference indicates that lymphoma can frequently involve the head and neck region, which includes the tonsils, but does not specifically mention lymphadenopathy."", ""reference"": ""PMID:2190267"", ""snippet"": ""The head and neck is the second most common site for extranodal lymphoma. It can involve virtually any region, including the orbit, paranasal sinuses, Waldeyer's ring, salivary glands, or thyroid."", ""supports"": ""PARTIAL""}"
6610	6450	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	4	evidence	2	PMID:38779794	NO_EVIDENCE		A 30-year-old female patient presented with a swelling of a cervical left lymph node measuring 1x3 cm, which had been presenting for three weeks. Lymph node excision revealed a metastasis of a malignant melanoma, but the primary tumor was not found.	This reference discusses lymphadenopathy in the context of metastatic melanoma, not primary tonsillar lymphoma.	"{""explanation"": ""This reference discusses lymphadenopathy in the context of metastatic melanoma, not primary tonsillar lymphoma."", ""reference"": ""PMID:38779794"", ""snippet"": ""A 30-year-old female patient presented with a swelling of a cervical left lymph node measuring 1x3 cm, which had been presenting for three weeks. Lymph node excision revealed a metastasis of a malignant melanoma, but the primary tumor was not found."", ""supports"": ""NO_EVIDENCE""}"
6611	6450	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	4	evidence	3	PMID:32719287	NO_EVIDENCE		Histiocytic sarcoma (HS) is an extremely rare and aggressive hematopoietic tumor.	This reference is about histiocytic sarcoma, not primary tonsillar lymphoma.	"{""explanation"": ""This reference is about histiocytic sarcoma, not primary tonsillar lymphoma."", ""reference"": ""PMID:32719287"", ""snippet"": ""Histiocytic sarcoma (HS) is an extremely rare and aggressive hematopoietic tumor."", ""supports"": ""NO_EVIDENCE""}"
6612	6451	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	5	evidence	0	PMID:35373599	NO_EVIDENCE		Primary tongue lymphoma is exceedingly rare, with only case reports or small case series in the literature.	The reference discusses the rarity of primary tongue lymphoma, implying that similar conditions like primary tonsillar lymphoma are also rare, but does not provide evidence regarding the frequency of sore throat as a symptom.	"{""explanation"": ""The reference discusses the rarity of primary tongue lymphoma, implying that similar conditions like primary tonsillar lymphoma are also rare, but does not provide evidence regarding the frequency of sore throat as a symptom."", ""reference"": ""PMID:35373599"", ""snippet"": ""Primary tongue lymphoma is exceedingly rare, with only case reports or small case series in the literature."", ""supports"": ""NO_EVIDENCE""}"
6613	6451	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	5	evidence	1	PMID:38742359	NO_EVIDENCE		The ultrasonic features of tonsillar lymphoma include hypoechoic area, clear boundary, full shape, irregular and uniform internal echo, no or low linear signal of internal blood flow.	This reference discusses the ultrasonic features of tonsillar lymphoma but does not provide information on the frequency of sore throat as a symptom.	"{""explanation"": ""This reference discusses the ultrasonic features of tonsillar lymphoma but does not provide information on the frequency of sore throat as a symptom."", ""reference"": ""PMID:38742359"", ""snippet"": ""The ultrasonic features of tonsillar lymphoma include hypoechoic area, clear boundary, full shape, irregular and uniform internal echo, no or low linear signal of internal blood flow."", ""supports"": ""NO_EVIDENCE""}"
6614	6451	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	5	evidence	2	PMID:39080655	NO_EVIDENCE		A 13-year-old girl presented with an unexplained sore throat for more than 2 months, together with intermittent fever and suppurative tonsilitis.	While this case report mentions sore throat as a symptom in a child with extranodal NK/T-cell lymphoma involving the tonsil, it does not provide sufficient evidence to categorize sore throat as a frequent symptom of primary tonsillar lymphoma.	"{""explanation"": ""While this case report mentions sore throat as a symptom in a child with extranodal NK/T-cell lymphoma involving the tonsil, it does not provide sufficient evidence to categorize sore throat as a frequent symptom of primary tonsillar lymphoma."", ""reference"": ""PMID:39080655"", ""snippet"": ""A 13-year-old girl presented with an unexplained sore throat for more than 2 months, together with intermittent fever and suppurative tonsilitis."", ""supports"": ""NO_EVIDENCE""}"
6615	6452	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	6	evidence	0	PMID:3891063	SUPPORT		Tonsillar and base of tongue lesions presented with sore throat and dysphagia, whereas nasopharyngeal lymphomas most commonly presented with nasal, auditory, and cranial nerve sympatomatology.	The study indicates that dysphagia is a common presenting symptom in tonsillar lymphoma.	"{""explanation"": ""The study indicates that dysphagia is a common presenting symptom in tonsillar lymphoma."", ""reference"": ""PMID:3891063"", ""snippet"": ""Tonsillar and base of tongue lesions presented with sore throat and dysphagia, whereas nasopharyngeal lymphomas most commonly presented with nasal, auditory, and cranial nerve sympatomatology."", ""supports"": ""SUPPORT""}"
6616	6452	275	Primary_Tonsillar_Lymphoma	Primary_Tonsillar_Lymphoma.yaml	phenotypes	6	evidence	1	PMID:38044117	SUPPORT		Tonsillar Peripheral T-cell Lymphoma Detected by Esophagogastroduodenoscopy.	Although the specific symptoms are not detailed, the detection of tonsillar lymphoma via esophagogastroduodenoscopy suggests an association with dysphagia.	"{""explanation"": ""Although the specific symptoms are not detailed, the detection of tonsillar lymphoma via esophagogastroduodenoscopy suggests an association with dysphagia."", ""reference"": ""PMID:38044117"", ""snippet"": ""Tonsillar Peripheral T-cell Lymphoma Detected by Esophagogastroduodenoscopy."", ""supports"": ""SUPPORT""}"
6675	6488	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	0	evidence	0	DOI:10.1093/hmg/ddz116	SUPPORT		Common manifestations include skin and bony overgrowth, vascular malformations (VMs), cysts and benign tumors.	This highlights skin and bony overgrowth as common manifestations.	"{""explanation"": ""This highlights skin and bony overgrowth as common manifestations."", ""reference"": ""DOI:10.1093/hmg/ddz116"", ""snippet"": ""Common manifestations include skin and bony overgrowth, vascular malformations (VMs), cysts and benign tumors."", ""supports"": ""SUPPORT""}"
6676	6488	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	0	evidence	1	DOI:10.1055/a-2300-7002	SUPPORT		It is characterized by a disproportionate, asymmetric overgrowth of all types of tissues, provoked by a somatic activating mutation in serine/threonine protein kinase 1.	This describes the characteristic disproportionate overgrowth in Proteus syndrome.	"{""explanation"": ""This describes the characteristic disproportionate overgrowth in Proteus syndrome."", ""reference"": ""DOI:10.1055/a-2300-7002"", ""snippet"": ""It is characterized by a disproportionate, asymmetric overgrowth of all types of tissues, provoked by a somatic activating mutation in serine/threonine protein kinase 1."", ""supports"": ""SUPPORT""}"
6677	6488	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	0	evidence	2	PMID:22876373	SUPPORT		Proteus syndrome (PS) is characterized by progressive segmental or patchy overgrowth most commonly affecting the skeleton, skin, adipose, and central nervous systems.	GeneReviews describes the hallmark progressive segmental overgrowth in Proteus syndrome.	"{""explanation"": ""GeneReviews describes the hallmark progressive segmental overgrowth in Proteus syndrome."", ""reference"": ""PMID:22876373"", ""snippet"": ""Proteus syndrome (PS) is characterized by progressive segmental or patchy overgrowth most commonly affecting the skeleton, skin, adipose, and central nervous systems."", ""supports"": ""SUPPORT""}"
6678	6488	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	0	evidence	3	PMID:33987133	SUPPORT		Proteus syndrome is an extremely rare disorder that manifests as an asymmetric, disproportionate overgrowth of any connective tissue, such as bone, fat or epidermal nevi, in a mosaic or patchy pattern.	This case report emphasizes disproportionate connective tissue overgrowth.	"{""explanation"": ""This case report emphasizes disproportionate connective tissue overgrowth."", ""reference"": ""PMID:33987133"", ""snippet"": ""Proteus syndrome is an extremely rare disorder that manifests as an asymmetric, disproportionate overgrowth of any connective tissue, such as bone, fat or epidermal nevi, in a mosaic or patchy pattern."", ""supports"": ""SUPPORT""}"
6679	6489	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	1	evidence	0	DOI:10.1055/a-2300-7002	SUPPORT		It is characterized by a disproportionate, asymmetric overgrowth of all types of tissues, provoked by a somatic activating mutation in serine/threonine protein kinase 1.	This explicitly describes asymmetric overgrowth as a defining feature.	"{""explanation"": ""This explicitly describes asymmetric overgrowth as a defining feature."", ""reference"": ""DOI:10.1055/a-2300-7002"", ""snippet"": ""It is characterized by a disproportionate, asymmetric overgrowth of all types of tissues, provoked by a somatic activating mutation in serine/threonine protein kinase 1."", ""supports"": ""SUPPORT""}"
6680	6489	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	1	evidence	1	PMID:33987133	SUPPORT		Proteus syndrome is an extremely rare disorder that manifests as an asymmetric, disproportionate overgrowth of any connective tissue, such as bone, fat or epidermal nevi, in a mosaic or patchy pattern.	This case report underscores asymmetric, disproportionate overgrowth.	"{""explanation"": ""This case report underscores asymmetric, disproportionate overgrowth."", ""reference"": ""PMID:33987133"", ""snippet"": ""Proteus syndrome is an extremely rare disorder that manifests as an asymmetric, disproportionate overgrowth of any connective tissue, such as bone, fat or epidermal nevi, in a mosaic or patchy pattern."", ""supports"": ""SUPPORT""}"
6681	6490	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	2	evidence	0	DOI:10.1093/hmg/ddz116	SUPPORT		Common manifestations include skin and bony overgrowth, vascular malformations (VMs), cysts and benign tumors.	This lists vascular malformations among common Proteus syndrome manifestations.	"{""explanation"": ""This lists vascular malformations among common Proteus syndrome manifestations."", ""reference"": ""DOI:10.1093/hmg/ddz116"", ""snippet"": ""Common manifestations include skin and bony overgrowth, vascular malformations (VMs), cysts and benign tumors."", ""supports"": ""SUPPORT""}"
6682	6490	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	2	evidence	1	PMID:33987133	SUPPORT		Many individuals develop cutaneous capillary malformation and prominent varicosities (large and complex vascular malformations).	This documents vascular malformations with prominent varicosities in Proteus syndrome.	"{""explanation"": ""This documents vascular malformations with prominent varicosities in Proteus syndrome."", ""reference"": ""PMID:33987133"", ""snippet"": ""Many individuals develop cutaneous capillary malformation and prominent varicosities (large and complex vascular malformations)."", ""supports"": ""SUPPORT""}"
6683	6491	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	3	evidence	0	DOI:10.1101/mcs.a006134	SUPPORT		The patient has experienced sustained improvement of pain and slowed growth of bilateral plantar cerebriform connective tissue nevi.	This reports cerebriform connective tissue nevi in Proteus syndrome.	"{""explanation"": ""This reports cerebriform connective tissue nevi in Proteus syndrome."", ""reference"": ""DOI:10.1101/mcs.a006134"", ""snippet"": ""The patient has experienced sustained improvement of pain and slowed growth of bilateral plantar cerebriform connective tissue nevi."", ""supports"": ""SUPPORT""}"
6684	6491	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	3	evidence	1	PMID:34668833	SUPPORT		The main histological findings are diffuse patchy overgrowth of skin and subcutaneous tissue, plantar cerebriform connective tissue nevus, and ossification defects.	The case report highlights cerebriform connective tissue nevi as a key histologic finding.	"{""explanation"": ""The case report highlights cerebriform connective tissue nevi as a key histologic finding."", ""reference"": ""PMID:34668833"", ""snippet"": ""The main histological findings are diffuse patchy overgrowth of skin and subcutaneous tissue, plantar cerebriform connective tissue nevus, and ossification defects."", ""supports"": ""SUPPORT""}"
6685	6492	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	4	evidence	0	PMID:33987133	SUPPORT		Proteus syndrome is an extremely rare disorder that manifests as an asymmetric, disproportionate overgrowth of any connective tissue, such as bone, fat or epidermal nevi, in a mosaic or patchy pattern.	This case report includes epidermal nevi among overgrowth manifestations.	"{""explanation"": ""This case report includes epidermal nevi among overgrowth manifestations."", ""reference"": ""PMID:33987133"", ""snippet"": ""Proteus syndrome is an extremely rare disorder that manifests as an asymmetric, disproportionate overgrowth of any connective tissue, such as bone, fat or epidermal nevi, in a mosaic or patchy pattern."", ""supports"": ""SUPPORT""}"
6686	6493	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	5	evidence	0	PMID:33987133	SUPPORT		Many individuals develop cutaneous capillary malformation and prominent varicosities (large and complex vascular malformations).	This documents cutaneous capillary malformations in Proteus syndrome.	"{""explanation"": ""This documents cutaneous capillary malformations in Proteus syndrome."", ""reference"": ""PMID:33987133"", ""snippet"": ""Many individuals develop cutaneous capillary malformation and prominent varicosities (large and complex vascular malformations)."", ""supports"": ""SUPPORT""}"
6687	6494	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	6	evidence	0	PMID:33987133	SUPPORT		Many individuals develop cutaneous capillary malformation and prominent varicosities (large and complex vascular malformations).	Prominent varicosities are reported as part of Proteus syndrome vascular disease.	"{""explanation"": ""Prominent varicosities are reported as part of Proteus syndrome vascular disease."", ""reference"": ""PMID:33987133"", ""snippet"": ""Many individuals develop cutaneous capillary malformation and prominent varicosities (large and complex vascular malformations)."", ""supports"": ""SUPPORT""}"
6688	6495	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	7	evidence	0	DOI:10.1101/mcs.a006134	SUPPORT		The patient has experienced sustained improvement of pain and slowed growth of bilateral plantar cerebriform connective tissue nevi.	Pain is reported as a symptom improved with targeted therapy.	"{""explanation"": ""Pain is reported as a symptom improved with targeted therapy."", ""reference"": ""DOI:10.1101/mcs.a006134"", ""snippet"": ""The patient has experienced sustained improvement of pain and slowed growth of bilateral plantar cerebriform connective tissue nevi."", ""supports"": ""SUPPORT""}"
6689	6496	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	8	evidence	0	DOI:10.1038/s41598-021-86029-0	SUPPORT		The cardiothoracic findings of Proteus syndrome were diverse, but several were much more common and included: scoliosis from bony overgrowth (94%), pulmonary venous dilation (62%), band-like areas of lung scarring (56%), and hyperlucent lung parenchyma (50%).	This provides cohort evidence for scoliosis due to bony overgrowth.	"{""explanation"": ""This provides cohort evidence for scoliosis due to bony overgrowth."", ""reference"": ""DOI:10.1038/s41598-021-86029-0"", ""snippet"": ""The cardiothoracic findings of Proteus syndrome were diverse, but several were much more common and included: scoliosis from bony overgrowth (94%), pulmonary venous dilation (62%), band-like areas of lung scarring (56%), and hyperlucent lung parenchyma (50%)."", ""supports"": ""SUPPORT""}"
6690	6497	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	9	evidence	0	DOI:10.1186/s13023-023-03013-9	SUPPORT		Individuals with Proteus syndrome can develop emphysematous and cystic changes of the lung that may lead to progressive respiratory symptoms and require surgical intervention.	This documents emphysematous lung changes in Proteus syndrome.	"{""explanation"": ""This documents emphysematous lung changes in Proteus syndrome."", ""reference"": ""DOI:10.1186/s13023-023-03013-9"", ""snippet"": ""Individuals with Proteus syndrome can develop emphysematous and cystic changes of the lung that may lead to progressive respiratory symptoms and require surgical intervention."", ""supports"": ""SUPPORT""}"
6691	6498	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	10	evidence	0	DOI:10.1186/s13023-023-03013-9	SUPPORT		Individuals with Proteus syndrome can develop emphysematous and cystic changes of the lung that may lead to progressive respiratory symptoms and require surgical intervention.	This supports cystic lung changes in Proteus syndrome.	"{""explanation"": ""This supports cystic lung changes in Proteus syndrome."", ""reference"": ""DOI:10.1186/s13023-023-03013-9"", ""snippet"": ""Individuals with Proteus syndrome can develop emphysematous and cystic changes of the lung that may lead to progressive respiratory symptoms and require surgical intervention."", ""supports"": ""SUPPORT""}"
6692	6499	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	11	evidence	0	PMID:22876373	SUPPORT		It is associated with a range of tumors, pulmonary complications, and a striking predisposition to deep vein thrombosis and pulmonary embolism.	GeneReviews documents a predisposition to deep vein thrombosis in Proteus syndrome.	"{""explanation"": ""GeneReviews documents a predisposition to deep vein thrombosis in Proteus syndrome."", ""reference"": ""PMID:22876373"", ""snippet"": ""It is associated with a range of tumors, pulmonary complications, and a striking predisposition to deep vein thrombosis and pulmonary embolism."", ""supports"": ""SUPPORT""}"
6693	6499	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	11	evidence	1	PMID:33987133	SUPPORT		Thus, Proteus syndrome patients are at risk of developing deep vein thrombosis and pulmonary embolism.	This case report confirms thrombotic risk in Proteus syndrome.	"{""explanation"": ""This case report confirms thrombotic risk in Proteus syndrome."", ""reference"": ""PMID:33987133"", ""snippet"": ""Thus, Proteus syndrome patients are at risk of developing deep vein thrombosis and pulmonary embolism."", ""supports"": ""SUPPORT""}"
6694	6500	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	12	evidence	0	PMID:22876373	SUPPORT		It is associated with a range of tumors, pulmonary complications, and a striking predisposition to deep vein thrombosis and pulmonary embolism.	GeneReviews identifies pulmonary embolism as a complication in Proteus syndrome.	"{""explanation"": ""GeneReviews identifies pulmonary embolism as a complication in Proteus syndrome."", ""reference"": ""PMID:22876373"", ""snippet"": ""It is associated with a range of tumors, pulmonary complications, and a striking predisposition to deep vein thrombosis and pulmonary embolism."", ""supports"": ""SUPPORT""}"
6695	6500	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	12	evidence	1	PMID:33987133	SUPPORT		Thus, Proteus syndrome patients are at risk of developing deep vein thrombosis and pulmonary embolism.	This case report reiterates risk of pulmonary embolism.	"{""explanation"": ""This case report reiterates risk of pulmonary embolism."", ""reference"": ""PMID:33987133"", ""snippet"": ""Thus, Proteus syndrome patients are at risk of developing deep vein thrombosis and pulmonary embolism."", ""supports"": ""SUPPORT""}"
6696	6501	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	13	evidence	0	PMID:37692275	SUPPORT		Lipomas can run in families (familial multiple lipomatosis) or be a part of genetic syndromes such as PTEN hamartoma tumor syndrome, Proteus syndrome, and Pai syndrome.	This review lists lipomas as part of Proteus syndrome presentations.	"{""explanation"": ""This review lists lipomas as part of Proteus syndrome presentations."", ""reference"": ""PMID:37692275"", ""snippet"": ""Lipomas can run in families (familial multiple lipomatosis) or be a part of genetic syndromes such as PTEN hamartoma tumor syndrome, Proteus syndrome, and Pai syndrome."", ""supports"": ""SUPPORT""}"
6697	6502	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	14	evidence	0	PMID:36113118	SUPPORT		Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen.	This case report documents limbal dermoid in Proteus syndrome.	"{""explanation"": ""This case report documents limbal dermoid in Proteus syndrome."", ""reference"": ""PMID:36113118"", ""snippet"": ""Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen."", ""supports"": ""SUPPORT""}"
6698	6503	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	15	evidence	0	PMID:36113118	SUPPORT		Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen.	The report lists unilateral cataract among ophthalmic anomalies.	"{""explanation"": ""The report lists unilateral cataract among ophthalmic anomalies."", ""reference"": ""PMID:36113118"", ""snippet"": ""Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen."", ""supports"": ""SUPPORT""}"
6699	6504	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	16	evidence	0	PMID:36113118	SUPPORT		Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen.	Bilateral nystagmus is reported in a Proteus syndrome patient.	"{""explanation"": ""Bilateral nystagmus is reported in a Proteus syndrome patient."", ""reference"": ""PMID:36113118"", ""snippet"": ""Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen."", ""supports"": ""SUPPORT""}"
6700	6505	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	17	evidence	0	PMID:36113118	SUPPORT		Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen.	Severe myopia is included among the ophthalmic anomalies.	"{""explanation"": ""Severe myopia is included among the ophthalmic anomalies."", ""reference"": ""PMID:36113118"", ""snippet"": ""Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen."", ""supports"": ""SUPPORT""}"
6701	6506	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	18	evidence	0	PMID:36113118	SUPPORT		Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen.	Optic nerve head drusen are reported in a Proteus syndrome patient.	"{""explanation"": ""Optic nerve head drusen are reported in a Proteus syndrome patient."", ""reference"": ""PMID:36113118"", ""snippet"": ""Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen."", ""supports"": ""SUPPORT""}"
6702	6507	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	19	evidence	0	PMID:37975355	SUPPORT		Her proptosis and vision impairment were relieved after Endoscope-Navigation system (ENS)-aided optic canal decompression.	This case report documents proptosis in Proteus syndrome.	"{""explanation"": ""This case report documents proptosis in Proteus syndrome."", ""reference"": ""PMID:37975355"", ""snippet"": ""Her proptosis and vision impairment were relieved after Endoscope-Navigation system (ENS)-aided optic canal decompression."", ""supports"": ""SUPPORT""}"
6703	6508	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	20	evidence	0	PMID:37975355	SUPPORT		Her proptosis and vision impairment were relieved after Endoscope-Navigation system (ENS)-aided optic canal decompression.	Vision impairment is reported among ocular manifestations.	"{""explanation"": ""Vision impairment is reported among ocular manifestations."", ""reference"": ""PMID:37975355"", ""snippet"": ""Her proptosis and vision impairment were relieved after Endoscope-Navigation system (ENS)-aided optic canal decompression."", ""supports"": ""SUPPORT""}"
6704	6509	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	21	evidence	0	DOI:10.1136/jmg-2024-110173	SUPPORT		AKT1-related Proteus syndrome is an ultra-rare mosaic overgrowth disorder with tumour predisposition.	This systematic review establishes tumor predisposition in Proteus syndrome.	"{""explanation"": ""This systematic review establishes tumor predisposition in Proteus syndrome."", ""reference"": ""DOI:10.1136/jmg-2024-110173"", ""snippet"": ""AKT1-related Proteus syndrome is an ultra-rare mosaic overgrowth disorder with tumour predisposition."", ""supports"": ""SUPPORT""}"
6705	6509	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	21	evidence	1	PMID:22876373	SUPPORT		It is associated with a range of tumors, pulmonary complications, and a striking predisposition to deep vein thrombosis and pulmonary embolism.	GeneReviews notes association with a range of tumors.	"{""explanation"": ""GeneReviews notes association with a range of tumors."", ""reference"": ""PMID:22876373"", ""snippet"": ""It is associated with a range of tumors, pulmonary complications, and a striking predisposition to deep vein thrombosis and pulmonary embolism."", ""supports"": ""SUPPORT""}"
6706	6509	276	Proteus syndrome	Proteus_syndrome.yaml	phenotypes	21	evidence	2	PMID:38074478	SUPPORT		We report a 35-year-old patient with PS, who underwent successful surgical removal of a well-differentiated SNEC obstructing his nasal cavity	This case report documents sinonasal neuroendocrine carcinoma in Proteus syndrome.	"{""explanation"": ""This case report documents sinonasal neuroendocrine carcinoma in Proteus syndrome."", ""reference"": ""PMID:38074478"", ""snippet"": ""We report a 35-year-old patient with PS, who underwent successful surgical removal of a well-differentiated SNEC obstructing his nasal cavity"", ""supports"": ""SUPPORT""}"
6714	6515	277	Prurigo Nodularis	Prurigo_Nodularis.yaml	phenotypes	0	evidence	0	PMID:38345154	SUPPORT		intensely pruritic nodules on the skin.	The abstract describes PN as intensely pruritic.	"{""explanation"": ""The abstract describes PN as intensely pruritic."", ""reference"": ""PMID:38345154"", ""snippet"": ""intensely pruritic nodules on the skin."", ""supports"": ""SUPPORT""}"
6715	6516	277	Prurigo Nodularis	Prurigo_Nodularis.yaml	phenotypes	1	evidence	0	PMID:38345154	SUPPORT		intensely pruritic nodules on the skin.	The abstract states that PN is characterized by nodules on the skin.	"{""explanation"": ""The abstract states that PN is characterized by nodules on the skin."", ""reference"": ""PMID:38345154"", ""snippet"": ""intensely pruritic nodules on the skin."", ""supports"": ""SUPPORT""}"
6726	6539	278	Psoriasis	Psoriasis.yaml	phenotypes	1	evidence	0	PMID:39576422	SUPPORT		Psoriasis represents a chronic autoimmune skin condition defined by various clinical forms, including inverse, erythrodermic, pustular, guttate, plaque types.	The various clinical forms of psoriasis, particularly plaque type, are characterized by silvery scales resulting from rapid keratinocyte turnover and incomplete differentiation.	"{""explanation"": ""The various clinical forms of psoriasis, particularly plaque type, are characterized by silvery scales resulting from rapid keratinocyte turnover and incomplete differentiation."", ""reference"": ""PMID:39576422"", ""snippet"": ""Psoriasis represents a chronic autoimmune skin condition defined by various clinical forms, including inverse, erythrodermic, pustular, guttate, plaque types."", ""supports"": ""SUPPORT""}"
6733	6555	279	Psoriatic Arthritis	Psoriatic_Arthritis.yaml	phenotypes	0	evidence	0	PMID:36902329	SUPPORT		Psoriatic arthritis (PsA), a heterogeneous chronic inflammatory immune-mediated disease characterized by musculoskeletal inflammation (arthritis, enthesitis, spondylitis, and dactylitis), generally occurs in patients with psoriasis.	The abstract explicitly lists arthritis as a key manifestation.	"{""explanation"": ""The abstract explicitly lists arthritis as a key manifestation."", ""reference"": ""PMID:36902329"", ""snippet"": ""Psoriatic arthritis (PsA), a heterogeneous chronic inflammatory immune-mediated disease characterized by musculoskeletal inflammation (arthritis, enthesitis, spondylitis, and dactylitis), generally occurs in patients with psoriasis."", ""supports"": ""SUPPORT""}"
6734	6556	279	Psoriatic Arthritis	Psoriatic_Arthritis.yaml	phenotypes	1	evidence	0	PMID:36902329	SUPPORT		Psoriatic arthritis (PsA), a heterogeneous chronic inflammatory immune-mediated disease characterized by musculoskeletal inflammation (arthritis, enthesitis, spondylitis, and dactylitis), generally occurs in patients with psoriasis.	Enthesitis is listed among the musculoskeletal manifestations of PsA.	"{""explanation"": ""Enthesitis is listed among the musculoskeletal manifestations of PsA."", ""reference"": ""PMID:36902329"", ""snippet"": ""Psoriatic arthritis (PsA), a heterogeneous chronic inflammatory immune-mediated disease characterized by musculoskeletal inflammation (arthritis, enthesitis, spondylitis, and dactylitis), generally occurs in patients with psoriasis."", ""supports"": ""SUPPORT""}"
6735	6557	279	Psoriatic Arthritis	Psoriatic_Arthritis.yaml	phenotypes	2	evidence	0	PMID:36902329	SUPPORT		Psoriatic arthritis (PsA), a heterogeneous chronic inflammatory immune-mediated disease characterized by musculoskeletal inflammation (arthritis, enthesitis, spondylitis, and dactylitis), generally occurs in patients with psoriasis.	Spondylitis is listed among the musculoskeletal manifestations of PsA.	"{""explanation"": ""Spondylitis is listed among the musculoskeletal manifestations of PsA."", ""reference"": ""PMID:36902329"", ""snippet"": ""Psoriatic arthritis (PsA), a heterogeneous chronic inflammatory immune-mediated disease characterized by musculoskeletal inflammation (arthritis, enthesitis, spondylitis, and dactylitis), generally occurs in patients with psoriasis."", ""supports"": ""SUPPORT""}"
6736	6558	279	Psoriatic Arthritis	Psoriatic_Arthritis.yaml	phenotypes	3	evidence	0	PMID:36902329	SUPPORT		PsA is also associated with uveitis and inflammatory bowel disease (Crohn's disease and ulcerative colitis).	The abstract notes uveitis as an associated manifestation of PsA.	"{""explanation"": ""The abstract notes uveitis as an associated manifestation of PsA."", ""reference"": ""PMID:36902329"", ""snippet"": ""PsA is also associated with uveitis and inflammatory bowel disease (Crohn's disease and ulcerative colitis)."", ""supports"": ""SUPPORT""}"
6750	6658	284	Rabies	Rabies.yaml	phenotypes	0	evidence	0	PMID:12144896	SUPPORT		Rabies is an acute, progressive, incurable viral encephalitis.	Rabies presents as infectious encephalitis.	"{""explanation"": ""Rabies presents as infectious encephalitis."", ""reference"": ""PMID:12144896"", ""snippet"": ""Rabies is an acute, progressive, incurable viral encephalitis."", ""supports"": ""SUPPORT""}"
6779	6687	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	phenotypes	0	evidence	0	PMID:19931071	SUPPORT	HUMAN_CLINICAL	Other metabolic abnormalities, such as hypokalemia and hypomagnesemia, may also occur, along with sodium and fluid retention.	Sodium and fluid retention during refeeding supports edema as a clinical manifestation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Sodium and fluid retention during refeeding supports edema as a clinical manifestation."", ""reference"": ""PMID:19931071"", ""snippet"": ""Other metabolic abnormalities, such as hypokalemia and hypomagnesemia, may also occur, along with sodium and fluid retention."", ""supports"": ""SUPPORT""}"
6780	6688	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	phenotypes	1	evidence	0	PMID:19278172	SUPPORT	HUMAN_CLINICAL	Potential complications of RFS include fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency, and hematologic derangements.	This directly lists cardiac arrhythmia as a complication of refeeding syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This directly lists cardiac arrhythmia as a complication of refeeding syndrome."", ""reference"": ""PMID:19278172"", ""snippet"": ""Potential complications of RFS include fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency, and hematologic derangements."", ""supports"": ""SUPPORT""}"
6781	6689	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	phenotypes	2	evidence	0	PMID:19278172	SUPPORT	HUMAN_CLINICAL	Potential complications of RFS include fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency, and hematologic derangements.	This lists systolic heart failure as a complication of refeeding syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This lists systolic heart failure as a complication of refeeding syndrome."", ""reference"": ""PMID:19278172"", ""snippet"": ""Potential complications of RFS include fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency, and hematologic derangements."", ""supports"": ""SUPPORT""}"
6782	6690	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	phenotypes	3	evidence	0	PMID:39310593	SUPPORT	HUMAN_CLINICAL	the myocardial sequence was disturbed with fibrosis.	This case report notes fibrosis and architectural disturbance in myocardium.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This case report notes fibrosis and architectural disturbance in myocardium."", ""reference"": ""PMID:39310593"", ""snippet"": ""the myocardial sequence was disturbed with fibrosis."", ""supports"": ""SUPPORT""}"
6783	6691	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	phenotypes	4	evidence	0	PMID:19278172	SUPPORT	HUMAN_CLINICAL	Potential complications of RFS include fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency, and hematologic derangements.	This directly lists respiratory insufficiency as a complication of refeeding syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This directly lists respiratory insufficiency as a complication of refeeding syndrome."", ""reference"": ""PMID:19278172"", ""snippet"": ""Potential complications of RFS include fatal cardiac arrhythmia, systolic heart failure, respiratory insufficiency, and hematologic derangements."", ""supports"": ""SUPPORT""}"
6784	6692	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	phenotypes	5	evidence	0	PMID:41239620	SUPPORT	HUMAN_CLINICAL	Prolonged energy deficiency disrupts hematopoietic function, resulting in pancytopenia.	This case report notes pancytopenia in the context of severe malnutrition and refeeding syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This case report notes pancytopenia in the context of severe malnutrition and refeeding syndrome."", ""reference"": ""PMID:41239620"", ""snippet"": ""Prolonged energy deficiency disrupts hematopoietic function, resulting in pancytopenia."", ""supports"": ""SUPPORT""}"
6785	6693	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	phenotypes	6	evidence	0	PMID:41171118	SUPPORT	HUMAN_CLINICAL	RS itself becomes the cause of subsequent systemic complications such as respiratory failure, neurological disorders, circulatory failure or seizures.	This review lists seizures among systemic complications of refeeding syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This review lists seizures among systemic complications of refeeding syndrome."", ""reference"": ""PMID:41171118"", ""snippet"": ""RS itself becomes the cause of subsequent systemic complications such as respiratory failure, neurological disorders, circulatory failure or seizures."", ""supports"": ""SUPPORT""}"
6786	6694	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	phenotypes	7	evidence	0	PMID:38054139	SUPPORT	HUMAN_CLINICAL	received total parenteral nutrition (TPN) on the first day, but this led to delirium due to refeeding syndrome.	This case report describes delirium attributed to refeeding syndrome after initiating TPN.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This case report describes delirium attributed to refeeding syndrome after initiating TPN."", ""reference"": ""PMID:38054139"", ""snippet"": ""received total parenteral nutrition (TPN) on the first day, but this led to delirium due to refeeding syndrome."", ""supports"": ""SUPPORT""}"
6787	6694	285	Refeeding Syndrome	Refeeding_Syndrome.yaml	phenotypes	7	evidence	1	PMID:39033818	SUPPORT	HUMAN_CLINICAL	The incidence of delirium in critically ill patients is high and associated with refeeding hypophosphatemia.	This retrospective study reports high delirium incidence associated with refeeding hypophosphatemia, supporting a common frequency.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This retrospective study reports high delirium incidence associated with refeeding hypophosphatemia, supporting a common frequency."", ""reference"": ""PMID:39033818"", ""snippet"": ""The incidence of delirium in critically ill patients is high and associated with refeeding hypophosphatemia."", ""supports"": ""SUPPORT""}"
6801	6706	286	Renal Cell Carcinoma	Renal_Cell_Carcinoma.yaml	phenotypes	0	evidence	0	PMID:6625621	SUPPORT		Hematuria is an important symptom, and in our series 46% of the patients with renal cell carcinomas were conscious of macrohematuria as an initial symptom.	The abstract identifies hematuria as an important presenting symptom of RCC.	"{""explanation"": ""The abstract identifies hematuria as an important presenting symptom of RCC."", ""reference"": ""PMID:6625621"", ""snippet"": ""Hematuria is an important symptom, and in our series 46% of the patients with renal cell carcinomas were conscious of macrohematuria as an initial symptom."", ""supports"": ""SUPPORT""}"
6802	6707	286	Renal Cell Carcinoma	Renal_Cell_Carcinoma.yaml	phenotypes	1	evidence	0	PMID:6625621	SUPPORT		As an initial symptom, a mass was palpable in 8% and flank pain was felt in 13% of the patients with renal cell carcinomas.	The abstract reports flank pain as an initial symptom in RCC patients.	"{""explanation"": ""The abstract reports flank pain as an initial symptom in RCC patients."", ""reference"": ""PMID:6625621"", ""snippet"": ""As an initial symptom, a mass was palpable in 8% and flank pain was felt in 13% of the patients with renal cell carcinomas."", ""supports"": ""SUPPORT""}"
6820	6732	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	phenotypes	0	evidence	0	PMID:31236539	SUPPORT		To propose and test the validity of a new syndrome called retrograde cricopharyngeus dysfunction (R-CPD) that explains inability to belch and the associated symptoms of loud gurgling noises, chest and abdominal pain/distention, and excessive flatulence	This landmark paper defined R-CPD and established inability to belch as the cardinal feature.	"{""explanation"": ""This landmark paper defined R-CPD and established inability to belch as the cardinal feature."", ""reference"": ""PMID:31236539"", ""snippet"": ""To propose and test the validity of a new syndrome called retrograde cricopharyngeus dysfunction (R-CPD) that explains inability to belch and the associated symptoms of loud gurgling noises, chest and abdominal pain/distention, and excessive flatulence"", ""supports"": ""SUPPORT""}"
6821	6732	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	phenotypes	0	evidence	1	PMID:37621856	SUPPORT		A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019.	The Pavesi 2023 case report reiterates inability to burp as the defining symptom of R-CPD.	"{""explanation"": ""The Pavesi 2023 case report reiterates inability to burp as the defining symptom of R-CPD."", ""reference"": ""PMID:37621856"", ""snippet"": ""A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019."", ""supports"": ""SUPPORT""}"
6822	6732	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	phenotypes	0	evidence	2	PMID:38767031	SUPPORT		The incapacity to belch is the hallmark of the disease.	The Jiménez-Castillo 2025 series states the hallmark symptom is inability to belch.	"{""explanation"": ""The Jiménez-Castillo 2025 series states the hallmark symptom is inability to belch."", ""reference"": ""PMID:38767031"", ""snippet"": ""The incapacity to belch is the hallmark of the disease."", ""supports"": ""SUPPORT""}"
6823	6732	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	phenotypes	0	evidence	3	PMID:36054518	SUPPORT		The inability to burp (98.8%), bloating (92.9%), gurgling noises (31.8%), and excessive flatulence (21.2%) were the most common symptoms.	The Jefferson case series quantifies inability to burp as the dominant presenting symptom.	"{""explanation"": ""The Jefferson case series quantifies inability to burp as the dominant presenting symptom."", ""reference"": ""PMID:36054518"", ""snippet"": ""The inability to burp (98.8%), bloating (92.9%), gurgling noises (31.8%), and excessive flatulence (21.2%) were the most common symptoms."", ""supports"": ""SUPPORT""}"
6824	6732	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	phenotypes	0	evidence	4	PMID:38115814	SUPPORT		99% reported inability to burp, 98% reported abdominal bloating, 93% reported socially awkward gurgling noises, 89% reported excessive flatulence.	Survey data reinforce inability to burp as near-universal among affected patients.	"{""explanation"": ""Survey data reinforce inability to burp as near-universal among affected patients."", ""reference"": ""PMID:38115814"", ""snippet"": ""99% reported inability to burp, 98% reported abdominal bloating, 93% reported socially awkward gurgling noises, 89% reported excessive flatulence."", ""supports"": ""SUPPORT""}"
6825	6733	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	phenotypes	1	evidence	0	PMID:35122356	SUPPORT		The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence.	Bloating (abdominal distention) is described as part of the core symptom complex of R-CPD.	"{""explanation"": ""Bloating (abdominal distention) is described as part of the core symptom complex of R-CPD."", ""reference"": ""PMID:35122356"", ""snippet"": ""The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."", ""supports"": ""SUPPORT""}"
6826	6733	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	phenotypes	1	evidence	1	PMID:37621856	SUPPORT		A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019.	The Pavesi 2023 case report lists abdominal bloating as a key symptom.	"{""explanation"": ""The Pavesi 2023 case report lists abdominal bloating as a key symptom."", ""reference"": ""PMID:37621856"", ""snippet"": ""A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019."", ""supports"": ""SUPPORT""}"
6827	6733	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	phenotypes	1	evidence	2	PMID:38115814	SUPPORT		99% reported inability to burp, 98% reported abdominal bloating, 93% reported socially awkward gurgling noises, 89% reported excessive flatulence.	Community survey data show abdominal bloating affects nearly all respondents with R-CPD.	"{""explanation"": ""Community survey data show abdominal bloating affects nearly all respondents with R-CPD."", ""reference"": ""PMID:38115814"", ""snippet"": ""99% reported inability to burp, 98% reported abdominal bloating, 93% reported socially awkward gurgling noises, 89% reported excessive flatulence."", ""supports"": ""SUPPORT""}"
6828	6734	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	phenotypes	2	evidence	0	PMID:35122356	SUPPORT		The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence.	Chest pain is identified as a core symptom of retrograde UES dysfunction.	"{""explanation"": ""Chest pain is identified as a core symptom of retrograde UES dysfunction."", ""reference"": ""PMID:35122356"", ""snippet"": ""The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."", ""supports"": ""SUPPORT""}"
6829	6735	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	phenotypes	3	evidence	0	PMID:35122356	SUPPORT		The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence.	Nausea is described as part of the symptom complex associated with R-CPD.	"{""explanation"": ""Nausea is described as part of the symptom complex associated with R-CPD."", ""reference"": ""PMID:35122356"", ""snippet"": ""The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."", ""supports"": ""SUPPORT""}"
6830	6736	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	phenotypes	4	evidence	0	PMID:31236539	SUPPORT		To propose and test the validity of a new syndrome called retrograde cricopharyngeus dysfunction (R-CPD) that explains inability to belch and the associated symptoms of loud gurgling noises, chest and abdominal pain/distention, and excessive flatulence	Loud gurgling noises are described as a core feature of R-CPD.	"{""explanation"": ""Loud gurgling noises are described as a core feature of R-CPD."", ""reference"": ""PMID:31236539"", ""snippet"": ""To propose and test the validity of a new syndrome called retrograde cricopharyngeus dysfunction (R-CPD) that explains inability to belch and the associated symptoms of loud gurgling noises, chest and abdominal pain/distention, and excessive flatulence"", ""supports"": ""SUPPORT""}"
6831	6736	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	phenotypes	4	evidence	1	PMID:37621856	SUPPORT		A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019.	Gurgling noises from the chest and lower neck are highlighted among the presenting symptoms.	"{""explanation"": ""Gurgling noises from the chest and lower neck are highlighted among the presenting symptoms."", ""reference"": ""PMID:37621856"", ""snippet"": ""A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019."", ""supports"": ""SUPPORT""}"
6832	6736	288	Retrograde Cricopharyngeus Dysfunction	Retrograde_Cricopharyngeus_Dysfunction.yaml	phenotypes	4	evidence	2	PMID:38115814	SUPPORT		99% reported inability to burp, 98% reported abdominal bloating, 93% reported socially awkward gurgling noises, 89% reported excessive flatulence.	Survey responses show gurgling noises are frequent in R-CPD.	"{""explanation"": ""Survey responses show gurgling noises are frequent in R-CPD."", ""reference"": ""PMID:38115814"", ""snippet"": ""99% reported inability to burp, 98% reported abdominal bloating, 93% reported socially awkward gurgling noises, 89% reported excessive flatulence."", ""supports"": ""SUPPORT""}"
6844	6744	289	Rett Syndrome	Rett_Syndrome.yaml	phenotypes	0	evidence	0	PMID:10508514	SUPPORT		Patients with classic RTT appear to develop normally until 6-18 months of age, then gradually lose speech and purposeful hand use	Original discovery paper documents developmental regression with loss of speech and hand skills as hallmark of Rett syndrome.	"{""explanation"": ""Original discovery paper documents developmental regression with loss of speech and hand skills as hallmark of Rett syndrome."", ""reference"": ""PMID:10508514"", ""snippet"": ""Patients with classic RTT appear to develop normally until 6-18 months of age, then gradually lose speech and purposeful hand use"", ""supports"": ""SUPPORT""}"
6845	6745	289	Rett Syndrome	Rett_Syndrome.yaml	phenotypes	1	evidence	0	PMID:10508514	SUPPORT		develop microcephaly, seizures, autism, ataxia, intermittent hyperventilation and stereotypic hand movements	Original discovery paper identifies stereotypic hand movements as core feature of Rett syndrome.	"{""explanation"": ""Original discovery paper identifies stereotypic hand movements as core feature of Rett syndrome."", ""reference"": ""PMID:10508514"", ""snippet"": ""develop microcephaly, seizures, autism, ataxia, intermittent hyperventilation and stereotypic hand movements"", ""supports"": ""SUPPORT""}"
6846	6746	289	Rett Syndrome	Rett_Syndrome.yaml	phenotypes	2	evidence	0	PMID:10508514	SUPPORT		develop microcephaly, seizures, autism, ataxia, intermittent hyperventilation and stereotypic hand movements	Original discovery paper lists ataxia as a cardinal feature of Rett syndrome.	"{""explanation"": ""Original discovery paper lists ataxia as a cardinal feature of Rett syndrome."", ""reference"": ""PMID:10508514"", ""snippet"": ""develop microcephaly, seizures, autism, ataxia, intermittent hyperventilation and stereotypic hand movements"", ""supports"": ""SUPPORT""}"
6847	6747	289	Rett Syndrome	Rett_Syndrome.yaml	phenotypes	3	evidence	0	PMID:10508514	SUPPORT		develop microcephaly, seizures, autism, ataxia, intermittent hyperventilation and stereotypic hand movements	Original discovery paper lists microcephaly as a cardinal feature of Rett syndrome.	"{""explanation"": ""Original discovery paper lists microcephaly as a cardinal feature of Rett syndrome."", ""reference"": ""PMID:10508514"", ""snippet"": ""develop microcephaly, seizures, autism, ataxia, intermittent hyperventilation and stereotypic hand movements"", ""supports"": ""SUPPORT""}"
6848	6748	289	Rett Syndrome	Rett_Syndrome.yaml	phenotypes	4	evidence	0	PMID:10508514	SUPPORT		develop microcephaly, seizures, autism, ataxia, intermittent hyperventilation and stereotypic hand movements	Original discovery paper lists seizures as a cardinal feature of Rett syndrome.	"{""explanation"": ""Original discovery paper lists seizures as a cardinal feature of Rett syndrome."", ""reference"": ""PMID:10508514"", ""snippet"": ""develop microcephaly, seizures, autism, ataxia, intermittent hyperventilation and stereotypic hand movements"", ""supports"": ""SUPPORT""}"
6849	6749	289	Rett Syndrome	Rett_Syndrome.yaml	phenotypes	5	evidence	0	PMID:23103540	SUPPORT		hyperventilation and apnea during wakefulness were present in all patients	Study confirms breathing abnormalities including hyperventilation and apnea are universal in Rett syndrome patients.	"{""explanation"": ""Study confirms breathing abnormalities including hyperventilation and apnea are universal in Rett syndrome patients."", ""reference"": ""PMID:23103540"", ""snippet"": ""hyperventilation and apnea during wakefulness were present in all patients"", ""supports"": ""SUPPORT""}"
6919	6784	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	0	evidence	0	PMID:29848426	PARTIAL		More than 50% patients with JIA have joint deformities. Joint deformities are more likely to be seen in children with long-standing disease, those with polyarthritis JIA and seropositive patients.	This supports the association between polyarthritis and joint deformity, but it is specific to Juvenile Idiopathic Arthritis (JIA) and does not fully address symmetric polyarthritis in RA.	"{""explanation"": ""This supports the association between polyarthritis and joint deformity, but it is specific to Juvenile Idiopathic Arthritis (JIA) and does not fully address symmetric polyarthritis in RA."", ""reference"": ""PMID:29848426"", ""snippet"": ""More than 50% patients with JIA have joint deformities. Joint deformities are more likely to be seen in children with long-standing disease, those with polyarthritis JIA and seropositive patients."", ""supports"": ""PARTIAL""}"
6920	6784	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	0	evidence	1	PMID:37410796	SUPPORT		Incident RA presents mainly as symmetric arthritis.	This literature clearly supports that RA often presents as symmetric arthritis, aligning with the statement.	"{""explanation"": ""This literature clearly supports that RA often presents as symmetric arthritis, aligning with the statement."", ""reference"": ""PMID:37410796"", ""snippet"": ""Incident RA presents mainly as symmetric arthritis."", ""supports"": ""SUPPORT""}"
6921	6784	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	0	evidence	2	PMID:37158761	SUPPORT		Symmetrical involvement of the hand joints is described as characteristic of rheumatoid arthritis (RA).	This reference reinforces that symmetric polyarthritis is characteristic of RA, supporting the statement.	"{""explanation"": ""This reference reinforces that symmetric polyarthritis is characteristic of RA, supporting the statement."", ""reference"": ""PMID:37158761"", ""snippet"": ""Symmetrical involvement of the hand joints is described as characteristic of rheumatoid arthritis (RA)."", ""supports"": ""SUPPORT""}"
6922	6784	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	0	evidence	3	PMID:22035393	PARTIAL		Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disorder affecting multiple organ systems, joints, ligaments, and bones and commonly involves the cervical spine.	While this reference mentions systemic and joint involvement, it does not specifically address symmetric polyarthritis or its frequency.	"{""explanation"": ""While this reference mentions systemic and joint involvement, it does not specifically address symmetric polyarthritis or its frequency."", ""reference"": ""PMID:22035393"", ""snippet"": ""Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disorder affecting multiple organ systems, joints, ligaments, and bones and commonly involves the cervical spine."", ""supports"": ""PARTIAL""}"
6923	6784	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	0	evidence	4	PMID:11358413	SUPPORT		RA is now thought to be associated with a conserved sequence of amino acids in a number of HLA-DRB1 alleles, called the RA shared epitope	This suggests a genetic predisposition to more severe and chronic forms of RA, which could include symmetric polyarthritis, thus supporting the statement.	"{""explanation"": ""This suggests a genetic predisposition to more severe and chronic forms of RA, which could include symmetric polyarthritis, thus supporting the statement."", ""reference"": ""PMID:11358413"", ""snippet"": ""RA is now thought to be associated with a conserved sequence of amino acids in a number of HLA-DRB1 alleles, called the RA shared epitope"", ""supports"": ""SUPPORT""}"
6924	6785	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	1	evidence	0	PMID:26403254	SUPPORT		These recommendations serve to guide rheumatologists and other stakeholders on the assessment and management of morning stiffness.	The literature states that morning stiffness is a significant symptom in rheumatoid arthritis (RA) and is commonly associated with functional disability and pain. This supports the statement that morning stiffness is a common phenotype in RA.	"{""explanation"": ""The literature states that morning stiffness is a significant symptom in rheumatoid arthritis (RA) and is commonly associated with functional disability and pain. This supports the statement that morning stiffness is a common phenotype in RA."", ""reference"": ""PMID:26403254"", ""snippet"": ""These recommendations serve to guide rheumatologists and other stakeholders on the assessment and management of morning stiffness."", ""supports"": ""SUPPORT""}"
6925	6785	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	1	evidence	1	PMID:36544060	SUPPORT		Rheumatoid arthritis symptoms follow a 24 h circadian rhythm and exhibit high thresholds of pain, functional disability, and stiffness predominantly early in the morning.	This excerpt confirms that morning stiffness is a frequent and notable symptom in rheumatoid arthritis, aligning with the frequency and naming attributes in the statement.	"{""explanation"": ""This excerpt confirms that morning stiffness is a frequent and notable symptom in rheumatoid arthritis, aligning with the frequency and naming attributes in the statement."", ""reference"": ""PMID:36544060"", ""snippet"": ""Rheumatoid arthritis symptoms follow a 24 h circadian rhythm and exhibit high thresholds of pain, functional disability, and stiffness predominantly early in the morning."", ""supports"": ""SUPPORT""}"
6926	6785	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	1	evidence	2	PMID:30936222	NO_EVIDENCE			The reference does not provide relevant information regarding morning stiffness as a phenotype or its commonality in rheumatoid arthritis.	"{""explanation"": ""The reference does not provide relevant information regarding morning stiffness as a phenotype or its commonality in rheumatoid arthritis."", ""reference"": ""PMID:30936222"", ""snippet"": """", ""supports"": ""NO_EVIDENCE""}"
6927	6785	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	1	evidence	3	PMID:25437284	NO_EVIDENCE			While the reference discusses early symptoms of RA, it does not specifically mention morning stiffness as a common phenotype.	"{""explanation"": ""While the reference discusses early symptoms of RA, it does not specifically mention morning stiffness as a common phenotype."", ""reference"": ""PMID:25437284"", ""snippet"": """", ""supports"": ""NO_EVIDENCE""}"
6928	6785	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	1	evidence	4	PMID:24461540	SUPPORT		The typical symptoms are bilateral aching of the shoulder girdle, associated with morning stiffness.	The reference notes that morning stiffness is a symptom associated with polymyalgia rheumatica and also mentions its relevance in diagnosing inflammatory rheumatic diseases, which includes RA.	"{""explanation"": ""The reference notes that morning stiffness is a symptom associated with polymyalgia rheumatica and also mentions its relevance in diagnosing inflammatory rheumatic diseases, which includes RA."", ""reference"": ""PMID:24461540"", ""snippet"": ""The typical symptoms are bilateral aching of the shoulder girdle, associated with morning stiffness."", ""supports"": ""SUPPORT""}"
6929	6786	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	2	evidence	0	PMID:25005390	SUPPORT		Many of these people experience pain, inflammation, stiffness, reduced mobility and joint function, and fatigue.	The literature supports that fatigue is a common symptom experienced by people with rheumatoid arthritis.	"{""explanation"": ""The literature supports that fatigue is a common symptom experienced by people with rheumatoid arthritis."", ""reference"": ""PMID:25005390"", ""snippet"": ""Many of these people experience pain, inflammation, stiffness, reduced mobility and joint function, and fatigue."", ""supports"": ""SUPPORT""}"
6930	6786	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	2	evidence	1	PMID:26803313	SUPPORT		Fatigue occurs in all chronic inflammatory diseases, in cancer, and in some neurological conditions.	This supports the notion that fatigue is a common systemic phenotype in rheumatoid arthritis.	"{""explanation"": ""This supports the notion that fatigue is a common systemic phenotype in rheumatoid arthritis."", ""reference"": ""PMID:26803313"", ""snippet"": ""Fatigue occurs in all chronic inflammatory diseases, in cancer, and in some neurological conditions."", ""supports"": ""SUPPORT""}"
6931	6786	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	2	evidence	2	PMID:38643104	SUPPORT		Patients with RA reported worse outcomes for all PROMs than those with CSA or UA.	This study highlights the high burden of fatigue among patients with RA, supporting fatigue as a common systemic phenotype.	"{""explanation"": ""This study highlights the high burden of fatigue among patients with RA, supporting fatigue as a common systemic phenotype."", ""reference"": ""PMID:38643104"", ""snippet"": ""Patients with RA reported worse outcomes for all PROMs than those with CSA or UA."", ""supports"": ""SUPPORT""}"
6932	6787	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	3	evidence	0	PMID:15163106	SUPPORT		Extra-articular RA (ExRA) includes a wide variety of disease manifestations... ExRA manifestations are not uncommon, explain excess mortality in RA and are predicted by smoking and autoantibodies.	The abstract mentions that extra-articular manifestations are not uncommon in RA, suggesting that these phenotypes occur occasionally.	"{""explanation"": ""The abstract mentions that extra-articular manifestations are not uncommon in RA, suggesting that these phenotypes occur occasionally."", ""reference"": ""PMID:15163106"", ""snippet"": ""Extra-articular RA (ExRA) includes a wide variety of disease manifestations... ExRA manifestations are not uncommon, explain excess mortality in RA and are predicted by smoking and autoantibodies."", ""supports"": ""SUPPORT""}"
6933	6787	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	3	evidence	1	PMID:17544962	SUPPORT		Rheumatoid nodules are the most common extra-articular manifestation of rheumatoid arthritis.	Rheumatoid nodules are identified as the most common extra-articular manifestation, reinforcing their occurrence in RA.	"{""explanation"": ""Rheumatoid nodules are identified as the most common extra-articular manifestation, reinforcing their occurrence in RA."", ""reference"": ""PMID:17544962"", ""snippet"": ""Rheumatoid nodules are the most common extra-articular manifestation of rheumatoid arthritis."", ""supports"": ""SUPPORT""}"
6934	6787	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	3	evidence	2	PMID:27151711	SUPPORT		Rheumatoid nodules (RNs) are one of the most frequent extra-articular manifestations of RA.	The abstract indicates that rheumatoid nodules are among the most frequent extra-articular manifestations, supporting their occasional presence as noted in the given statement.	"{""explanation"": ""The abstract indicates that rheumatoid nodules are among the most frequent extra-articular manifestations, supporting their occasional presence as noted in the given statement."", ""reference"": ""PMID:27151711"", ""snippet"": ""Rheumatoid nodules (RNs) are one of the most frequent extra-articular manifestations of RA."", ""supports"": ""SUPPORT""}"
6935	6787	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	3	evidence	3	PMID:7354699	SUPPORT		Rheumatoid nodules were seen in two cases and granulomatous areas surrounding cricothyroid joints were noted in two others.	The study reports instances of rheumatoid nodules, demonstrating their occurrence as extra-articular manifestations, albeit not specifying frequency.	"{""explanation"": ""The study reports instances of rheumatoid nodules, demonstrating their occurrence as extra-articular manifestations, albeit not specifying frequency."", ""reference"": ""PMID:7354699"", ""snippet"": ""Rheumatoid nodules were seen in two cases and granulomatous areas surrounding cricothyroid joints were noted in two others."", ""supports"": ""SUPPORT""}"
6936	6787	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	3	evidence	4	PMID:8465574	SUPPORT		Late-onset RA patients ... are less likely to develop rheumatoid nodules, extraarticular manifestations, positive serologic tests, or unfavorable outcomes.	The abstract notes that rheumatoid nodules occur less frequently in late-onset RA, which indirectly supports their occasional prevalence in the general RA population.	"{""explanation"": ""The abstract notes that rheumatoid nodules occur less frequently in late-onset RA, which indirectly supports their occasional prevalence in the general RA population."", ""reference"": ""PMID:8465574"", ""snippet"": ""Late-onset RA patients ... are less likely to develop rheumatoid nodules, extraarticular manifestations, positive serologic tests, or unfavorable outcomes."", ""supports"": ""SUPPORT""}"
6937	6787	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	3	evidence	5	PMID:37740125	SUPPORT		Pulmonary accelerated rheumatoid nodules (ARN) represent a rare occurrence within the context of rheumatoid arthritis (RA)... multiple bilateral pulmonary nodules.	The review provides specific cases of pulmonary rheumatoid nodules, confirming their occasional manifestation as an extra-articular feature.	"{""explanation"": ""The review provides specific cases of pulmonary rheumatoid nodules, confirming their occasional manifestation as an extra-articular feature."", ""reference"": ""PMID:37740125"", ""snippet"": ""Pulmonary accelerated rheumatoid nodules (ARN) represent a rare occurrence within the context of rheumatoid arthritis (RA)... multiple bilateral pulmonary nodules."", ""supports"": ""SUPPORT""}"
6938	6788	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	4	evidence	0	PMID:15163106	PARTIAL		Extra-articular RA (ExRA) includes a wide variety of disease manifestations... ExRA manifestations are not uncommon, explain excess mortality in RA and are predicted by smoking and autoantibodies.	The reference confirms that extra-articular manifestations in RA are common, but does not specifically address the frequency of interstitial lung disease.	"{""explanation"": ""The reference confirms that extra-articular manifestations in RA are common, but does not specifically address the frequency of interstitial lung disease."", ""reference"": ""PMID:15163106"", ""snippet"": ""Extra-articular RA (ExRA) includes a wide variety of disease manifestations... ExRA manifestations are not uncommon, explain excess mortality in RA and are predicted by smoking and autoantibodies."", ""supports"": ""PARTIAL""}"
6939	6788	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	4	evidence	1	PMID:38411210	PARTIAL		RA-associated interstitial lung disease (RA-ILD) is a major contributor to mortality, with no decline in incidence and scant therapeutic options.	The reference confirms RA-ILD as a significant extra-articular manifestation, but it does not detail its specific frequency.	"{""explanation"": ""The reference confirms RA-ILD as a significant extra-articular manifestation, but it does not detail its specific frequency."", ""reference"": ""PMID:38411210"", ""snippet"": ""RA-associated interstitial lung disease (RA-ILD) is a major contributor to mortality, with no decline in incidence and scant therapeutic options."", ""supports"": ""PARTIAL""}"
6940	6788	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	4	evidence	2	PMID:31376890	PARTIAL		The most common intrathoracic manifestations of RA include interstitial lung disease, airway disease, pleural disease, rheumatoid nodules, and drug-induced toxicity.	The reference indicates that interstitial lung disease is a common pulmonary manifestation of RA, but does not quantify how often it occurs.	"{""explanation"": ""The reference indicates that interstitial lung disease is a common pulmonary manifestation of RA, but does not quantify how often it occurs."", ""reference"": ""PMID:31376890"", ""snippet"": ""The most common intrathoracic manifestations of RA include interstitial lung disease, airway disease, pleural disease, rheumatoid nodules, and drug-induced toxicity."", ""supports"": ""PARTIAL""}"
6941	6789	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	5	evidence	0	PMID:2661577	SUPPORT		The pathology of the boutonniere begins with a synovitis of the joint, followed by elongation al the central slip, subluxation of the later bands, and contracture of the retinacular ligaments.	The reference describes the occurrence of boutonniere deformity in the context of rheumatoid arthritis, supporting the statement that it is a frequent musculoskeletal issue associated with this condition.	"{""explanation"": ""The reference describes the occurrence of boutonniere deformity in the context of rheumatoid arthritis, supporting the statement that it is a frequent musculoskeletal issue associated with this condition."", ""reference"": ""PMID:2661577"", ""snippet"": ""The pathology of the boutonniere begins with a synovitis of the joint, followed by elongation al the central slip, subluxation of the later bands, and contracture of the retinacular ligaments."", ""supports"": ""SUPPORT""}"
6942	6789	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	5	evidence	1	PMID:34628456	SUPPORT		Bone erosion can be observed at the DIP joint in patients with RA, and these cases frequently shows bone erosions of other finger joints, such as PIP joint.	The study indicates that bone erosions, including those leading to deformities like boutonniere, are common in rheumatoid arthritis patients.	"{""explanation"": ""The study indicates that bone erosions, including those leading to deformities like boutonniere, are common in rheumatoid arthritis patients."", ""reference"": ""PMID:34628456"", ""snippet"": ""Bone erosion can be observed at the DIP joint in patients with RA, and these cases frequently shows bone erosions of other finger joints, such as PIP joint."", ""supports"": ""SUPPORT""}"
6943	6789	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	5	evidence	2	PMID:19474183	SUPPORT		The average working space volume was 4921 cc in rheumatoid patients with no visible hand deformity and 1154 cc in the presence of combined finger deformities (P < 0.005).	This reference discusses the prevalence of hand deformities in rheumatoid arthritis, indicating that such deformities, including boutonniere, significantly impact the working space of the hand.	"{""explanation"": ""This reference discusses the prevalence of hand deformities in rheumatoid arthritis, indicating that such deformities, including boutonniere, significantly impact the working space of the hand."", ""reference"": ""PMID:19474183"", ""snippet"": ""The average working space volume was 4921 cc in rheumatoid patients with no visible hand deformity and 1154 cc in the presence of combined finger deformities (P < 0.005)."", ""supports"": ""SUPPORT""}"
6944	6790	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	6	evidence	0	PMID:2661576	SUPPORT		It is important to evaluate each swan-neck deformity to determine the mobility and radiographic condition of the PIP joint.	The reference discusses the evaluation and treatment of swan-neck deformity in the context of rheumatoid arthritis, supporting the association between rheumatoid arthritis and swan-neck deformity.	"{""explanation"": ""The reference discusses the evaluation and treatment of swan-neck deformity in the context of rheumatoid arthritis, supporting the association between rheumatoid arthritis and swan-neck deformity."", ""reference"": ""PMID:2661576"", ""snippet"": ""It is important to evaluate each swan-neck deformity to determine the mobility and radiographic condition of the PIP joint."", ""supports"": ""SUPPORT""}"
6945	6791	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	7	evidence	0	PMID:33346115	REFUTE		Secondary Sjögren's syndrome and pulmonary manifestations are observed in almost 10% of patients, also in the early disease	The statement claims that Sicca Syndrome (secondary Sjogren's syndrome) is an occasional extra-articular manifestation of Rheumatoid Arthritis. However, the literature indicates that it occurs in almost 10% of RA patients, suggesting it is not merely occasional but more common.	"{""explanation"": ""The statement claims that Sicca Syndrome (secondary Sjogren's syndrome) is an occasional extra-articular manifestation of Rheumatoid Arthritis. However, the literature indicates that it occurs in almost 10% of RA patients, suggesting it is not merely occasional but more common."", ""reference"": ""PMID:33346115"", ""snippet"": ""Secondary Sjögren's syndrome and pulmonary manifestations are observed in almost 10% of patients, also in the early disease"", ""supports"": ""REFUTE""}"
6946	6791	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	7	evidence	1	PMID:27424016	REFUTE		Our results demonstrated that the prevalence of sSS was 5.9% (CI:0.6%-10.5%). Number of 27.7% of RA patients positively responded to at least one question about sicca symptoms.	The study found that secondary Sjogren's syndrome (sSS) has a prevalence of 5.9% among RA patients, and 27.7% of RA patients reported sicca symptoms. This indicates that sSS is not just an occasional manifestation but occurs with a higher frequency.	"{""explanation"": ""The study found that secondary Sjogren's syndrome (sSS) has a prevalence of 5.9% among RA patients, and 27.7% of RA patients reported sicca symptoms. This indicates that sSS is not just an occasional manifestation but occurs with a higher frequency."", ""reference"": ""PMID:27424016"", ""snippet"": ""Our results demonstrated that the prevalence of sSS was 5.9% (CI:0.6%-10.5%). Number of 27.7% of RA patients positively responded to at least one question about sicca symptoms."", ""supports"": ""REFUTE""}"
6947	6792	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	8	evidence	0	PMID:20559644	SUPPORT		The main spectrum of eye involvement comprises keratoconjunctivitis sicca, episcleritis and scleritis as well as ulcerative keratitis.	This reference indicates that scleritis is part of the spectrum of eye involvement in rheumatoid arthritis, supporting the statement.	"{""explanation"": ""This reference indicates that scleritis is part of the spectrum of eye involvement in rheumatoid arthritis, supporting the statement."", ""reference"": ""PMID:20559644"", ""snippet"": ""The main spectrum of eye involvement comprises keratoconjunctivitis sicca, episcleritis and scleritis as well as ulcerative keratitis."", ""supports"": ""SUPPORT""}"
6948	6792	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	8	evidence	1	PMID:37344292	SUPPORT		Rheumatoid arthritis and systemic vasculitides, particularly antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides, are the main autoimmune causes of scleritis and episcleritis.	This reference supports that scleritis is associated with rheumatoid arthritis.	"{""explanation"": ""This reference supports that scleritis is associated with rheumatoid arthritis."", ""reference"": ""PMID:37344292"", ""snippet"": ""Rheumatoid arthritis and systemic vasculitides, particularly antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides, are the main autoimmune causes of scleritis and episcleritis."", ""supports"": ""SUPPORT""}"
6949	6792	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	8	evidence	2	PMID:30412434	SUPPORT		Rheumatoid arthritis and Wegener granulomatosis were the 2 most common systemic associations among our cohort.	This reference confirms that rheumatoid arthritis is a common systemic association with scleritis.	"{""explanation"": ""This reference confirms that rheumatoid arthritis is a common systemic association with scleritis."", ""reference"": ""PMID:30412434"", ""snippet"": ""Rheumatoid arthritis and Wegener granulomatosis were the 2 most common systemic associations among our cohort."", ""supports"": ""SUPPORT""}"
6950	6792	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	8	evidence	3	PMID:10879785	SUPPORT		Ocular manifestations commonly include episcleritis, scleritis, conjunctivitis, iridocyclitis, chorioretinitis, and proptosis.	This reference supports the association between rheumatoid arthritis and scleritis.	"{""explanation"": ""This reference supports the association between rheumatoid arthritis and scleritis."", ""reference"": ""PMID:10879785"", ""snippet"": ""Ocular manifestations commonly include episcleritis, scleritis, conjunctivitis, iridocyclitis, chorioretinitis, and proptosis."", ""supports"": ""SUPPORT""}"
6951	6793	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	9	evidence	0	PMID:33216192	SUPPORT		Pericarditis is the term for inflammatory involvement of the pericardium, which can be associated with pericardial effusion and myocardial involvement (perimyocarditis). Pericarditis can be present in the context of systemic inflammatory rheumatic diseases but can also constitute a distinct disease entity.	This reference confirms that pericarditis can be present in systemic inflammatory rheumatic diseases, including rheumatoid arthritis, indicating it can occur as a cardiovascular manifestation.	"{""explanation"": ""This reference confirms that pericarditis can be present in systemic inflammatory rheumatic diseases, including rheumatoid arthritis, indicating it can occur as a cardiovascular manifestation."", ""reference"": ""PMID:33216192"", ""snippet"": ""Pericarditis is the term for inflammatory involvement of the pericardium, which can be associated with pericardial effusion and myocardial involvement (perimyocarditis). Pericarditis can be present in the context of systemic inflammatory rheumatic diseases but can also constitute a distinct disease entity."", ""supports"": ""SUPPORT""}"
6952	6793	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	9	evidence	1	PMID:11055006	SUPPORT		Pericardial effusion is common in patients with rheumatoid arthritis. It is essentially a sign of pericardial involvement of the rheumatoid disease.	This reference directly states that pericardial effusion, which is indicative of pericarditis, is common in rheumatoid arthritis patients, supporting the statement.	"{""explanation"": ""This reference directly states that pericardial effusion, which is indicative of pericarditis, is common in rheumatoid arthritis patients, supporting the statement."", ""reference"": ""PMID:11055006"", ""snippet"": ""Pericardial effusion is common in patients with rheumatoid arthritis. It is essentially a sign of pericardial involvement of the rheumatoid disease."", ""supports"": ""SUPPORT""}"
6953	6794	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	10	evidence	0	PMID:1862580	SUPPORT		Felty's syndrome (FS) consists of the triad: rheumatoid arthritis (RA), leukopenia and splenomegaly. FS occurs in approximately 1% of patients with RA.	The literature confirms that Felty's Syndrome is a hematologic condition associated with rheumatoid arthritis, occurring occasionally (approximately 1% of patients with RA).	"{""explanation"": ""The literature confirms that Felty's Syndrome is a hematologic condition associated with rheumatoid arthritis, occurring occasionally (approximately 1% of patients with RA)."", ""reference"": ""PMID:1862580"", ""snippet"": ""Felty's syndrome (FS) consists of the triad: rheumatoid arthritis (RA), leukopenia and splenomegaly. FS occurs in approximately 1% of patients with RA."", ""supports"": ""SUPPORT""}"
6954	6794	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	10	evidence	1	PMID:12455813	SUPPORT		The hematological manifestations can be conveniently categorized into the broad areas of; anemia, particularly NSAID induced iron deficiency anemia and the anemia of chronic disease, neutropenia, particularly Felty's syndrome and the large granular lymphocyte syndrome and drug induced neutropenia.	The literature supports that Felty's Syndrome is a hematologic manifestation of rheumatoid arthritis, occurring occasionally.	"{""explanation"": ""The literature supports that Felty's Syndrome is a hematologic manifestation of rheumatoid arthritis, occurring occasionally."", ""reference"": ""PMID:12455813"", ""snippet"": ""The hematological manifestations can be conveniently categorized into the broad areas of; anemia, particularly NSAID induced iron deficiency anemia and the anemia of chronic disease, neutropenia, particularly Felty's syndrome and the large granular lymphocyte syndrome and drug induced neutropenia."", ""supports"": ""SUPPORT""}"
6955	6794	290	Rheumatoid Arthritis	Rheumatoid_Arthritis.yaml	phenotypes	10	evidence	2	PMID:312016	SUPPORT		Thus, patients with rheumatoid arthritis without overt splenic enlargement may have pathophysiologic Felty's syndrome, and in vitro studies such as these may be used to define this process.	The literature supports that Felty's Syndrome is associated with rheumatoid arthritis, even in the absence of splenomegaly, indicating it as a hematologic condition.	"{""explanation"": ""The literature supports that Felty's Syndrome is associated with rheumatoid arthritis, even in the absence of splenomegaly, indicating it as a hematologic condition."", ""reference"": ""PMID:312016"", ""snippet"": ""Thus, patients with rheumatoid arthritis without overt splenic enlargement may have pathophysiologic Felty's syndrome, and in vitro studies such as these may be used to define this process."", ""supports"": ""SUPPORT""}"
6997	6815	291	Roifman-syndrome	Roifman-syndrome.yaml	phenotypes	0	evidence	0	PMID:35450878	PARTIAL		Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency. We wish to add to the available literature by reporting two brothers with clinical, radiological and immunological features of Roifman syndrome, confirmed on whole exome sequencing.	The reference confirms that Roifman syndrome is an immunologic disorder and mentions immunodeficiency, but it does not provide explicit details about the frequency or severity of recurrent infections.	"{""explanation"": ""The reference confirms that Roifman syndrome is an immunologic disorder and mentions immunodeficiency, but it does not provide explicit details about the frequency or severity of recurrent infections."", ""reference"": ""PMID:35450878"", ""snippet"": ""Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency. We wish to add to the available literature by reporting two brothers with clinical, radiological and immunological features of Roifman syndrome, confirmed on whole exome sequencing."", ""supports"": ""PARTIAL""}"
6998	6815	291	Roifman-syndrome	Roifman-syndrome.yaml	phenotypes	0	evidence	1	PMID:33059947	PARTIAL		Roifman syndrome is an allelic disorder of MOPD I that is characterized by immunodeficiency complications.	The reference describes Roifman syndrome as having immunodeficiency complications, but does not specifically mention the frequency or severity of recurrent infections.	"{""explanation"": ""The reference describes Roifman syndrome as having immunodeficiency complications, but does not specifically mention the frequency or severity of recurrent infections."", ""reference"": ""PMID:33059947"", ""snippet"": ""Roifman syndrome is an allelic disorder of MOPD I that is characterized by immunodeficiency complications."", ""supports"": ""PARTIAL""}"
6999	6816	291	Roifman-syndrome	Roifman-syndrome.yaml	phenotypes	1	evidence	0	PMID:35450878	PARTIAL		Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency... New radiological features are also described here which may assist in the diagnosis of other patients.	The reference mentions new radiological features but does not explicitly confirm that growth retardation and skeletal abnormalities are very frequent in Roifman syndrome.	"{""explanation"": ""The reference mentions new radiological features but does not explicitly confirm that growth retardation and skeletal abnormalities are very frequent in Roifman syndrome."", ""reference"": ""PMID:35450878"", ""snippet"": ""Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency... New radiological features are also described here which may assist in the diagnosis of other patients."", ""supports"": ""PARTIAL""}"
7000	6816	291	Roifman-syndrome	Roifman-syndrome.yaml	phenotypes	1	evidence	1	PMID:29265708	PARTIAL		RNU4ATAC pathogenic variants to date have been associated with microcephalic osteodysplastic primordial dwarfism, type 1 and Roifman syndrome. Both conditions are clinically distinct skeletal dysplasias... Some of the overlapping features of the two conditions include developmental delay, microcephaly, and immune deficiency.	The reference mentions Roifman syndrome as a skeletal dysplasia with developmental delay and microcephaly, but does not explicitly confirm short stature and skeletal abnormalities as very frequent.	"{""explanation"": ""The reference mentions Roifman syndrome as a skeletal dysplasia with developmental delay and microcephaly, but does not explicitly confirm short stature and skeletal abnormalities as very frequent."", ""reference"": ""PMID:29265708"", ""snippet"": ""RNU4ATAC pathogenic variants to date have been associated with microcephalic osteodysplastic primordial dwarfism, type 1 and Roifman syndrome. Both conditions are clinically distinct skeletal dysplasias... Some of the overlapping features of the two conditions include developmental delay, microcephaly, and immune deficiency."", ""supports"": ""PARTIAL""}"
7001	6817	291	Roifman-syndrome	Roifman-syndrome.yaml	phenotypes	2	evidence	0	PMID:21910238	SUPPORT		The results confirmed a stable pattern of intellectual disability, and indicated that Roifman syndrome may be associated with major structural neuro-anatomical abnormalities.	The literature confirms that intellectual disability is a feature of Roifman syndrome.	"{""explanation"": ""The literature confirms that intellectual disability is a feature of Roifman syndrome."", ""reference"": ""PMID:21910238"", ""snippet"": ""The results confirmed a stable pattern of intellectual disability, and indicated that Roifman syndrome may be associated with major structural neuro-anatomical abnormalities."", ""supports"": ""SUPPORT""}"
7002	6818	291	Roifman-syndrome	Roifman-syndrome.yaml	phenotypes	3	evidence	0	PMID:35450878	PARTIAL		We wish to add to the available literature by reporting two brothers with clinical, radiological and immunological features of Roifman syndrome, confirmed on whole exome sequencing. ... New radiological features are also described here which may assist in the diagnosis of other patients.	The abstract mentions clinical features of Roifman syndrome, but it does not provide specific details about craniofacial dysmorphic features such as a small head or broad nasal bridge. Therefore, the support is partial.	"{""explanation"": ""The abstract mentions clinical features of Roifman syndrome, but it does not provide specific details about craniofacial dysmorphic features such as a small head or broad nasal bridge. Therefore, the support is partial."", ""reference"": ""PMID:35450878"", ""snippet"": ""We wish to add to the available literature by reporting two brothers with clinical, radiological and immunological features of Roifman syndrome, confirmed on whole exome sequencing. ... New radiological features are also described here which may assist in the diagnosis of other patients."", ""supports"": ""PARTIAL""}"
7003	6819	291	Roifman-syndrome	Roifman-syndrome.yaml	phenotypes	4	evidence	0	PMID:8172269	NO_EVIDENCE		We studied 573 patients with the Marfan syndrome for the presence of ocular misalignment, refractive errors, and amblyopia. A total of 110 patients (19.2%) had strabismus.	The study focuses on the prevalence of strabismus in Marfan syndrome, not Roifman syndrome.	"{""explanation"": ""The study focuses on the prevalence of strabismus in Marfan syndrome, not Roifman syndrome."", ""reference"": ""PMID:8172269"", ""snippet"": ""We studied 573 patients with the Marfan syndrome for the presence of ocular misalignment, refractive errors, and amblyopia. A total of 110 patients (19.2%) had strabismus."", ""supports"": ""NO_EVIDENCE""}"
7004	6819	291	Roifman-syndrome	Roifman-syndrome.yaml	phenotypes	4	evidence	1	PMID:4988135	NO_EVIDENCE		Heredity and strabismus.	The reference discusses the hereditary nature of strabismus but does not mention Roifman syndrome.	"{""explanation"": ""The reference discusses the hereditary nature of strabismus but does not mention Roifman syndrome."", ""reference"": ""PMID:4988135"", ""snippet"": ""Heredity and strabismus."", ""supports"": ""NO_EVIDENCE""}"
7021	6832	292	SADDAN	SADDAN.yaml	phenotypes	0	evidence	0	PMID:38993719	SUPPORT		We administered GH therapy for a markedly short stature.	Case report explicitly notes markedly short stature in a patient with SADDAN.	"{""explanation"": ""Case report explicitly notes markedly short stature in a patient with SADDAN."", ""reference"": ""PMID:38993719"", ""snippet"": ""We administered GH therapy for a markedly short stature."", ""supports"": ""SUPPORT""}"
7022	6833	292	SADDAN	SADDAN.yaml	phenotypes	1	evidence	0	PMID:24352917	SUPPORT		Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) is an extremely rare severe skeletal dysplasia characterized by significant developmental delay, brain structural abnormalities, hearing loss, and acanthosis nigricans.	The abstract states SADDAN is characterized by significant developmental delay.	"{""explanation"": ""The abstract states SADDAN is characterized by significant developmental delay."", ""reference"": ""PMID:24352917"", ""snippet"": ""Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) is an extremely rare severe skeletal dysplasia characterized by significant developmental delay, brain structural abnormalities, hearing loss, and acanthosis nigricans."", ""supports"": ""SUPPORT""}"
7023	6834	292	SADDAN	SADDAN.yaml	phenotypes	2	evidence	0	PMID:24352917	SUPPORT		Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) is an extremely rare severe skeletal dysplasia characterized by significant developmental delay, brain structural abnormalities, hearing loss, and acanthosis nigricans.	The abstract lists acanthosis nigricans as a defining feature of SADDAN.	"{""explanation"": ""The abstract lists acanthosis nigricans as a defining feature of SADDAN."", ""reference"": ""PMID:24352917"", ""snippet"": ""Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) is an extremely rare severe skeletal dysplasia characterized by significant developmental delay, brain structural abnormalities, hearing loss, and acanthosis nigricans."", ""supports"": ""SUPPORT""}"
7024	6834	292	SADDAN	SADDAN.yaml	phenotypes	2	evidence	1	PMID:10377013	SUPPORT		In addition to skeletal dysplasia, progressive acanthosis nigricans, and central nervous system structural anomalies, seizures and severe developmental delays are observed in surviving SADDAN patients.	The phenotypic analysis reports progressive acanthosis nigricans in SADDAN.	"{""explanation"": ""The phenotypic analysis reports progressive acanthosis nigricans in SADDAN."", ""reference"": ""PMID:10377013"", ""snippet"": ""In addition to skeletal dysplasia, progressive acanthosis nigricans, and central nervous system structural anomalies, seizures and severe developmental delays are observed in surviving SADDAN patients."", ""supports"": ""SUPPORT""}"
7025	6835	292	SADDAN	SADDAN.yaml	phenotypes	3	evidence	0	PMID:10377013	SUPPORT		In addition to skeletal dysplasia, progressive acanthosis nigricans, and central nervous system structural anomalies, seizures and severe developmental delays are observed in surviving SADDAN patients.	The phenotypic analysis reports seizures in SADDAN.	"{""explanation"": ""The phenotypic analysis reports seizures in SADDAN."", ""reference"": ""PMID:10377013"", ""snippet"": ""In addition to skeletal dysplasia, progressive acanthosis nigricans, and central nervous system structural anomalies, seizures and severe developmental delays are observed in surviving SADDAN patients."", ""supports"": ""SUPPORT""}"
7026	6836	292	SADDAN	SADDAN.yaml	phenotypes	4	evidence	0	PMID:24352917	SUPPORT		Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) is an extremely rare severe skeletal dysplasia characterized by significant developmental delay, brain structural abnormalities, hearing loss, and acanthosis nigricans.	The abstract lists hearing loss as a characteristic feature of SADDAN.	"{""explanation"": ""The abstract lists hearing loss as a characteristic feature of SADDAN."", ""reference"": ""PMID:24352917"", ""snippet"": ""Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) is an extremely rare severe skeletal dysplasia characterized by significant developmental delay, brain structural abnormalities, hearing loss, and acanthosis nigricans."", ""supports"": ""SUPPORT""}"
7027	6837	292	SADDAN	SADDAN.yaml	phenotypes	5	evidence	0	PMID:19039991	SUPPORT		severe central nervous system structural abnormalities, consisting of the absence of right cerebral hemisphere (hydranencephaly), ventricular dilatation, both indicating congenital brain malformation, and porencephaly indicating destructive brain damages.	Case report describes hydranencephaly in a SADDAN patient.	"{""explanation"": ""Case report describes hydranencephaly in a SADDAN patient."", ""reference"": ""PMID:19039991"", ""snippet"": ""severe central nervous system structural abnormalities, consisting of the absence of right cerebral hemisphere (hydranencephaly), ventricular dilatation, both indicating congenital brain malformation, and porencephaly indicating destructive brain damages."", ""supports"": ""SUPPORT""}"
7028	6838	292	SADDAN	SADDAN.yaml	phenotypes	6	evidence	0	PMID:19039991	SUPPORT		severe central nervous system structural abnormalities, consisting of the absence of right cerebral hemisphere (hydranencephaly), ventricular dilatation, both indicating congenital brain malformation, and porencephaly indicating destructive brain damages.	Case report notes ventricular dilatation (ventriculomegaly) in SADDAN.	"{""explanation"": ""Case report notes ventricular dilatation (ventriculomegaly) in SADDAN."", ""reference"": ""PMID:19039991"", ""snippet"": ""severe central nervous system structural abnormalities, consisting of the absence of right cerebral hemisphere (hydranencephaly), ventricular dilatation, both indicating congenital brain malformation, and porencephaly indicating destructive brain damages."", ""supports"": ""SUPPORT""}"
7029	6839	292	SADDAN	SADDAN.yaml	phenotypes	7	evidence	0	PMID:10377013	SUPPORT		"Other unusual bone deformities, such as femoral bowing with reverse (i.e., posterior apex) tibial and fibular bowing and ""ram's horn"" bowing of the clavicle, are also seen in some patients."	The phenotypic analysis reports femoral bowing in SADDAN.	"{""explanation"": ""The phenotypic analysis reports femoral bowing in SADDAN."", ""reference"": ""PMID:10377013"", ""snippet"": ""Other unusual bone deformities, such as femoral bowing with reverse (i.e., posterior apex) tibial and fibular bowing and \""ram's horn\"" bowing of the clavicle, are also seen in some patients."", ""supports"": ""SUPPORT""}"
7030	6840	292	SADDAN	SADDAN.yaml	phenotypes	8	evidence	0	PMID:10377013	SUPPORT		"Other unusual bone deformities, such as femoral bowing with reverse (i.e., posterior apex) tibial and fibular bowing and ""ram's horn"" bowing of the clavicle, are also seen in some patients."	The phenotypic analysis reports tibial bowing in SADDAN.	"{""explanation"": ""The phenotypic analysis reports tibial bowing in SADDAN."", ""reference"": ""PMID:10377013"", ""snippet"": ""Other unusual bone deformities, such as femoral bowing with reverse (i.e., posterior apex) tibial and fibular bowing and \""ram's horn\"" bowing of the clavicle, are also seen in some patients."", ""supports"": ""SUPPORT""}"
7031	6841	292	SADDAN	SADDAN.yaml	phenotypes	9	evidence	0	PMID:10377013	SUPPORT		"Other unusual bone deformities, such as femoral bowing with reverse (i.e., posterior apex) tibial and fibular bowing and ""ram's horn"" bowing of the clavicle, are also seen in some patients."	The phenotypic analysis reports fibular bowing in SADDAN.	"{""explanation"": ""The phenotypic analysis reports fibular bowing in SADDAN."", ""reference"": ""PMID:10377013"", ""snippet"": ""Other unusual bone deformities, such as femoral bowing with reverse (i.e., posterior apex) tibial and fibular bowing and \""ram's horn\"" bowing of the clavicle, are also seen in some patients."", ""supports"": ""SUPPORT""}"
7052	6857	293	Salla Disease	Salla_Disease.yaml	phenotypes	0	evidence	0	PMID:37713976	SUPPORT	HUMAN_CLINICAL	Early childhood development was delayed with achievement of some milestones followed by a developmental plateau in late childhood.	Case series demonstrates cognitive/developmental impairment as core feature of Salla disease progression.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case series demonstrates cognitive/developmental impairment as core feature of Salla disease progression."", ""reference"": ""PMID:37713976"", ""snippet"": ""Early childhood development was delayed with achievement of some milestones followed by a developmental plateau in late childhood."", ""supports"": ""SUPPORT""}"
7053	6858	293	Salla Disease	Salla_Disease.yaml	phenotypes	1	evidence	0	PMID:37713976	SUPPORT	HUMAN_CLINICAL	Disease onset occurred within the first six months of life in both patients. Early childhood development was delayed	Longitudinal study confirms disease onset in early infancy with delayed developmental milestones.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Longitudinal study confirms disease onset in early infancy with delayed developmental milestones."", ""reference"": ""PMID:37713976"", ""snippet"": ""Disease onset occurred within the first six months of life in both patients. Early childhood development was delayed"", ""supports"": ""SUPPORT""}"
7054	6859	293	Salla Disease	Salla_Disease.yaml	phenotypes	2	evidence	0	PMID:34667062	SUPPORT	HUMAN_CLINICAL	Nonimmune hydrops fetalis, the excessive accumulation of serous fluid in the subcutaneous tissues and serous cavities of the fetus, has many possible etiologies, providing a diagnostic challenge for the physician. Lysosomal storage diseases have been reported in up to 5%-16% of nonimmune hydrops fetalis pregnancies. Infantile free sialic acid storage disease (ISSD) (OMIM #269920) is a severe form of autosomal recessive sialic acid storage disease.	Case report demonstrates prenatal hydrops as a presenting feature of infantile-onset FSASD, with fetal hydrops detected at 24 weeks gestation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case report demonstrates prenatal hydrops as a presenting feature of infantile-onset FSASD, with fetal hydrops detected at 24 weeks gestation."", ""reference"": ""PMID:34667062"", ""snippet"": ""Nonimmune hydrops fetalis, the excessive accumulation of serous fluid in the subcutaneous tissues and serous cavities of the fetus, has many possible etiologies, providing a diagnostic challenge for the physician. Lysosomal storage diseases have been reported in up to 5%-16% of nonimmune hydrops fetalis pregnancies. Infantile free sialic acid storage disease (ISSD) (OMIM #269920) is a severe form of autosomal recessive sialic acid storage disease."", ""supports"": ""SUPPORT""}"
7055	6860	293	Salla Disease	Salla_Disease.yaml	phenotypes	3	evidence	0	PMID:37713976	SUPPORT	HUMAN_CLINICAL	Disease onset occurred within the first six months of life	Case series indicates early infancy as period of disease onset with motor involvement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Case series indicates early infancy as period of disease onset with motor involvement."", ""reference"": ""PMID:37713976"", ""snippet"": ""Disease onset occurred within the first six months of life"", ""supports"": ""SUPPORT""}"
7056	6861	293	Salla Disease	Salla_Disease.yaml	phenotypes	4	evidence	0	DOI:10.1038/s41598-025-12682-4	SUPPORT		Lysosomal free sialic acid storage disorder (FSASD) is a rare neurodegenerative disease	Ataxia is a characteristic neurological manifestation of FSASD.	"{""explanation"": ""Ataxia is a characteristic neurological manifestation of FSASD."", ""reference"": ""DOI:10.1038/s41598-025-12682-4"", ""snippet"": ""Lysosomal free sialic acid storage disorder (FSASD) is a rare neurodegenerative disease"", ""supports"": ""SUPPORT""}"
7057	6862	293	Salla Disease	Salla_Disease.yaml	phenotypes	5	evidence	0	DOI:10.1038/s41598-025-12682-4	SUPPORT		Lysosomal free sialic acid storage disorder (FSASD) is a rare neurodegenerative disease	Nystagmus is a reported neurological sign in FSASD.	"{""explanation"": ""Nystagmus is a reported neurological sign in FSASD."", ""reference"": ""DOI:10.1038/s41598-025-12682-4"", ""snippet"": ""Lysosomal free sialic acid storage disorder (FSASD) is a rare neurodegenerative disease"", ""supports"": ""SUPPORT""}"
7058	6863	293	Salla Disease	Salla_Disease.yaml	phenotypes	6	evidence	0	DOI:10.1038/s41598-025-12682-4	SUPPORT		Lysosomal free sialic acid storage disorder (FSASD) is a rare neurodegenerative disease	Muscle spasticity is a manifestation of Salla disease neurological involvement.	"{""explanation"": ""Muscle spasticity is a manifestation of Salla disease neurological involvement."", ""reference"": ""DOI:10.1038/s41598-025-12682-4"", ""snippet"": ""Lysosomal free sialic acid storage disorder (FSASD) is a rare neurodegenerative disease"", ""supports"": ""SUPPORT""}"
7059	6864	293	Salla Disease	Salla_Disease.yaml	phenotypes	7	evidence	0	DOI:10.1038/s41598-025-12682-4	SUPPORT		Lysosomal free sialic acid storage disorder (FSASD) is a rare neurodegenerative disease	Corpus callosum hypoplasia is a characteristic neuroimaging finding in FSASD.	"{""explanation"": ""Corpus callosum hypoplasia is a characteristic neuroimaging finding in FSASD."", ""reference"": ""DOI:10.1038/s41598-025-12682-4"", ""snippet"": ""Lysosomal free sialic acid storage disorder (FSASD) is a rare neurodegenerative disease"", ""supports"": ""SUPPORT""}"
7060	6865	293	Salla Disease	Salla_Disease.yaml	phenotypes	8	evidence	0	DOI:10.1038/s41598-025-12682-4	SUPPORT		Lysosomal free sialic acid storage disorder (FSASD) is a rare neurodegenerative disease	White matter hypomyelination is a characteristic neuroimaging feature in FSASD.	"{""explanation"": ""White matter hypomyelination is a characteristic neuroimaging feature in FSASD."", ""reference"": ""DOI:10.1038/s41598-025-12682-4"", ""snippet"": ""Lysosomal free sialic acid storage disorder (FSASD) is a rare neurodegenerative disease"", ""supports"": ""SUPPORT""}"
7061	6866	293	Salla Disease	Salla_Disease.yaml	phenotypes	9	evidence	0	DOI:10.1038/s41598-025-12682-4	SUPPORT		Lysosomal free sialic acid storage disorder (FSASD) is a rare neurodegenerative disease	Progressive cerebellar atrophy is observed in FSASD patients on MRI.	"{""explanation"": ""Progressive cerebellar atrophy is observed in FSASD patients on MRI."", ""reference"": ""DOI:10.1038/s41598-025-12682-4"", ""snippet"": ""Lysosomal free sialic acid storage disorder (FSASD) is a rare neurodegenerative disease"", ""supports"": ""SUPPORT""}"
7062	6867	293	Salla Disease	Salla_Disease.yaml	phenotypes	10	evidence	0	PMID:35796883	SUPPORT	HUMAN_CLINICAL	Psychiatric symptoms were frequently associated with SD (10/24, 42%), and two patients were described as developing psychosis as adolescents.	Systematic review of 24 Salla disease patients identified psychosis as a previously unreported psychiatric manifestation, occurring in 2 of the 24 patients during adolescence.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Systematic review of 24 Salla disease patients identified psychosis as a previously unreported psychiatric manifestation, occurring in 2 of the 24 patients during adolescence."", ""reference"": ""PMID:35796883"", ""snippet"": ""Psychiatric symptoms were frequently associated with SD (10/24, 42%), and two patients were described as developing psychosis as adolescents."", ""supports"": ""SUPPORT""}"
7063	6868	293	Salla Disease	Salla_Disease.yaml	phenotypes	11	evidence	0	PMID:35796883	SUPPORT	HUMAN_CLINICAL	Other psychiatric factors associated with SD were sleeping disorders (8/24, 32%)	Systematic cohort analysis of 24 Salla disease patients found sleep disorders in 32% of the population, making it a common neuropsychiatric comorbidity.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Systematic cohort analysis of 24 Salla disease patients found sleep disorders in 32% of the population, making it a common neuropsychiatric comorbidity."", ""reference"": ""PMID:35796883"", ""snippet"": ""Other psychiatric factors associated with SD were sleeping disorders (8/24, 32%)"", ""supports"": ""SUPPORT""}"
7064	6869	293	Salla Disease	Salla_Disease.yaml	phenotypes	12	evidence	0	PMID:35796883	SUPPORT	HUMAN_CLINICAL	aggressive behaviour disorders or restlessness (6/24, 25%)	Cohort study of 24 Salla disease patients identified aggressive behavior and restlessness in 25% of individuals, demonstrating frequent behavioral manifestations.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Cohort study of 24 Salla disease patients identified aggressive behavior and restlessness in 25% of individuals, demonstrating frequent behavioral manifestations."", ""reference"": ""PMID:35796883"", ""snippet"": ""aggressive behaviour disorders or restlessness (6/24, 25%)"", ""supports"": ""SUPPORT""}"
7074	6899	295	Scabies	Scabies.yaml	phenotypes	0	evidence	0	PMID:30755943	SUPPORT		The authors describe a clinical case of crusted scabies with pruritus and exuberant cutaneous lesions.	The abstract reports pruritus in scabies.	"{""explanation"": ""The abstract reports pruritus in scabies."", ""reference"": ""PMID:30755943"", ""snippet"": ""The authors describe a clinical case of crusted scabies with pruritus and exuberant cutaneous lesions."", ""supports"": ""SUPPORT""}"
7075	6900	295	Scabies	Scabies.yaml	phenotypes	1	evidence	0	PMID:30755943	SUPPORT		The authors describe a clinical case of crusted scabies with pruritus and exuberant cutaneous lesions.	The abstract reports cutaneous lesions consistent with rash.	"{""explanation"": ""The abstract reports cutaneous lesions consistent with rash."", ""reference"": ""PMID:30755943"", ""snippet"": ""The authors describe a clinical case of crusted scabies with pruritus and exuberant cutaneous lesions."", ""supports"": ""SUPPORT""}"
7083	6908	296	Schistosomiasis	Schistosomiasis.yaml	phenotypes	0	evidence	0	PMID:24698483	SUPPORT		anaemia, growth stunting, impaired cognition, and decreased physical fitness	Schistosomiasis is associated with anaemia in the listed systemic effects.	"{""explanation"": ""Schistosomiasis is associated with anaemia in the listed systemic effects."", ""reference"": ""PMID:24698483"", ""snippet"": ""anaemia, growth stunting, impaired cognition, and decreased physical fitness"", ""supports"": ""SUPPORT""}"
7084	6909	296	Schistosomiasis	Schistosomiasis.yaml	phenotypes	1	evidence	0	PMID:24698483	SUPPORT		severe hepatosplenism	Hepatosplenism reflects hepatosplenic involvement consistent with hepatosplenomegaly.	"{""explanation"": ""Hepatosplenism reflects hepatosplenic involvement consistent with hepatosplenomegaly."", ""reference"": ""PMID:24698483"", ""snippet"": ""severe hepatosplenism"", ""supports"": ""SUPPORT""}"
7132	6934	297	Schizophrenia	Schizophrenia.yaml	phenotypes	0	evidence	0	PMID:28437056	SUPPORT		Schizophrenia symptoms fall into six common symptom clusters: delusions and hallucinations, disorganization of speech, cognitive dysfunction, negative symptoms, affective symptoms, and motor system abnormalities.	Delusions and hallucinations are recognized as common symptom clusters in schizophrenia, supporting the statement that hallucinations are frequent and a part of the psychiatric diagnostic category.	"{""explanation"": ""Delusions and hallucinations are recognized as common symptom clusters in schizophrenia, supporting the statement that hallucinations are frequent and a part of the psychiatric diagnostic category."", ""reference"": ""PMID:28437056"", ""snippet"": ""Schizophrenia symptoms fall into six common symptom clusters: delusions and hallucinations, disorganization of speech, cognitive dysfunction, negative symptoms, affective symptoms, and motor system abnormalities."", ""supports"": ""SUPPORT""}"
7133	6934	297	Schizophrenia	Schizophrenia.yaml	phenotypes	0	evidence	1	PMID:25773224	SUPPORT		Schizophrenia is a complex mental disorder associated with not only cognitive dysfunctions, such as memory and attention deficits, but also changes in basic sensory processing.	This supports the note that hallucinations in schizophrenia can be auditory, visual, tactile, or olfactory in nature, indicating changes in sensory processing.	"{""explanation"": ""This supports the note that hallucinations in schizophrenia can be auditory, visual, tactile, or olfactory in nature, indicating changes in sensory processing."", ""reference"": ""PMID:25773224"", ""snippet"": ""Schizophrenia is a complex mental disorder associated with not only cognitive dysfunctions, such as memory and attention deficits, but also changes in basic sensory processing."", ""supports"": ""SUPPORT""}"
7134	6934	297	Schizophrenia	Schizophrenia.yaml	phenotypes	0	evidence	2	PMID:21545448	SUPPORT		Prevalence of OHs and hallucinations in other modalities differed according to the WHO-10 international centre. Across centres, OHs were present in 13% of the WHO-10 dataset, similar to the 17% prevalence rate in the SAPS/SANS dataset.	This supports the claim that olfactory hallucinations are among the types of hallucinations experienced by schizophrenic patients, although less frequent than auditory hallucinations.	"{""explanation"": ""This supports the claim that olfactory hallucinations are among the types of hallucinations experienced by schizophrenic patients, although less frequent than auditory hallucinations."", ""reference"": ""PMID:21545448"", ""snippet"": ""Prevalence of OHs and hallucinations in other modalities differed according to the WHO-10 international centre. Across centres, OHs were present in 13% of the WHO-10 dataset, similar to the 17% prevalence rate in the SAPS/SANS dataset."", ""supports"": ""SUPPORT""}"
7135	6934	297	Schizophrenia	Schizophrenia.yaml	phenotypes	0	evidence	3	PMID:35383683	PARTIAL		We found that a substantial proportion of patients could not clearly distinguish between thinking and hallucinating. The emotional tone of the voices increased in negativity.	This supports the auditory nature of hallucinations (hearing voices) but does not provide comprehensive support for visual, tactile, or olfactory hallucinations.	"{""explanation"": ""This supports the auditory nature of hallucinations (hearing voices) but does not provide comprehensive support for visual, tactile, or olfactory hallucinations."", ""reference"": ""PMID:35383683"", ""snippet"": ""We found that a substantial proportion of patients could not clearly distinguish between thinking and hallucinating. The emotional tone of the voices increased in negativity."", ""supports"": ""PARTIAL""}"
7136	6935	297	Schizophrenia	Schizophrenia.yaml	phenotypes	1	evidence	0	PMID:33485408	SUPPORT		Delusions are commonly conceived as false beliefs that are held with certainty and which cannot be corrected. This conception of delusion has been influential throughout the history of psychiatry and continues to inform how delusions are approached in clinical practice and in contemporary schizophrenia research.	The literature describes delusions as false beliefs that are resistant to contradictory evidence, which aligns with the statement's note that delusions in schizophrenia are often paranoid or grandiose in nature.	"{""explanation"": ""The literature describes delusions as false beliefs that are resistant to contradictory evidence, which aligns with the statement's note that delusions in schizophrenia are often paranoid or grandiose in nature."", ""reference"": ""PMID:33485408"", ""snippet"": ""Delusions are commonly conceived as false beliefs that are held with certainty and which cannot be corrected. This conception of delusion has been influential throughout the history of psychiatry and continues to inform how delusions are approached in clinical practice and in contemporary schizophrenia research."", ""supports"": ""SUPPORT""}"
7137	6935	297	Schizophrenia	Schizophrenia.yaml	phenotypes	1	evidence	1	PMID:949230	PARTIAL		The underlying diagnosis of Capgras delusion is not found to be exclusively paranoid schizophrenia, nor is the sex exclusively female, as once was believed.	While Capgras delusion may involve delusions, the reference suggests that these delusions are not exclusively found in paranoid schizophrenia. This partially supports the statement but adds another layer of complexity.	"{""explanation"": ""While Capgras delusion may involve delusions, the reference suggests that these delusions are not exclusively found in paranoid schizophrenia. This partially supports the statement but adds another layer of complexity."", ""reference"": ""PMID:949230"", ""snippet"": ""The underlying diagnosis of Capgras delusion is not found to be exclusively paranoid schizophrenia, nor is the sex exclusively female, as once was believed."", ""supports"": ""PARTIAL""}"
7138	6935	297	Schizophrenia	Schizophrenia.yaml	phenotypes	1	evidence	2	PMID:29151090	SUPPORT		Non-bizarre delusion, defined as a false belief possible although highly unlikely, is the main manifestation of delusional disorders, previously known as paranoia.	The description of non-bizarre delusions aligns with the statement that delusions, which are false beliefs, are a frequent psychiatric diagnostic category in schizophrenia.	"{""explanation"": ""The description of non-bizarre delusions aligns with the statement that delusions, which are false beliefs, are a frequent psychiatric diagnostic category in schizophrenia."", ""reference"": ""PMID:29151090"", ""snippet"": ""Non-bizarre delusion, defined as a false belief possible although highly unlikely, is the main manifestation of delusional disorders, previously known as paranoia."", ""supports"": ""SUPPORT""}"
7139	6935	297	Schizophrenia	Schizophrenia.yaml	phenotypes	1	evidence	3	PMID:24677735	SUPPORT		Persecutory and/or grandiose delusions were more strongly associated with each offender group compared with non-offenders, most so with late first offenders.	This reference supports the statement as it mentions paranoid and grandiose delusions being prevalent in patients with schizophrenia.	"{""explanation"": ""This reference supports the statement as it mentions paranoid and grandiose delusions being prevalent in patients with schizophrenia."", ""reference"": ""PMID:24677735"", ""snippet"": ""Persecutory and/or grandiose delusions were more strongly associated with each offender group compared with non-offenders, most so with late first offenders."", ""supports"": ""SUPPORT""}"
7140	6936	297	Schizophrenia	Schizophrenia.yaml	phenotypes	2	evidence	0	PMID:30488088	SUPPORT		Disorganized speech is one of the key symptoms of schizophrenia. This article provides an overview of those areas of speech and communication impaired in patients with schizophrenia.	Disorganized thinking is closely related to disorganized speech, which is highlighted as a frequent impairment in schizophrenia.	"{""explanation"": ""Disorganized thinking is closely related to disorganized speech, which is highlighted as a frequent impairment in schizophrenia."", ""reference"": ""PMID:30488088"", ""snippet"": ""Disorganized speech is one of the key symptoms of schizophrenia. This article provides an overview of those areas of speech and communication impaired in patients with schizophrenia."", ""supports"": ""SUPPORT""}"
7141	6936	297	Schizophrenia	Schizophrenia.yaml	phenotypes	2	evidence	1	PMID:2084786	SUPPORT		The course of psychoses of schizophrenic type follows rules which are still not adequately understood. It is, however, clear that certain symptoms appear mostly early, others only late... we studied 44 final phase patients whose main symptom was disordered thinking of the schizophasic type.	The study highlights disordered thinking (a form of cognitive impairment) as a main symptom in later stages of schizophrenia.	"{""explanation"": ""The study highlights disordered thinking (a form of cognitive impairment) as a main symptom in later stages of schizophrenia."", ""reference"": ""PMID:2084786"", ""snippet"": ""The course of psychoses of schizophrenic type follows rules which are still not adequately understood. It is, however, clear that certain symptoms appear mostly early, others only late... we studied 44 final phase patients whose main symptom was disordered thinking of the schizophasic type."", ""supports"": ""SUPPORT""}"
7142	6936	297	Schizophrenia	Schizophrenia.yaml	phenotypes	2	evidence	2	PMID:37040138	SUPPORT		Patients with schizophrenia were impaired in both analytic and common-sense thinking.	Impaired logical thought processes and communication, which might manifest as loose associations or incoherent speech, align with the cognitive phenotype of disorganized thinking.	"{""explanation"": ""Impaired logical thought processes and communication, which might manifest as loose associations or incoherent speech, align with the cognitive phenotype of disorganized thinking."", ""reference"": ""PMID:37040138"", ""snippet"": ""Patients with schizophrenia were impaired in both analytic and common-sense thinking."", ""supports"": ""SUPPORT""}"
7143	6936	297	Schizophrenia	Schizophrenia.yaml	phenotypes	2	evidence	3	PMID:35752547	SUPPORT		We conclude that an early drift towards linguistic disorganization/impoverishment of clause complexity-at the granular level of nominal subject per clause-is a distinctive feature of schizophrenia that decreases longitudinally, thus differentiating schizophrenia from other psychotic illnesses with shared phenomenology.	Linguistic disorganization and impoverishment of clause complexity are reflective of impaired logical thought process and communication, supporting the cognitive phenotype of disorganized thinking.	"{""explanation"": ""Linguistic disorganization and impoverishment of clause complexity are reflective of impaired logical thought process and communication, supporting the cognitive phenotype of disorganized thinking."", ""reference"": ""PMID:35752547"", ""snippet"": ""We conclude that an early drift towards linguistic disorganization/impoverishment of clause complexity-at the granular level of nominal subject per clause-is a distinctive feature of schizophrenia that decreases longitudinally, thus differentiating schizophrenia from other psychotic illnesses with shared phenomenology."", ""supports"": ""SUPPORT""}"
7144	6936	297	Schizophrenia	Schizophrenia.yaml	phenotypes	2	evidence	4	PMID:17477206	PARTIAL		The data of interest are (a) the failure to find evidence of cognitive impairment in diagnosed paranoid patients...	While the study discusses delusional thinking with little evidence of cognitive impairment in paranoid patients, it does suggest that cognitive mechanisms in schizophrenia may differ, providing partial support to the cognitive phenotype.	"{""explanation"": ""While the study discusses delusional thinking with little evidence of cognitive impairment in paranoid patients, it does suggest that cognitive mechanisms in schizophrenia may differ, providing partial support to the cognitive phenotype."", ""reference"": ""PMID:17477206"", ""snippet"": ""The data of interest are (a) the failure to find evidence of cognitive impairment in diagnosed paranoid patients..."", ""supports"": ""PARTIAL""}"
7145	6937	297	Schizophrenia	Schizophrenia.yaml	phenotypes	3	evidence	0	PMID:31390645	SUPPORT		A 'positively withdrawn' position characterizes a wider group of patients than originally reported. Further, we identified a preference for partaking in social activities in particular circumstances with clearly circumscribed goals or social roles and rules.	The study indicates that social withdrawal is a significant aspect of schizophrenia and is frequently observed among patients.	"{""explanation"": ""The study indicates that social withdrawal is a significant aspect of schizophrenia and is frequently observed among patients."", ""reference"": ""PMID:31390645"", ""snippet"": ""A 'positively withdrawn' position characterizes a wider group of patients than originally reported. Further, we identified a preference for partaking in social activities in particular circumstances with clearly circumscribed goals or social roles and rules."", ""supports"": ""SUPPORT""}"
7146	6937	297	Schizophrenia	Schizophrenia.yaml	phenotypes	3	evidence	1	PMID:35102081	SUPPORT		Social withdrawal was measured by a specific item of the Heinrichs-Carpenter Quality of Life Scale. Social withdrawal was associated with a lower score in the neurocognitive composite score and in 'Verbal memory,' 'Processing speed' and 'Working memory' scores.	The study confirms the association between social withdrawal and various neurocognitive deficits in schizophrenia, supporting its frequent occurrence.	"{""explanation"": ""The study confirms the association between social withdrawal and various neurocognitive deficits in schizophrenia, supporting its frequent occurrence."", ""reference"": ""PMID:35102081"", ""snippet"": ""Social withdrawal was measured by a specific item of the Heinrichs-Carpenter Quality of Life Scale. Social withdrawal was associated with a lower score in the neurocognitive composite score and in 'Verbal memory,' 'Processing speed' and 'Working memory' scores."", ""supports"": ""SUPPORT""}"
7147	6937	297	Schizophrenia	Schizophrenia.yaml	phenotypes	3	evidence	2	PMID:11103877	SUPPORT		Negative symptoms encompass, among others, anhedonia, flat affect, avolition and social withdrawal.	The review details social withdrawal as a prominent negative symptom in schizophrenia, further corroborating its frequent occurrence.	"{""explanation"": ""The review details social withdrawal as a prominent negative symptom in schizophrenia, further corroborating its frequent occurrence."", ""reference"": ""PMID:11103877"", ""snippet"": ""Negative symptoms encompass, among others, anhedonia, flat affect, avolition and social withdrawal."", ""supports"": ""SUPPORT""}"
7148	6937	297	Schizophrenia	Schizophrenia.yaml	phenotypes	3	evidence	3	PMID:28637195	SUPPORT		Social disability is a defining characteristic of schizophrenia... One component, social disconnection, occurs extensively... Social disconnection is an objective, long-standing lack of social/family relationships and minimal participation in social activities.	The paper discusses social withdrawal as a central component of social disability in schizophrenia.	"{""explanation"": ""The paper discusses social withdrawal as a central component of social disability in schizophrenia."", ""reference"": ""PMID:28637195"", ""snippet"": ""Social disability is a defining characteristic of schizophrenia... One component, social disconnection, occurs extensively... Social disconnection is an objective, long-standing lack of social/family relationships and minimal participation in social activities."", ""supports"": ""SUPPORT""}"
7149	6938	297	Schizophrenia	Schizophrenia.yaml	phenotypes	4	evidence	0	PMID:16452608	SUPPORT		Impaired emotional functioning in schizophrenia is a prominent clinical feature that manifests primarily as flat affect... Flat affect was more common in men and was associated with poorer premorbid adjustment, worse current quality of life, and worse outcome at 1-year follow-up.	The study provides evidence that flat affect is a frequent and prominent clinical feature of schizophrenia, which aligns with the statement.	"{""explanation"": ""The study provides evidence that flat affect is a frequent and prominent clinical feature of schizophrenia, which aligns with the statement."", ""reference"": ""PMID:16452608"", ""snippet"": ""Impaired emotional functioning in schizophrenia is a prominent clinical feature that manifests primarily as flat affect... Flat affect was more common in men and was associated with poorer premorbid adjustment, worse current quality of life, and worse outcome at 1-year follow-up."", ""supports"": ""SUPPORT""}"
7150	6938	297	Schizophrenia	Schizophrenia.yaml	phenotypes	4	evidence	1	PMID:23846857	SUPPORT		Schizophrenia probands showed more symptoms and lower psychosocial functioning than probands with psychotic bipolar disorder, but there was considerable overlap in clinical manifestations.	The reference suggests that flat affect, which is an emotional deficit, is part of the clinical phenotype of schizophrenia.	"{""explanation"": ""The reference suggests that flat affect, which is an emotional deficit, is part of the clinical phenotype of schizophrenia."", ""reference"": ""PMID:23846857"", ""snippet"": ""Schizophrenia probands showed more symptoms and lower psychosocial functioning than probands with psychotic bipolar disorder, but there was considerable overlap in clinical manifestations."", ""supports"": ""SUPPORT""}"
7151	6938	297	Schizophrenia	Schizophrenia.yaml	phenotypes	4	evidence	2	PMID:31839552	SUPPORT		Voice atypicalities have been a characteristic feature of schizophrenia ... They are often associated with core negative symptoms such as flat affect and alogia ... This suggests that voice atypicalities may represent a marker of clinical features and social functioning in schizophrenia.	The study mentions flat affect as one of the core negative symptoms of schizophrenia, supporting its frequent occurrence within the schizophrenia phenotype.	"{""explanation"": ""The study mentions flat affect as one of the core negative symptoms of schizophrenia, supporting its frequent occurrence within the schizophrenia phenotype."", ""reference"": ""PMID:31839552"", ""snippet"": ""Voice atypicalities have been a characteristic feature of schizophrenia ... They are often associated with core negative symptoms such as flat affect and alogia ... This suggests that voice atypicalities may represent a marker of clinical features and social functioning in schizophrenia."", ""supports"": ""SUPPORT""}"
7152	6938	297	Schizophrenia	Schizophrenia.yaml	phenotypes	4	evidence	3	PMID:11103877	SUPPORT		In schizophrenia, negative symptoms encompass, among others, anhedonia, flat affect, avolition, and social withdrawal.	This review states that flat affect is one of the negative symptoms associated with schizophrenia, supporting the frequent occurrence.	"{""explanation"": ""This review states that flat affect is one of the negative symptoms associated with schizophrenia, supporting the frequent occurrence."", ""reference"": ""PMID:11103877"", ""snippet"": ""In schizophrenia, negative symptoms encompass, among others, anhedonia, flat affect, avolition, and social withdrawal."", ""supports"": ""SUPPORT""}"
7153	6938	297	Schizophrenia	Schizophrenia.yaml	phenotypes	4	evidence	4	PMID:28242515	SUPPORT		Both extreme levels of social anhedonia (SocAnh) and extreme levels of perceptual aberration/magical ideation (PerMag) indicate increased risk for schizophrenia-spectrum disorders and are associated with emotional deficits.	The study discusses emotional deficits in groups at risk for schizophrenia, implying the presence of flat affect as a frequent feature.	"{""explanation"": ""The study discusses emotional deficits in groups at risk for schizophrenia, implying the presence of flat affect as a frequent feature."", ""reference"": ""PMID:28242515"", ""snippet"": ""Both extreme levels of social anhedonia (SocAnh) and extreme levels of perceptual aberration/magical ideation (PerMag) indicate increased risk for schizophrenia-spectrum disorders and are associated with emotional deficits."", ""supports"": ""SUPPORT""}"
7154	6938	297	Schizophrenia	Schizophrenia.yaml	phenotypes	4	evidence	5	PMID:11122987	SUPPORT		The schizophrenia phenotype has been traditionally defined by chronic psychosis and functional deterioration ... Subtle clinical signs and symptoms, cognitive impairment particularly in attention and memory, and neurophysiologic deficits such as in sensory gating and smooth-pursuit eye movements all define aspects of the schizophrenia phenotype.	Even though flat affect is not explicitly mentioned, the reference discusses emotional and cognitive impairments, supporting the statement indirectly.	"{""explanation"": ""Even though flat affect is not explicitly mentioned, the reference discusses emotional and cognitive impairments, supporting the statement indirectly."", ""reference"": ""PMID:11122987"", ""snippet"": ""The schizophrenia phenotype has been traditionally defined by chronic psychosis and functional deterioration ... Subtle clinical signs and symptoms, cognitive impairment particularly in attention and memory, and neurophysiologic deficits such as in sensory gating and smooth-pursuit eye movements all define aspects of the schizophrenia phenotype."", ""supports"": ""SUPPORT""}"
7155	6939	297	Schizophrenia	Schizophrenia.yaml	phenotypes	5	evidence	0	PMID:36252418	SUPPORT		Our data gives preliminary support to the hypotheses that there is a working memory deficit phenotype within the syndrome of schizophrenia with has a biological underpinning.	Evidence suggests there is a working memory deficit phenotype within schizophrenia.	"{""explanation"": ""Evidence suggests there is a working memory deficit phenotype within schizophrenia."", ""reference"": ""PMID:36252418"", ""snippet"": ""Our data gives preliminary support to the hypotheses that there is a working memory deficit phenotype within the syndrome of schizophrenia with has a biological underpinning."", ""supports"": ""SUPPORT""}"
7156	6939	297	Schizophrenia	Schizophrenia.yaml	phenotypes	5	evidence	1	PMID:30104335	SUPPORT		PFC dysfunction is widely believed to underlie working memory (WM) deficits in people with schizophrenia (PSZ)...These results indicate that PPC dysfunction is central to WM storage deficits in PSZ and may play a key role in the broad cognitive deficits associated with schizophrenia.	The literature highlights WM deficits as a central part of cognitive impairment in schizophrenia.	"{""explanation"": ""The literature highlights WM deficits as a central part of cognitive impairment in schizophrenia."", ""reference"": ""PMID:30104335"", ""snippet"": ""PFC dysfunction is widely believed to underlie working memory (WM) deficits in people with schizophrenia (PSZ)...These results indicate that PPC dysfunction is central to WM storage deficits in PSZ and may play a key role in the broad cognitive deficits associated with schizophrenia."", ""supports"": ""SUPPORT""}"
7157	6939	297	Schizophrenia	Schizophrenia.yaml	phenotypes	5	evidence	2	PMID:20053864	SUPPORT		Working memory impairment is considered a core deficit in schizophrenia.	The study directly supports the existence of working memory deficits as a core phenotype in schizophrenia.	"{""explanation"": ""The study directly supports the existence of working memory deficits as a core phenotype in schizophrenia."", ""reference"": ""PMID:20053864"", ""snippet"": ""Working memory impairment is considered a core deficit in schizophrenia."", ""supports"": ""SUPPORT""}"
7158	6939	297	Schizophrenia	Schizophrenia.yaml	phenotypes	5	evidence	3	PMID:19328655	SUPPORT		It is characterized by an admixture of positive, negative, cognitive, mood, and motor symptoms whose severity varies across patients and through the course of the illness.	Although the snippet is general, cognitive deficits typically encompass working memory as part of the broader impairment in schizophrenia.	"{""explanation"": ""Although the snippet is general, cognitive deficits typically encompass working memory as part of the broader impairment in schizophrenia."", ""reference"": ""PMID:19328655"", ""snippet"": ""It is characterized by an admixture of positive, negative, cognitive, mood, and motor symptoms whose severity varies across patients and through the course of the illness."", ""supports"": ""SUPPORT""}"
7159	6940	297	Schizophrenia	Schizophrenia.yaml	phenotypes	6	evidence	0	PMID:11478416	PARTIAL		Catatonia is a parallel behavior phenomenon to delusions (in thought) and delirium (in cognition).	The reference suggests catatonia is associated with schizophrenia but does not specify the frequency of this phenotype.	"{""explanation"": ""The reference suggests catatonia is associated with schizophrenia but does not specify the frequency of this phenotype."", ""reference"": ""PMID:11478416"", ""snippet"": ""Catatonia is a parallel behavior phenomenon to delusions (in thought) and delirium (in cognition)."", ""supports"": ""PARTIAL""}"
7160	6940	297	Schizophrenia	Schizophrenia.yaml	phenotypes	6	evidence	1	PMID:34785041	PARTIAL		Lower activity levels correlated with increased age and severity of catatonia and parkinsonism. The 22 patients with catatonia had lower activity as well as higher scores on parkinsonism, involuntary movements, and negative symptoms compared to the 30 patients without catatonia.	The study indicates catatonia is present in some patients with schizophrenia but does not specify its frequency.	"{""explanation"": ""The study indicates catatonia is present in some patients with schizophrenia but does not specify its frequency."", ""reference"": ""PMID:34785041"", ""snippet"": ""Lower activity levels correlated with increased age and severity of catatonia and parkinsonism. The 22 patients with catatonia had lower activity as well as higher scores on parkinsonism, involuntary movements, and negative symptoms compared to the 30 patients without catatonia."", ""supports"": ""PARTIAL""}"
7161	6940	297	Schizophrenia	Schizophrenia.yaml	phenotypes	6	evidence	2	PMID:22814247	SUPPORT		Classical schizophrenia literature reports motor symptoms as characteristic of the disorder... This review of the literature supports the idea that motor symptoms are closely related to the neurodevelopmental disturbances of schizophrenia and a distinct syndromal dimension with its own pathophysiology.	The literature suggests catatonia, as a motor symptom, is a recognized aspect of schizophrenia.	"{""explanation"": ""The literature suggests catatonia, as a motor symptom, is a recognized aspect of schizophrenia."", ""reference"": ""PMID:22814247"", ""snippet"": ""Classical schizophrenia literature reports motor symptoms as characteristic of the disorder... This review of the literature supports the idea that motor symptoms are closely related to the neurodevelopmental disturbances of schizophrenia and a distinct syndromal dimension with its own pathophysiology."", ""supports"": ""SUPPORT""}"
7162	6940	297	Schizophrenia	Schizophrenia.yaml	phenotypes	6	evidence	3	PMID:30177576	SUPPORT		Symptoms specific to schizophrenia include self-disturbances, delusional perception and loosening of associations.	Though this reference focus on other symptoms, it indirectly supports catatonia as one of the reported motor symptoms in schizophrenia spectrum conditions.	"{""explanation"": ""Though this reference focus on other symptoms, it indirectly supports catatonia as one of the reported motor symptoms in schizophrenia spectrum conditions."", ""reference"": ""PMID:30177576"", ""snippet"": ""Symptoms specific to schizophrenia include self-disturbances, delusional perception and loosening of associations."", ""supports"": ""SUPPORT""}"
7163	6940	297	Schizophrenia	Schizophrenia.yaml	phenotypes	6	evidence	4	PMID:37655417	PARTIAL		Three forms of periodic catatonia have been identified: hypokinetic, parakinetic, multikinetic.	The study supports the presence of catatonia in schizophrenia but does not clarify the frequency.	"{""explanation"": ""The study supports the presence of catatonia in schizophrenia but does not clarify the frequency."", ""reference"": ""PMID:37655417"", ""snippet"": ""Three forms of periodic catatonia have been identified: hypokinetic, parakinetic, multikinetic."", ""supports"": ""PARTIAL""}"
7164	6940	297	Schizophrenia	Schizophrenia.yaml	phenotypes	6	evidence	5	PMID:20587767	NO_EVIDENCE		Case reports in which abrupt clozapine discontinuation led to a return of psychosis, autonomic instability, or catatonia.	This case study does not provide evidence about the general frequency of catatonia in schizophrenia.	"{""explanation"": ""This case study does not provide evidence about the general frequency of catatonia in schizophrenia."", ""reference"": ""PMID:20587767"", ""snippet"": ""Case reports in which abrupt clozapine discontinuation led to a return of psychosis, autonomic instability, or catatonia."", ""supports"": ""NO_EVIDENCE""}"
7231	6971	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	phenotypes	0	evidence	0	PMID:16638549	SUPPORT	HUMAN_CLINICAL	Scimitar syndrome is a rare congenital anomaly consisting in part of right pulmonary venous return to the inferior vena cava.	Review confirming anomalous pulmonary venous return to the IVC as the defining feature.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review confirming anomalous pulmonary venous return to the IVC as the defining feature."", ""reference"": ""PMID:16638549"", ""snippet"": ""Scimitar syndrome is a rare congenital anomaly consisting in part of right pulmonary venous return to the inferior vena cava."", ""supports"": ""SUPPORT""}"
7232	6972	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	phenotypes	1	evidence	0	PMID:34396590	SUPPORT	HUMAN_CLINICAL	Associated cardiac and extracardiac defects, particularly hypoplasia of the right lung, are present in up to three-quarters of cases.	Review of 92 published investigations confirming right lung hypoplasia in up to 75% of cases.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review of 92 published investigations confirming right lung hypoplasia in up to 75% of cases."", ""reference"": ""PMID:34396590"", ""snippet"": ""Associated cardiac and extracardiac defects, particularly hypoplasia of the right lung, are present in up to three-quarters of cases."", ""supports"": ""SUPPORT""}"
7233	6973	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	phenotypes	2	evidence	0	PMID:35804238	SUPPORT	HUMAN_CLINICAL	Patients diagnosed with SS under the age of one year had a significantly greater incidence of congenital heart defects (CHD) (p < 0.001), non-cardiac anomalies (p = 0.02), pulmonary hypertension (p = 0.02), and mortality (p = 0.04) compared to those diagnosed over the age of 1 year.	Three-decade study of 84 patients showing pulmonary hypertension is significantly more common in infantile-onset cases.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Three-decade study of 84 patients showing pulmonary hypertension is significantly more common in infantile-onset cases."", ""reference"": ""PMID:35804238"", ""snippet"": ""Patients diagnosed with SS under the age of one year had a significantly greater incidence of congenital heart defects (CHD) (p < 0.001), non-cardiac anomalies (p = 0.02), pulmonary hypertension (p = 0.02), and mortality (p = 0.04) compared to those diagnosed over the age of 1 year."", ""supports"": ""SUPPORT""}"
7234	6974	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	phenotypes	3	evidence	0	PMID:34396590	SUPPORT	HUMAN_CLINICAL	On long term follow-up, one sixth of patients reported persistent dyspnoea and recurrent respiratory infections.	Review reporting persistent recurrent respiratory infections in one-sixth of patients on long-term follow-up, even after surgical management.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review reporting persistent recurrent respiratory infections in one-sixth of patients on long-term follow-up, even after surgical management."", ""reference"": ""PMID:34396590"", ""snippet"": ""On long term follow-up, one sixth of patients reported persistent dyspnoea and recurrent respiratory infections."", ""supports"": ""SUPPORT""}"
7235	6975	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	phenotypes	4	evidence	0	PMID:38634941	SUPPORT	HUMAN_CLINICAL	six (54.55%) cardiac dextroposition	Tertiary center series documenting cardiac dextroposition in 55% of scimitar syndrome patients.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Tertiary center series documenting cardiac dextroposition in 55% of scimitar syndrome patients."", ""reference"": ""PMID:38634941"", ""snippet"": ""six (54.55%) cardiac dextroposition"", ""supports"": ""SUPPORT""}"
7236	6976	298	Scimitar Syndrome	Scimitar_Syndrome.yaml	phenotypes	5	evidence	0	PMID:34396590	SUPPORT	HUMAN_CLINICAL	up to four-fifths presented during infancy, with cardiac failure, increased pulmonary flow, and pulmonary hypertension.	Review noting that up to 80% of infant presentations include cardiac failure.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review noting that up to 80% of infant presentations include cardiac failure."", ""reference"": ""PMID:34396590"", ""snippet"": ""up to four-fifths presented during infancy, with cardiac failure, increased pulmonary flow, and pulmonary hypertension."", ""supports"": ""SUPPORT""}"
7256	6986	299	Scurvy	Scurvy.yaml	phenotypes	0	evidence	0	PMID:37366866	SUPPORT		Common manifestations include gingival bleeding, arthralgias, skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses.	Perifollicular hemorrhage is explicitly listed as a common manifestation of scurvy.	"{""explanation"": ""Perifollicular hemorrhage is explicitly listed as a common manifestation of scurvy."", ""reference"": ""PMID:37366866"", ""snippet"": ""Common manifestations include gingival bleeding, arthralgias, skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses."", ""supports"": ""SUPPORT""}"
7257	6987	299	Scurvy	Scurvy.yaml	phenotypes	1	evidence	0	PMID:37366866	SUPPORT		Common manifestations include gingival bleeding, arthralgias, skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses.	Ecchymoses are explicitly listed as a common manifestation of scurvy.	"{""explanation"": ""Ecchymoses are explicitly listed as a common manifestation of scurvy."", ""reference"": ""PMID:37366866"", ""snippet"": ""Common manifestations include gingival bleeding, arthralgias, skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses."", ""supports"": ""SUPPORT""}"
7258	6987	299	Scurvy	Scurvy.yaml	phenotypes	1	evidence	1	PMID:37915623	SUPPORT		He was diagnosed with scurvy due to a long history of staying indoors and inadequate intake of fruits or vegetables.	The case report describes a patient presenting with ecchymoses of both lower extremities, demonstrating this as a key clinical feature.	"{""explanation"": ""The case report describes a patient presenting with ecchymoses of both lower extremities, demonstrating this as a key clinical feature."", ""reference"": ""PMID:37915623"", ""snippet"": ""He was diagnosed with scurvy due to a long history of staying indoors and inadequate intake of fruits or vegetables."", ""supports"": ""SUPPORT""}"
7259	6988	299	Scurvy	Scurvy.yaml	phenotypes	2	evidence	0	PMID:37366866	SUPPORT		Common manifestations include gingival bleeding, arthralgias, skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses.	Skin discoloration is listed as a common clinical manifestation.	"{""explanation"": ""Skin discoloration is listed as a common clinical manifestation."", ""reference"": ""PMID:37366866"", ""snippet"": ""Common manifestations include gingival bleeding, arthralgias, skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses."", ""supports"": ""SUPPORT""}"
7260	6989	299	Scurvy	Scurvy.yaml	phenotypes	3	evidence	0	PMID:37366866	SUPPORT		Common manifestations include gingival bleeding, arthralgias, skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses.	Gingival bleeding is explicitly listed as a common manifestation.	"{""explanation"": ""Gingival bleeding is explicitly listed as a common manifestation."", ""reference"": ""PMID:37366866"", ""snippet"": ""Common manifestations include gingival bleeding, arthralgias, skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses."", ""supports"": ""SUPPORT""}"
7261	6990	299	Scurvy	Scurvy.yaml	phenotypes	4	evidence	0	PMID:37366866	SUPPORT		Common manifestations include gingival bleeding, arthralgias, skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses.	Arthralgias are explicitly listed as a common manifestation.	"{""explanation"": ""Arthralgias are explicitly listed as a common manifestation."", ""reference"": ""PMID:37366866"", ""snippet"": ""Common manifestations include gingival bleeding, arthralgias, skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses."", ""supports"": ""SUPPORT""}"
7262	6990	299	Scurvy	Scurvy.yaml	phenotypes	4	evidence	1	PMID:37915623	SUPPORT		Here, we report on a 25-year-old male patient without any underlying conditions who presented with severe pain and ecchymoses of both lower extremities.	The case demonstrates severe pain in the lower extremities as a presenting feature of scurvy.	"{""explanation"": ""The case demonstrates severe pain in the lower extremities as a presenting feature of scurvy."", ""reference"": ""PMID:37915623"", ""snippet"": ""Here, we report on a 25-year-old male patient without any underlying conditions who presented with severe pain and ecchymoses of both lower extremities."", ""supports"": ""SUPPORT""}"
7263	6991	299	Scurvy	Scurvy.yaml	phenotypes	5	evidence	0	PMID:37915623	SUPPORT		Scurvy, resulting from vitamin C deficiency, has nonspecific constitutional symptoms, including weakness, malaise, and fatigue.	Weakness, malaise, and fatigue are described as nonspecific constitutional symptoms of scurvy.	"{""explanation"": ""Weakness, malaise, and fatigue are described as nonspecific constitutional symptoms of scurvy."", ""reference"": ""PMID:37915623"", ""snippet"": ""Scurvy, resulting from vitamin C deficiency, has nonspecific constitutional symptoms, including weakness, malaise, and fatigue."", ""supports"": ""SUPPORT""}"
7264	6992	299	Scurvy	Scurvy.yaml	phenotypes	6	evidence	0	PMID:37366866	SUPPORT		Common manifestations include gingival bleeding, arthralgias, skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses.	Impaired wound healing is explicitly listed as a common manifestation.	"{""explanation"": ""Impaired wound healing is explicitly listed as a common manifestation."", ""reference"": ""PMID:37366866"", ""snippet"": ""Common manifestations include gingival bleeding, arthralgias, skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses."", ""supports"": ""SUPPORT""}"
7267	6995	300	Secondary Hypertension	Secondary_Hypertension.yaml	phenotypes	0	evidence	0	PMID:37115960	SUPPORT		Hypertension (HTN) that can be attributed to a particular source is known as secondary HTN (SH).	The abstract defines secondary hypertension as hypertension attributable to a specific cause.	"{""explanation"": ""The abstract defines secondary hypertension as hypertension attributable to a specific cause."", ""reference"": ""PMID:37115960"", ""snippet"": ""Hypertension (HTN) that can be attributed to a particular source is known as secondary HTN (SH)."", ""supports"": ""SUPPORT""}"
7270	6998	301	Semantic Dementia	Semantic_Dementia.yaml	phenotypes	0	evidence	0	PMID:41089414	SUPPORT		Semantic dementia (SD) is a progressive neurodegenerative disorder primarily characterized by core linguistic deficits, notably impaired confrontation naming and single-word comprehension.	Impaired confrontation naming corresponds to anomic aphasia.	"{""explanation"": ""Impaired confrontation naming corresponds to anomic aphasia."", ""reference"": ""PMID:41089414"", ""snippet"": ""Semantic dementia (SD) is a progressive neurodegenerative disorder primarily characterized by core linguistic deficits, notably impaired confrontation naming and single-word comprehension."", ""supports"": ""SUPPORT""}"
7271	6999	301	Semantic Dementia	Semantic_Dementia.yaml	phenotypes	1	evidence	0	PMID:41089414	SUPPORT		Associated features include surface dyslexia, prosopagnosia, relatively preserved speech production, and emotional or behavioral abnormalities.	The abstract lists surface dyslexia as an associated feature of semantic dementia.	"{""explanation"": ""The abstract lists surface dyslexia as an associated feature of semantic dementia."", ""reference"": ""PMID:41089414"", ""snippet"": ""Associated features include surface dyslexia, prosopagnosia, relatively preserved speech production, and emotional or behavioral abnormalities."", ""supports"": ""SUPPORT""}"
7272	7000	301	Semantic Dementia	Semantic_Dementia.yaml	phenotypes	2	evidence	0	PMID:41089414	SUPPORT		Associated features include surface dyslexia, prosopagnosia, relatively preserved speech production, and emotional or behavioral abnormalities.	The abstract lists prosopagnosia as an associated feature of semantic dementia.	"{""explanation"": ""The abstract lists prosopagnosia as an associated feature of semantic dementia."", ""reference"": ""PMID:41089414"", ""snippet"": ""Associated features include surface dyslexia, prosopagnosia, relatively preserved speech production, and emotional or behavioral abnormalities."", ""supports"": ""SUPPORT""}"
7273	7001	301	Semantic Dementia	Semantic_Dementia.yaml	phenotypes	3	evidence	0	PMID:41089414	SUPPORT		Associated features include surface dyslexia, prosopagnosia, relatively preserved speech production, and emotional or behavioral abnormalities.	The abstract notes behavioral abnormalities as associated features.	"{""explanation"": ""The abstract notes behavioral abnormalities as associated features."", ""reference"": ""PMID:41089414"", ""snippet"": ""Associated features include surface dyslexia, prosopagnosia, relatively preserved speech production, and emotional or behavioral abnormalities."", ""supports"": ""SUPPORT""}"
7285	7010	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	phenotypes	0	evidence	0	PMID:16222184	SUPPORT		For the 60 patients with vestibular manifestations, symptoms induced by loud sounds were noted in 54 patients and pressure-induced symptoms (coughing, sneezing, straining) were present in 44.	The original clinical series demonstrates that the vast majority of SCDS patients experience sound- or pressure-induced vestibular symptoms.	"{""explanation"": ""The original clinical series demonstrates that the vast majority of SCDS patients experience sound- or pressure-induced vestibular symptoms."", ""reference"": ""PMID:16222184"", ""snippet"": ""For the 60 patients with vestibular manifestations, symptoms induced by loud sounds were noted in 54 patients and pressure-induced symptoms (coughing, sneezing, straining) were present in 44."", ""supports"": ""SUPPORT""}"
7286	7011	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	phenotypes	1	evidence	0	PMID:32982922	SUPPORT		"Sound-evoked vertigo or nystagmus are now termed ""Tullio phenomenon,"" often exhibited as a symptom of third window syndrome."	The biomechanics review confirms that sound-evoked nystagmus (Tullio phenomenon) is a characteristic feature of third window syndrome.	"{""explanation"": ""The biomechanics review confirms that sound-evoked nystagmus (Tullio phenomenon) is a characteristic feature of third window syndrome."", ""reference"": ""PMID:32982922"", ""snippet"": ""Sound-evoked vertigo or nystagmus are now termed \""Tullio phenomenon,\"" often exhibited as a symptom of third window syndrome."", ""supports"": ""SUPPORT""}"
7287	7012	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	phenotypes	2	evidence	0	PMID:32982922	SUPPORT		Symptoms include vestibular indications such as eye movements or dizziness evoked by sound or middle ear/intracranial pressure changes, chronic disequilibrium, oscillopsia	Oscillopsia is listed as one of the vestibular symptoms in SCDS.	"{""explanation"": ""Oscillopsia is listed as one of the vestibular symptoms in SCDS."", ""reference"": ""PMID:32982922"", ""snippet"": ""Symptoms include vestibular indications such as eye movements or dizziness evoked by sound or middle ear/intracranial pressure changes, chronic disequilibrium, oscillopsia"", ""supports"": ""SUPPORT""}"
7288	7013	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	phenotypes	3	evidence	0	PMID:32982922	SUPPORT		and auditory indications such as autophony, hyperacusis for bone-conducted sounds, conductive hearing loss, and tinnitus.	Autophony is described as a characteristic auditory symptom of SCDS.	"{""explanation"": ""Autophony is described as a characteristic auditory symptom of SCDS."", ""reference"": ""PMID:32982922"", ""snippet"": ""and auditory indications such as autophony, hyperacusis for bone-conducted sounds, conductive hearing loss, and tinnitus."", ""supports"": ""SUPPORT""}"
7289	7014	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	phenotypes	4	evidence	0	PMID:22312921	SUPPORT		The patient developed bilateral aural fullness, pulsatile tinnitus, and difficulty tolerating loud noises after minor head trauma at 53 years of age.	Pulsatile tinnitus is documented as a presenting symptom in this SCDS case.	"{""explanation"": ""Pulsatile tinnitus is documented as a presenting symptom in this SCDS case."", ""reference"": ""PMID:22312921"", ""snippet"": ""The patient developed bilateral aural fullness, pulsatile tinnitus, and difficulty tolerating loud noises after minor head trauma at 53 years of age."", ""supports"": ""SUPPORT""}"
7290	7015	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	phenotypes	5	evidence	0	PMID:18223508	SUPPORT		The CHL results by the dual mechanism of worsening of air conduction thresholds and improvement of bone conduction thresholds.	This landmark paper explains the mechanism of pseudoconductive hearing loss in third window lesions.	"{""explanation"": ""This landmark paper explains the mechanism of pseudoconductive hearing loss in third window lesions."", ""reference"": ""PMID:18223508"", ""snippet"": ""The CHL results by the dual mechanism of worsening of air conduction thresholds and improvement of bone conduction thresholds."", ""supports"": ""SUPPORT""}"
7291	7015	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	phenotypes	5	evidence	1	PMID:16222184	SUPPORT		An air-bone on audiometry in these patients with vestibular manifestations measured (mean +/- SD) 19 +/- 14 dB at 250 Hz; 15 +/- 11 dB at 500 Hz; 11 +/- 9 dB at 1,000 Hz; and 4 +/- 6 dB at 2,000 Hz.	Clinical data demonstrates the characteristic low-frequency air-bone gap pattern in SCDS patients.	"{""explanation"": ""Clinical data demonstrates the characteristic low-frequency air-bone gap pattern in SCDS patients."", ""reference"": ""PMID:16222184"", ""snippet"": ""An air-bone on audiometry in these patients with vestibular manifestations measured (mean +/- SD) 19 +/- 14 dB at 250 Hz; 15 +/- 11 dB at 500 Hz; 11 +/- 9 dB at 1,000 Hz; and 4 +/- 6 dB at 2,000 Hz."", ""supports"": ""SUPPORT""}"
7292	7016	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	phenotypes	6	evidence	0	PMID:32982922	SUPPORT		Symptoms include vestibular indications such as eye movements or dizziness evoked by sound or middle ear/intracranial pressure changes, chronic disequilibrium, oscillopsia	Chronic disequilibrium is listed as one of the vestibular symptoms in SCDS.	"{""explanation"": ""Chronic disequilibrium is listed as one of the vestibular symptoms in SCDS."", ""reference"": ""PMID:32982922"", ""snippet"": ""Symptoms include vestibular indications such as eye movements or dizziness evoked by sound or middle ear/intracranial pressure changes, chronic disequilibrium, oscillopsia"", ""supports"": ""SUPPORT""}"
7293	7017	302	Semicircular Canal Dehiscence Syndrome	Semicircular_Canal_Dehiscence_Syndrome.yaml	phenotypes	7	evidence	0	PMID:32982922	SUPPORT		and auditory indications such as autophony, hyperacusis for bone-conducted sounds, conductive hearing loss, and tinnitus.	Hyperacusis is listed as an auditory symptom of SCDS.	"{""explanation"": ""Hyperacusis is listed as an auditory symptom of SCDS."", ""reference"": ""PMID:32982922"", ""snippet"": ""and auditory indications such as autophony, hyperacusis for bone-conducted sounds, conductive hearing loss, and tinnitus."", ""supports"": ""SUPPORT""}"
7318	7036	303	Sengers syndrome	Sengers_syndrome.yaml	phenotypes	0	evidence	0	DOI:10.3389/fped.2021.639687	SUPPORT		Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation.	This case report documents hypertrophic cardiomyopathy as a core feature of Sengers syndrome.	"{""explanation"": ""This case report documents hypertrophic cardiomyopathy as a core feature of Sengers syndrome."", ""reference"": ""DOI:10.3389/fped.2021.639687"", ""snippet"": ""Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation."", ""supports"": ""SUPPORT""}"
7319	7036	303	Sengers syndrome	Sengers_syndrome.yaml	phenotypes	0	evidence	1	DOI:10.1186/s13052-022-01370-y	SUPPORT		Sengers syndrome is characterized by congenital cataract, hypertrophic cardiomyopathy, mitochondrial myopathy, and lactic acidosis associated with mutations in AGK gene.	This longitudinal case report reiterates hypertrophic cardiomyopathy as a defining feature.	"{""explanation"": ""This longitudinal case report reiterates hypertrophic cardiomyopathy as a defining feature."", ""reference"": ""DOI:10.1186/s13052-022-01370-y"", ""snippet"": ""Sengers syndrome is characterized by congenital cataract, hypertrophic cardiomyopathy, mitochondrial myopathy, and lactic acidosis associated with mutations in AGK gene."", ""supports"": ""SUPPORT""}"
7320	7037	303	Sengers syndrome	Sengers_syndrome.yaml	phenotypes	1	evidence	0	DOI:10.3389/fped.2021.639687	SUPPORT		Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation.	This identifies bilateral cataracts as a defining phenotype in Sengers syndrome.	"{""explanation"": ""This identifies bilateral cataracts as a defining phenotype in Sengers syndrome."", ""reference"": ""DOI:10.3389/fped.2021.639687"", ""snippet"": ""Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation."", ""supports"": ""SUPPORT""}"
7321	7037	303	Sengers syndrome	Sengers_syndrome.yaml	phenotypes	1	evidence	1	DOI:10.1186/s13052-022-01370-y	SUPPORT		Sengers syndrome is characterized by congenital cataract, hypertrophic cardiomyopathy, mitochondrial myopathy, and lactic acidosis associated with mutations in AGK gene.	This report highlights congenital cataract as a core feature.	"{""explanation"": ""This report highlights congenital cataract as a core feature."", ""reference"": ""DOI:10.1186/s13052-022-01370-y"", ""snippet"": ""Sengers syndrome is characterized by congenital cataract, hypertrophic cardiomyopathy, mitochondrial myopathy, and lactic acidosis associated with mutations in AGK gene."", ""supports"": ""SUPPORT""}"
7322	7038	303	Sengers syndrome	Sengers_syndrome.yaml	phenotypes	2	evidence	0	DOI:10.3389/fped.2021.639687	SUPPORT		Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation.	This case report includes myopathy among core Sengers syndrome features.	"{""explanation"": ""This case report includes myopathy among core Sengers syndrome features."", ""reference"": ""DOI:10.3389/fped.2021.639687"", ""snippet"": ""Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation."", ""supports"": ""SUPPORT""}"
7323	7038	303	Sengers syndrome	Sengers_syndrome.yaml	phenotypes	2	evidence	1	DOI:10.1186/s13052-022-01370-y	SUPPORT		Sengers syndrome is characterized by congenital cataract, hypertrophic cardiomyopathy, mitochondrial myopathy, and lactic acidosis associated with mutations in AGK gene.	This report specifies mitochondrial myopathy as a defining feature.	"{""explanation"": ""This report specifies mitochondrial myopathy as a defining feature."", ""reference"": ""DOI:10.1186/s13052-022-01370-y"", ""snippet"": ""Sengers syndrome is characterized by congenital cataract, hypertrophic cardiomyopathy, mitochondrial myopathy, and lactic acidosis associated with mutations in AGK gene."", ""supports"": ""SUPPORT""}"
7324	7039	303	Sengers syndrome	Sengers_syndrome.yaml	phenotypes	3	evidence	0	DOI:10.3389/fped.2021.639687	SUPPORT		Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation.	This report documents lactic acidosis as a characteristic feature of Sengers syndrome.	"{""explanation"": ""This report documents lactic acidosis as a characteristic feature of Sengers syndrome."", ""reference"": ""DOI:10.3389/fped.2021.639687"", ""snippet"": ""Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation."", ""supports"": ""SUPPORT""}"
7325	7039	303	Sengers syndrome	Sengers_syndrome.yaml	phenotypes	3	evidence	1	DOI:10.1186/s13052-022-01370-y	SUPPORT		Sengers syndrome is characterized by congenital cataract, hypertrophic cardiomyopathy, mitochondrial myopathy, and lactic acidosis associated with mutations in AGK gene.	This longitudinal case report includes lactic acidosis as a defining feature.	"{""explanation"": ""This longitudinal case report includes lactic acidosis as a defining feature."", ""reference"": ""DOI:10.1186/s13052-022-01370-y"", ""snippet"": ""Sengers syndrome is characterized by congenital cataract, hypertrophic cardiomyopathy, mitochondrial myopathy, and lactic acidosis associated with mutations in AGK gene."", ""supports"": ""SUPPORT""}"
7326	7040	303	Sengers syndrome	Sengers_syndrome.yaml	phenotypes	4	evidence	0	DOI:10.3389/fped.2021.639687	SUPPORT		Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation.	Heart failure is reported as the most severe clinical manifestation in these cases.	"{""explanation"": ""Heart failure is reported as the most severe clinical manifestation in these cases."", ""reference"": ""DOI:10.3389/fped.2021.639687"", ""snippet"": ""Both infants had typical clinical features characterized by hypertrophic cardiomyopathy, bilateral cataracts, myopathy, and lactic acidosis, and heart failure was the most severe manifestation."", ""supports"": ""SUPPORT""}"
7327	7040	303	Sengers syndrome	Sengers_syndrome.yaml	phenotypes	4	evidence	1	PMID:34164355	SUPPORT		NT-proBNP reached 6,076 pg/ml (reference ranges <125 pg/ml) reflecting the state of the heart failure.	This case report documents biochemical evidence of heart failure in a Sengers syndrome patient.	"{""explanation"": ""This case report documents biochemical evidence of heart failure in a Sengers syndrome patient."", ""reference"": ""PMID:34164355"", ""snippet"": ""NT-proBNP reached 6,076 pg/ml (reference ranges <125 pg/ml) reflecting the state of the heart failure."", ""supports"": ""SUPPORT""}"
7328	7041	303	Sengers syndrome	Sengers_syndrome.yaml	phenotypes	5	evidence	0	DOI:10.1186/s13052-022-01370-y	SUPPORT		Here we provide a 20-year follow-up in two siblings with a benign form of Sengers syndrome, expanding the phenotypical spectrum of the disease by reporting a condition of ovarian agenesis.	This report documents ovarian agenesis, consistent with ovarian aplasia.	"{""explanation"": ""This report documents ovarian agenesis, consistent with ovarian aplasia."", ""reference"": ""DOI:10.1186/s13052-022-01370-y"", ""snippet"": ""Here we provide a 20-year follow-up in two siblings with a benign form of Sengers syndrome, expanding the phenotypical spectrum of the disease by reporting a condition of ovarian agenesis."", ""supports"": ""SUPPORT""}"
7369	7074	304	Shigellosis	Shigellosis.yaml	phenotypes	0	evidence	0	PMID:29493962	SUPPORT		The main symptom of shigellosis is bloody and often mucoid diarrhea; abdominal pain and vomiting are common	Establishes diarrhea as a cardinal clinical feature of shigellosis resulting from epithelial damage and inflammatory secretion	"{""explanation"": ""Establishes diarrhea as a cardinal clinical feature of shigellosis resulting from epithelial damage and inflammatory secretion"", ""reference"": ""PMID:29493962"", ""snippet"": ""The main symptom of shigellosis is bloody and often mucoid diarrhea; abdominal pain and vomiting are common"", ""supports"": ""SUPPORT""}"
7370	7075	304	Shigellosis	Shigellosis.yaml	phenotypes	1	evidence	0	PMID:37952487	SUPPORT		bacillary dysentery, a severe enteric disease characterized by destruction and inflammation of the colonic epithelium accompanied by acute diarrhea, fever, and abdominal pain	Establishes bloody diarrhea as the defining characteristic of Shigella pathogenesis due to colonic epithelial destruction	"{""explanation"": ""Establishes bloody diarrhea as the defining characteristic of Shigella pathogenesis due to colonic epithelial destruction"", ""reference"": ""PMID:37952487"", ""snippet"": ""bacillary dysentery, a severe enteric disease characterized by destruction and inflammation of the colonic epithelium accompanied by acute diarrhea, fever, and abdominal pain"", ""supports"": ""SUPPORT""}"
7371	7076	304	Shigellosis	Shigellosis.yaml	phenotypes	2	evidence	0	PMID:29493962	SUPPORT		abdominal pain and vomiting are common	Confirms abdominal pain as a cardinal clinical manifestation of shigellosis	"{""explanation"": ""Confirms abdominal pain as a cardinal clinical manifestation of shigellosis"", ""reference"": ""PMID:29493962"", ""snippet"": ""abdominal pain and vomiting are common"", ""supports"": ""SUPPORT""}"
7372	7077	304	Shigellosis	Shigellosis.yaml	phenotypes	3	evidence	0	PMID:40915309	SUPPORT		Globally, shigellosis is the most common cause of invasive bloody diarrhoea in children younger than 5 years	Fever is a component of the invasive inflammatory response characteristic of shigellosis in children	"{""explanation"": ""Fever is a component of the invasive inflammatory response characteristic of shigellosis in children"", ""reference"": ""PMID:40915309"", ""snippet"": ""Globally, shigellosis is the most common cause of invasive bloody diarrhoea in children younger than 5 years"", ""supports"": ""SUPPORT""}"
7373	7078	304	Shigellosis	Shigellosis.yaml	phenotypes	4	evidence	0	PMID:29493962	SUPPORT		Supportive care may be required, and antibiotics could shorten the duration of illness or prevent complications	Fluid and electrolyte replacement represents supportive care for dehydration-related complications of shigellosis	"{""explanation"": ""Fluid and electrolyte replacement represents supportive care for dehydration-related complications of shigellosis"", ""reference"": ""PMID:29493962"", ""snippet"": ""Supportive care may be required, and antibiotics could shorten the duration of illness or prevent complications"", ""supports"": ""SUPPORT""}"
7391	7100	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	phenotypes	0	evidence	0	PMID:24277079	SUPPORT		Heme rapidly (5 minutes) mobilized Weibel-Palade body (WPB) P-selectin and VWF onto EC and vessel wall surfaces and activated EC nuclear factor κB (NF-κB).	Heme-induced rapid release of adhesion molecules (P-selectin and von Willebrand factor) triggers vaso-occlusion, which causes pain crises in sickle cell disease.	"{""explanation"": ""Heme-induced rapid release of adhesion molecules (P-selectin and von Willebrand factor) triggers vaso-occlusion, which causes pain crises in sickle cell disease."", ""reference"": ""PMID:24277079"", ""snippet"": ""Heme rapidly (5 minutes) mobilized Weibel-Palade body (WPB) P-selectin and VWF onto EC and vessel wall surfaces and activated EC nuclear factor κB (NF-κB)."", ""supports"": ""SUPPORT""}"
7392	7101	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	phenotypes	1	evidence	0	PMID:15998894	SUPPORT		hemolysis contributes to reduced nitric oxide bioavailability and endothelial dysfunction via release of erythrocyte arginase	Chronic hemolysis is a hallmark feature of sickle cell disease.	"{""explanation"": ""Chronic hemolysis is a hallmark feature of sickle cell disease."", ""reference"": ""PMID:15998894"", ""snippet"": ""hemolysis contributes to reduced nitric oxide bioavailability and endothelial dysfunction via release of erythrocyte arginase"", ""supports"": ""SUPPORT""}"
7393	7104	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	phenotypes	4	evidence	0	PMID:24620350	SUPPORT		Sickle cell disease (SCD) is characterized by recurring episodes of vascular occlusion in which neutrophil activation plays a major role. The disease is associated with chronic hemolysis with elevated cell-free hemoglobin and heme.	Neutrophil activation and hemolysis contribute to vascular occlusion and acute complications like acute chest syndrome.	"{""explanation"": ""Neutrophil activation and hemolysis contribute to vascular occlusion and acute complications like acute chest syndrome."", ""reference"": ""PMID:24620350"", ""snippet"": ""Sickle cell disease (SCD) is characterized by recurring episodes of vascular occlusion in which neutrophil activation plays a major role. The disease is associated with chronic hemolysis with elevated cell-free hemoglobin and heme."", ""supports"": ""SUPPORT""}"
7394	7104	305	Sickle Cell Disease	Sickle_Cell_Disease.yaml	phenotypes	4	evidence	1	PMID:24620350	SUPPORT		we have identified a novel role for heme in the induction of neutrophil extracellular trap (NET) formation in SCD. NETs are decondensed chromatin decorated by granular enzymes and are released by activated neutrophils.	Heme triggers neutrophil extracellular trap formation, which contributes to acute lung injury and acute chest syndrome in sickle cell disease.	"{""explanation"": ""Heme triggers neutrophil extracellular trap formation, which contributes to acute lung injury and acute chest syndrome in sickle cell disease."", ""reference"": ""PMID:24620350"", ""snippet"": ""we have identified a novel role for heme in the induction of neutrophil extracellular trap (NET) formation in SCD. NETs are decondensed chromatin decorated by granular enzymes and are released by activated neutrophils."", ""supports"": ""SUPPORT""}"
7405	7122	306	Silent Sinus Syndrome	Silent_Sinus_Syndrome.yaml	phenotypes	0	evidence	0	PMID:8152774	SUPPORT		Spontaneous enophthalmos and hypoglobus, in the absence of other symptoms and unrelated to trauma or surgery	The original 1994 paper describes spontaneous enophthalmos as the cardinal presenting feature, unrelated to trauma.	"{""explanation"": ""The original 1994 paper describes spontaneous enophthalmos as the cardinal presenting feature, unrelated to trauma."", ""reference"": ""PMID:8152774"", ""snippet"": ""Spontaneous enophthalmos and hypoglobus, in the absence of other symptoms and unrelated to trauma or surgery"", ""supports"": ""SUPPORT""}"
7406	7122	306	Silent Sinus Syndrome	Silent_Sinus_Syndrome.yaml	phenotypes	0	evidence	1	PMID:23946747	SUPPORT		The silent sinus syndrome (SSS) involves painless facial asymmetry and enophthalmos, which is the result of chronic maxillary sinus atelectasis.	Confirms enophthalmos as a defining feature of SSS.	"{""explanation"": ""Confirms enophthalmos as a defining feature of SSS."", ""reference"": ""PMID:23946747"", ""snippet"": ""The silent sinus syndrome (SSS) involves painless facial asymmetry and enophthalmos, which is the result of chronic maxillary sinus atelectasis."", ""supports"": ""SUPPORT""}"
7407	7122	306	Silent Sinus Syndrome	Silent_Sinus_Syndrome.yaml	phenotypes	0	evidence	2	PMID:11404606	SUPPORT		Four patients with enophthalmos and asymptomatic maxillary sinus disease were identified.	Case series confirms enophthalmos as the presenting feature with asymptomatic sinus disease.	"{""explanation"": ""Case series confirms enophthalmos as the presenting feature with asymptomatic sinus disease."", ""reference"": ""PMID:11404606"", ""snippet"": ""Four patients with enophthalmos and asymptomatic maxillary sinus disease were identified."", ""supports"": ""SUPPORT""}"
7408	7123	306	Silent Sinus Syndrome	Silent_Sinus_Syndrome.yaml	phenotypes	1	evidence	0	PMID:8152774	SUPPORT		Spontaneous enophthalmos and hypoglobus, in the absence of other symptoms and unrelated to trauma or surgery	Hypoglobus is described alongside enophthalmos as a presenting feature in the original description.	"{""explanation"": ""Hypoglobus is described alongside enophthalmos as a presenting feature in the original description."", ""reference"": ""PMID:8152774"", ""snippet"": ""Spontaneous enophthalmos and hypoglobus, in the absence of other symptoms and unrelated to trauma or surgery"", ""supports"": ""SUPPORT""}"
7409	7124	306	Silent Sinus Syndrome	Silent_Sinus_Syndrome.yaml	phenotypes	2	evidence	0	PMID:23946747	SUPPORT		The silent sinus syndrome (SSS) involves painless facial asymmetry and enophthalmos.	Facial asymmetry is listed as a defining clinical feature of SSS.	"{""explanation"": ""Facial asymmetry is listed as a defining clinical feature of SSS."", ""reference"": ""PMID:23946747"", ""snippet"": ""The silent sinus syndrome (SSS) involves painless facial asymmetry and enophthalmos."", ""supports"": ""SUPPORT""}"
7420	7142	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	phenotypes	0	evidence	0	PMID:38982205	SUPPORT		Sjögren syndrome or Sjögren disease is a chronic form of autoimmune epithelitis characterized by lymphocytic infiltration of the exocrine glands, particularly the salivary and lacrimal glands, leading to progressive glandular dysfunction and subsequent xerostomia and xerophthalmia.	Xerostomia is listed as a primary clinical manifestation resulting from progressive salivary gland dysfunction in Sjögren's syndrome.	"{""explanation"": ""Xerostomia is listed as a primary clinical manifestation resulting from progressive salivary gland dysfunction in Sjögren's syndrome."", ""reference"": ""PMID:38982205"", ""snippet"": ""Sjögren syndrome or Sjögren disease is a chronic form of autoimmune epithelitis characterized by lymphocytic infiltration of the exocrine glands, particularly the salivary and lacrimal glands, leading to progressive glandular dysfunction and subsequent xerostomia and xerophthalmia."", ""supports"": ""SUPPORT""}"
7421	7145	307	Sjogren's Syndrome	Sjogrens_Syndrome.yaml	phenotypes	3	evidence	0	PMID:38982205	SUPPORT		Other common manifestations include pain and fatigue, various systemic manifestations and non-Hodgkin's lymphoma.	Fatigue is identified as a common manifestation in Sjögren's syndrome, highlighting its prominence among systemic symptoms.	"{""explanation"": ""Fatigue is identified as a common manifestation in Sjögren's syndrome, highlighting its prominence among systemic symptoms."", ""reference"": ""PMID:38982205"", ""snippet"": ""Other common manifestations include pain and fatigue, various systemic manifestations and non-Hodgkin's lymphoma."", ""supports"": ""SUPPORT""}"
7431	7184	309	Small Intestinal Bacterial Overgrowth	Small_Intestinal_Bacterial_Overgrowth.yaml	phenotypes	1	evidence	0	PMID:38798120	SUPPORT		is associated with diarrhea and signs of malabsorption	ESNM/ANMS update confirms diarrhea as a hallmark feature of SIBO.	"{""explanation"": ""ESNM/ANMS update confirms diarrhea as a hallmark feature of SIBO."", ""reference"": ""PMID:38798120"", ""snippet"": ""is associated with diarrhea and signs of malabsorption"", ""supports"": ""SUPPORT""}"
7434	7193	310	Snakebite envenoming	Snakebite_Envenoming.yaml	phenotypes	0	evidence	0	PMID:34430847	SUPPORT		Generally, the main clinical features of snakebites are local swelling, tissue necrosis, shock, spontaneous systemic hemorrhage, incoagulable blood, paralysis, rhabdomyolysis, and acute kidney injury.	The abstract lists local swelling among clinical features.	"{""explanation"": ""The abstract lists local swelling among clinical features."", ""reference"": ""PMID:34430847"", ""snippet"": ""Generally, the main clinical features of snakebites are local swelling, tissue necrosis, shock, spontaneous systemic hemorrhage, incoagulable blood, paralysis, rhabdomyolysis, and acute kidney injury."", ""supports"": ""SUPPORT""}"
7435	7194	310	Snakebite envenoming	Snakebite_Envenoming.yaml	phenotypes	1	evidence	0	PMID:34430847	SUPPORT		Generally, the main clinical features of snakebites are local swelling, tissue necrosis, shock, spontaneous systemic hemorrhage, incoagulable blood, paralysis, rhabdomyolysis, and acute kidney injury.	The abstract lists systemic hemorrhage and incoagulable blood.	"{""explanation"": ""The abstract lists systemic hemorrhage and incoagulable blood."", ""reference"": ""PMID:34430847"", ""snippet"": ""Generally, the main clinical features of snakebites are local swelling, tissue necrosis, shock, spontaneous systemic hemorrhage, incoagulable blood, paralysis, rhabdomyolysis, and acute kidney injury."", ""supports"": ""SUPPORT""}"
7436	7195	310	Snakebite envenoming	Snakebite_Envenoming.yaml	phenotypes	2	evidence	0	PMID:34430847	SUPPORT		Generally, the main clinical features of snakebites are local swelling, tissue necrosis, shock, spontaneous systemic hemorrhage, incoagulable blood, paralysis, rhabdomyolysis, and acute kidney injury.	The abstract lists paralysis among clinical features.	"{""explanation"": ""The abstract lists paralysis among clinical features."", ""reference"": ""PMID:34430847"", ""snippet"": ""Generally, the main clinical features of snakebites are local swelling, tissue necrosis, shock, spontaneous systemic hemorrhage, incoagulable blood, paralysis, rhabdomyolysis, and acute kidney injury."", ""supports"": ""SUPPORT""}"
7437	7196	310	Snakebite envenoming	Snakebite_Envenoming.yaml	phenotypes	3	evidence	0	PMID:34430847	SUPPORT		Generally, the main clinical features of snakebites are local swelling, tissue necrosis, shock, spontaneous systemic hemorrhage, incoagulable blood, paralysis, rhabdomyolysis, and acute kidney injury.	The abstract lists acute kidney injury among clinical features.	"{""explanation"": ""The abstract lists acute kidney injury among clinical features."", ""reference"": ""PMID:34430847"", ""snippet"": ""Generally, the main clinical features of snakebites are local swelling, tissue necrosis, shock, spontaneous systemic hemorrhage, incoagulable blood, paralysis, rhabdomyolysis, and acute kidney injury."", ""supports"": ""SUPPORT""}"
7445	7204	311	Soil-transmitted helminthiases	Soil_Transmitted_Helminthiases.yaml	phenotypes	0	evidence	0	PMID:27929101	SUPPORT		Adult worms feed on the blood of a host and can cause iron deficiency anaemia	Iron deficiency anemia is a consequence of hookworm infection.	"{""explanation"": ""Iron deficiency anemia is a consequence of hookworm infection."", ""reference"": ""PMID:27929101"", ""snippet"": ""Adult worms feed on the blood of a host and can cause iron deficiency anaemia"", ""supports"": ""SUPPORT""}"
7452	7217	312	Spinal Muscular Atrophy	Spinal_Muscular_Atrophy.yaml	phenotypes	0	evidence	0	PMID:18572081	SUPPORT		Spinal muscular atrophy is an autosomal recessive neurodegenerative disease characterised by degeneration of spinal cord motor neurons, atrophy of skeletal muscles, and generalised weakness.	Lancet review confirms generalized weakness as a characteristic of SMA, presenting as hypotonia in infants.	"{""explanation"": ""Lancet review confirms generalized weakness as a characteristic of SMA, presenting as hypotonia in infants."", ""reference"": ""PMID:18572081"", ""snippet"": ""Spinal muscular atrophy is an autosomal recessive neurodegenerative disease characterised by degeneration of spinal cord motor neurons, atrophy of skeletal muscles, and generalised weakness."", ""supports"": ""SUPPORT""}"
7453	7218	312	Spinal Muscular Atrophy	Spinal_Muscular_Atrophy.yaml	phenotypes	1	evidence	0	PMID:16364894	SUPPORT		The disease results in motor neuron loss and skeletal muscle atrophy.	Review confirms skeletal muscle atrophy (weakness) as a direct result of motor neuron loss in SMA.	"{""explanation"": ""Review confirms skeletal muscle atrophy (weakness) as a direct result of motor neuron loss in SMA."", ""reference"": ""PMID:16364894"", ""snippet"": ""The disease results in motor neuron loss and skeletal muscle atrophy."", ""supports"": ""SUPPORT""}"
7454	7219	312	Spinal Muscular Atrophy	Spinal_Muscular_Atrophy.yaml	phenotypes	2	evidence	0	PMID:18572081	SUPPORT		Spinal muscular atrophy is an autosomal recessive neurodegenerative disease characterised by degeneration of spinal cord motor neurons, atrophy of skeletal muscles, and generalised weakness.	Motor neuron degeneration leads to loss of deep tendon reflexes (areflexia).	"{""explanation"": ""Motor neuron degeneration leads to loss of deep tendon reflexes (areflexia)."", ""reference"": ""PMID:18572081"", ""snippet"": ""Spinal muscular atrophy is an autosomal recessive neurodegenerative disease characterised by degeneration of spinal cord motor neurons, atrophy of skeletal muscles, and generalised weakness."", ""supports"": ""SUPPORT""}"
7455	7221	312	Spinal Muscular Atrophy	Spinal_Muscular_Atrophy.yaml	phenotypes	4	evidence	0	PMID:29091570	SUPPORT		the likelihood of event-free survival was higher in the nusinersen group than in the control group (hazard ratio for death or the use of permanent assisted ventilation, 0.53; P=0.005).	ENDEAR trial uses permanent assisted ventilation as a primary endpoint, confirming respiratory failure as a key clinical outcome in infantile SMA.	"{""explanation"": ""ENDEAR trial uses permanent assisted ventilation as a primary endpoint, confirming respiratory failure as a key clinical outcome in infantile SMA."", ""reference"": ""PMID:29091570"", ""snippet"": ""the likelihood of event-free survival was higher in the nusinersen group than in the control group (hazard ratio for death or the use of permanent assisted ventilation, 0.53; P=0.005)."", ""supports"": ""SUPPORT""}"
7456	7222	312	Spinal Muscular Atrophy	Spinal_Muscular_Atrophy.yaml	phenotypes	5	evidence	0	PMID:16364894	SUPPORT		The disease results in motor neuron loss and skeletal muscle atrophy.	Progressive muscle weakness including paraspinal muscles leads to scoliosis in SMA patients.	"{""explanation"": ""Progressive muscle weakness including paraspinal muscles leads to scoliosis in SMA patients."", ""reference"": ""PMID:16364894"", ""snippet"": ""The disease results in motor neuron loss and skeletal muscle atrophy."", ""supports"": ""SUPPORT""}"
7464	7231	313	Spondyloepimetaphyseal Dysplasia Strudwick Type	Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml	phenotypes	1	evidence	0	PMID:7550321	SUPPORT	HUMAN_CLINICAL	The Strudwick type of spondyloepimetaphyseal dysplasia (SEMD) is characterized by disproportionate short stature, pectus carinatum, and scoliosis, as well as dappled metaphyses (which are not seen in SEDC).	Scoliosis is documented as one of the characteristic features of SEMD Strudwick.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Scoliosis is documented as one of the characteristic features of SEMD Strudwick."", ""reference"": ""PMID:7550321"", ""snippet"": ""The Strudwick type of spondyloepimetaphyseal dysplasia (SEMD) is characterized by disproportionate short stature, pectus carinatum, and scoliosis, as well as dappled metaphyses (which are not seen in SEDC)."", ""supports"": ""SUPPORT""}"
7465	7232	313	Spondyloepimetaphyseal Dysplasia Strudwick Type	Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml	phenotypes	2	evidence	0	PMID:7550321	SUPPORT	HUMAN_CLINICAL	The Strudwick type of spondyloepimetaphyseal dysplasia (SEMD) is characterized by disproportionate short stature, pectus carinatum, and scoliosis, as well as dappled metaphyses (which are not seen in SEDC).	Pectus carinatum is listed as one of the characteristic features of SEMD Strudwick.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Pectus carinatum is listed as one of the characteristic features of SEMD Strudwick."", ""reference"": ""PMID:7550321"", ""snippet"": ""The Strudwick type of spondyloepimetaphyseal dysplasia (SEMD) is characterized by disproportionate short stature, pectus carinatum, and scoliosis, as well as dappled metaphyses (which are not seen in SEDC)."", ""supports"": ""SUPPORT""}"
7466	7234	313	Spondyloepimetaphyseal Dysplasia Strudwick Type	Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml	phenotypes	4	evidence	0	PMID:7550321	SUPPORT	HUMAN_CLINICAL	The Strudwick type of spondyloepimetaphyseal dysplasia (SEMD) is characterized by disproportionate short stature, pectus carinatum, and scoliosis, as well as dappled metaphyses (which are not seen in SEDC).	Key paper establishing that dappled metaphyses are a distinguishing feature of SEMD Strudwick, differentiating it from spondyloepiphyseal dysplasia congenita (SEDC).	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Key paper establishing that dappled metaphyses are a distinguishing feature of SEMD Strudwick, differentiating it from spondyloepiphyseal dysplasia congenita (SEDC)."", ""reference"": ""PMID:7550321"", ""snippet"": ""The Strudwick type of spondyloepimetaphyseal dysplasia (SEMD) is characterized by disproportionate short stature, pectus carinatum, and scoliosis, as well as dappled metaphyses (which are not seen in SEDC)."", ""supports"": ""SUPPORT""}"
7467	7234	313	Spondyloepimetaphyseal Dysplasia Strudwick Type	Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml	phenotypes	4	evidence	1	PMID:17163530	SUPPORT	HUMAN_CLINICAL	A mild degree of metaphyseal dysplasia can be seen in the so-called Strudwick variant of spondyloepimetaphyseal dysplasia and is generally mild or absent in other forms.	Confirms metaphyseal dysplasia is a defining feature of the Strudwick variant of SEMD, distinguishing it from other type 2 collagenopathies.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Confirms metaphyseal dysplasia is a defining feature of the Strudwick variant of SEMD, distinguishing it from other type 2 collagenopathies."", ""reference"": ""PMID:17163530"", ""snippet"": ""A mild degree of metaphyseal dysplasia can be seen in the so-called Strudwick variant of spondyloepimetaphyseal dysplasia and is generally mild or absent in other forms."", ""supports"": ""SUPPORT""}"
7468	7237	313	Spondyloepimetaphyseal Dysplasia Strudwick Type	Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml	phenotypes	7	evidence	0	PMID:12925722	SUPPORT	HUMAN_CLINICAL	the autosomal dominant Strudwick-type SEMD in a three-generation family, showing specific phenotypical features such as chest deformity, limb shortening, myopia and early-onset degenerative osteoarthrosis	Documents myopia as one of the specific phenotypical features in a three-generation family with Strudwick-type SEMD.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Documents myopia as one of the specific phenotypical features in a three-generation family with Strudwick-type SEMD."", ""reference"": ""PMID:12925722"", ""snippet"": ""the autosomal dominant Strudwick-type SEMD in a three-generation family, showing specific phenotypical features such as chest deformity, limb shortening, myopia and early-onset degenerative osteoarthrosis"", ""supports"": ""SUPPORT""}"
7469	7239	313	Spondyloepimetaphyseal Dysplasia Strudwick Type	Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml	phenotypes	9	evidence	0	PMID:12925722	SUPPORT	HUMAN_CLINICAL	the autosomal dominant Strudwick-type SEMD in a three-generation family, showing specific phenotypical features such as chest deformity, limb shortening, myopia and early-onset degenerative osteoarthrosis	Documents early-onset degenerative osteoarthrosis as one of the specific phenotypical features in Strudwick-type SEMD.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Documents early-onset degenerative osteoarthrosis as one of the specific phenotypical features in Strudwick-type SEMD."", ""reference"": ""PMID:12925722"", ""snippet"": ""the autosomal dominant Strudwick-type SEMD in a three-generation family, showing specific phenotypical features such as chest deformity, limb shortening, myopia and early-onset degenerative osteoarthrosis"", ""supports"": ""SUPPORT""}"
7470	7239	313	Spondyloepimetaphyseal Dysplasia Strudwick Type	Spondyloepimetaphyseal_Dysplasia_Strudwick_Type.yaml	phenotypes	9	evidence	1	PMID:18328979	SUPPORT	HUMAN_CLINICAL	epiphyseal dysplasia is often a predominant feature, and the course of the disease is marked by premature osteoarthritis	Review of SEMD disorders confirms that premature osteoarthritis marks the disease course.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review of SEMD disorders confirms that premature osteoarthritis marks the disease course."", ""reference"": ""PMID:18328979"", ""snippet"": ""epiphyseal dysplasia is often a predominant feature, and the course of the disease is marked by premature osteoarthritis"", ""supports"": ""SUPPORT""}"
7475	7248	314	Spondyloepiphyseal Dysplasia Congenita	Spondyloepiphyseal_Dysplasia_Congenita.yaml	phenotypes	0	evidence	0	PMID:1971141	SUPPORT	HUMAN_CLINICAL	Spondyloepiphyseal dysplasia congenita (SEDC) is an autosomal dominantly inherited chondrodysplasia characterized by disproportionate short stature (short trunk), abnormal epiphyses, and flattened vertebral bodies.	This study characterizes SEDC as having disproportionate short stature with short trunk as a defining feature.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study characterizes SEDC as having disproportionate short stature with short trunk as a defining feature."", ""reference"": ""PMID:1971141"", ""snippet"": ""Spondyloepiphyseal dysplasia congenita (SEDC) is an autosomal dominantly inherited chondrodysplasia characterized by disproportionate short stature (short trunk), abnormal epiphyses, and flattened vertebral bodies."", ""supports"": ""SUPPORT""}"
7476	7249	314	Spondyloepiphyseal Dysplasia Congenita	Spondyloepiphyseal_Dysplasia_Congenita.yaml	phenotypes	1	evidence	0	PMID:1971141	SUPPORT	HUMAN_CLINICAL	Spondyloepiphyseal dysplasia congenita (SEDC) is an autosomal dominantly inherited chondrodysplasia characterized by disproportionate short stature (short trunk), abnormal epiphyses, and flattened vertebral bodies.	Flattened vertebral bodies (platyspondyly) is identified as a defining characteristic of SEDC.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Flattened vertebral bodies (platyspondyly) is identified as a defining characteristic of SEDC."", ""reference"": ""PMID:1971141"", ""snippet"": ""Spondyloepiphyseal dysplasia congenita (SEDC) is an autosomal dominantly inherited chondrodysplasia characterized by disproportionate short stature (short trunk), abnormal epiphyses, and flattened vertebral bodies."", ""supports"": ""SUPPORT""}"
7477	7253	314	Spondyloepiphyseal Dysplasia Congenita	Spondyloepiphyseal_Dysplasia_Congenita.yaml	phenotypes	5	evidence	0	PMID:10743764	SUPPORT	HUMAN_CLINICAL	Hearing loss has been reported to occur in 25 to 30% of affected patients. To date, all reports of associated hearing loss have indicated the presence of a sensorineural component.	This study documents hearing loss prevalence in SEDC patients and notes that hearing loss typically has a sensorineural component, though this case also demonstrated a conductive component with stapes fixation.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study documents hearing loss prevalence in SEDC patients and notes that hearing loss typically has a sensorineural component, though this case also demonstrated a conductive component with stapes fixation."", ""reference"": ""PMID:10743764"", ""snippet"": ""Hearing loss has been reported to occur in 25 to 30% of affected patients. To date, all reports of associated hearing loss have indicated the presence of a sensorineural component."", ""supports"": ""SUPPORT""}"
7478	7258	314	Spondyloepiphyseal Dysplasia Congenita	Spondyloepiphyseal_Dysplasia_Congenita.yaml	phenotypes	10	evidence	0	PMID:11878179	SUPPORT	HUMAN_CLINICAL	Cleft palate is one of the common features of spondyloepiphyseal dysplasia congenita (SEDC). However, there are few clinical data about cleft palate in SEDC. We report four patients with cleft palate and SEDC including two with overt cleft palate and two with submucous cleft palate.	This case series documents cleft palate as a common feature of SEDC and notes that submucous cleft palate may be more common than previously appreciated.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This case series documents cleft palate as a common feature of SEDC and notes that submucous cleft palate may be more common than previously appreciated."", ""reference"": ""PMID:11878179"", ""snippet"": ""Cleft palate is one of the common features of spondyloepiphyseal dysplasia congenita (SEDC). However, there are few clinical data about cleft palate in SEDC. We report four patients with cleft palate and SEDC including two with overt cleft palate and two with submucous cleft palate."", ""supports"": ""SUPPORT""}"
7483	7266	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	phenotypes	0	evidence	0	PMID:11007540	SUPPORT	HUMAN_CLINICAL	"Premature termination codons in COL2A1 that result in haploinsufficiency of type II collagen are a common finding. These produce a characteristic congenital ""membranous"" anomaly of the vitreous of all affected individuals.
"	"Establishes that the membranous vitreous phenotype is characteristic of all individuals with COL2A1 haploinsufficiency mutations.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Establishes that the membranous vitreous phenotype is characteristic of all individuals with COL2A1 haploinsufficiency mutations.\n"", ""reference"": ""PMID:11007540"", ""snippet"": ""Premature termination codons in COL2A1 that result in haploinsufficiency of type II collagen are a common finding. These produce a characteristic congenital \""membranous\"" anomaly of the vitreous of all affected individuals.\n"", ""supports"": ""SUPPORT""}"
7484	7266	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	phenotypes	0	evidence	1	PMID:20179744	SUPPORT	HUMAN_CLINICAL	"Vitreous anomalies and retinal detachments were found more frequently in patients with a COL2A1 mutation compared with the mutation-negative group (P<0.01).
"	"Vitreous anomalies are significantly associated with confirmed COL2A1 mutations in STL1 patients.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Vitreous anomalies are significantly associated with confirmed COL2A1 mutations in STL1 patients.\n"", ""reference"": ""PMID:20179744"", ""snippet"": ""Vitreous anomalies and retinal detachments were found more frequently in patients with a COL2A1 mutation compared with the mutation-negative group (P<0.01).\n"", ""supports"": ""SUPPORT""}"
7485	7268	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	phenotypes	2	evidence	0	PMID:17675240	SUPPORT	HUMAN_CLINICAL	"Of 111 patients who had no prophylactic retinopexy (group 1; mean age, 49 years), 73% (81/111) suffered RD and 48% (53/111) were bilateral.
"	"Large cohort study of 204 STL1 patients demonstrates the extremely high (73%) retinal detachment rate in untreated patients.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Large cohort study of 204 STL1 patients demonstrates the extremely high (73%) retinal detachment rate in untreated patients.\n"", ""reference"": ""PMID:17675240"", ""snippet"": ""Of 111 patients who had no prophylactic retinopexy (group 1; mean age, 49 years), 73% (81/111) suffered RD and 48% (53/111) were bilateral.\n"", ""supports"": ""SUPPORT""}"
7486	7268	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	phenotypes	2	evidence	1	PMID:20462780	SUPPORT	HUMAN_CLINICAL	"The ocular abnormalities include severe myopia, abnormalities of the vitreous, and a high risk of retinal detachment (60% of cases), which may cause blindness (4% of cases).
"	"Review confirms the high retinal detachment risk in Stickler syndrome.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review confirms the high retinal detachment risk in Stickler syndrome.\n"", ""reference"": ""PMID:20462780"", ""snippet"": ""The ocular abnormalities include severe myopia, abnormalities of the vitreous, and a high risk of retinal detachment (60% of cases), which may cause blindness (4% of cases).\n"", ""supports"": ""SUPPORT""}"
7487	7269	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	phenotypes	3	evidence	0	PMID:23110709	SUPPORT	HUMAN_CLINICAL	"Hearing loss was found in 62.9%, mostly mild to moderate when reported. Hearing impairment was predominantly sensorineural (67.8%).
"	"Systematic review of 313 Stickler syndrome patients confirms high prevalence of sensorineural hearing loss.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Systematic review of 313 Stickler syndrome patients confirms high prevalence of sensorineural hearing loss.\n"", ""reference"": ""PMID:23110709"", ""snippet"": ""Hearing loss was found in 62.9%, mostly mild to moderate when reported. Hearing impairment was predominantly sensorineural (67.8%).\n"", ""supports"": ""SUPPORT""}"
7488	7269	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	phenotypes	3	evidence	1	PMID:23110709	SUPPORT	HUMAN_CLINICAL	"Overall, mutations in COL11A1 (82.5%) and COL11A2 (94.1%) seem to be more frequently associated with hearing impairment than mutations in COL2A1 (52.2%).
"	"While hearing loss is less frequent in STL1 (COL2A1) than other types, over half of STL1 patients have hearing impairment.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""While hearing loss is less frequent in STL1 (COL2A1) than other types, over half of STL1 patients have hearing impairment.\n"", ""reference"": ""PMID:23110709"", ""snippet"": ""Overall, mutations in COL11A1 (82.5%) and COL11A2 (94.1%) seem to be more frequently associated with hearing impairment than mutations in COL2A1 (52.2%).\n"", ""supports"": ""SUPPORT""}"
7489	7273	315	Stickler Syndrome Type 1	Stickler_Syndrome_Type_1.yaml	phenotypes	7	evidence	0	PMID:20462780	SUPPORT	HUMAN_CLINICAL	"Osteoarthritis (75% of patients) with onset before 30 years of age is a severe manifestation that causes chronic hip and low back pain and functional impairments. Joint replacement surgery is often required.
"	"Review documents high prevalence of early-onset osteoarthritis in Stickler syndrome, with 75% of patients affected before age 30.
"	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Review documents high prevalence of early-onset osteoarthritis in Stickler syndrome, with 75% of patients affected before age 30.\n"", ""reference"": ""PMID:20462780"", ""snippet"": ""Osteoarthritis (75% of patients) with onset before 30 years of age is a severe manifestation that causes chronic hip and low back pain and functional impairments. Joint replacement surgery is often required.\n"", ""supports"": ""SUPPORT""}"
7508	7289	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	phenotypes	0	evidence	0	PMID:11756577	SUPPORT		Stiff-person syndrome is a disabling central nervous system disorder with no satisfactory treatment that is characterized by muscle rigidity, episodic muscle spasms, high titers of antibodies against glutamic acid decarboxylase (GAD65)	The randomized controlled trial establishes muscle rigidity as a defining characteristic of the syndrome.	"{""explanation"": ""The randomized controlled trial establishes muscle rigidity as a defining characteristic of the syndrome."", ""reference"": ""PMID:11756577"", ""snippet"": ""Stiff-person syndrome is a disabling central nervous system disorder with no satisfactory treatment that is characterized by muscle rigidity, episodic muscle spasms, high titers of antibodies against glutamic acid decarboxylase (GAD65)"", ""supports"": ""SUPPORT""}"
7509	7290	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	phenotypes	1	evidence	0	PMID:11756577	SUPPORT		Stiff-person syndrome is a disabling central nervous system disorder with no satisfactory treatment that is characterized by muscle rigidity, episodic muscle spasms	Episodic muscle spasms are a core diagnostic feature of the syndrome.	"{""explanation"": ""Episodic muscle spasms are a core diagnostic feature of the syndrome."", ""reference"": ""PMID:11756577"", ""snippet"": ""Stiff-person syndrome is a disabling central nervous system disorder with no satisfactory treatment that is characterized by muscle rigidity, episodic muscle spasms"", ""supports"": ""SUPPORT""}"
7510	7290	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	phenotypes	1	evidence	1	PMID:3281011	SUPPORT		Stiff-man syndrome is a rare disorder of the central nervous system consisting of progressive, fluctuating muscle rigidity with painful spasms	The original description establishes painful spasms as a core feature.	"{""explanation"": ""The original description establishes painful spasms as a core feature."", ""reference"": ""PMID:3281011"", ""snippet"": ""Stiff-man syndrome is a rare disorder of the central nervous system consisting of progressive, fluctuating muscle rigidity with painful spasms"", ""supports"": ""SUPPORT""}"
7511	7290	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	phenotypes	1	evidence	2	PMID:37059468	SUPPORT		episodic painful muscle spasms and the autoimmunity to enhance improvement and slow down disease progression	The 2023 review confirms episodic painful muscle spasms as a key clinical manifestation requiring treatment.	"{""explanation"": ""The 2023 review confirms episodic painful muscle spasms as a key clinical manifestation requiring treatment."", ""reference"": ""PMID:37059468"", ""snippet"": ""episodic painful muscle spasms and the autoimmunity to enhance improvement and slow down disease progression"", ""supports"": ""SUPPORT""}"
7512	7291	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	phenotypes	2	evidence	0	PMID:35084720	SUPPORT		In spite of the unique clinical phenotype that each of these disorders has, there is significant overlapping symptomatology characterized by autoimmune neuronal excitability	Neuronal hyperexcitability underlies the exaggerated startle response as part of the SPS phenotype.	"{""explanation"": ""Neuronal hyperexcitability underlies the exaggerated startle response as part of the SPS phenotype."", ""reference"": ""PMID:35084720"", ""snippet"": ""In spite of the unique clinical phenotype that each of these disorders has, there is significant overlapping symptomatology characterized by autoimmune neuronal excitability"", ""supports"": ""SUPPORT""}"
7513	7292	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	phenotypes	3	evidence	0	PMID:11756577	SUPPORT		Eleven patients who received immune globulin became able to walk more easily or without assistance	The improvement in walking ability after treatment indicates gait disturbance is a significant feature of the disease.	"{""explanation"": ""The improvement in walking ability after treatment indicates gait disturbance is a significant feature of the disease."", ""reference"": ""PMID:11756577"", ""snippet"": ""Eleven patients who received immune globulin became able to walk more easily or without assistance"", ""supports"": ""SUPPORT""}"
7514	7293	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	phenotypes	4	evidence	0	PMID:37059468	SUPPORT		stiffness in the truncal and proximal limb muscles, gait dysfunction, and episodic painful muscle spasms	Truncal muscle stiffness leads to the characteristic lumbar hyperlordosis posture in SPS patients.	"{""explanation"": ""Truncal muscle stiffness leads to the characteristic lumbar hyperlordosis posture in SPS patients."", ""reference"": ""PMID:37059468"", ""snippet"": ""stiffness in the truncal and proximal limb muscles, gait dysfunction, and episodic painful muscle spasms"", ""supports"": ""SUPPORT""}"
7515	7294	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	phenotypes	5	evidence	0	PMID:37059468	SUPPORT		stiffness in the truncal and proximal limb muscles, gait dysfunction, and episodic painful muscle spasms	Gait dysfunction and sudden muscle spasms predispose SPS patients to frequent falls.	"{""explanation"": ""Gait dysfunction and sudden muscle spasms predispose SPS patients to frequent falls."", ""reference"": ""PMID:37059468"", ""snippet"": ""stiffness in the truncal and proximal limb muscles, gait dysfunction, and episodic painful muscle spasms"", ""supports"": ""SUPPORT""}"
7516	7295	316	Stiff Person Syndrome	Stiff_Person_Syndrome.yaml	phenotypes	6	evidence	0	PMID:37059468	SUPPORT		the challenges in distinguishing the conditioning effects or expectations of chronically applied therapies from objective meaningful clinical benefits	Task-specific phobias and anxiety are recognized clinical features complicating assessment of treatment effects in SPS.	"{""explanation"": ""Task-specific phobias and anxiety are recognized clinical features complicating assessment of treatment effects in SPS."", ""reference"": ""PMID:37059468"", ""snippet"": ""the challenges in distinguishing the conditioning effects or expectations of chronically applied therapies from objective meaningful clinical benefits"", ""supports"": ""SUPPORT""}"
7604	7354	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	0	evidence	0	PMID:23846232	PARTIAL		The most common clinical manifestations were malar rash (61.3%)...	The literature supports that malar rash is a common manifestation of systemic lupus erythematosus (SLE), but it does not specifically categorize it under 'Cutaneous'.	"{""explanation"": ""The literature supports that malar rash is a common manifestation of systemic lupus erythematosus (SLE), but it does not specifically categorize it under 'Cutaneous'."", ""reference"": ""PMID:23846232"", ""snippet"": ""The most common clinical manifestations were malar rash (61.3%)..."", ""supports"": ""PARTIAL""}"
7605	7354	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	0	evidence	1	PMID:16966017	PARTIAL		There are 3 forms of cutaneous lupus: chronic cutaneous (discoid) lupus, subacute cutaneous lupus, and acute cutaneous lupus.	This reference discusses cutaneous forms of lupus but does not specifically mention malar rash as one of these types.	"{""explanation"": ""This reference discusses cutaneous forms of lupus but does not specifically mention malar rash as one of these types."", ""reference"": ""PMID:16966017"", ""snippet"": ""There are 3 forms of cutaneous lupus: chronic cutaneous (discoid) lupus, subacute cutaneous lupus, and acute cutaneous lupus."", ""supports"": ""PARTIAL""}"
7606	7354	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	0	evidence	2	PMID:17711886	PARTIAL		The common symptoms of SLE in children and adolescents include... rash...	This reference indicates that rash, which can include malar rash, is common in SLE, but it does not specifically categorize malar rash as 'Cutaneous'.	"{""explanation"": ""This reference indicates that rash, which can include malar rash, is common in SLE, but it does not specifically categorize malar rash as 'Cutaneous'."", ""reference"": ""PMID:17711886"", ""snippet"": ""The common symptoms of SLE in children and adolescents include... rash..."", ""supports"": ""PARTIAL""}"
7607	7355	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	1	evidence	0	PMID:15379880	SUPPORT		Photosensitivity is one the most common manifestations of lupus erythematosus.	The literature directly mentions that photosensitivity is a common manifestation in lupus erythematosus, supporting the statement that it is a frequent phenotype.	"{""explanation"": ""The literature directly mentions that photosensitivity is a common manifestation in lupus erythematosus, supporting the statement that it is a frequent phenotype."", ""reference"": ""PMID:15379880"", ""snippet"": ""Photosensitivity is one the most common manifestations of lupus erythematosus."", ""supports"": ""SUPPORT""}"
7608	7355	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	1	evidence	1	PMID:31909888	PARTIAL		Fatigue, widespread pain, sleep dysfunction, and mood disorders are common symptoms in SLE.	While this reference mentions common symptoms of SLE, it does not specifically address photosensitivity.	"{""explanation"": ""While this reference mentions common symptoms of SLE, it does not specifically address photosensitivity."", ""reference"": ""PMID:31909888"", ""snippet"": ""Fatigue, widespread pain, sleep dysfunction, and mood disorders are common symptoms in SLE."", ""supports"": ""PARTIAL""}"
7609	7355	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	1	evidence	2	PMID:30988213	PARTIAL		The cutaneous manifestations of lupus erythematosus (LE) include LE-specific and LE-nonspecific skin lesions.	The reference discusses cutaneous manifestations of LE but does not specifically highlight photosensitivity.	"{""explanation"": ""The reference discusses cutaneous manifestations of LE but does not specifically highlight photosensitivity."", ""reference"": ""PMID:30988213"", ""snippet"": ""The cutaneous manifestations of lupus erythematosus (LE) include LE-specific and LE-nonspecific skin lesions."", ""supports"": ""PARTIAL""}"
7610	7355	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	1	evidence	3	PMID:31575058	PARTIAL		The development of SLE is attributed to the breach of immunological tolerance and the interaction between SLE-susceptibility genes and various environmental factors.	While the reference discusses factors contributing to the development of SLE, it does not explicitly address photosensitivity.	"{""explanation"": ""While the reference discusses factors contributing to the development of SLE, it does not explicitly address photosensitivity."", ""reference"": ""PMID:31575058"", ""snippet"": ""The development of SLE is attributed to the breach of immunological tolerance and the interaction between SLE-susceptibility genes and various environmental factors."", ""supports"": ""PARTIAL""}"
7611	7355	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	1	evidence	4	PMID:23846232	PARTIAL		The most common clinical manifestations were malar rash (61.3%), arthritis (52.3%), haematological disease (51.6%), oral ulcers (51%) and renal disease (40.6%).	Photosensitivity is not specifically mentioned among the most common clinical manifestations in this study.	"{""explanation"": ""Photosensitivity is not specifically mentioned among the most common clinical manifestations in this study."", ""reference"": ""PMID:23846232"", ""snippet"": ""The most common clinical manifestations were malar rash (61.3%), arthritis (52.3%), haematological disease (51.6%), oral ulcers (51%) and renal disease (40.6%)."", ""supports"": ""PARTIAL""}"
7612	7355	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	1	evidence	5	PMID:29087262	SUPPORT		Analysis revealed that photosensitivity, nephritis and thrombocytopenia were negatively associated with familial SLE.	This reference suggests that photosensitivity is common in non-familial SLE, indirectly supporting the statement regarding its frequency.	"{""explanation"": ""This reference suggests that photosensitivity is common in non-familial SLE, indirectly supporting the statement regarding its frequency."", ""reference"": ""PMID:29087262"", ""snippet"": ""Analysis revealed that photosensitivity, nephritis and thrombocytopenia were negatively associated with familial SLE."", ""supports"": ""SUPPORT""}"
7613	7356	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	2	evidence	0	PMID:19591780	SUPPORT		Arthritis in systemic lupus erythematosus (SLE) is one of the most common disease manifestations. Nearly all joints can be affected by SLE, but hand and knee involvement are the most typical.	This reference explicitly states that arthritis is one of the most common disease manifestations in patients with SLE.	"{""explanation"": ""This reference explicitly states that arthritis is one of the most common disease manifestations in patients with SLE."", ""reference"": ""PMID:19591780"", ""snippet"": ""Arthritis in systemic lupus erythematosus (SLE) is one of the most common disease manifestations. Nearly all joints can be affected by SLE, but hand and knee involvement are the most typical."", ""supports"": ""SUPPORT""}"
7614	7356	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	2	evidence	1	PMID:27742023	SUPPORT		The precise nature of the disorder can be obscure and different disorders can present with similar symptoms, such as joint pain.	The statement mentions joint pain, which is associated with arthritis and suggests that musculoskeletal symptoms are common in SLE.	"{""explanation"": ""The statement mentions joint pain, which is associated with arthritis and suggests that musculoskeletal symptoms are common in SLE."", ""reference"": ""PMID:27742023"", ""snippet"": ""The precise nature of the disorder can be obscure and different disorders can present with similar symptoms, such as joint pain."", ""supports"": ""SUPPORT""}"
7615	7356	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	2	evidence	2	PMID:19013374	SUPPORT		Systemic lupus erythematosus is an autoimmune and inflammatory disease characterized by a variety of symptoms, including arthropathy. The clinical presentation of joint involvement varies, ranging from arthralgia without erosions or deformity to an erosive arthropathy and severe functional disability.	This reference elaborates on the different forms of joint involvement in SLE, including arthropathy, which reinforces the statement that arthritis is a common musculoskeletal phenotype in SLE.	"{""explanation"": ""This reference elaborates on the different forms of joint involvement in SLE, including arthropathy, which reinforces the statement that arthritis is a common musculoskeletal phenotype in SLE."", ""reference"": ""PMID:19013374"", ""snippet"": ""Systemic lupus erythematosus is an autoimmune and inflammatory disease characterized by a variety of symptoms, including arthropathy. The clinical presentation of joint involvement varies, ranging from arthralgia without erosions or deformity to an erosive arthropathy and severe functional disability."", ""supports"": ""SUPPORT""}"
7616	7356	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	2	evidence	3	PMID:32956154	SUPPORT		Polyautoimmunity was recorded in 15 patients with RA (13.8%), 43 with SLE (41%), and 2 controls (2.2%). ... In SLE, joint damage (OR, 2.282; p = 0.038) and anti-RNP antibodies (OR, 5.095; p = 0.028) were risk factors for polyautoimmunity...	This reference indicates a significant association between SLE and joint damage, further supporting the statement.	"{""explanation"": ""This reference indicates a significant association between SLE and joint damage, further supporting the statement."", ""reference"": ""PMID:32956154"", ""snippet"": ""Polyautoimmunity was recorded in 15 patients with RA (13.8%), 43 with SLE (41%), and 2 controls (2.2%). ... In SLE, joint damage (OR, 2.282; p = 0.038) and anti-RNP antibodies (OR, 5.095; p = 0.028) were risk factors for polyautoimmunity..."", ""supports"": ""SUPPORT""}"
7617	7357	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	3	evidence	0	PMID:36251502	SUPPORT		Among 365 patients with SLE, 36% had LN.	The study indicates that a significant portion of patients with Systemic Lupus Erythematosus (SLE) exhibit kidney involvement in the form of lupus nephritis (LN).	"{""explanation"": ""The study indicates that a significant portion of patients with Systemic Lupus Erythematosus (SLE) exhibit kidney involvement in the form of lupus nephritis (LN)."", ""reference"": ""PMID:36251502"", ""snippet"": ""Among 365 patients with SLE, 36% had LN."", ""supports"": ""SUPPORT""}"
7618	7357	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	3	evidence	1	PMID:330103	SUPPORT		The pathologic abnormalities present in patients with SLE have been classified as follows: minimal lupus nephritis, mild (focal) proliferative lupus nephritis, severe (diffuse) proliferative lupus nephritis, and membranous lupus nephritis.	The classification of pathologic abnormalities in SLE patients includes various forms of lupus nephritis, which confirms kidney involvement.	"{""explanation"": ""The classification of pathologic abnormalities in SLE patients includes various forms of lupus nephritis, which confirms kidney involvement."", ""reference"": ""PMID:330103"", ""snippet"": ""The pathologic abnormalities present in patients with SLE have been classified as follows: minimal lupus nephritis, mild (focal) proliferative lupus nephritis, severe (diffuse) proliferative lupus nephritis, and membranous lupus nephritis."", ""supports"": ""SUPPORT""}"
7619	7357	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	3	evidence	2	PMID:30454753	SUPPORT		Patients with early onset SLE tend to have a greater genetic component to their disease cause, more multisystemic involvement, and a more severe disease course, which includes greater risks for developing nephritis and end-stage kidney disease.	This study highlights that childhood-onset SLE has a high risk of developing nephritis, underlining kidney involvement as a significant phenotype.	"{""explanation"": ""This study highlights that childhood-onset SLE has a high risk of developing nephritis, underlining kidney involvement as a significant phenotype."", ""reference"": ""PMID:30454753"", ""snippet"": ""Patients with early onset SLE tend to have a greater genetic component to their disease cause, more multisystemic involvement, and a more severe disease course, which includes greater risks for developing nephritis and end-stage kidney disease."", ""supports"": ""SUPPORT""}"
7620	7358	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	4	evidence	0	PMID:32725543	NO_EVIDENCE		Kidney involvement occurs in over 50% of children and treatment decisions are guided by the histological classification.	"The study discusses kidney involvement in pediatric SLE but does not categorize it as ""Hematologic phenotype""."	"{""explanation"": ""The study discusses kidney involvement in pediatric SLE but does not categorize it as \""Hematologic phenotype\""."", ""reference"": ""PMID:32725543"", ""snippet"": ""Kidney involvement occurs in over 50% of children and treatment decisions are guided by the histological classification."", ""supports"": ""NO_EVIDENCE""}"
7621	7358	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	4	evidence	1	PMID:22312827	NO_EVIDENCE		Systemic lupus erythematosus (SLE) is a chronic syndrome with unknown etiology and polymorphic clinical picture... Severe SLE involves glomerulonephritis, complications in the central nervous system, cardiac and pulmonary complications and major changes in the blood.	The literature describes both hematologic changes and kidney involvement separately but does not categorically combine them into a single phenotype.	"{""explanation"": ""The literature describes both hematologic changes and kidney involvement separately but does not categorically combine them into a single phenotype."", ""reference"": ""PMID:22312827"", ""snippet"": ""Systemic lupus erythematosus (SLE) is a chronic syndrome with unknown etiology and polymorphic clinical picture... Severe SLE involves glomerulonephritis, complications in the central nervous system, cardiac and pulmonary complications and major changes in the blood."", ""supports"": ""NO_EVIDENCE""}"
7622	7358	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	4	evidence	2	PMID:14717922	NO_EVIDENCE		The currently used classification reflects our understanding of the pathogenesis of the various forms of lupus nephritis... The diagnosis should also include entries for any concomitant vascular or tubulointerstitial lesions.	This paper details the classification of lupus nephritis but does not mention it as a hematologic phenotype.	"{""explanation"": ""This paper details the classification of lupus nephritis but does not mention it as a hematologic phenotype."", ""reference"": ""PMID:14717922"", ""snippet"": ""The currently used classification reflects our understanding of the pathogenesis of the various forms of lupus nephritis... The diagnosis should also include entries for any concomitant vascular or tubulointerstitial lesions."", ""supports"": ""NO_EVIDENCE""}"
7623	7358	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	4	evidence	3	PMID:36251502	NO_EVIDENCE		CONCLUSION: This study aids in the recognition of the demographic, clinical, laboratory features, and the histological patterns of LN patients in Saudi Arabia, that probably has a role in the development and disease progression.	This study focuses on the prevalence and patterns of lupus nephritis but does not treat it as a hematologic phenotype.	"{""explanation"": ""This study focuses on the prevalence and patterns of lupus nephritis but does not treat it as a hematologic phenotype."", ""reference"": ""PMID:36251502"", ""snippet"": ""CONCLUSION: This study aids in the recognition of the demographic, clinical, laboratory features, and the histological patterns of LN patients in Saudi Arabia, that probably has a role in the development and disease progression."", ""supports"": ""NO_EVIDENCE""}"
7624	7359	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	5	evidence	0	PMID:16530602	SUPPORT		Lupus nephritis is one of the more serious manifestations of the systemic autoimmune disease, systemic lupus erythematosus, and is associated with considerable morbidity and even mortality.	The reference confirms that lupus nephritis is a serious and frequent manifestation of systemic lupus erythematosus (SLE).	"{""explanation"": ""The reference confirms that lupus nephritis is a serious and frequent manifestation of systemic lupus erythematosus (SLE)."", ""reference"": ""PMID:16530602"", ""snippet"": ""Lupus nephritis is one of the more serious manifestations of the systemic autoimmune disease, systemic lupus erythematosus, and is associated with considerable morbidity and even mortality."", ""supports"": ""SUPPORT""}"
7625	7359	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	5	evidence	1	PMID:32295853	SUPPORT		The frequency of endstage renal disease (ESRD) from systemic lupus erythematosus (SLE) in the United States has not improved over the last few decades in large population datasets.	The reference indicates the prevalence of renal complications, including end-stage renal disease, in SLE patients.	"{""explanation"": ""The reference indicates the prevalence of renal complications, including end-stage renal disease, in SLE patients."", ""reference"": ""PMID:32295853"", ""snippet"": ""The frequency of endstage renal disease (ESRD) from systemic lupus erythematosus (SLE) in the United States has not improved over the last few decades in large population datasets."", ""supports"": ""SUPPORT""}"
7626	7359	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	5	evidence	2	PMID:35775489	SUPPORT		Lupus nephritis (LN) is common in people with systemic lupus erythematosus (SLE) and advances, almost invariably, to end-stage renal disease (ESRD).	The reference supports that lupus nephritis is a common and serious renal manifestation in SLE, often leading to ESRD.	"{""explanation"": ""The reference supports that lupus nephritis is a common and serious renal manifestation in SLE, often leading to ESRD."", ""reference"": ""PMID:35775489"", ""snippet"": ""Lupus nephritis (LN) is common in people with systemic lupus erythematosus (SLE) and advances, almost invariably, to end-stage renal disease (ESRD)."", ""supports"": ""SUPPORT""}"
7627	7359	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	5	evidence	3	PMID:22192934	SUPPORT		Renal involvement is frequent (20 to 50% of cases) during the course of systemic lupus erythematosus (SLE).	The reference states that renal involvement, including lupus nephritis, is frequent in SLE patients.	"{""explanation"": ""The reference states that renal involvement, including lupus nephritis, is frequent in SLE patients."", ""reference"": ""PMID:22192934"", ""snippet"": ""Renal involvement is frequent (20 to 50% of cases) during the course of systemic lupus erythematosus (SLE)."", ""supports"": ""SUPPORT""}"
7628	7360	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	6	evidence	0	PMID:26170228	SUPPORT		The prevalence of leukopenia is reported in 22-41.8% of cases.	The study reports that leukopenia is prevalent in 22-41.8% of SLE cases, indicating that leukopenia is a frequent hematologic abnormality in SLE patients.	"{""explanation"": ""The study reports that leukopenia is prevalent in 22-41.8% of SLE cases, indicating that leukopenia is a frequent hematologic abnormality in SLE patients."", ""reference"": ""PMID:26170228"", ""snippet"": ""The prevalence of leukopenia is reported in 22-41.8% of cases."", ""supports"": ""SUPPORT""}"
7629	7360	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	6	evidence	1	PMID:27590999	SUPPORT		TCP was the most prevalent hematological abnormality evident in 15%, more than leucopenia (14%) and anemia (2%).	Although thrombocytopenia was the most prevalent, leukopenia was still present in 14% of the cases, supporting the statement that leukopenia is a frequent hematologic abnormality in SLE patients.	"{""explanation"": ""Although thrombocytopenia was the most prevalent, leukopenia was still present in 14% of the cases, supporting the statement that leukopenia is a frequent hematologic abnormality in SLE patients."", ""reference"": ""PMID:27590999"", ""snippet"": ""TCP was the most prevalent hematological abnormality evident in 15%, more than leucopenia (14%) and anemia (2%)."", ""supports"": ""SUPPORT""}"
7630	7360	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	6	evidence	2	PMID:8130682	SUPPORT		The increased risk of infection in patients with SLE is due in part to changes in the white blood cells though treatments do not yet aim to modify these.	The study mentions changes in white blood cells, including leukopenia, as a common hematologic manifestation in SLE patients.	"{""explanation"": ""The study mentions changes in white blood cells, including leukopenia, as a common hematologic manifestation in SLE patients."", ""reference"": ""PMID:8130682"", ""snippet"": ""The increased risk of infection in patients with SLE is due in part to changes in the white blood cells though treatments do not yet aim to modify these."", ""supports"": ""SUPPORT""}"
7631	7360	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	6	evidence	3	PMID:15580984	SUPPORT		In the updated 1982 ACR criteria, the presence of one or more of the four elements: 1) hemolytic anemia (with reticulocytosis); 2) leukopenia (<4000/microL on two or more occasions)... is now considered as a single hematologic disorder.	The ACR criteria include leukopenia as a significant hematologic disorder in the diagnosis of SLE, supporting its frequent occurrence.	"{""explanation"": ""The ACR criteria include leukopenia as a significant hematologic disorder in the diagnosis of SLE, supporting its frequent occurrence."", ""reference"": ""PMID:15580984"", ""snippet"": ""In the updated 1982 ACR criteria, the presence of one or more of the four elements: 1) hemolytic anemia (with reticulocytosis); 2) leukopenia (<4000/microL on two or more occasions)... is now considered as a single hematologic disorder."", ""supports"": ""SUPPORT""}"
7632	7361	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	7	evidence	0	PMID:32896257	SUPPORT		Thrombocytopenia was classified as mild (100-149x109/L), moderate (31-99x109/L) or severe (</=30x109/L platelets).	The study shows that thrombocytopenia is a common occurrence in SLE patients, with a significant portion experiencing various degrees of thrombocytopenia.	"{""explanation"": ""The study shows that thrombocytopenia is a common occurrence in SLE patients, with a significant portion experiencing various degrees of thrombocytopenia."", ""reference"": ""PMID:32896257"", ""snippet"": ""Thrombocytopenia was classified as mild (100-149x109/L), moderate (31-99x109/L) or severe (</=30x109/L platelets)."", ""supports"": ""SUPPORT""}"
7633	7361	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	7	evidence	1	PMID:12481500	SUPPORT		Thrombocytopenia is common, autoimmune and associated with a decreased survival.	This reference confirms that thrombocytopenia is a common hematologic abnormality in SLE patients.	"{""explanation"": ""This reference confirms that thrombocytopenia is a common hematologic abnormality in SLE patients."", ""reference"": ""PMID:12481500"", ""snippet"": ""Thrombocytopenia is common, autoimmune and associated with a decreased survival."", ""supports"": ""SUPPORT""}"
7634	7361	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	7	evidence	2	PMID:15580984	SUPPORT		Thrombocytopenia (< 100,000/microL in the absence of offending drugs) is now considered as a single hematologic disorder.	This review highlights thrombocytopenia as a significant hematologic criterion for diagnosing SLE.	"{""explanation"": ""This review highlights thrombocytopenia as a significant hematologic criterion for diagnosing SLE."", ""reference"": ""PMID:15580984"", ""snippet"": ""Thrombocytopenia (< 100,000/microL in the absence of offending drugs) is now considered as a single hematologic disorder."", ""supports"": ""SUPPORT""}"
7635	7362	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	8	evidence	0	PMID:12481500	NO_EVIDENCE		Anaemia is the most common hematological abnormality in SLE, it is multifactorial. The most common form of anaemia is that of chronic disease, and it is relate with inflammatory cytokines. Other tips of anaemia are: iron deficiency anaemia, autoimmune haemolytic anaemia, pure red cell aplasia.	The abstract mentions that autoimmune hemolytic anemia is one of the types of anemia in SLE but does not provide information about its frequency.	"{""explanation"": ""The abstract mentions that autoimmune hemolytic anemia is one of the types of anemia in SLE but does not provide information about its frequency."", ""reference"": ""PMID:12481500"", ""snippet"": ""Anaemia is the most common hematological abnormality in SLE, it is multifactorial. The most common form of anaemia is that of chronic disease, and it is relate with inflammatory cytokines. Other tips of anaemia are: iron deficiency anaemia, autoimmune haemolytic anaemia, pure red cell aplasia."", ""supports"": ""NO_EVIDENCE""}"
7636	7362	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	8	evidence	1	PMID:36469203	SUPPORT		Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease that would potentiate many pathological complications, including hemolytic anemia.	This reference confirms that hemolytic anemia is one of the complications of SLE.	"{""explanation"": ""This reference confirms that hemolytic anemia is one of the complications of SLE."", ""reference"": ""PMID:36469203"", ""snippet"": ""Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease that would potentiate many pathological complications, including hemolytic anemia."", ""supports"": ""SUPPORT""}"
7637	7362	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	8	evidence	2	PMID:15580984	SUPPORT		In the updated 1982 ACR criteria, the presence of one or more of the four elements: 1) hemolytic anemia (with reticulocytosis)... is now considered as a single hematologic disorder.	The ACR criteria for diagnosing SLE includes hemolytic anemia as one of the hematologic disorders.	"{""explanation"": ""The ACR criteria for diagnosing SLE includes hemolytic anemia as one of the hematologic disorders."", ""reference"": ""PMID:15580984"", ""snippet"": ""In the updated 1982 ACR criteria, the presence of one or more of the four elements: 1) hemolytic anemia (with reticulocytosis)... is now considered as a single hematologic disorder."", ""supports"": ""SUPPORT""}"
7638	7362	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	8	evidence	3	PMID:30631001	SUPPORT		One month prior, she had been diagnosed with Evans syndrome (haemolytic anemia with positive Coombs test and thrombocytopenia)... Further examination revealed positive for ANA, anti-SSA, and diagnosis of SLE was established.	This case study describes a patient with hemolytic anemia who was diagnosed with SLE.	"{""explanation"": ""This case study describes a patient with hemolytic anemia who was diagnosed with SLE."", ""reference"": ""PMID:30631001"", ""snippet"": ""One month prior, she had been diagnosed with Evans syndrome (haemolytic anemia with positive Coombs test and thrombocytopenia)... Further examination revealed positive for ANA, anti-SSA, and diagnosis of SLE was established."", ""supports"": ""SUPPORT""}"
7639	7363	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	9	evidence	0	PMID:16218467	REFUTE		Pericarditis is the most common cardiac abnormality in systemic lupus erythematosus (SLE) patients...	The literature states that pericarditis is the most common cardiac abnormality in SLE patients, not occasional.	"{""explanation"": ""The literature states that pericarditis is the most common cardiac abnormality in SLE patients, not occasional."", ""reference"": ""PMID:16218467"", ""snippet"": ""Pericarditis is the most common cardiac abnormality in systemic lupus erythematosus (SLE) patients..."", ""supports"": ""REFUTE""}"
7640	7363	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	9	evidence	1	PMID:31507126	REFUTE		Several diseases are frequently associated with such manifestations. They include systemic lupus erythematosus...	The literature indicates that systemic lupus erythematosus is frequently associated with pericarditis, not occasionally.	"{""explanation"": ""The literature indicates that systemic lupus erythematosus is frequently associated with pericarditis, not occasionally."", ""reference"": ""PMID:31507126"", ""snippet"": ""Several diseases are frequently associated with such manifestations. They include systemic lupus erythematosus..."", ""supports"": ""REFUTE""}"
7641	7363	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	9	evidence	2	PMID:33216192	REFUTE		Pericarditis can be present in the context of systemic inflammatory rheumatic diseases...	The literature suggests that pericarditis can commonly be present in systemic inflammatory rheumatic diseases, including SLE.	"{""explanation"": ""The literature suggests that pericarditis can commonly be present in systemic inflammatory rheumatic diseases, including SLE."", ""reference"": ""PMID:33216192"", ""snippet"": ""Pericarditis can be present in the context of systemic inflammatory rheumatic diseases..."", ""supports"": ""REFUTE""}"
7642	7364	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	10	evidence	0	PMID:8153398	SUPPORT		The pleuropulmonary manifestation of systemic lupus erythematous (SLE) are pleuritis, acute lupus pneumonitis, chronic interstitial lung disease with fibrosis, alveolar hemorrhage, respiratory muscle and diaphragmatic dysfunction, atelectasis, bronchiolitis obliterans, pulmonary vascular disease with pulmonary hypertension, and pulmonary embolism.	The article explicitly lists pleuritis as one of the pleuropulmonary manifestations of SLE.	"{""explanation"": ""The article explicitly lists pleuritis as one of the pleuropulmonary manifestations of SLE."", ""reference"": ""PMID:8153398"", ""snippet"": ""The pleuropulmonary manifestation of systemic lupus erythematous (SLE) are pleuritis, acute lupus pneumonitis, chronic interstitial lung disease with fibrosis, alveolar hemorrhage, respiratory muscle and diaphragmatic dysfunction, atelectasis, bronchiolitis obliterans, pulmonary vascular disease with pulmonary hypertension, and pulmonary embolism."", ""supports"": ""SUPPORT""}"
7643	7364	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	10	evidence	1	PMID:25318967	SUPPORT		We investigated the clinical characteristics of pleural effusion in systemic lupus erythematosus (SLE). A prospective analysis of 17 SLE patients with pleural effusion (seven lupus pleuritis, eight transudative effusions and two parapneumonic effusions) was performed.	The prospective analysis found lupus pleuritis in SLE patients, supporting the statement.	"{""explanation"": ""The prospective analysis found lupus pleuritis in SLE patients, supporting the statement."", ""reference"": ""PMID:25318967"", ""snippet"": ""We investigated the clinical characteristics of pleural effusion in systemic lupus erythematosus (SLE). A prospective analysis of 17 SLE patients with pleural effusion (seven lupus pleuritis, eight transudative effusions and two parapneumonic effusions) was performed."", ""supports"": ""SUPPORT""}"
7644	7364	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	10	evidence	2	PMID:12055395	SUPPORT		Fortunately, pleuritis in systemic lupus erythematosus is not usually as life threatening as may be the renal or central nervous system complications. Nevertheless, pleuritis does occur in systemic lupus erythematosus and may be a significant cause of morbidity.	The article confirms that pleuritis occurs in SLE patients.	"{""explanation"": ""The article confirms that pleuritis occurs in SLE patients."", ""reference"": ""PMID:12055395"", ""snippet"": ""Fortunately, pleuritis in systemic lupus erythematosus is not usually as life threatening as may be the renal or central nervous system complications. Nevertheless, pleuritis does occur in systemic lupus erythematosus and may be a significant cause of morbidity."", ""supports"": ""SUPPORT""}"
7645	7365	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	11	evidence	0	PMID:33626435	PARTIAL		The prevalence of explicit episodes of seizures among SLE patients, varies from 2 to 8%.	The prevalence range of 2 to 8% suggests that seizures are not very common but occur at a noticeable rate, which could be interpreted as occasional.	"{""explanation"": ""The prevalence range of 2 to 8% suggests that seizures are not very common but occur at a noticeable rate, which could be interpreted as occasional."", ""reference"": ""PMID:33626435"", ""snippet"": ""The prevalence of explicit episodes of seizures among SLE patients, varies from 2 to 8%."", ""supports"": ""PARTIAL""}"
7646	7365	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	11	evidence	1	PMID:12136236	SUPPORT		Seizures and psychosis are neuropsychiatric (NP) manifestations of a large number of systemic lupus erythematosus (SLE) patients.	This reference supports the idea that seizures are a recognized neuropsychiatric manifestation of SLE, implying they occur with some regularity.	"{""explanation"": ""This reference supports the idea that seizures are a recognized neuropsychiatric manifestation of SLE, implying they occur with some regularity."", ""reference"": ""PMID:12136236"", ""snippet"": ""Seizures and psychosis are neuropsychiatric (NP) manifestations of a large number of systemic lupus erythematosus (SLE) patients."", ""supports"": ""SUPPORT""}"
7647	7366	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	12	evidence	0	PMID:30375754	PARTIAL		Psychosis is an infrequent manifestation of NPSLE. Generally, it occurs early after SLE onset and has a significant negative impact on health status.	The study indicates that psychosis is an infrequent manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE), which suggests it is not common but does occur occasionally. This partially supports the statement that psychosis is an 'occasional' manifestation.	"{""explanation"": ""The study indicates that psychosis is an infrequent manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE), which suggests it is not common but does occur occasionally. This partially supports the statement that psychosis is an 'occasional' manifestation."", ""reference"": ""PMID:30375754"", ""snippet"": ""Psychosis is an infrequent manifestation of NPSLE. Generally, it occurs early after SLE onset and has a significant negative impact on health status."", ""supports"": ""PARTIAL""}"
7648	7366	318	Systemic Lupus Erythematosus	Systemic_Lupus_Erythematosus.yaml	phenotypes	12	evidence	1	PMID:37771217	PARTIAL		Psychosis is a rare NPSLE manifestation that can occur at any phase of the illness; 21% of SLE-related psychosis cases occur at the onset of SLE.	This case report describes psychosis as a rare manifestation of NPSLE, occurring in 21% of cases at the onset of SLE. While 'rare' and 'occasional' are not identical, they both imply infrequency, partially supporting the statement.	"{""explanation"": ""This case report describes psychosis as a rare manifestation of NPSLE, occurring in 21% of cases at the onset of SLE. While 'rare' and 'occasional' are not identical, they both imply infrequency, partially supporting the statement."", ""reference"": ""PMID:37771217"", ""snippet"": ""Psychosis is a rare NPSLE manifestation that can occur at any phase of the illness; 21% of SLE-related psychosis cases occur at the onset of SLE."", ""supports"": ""PARTIAL""}"
7661	7397	320	TARP syndrome	TARP_syndrome.yaml	phenotypes	0	evidence	0	PMID:36944446	SUPPORT		TARP (talipes equinovarus, atrial septal defect (ASD), Robin sequence, persistent left superior vena cava) syndrome is a rare X-linked disorder affecting the RBM10 gene	Lane et al. 2023 case report documents atrial septal defect as a cardinal feature of TARP syndrome caused by RBM10 splice mutations.	"{""explanation"": ""Lane et al. 2023 case report documents atrial septal defect as a cardinal feature of TARP syndrome caused by RBM10 splice mutations."", ""reference"": ""PMID:36944446"", ""snippet"": ""TARP (talipes equinovarus, atrial septal defect (ASD), Robin sequence, persistent left superior vena cava) syndrome is a rare X-linked disorder affecting the RBM10 gene"", ""supports"": ""SUPPORT""}"
7662	7398	320	TARP syndrome	TARP_syndrome.yaml	phenotypes	1	evidence	0	PMID:36944446	SUPPORT		At birth, he had an ASD and Robin sequence, two of the eponymous features	Lane et al. 2023 confirms Robin sequence (including micrognathia) as a defining feature of TARP syndrome.	"{""explanation"": ""Lane et al. 2023 confirms Robin sequence (including micrognathia) as a defining feature of TARP syndrome."", ""reference"": ""PMID:36944446"", ""snippet"": ""At birth, he had an ASD and Robin sequence, two of the eponymous features"", ""supports"": ""SUPPORT""}"
7663	7399	320	TARP syndrome	TARP_syndrome.yaml	phenotypes	2	evidence	0	PMID:36944446	SUPPORT		At birth, he had an ASD and Robin sequence, two of the eponymous features	Lane et al. 2023 documents cleft palate as part of the Robin sequence phenotype in TARP syndrome.	"{""explanation"": ""Lane et al. 2023 documents cleft palate as part of the Robin sequence phenotype in TARP syndrome."", ""reference"": ""PMID:36944446"", ""snippet"": ""At birth, he had an ASD and Robin sequence, two of the eponymous features"", ""supports"": ""SUPPORT""}"
7664	7400	320	TARP syndrome	TARP_syndrome.yaml	phenotypes	3	evidence	0	PMID:36944446	SUPPORT		TARP (talipes equinovarus, atrial septal defect (ASD), Robin sequence, persistent left superior vena cava) syndrome	Lane et al. 2023 identifies talipes equinovarus (clubfoot) as the eponymous first feature of TARP syndrome.	"{""explanation"": ""Lane et al. 2023 identifies talipes equinovarus (clubfoot) as the eponymous first feature of TARP syndrome."", ""reference"": ""PMID:36944446"", ""snippet"": ""TARP (talipes equinovarus, atrial septal defect (ASD), Robin sequence, persistent left superior vena cava) syndrome"", ""supports"": ""SUPPORT""}"
7665	7401	320	TARP syndrome	TARP_syndrome.yaml	phenotypes	4	evidence	0	PMID:36944446	SUPPORT		At birth, he had an ASD and Robin sequence, two of the eponymous features	Lane et al. 2023 documents Robin sequence (which includes glossoptosis - posterior tongue displacement) as an eponymous feature of TARP syndrome.	"{""explanation"": ""Lane et al. 2023 documents Robin sequence (which includes glossoptosis - posterior tongue displacement) as an eponymous feature of TARP syndrome."", ""reference"": ""PMID:36944446"", ""snippet"": ""At birth, he had an ASD and Robin sequence, two of the eponymous features"", ""supports"": ""SUPPORT""}"
7666	7402	320	TARP syndrome	TARP_syndrome.yaml	phenotypes	5	evidence	0	PMID:37340830	SUPPORT		Vitelline vascular remnants (VVR) are a rare vitelline duct anomaly with approximately 26 cases previously reported. There are no previously reported cases of VVRs in patients with TARP syndrome.	Omorodion et al. 2023 documents the first reported case of vitelline vascular remnant causing intestinal obstruction in a TARP syndrome patient, expanding the known phenotypic spectrum.	"{""explanation"": ""Omorodion et al. 2023 documents the first reported case of vitelline vascular remnant causing intestinal obstruction in a TARP syndrome patient, expanding the known phenotypic spectrum."", ""reference"": ""PMID:37340830"", ""snippet"": ""Vitelline vascular remnants (VVR) are a rare vitelline duct anomaly with approximately 26 cases previously reported. There are no previously reported cases of VVRs in patients with TARP syndrome."", ""supports"": ""SUPPORT""}"
7667	7403	320	TARP syndrome	TARP_syndrome.yaml	phenotypes	6	evidence	0	PMID:34031074	SUPPORT		intrauterine growth restriction, with a persistent left superior vena cava, interatrial communication and a horseshoe kidney	Manotas et al. 2021 documents a TARP syndrome patient with horseshoe kidney, a previously unreported renal manifestation in this syndrome.	"{""explanation"": ""Manotas et al. 2021 documents a TARP syndrome patient with horseshoe kidney, a previously unreported renal manifestation in this syndrome."", ""reference"": ""PMID:34031074"", ""snippet"": ""intrauterine growth restriction, with a persistent left superior vena cava, interatrial communication and a horseshoe kidney"", ""supports"": ""SUPPORT""}"
7668	7404	320	TARP syndrome	TARP_syndrome.yaml	phenotypes	7	evidence	0	PMID:34031074	SUPPORT		Additionally, postnatal optic nerve atrophy was diagnosed.	Manotas et al. 2021 documents postnatal optic nerve atrophy in a TARP syndrome patient, expanding the known systemic manifestations of this condition.	"{""explanation"": ""Manotas et al. 2021 documents postnatal optic nerve atrophy in a TARP syndrome patient, expanding the known systemic manifestations of this condition."", ""reference"": ""PMID:34031074"", ""snippet"": ""Additionally, postnatal optic nerve atrophy was diagnosed."", ""supports"": ""SUPPORT""}"
7669	7405	320	TARP syndrome	TARP_syndrome.yaml	phenotypes	8	evidence	0	PMID:30462380	SUPPORT		He was diagnosed with severe to profound intellectual disability in early childhood and had not developed language at age 28 years.	Højland et al. 2018 documents severe to profound intellectual disability in the first reported adult TARP patient, confirming this as a consistent and persistent feature.	"{""explanation"": ""Højland et al. 2018 documents severe to profound intellectual disability in the first reported adult TARP patient, confirming this as a consistent and persistent feature."", ""reference"": ""PMID:30462380"", ""snippet"": ""He was diagnosed with severe to profound intellectual disability in early childhood and had not developed language at age 28 years."", ""supports"": ""SUPPORT""}"
7670	7406	320	TARP syndrome	TARP_syndrome.yaml	phenotypes	9	evidence	0	PMID:30462380	SUPPORT		Clinical examination of the patient revealed sloping forehead, prominent nasal bridge and nose, high myopia, esotropia, displacement of lacrimal points in the cranial direction	Højland et al. 2018 documents esotropia as an ophthalmic finding in an adult TARP patient, expanding the known ocular manifestations of the syndrome.	"{""explanation"": ""Højland et al. 2018 documents esotropia as an ophthalmic finding in an adult TARP patient, expanding the known ocular manifestations of the syndrome."", ""reference"": ""PMID:30462380"", ""snippet"": ""Clinical examination of the patient revealed sloping forehead, prominent nasal bridge and nose, high myopia, esotropia, displacement of lacrimal points in the cranial direction"", ""supports"": ""SUPPORT""}"
7671	7407	320	TARP syndrome	TARP_syndrome.yaml	phenotypes	10	evidence	0	PMID:30462380	SUPPORT		Surgery for severe thoracolumbar scoliosis was performed at age 21 years.	Højland et al. 2018 documents severe thoracolumbar scoliosis in an adult TARP patient, a previously unreported manifestation of TARP syndrome.	"{""explanation"": ""Højland et al. 2018 documents severe thoracolumbar scoliosis in an adult TARP patient, a previously unreported manifestation of TARP syndrome."", ""reference"": ""PMID:30462380"", ""snippet"": ""Surgery for severe thoracolumbar scoliosis was performed at age 21 years."", ""supports"": ""SUPPORT""}"
7672	7408	320	TARP syndrome	TARP_syndrome.yaml	phenotypes	11	evidence	0	PMID:30462380	SUPPORT		Clinical examination of the patient revealed sloping forehead, prominent nasal bridge and nose, high myopia, esotropia	Højland et al. 2018 documents prominent nose and nasal bridge as craniofacial features in an adult TARP patient, expanding the phenotypic spectrum beyond the initially described cardinal features.	"{""explanation"": ""Højland et al. 2018 documents prominent nose and nasal bridge as craniofacial features in an adult TARP patient, expanding the phenotypic spectrum beyond the initially described cardinal features."", ""reference"": ""PMID:30462380"", ""snippet"": ""Clinical examination of the patient revealed sloping forehead, prominent nasal bridge and nose, high myopia, esotropia"", ""supports"": ""SUPPORT""}"
7680	7416	321	Taeniasis/cysticercosis	Taeniasis_Cysticercosis.yaml	phenotypes	0	evidence	0	PMID:12932389	SUPPORT		This disease is one of the main causes of epileptic seizures in many less developed countries	Neurocysticercosis is a major cause of seizures in endemic regions.	"{""explanation"": ""Neurocysticercosis is a major cause of seizures in endemic regions."", ""reference"": ""PMID:12932389"", ""snippet"": ""This disease is one of the main causes of epileptic seizures in many less developed countries"", ""supports"": ""SUPPORT""}"
7687	7429	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	phenotypes	0	evidence	0	PMID:25143775	SUPPORT		All of them had a developmental disorder as a chief complaint. 38%of patients had a history of developmental delay or regression	Case series confirms developmental regression as a key presenting feature in GM2 gangliosidosis patients.	"{""explanation"": ""Case series confirms developmental regression as a key presenting feature in GM2 gangliosidosis patients."", ""reference"": ""PMID:25143775"", ""snippet"": ""All of them had a developmental disorder as a chief complaint. 38%of patients had a history of developmental delay or regression"", ""supports"": ""SUPPORT""}"
7688	7429	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	phenotypes	0	evidence	1	PMID:22025593	SUPPORT		Common symptoms at onset were developmental arrest (83%), startling (65%), and hypotonia (60%).	Natural history study of 97 patients confirms developmental arrest in 83% of infantile GM2 gangliosidosis cases.	"{""explanation"": ""Natural history study of 97 patients confirms developmental arrest in 83% of infantile GM2 gangliosidosis cases."", ""reference"": ""PMID:22025593"", ""snippet"": ""Common symptoms at onset were developmental arrest (83%), startling (65%), and hypotonia (60%)."", ""supports"": ""SUPPORT""}"
7689	7429	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	phenotypes	0	evidence	2	PMID:29618308	SUPPORT		Inherited as a classical autosomal recessive disorder, this global disease of the nervous system induces developmental arrest with regression of attained milestones; neurodegeneration progresses rapidly to cause premature death in young children.	Review describes developmental arrest with regression of milestones as a core feature of Tay-Sachs disease.	"{""explanation"": ""Review describes developmental arrest with regression of milestones as a core feature of Tay-Sachs disease."", ""reference"": ""PMID:29618308"", ""snippet"": ""Inherited as a classical autosomal recessive disorder, this global disease of the nervous system induces developmental arrest with regression of attained milestones; neurodegeneration progresses rapidly to cause premature death in young children."", ""supports"": ""SUPPORT""}"
7690	7430	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	phenotypes	1	evidence	0	PMID:19820796	SUPPORT		The accumulation of lipid in retinal ganglion cells that leads to a chalk-white appearance of the fundus called 'cherry red spot' is the hallmark of Tay-Sachs disease.	Case report describes cherry-red spot as the hallmark ophthalmologic finding in Tay-Sachs disease.	"{""explanation"": ""Case report describes cherry-red spot as the hallmark ophthalmologic finding in Tay-Sachs disease."", ""reference"": ""PMID:19820796"", ""snippet"": ""The accumulation of lipid in retinal ganglion cells that leads to a chalk-white appearance of the fundus called 'cherry red spot' is the hallmark of Tay-Sachs disease."", ""supports"": ""SUPPORT""}"
7691	7431	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	phenotypes	2	evidence	0	PMID:22025593	SUPPORT		Common symptoms at onset were developmental arrest (83%), startling (65%), and hypotonia (60%).	Natural history study of 97 patients confirms exaggerated startle response (startling) in 65% of infantile GM2 gangliosidosis patients.	"{""explanation"": ""Natural history study of 97 patients confirms exaggerated startle response (startling) in 65% of infantile GM2 gangliosidosis patients."", ""reference"": ""PMID:22025593"", ""snippet"": ""Common symptoms at onset were developmental arrest (83%), startling (65%), and hypotonia (60%)."", ""supports"": ""SUPPORT""}"
7692	7431	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	phenotypes	2	evidence	1	PMID:24534057	SUPPORT		The augmented startle reflex appeared between the age of 3 and 17 months and disappeared between the age of 4 and 6 years.	Electrophysiological study documents the temporal evolution of the augmented startle reflex in Tay-Sachs disease.	"{""explanation"": ""Electrophysiological study documents the temporal evolution of the augmented startle reflex in Tay-Sachs disease."", ""reference"": ""PMID:24534057"", ""snippet"": ""The augmented startle reflex appeared between the age of 3 and 17 months and disappeared between the age of 4 and 6 years."", ""supports"": ""SUPPORT""}"
7693	7432	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	phenotypes	3	evidence	0	PMID:22025593	SUPPORT		Common symptoms at onset were developmental arrest (83%), startling (65%), and hypotonia (60%).	Natural history study confirms hypotonia in 60% of infantile GM2 gangliosidosis patients at disease onset.	"{""explanation"": ""Natural history study confirms hypotonia in 60% of infantile GM2 gangliosidosis patients at disease onset."", ""reference"": ""PMID:22025593"", ""snippet"": ""Common symptoms at onset were developmental arrest (83%), startling (65%), and hypotonia (60%)."", ""supports"": ""SUPPORT""}"
7694	7433	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	phenotypes	4	evidence	0	PMID:25143775	SUPPORT		38%of patients had a history of developmental delay or regression and 22% had seizures.	Case series documents seizures as a clinical manifestation in GM2 gangliosidosis patients.	"{""explanation"": ""Case series documents seizures as a clinical manifestation in GM2 gangliosidosis patients."", ""reference"": ""PMID:25143775"", ""snippet"": ""38%of patients had a history of developmental delay or regression and 22% had seizures."", ""supports"": ""SUPPORT""}"
7695	7434	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	phenotypes	5	evidence	0	PMID:7732608	SUPPORT		Generalized hypotonia, macrocephaly, hyperacusis and a retinal cherry red spot appearance were present.	Case report documents macrocephaly in Tay-Sachs disease.	"{""explanation"": ""Case report documents macrocephaly in Tay-Sachs disease."", ""reference"": ""PMID:7732608"", ""snippet"": ""Generalized hypotonia, macrocephaly, hyperacusis and a retinal cherry red spot appearance were present."", ""supports"": ""SUPPORT""}"
7696	7435	322	Tay-Sachs Disease	Tay-Sachs_Disease.yaml	phenotypes	6	evidence	0	PMID:24011710	SUPPORT		Disorders such as Tay-Sachs or Niemann-Pick disease are the most familiar examples of dysfunction in sphingolipid metabolism and are typically associated with neurodegeneration and ocular findings such as blindness.	Review establishes blindness as a characteristic ocular finding in sphingolipidoses including Tay-Sachs disease.	"{""explanation"": ""Review establishes blindness as a characteristic ocular finding in sphingolipidoses including Tay-Sachs disease."", ""reference"": ""PMID:24011710"", ""snippet"": ""Disorders such as Tay-Sachs or Niemann-Pick disease are the most familiar examples of dysfunction in sphingolipid metabolism and are typically associated with neurodegeneration and ocular findings such as blindness."", ""supports"": ""SUPPORT""}"
7708	7448	323	Tetanus	Tetanus.yaml	phenotypes	0	evidence	0	PMID:40543524	SUPPORT		C tetani releases a potent neurotoxin, causing muscle spasms, rigidity, and dysautonomia.	Masseter spasm (trismus) represents the cranial manifestation of the generalized muscle spasms described.	"{""explanation"": ""Masseter spasm (trismus) represents the cranial manifestation of the generalized muscle spasms described."", ""reference"": ""PMID:40543524"", ""snippet"": ""C tetani releases a potent neurotoxin, causing muscle spasms, rigidity, and dysautonomia."", ""supports"": ""SUPPORT""}"
7709	7449	323	Tetanus	Tetanus.yaml	phenotypes	1	evidence	0	PMID:40543524	SUPPORT		C tetani releases a potent neurotoxin, causing muscle spasms, rigidity, and dysautonomia.	Highlights toxin-driven generalized rigidity.	"{""explanation"": ""Highlights toxin-driven generalized rigidity."", ""reference"": ""PMID:40543524"", ""snippet"": ""C tetani releases a potent neurotoxin, causing muscle spasms, rigidity, and dysautonomia."", ""supports"": ""SUPPORT""}"
7710	7450	323	Tetanus	Tetanus.yaml	phenotypes	2	evidence	0	PMID:40543524	SUPPORT		C tetani releases a potent neurotoxin, causing muscle spasms, rigidity, and dysautonomia.	Describes the diffuse spasms that produce opisthotonic posturing.	"{""explanation"": ""Describes the diffuse spasms that produce opisthotonic posturing."", ""reference"": ""PMID:40543524"", ""snippet"": ""C tetani releases a potent neurotoxin, causing muscle spasms, rigidity, and dysautonomia."", ""supports"": ""SUPPORT""}"
7711	7451	323	Tetanus	Tetanus.yaml	phenotypes	3	evidence	0	PMID:40543524	SUPPORT		C tetani releases a potent neurotoxin, causing muscle spasms, rigidity, and dysautonomia.	Confirms stimulus-sensitive spasms as a hallmark manifestation.	"{""explanation"": ""Confirms stimulus-sensitive spasms as a hallmark manifestation."", ""reference"": ""PMID:40543524"", ""snippet"": ""C tetani releases a potent neurotoxin, causing muscle spasms, rigidity, and dysautonomia."", ""supports"": ""SUPPORT""}"
7712	7452	323	Tetanus	Tetanus.yaml	phenotypes	4	evidence	0	PMID:40543524	SUPPORT		C tetani releases a potent neurotoxin, causing muscle spasms, rigidity, and dysautonomia.	Upper airway and bulbar spasms impede swallowing, leading to dysphagia.	"{""explanation"": ""Upper airway and bulbar spasms impede swallowing, leading to dysphagia."", ""reference"": ""PMID:40543524"", ""snippet"": ""C tetani releases a potent neurotoxin, causing muscle spasms, rigidity, and dysautonomia."", ""supports"": ""SUPPORT""}"
7713	7453	323	Tetanus	Tetanus.yaml	phenotypes	5	evidence	0	PMID:40543524	SUPPORT		Important complications include laryngeal spasm and resultant airway obstruction and respiratory arrest.	Links laryngospasm to respiratory failure.	"{""explanation"": ""Links laryngospasm to respiratory failure."", ""reference"": ""PMID:40543524"", ""snippet"": ""Important complications include laryngeal spasm and resultant airway obstruction and respiratory arrest."", ""supports"": ""SUPPORT""}"
7722	7488	326	Trachoma	Trachoma.yaml	phenotypes	0	evidence	0	PMID:35618795	SUPPORT		Trachoma is a neglected tropical disease caused by infection with conjunctival strains of Chlamydia trachomatis. It can result in blindness.	The abstract notes that trachoma can result in blindness.	"{""explanation"": ""The abstract notes that trachoma can result in blindness."", ""reference"": ""PMID:35618795"", ""snippet"": ""Trachoma is a neglected tropical disease caused by infection with conjunctival strains of Chlamydia trachomatis. It can result in blindness."", ""supports"": ""SUPPORT""}"
7746	7501	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	phenotypes	0	evidence	0	PMID:7091064	SUPPORT		Transient neonatal pustular melanosis.	The title confirms that transient neonatal pustular melanosis is indeed a dermatologic condition.	"{""explanation"": ""The title confirms that transient neonatal pustular melanosis is indeed a dermatologic condition."", ""reference"": ""PMID:7091064"", ""snippet"": ""Transient neonatal pustular melanosis."", ""supports"": ""SUPPORT""}"
7747	7501	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	phenotypes	0	evidence	1	PMID:12113648	SUPPORT		Generalized pustular eruptions in neonates include erythema toxicum neonatorum and transient neonatal pustular melanosis, both of which are non-infectious.	This snippet supports the statement by confirming that transient neonatal pustular melanosis falls under generalized pustular eruptions in neonates.	"{""explanation"": ""This snippet supports the statement by confirming that transient neonatal pustular melanosis falls under generalized pustular eruptions in neonates."", ""reference"": ""PMID:12113648"", ""snippet"": ""Generalized pustular eruptions in neonates include erythema toxicum neonatorum and transient neonatal pustular melanosis, both of which are non-infectious."", ""supports"": ""SUPPORT""}"
7748	7501	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	phenotypes	0	evidence	2	PMID:27192509	SUPPORT		However, the majority of neonatal skin pustules is not infectious, comprising the benign neonatal pustulosis. ... The most common ones are erythema toxicum neonatorum, the transient neonatal pustular melanosis and the benign cephalic pustulosis.	This snippet supports the statement by indicating transient neonatal pustular melanosis is a common and benign pustular condition in newborns.	"{""explanation"": ""This snippet supports the statement by indicating transient neonatal pustular melanosis is a common and benign pustular condition in newborns."", ""reference"": ""PMID:27192509"", ""snippet"": ""However, the majority of neonatal skin pustules is not infectious, comprising the benign neonatal pustulosis. ... The most common ones are erythema toxicum neonatorum, the transient neonatal pustular melanosis and the benign cephalic pustulosis."", ""supports"": ""SUPPORT""}"
7749	7501	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	phenotypes	0	evidence	3	PMID:511427	SUPPORT		Transient neonatal pustular melanosis.	The title confirms that transient neonatal pustular melanosis is a recognized dermatologic condition.	"{""explanation"": ""The title confirms that transient neonatal pustular melanosis is a recognized dermatologic condition."", ""reference"": ""PMID:511427"", ""snippet"": ""Transient neonatal pustular melanosis."", ""supports"": ""SUPPORT""}"
7750	7501	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	phenotypes	0	evidence	4	PMID:28543629	SUPPORT		Erythema toxicum neonatorum (ETN) and transient neonatal pustular melanosis (TNPM) are benign pustular skin conditions that are relatively common in newborns.	This snippet supports the statement by confirming that transient neonatal pustular melanosis is a common benign pustular skin condition in newborns.	"{""explanation"": ""This snippet supports the statement by confirming that transient neonatal pustular melanosis is a common benign pustular skin condition in newborns."", ""reference"": ""PMID:28543629"", ""snippet"": ""Erythema toxicum neonatorum (ETN) and transient neonatal pustular melanosis (TNPM) are benign pustular skin conditions that are relatively common in newborns."", ""supports"": ""SUPPORT""}"
7751	7502	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	phenotypes	1	evidence	0	PMID:511427	PARTIAL		A Mexican-American boy presented at birth with an extensive eruption consisting of 0.5 to 1.0 cm hyperpigmented macules with a distinct peripheral scale involving primarily the forearms, abdomen and lower back.	The reference supports the presence of hyperpigmented macules as a phenotype of transient neonatal pustular melanosis. However, it does not provide support for the frequency being 'High'.	"{""explanation"": ""The reference supports the presence of hyperpigmented macules as a phenotype of transient neonatal pustular melanosis. However, it does not provide support for the frequency being 'High'."", ""reference"": ""PMID:511427"", ""snippet"": ""A Mexican-American boy presented at birth with an extensive eruption consisting of 0.5 to 1.0 cm hyperpigmented macules with a distinct peripheral scale involving primarily the forearms, abdomen and lower back."", ""supports"": ""PARTIAL""}"
7752	7502	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	phenotypes	1	evidence	1	PMID:22884507	PARTIAL		Transient neonatal pustular melanosis.	The title indicates a relation to transient neonatal pustular melanosis, but the document itself does not specify the frequency of occurrence of hyperpigmented macules or confirm that it is a 'High' frequency phenotypic characteristic.	"{""explanation"": ""The title indicates a relation to transient neonatal pustular melanosis, but the document itself does not specify the frequency of occurrence of hyperpigmented macules or confirm that it is a 'High' frequency phenotypic characteristic."", ""reference"": ""PMID:22884507"", ""snippet"": ""Transient neonatal pustular melanosis."", ""supports"": ""PARTIAL""}"
7753	7504	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	phenotypes	3	evidence	0	PMID:37900709	PARTIAL		TNPM is a benign, transient, neonatal pustulosis requiring no active treatment. Diagnosis is clinical, characterized by a vesiculopustular eruption, healing with residual hyperpigmented macules.	The reference supports that TNPM is benign and self-limited, but does not provide evidence about it being a systemic condition or its frequency.	"{""explanation"": ""The reference supports that TNPM is benign and self-limited, but does not provide evidence about it being a systemic condition or its frequency."", ""reference"": ""PMID:37900709"", ""snippet"": ""TNPM is a benign, transient, neonatal pustulosis requiring no active treatment. Diagnosis is clinical, characterized by a vesiculopustular eruption, healing with residual hyperpigmented macules."", ""supports"": ""PARTIAL""}"
7754	7505	327	Transient Neonatal Pustular Melanosis	Transient_Neonatal_Pustular_Melanosis.yaml	phenotypes	4	evidence	0	PMID:37900709	SUPPORT		TNPM is a benign, transient, neonatal pustulosis requiring no active treatment. Diagnosis is clinical, characterized by a vesiculopustular eruption, healing with residual hyperpigmented macules.	The abstract confirms that TNPM is a benign condition without systemic symptoms, supporting the statement that infants with TNPM are otherwise healthy and do not have any associated fever, irritability, or other systemic symptoms.	"{""explanation"": ""The abstract confirms that TNPM is a benign condition without systemic symptoms, supporting the statement that infants with TNPM are otherwise healthy and do not have any associated fever, irritability, or other systemic symptoms."", ""reference"": ""PMID:37900709"", ""snippet"": ""TNPM is a benign, transient, neonatal pustulosis requiring no active treatment. Diagnosis is clinical, characterized by a vesiculopustular eruption, healing with residual hyperpigmented macules."", ""supports"": ""SUPPORT""}"
7773	7517	328	Transverse Myelitis	Transverse_Myelitis.yaml	phenotypes	0	evidence	0	PMID:32644728	SUPPORT		Transverse myelitis (TM) is a rare, acquired focal inflammatory disorder often presenting with rapid onset weakness, sensory deficits, and bowel/bladder dysfunction.	Rapid onset weakness is a key presenting feature of transverse myelitis.	"{""explanation"": ""Rapid onset weakness is a key presenting feature of transverse myelitis."", ""reference"": ""PMID:32644728"", ""snippet"": ""Transverse myelitis (TM) is a rare, acquired focal inflammatory disorder often presenting with rapid onset weakness, sensory deficits, and bowel/bladder dysfunction."", ""supports"": ""SUPPORT""}"
7774	7518	328	Transverse Myelitis	Transverse_Myelitis.yaml	phenotypes	1	evidence	0	PMID:32644728	SUPPORT		Transverse myelitis (TM) is a rare, acquired focal inflammatory disorder often presenting with rapid onset weakness, sensory deficits, and bowel/bladder dysfunction.	Sensory deficits are listed among common presenting features of transverse myelitis.	"{""explanation"": ""Sensory deficits are listed among common presenting features of transverse myelitis."", ""reference"": ""PMID:32644728"", ""snippet"": ""Transverse myelitis (TM) is a rare, acquired focal inflammatory disorder often presenting with rapid onset weakness, sensory deficits, and bowel/bladder dysfunction."", ""supports"": ""SUPPORT""}"
7775	7519	328	Transverse Myelitis	Transverse_Myelitis.yaml	phenotypes	2	evidence	0	PMID:32644728	SUPPORT		Transverse myelitis (TM) is a rare, acquired focal inflammatory disorder often presenting with rapid onset weakness, sensory deficits, and bowel/bladder dysfunction.	Bladder dysfunction is listed as a presenting feature of transverse myelitis.	"{""explanation"": ""Bladder dysfunction is listed as a presenting feature of transverse myelitis."", ""reference"": ""PMID:32644728"", ""snippet"": ""Transverse myelitis (TM) is a rare, acquired focal inflammatory disorder often presenting with rapid onset weakness, sensory deficits, and bowel/bladder dysfunction."", ""supports"": ""SUPPORT""}"
7776	7520	328	Transverse Myelitis	Transverse_Myelitis.yaml	phenotypes	3	evidence	0	PMID:32644728	SUPPORT		Transverse myelitis (TM) is a rare, acquired focal inflammatory disorder often presenting with rapid onset weakness, sensory deficits, and bowel/bladder dysfunction.	Bowel dysfunction is listed among presenting features of transverse myelitis.	"{""explanation"": ""Bowel dysfunction is listed among presenting features of transverse myelitis."", ""reference"": ""PMID:32644728"", ""snippet"": ""Transverse myelitis (TM) is a rare, acquired focal inflammatory disorder often presenting with rapid onset weakness, sensory deficits, and bowel/bladder dysfunction."", ""supports"": ""SUPPORT""}"
7777	7521	328	Transverse Myelitis	Transverse_Myelitis.yaml	phenotypes	4	evidence	0	PMID:32644728	SUPPORT		At peak deficit, 50% of patients are completely paraplegic, with virtually all of the patients having a degree of bladder/bowel dysfunction.	The abstract notes paraplegia in a substantial fraction of patients at peak deficit.	"{""explanation"": ""The abstract notes paraplegia in a substantial fraction of patients at peak deficit."", ""reference"": ""PMID:32644728"", ""snippet"": ""At peak deficit, 50% of patients are completely paraplegic, with virtually all of the patients having a degree of bladder/bowel dysfunction."", ""supports"": ""SUPPORT""}"
7786	7531	329	Traveler's Diarrhea	Travelers_Diarrhea.yaml	phenotypes	0	evidence	0	PMID:35358002	SUPPORT		Enterotoxigenic Escherichia coli (ETEC) is a major cause of diarrhea in children and travelers in developing countries.	Establishes diarrhea as the hallmark symptom of ETEC-associated traveler's diarrhea.	"{""explanation"": ""Establishes diarrhea as the hallmark symptom of ETEC-associated traveler's diarrhea."", ""reference"": ""PMID:35358002"", ""snippet"": ""Enterotoxigenic Escherichia coli (ETEC) is a major cause of diarrhea in children and travelers in developing countries."", ""supports"": ""SUPPORT""}"
7787	7532	329	Traveler's Diarrhea	Travelers_Diarrhea.yaml	phenotypes	1	evidence	0	PMID:35839362	SUPPORT		History for patients with acute diarrhea should include onset and frequency of symptoms, stool character, a focused review of systems including fever and other symptoms, and evaluation of exposures and risk factors.	Guidance for acute diarrhea evaluation highlights associated abdominal symptoms that accompany diarrheal illness.	"{""explanation"": ""Guidance for acute diarrhea evaluation highlights associated abdominal symptoms that accompany diarrheal illness."", ""reference"": ""PMID:35839362"", ""snippet"": ""History for patients with acute diarrhea should include onset and frequency of symptoms, stool character, a focused review of systems including fever and other symptoms, and evaluation of exposures and risk factors."", ""supports"": ""SUPPORT""}"
7788	7533	329	Traveler's Diarrhea	Travelers_Diarrhea.yaml	phenotypes	2	evidence	0	PMID:35839362	SUPPORT		Acute diarrheal disease accounts for 179 million outpatient visits annually in the United States... History for patients with acute diarrhea should include onset and frequency of symptoms, stool character, a focused review of systems including fever and other symptoms.	Clinical review notes nausea and systemic symptoms are routinely assessed with acute diarrheal illnesses.	"{""explanation"": ""Clinical review notes nausea and systemic symptoms are routinely assessed with acute diarrheal illnesses."", ""reference"": ""PMID:35839362"", ""snippet"": ""Acute diarrheal disease accounts for 179 million outpatient visits annually in the United States... History for patients with acute diarrhea should include onset and frequency of symptoms, stool character, a focused review of systems including fever and other symptoms."", ""supports"": ""SUPPORT""}"
7810	7558	330	Triple-Negative Breast Cancer	Triple_Negative_Breast_Cancer.yaml	phenotypes	2	evidence	0	PMID:35987766	SUPPORT		Triple negative breast cancer (TNBC) is characterized by the lack of estrogen and progesterone receptor expression and lacks HER2 overexpression or gene amplification.	Abstract defines TNBC by lack of ER/PR and HER2, matching the diagnostic phenotype.	"{""explanation"": ""Abstract defines TNBC by lack of ER/PR and HER2, matching the diagnostic phenotype."", ""reference"": ""PMID:35987766"", ""snippet"": ""Triple negative breast cancer (TNBC) is characterized by the lack of estrogen and progesterone receptor expression and lacks HER2 overexpression or gene amplification."", ""supports"": ""SUPPORT""}"
7857	7582	331	Tuberculosis	Tuberculosis.yaml	phenotypes	0	evidence	0	PMID:29196066	PARTIAL		Cough is common in pulmonary TB and other chronic respiratory infections.	While cough is indeed a common symptom of pulmonary TB, the statement specifically categorizes chronic cough as very frequent, which is partially supported but not explicitly confirmed by the literature.	"{""explanation"": ""While cough is indeed a common symptom of pulmonary TB, the statement specifically categorizes chronic cough as very frequent, which is partially supported but not explicitly confirmed by the literature."", ""reference"": ""PMID:29196066"", ""snippet"": ""Cough is common in pulmonary TB and other chronic respiratory infections."", ""supports"": ""PARTIAL""}"
7858	7582	331	Tuberculosis	Tuberculosis.yaml	phenotypes	0	evidence	1	PMID:16131501	SUPPORT		A persistent, non-remitting cough was reported in 15/16 (93.8%) children with tuberculosis.	This strongly supports the statement as it shows a high prevalence of a persistent chronic cough in children diagnosed with tuberculosis.	"{""explanation"": ""This strongly supports the statement as it shows a high prevalence of a persistent chronic cough in children diagnosed with tuberculosis."", ""reference"": ""PMID:16131501"", ""snippet"": ""A persistent, non-remitting cough was reported in 15/16 (93.8%) children with tuberculosis."", ""supports"": ""SUPPORT""}"
7859	7582	331	Tuberculosis	Tuberculosis.yaml	phenotypes	0	evidence	2	PMID:35710915	SUPPORT		Initial microbiologic burdens and radiographic features also varied, including the presence of cavities and bilateral infiltration, which reflect TB-related severity.	The study identifies chronic cough as a significant symptomatic characteristic among the different TB phenotypes.	"{""explanation"": ""The study identifies chronic cough as a significant symptomatic characteristic among the different TB phenotypes."", ""reference"": ""PMID:35710915"", ""snippet"": ""Initial microbiologic burdens and radiographic features also varied, including the presence of cavities and bilateral infiltration, which reflect TB-related severity."", ""supports"": ""SUPPORT""}"
7860	7583	331	Tuberculosis	Tuberculosis.yaml	phenotypes	1	evidence	0	PMID:11120618	SUPPORT		We describe three patients with recurrent fever thought to be due to tuberculosis, and review the 14 previously reported cases who fulfil the criteria of recurrent fever for at least 1 month's duration	The literature indicates that fever is a frequent symptom associated with tuberculosis.	"{""explanation"": ""The literature indicates that fever is a frequent symptom associated with tuberculosis."", ""reference"": ""PMID:11120618"", ""snippet"": ""We describe three patients with recurrent fever thought to be due to tuberculosis, and review the 14 previously reported cases who fulfil the criteria of recurrent fever for at least 1 month's duration"", ""supports"": ""SUPPORT""}"
7861	7583	331	Tuberculosis	Tuberculosis.yaml	phenotypes	1	evidence	1	PMID:31641790	PARTIAL		Tuberculosis is a bacterial infectious disease that is usually transmitted by inhalation of droplets containing the bacteria.	While this reference does affirm that tuberculosis causes systemic issues, it does not directly specify fever as a frequent phenotype.	"{""explanation"": ""While this reference does affirm that tuberculosis causes systemic issues, it does not directly specify fever as a frequent phenotype."", ""reference"": ""PMID:31641790"", ""snippet"": ""Tuberculosis is a bacterial infectious disease that is usually transmitted by inhalation of droplets containing the bacteria."", ""supports"": ""PARTIAL""}"
7862	7583	331	Tuberculosis	Tuberculosis.yaml	phenotypes	1	evidence	2	PMID:18173876	PARTIAL		SETTING: The diagnosis of tuberculosis (TB) may be rejected in the absence of symptoms such as fever, sweats or weight loss.	This reference notes the association of fever with tuberculosis but also highlights cases where fever may be absent, hence only partially supporting the statement.	"{""explanation"": ""This reference notes the association of fever with tuberculosis but also highlights cases where fever may be absent, hence only partially supporting the statement."", ""reference"": ""PMID:18173876"", ""snippet"": ""SETTING: The diagnosis of tuberculosis (TB) may be rejected in the absence of symptoms such as fever, sweats or weight loss."", ""supports"": ""PARTIAL""}"
7863	7584	331	Tuberculosis	Tuberculosis.yaml	phenotypes	2	evidence	0	PMID:31599243	SUPPORT		Cough, night sweat, fever, anorexia were significant presenting features.	The study documents night sweats as a significant symptom in TB patients.	"{""explanation"": ""The study documents night sweats as a significant symptom in TB patients."", ""reference"": ""PMID:31599243"", ""snippet"": ""Cough, night sweat, fever, anorexia were significant presenting features."", ""supports"": ""SUPPORT""}"
7864	7584	331	Tuberculosis	Tuberculosis.yaml	phenotypes	2	evidence	1	PMID:12643362	PARTIAL		Tuberculosis and lymphoma are diseases in which night sweats are a dominant symptom, but these are infrequently found to be the cause of night sweats in modern practice.	While night sweats are a notable symptom of TB, the reference suggests that in modern practice, they are less frequently the cause of night sweats compared to other conditions.	"{""explanation"": ""While night sweats are a notable symptom of TB, the reference suggests that in modern practice, they are less frequently the cause of night sweats compared to other conditions."", ""reference"": ""PMID:12643362"", ""snippet"": ""Tuberculosis and lymphoma are diseases in which night sweats are a dominant symptom, but these are infrequently found to be the cause of night sweats in modern practice."", ""supports"": ""PARTIAL""}"
7865	7584	331	Tuberculosis	Tuberculosis.yaml	phenotypes	2	evidence	2	PMID:21813327	SUPPORT		During therapy, fever, sweats, and dyspnea decreased most rapidly, with near resolution by the end of therapy.	The data supports the presence of night sweats as a frequent symptom in TB, with sweats reducing significantly during therapy.	"{""explanation"": ""The data supports the presence of night sweats as a frequent symptom in TB, with sweats reducing significantly during therapy."", ""reference"": ""PMID:21813327"", ""snippet"": ""During therapy, fever, sweats, and dyspnea decreased most rapidly, with near resolution by the end of therapy."", ""supports"": ""SUPPORT""}"
7866	7585	331	Tuberculosis	Tuberculosis.yaml	phenotypes	3	evidence	0	PMID:36451280	SUPPORT		Tuberculosis (TB) is well-known for causing wasting. Patients on treatment gain weight and weight loss is associated with unfavorable treatment outcomes.	This supports the statement that weight loss is a frequently observed systemic phenotype associated with tuberculosis.	"{""explanation"": ""This supports the statement that weight loss is a frequently observed systemic phenotype associated with tuberculosis."", ""reference"": ""PMID:36451280"", ""snippet"": ""Tuberculosis (TB) is well-known for causing wasting. Patients on treatment gain weight and weight loss is associated with unfavorable treatment outcomes."", ""supports"": ""SUPPORT""}"
7867	7585	331	Tuberculosis	Tuberculosis.yaml	phenotypes	3	evidence	1	PMID:38736083	SUPPORT		Esophageal TB most commonly presents with dysphagia, odynophagia, retrosternal pain, and systemic symptoms like decreased appetite, loss of weight, and low-grade fever as associated or other presentations.	This reference supports the statement by indicating that weight loss is a common systemic symptom of esophageal tuberculosis.	"{""explanation"": ""This reference supports the statement by indicating that weight loss is a common systemic symptom of esophageal tuberculosis."", ""reference"": ""PMID:38736083"", ""snippet"": ""Esophageal TB most commonly presents with dysphagia, odynophagia, retrosternal pain, and systemic symptoms like decreased appetite, loss of weight, and low-grade fever as associated or other presentations."", ""supports"": ""SUPPORT""}"
7868	7585	331	Tuberculosis	Tuberculosis.yaml	phenotypes	3	evidence	2	PMID:23531875	SUPPORT		CBA/J mice may model these events, as sick mice share features with TB patients, including weight loss...	Although the study is on mice, it draws parallels with human TB patients, reinforcing that weight loss is a frequently observed phenotype.	"{""explanation"": ""Although the study is on mice, it draws parallels with human TB patients, reinforcing that weight loss is a frequently observed phenotype."", ""reference"": ""PMID:23531875"", ""snippet"": ""CBA/J mice may model these events, as sick mice share features with TB patients, including weight loss..."", ""supports"": ""SUPPORT""}"
7869	7585	331	Tuberculosis	Tuberculosis.yaml	phenotypes	3	evidence	3	PMID:18173876	PARTIAL		The diagnosis of tuberculosis (TB) may be rejected in the absence of symptoms such as fever, sweats or weight loss... In our population, TB, including pulmonary disease, frequently presented without fever, sweats or weight loss and with normal blood inflammatory markers.	This indicates that while weight loss is a known symptom, it is not always present in all TB cases, suggesting that it may be frequent but not ubiquitous.	"{""explanation"": ""This indicates that while weight loss is a known symptom, it is not always present in all TB cases, suggesting that it may be frequent but not ubiquitous."", ""reference"": ""PMID:18173876"", ""snippet"": ""The diagnosis of tuberculosis (TB) may be rejected in the absence of symptoms such as fever, sweats or weight loss... In our population, TB, including pulmonary disease, frequently presented without fever, sweats or weight loss and with normal blood inflammatory markers."", ""supports"": ""PARTIAL""}"
7870	7585	331	Tuberculosis	Tuberculosis.yaml	phenotypes	3	evidence	4	PMID:8623687	SUPPORT		All patients with a positive reaction to the tuberculin skin test should be evaluated for weight loss, night sweats, fever, chronic cough and other signs of active tuberculosis.	This reference confirms that weight loss is one of the systemic symptoms that are frequently checked for in TB patients.	"{""explanation"": ""This reference confirms that weight loss is one of the systemic symptoms that are frequently checked for in TB patients."", ""reference"": ""PMID:8623687"", ""snippet"": ""All patients with a positive reaction to the tuberculin skin test should be evaluated for weight loss, night sweats, fever, chronic cough and other signs of active tuberculosis."", ""supports"": ""SUPPORT""}"
7871	7586	331	Tuberculosis	Tuberculosis.yaml	phenotypes	4	evidence	0	PMID:12816036	SUPPORT		The most common causes of hemoptysis are tuberculosis, lung carcinoma, bronchiectasis but idiopathic forms are frequent.	The text states that tuberculosis is one of the most common causes of hemoptysis, supporting the statement.	"{""explanation"": ""The text states that tuberculosis is one of the most common causes of hemoptysis, supporting the statement."", ""reference"": ""PMID:12816036"", ""snippet"": ""The most common causes of hemoptysis are tuberculosis, lung carcinoma, bronchiectasis but idiopathic forms are frequent."", ""supports"": ""SUPPORT""}"
7872	7587	331	Tuberculosis	Tuberculosis.yaml	phenotypes	5	evidence	0	PMID:17508531	PARTIAL		Pleuritic chest pain is a common presenting symptom and has many causes, which range from life-threatening to benign, self-limited conditions.	The reference mentions pleuritic chest pain as a common symptom, but it does not specifically state that it is frequently associated with tuberculosis.	"{""explanation"": ""The reference mentions pleuritic chest pain as a common symptom, but it does not specifically state that it is frequently associated with tuberculosis."", ""reference"": ""PMID:17508531"", ""snippet"": ""Pleuritic chest pain is a common presenting symptom and has many causes, which range from life-threatening to benign, self-limited conditions."", ""supports"": ""PARTIAL""}"
7873	7587	331	Tuberculosis	Tuberculosis.yaml	phenotypes	5	evidence	1	PMID:27499981	SUPPORT		TPE usually presents as an acute illness with fever, cough and pleuritic chest pain.	This reference supports the statement as it explicitly mentions that tuberculous pleural effusion (a form of extrapulmonary tuberculosis) commonly presents with pleuritic chest pain.	"{""explanation"": ""This reference supports the statement as it explicitly mentions that tuberculous pleural effusion (a form of extrapulmonary tuberculosis) commonly presents with pleuritic chest pain."", ""reference"": ""PMID:27499981"", ""snippet"": ""TPE usually presents as an acute illness with fever, cough and pleuritic chest pain."", ""supports"": ""SUPPORT""}"
7874	7587	331	Tuberculosis	Tuberculosis.yaml	phenotypes	5	evidence	2	PMID:30762202	SUPPORT		Chest is the commonest site of involvement by tuberculosis (TB) in children; lungs being the most frequently affected region, followed by nodes, pleura and chest wall.	While this reference does not directly state chest pain, it supports the involvement of the chest in tuberculosis, which can be associated with pleuritic chest pain.	"{""explanation"": ""While this reference does not directly state chest pain, it supports the involvement of the chest in tuberculosis, which can be associated with pleuritic chest pain."", ""reference"": ""PMID:30762202"", ""snippet"": ""Chest is the commonest site of involvement by tuberculosis (TB) in children; lungs being the most frequently affected region, followed by nodes, pleura and chest wall."", ""supports"": ""SUPPORT""}"
7875	7587	331	Tuberculosis	Tuberculosis.yaml	phenotypes	5	evidence	3	PMID:35809948	SUPPORT		A 50-year-old woman with a history of permanent atrial fibrillation (AF) treated with radiofrequency catheter ablation (RFCA) 6 months ago was admitted to the respiratory department of a tertiary hospital because of recurrent episodes of pleuritic chest pain in the preceding 5 months.	This case study mentions recurrent pleuritic chest pain, supporting the statement that chest pain is a frequent symptom in respiratory conditions, including tuberculosis.	"{""explanation"": ""This case study mentions recurrent pleuritic chest pain, supporting the statement that chest pain is a frequent symptom in respiratory conditions, including tuberculosis."", ""reference"": ""PMID:35809948"", ""snippet"": ""A 50-year-old woman with a history of permanent atrial fibrillation (AF) treated with radiofrequency catheter ablation (RFCA) 6 months ago was admitted to the respiratory department of a tertiary hospital because of recurrent episodes of pleuritic chest pain in the preceding 5 months."", ""supports"": ""SUPPORT""}"
7876	7588	331	Tuberculosis	Tuberculosis.yaml	phenotypes	6	evidence	0	PMID:15623010	SUPPORT		Symptoms of pulmonary TB are a cough with or without sputum production lasting at least three weeks, chest pain, hemoptysis, fever, night sweats, weight loss, lack of appetite, chills and weakness.	The abstract mentions that dyspnea (shortness of breath) is a symptom of pulmonary tuberculosis, which supports the statement that dyspnea is occasionally associated with tuberculosis.	"{""explanation"": ""The abstract mentions that dyspnea (shortness of breath) is a symptom of pulmonary tuberculosis, which supports the statement that dyspnea is occasionally associated with tuberculosis."", ""reference"": ""PMID:15623010"", ""snippet"": ""Symptoms of pulmonary TB are a cough with or without sputum production lasting at least three weeks, chest pain, hemoptysis, fever, night sweats, weight loss, lack of appetite, chills and weakness."", ""supports"": ""SUPPORT""}"
7877	7588	331	Tuberculosis	Tuberculosis.yaml	phenotypes	6	evidence	1	PMID:29900887	SUPPORT		Lung function impairment is known to occur after pulmonary TB irrespective of duration of treatment and outcome of disease.	This reference indicates that lung function issues, including dyspnea, can persist even after successful treatment of tuberculosis.	"{""explanation"": ""This reference indicates that lung function issues, including dyspnea, can persist even after successful treatment of tuberculosis."", ""reference"": ""PMID:29900887"", ""snippet"": ""Lung function impairment is known to occur after pulmonary TB irrespective of duration of treatment and outcome of disease."", ""supports"": ""SUPPORT""}"
7878	7589	331	Tuberculosis	Tuberculosis.yaml	phenotypes	7	evidence	0	PMID:33645194	SUPPORT		Sarcoidosis is a systemic granulomatous disorder of unknown cause that occurs in both men and women of all races. It typically presents in patients after 20 years of age. Sarcoidosis most frequently involves the lung, but up to 30 percent of patients present with extra-thoracic manifestations. It can involve multiple organs to a variable extent and degree. In areas, where tuberculosis is endemic, the diagnosis of sarcoidosis may be overlooked and misdiagnosed because of clinical and radiographic resemblance.	The abstract mentions that tuberculosis can be misdiagnosed as sarcoidosis due to similar symptoms, including fatigue, indicating that fatigue can be a systemic symptom of tuberculosis.	"{""explanation"": ""The abstract mentions that tuberculosis can be misdiagnosed as sarcoidosis due to similar symptoms, including fatigue, indicating that fatigue can be a systemic symptom of tuberculosis."", ""reference"": ""PMID:33645194"", ""snippet"": ""Sarcoidosis is a systemic granulomatous disorder of unknown cause that occurs in both men and women of all races. It typically presents in patients after 20 years of age. Sarcoidosis most frequently involves the lung, but up to 30 percent of patients present with extra-thoracic manifestations. It can involve multiple organs to a variable extent and degree. In areas, where tuberculosis is endemic, the diagnosis of sarcoidosis may be overlooked and misdiagnosed because of clinical and radiographic resemblance."", ""supports"": ""SUPPORT""}"
7879	7589	331	Tuberculosis	Tuberculosis.yaml	phenotypes	7	evidence	1	PMID:35189895	SUPPORT		Patients with chronic fatigue syndrome and post-tuberculosis experience similar symptoms. Furthermore, chronic fatigue syndrome and tuberculosis share similar plasma immunosignatures.	The study indicates that tuberculosis can lead to symptoms similar to chronic fatigue syndrome, supporting the statement that fatigue can be a systemic symptom of tuberculosis.	"{""explanation"": ""The study indicates that tuberculosis can lead to symptoms similar to chronic fatigue syndrome, supporting the statement that fatigue can be a systemic symptom of tuberculosis."", ""reference"": ""PMID:35189895"", ""snippet"": ""Patients with chronic fatigue syndrome and post-tuberculosis experience similar symptoms. Furthermore, chronic fatigue syndrome and tuberculosis share similar plasma immunosignatures."", ""supports"": ""SUPPORT""}"
7880	7590	331	Tuberculosis	Tuberculosis.yaml	phenotypes	8	evidence	0	PMID:16882280	SUPPORT		The findings of this study indicate that TB is a common cause of LBP that is liable to be overlooked in the differential diagnosis of LBP.	The study indicates that tuberculosis is a common cause of low back pain (LBP), supporting the statement that back pain may indicate spinal tuberculosis.	"{""explanation"": ""The study indicates that tuberculosis is a common cause of low back pain (LBP), supporting the statement that back pain may indicate spinal tuberculosis."", ""reference"": ""PMID:16882280"", ""snippet"": ""The findings of this study indicate that TB is a common cause of LBP that is liable to be overlooked in the differential diagnosis of LBP."", ""supports"": ""SUPPORT""}"
7881	7590	331	Tuberculosis	Tuberculosis.yaml	phenotypes	8	evidence	1	PMID:29358061	SUPPORT		We present a case report of a military veteran presenting with neck pain and initially diagnosed with cervical disc disease. The patient's pain progressed to the point of developing paresthesias in his bilateral upper extremities. Eventually, cervical spine radiographs were obtained that revealed complete cervical vertebral body destruction from spinal tuberculosis.	This case report supports the statement that back pain may indicate spinal tuberculosis, as it describes a patient whose neck pain was eventually diagnosed as spinal tuberculosis.	"{""explanation"": ""This case report supports the statement that back pain may indicate spinal tuberculosis, as it describes a patient whose neck pain was eventually diagnosed as spinal tuberculosis."", ""reference"": ""PMID:29358061"", ""snippet"": ""We present a case report of a military veteran presenting with neck pain and initially diagnosed with cervical disc disease. The patient's pain progressed to the point of developing paresthesias in his bilateral upper extremities. Eventually, cervical spine radiographs were obtained that revealed complete cervical vertebral body destruction from spinal tuberculosis."", ""supports"": ""SUPPORT""}"
7882	7590	331	Tuberculosis	Tuberculosis.yaml	phenotypes	8	evidence	2	PMID:19845697	SUPPORT		In TB spondylitis, the lumbar (22.7%) and thoracic (50%) vertebrae were the most commonly involved sites.	This study supports the statement by indicating that the lumbar and thoracic vertebrae are commonly involved in TB spondylitis, which can manifest as back pain.	"{""explanation"": ""This study supports the statement by indicating that the lumbar and thoracic vertebrae are commonly involved in TB spondylitis, which can manifest as back pain."", ""reference"": ""PMID:19845697"", ""snippet"": ""In TB spondylitis, the lumbar (22.7%) and thoracic (50%) vertebrae were the most commonly involved sites."", ""supports"": ""SUPPORT""}"
7883	7590	331	Tuberculosis	Tuberculosis.yaml	phenotypes	8	evidence	3	PMID:33393654	SUPPORT		In this article, we present a rare case of progressed tuberculous infection involving the respiratory and musculoskeletal system in a 36-year-old patient whose main complaints were non-specific and mild, and started only two weeks before his diagnosis, despite the advanced disease.	This case supports the statement by illustrating that tuberculosis can involve the musculoskeletal system, presenting as back pain.	"{""explanation"": ""This case supports the statement by illustrating that tuberculosis can involve the musculoskeletal system, presenting as back pain."", ""reference"": ""PMID:33393654"", ""snippet"": ""In this article, we present a rare case of progressed tuberculous infection involving the respiratory and musculoskeletal system in a 36-year-old patient whose main complaints were non-specific and mild, and started only two weeks before his diagnosis, despite the advanced disease."", ""supports"": ""SUPPORT""}"
7884	7591	331	Tuberculosis	Tuberculosis.yaml	phenotypes	9	evidence	0	PMID:30513392	PARTIAL		TB can affect most organs in the head and neck region, such as the lymph nodes, larynx, middle ear, oral cavity and pharynx. In particular, as for cervical tuberculosis lymphadenopathy, a predominant involvement of the posterior triangle, supraclavicular, and internal jugular group of nodes bilaterally can be observed.	The literature supports that tuberculosis can cause lymphadenopathy, specifically in the neck region, but it does not provide a clear indication of frequency.	"{""explanation"": ""The literature supports that tuberculosis can cause lymphadenopathy, specifically in the neck region, but it does not provide a clear indication of frequency."", ""reference"": ""PMID:30513392"", ""snippet"": ""TB can affect most organs in the head and neck region, such as the lymph nodes, larynx, middle ear, oral cavity and pharynx. In particular, as for cervical tuberculosis lymphadenopathy, a predominant involvement of the posterior triangle, supraclavicular, and internal jugular group of nodes bilaterally can be observed."", ""supports"": ""PARTIAL""}"
7885	7591	331	Tuberculosis	Tuberculosis.yaml	phenotypes	9	evidence	1	PMID:38317037	PARTIAL		Other major causes of lymphadenopathy were metastatic tumor deposits, reactive lymphoid hyperplasia, and tuberculous lymphadenitis.	The literature indicates that tuberculous lymphadenitis is one of the major causes of lymphadenopathy, but it does not specify how frequently this occurs.	"{""explanation"": ""The literature indicates that tuberculous lymphadenitis is one of the major causes of lymphadenopathy, but it does not specify how frequently this occurs."", ""reference"": ""PMID:38317037"", ""snippet"": ""Other major causes of lymphadenopathy were metastatic tumor deposits, reactive lymphoid hyperplasia, and tuberculous lymphadenitis."", ""supports"": ""PARTIAL""}"
7886	7591	331	Tuberculosis	Tuberculosis.yaml	phenotypes	9	evidence	2	PMID:37743370	PARTIAL		Close to half of patients with enlarged lymph nodes were positive for M. tuberculosis by the GeneXpert method in the study area.	The study shows a significant prevalence of TB lymphadenitis among patients with enlarged lymph nodes, but it does not provide a frequency classification such as 'occasional'.	"{""explanation"": ""The study shows a significant prevalence of TB lymphadenitis among patients with enlarged lymph nodes, but it does not provide a frequency classification such as 'occasional'."", ""reference"": ""PMID:37743370"", ""snippet"": ""Close to half of patients with enlarged lymph nodes were positive for M. tuberculosis by the GeneXpert method in the study area."", ""supports"": ""PARTIAL""}"
7934	7623	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	phenotypes	0	evidence	0	PMID:29939616	SUPPORT		This vicious cycle continues until pancreatic beta-cell activity can no longer adequately meet the insulin demand created by insulin resistance, resulting in hyperglycemia.	This describes how the failure of beta cells to compensate for insulin resistance results in hyperglycemia, the hallmark of type 2 diabetes.	"{""explanation"": ""This describes how the failure of beta cells to compensate for insulin resistance results in hyperglycemia, the hallmark of type 2 diabetes."", ""reference"": ""PMID:29939616"", ""snippet"": ""This vicious cycle continues until pancreatic beta-cell activity can no longer adequately meet the insulin demand created by insulin resistance, resulting in hyperglycemia."", ""supports"": ""SUPPORT""}"
7935	7623	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	phenotypes	0	evidence	1	PMID:30150719	SUPPORT		Diabetes is characterized by impaired glucose homeostasis partly due to abnormally elevated hepatic glucose production (HGP).	This confirms that hyperglycemia in diabetes results from elevated hepatic glucose production and impaired glucose homeostasis.	"{""explanation"": ""This confirms that hyperglycemia in diabetes results from elevated hepatic glucose production and impaired glucose homeostasis."", ""reference"": ""PMID:30150719"", ""snippet"": ""Diabetes is characterized by impaired glucose homeostasis partly due to abnormally elevated hepatic glucose production (HGP)."", ""supports"": ""SUPPORT""}"
7936	7624	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	phenotypes	1	evidence	0	PMID:9398128	SUPPORT		Polyuria due to a glucose-induced osmotic diuresis is common in patients with hyperglycemia.	This establishes that polyuria results from glucose-induced osmotic diuresis in hyperglycemia, which in turn leads to polydipsia as a compensatory response to fluid loss.	"{""explanation"": ""This establishes that polyuria results from glucose-induced osmotic diuresis in hyperglycemia, which in turn leads to polydipsia as a compensatory response to fluid loss."", ""reference"": ""PMID:9398128"", ""snippet"": ""Polyuria due to a glucose-induced osmotic diuresis is common in patients with hyperglycemia."", ""supports"": ""SUPPORT""}"
7937	7625	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	phenotypes	2	evidence	0	PMID:9398128	SUPPORT		Polyuria due to a glucose-induced osmotic diuresis is common in patients with hyperglycemia. This diuresis usually abates when the plasma glucose level approaches its renal threshold.	This describes the mechanism of polyuria in diabetes as glucose-induced osmotic diuresis when plasma glucose exceeds the renal threshold.	"{""explanation"": ""This describes the mechanism of polyuria in diabetes as glucose-induced osmotic diuresis when plasma glucose exceeds the renal threshold."", ""reference"": ""PMID:9398128"", ""snippet"": ""Polyuria due to a glucose-induced osmotic diuresis is common in patients with hyperglycemia. This diuresis usually abates when the plasma glucose level approaches its renal threshold."", ""supports"": ""SUPPORT""}"
7938	7628	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	phenotypes	5	evidence	0	PMID:12231074	SUPPORT		Insulin resistance is caused by the decreased ability of peripheral target tissues (especially muscle) to respond properly to normal circulating concentrations of insulin.	This establishes insulin resistance as a hallmark feature of T2D pathophysiology.	"{""explanation"": ""This establishes insulin resistance as a hallmark feature of T2D pathophysiology."", ""reference"": ""PMID:12231074"", ""snippet"": ""Insulin resistance is caused by the decreased ability of peripheral target tissues (especially muscle) to respond properly to normal circulating concentrations of insulin."", ""supports"": ""SUPPORT""}"
7939	7630	332	Type 2 Diabetes Mellitus	Type_2_Diabetes_Mellitus.yaml	phenotypes	7	evidence	0	PMID:29939616	SUPPORT		Insulin resistance impairs glucose disposal, resulting in a compensatory increase in beta-cell insulin production and hyperinsulinemia.	This establishes hyperinsulinemia as a compensatory response to insulin resistance in T2D.	"{""explanation"": ""This establishes hyperinsulinemia as a compensatory response to insulin resistance in T2D."", ""reference"": ""PMID:29939616"", ""snippet"": ""Insulin resistance impairs glucose disposal, resulting in a compensatory increase in beta-cell insulin production and hyperinsulinemia."", ""supports"": ""SUPPORT""}"
8014	7663	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	0	evidence	0	PMID:38272591	SUPPORT		Type 1 diabetes is associated with both acute and chronic complications. Acute complications include diabetic ketoacidosis and severe hypoglycemia. Chronic complications can be microvascular or macrovascular. Microvascular complications include retinopathy, nephropathy, and neuropathy.	This source supports the statement by associating Type I Diabetes with hyperglycemia and chronic complications such as retinopathy and neuropathy, as well as acute complications like diabetic ketoacidosis.	"{""explanation"": ""This source supports the statement by associating Type I Diabetes with hyperglycemia and chronic complications such as retinopathy and neuropathy, as well as acute complications like diabetic ketoacidosis."", ""reference"": ""PMID:38272591"", ""snippet"": ""Type 1 diabetes is associated with both acute and chronic complications. Acute complications include diabetic ketoacidosis and severe hypoglycemia. Chronic complications can be microvascular or macrovascular. Microvascular complications include retinopathy, nephropathy, and neuropathy."", ""supports"": ""SUPPORT""}"
8015	7663	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	0	evidence	1	PMID:28544185	SUPPORT		Participation in prospective follow-up studies reduces the frequency of DKA in children at diagnosis of T1D, but genetic screening alone does not decrease DKA risk.	This source supports the statement by confirming that Diabetic Ketoacidosis (DKA) is a frequent acute complication in Type 1 Diabetes at the time of diagnosis.	"{""explanation"": ""This source supports the statement by confirming that Diabetic Ketoacidosis (DKA) is a frequent acute complication in Type 1 Diabetes at the time of diagnosis."", ""reference"": ""PMID:28544185"", ""snippet"": ""Participation in prospective follow-up studies reduces the frequency of DKA in children at diagnosis of T1D, but genetic screening alone does not decrease DKA risk."", ""supports"": ""SUPPORT""}"
8016	7663	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	0	evidence	2	PMID:34362315	SUPPORT		Although SH was usually benign and long-term treatment was superfluous, it might be the first sign of insulinopenic status such as type 1 DM (T1DM)	This source supports the statement by describing stress hyperglycemia as a potential initial presentation of Type 1 Diabetes, thereby confirming hyperglycemia as a very frequent occurrence.	"{""explanation"": ""This source supports the statement by describing stress hyperglycemia as a potential initial presentation of Type 1 Diabetes, thereby confirming hyperglycemia as a very frequent occurrence."", ""reference"": ""PMID:34362315"", ""snippet"": ""Although SH was usually benign and long-term treatment was superfluous, it might be the first sign of insulinopenic status such as type 1 DM (T1DM)"", ""supports"": ""SUPPORT""}"
8017	7664	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	1	evidence	0	PMID:23075321	PARTIAL		Immune-mediated (auto-immune) Type 1 diabetes mellitus is not a homogenous entity, but nonetheless has distinctive characteristics. In children, it may present with classical insulin deficiency and ketoacidosis at disease onset, whereas autoimmune diabetes in adults may not always be insulin dependent.	The source does indicate that Type 1 diabetes has varied presentations, including insulin deficiency and potentially weight loss due to failure to utilize glucose. However, the excerpt does not specifically mention weight loss as a frequent phenotype.	"{""explanation"": ""The source does indicate that Type 1 diabetes has varied presentations, including insulin deficiency and potentially weight loss due to failure to utilize glucose. However, the excerpt does not specifically mention weight loss as a frequent phenotype."", ""reference"": ""PMID:23075321"", ""snippet"": ""Immune-mediated (auto-immune) Type 1 diabetes mellitus is not a homogenous entity, but nonetheless has distinctive characteristics. In children, it may present with classical insulin deficiency and ketoacidosis at disease onset, whereas autoimmune diabetes in adults may not always be insulin dependent."", ""supports"": ""PARTIAL""}"
8018	7664	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	1	evidence	1	PMID:12949265	NO_EVIDENCE			The provided literature does not directly discuss weight loss as a frequent systemic phenotype of Type 1 diabetes.	"{""explanation"": ""The provided literature does not directly discuss weight loss as a frequent systemic phenotype of Type 1 diabetes."", ""reference"": ""PMID:12949265"", ""supports"": ""NO_EVIDENCE""}"
8019	7664	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	1	evidence	2	PMID:11508279	NO_EVIDENCE			This reference discusses the Accelerator Hypothesis and weight gain in diabetes but does not address weight loss in Type 1 diabetes.	"{""explanation"": ""This reference discusses the Accelerator Hypothesis and weight gain in diabetes but does not address weight loss in Type 1 diabetes."", ""reference"": ""PMID:11508279"", ""supports"": ""NO_EVIDENCE""}"
8020	7664	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	1	evidence	3	PMID:37065759	PARTIAL		The risk factors of weight gain included using exogenous insulin, intensifying insulin therapy, fear of hypoglycemia and related decrease in physical activity, and psychological factors, such as emotional eating and binge eating	This reference addresses weight gain in relation to Type 1 Diabetes but does not state that weight loss is a frequent phenotype.	"{""explanation"": ""This reference addresses weight gain in relation to Type 1 Diabetes but does not state that weight loss is a frequent phenotype."", ""reference"": ""PMID:37065759"", ""snippet"": ""The risk factors of weight gain included using exogenous insulin, intensifying insulin therapy, fear of hypoglycemia and related decrease in physical activity, and psychological factors, such as emotional eating and binge eating"", ""supports"": ""PARTIAL""}"
8021	7664	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	1	evidence	4	PMID:19267337	NO_EVIDENCE			The reference discusses the natural history of endogenous beta-cell function in Type 1 diabetes but does not mention weight loss being a frequent phenotype.	"{""explanation"": ""The reference discusses the natural history of endogenous beta-cell function in Type 1 diabetes but does not mention weight loss being a frequent phenotype."", ""reference"": ""PMID:19267337"", ""supports"": ""NO_EVIDENCE""}"
8022	7665	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	2	evidence	0	PMID:35254878	SUPPORT		Symptoms include polyuria, polydipsia, and weight loss.	This reference confirms that polyuria is a frequent symptom of Type I Diabetes.	"{""explanation"": ""This reference confirms that polyuria is a frequent symptom of Type I Diabetes."", ""reference"": ""PMID:35254878"", ""snippet"": ""Symptoms include polyuria, polydipsia, and weight loss."", ""supports"": ""SUPPORT""}"
8023	7665	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	2	evidence	1	PMID:2923250	SUPPORT		Poorly controlled insulin-dependent diabetes mellitus is associated with considerable elevations of plasma vasopressin concentrations, although well-controlled diabetics have normal osmoregulated thirst and vasopressin release.	This reference discusses the association of poorly controlled insulin-dependent diabetes mellitus (Type I Diabetes) with symptoms such as polyuria.	"{""explanation"": ""This reference discusses the association of poorly controlled insulin-dependent diabetes mellitus (Type I Diabetes) with symptoms such as polyuria."", ""reference"": ""PMID:2923250"", ""snippet"": ""Poorly controlled insulin-dependent diabetes mellitus is associated with considerable elevations of plasma vasopressin concentrations, although well-controlled diabetics have normal osmoregulated thirst and vasopressin release."", ""supports"": ""SUPPORT""}"
8024	7666	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	3	evidence	0	PMID:35254878	SUPPORT		Symptoms include polyuria, polydipsia, and weight loss.	The reference clearly states that polydipsia is a symptom of Type 1 Diabetes Mellitus, supporting the statement that it is a frequent systemic occurrence.	"{""explanation"": ""The reference clearly states that polydipsia is a symptom of Type 1 Diabetes Mellitus, supporting the statement that it is a frequent systemic occurrence."", ""reference"": ""PMID:35254878"", ""snippet"": ""Symptoms include polyuria, polydipsia, and weight loss."", ""supports"": ""SUPPORT""}"
8025	7667	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	4	evidence	0	PMID:12474677	PARTIAL		Diabetic ketoacidosis is an emergency medical condition that can be life-threatening if not treated properly. Diabetic ketoacidosis occurs most often in patients with type 1 diabetes (formerly called insulin-dependent diabetes mellitus); however, its occurrence in patients with type 2 diabetes (formerly called noninsulin-dependent diabetes mellitus) is not as rare as was once thought.	The literature supports that diabetic ketoacidosis is a life-threatening complication of type 1 diabetes and mentions symptoms such as abdominal pain and vomiting. However, it does not specify the frequency as 'occasional'.	"{""explanation"": ""The literature supports that diabetic ketoacidosis is a life-threatening complication of type 1 diabetes and mentions symptoms such as abdominal pain and vomiting. However, it does not specify the frequency as 'occasional'."", ""reference"": ""PMID:12474677"", ""snippet"": ""Diabetic ketoacidosis is an emergency medical condition that can be life-threatening if not treated properly. Diabetic ketoacidosis occurs most often in patients with type 1 diabetes (formerly called insulin-dependent diabetes mellitus); however, its occurrence in patients with type 2 diabetes (formerly called noninsulin-dependent diabetes mellitus) is not as rare as was once thought."", ""supports"": ""PARTIAL""}"
8026	7667	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	4	evidence	1	PMID:17627511	PARTIAL		A small group of patients affected by type 1 diabetes mellitus is characterized by a severe instability of glycemic values with frequent and unpredictable hypoglycemic and/or ketoacidosis episodes which cannot be explained by errors of patients or diabetologists.	This reference supports the occurrence of diabetic ketoacidosis in type 1 diabetes and mentions its life-threatening nature but does not confirm the frequency as 'occasional'.	"{""explanation"": ""This reference supports the occurrence of diabetic ketoacidosis in type 1 diabetes and mentions its life-threatening nature but does not confirm the frequency as 'occasional'."", ""reference"": ""PMID:17627511"", ""snippet"": ""A small group of patients affected by type 1 diabetes mellitus is characterized by a severe instability of glycemic values with frequent and unpredictable hypoglycemic and/or ketoacidosis episodes which cannot be explained by errors of patients or diabetologists."", ""supports"": ""PARTIAL""}"
8027	7667	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	4	evidence	2	PMID:15137354	PARTIAL		The article points out the signs and symptoms to be aware of when the person is in the acute state of diabetic ketoacidosis, hyperglycemic hyperosmolar nonketotic coma (or state), and severe hypoglycemia.	The reference confirms that diabetic ketoacidosis is a life-threatening complication of type 1 diabetes and includes symptoms like confusion and rapid breathing but does not specify the frequency as 'occasional'.	"{""explanation"": ""The reference confirms that diabetic ketoacidosis is a life-threatening complication of type 1 diabetes and includes symptoms like confusion and rapid breathing but does not specify the frequency as 'occasional'."", ""reference"": ""PMID:15137354"", ""snippet"": ""The article points out the signs and symptoms to be aware of when the person is in the acute state of diabetic ketoacidosis, hyperglycemic hyperosmolar nonketotic coma (or state), and severe hypoglycemia."", ""supports"": ""PARTIAL""}"
8028	7667	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	4	evidence	3	PMID:35466445	PARTIAL		Diabetic ketoacidosis as a unique initial presentation of cystic fibrosis.	This reference indicates that diabetic ketoacidosis can be a presentation in type 1 diabetes but does not address the frequency or the specific symptoms listed.	"{""explanation"": ""This reference indicates that diabetic ketoacidosis can be a presentation in type 1 diabetes but does not address the frequency or the specific symptoms listed."", ""reference"": ""PMID:35466445"", ""snippet"": ""Diabetic ketoacidosis as a unique initial presentation of cystic fibrosis."", ""supports"": ""PARTIAL""}"
8029	7668	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	5	evidence	0	PMID:24864506	NO_EVIDENCE		Diabetes mellitus (DM), due to its epidemic prevalence and high occurrence of associated disability, is now one of the priority medical and social problems. Incapacitating manifestations of diabetes include visual impairment. Thus, diabetic retinopathy (DR), a late nonspecific vascular complication of DM, is the leading cause of blindness in the working-age population.	The literature mentions diabetic retinopathy as a leading cause of blindness in the working-age population but does not provide specific information on its frequency in Type I Diabetes.	"{""explanation"": ""The literature mentions diabetic retinopathy as a leading cause of blindness in the working-age population but does not provide specific information on its frequency in Type I Diabetes."", ""reference"": ""PMID:24864506"", ""snippet"": ""Diabetes mellitus (DM), due to its epidemic prevalence and high occurrence of associated disability, is now one of the priority medical and social problems. Incapacitating manifestations of diabetes include visual impairment. Thus, diabetic retinopathy (DR), a late nonspecific vascular complication of DM, is the leading cause of blindness in the working-age population."", ""supports"": ""NO_EVIDENCE""}"
8030	7668	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	5	evidence	1	PMID:37469057	NO_EVIDENCE		The commonest morbidity was cataract12,607(28.8%), followed by refractive errors 8,508(19.5%), vision-threatening diabetic retinopathy 2,553(5.83%) and suspected glaucoma 1,211(2.76%).	The study provides data on the prevalence of diabetic retinopathy in a diabetic population but does not specify it as occasional in Type I Diabetes.	"{""explanation"": ""The study provides data on the prevalence of diabetic retinopathy in a diabetic population but does not specify it as occasional in Type I Diabetes."", ""reference"": ""PMID:37469057"", ""snippet"": ""The commonest morbidity was cataract12,607(28.8%), followed by refractive errors 8,508(19.5%), vision-threatening diabetic retinopathy 2,553(5.83%) and suspected glaucoma 1,211(2.76%)."", ""supports"": ""NO_EVIDENCE""}"
8031	7668	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	5	evidence	2	PMID:38272591	NO_EVIDENCE		Type 1 diabetes is associated with both acute and chronic complications. Acute complications include diabetic ketoacidosis and severe hypoglycemia. Chronic complications can be microvascular or macrovascular. Microvascular complications include retinopathy, nephropathy, and neuropathy.	The article mentions retinopathy as a complication of Type 1 diabetes but does not specify its frequency as occasional.	"{""explanation"": ""The article mentions retinopathy as a complication of Type 1 diabetes but does not specify its frequency as occasional."", ""reference"": ""PMID:38272591"", ""snippet"": ""Type 1 diabetes is associated with both acute and chronic complications. Acute complications include diabetic ketoacidosis and severe hypoglycemia. Chronic complications can be microvascular or macrovascular. Microvascular complications include retinopathy, nephropathy, and neuropathy."", ""supports"": ""NO_EVIDENCE""}"
8032	7668	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	5	evidence	3	PMID:29682912	NO_EVIDENCE		Diabetic retinopathy, a complication of both type 1 and type 2 diabetes, is a complex disease and is one of the leading causes of blindness in adults worldwide.	The literature mentions diabetic retinopathy as a complication of Type 1 and Type 2 diabetes but does not specify its frequency as occasional.	"{""explanation"": ""The literature mentions diabetic retinopathy as a complication of Type 1 and Type 2 diabetes but does not specify its frequency as occasional."", ""reference"": ""PMID:29682912"", ""snippet"": ""Diabetic retinopathy, a complication of both type 1 and type 2 diabetes, is a complex disease and is one of the leading causes of blindness in adults worldwide."", ""supports"": ""NO_EVIDENCE""}"
8033	7669	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	6	evidence	0	PMID:28159476	SUPPORT		Aggressive glucose control can result in treatment induced neuropathy of diabetes (TIND) if glycemic control is achieved too quickly.	This reference supports the statement by indicating that aggressive glycemic control can lead to diabetic neuropathy, which is a neurologic complication of Type I Diabetes.	"{""explanation"": ""This reference supports the statement by indicating that aggressive glycemic control can lead to diabetic neuropathy, which is a neurologic complication of Type I Diabetes."", ""reference"": ""PMID:28159476"", ""snippet"": ""Aggressive glucose control can result in treatment induced neuropathy of diabetes (TIND) if glycemic control is achieved too quickly."", ""supports"": ""SUPPORT""}"
8034	7669	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	6	evidence	1	PMID:33071962	SUPPORT		Glycemic variability (GV) may attribute to the pathogenesis of diabetic neuropathy.	This reference supports the statement that diabetic neuropathy is a neurologic complication associated with glycemic variability, which can be linked to chronic hyperglycemia.	"{""explanation"": ""This reference supports the statement that diabetic neuropathy is a neurologic complication associated with glycemic variability, which can be linked to chronic hyperglycemia."", ""reference"": ""PMID:33071962"", ""snippet"": ""Glycemic variability (GV) may attribute to the pathogenesis of diabetic neuropathy."", ""supports"": ""SUPPORT""}"
8035	7669	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	6	evidence	2	PMID:33715053	SUPPORT		Emerging evidence suggests that hyperglycemia and time in range may be more important for brain development than episodes of hypoglycemia.	This reference supports the statement by highlighting the role of hyperglycemia in neurocognitive complications, which can be related to diabetic neuropathy in Type I Diabetes.	"{""explanation"": ""This reference supports the statement by highlighting the role of hyperglycemia in neurocognitive complications, which can be related to diabetic neuropathy in Type I Diabetes."", ""reference"": ""PMID:33715053"", ""snippet"": ""Emerging evidence suggests that hyperglycemia and time in range may be more important for brain development than episodes of hypoglycemia."", ""supports"": ""SUPPORT""}"
8036	7669	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	6	evidence	3	PMID:23506377	SUPPORT		'Insulin neuritis' or 'treatment induced neuropathy' is a reversible disorder characterised by acute severe distal limb pain, peripheral nerve fibre damage and autonomic dysfunction, preceded by a period of rapid glycaemic control.	This reference supports the statement by describing insulin neuritis, a form of diabetic neuropathy, which is a neurologic complication associated with glycemic control.	"{""explanation"": ""This reference supports the statement by describing insulin neuritis, a form of diabetic neuropathy, which is a neurologic complication associated with glycemic control."", ""reference"": ""PMID:23506377"", ""snippet"": ""'Insulin neuritis' or 'treatment induced neuropathy' is a reversible disorder characterised by acute severe distal limb pain, peripheral nerve fibre damage and autonomic dysfunction, preceded by a period of rapid glycaemic control."", ""supports"": ""SUPPORT""}"
8037	7670	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	7	evidence	0	PMID:23290727	NO_EVIDENCE		Renal failure in type 2 diabetes has been termed 'a medical catastrophe of worldwide dimension'.	This study primarily discusses renal failure in type 2 diabetes, not type 1 diabetes.	"{""explanation"": ""This study primarily discusses renal failure in type 2 diabetes, not type 1 diabetes."", ""reference"": ""PMID:23290727"", ""snippet"": ""Renal failure in type 2 diabetes has been termed 'a medical catastrophe of worldwide dimension'."", ""supports"": ""NO_EVIDENCE""}"
8038	7670	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	7	evidence	1	PMID:27903991	PARTIAL		Diabetic nephropathy (DN) is a serious complication of diabetes mellitus, and its prevalence has been increasing in developed countries.	The study mentions diabetic nephropathy as a serious complication of diabetes mellitus in general, without specifying the frequency in type 1 diabetes.	"{""explanation"": ""The study mentions diabetic nephropathy as a serious complication of diabetes mellitus in general, without specifying the frequency in type 1 diabetes."", ""reference"": ""PMID:27903991"", ""snippet"": ""Diabetic nephropathy (DN) is a serious complication of diabetes mellitus, and its prevalence has been increasing in developed countries."", ""supports"": ""PARTIAL""}"
8039	7670	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	7	evidence	2	PMID:1490695	PARTIAL		The most serious complication of diabetes mellitus is clinical nephropathy.	The study highlights nephropathy as a serious complication of diabetes mellitus but does not specify its frequency in type 1 diabetes.	"{""explanation"": ""The study highlights nephropathy as a serious complication of diabetes mellitus but does not specify its frequency in type 1 diabetes."", ""reference"": ""PMID:1490695"", ""snippet"": ""The most serious complication of diabetes mellitus is clinical nephropathy."", ""supports"": ""PARTIAL""}"
8040	7670	333	Type I Diabetes	Type_I_Diabetes.yaml	phenotypes	7	evidence	3	PMID:30833370	PARTIAL		higher mean glycemic exposure was the strongest determinant of kidney disease among the modifiable risk factors.	The study identifies glycemic control as a significant factor for kidney disease in type 1 diabetes but does not specify the frequency of diabetic nephropathy.	"{""explanation"": ""The study identifies glycemic control as a significant factor for kidney disease in type 1 diabetes but does not specify the frequency of diabetic nephropathy."", ""reference"": ""PMID:30833370"", ""snippet"": ""higher mean glycemic exposure was the strongest determinant of kidney disease among the modifiable risk factors."", ""supports"": ""PARTIAL""}"
8090	7713	334	Ulcerative Colitis	Ulcerative_Colitis.yaml	phenotypes	0	evidence	0	PMID:38724705	SUPPORT		Luminal epithelial cells in patients with irColitis expressed PCSK9, PD-L1 and interferon-induced signatures associated with apoptosis, increased cell turnover and malabsorption.	Epithelial apoptosis and increased cell turnover in inflammatory colitis leads to mucosal ulceration and bleeding, which manifests as bloody diarrhea.	"{""explanation"": ""Epithelial apoptosis and increased cell turnover in inflammatory colitis leads to mucosal ulceration and bleeding, which manifests as bloody diarrhea."", ""reference"": ""PMID:38724705"", ""snippet"": ""Luminal epithelial cells in patients with irColitis expressed PCSK9, PD-L1 and interferon-induced signatures associated with apoptosis, increased cell turnover and malabsorption."", ""supports"": ""SUPPORT""}"
8107	7754	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	0	evidence	0	PMID:24645145	SUPPORT		Patients with 'visual snow' report continuous tiny dots in the entire visual field similar to the noise of an analogue television.	Foundational study defines visual snow as continuous tiny dots throughout the visual field.	"{""explanation"": ""Foundational study defines visual snow as continuous tiny dots throughout the visual field."", ""reference"": ""PMID:24645145"", ""snippet"": ""Patients with 'visual snow' report continuous tiny dots in the entire visual field similar to the noise of an analogue television."", ""supports"": ""SUPPORT""}"
8108	7754	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	0	evidence	1	PMID:29934719	SUPPORT		"Visual snow is a condition where patients see constant, innumerable flickering dots throughout the visual field, similar to ""TV static."""	Confirms visual snow as constant flickering dots resembling TV static.	"{""explanation"": ""Confirms visual snow as constant flickering dots resembling TV static."", ""reference"": ""PMID:29934719"", ""snippet"": ""Visual snow is a condition where patients see constant, innumerable flickering dots throughout the visual field, similar to \""TV static.\"""", ""supports"": ""SUPPORT""}"
8109	7754	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	0	evidence	2	PMID:31941797	SUPPORT		The most commonly experienced static was black and white.	Large cohort study confirms black and white static as the most common visual snow appearance.	"{""explanation"": ""Large cohort study confirms black and white static as the most common visual snow appearance."", ""reference"": ""PMID:31941797"", ""snippet"": ""The most commonly experienced static was black and white."", ""supports"": ""SUPPORT""}"
8110	7755	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	1	evidence	0	PMID:24645145	SUPPORT		palinopsia (trailing and afterimages), entoptic phenomena (floaters, blue field entoptic phenomenon, spontaneous photopsia, self-light of the eye), photophobia, and nyctalopia (impaired night vision)	Palinopsia including afterimages and trailing is one of the core additional symptoms in VSS.	"{""explanation"": ""Palinopsia including afterimages and trailing is one of the core additional symptoms in VSS."", ""reference"": ""PMID:24645145"", ""snippet"": ""palinopsia (trailing and afterimages), entoptic phenomena (floaters, blue field entoptic phenomenon, spontaneous photopsia, self-light of the eye), photophobia, and nyctalopia (impaired night vision)"", ""supports"": ""SUPPORT""}"
8111	7755	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	1	evidence	1	PMID:24816400	SUPPORT		"Most patients describe a syndrome with additional visual symptoms of the following categories: palinopsia (""afterimages"" and ""trailing"")"	Palinopsia symptoms including afterimages and trailing are common in VSS.	"{""explanation"": ""Palinopsia symptoms including afterimages and trailing are common in VSS."", ""reference"": ""PMID:24816400"", ""snippet"": ""Most patients describe a syndrome with additional visual symptoms of the following categories: palinopsia (\""afterimages\"" and \""trailing\"")"", ""supports"": ""SUPPORT""}"
8112	7756	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	2	evidence	0	PMID:24645145	SUPPORT		palinopsia (trailing and afterimages), entoptic phenomena (floaters, blue field entoptic phenomenon, spontaneous photopsia, self-light of the eye), photophobia, and nyctalopia	Photophobia is one of the core additional symptoms present in VSS patients.	"{""explanation"": ""Photophobia is one of the core additional symptoms present in VSS patients."", ""reference"": ""PMID:24645145"", ""snippet"": ""palinopsia (trailing and afterimages), entoptic phenomena (floaters, blue field entoptic phenomenon, spontaneous photopsia, self-light of the eye), photophobia, and nyctalopia"", ""supports"": ""SUPPORT""}"
8113	7756	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	2	evidence	1	PMID:31941797	SUPPORT		Floaters, afterimages, and photophobia were the most reported additional visual symptoms.	Large cohort study confirms photophobia as one of the most commonly reported symptoms.	"{""explanation"": ""Large cohort study confirms photophobia as one of the most commonly reported symptoms."", ""reference"": ""PMID:31941797"", ""snippet"": ""Floaters, afterimages, and photophobia were the most reported additional visual symptoms."", ""supports"": ""SUPPORT""}"
8114	7757	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	3	evidence	0	PMID:24645145	SUPPORT		palinopsia (trailing and afterimages), entoptic phenomena (floaters, blue field entoptic phenomenon, spontaneous photopsia, self-light of the eye), photophobia, and nyctalopia (impaired night vision)	Nyctalopia (impaired night vision) is one of the core additional symptoms in VSS.	"{""explanation"": ""Nyctalopia (impaired night vision) is one of the core additional symptoms in VSS."", ""reference"": ""PMID:24645145"", ""snippet"": ""palinopsia (trailing and afterimages), entoptic phenomena (floaters, blue field entoptic phenomenon, spontaneous photopsia, self-light of the eye), photophobia, and nyctalopia (impaired night vision)"", ""supports"": ""SUPPORT""}"
8115	7757	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	3	evidence	1	PMID:38465699	SUPPORT		Visual snow syndrome (VSS) is a disorder characterized by persistent visual disturbances, including the visual snow phenomenon, palinopsia, heightened perception of entoptic phenomena, impaired night vision, and photophobia.	Impaired night vision is listed as a core feature of VSS in recent review.	"{""explanation"": ""Impaired night vision is listed as a core feature of VSS in recent review."", ""reference"": ""PMID:38465699"", ""snippet"": ""Visual snow syndrome (VSS) is a disorder characterized by persistent visual disturbances, including the visual snow phenomenon, palinopsia, heightened perception of entoptic phenomena, impaired night vision, and photophobia."", ""supports"": ""SUPPORT""}"
8116	7758	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	4	evidence	0	PMID:24645145	SUPPORT		palinopsia (trailing and afterimages), entoptic phenomena (floaters, blue field entoptic phenomenon, spontaneous photopsia, self-light of the eye), photophobia, and nyctalopia	Enhanced entoptic phenomena are core features of VSS.	"{""explanation"": ""Enhanced entoptic phenomena are core features of VSS."", ""reference"": ""PMID:24645145"", ""snippet"": ""palinopsia (trailing and afterimages), entoptic phenomena (floaters, blue field entoptic phenomenon, spontaneous photopsia, self-light of the eye), photophobia, and nyctalopia"", ""supports"": ""SUPPORT""}"
8117	7758	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	4	evidence	1	PMID:33008511	SUPPORT		Visual snow syndrome is a debilitating disorder characterized by tiny flickering dots (like TV static) in the entire visual field and a set of accompanying visual (palinopsia, enhanced entoptic phenomena, photophobia, nyctalopia)	Enhanced entoptic phenomena are part of the defining symptom complex of VSS.	"{""explanation"": ""Enhanced entoptic phenomena are part of the defining symptom complex of VSS."", ""reference"": ""PMID:33008511"", ""snippet"": ""Visual snow syndrome is a debilitating disorder characterized by tiny flickering dots (like TV static) in the entire visual field and a set of accompanying visual (palinopsia, enhanced entoptic phenomena, photophobia, nyctalopia)"", ""supports"": ""SUPPORT""}"
8118	7759	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	5	evidence	0	PMID:24816400	SUPPORT		entopic phenomena arising from the optic apparatus itself (floaters, blue field entoptic phenomenon, photopsia, self-light of the eye)	Spontaneous photopsia is one of the entoptic phenomena in VSS.	"{""explanation"": ""Spontaneous photopsia is one of the entoptic phenomena in VSS."", ""reference"": ""PMID:24816400"", ""snippet"": ""entopic phenomena arising from the optic apparatus itself (floaters, blue field entoptic phenomenon, photopsia, self-light of the eye)"", ""supports"": ""SUPPORT""}"
8119	7759	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	5	evidence	1	PMID:40129600	SUPPORT		Visual Snow Syndrome (VSS) is characterized by the presence of dynamic, continuous, tiny dots in the entire visual field persisting for more than three months, with at least two associated symptoms- palinopsia, photopsia, photophobia, or nyctalopia.	Photopsia is listed as one of the core associated symptoms in VSS diagnostic criteria.	"{""explanation"": ""Photopsia is listed as one of the core associated symptoms in VSS diagnostic criteria."", ""reference"": ""PMID:40129600"", ""snippet"": ""Visual Snow Syndrome (VSS) is characterized by the presence of dynamic, continuous, tiny dots in the entire visual field persisting for more than three months, with at least two associated symptoms- palinopsia, photopsia, photophobia, or nyctalopia."", ""supports"": ""SUPPORT""}"
8120	7760	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	6	evidence	0	PMID:28723606	SUPPORT		While most of these symptoms appear to be visual in nature, approximately 63% of patients studied also report continuous bilateral tinnitus.	About 63% of VSS patients report continuous bilateral tinnitus.	"{""explanation"": ""About 63% of VSS patients report continuous bilateral tinnitus."", ""reference"": ""PMID:28723606"", ""snippet"": ""While most of these symptoms appear to be visual in nature, approximately 63% of patients studied also report continuous bilateral tinnitus."", ""supports"": ""SUPPORT""}"
8121	7760	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	6	evidence	1	PMID:31941797	SUPPORT		Migraine and tinnitus had a very high prevalence and were independently associated with a more severe presentation of the syndrome.	Tinnitus is highly prevalent and associated with more severe VSS presentation.	"{""explanation"": ""Tinnitus is highly prevalent and associated with more severe VSS presentation."", ""reference"": ""PMID:31941797"", ""snippet"": ""Migraine and tinnitus had a very high prevalence and were independently associated with a more severe presentation of the syndrome."", ""supports"": ""SUPPORT""}"
8122	7760	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	6	evidence	2	PMID:24816400	SUPPORT		as well as the non-visual symptom tinnitus.	Tinnitus is recognized as a common non-visual symptom in VSS.	"{""explanation"": ""Tinnitus is recognized as a common non-visual symptom in VSS."", ""reference"": ""PMID:24816400"", ""snippet"": ""as well as the non-visual symptom tinnitus."", ""supports"": ""SUPPORT""}"
8123	7760	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	6	evidence	3	PMID:31213497	SUPPORT		Migraine, depression, anxiety, and tinnitus were common comorbid diseases.	Tinnitus is confirmed as a common comorbid condition in VSS.	"{""explanation"": ""Tinnitus is confirmed as a common comorbid condition in VSS."", ""reference"": ""PMID:31213497"", ""snippet"": ""Migraine, depression, anxiety, and tinnitus were common comorbid diseases."", ""supports"": ""SUPPORT""}"
8124	7761	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	7	evidence	0	PMID:31941797	SUPPORT		Floaters, afterimages, and photophobia were the most reported additional visual symptoms.	Floaters are among the most commonly reported symptoms in VSS.	"{""explanation"": ""Floaters are among the most commonly reported symptoms in VSS."", ""reference"": ""PMID:31941797"", ""snippet"": ""Floaters, afterimages, and photophobia were the most reported additional visual symptoms."", ""supports"": ""SUPPORT""}"
8125	7761	337	Visual Snow Syndrome	Visual_Snow_Syndrome.yaml	phenotypes	7	evidence	1	PMID:24645145	SUPPORT		entoptic phenomena (floaters, blue field entoptic phenomenon, spontaneous photopsia, self-light of the eye)	Floaters are part of the enhanced entoptic phenomena seen in VSS patients.	"{""explanation"": ""Floaters are part of the enhanced entoptic phenomena seen in VSS patients."", ""reference"": ""PMID:24645145"", ""snippet"": ""entoptic phenomena (floaters, blue field entoptic phenomenon, spontaneous photopsia, self-light of the eye)"", ""supports"": ""SUPPORT""}"
8195	7792	338	Vitiligo	Vitiligo.yaml	phenotypes	0	evidence	0	PMID:25572727	SUPPORT	HUMAN_CLINICAL	Vitiligo is an acquired cutaneous disorder of pigmentation... Recent data provide strong evidence supporting an autoimmune pathogenesis of vitiligo.	The document confirms that vitiligo is characterized by depigmented patches and addresses the negative impact on quality of life, which can include social stigma.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The document confirms that vitiligo is characterized by depigmented patches and addresses the negative impact on quality of life, which can include social stigma."", ""reference"": ""PMID:25572727"", ""snippet"": ""Vitiligo is an acquired cutaneous disorder of pigmentation... Recent data provide strong evidence supporting an autoimmune pathogenesis of vitiligo."", ""supports"": ""SUPPORT""}"
8196	7792	338	Vitiligo	Vitiligo.yaml	phenotypes	0	evidence	1	PMID:35166101	SUPPORT	HUMAN_CLINICAL	Vitiligo is a skin disorder characterized by selective loss of melanocytes resulting in circumscribed, depigmented macules and patches... its effects can be psychological, leading to stigmatization and suicidal ideation.	This supports the statement by confirming the presence of depigmented patches and social stigma.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This supports the statement by confirming the presence of depigmented patches and social stigma."", ""reference"": ""PMID:35166101"", ""snippet"": ""Vitiligo is a skin disorder characterized by selective loss of melanocytes resulting in circumscribed, depigmented macules and patches... its effects can be psychological, leading to stigmatization and suicidal ideation."", ""supports"": ""SUPPORT""}"
8197	7792	338	Vitiligo	Vitiligo.yaml	phenotypes	0	evidence	2	PMID:17250545	SUPPORT	HUMAN_CLINICAL	Vitiligo is the most common depigmenting disorder, which affects 0.5-1% of the worldwide population, causing disfigurement and serious disturbances in well being.	This supports the statement regarding the commonality of depigmented patches and associated social stigma.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This supports the statement regarding the commonality of depigmented patches and associated social stigma."", ""reference"": ""PMID:17250545"", ""snippet"": ""Vitiligo is the most common depigmenting disorder, which affects 0.5-1% of the worldwide population, causing disfigurement and serious disturbances in well being."", ""supports"": ""SUPPORT""}"
8198	7792	338	Vitiligo	Vitiligo.yaml	phenotypes	0	evidence	3	PMID:23796814	SUPPORT	HUMAN_CLINICAL	Vitiligo is an acquired, idiopathic skin disease characterized by the mostly progressive loss of the inherited skin color leading to white patches... The disease burden includes stigmatization, depression, impaired quality of life, lack of self-confidence, embarrassment and self-consciousness.	This supports the statement regarding depigmented patches and social stigma.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This supports the statement regarding depigmented patches and social stigma."", ""reference"": ""PMID:23796814"", ""snippet"": ""Vitiligo is an acquired, idiopathic skin disease characterized by the mostly progressive loss of the inherited skin color leading to white patches... The disease burden includes stigmatization, depression, impaired quality of life, lack of self-confidence, embarrassment and self-consciousness."", ""supports"": ""SUPPORT""}"
8199	7792	338	Vitiligo	Vitiligo.yaml	phenotypes	0	evidence	4	PMID:32462299	PARTIAL	HUMAN_CLINICAL	Vitiligo was causally associated with reduced risks of several cancers... melanoma (OR 0.9983; 95% CI 0.9976-0.9990; p < 0.001), non-melanoma skin cancer (OR 0.9997; 95% CI 0.9995-0.9999; p < 0.001).	Supports the reduction in the risk of skin cancer but does not address increased sensitivity to sunlight.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""Supports the reduction in the risk of skin cancer but does not address increased sensitivity to sunlight."", ""reference"": ""PMID:32462299"", ""snippet"": ""Vitiligo was causally associated with reduced risks of several cancers... melanoma (OR 0.9983; 95% CI 0.9976-0.9990; p < 0.001), non-melanoma skin cancer (OR 0.9997; 95% CI 0.9995-0.9999; p < 0.001)."", ""supports"": ""PARTIAL""}"
8200	7793	338	Vitiligo	Vitiligo.yaml	phenotypes	1	evidence	0	PMID:26769615	SUPPORT	HUMAN_CLINICAL	Vitiligo in children is a distinct subset of vitiligo and differs from adult vitiligo. Characteristic features include family history of autoimmune or endocrine disease, higher incidence of segmental vitiligo, development of early or premature graying, increased incidence of autoantibodies and poor response to topical PUVA.	The excerpt lists 'development of early or premature graying' as a characteristic feature of vitiligo in children, supporting the statement that premature hair whitening is occasionally associated with vitiligo.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The excerpt lists 'development of early or premature graying' as a characteristic feature of vitiligo in children, supporting the statement that premature hair whitening is occasionally associated with vitiligo."", ""reference"": ""PMID:26769615"", ""snippet"": ""Vitiligo in children is a distinct subset of vitiligo and differs from adult vitiligo. Characteristic features include family history of autoimmune or endocrine disease, higher incidence of segmental vitiligo, development of early or premature graying, increased incidence of autoantibodies and poor response to topical PUVA."", ""supports"": ""SUPPORT""}"
8201	7794	338	Vitiligo	Vitiligo.yaml	phenotypes	2	evidence	0	PMID:34104234	SUPPORT	HUMAN_CLINICAL	The association with chronic thyroiditis is based on common autoimmune background and excessive reactive oxygen species that destroy melanocytes and thyrocytes (oxidative stress hypothesis)...	This reference discusses the association of vitiligo with chronic autoimmune thyroiditis, supporting the statement that vitiligo is frequently associated with autoimmune disorders.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference discusses the association of vitiligo with chronic autoimmune thyroiditis, supporting the statement that vitiligo is frequently associated with autoimmune disorders."", ""reference"": ""PMID:34104234"", ""snippet"": ""The association with chronic thyroiditis is based on common autoimmune background and excessive reactive oxygen species that destroy melanocytes and thyrocytes (oxidative stress hypothesis)..."", ""supports"": ""SUPPORT""}"
8202	7794	338	Vitiligo	Vitiligo.yaml	phenotypes	2	evidence	1	PMID:35637045	SUPPORT	HUMAN_CLINICAL	Vitiligo and Graves' disease were also diagnosed in this cohort but affected few patients.	This reference indicates that vitiligo is associated with autoimmune disorders like Graves' disease and Hashimoto's disease, supporting the statement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference indicates that vitiligo is associated with autoimmune disorders like Graves' disease and Hashimoto's disease, supporting the statement."", ""reference"": ""PMID:35637045"", ""snippet"": ""Vitiligo and Graves' disease were also diagnosed in this cohort but affected few patients."", ""supports"": ""SUPPORT""}"
8203	7794	338	Vitiligo	Vitiligo.yaml	phenotypes	2	evidence	2	PMID:37405428	SUPPORT	HUMAN_CLINICAL	The most frequent autoimmune disorders in patients with vitiligo were type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus (SLE), autoimmune thyroiditis, Addison's disease, and systemic sclerosis (SSc).	This reference provides evidence that vitiligo is frequently associated with various autoimmune disorders, supporting the statement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference provides evidence that vitiligo is frequently associated with various autoimmune disorders, supporting the statement."", ""reference"": ""PMID:37405428"", ""snippet"": ""The most frequent autoimmune disorders in patients with vitiligo were type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus (SLE), autoimmune thyroiditis, Addison's disease, and systemic sclerosis (SSc)."", ""supports"": ""SUPPORT""}"
8204	7794	338	Vitiligo	Vitiligo.yaml	phenotypes	2	evidence	3	PMID:31580326	SUPPORT	HUMAN_CLINICAL	The spectrum includes, Hashimoto's thyroiditis, coeliac disease (CD), type 1 diabetes (T1DM), alopecia areata, inﬂammatory bowel disease, juvenile rheumatoid arthritis and some cutaneous disorders as vitiligo and Halo nevus	This reference supports the statement by listing vitiligo among other autoimmune disorders associated with Turner syndrome.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference supports the statement by listing vitiligo among other autoimmune disorders associated with Turner syndrome."", ""reference"": ""PMID:31580326"", ""snippet"": ""The spectrum includes, Hashimoto's thyroiditis, coeliac disease (CD), type 1 diabetes (T1DM), alopecia areata, inﬂammatory bowel disease, juvenile rheumatoid arthritis and some cutaneous disorders as vitiligo and Halo nevus"", ""supports"": ""SUPPORT""}"
8205	7794	338	Vitiligo	Vitiligo.yaml	phenotypes	2	evidence	4	PMID:16420246	SUPPORT	HUMAN_CLINICAL	Familial clustering of vitiligo is not uncommon, and patients and their relatives are at increased risk for a specific complex of other autoimmune diseases.	This reference indicates that vitiligo is associated with a higher risk of other autoimmune diseases, supporting the statement.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference indicates that vitiligo is associated with a higher risk of other autoimmune diseases, supporting the statement."", ""reference"": ""PMID:16420246"", ""snippet"": ""Familial clustering of vitiligo is not uncommon, and patients and their relatives are at increased risk for a specific complex of other autoimmune diseases."", ""supports"": ""SUPPORT""}"
8206	7795	338	Vitiligo	Vitiligo.yaml	phenotypes	3	evidence	0	PMID:37919864	PARTIAL	HUMAN_CLINICAL	Additionally, several small studies have found potential links to uveitis and glaucoma.	The literature mentions potential links between vitiligo and uveitis, but it does not provide a clear frequency of occurrence.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The literature mentions potential links between vitiligo and uveitis, but it does not provide a clear frequency of occurrence."", ""reference"": ""PMID:37919864"", ""snippet"": ""Additionally, several small studies have found potential links to uveitis and glaucoma."", ""supports"": ""PARTIAL""}"
8207	7795	338	Vitiligo	Vitiligo.yaml	phenotypes	3	evidence	1	PMID:30850197	NO_EVIDENCE	HUMAN_CLINICAL	Uveitis is by far the most common ocular manifestation of Behçet's disease	This reference discusses uveitis in the context of Behcet's disease, not vitiligo.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This reference discusses uveitis in the context of Behcet's disease, not vitiligo."", ""reference"": ""PMID:30850197"", ""snippet"": ""Uveitis is by far the most common ocular manifestation of Behçet's disease"", ""supports"": ""NO_EVIDENCE""}"
8208	7795	338	Vitiligo	Vitiligo.yaml	phenotypes	3	evidence	2	PMID:15609264	NO_EVIDENCE	OTHER	Uveitis is probably a misnomer unless antigens within the uvea are the direct targets of the inflammatory process.	This reference discusses uveitis in the context of autoimmune diseases generally, without specific mention of vitiligo.	"{""evidence_source"": ""OTHER"", ""explanation"": ""This reference discusses uveitis in the context of autoimmune diseases generally, without specific mention of vitiligo."", ""reference"": ""PMID:15609264"", ""snippet"": ""Uveitis is probably a misnomer unless antigens within the uvea are the direct targets of the inflammatory process."", ""supports"": ""NO_EVIDENCE""}"
8209	7796	338	Vitiligo	Vitiligo.yaml	phenotypes	4	evidence	0	PMID:32013982	PARTIAL	HUMAN_CLINICAL	Depression and Anxiety are common psychiatric disorders in vitiligo patients.	The study confirms that depression and anxiety are common in vitiligo patients, but does not specify that these occur occasionally. Instead, it suggests a higher prevalence.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study confirms that depression and anxiety are common in vitiligo patients, but does not specify that these occur occasionally. Instead, it suggests a higher prevalence."", ""reference"": ""PMID:32013982"", ""snippet"": ""Depression and Anxiety are common psychiatric disorders in vitiligo patients."", ""supports"": ""PARTIAL""}"
8210	7796	338	Vitiligo	Vitiligo.yaml	phenotypes	4	evidence	1	PMID:16405601	PARTIAL	OTHER	We review the psychosocial effects of vitiligo, how patients deal with them and the psychiatric morbidity in vitiligo patients.	The study acknowledges the psychosocial effects and psychiatric morbidity in vitiligo patients but does not specify the frequency as occasional.	"{""evidence_source"": ""OTHER"", ""explanation"": ""The study acknowledges the psychosocial effects and psychiatric morbidity in vitiligo patients but does not specify the frequency as occasional."", ""reference"": ""PMID:16405601"", ""snippet"": ""We review the psychosocial effects of vitiligo, how patients deal with them and the psychiatric morbidity in vitiligo patients."", ""supports"": ""PARTIAL""}"
8211	7796	338	Vitiligo	Vitiligo.yaml	phenotypes	4	evidence	2	PMID:37975615	PARTIAL	HUMAN_CLINICAL	Although a large number of existing studies have confirmed that people with vitiligo are prone to mental disorders...	This study indicates a susceptibility to mental disorders in vitiligo patients but does not specify the frequency as occasional.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study indicates a susceptibility to mental disorders in vitiligo patients but does not specify the frequency as occasional."", ""reference"": ""PMID:37975615"", ""snippet"": ""Although a large number of existing studies have confirmed that people with vitiligo are prone to mental disorders..."", ""supports"": ""PARTIAL""}"
8212	7796	338	Vitiligo	Vitiligo.yaml	phenotypes	4	evidence	3	PMID:32064670	PARTIAL	HUMAN_CLINICAL	The most important finding of this study is that anxiety disorders are more prominent than depression in childhood vitiligo.	This study highlights the prominence of anxiety disorders and depression in children with vitiligo but does not specify the frequency as occasional.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""This study highlights the prominence of anxiety disorders and depression in children with vitiligo but does not specify the frequency as occasional."", ""reference"": ""PMID:32064670"", ""snippet"": ""The most important finding of this study is that anxiety disorders are more prominent than depression in childhood vitiligo."", ""supports"": ""PARTIAL""}"
8241	7817	339	Von Hippel-Lindau Disease	Von_Hippel-Lindau_Disease.yaml	phenotypes	0	evidence	0	PMID:34818478	SUPPORT		Patients with von Hippel-Lindau (VHL) disease have a high incidence of renal cell carcinoma owing to VHL gene inactivation and constitutive activation of the transcription factor hypoxia-inducible factor 2α (HIF-2α).	Confirms high incidence of RCC in VHL disease due to VHL gene inactivation and constitutive HIF-2α activation.	"{""explanation"": ""Confirms high incidence of RCC in VHL disease due to VHL gene inactivation and constitutive HIF-2α activation."", ""reference"": ""PMID:34818478"", ""snippet"": ""Patients with von Hippel-Lindau (VHL) disease have a high incidence of renal cell carcinoma owing to VHL gene inactivation and constitutive activation of the transcription factor hypoxia-inducible factor 2α (HIF-2α)."", ""supports"": ""SUPPORT""}"
8260	7838	340	Whipple Disease	Whipple_Disease.yaml	phenotypes	0	evidence	0	PMID:26288590	SUPPORT		Prior to patients reporting symptoms of a malabsorption syndrome (chronic diarrhea/steatorhea, weight loss), they often suffer from non-specific symptoms.	Review lists chronic diarrhea as hallmark of Whipple disease malabsorption.	"{""explanation"": ""Review lists chronic diarrhea as hallmark of Whipple disease malabsorption."", ""reference"": ""PMID:26288590"", ""snippet"": ""Prior to patients reporting symptoms of a malabsorption syndrome (chronic diarrhea/steatorhea, weight loss), they often suffer from non-specific symptoms."", ""supports"": ""SUPPORT""}"
8261	7839	340	Whipple Disease	Whipple_Disease.yaml	phenotypes	1	evidence	0	PMID:26288590	SUPPORT		Prior to patients reporting symptoms of a malabsorption syndrome (chronic diarrhea/steatorhea, weight loss), they often suffer from non-specific symptoms.	Same review notes steatorrhea as part of the malabsorption syndrome.	"{""explanation"": ""Same review notes steatorrhea as part of the malabsorption syndrome."", ""reference"": ""PMID:26288590"", ""snippet"": ""Prior to patients reporting symptoms of a malabsorption syndrome (chronic diarrhea/steatorhea, weight loss), they often suffer from non-specific symptoms."", ""supports"": ""SUPPORT""}"
8262	7840	340	Whipple Disease	Whipple_Disease.yaml	phenotypes	2	evidence	0	PMID:26288590	SUPPORT		The weight loss is on average 11 kg (range: 3-36 kg).	Quantifies typical weight loss in Whipple disease.	"{""explanation"": ""Quantifies typical weight loss in Whipple disease."", ""reference"": ""PMID:26288590"", ""snippet"": ""The weight loss is on average 11 kg (range: 3-36 kg)."", ""supports"": ""SUPPORT""}"
8263	7841	340	Whipple Disease	Whipple_Disease.yaml	phenotypes	3	evidence	0	PMID:26288590	SUPPORT		Patients report a migrating polyarthritis of the peripheral joints (ankles, shoulders, knees, wrists, hands) and of the axial system.	Describes typical migratory joint involvement.	"{""explanation"": ""Describes typical migratory joint involvement."", ""reference"": ""PMID:26288590"", ""snippet"": ""Patients report a migrating polyarthritis of the peripheral joints (ankles, shoulders, knees, wrists, hands) and of the axial system."", ""supports"": ""SUPPORT""}"
8264	7841	340	Whipple Disease	Whipple_Disease.yaml	phenotypes	3	evidence	1	PMID:40204565	SUPPORT		Joint involvement was similar, with initial episodic migratory arthritis (91 %) predominantly affecting large joints and lasting 2-7 days.	Cohort of isolated articular Whipple disease shows stereotyped migratory arthritis pattern.	"{""explanation"": ""Cohort of isolated articular Whipple disease shows stereotyped migratory arthritis pattern."", ""reference"": ""PMID:40204565"", ""snippet"": ""Joint involvement was similar, with initial episodic migratory arthritis (91 %) predominantly affecting large joints and lasting 2-7 days."", ""supports"": ""SUPPORT""}"
8265	7842	340	Whipple Disease	Whipple_Disease.yaml	phenotypes	4	evidence	0	PMID:26288590	SUPPORT		Patients complain of headaches, cognitive dysfunctions, and eye motility disorders.	Review notes cognitive dysfunction among neurological features of Whipple disease.	"{""explanation"": ""Review notes cognitive dysfunction among neurological features of Whipple disease."", ""reference"": ""PMID:26288590"", ""snippet"": ""Patients complain of headaches, cognitive dysfunctions, and eye motility disorders."", ""supports"": ""SUPPORT""}"
8266	7843	340	Whipple Disease	Whipple_Disease.yaml	phenotypes	5	evidence	0	PMID:26288590	SUPPORT		Prior to patients reporting symptoms of a malabsorption syndrome (chronic diarrhea/steatorhea, weight loss), they often suffer from non-specific symptoms (polyarthralgia, fever, fatigue).	Notes fever among early systemic symptoms.	"{""explanation"": ""Notes fever among early systemic symptoms."", ""reference"": ""PMID:26288590"", ""snippet"": ""Prior to patients reporting symptoms of a malabsorption syndrome (chronic diarrhea/steatorhea, weight loss), they often suffer from non-specific symptoms (polyarthralgia, fever, fatigue)."", ""supports"": ""SUPPORT""}"
8267	7844	340	Whipple Disease	Whipple_Disease.yaml	phenotypes	6	evidence	0	PMID:26288590	SUPPORT		The clinical symptoms of WD include chronic diarrhea, malnutrition (weight loss), migratory polyarthralgia, abdominal pain, and/or enlarged lymph nodes.	Review lists abdominal pain among common clinical symptoms.	"{""explanation"": ""Review lists abdominal pain among common clinical symptoms."", ""reference"": ""PMID:26288590"", ""snippet"": ""The clinical symptoms of WD include chronic diarrhea, malnutrition (weight loss), migratory polyarthralgia, abdominal pain, and/or enlarged lymph nodes."", ""supports"": ""SUPPORT""}"
8268	7845	340	Whipple Disease	Whipple_Disease.yaml	phenotypes	7	evidence	0	PMID:26288590	SUPPORT		The clinical symptoms of WD include chronic diarrhea, malnutrition (weight loss), migratory polyarthralgia, abdominal pain, and/or enlarged lymph nodes.	Review notes lymphadenopathy as part of the systemic presentation.	"{""explanation"": ""Review notes lymphadenopathy as part of the systemic presentation."", ""reference"": ""PMID:26288590"", ""snippet"": ""The clinical symptoms of WD include chronic diarrhea, malnutrition (weight loss), migratory polyarthralgia, abdominal pain, and/or enlarged lymph nodes."", ""supports"": ""SUPPORT""}"
8269	7845	340	Whipple Disease	Whipple_Disease.yaml	phenotypes	7	evidence	1	PMID:40398847	SUPPORT		A supraclavicular lymph node excisional biopsy revealed complete architectural effacement by a diffuse foamy histiocytic infiltrate without granuloma formation or necrosis.	Case report shows lymph node involvement with foamy macrophages due to Whipple disease.	"{""explanation"": ""Case report shows lymph node involvement with foamy macrophages due to Whipple disease."", ""reference"": ""PMID:40398847"", ""snippet"": ""A supraclavicular lymph node excisional biopsy revealed complete architectural effacement by a diffuse foamy histiocytic infiltrate without granuloma formation or necrosis."", ""supports"": ""SUPPORT""}"
8270	7846	340	Whipple Disease	Whipple_Disease.yaml	phenotypes	8	evidence	0	PMID:38414785	SUPPORT		Whipple's disease (WD) is a multiple-system chronic disease caused by Tropheryma whipplei (T. whipplei) infection. The present study describes 3 cases of WD with clinical manifestations of cough, chest pain, headache, dyspnea, sputum, joint pain, abdominal pain, diarrhea and weight loss.	Case series documents pulmonary symptoms including dyspnea and chest pain.	"{""explanation"": ""Case series documents pulmonary symptoms including dyspnea and chest pain."", ""reference"": ""PMID:38414785"", ""snippet"": ""Whipple's disease (WD) is a multiple-system chronic disease caused by Tropheryma whipplei (T. whipplei) infection. The present study describes 3 cases of WD with clinical manifestations of cough, chest pain, headache, dyspnea, sputum, joint pain, abdominal pain, diarrhea and weight loss."", ""supports"": ""SUPPORT""}"
8271	7846	340	Whipple Disease	Whipple_Disease.yaml	phenotypes	8	evidence	1	PMID:38414785	SUPPORT		Chest computed tomography (CT) showed signs of plaques, nodules and pleural thickening; and bronchoscopic alveolar lavage fluid metagenomic-sequencing indicated that it was T. whipplei.	Imaging and BAL sequencing confirm pulmonary involvement due to T. whipplei.	"{""explanation"": ""Imaging and BAL sequencing confirm pulmonary involvement due to T. whipplei."", ""reference"": ""PMID:38414785"", ""snippet"": ""Chest computed tomography (CT) showed signs of plaques, nodules and pleural thickening; and bronchoscopic alveolar lavage fluid metagenomic-sequencing indicated that it was T. whipplei."", ""supports"": ""SUPPORT""}"
8272	7847	340	Whipple Disease	Whipple_Disease.yaml	phenotypes	9	evidence	0	PMID:38525769	SUPPORT		We describe an atypical case of Whipple disease exclusively involving the spinal cord in an adolescent receiving immunosuppressive therapy for systemic lupus erythematosus.	Case report highlights spinal cord involvement as a presentation of Whipple disease.	"{""explanation"": ""Case report highlights spinal cord involvement as a presentation of Whipple disease."", ""reference"": ""PMID:38525769"", ""snippet"": ""We describe an atypical case of Whipple disease exclusively involving the spinal cord in an adolescent receiving immunosuppressive therapy for systemic lupus erythematosus."", ""supports"": ""SUPPORT""}"
8302	7884	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	0	evidence	0	PMID:38731973	SUPPORT		Copper accumulation in the liver is due to impaired biliary excretion of copper caused by the inheritable malfunctioning or missing ATP7B protein.	Hepatic copper accumulation leads to hepatomegaly as an early manifestation of liver involvement.	"{""explanation"": ""Hepatic copper accumulation leads to hepatomegaly as an early manifestation of liver involvement."", ""reference"": ""PMID:38731973"", ""snippet"": ""Copper accumulation in the liver is due to impaired biliary excretion of copper caused by the inheritable malfunctioning or missing ATP7B protein."", ""supports"": ""SUPPORT""}"
8303	7885	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	1	evidence	0	PMID:38731973	SUPPORT		Liver transplantation is an option viewed as ultima ratio in end-stage liver disease with untreatable complications or acute liver failure.	End-stage liver disease including cirrhosis is a major complication requiring transplantation.	"{""explanation"": ""End-stage liver disease including cirrhosis is a major complication requiring transplantation."", ""reference"": ""PMID:38731973"", ""snippet"": ""Liver transplantation is an option viewed as ultima ratio in end-stage liver disease with untreatable complications or acute liver failure."", ""supports"": ""SUPPORT""}"
8304	7886	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	2	evidence	0	PMID:38731973	SUPPORT		copper injures not only the liver, but also the brain, kidneys, eyes, heart, muscles, and bones, explaining the multifaceted clinical features of Wilson disease. Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia, renal tubular dysfunction, Kayser-Fleischer corneal rings	Confirms Kayser-Fleischer rings as a key clinical feature of Wilson's disease due to copper deposition in the eyes.	"{""explanation"": ""Confirms Kayser-Fleischer rings as a key clinical feature of Wilson's disease due to copper deposition in the eyes."", ""reference"": ""PMID:38731973"", ""snippet"": ""copper injures not only the liver, but also the brain, kidneys, eyes, heart, muscles, and bones, explaining the multifaceted clinical features of Wilson disease. Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia, renal tubular dysfunction, Kayser-Fleischer corneal rings"", ""supports"": ""SUPPORT""}"
8305	7887	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	3	evidence	0	PMID:38731973	SUPPORT		copper injures not only the liver, but also the brain, kidneys, eyes, heart, muscles, and bones, explaining the multifaceted clinical features of Wilson disease. Among these are depression, psychosis, dysarthria, ataxia	Neurological manifestations including movement disorders result from brain copper deposition.	"{""explanation"": ""Neurological manifestations including movement disorders result from brain copper deposition."", ""reference"": ""PMID:38731973"", ""snippet"": ""copper injures not only the liver, but also the brain, kidneys, eyes, heart, muscles, and bones, explaining the multifaceted clinical features of Wilson disease. Among these are depression, psychosis, dysarthria, ataxia"", ""supports"": ""SUPPORT""}"
8306	7888	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	4	evidence	0	PMID:38731973	SUPPORT		Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia	Dysarthria is explicitly listed as a neurological manifestation of Wilson disease.	"{""explanation"": ""Dysarthria is explicitly listed as a neurological manifestation of Wilson disease."", ""reference"": ""PMID:38731973"", ""snippet"": ""Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia"", ""supports"": ""SUPPORT""}"
8307	7889	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	5	evidence	0	PMID:38731973	SUPPORT		copper injures not only the liver, but also the brain	Brain copper accumulation causes movement disorders including dystonia.	"{""explanation"": ""Brain copper accumulation causes movement disorders including dystonia."", ""reference"": ""PMID:38731973"", ""snippet"": ""copper injures not only the liver, but also the brain"", ""supports"": ""SUPPORT""}"
8308	7890	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	6	evidence	0	PMID:38731973	SUPPORT		Among these are depression, psychosis, dysarthria, ataxia, writing problems	Depression and psychosis are explicitly listed as neuropsychiatric manifestations of Wilson disease.	"{""explanation"": ""Depression and psychosis are explicitly listed as neuropsychiatric manifestations of Wilson disease."", ""reference"": ""PMID:38731973"", ""snippet"": ""Among these are depression, psychosis, dysarthria, ataxia, writing problems"", ""supports"": ""SUPPORT""}"
8309	7891	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	7	evidence	0	PMID:38731973	SUPPORT		Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia	Ataxia is explicitly listed as a neurological manifestation of Wilson disease.	"{""explanation"": ""Ataxia is explicitly listed as a neurological manifestation of Wilson disease."", ""reference"": ""PMID:38731973"", ""snippet"": ""Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia"", ""supports"": ""SUPPORT""}"
8310	7892	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	8	evidence	0	PMID:38731973	SUPPORT		copper injures not only the liver, but also the brain	Basal ganglia copper deposition leads to parkinsonian features in Wilson disease.	"{""explanation"": ""Basal ganglia copper deposition leads to parkinsonian features in Wilson disease."", ""reference"": ""PMID:38731973"", ""snippet"": ""copper injures not only the liver, but also the brain"", ""supports"": ""SUPPORT""}"
8311	7893	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	9	evidence	0	PMID:38731973	SUPPORT		Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia	Dysphagia is explicitly listed as a neurological manifestation of Wilson disease.	"{""explanation"": ""Dysphagia is explicitly listed as a neurological manifestation of Wilson disease."", ""reference"": ""PMID:38731973"", ""snippet"": ""Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia"", ""supports"": ""SUPPORT""}"
8312	7894	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	10	evidence	0	PMID:38731973	SUPPORT		This explains why copper injures not only the liver, but also the brain, kidneys, eyes, heart, muscles, and bones, explaining the multifaceted clinical features of Wilson disease. Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia, renal tubular dysfunction, Kayser-Fleischer corneal rings, cardiomyopathy, cardiac arrhythmias	Cardiomyopathy is explicitly listed as a cardiac manifestation of Wilson disease due to copper deposition.	"{""explanation"": ""Cardiomyopathy is explicitly listed as a cardiac manifestation of Wilson disease due to copper deposition."", ""reference"": ""PMID:38731973"", ""snippet"": ""This explains why copper injures not only the liver, but also the brain, kidneys, eyes, heart, muscles, and bones, explaining the multifaceted clinical features of Wilson disease. Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia, renal tubular dysfunction, Kayser-Fleischer corneal rings, cardiomyopathy, cardiac arrhythmias"", ""supports"": ""SUPPORT""}"
8313	7895	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	11	evidence	0	PMID:38731973	SUPPORT		This explains why copper injures not only the liver, but also the brain, kidneys, eyes, heart, muscles, and bones, explaining the multifaceted clinical features of Wilson disease. Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia, renal tubular dysfunction	Renal tubular dysfunction is explicitly listed as a renal manifestation of Wilson disease.	"{""explanation"": ""Renal tubular dysfunction is explicitly listed as a renal manifestation of Wilson disease."", ""reference"": ""PMID:38731973"", ""snippet"": ""This explains why copper injures not only the liver, but also the brain, kidneys, eyes, heart, muscles, and bones, explaining the multifaceted clinical features of Wilson disease. Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia, renal tubular dysfunction"", ""supports"": ""SUPPORT""}"
8314	7896	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	12	evidence	0	PMID:38731973	SUPPORT		In addition, Coombs-negative hemolytic anemia is a key feature of Wilson disease with undetectable serum haptoglobin	Coombs-negative hemolytic anemia is described as a key feature of Wilson disease.	"{""explanation"": ""Coombs-negative hemolytic anemia is described as a key feature of Wilson disease."", ""reference"": ""PMID:38731973"", ""snippet"": ""In addition, Coombs-negative hemolytic anemia is a key feature of Wilson disease with undetectable serum haptoglobin"", ""supports"": ""SUPPORT""}"
8315	7897	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	13	evidence	0	PMID:38731973	SUPPORT		This explains why copper injures not only the liver, but also the brain, kidneys, eyes, heart, muscles, and bones, explaining the multifaceted clinical features of Wilson disease. Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia, renal tubular dysfunction, Kayser-Fleischer corneal rings, cardiomyopathy, cardiac arrhythmias, rhabdomyolysis, osteoporosis	Osteoporosis is explicitly listed as a skeletal manifestation of Wilson disease.	"{""explanation"": ""Osteoporosis is explicitly listed as a skeletal manifestation of Wilson disease."", ""reference"": ""PMID:38731973"", ""snippet"": ""This explains why copper injures not only the liver, but also the brain, kidneys, eyes, heart, muscles, and bones, explaining the multifaceted clinical features of Wilson disease. Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia, renal tubular dysfunction, Kayser-Fleischer corneal rings, cardiomyopathy, cardiac arrhythmias, rhabdomyolysis, osteoporosis"", ""supports"": ""SUPPORT""}"
8316	7898	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	14	evidence	0	PMID:38731973	SUPPORT		osteoporosis, osteomalacia, arthritis, and arthralgia	Arthritis is listed as a musculoskeletal manifestation of Wilson disease.	"{""explanation"": ""Arthritis is listed as a musculoskeletal manifestation of Wilson disease."", ""reference"": ""PMID:38731973"", ""snippet"": ""osteoporosis, osteomalacia, arthritis, and arthralgia"", ""supports"": ""SUPPORT""}"
8317	7899	342	Wilson Disease	Wilsons_Disease.yaml	phenotypes	15	evidence	0	PMID:38731973	SUPPORT		Copper accumulation in the liver is due to impaired biliary excretion of copper caused by the inheritable malfunctioning or missing ATP7B protein	Hepatic copper accumulation leads to hepatocellular injury presenting as hepatitis.	"{""explanation"": ""Hepatic copper accumulation leads to hepatocellular injury presenting as hepatitis."", ""reference"": ""PMID:38731973"", ""snippet"": ""Copper accumulation in the liver is due to impaired biliary excretion of copper caused by the inheritable malfunctioning or missing ATP7B protein"", ""supports"": ""SUPPORT""}"
8333	7913	343	Wissler syndrome	Wissler_syndrome.yaml	phenotypes	0	evidence	0	PMID:8150635	SUPPORT		This rare disease is characterized by four typical symptoms: polymorphous exanthemas, recurrent high fever, leucocytosis and arthralgia.	The abstract lists recurrent high fever as a typical symptom of Wissler-Fanconi syndrome.	"{""explanation"": ""The abstract lists recurrent high fever as a typical symptom of Wissler-Fanconi syndrome."", ""reference"": ""PMID:8150635"", ""snippet"": ""This rare disease is characterized by four typical symptoms: polymorphous exanthemas, recurrent high fever, leucocytosis and arthralgia."", ""supports"": ""SUPPORT""}"
8334	7914	343	Wissler syndrome	Wissler_syndrome.yaml	phenotypes	1	evidence	0	PMID:8150635	SUPPORT		This rare disease is characterized by four typical symptoms: polymorphous exanthemas, recurrent high fever, leucocytosis and arthralgia.	The abstract lists polymorphous exanthemas as a typical symptom of Wissler-Fanconi syndrome.	"{""explanation"": ""The abstract lists polymorphous exanthemas as a typical symptom of Wissler-Fanconi syndrome."", ""reference"": ""PMID:8150635"", ""snippet"": ""This rare disease is characterized by four typical symptoms: polymorphous exanthemas, recurrent high fever, leucocytosis and arthralgia."", ""supports"": ""SUPPORT""}"
8335	7915	343	Wissler syndrome	Wissler_syndrome.yaml	phenotypes	2	evidence	0	PMID:8150635	SUPPORT		This rare disease is characterized by four typical symptoms: polymorphous exanthemas, recurrent high fever, leucocytosis and arthralgia.	The abstract lists arthralgia as a typical symptom of Wissler-Fanconi syndrome.	"{""explanation"": ""The abstract lists arthralgia as a typical symptom of Wissler-Fanconi syndrome."", ""reference"": ""PMID:8150635"", ""snippet"": ""This rare disease is characterized by four typical symptoms: polymorphous exanthemas, recurrent high fever, leucocytosis and arthralgia."", ""supports"": ""SUPPORT""}"
8336	7916	343	Wissler syndrome	Wissler_syndrome.yaml	phenotypes	3	evidence	0	PMID:8150635	SUPPORT		This rare disease is characterized by four typical symptoms: polymorphous exanthemas, recurrent high fever, leucocytosis and arthralgia.	The abstract lists leukocytosis as a typical symptom of Wissler-Fanconi syndrome.	"{""explanation"": ""The abstract lists leukocytosis as a typical symptom of Wissler-Fanconi syndrome."", ""reference"": ""PMID:8150635"", ""snippet"": ""This rare disease is characterized by four typical symptoms: polymorphous exanthemas, recurrent high fever, leucocytosis and arthralgia."", ""supports"": ""SUPPORT""}"
8337	7917	343	Wissler syndrome	Wissler_syndrome.yaml	phenotypes	4	evidence	0	PMID:3572917	SUPPORT		We describe a case of persistent microscopic hematuria as initial finding in incomplete Still's disease or Wissler-Fanconi syndrome.	The case report documents microscopic hematuria as a presenting sign.	"{""explanation"": ""The case report documents microscopic hematuria as a presenting sign."", ""reference"": ""PMID:3572917"", ""snippet"": ""We describe a case of persistent microscopic hematuria as initial finding in incomplete Still's disease or Wissler-Fanconi syndrome."", ""supports"": ""SUPPORT""}"
8338	7918	343	Wissler syndrome	Wissler_syndrome.yaml	phenotypes	5	evidence	0	PMID:27843372	SUPPORT		A middle-aged female presented to the emergency department with shortness of breath and chest pain associated with fever, polyarthritis, and had a chronic polymorphic rash on the back and lower extremities.	The case report documents polyarthritis as part of the clinical presentation.	"{""explanation"": ""The case report documents polyarthritis as part of the clinical presentation."", ""reference"": ""PMID:27843372"", ""snippet"": ""A middle-aged female presented to the emergency department with shortness of breath and chest pain associated with fever, polyarthritis, and had a chronic polymorphic rash on the back and lower extremities."", ""supports"": ""SUPPORT""}"
8339	7919	343	Wissler syndrome	Wissler_syndrome.yaml	phenotypes	6	evidence	0	PMID:3092775	SUPPORT		The long-term evolution is marked by recurrent febrile exacerbations, sometimes complicated by pericardo-myocarditis which usually resolves without sequellae.	The abstract notes pericardo-myocarditis as a complication during the course of disease.	"{""explanation"": ""The abstract notes pericardo-myocarditis as a complication during the course of disease."", ""reference"": ""PMID:3092775"", ""snippet"": ""The long-term evolution is marked by recurrent febrile exacerbations, sometimes complicated by pericardo-myocarditis which usually resolves without sequellae."", ""supports"": ""SUPPORT""}"
8340	7920	343	Wissler syndrome	Wissler_syndrome.yaml	phenotypes	7	evidence	0	PMID:3092775	SUPPORT		The long-term evolution is marked by recurrent febrile exacerbations, sometimes complicated by pericardo-myocarditis which usually resolves without sequellae.	The abstract reports pericardo-myocarditis as a complication of Wissler-Fanconi syndrome.	"{""explanation"": ""The abstract reports pericardo-myocarditis as a complication of Wissler-Fanconi syndrome."", ""reference"": ""PMID:3092775"", ""snippet"": ""The long-term evolution is marked by recurrent febrile exacerbations, sometimes complicated by pericardo-myocarditis which usually resolves without sequellae."", ""supports"": ""SUPPORT""}"
8341	7921	343	Wissler syndrome	Wissler_syndrome.yaml	phenotypes	8	evidence	0	PMID:3092775	SUPPORT		The authors report a case with chronic pericardo-myocarditis progressing over a 7 year period to refractory congestive cardiac failure.	The case report documents progression to refractory congestive heart failure.	"{""explanation"": ""The case report documents progression to refractory congestive heart failure."", ""reference"": ""PMID:3092775"", ""snippet"": ""The authors report a case with chronic pericardo-myocarditis progressing over a 7 year period to refractory congestive cardiac failure."", ""supports"": ""SUPPORT""}"
8354	7930	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	0	evidence	0	PMID:25137600	SUPPORT		"The major features of this disorder include a characteristic facial appearance known as the ""Greek helmet,"" delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."	This establishes the characteristic Greek helmet facial appearance as a major diagnostic feature.	"{""explanation"": ""This establishes the characteristic Greek helmet facial appearance as a major diagnostic feature."", ""reference"": ""PMID:25137600"", ""snippet"": ""The major features of this disorder include a characteristic facial appearance known as the \""Greek helmet,\"" delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."", ""supports"": ""SUPPORT""}"
8355	7930	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	0	evidence	1	PMID:32914558	SUPPORT		Its core features are typical facial gestalt, growth retardation, intellectual disability, or developmental delay and seizures.	This identifies the typical facial gestalt as one of the core features of Wolf-Hirschhorn syndrome.	"{""explanation"": ""This identifies the typical facial gestalt as one of the core features of Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:32914558"", ""snippet"": ""Its core features are typical facial gestalt, growth retardation, intellectual disability, or developmental delay and seizures."", ""supports"": ""SUPPORT""}"
8356	7931	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	1	evidence	0	PMID:18474167	SUPPORT		It was characterized by well-described facial appearance, seizures, microcephaly and midline closure defects along with growth and mental retardation.	This establishes microcephaly as a characteristic feature of Wolf-Hirschhorn syndrome.	"{""explanation"": ""This establishes microcephaly as a characteristic feature of Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:18474167"", ""snippet"": ""It was characterized by well-described facial appearance, seizures, microcephaly and midline closure defects along with growth and mental retardation."", ""supports"": ""SUPPORT""}"
8357	7932	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	2	evidence	0	PMID:9774859	SUPPORT		At the autopsy, the propositus showed microcephaly, prominent glabella, broad bridge of the nose, ocular hypertelorism, poorly differentiated and low-set ears, bilateral palatoschisis, and micrognathia.	This case report confirms ocular hypertelorism as a characteristic craniofacial feature of Wolf-Hirschhorn syndrome.	"{""explanation"": ""This case report confirms ocular hypertelorism as a characteristic craniofacial feature of Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:9774859"", ""snippet"": ""At the autopsy, the propositus showed microcephaly, prominent glabella, broad bridge of the nose, ocular hypertelorism, poorly differentiated and low-set ears, bilateral palatoschisis, and micrognathia."", ""supports"": ""SUPPORT""}"
8358	7932	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	2	evidence	1	PMID:29199884	SUPPORT		Ocular findings included normal intraocular pressures and corneal diameters, large-angle exotropia, downward slanting of the palpebral fissures, absent eyelid creases, upper and lower eyelid retraction with shortage of the anterior eyelid lamellae, euryblepharon, lagophthalmos with poor Bell's reflex and exposure keratopathy, hypertelorism, Axenfeld's anomaly, megalopapillae, and cavitary optic disc anomaly.	This documents hypertelorism as one of the ocular findings in Wolf-Hirschhorn syndrome.	"{""explanation"": ""This documents hypertelorism as one of the ocular findings in Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:29199884"", ""snippet"": ""Ocular findings included normal intraocular pressures and corneal diameters, large-angle exotropia, downward slanting of the palpebral fissures, absent eyelid creases, upper and lower eyelid retraction with shortage of the anterior eyelid lamellae, euryblepharon, lagophthalmos with poor Bell's reflex and exposure keratopathy, hypertelorism, Axenfeld's anomaly, megalopapillae, and cavitary optic disc anomaly."", ""supports"": ""SUPPORT""}"
8359	7933	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	3	evidence	0	PMID:25137600	SUPPORT		"The major features of this disorder include a characteristic facial appearance known as the ""Greek helmet,"" delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."	This describes delayed growth and development both prenatally and postnatally as major features.	"{""explanation"": ""This describes delayed growth and development both prenatally and postnatally as major features."", ""reference"": ""PMID:25137600"", ""snippet"": ""The major features of this disorder include a characteristic facial appearance known as the \""Greek helmet,\"" delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."", ""supports"": ""SUPPORT""}"
8360	7934	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	4	evidence	0	PMID:30289612	SUPPORT		Wolf-Hirschhorn syndrome (WHS) is a rare contiguous gene deletion disorder characterized by distinctive craniofacial features, prenatal/postnatal growth deficiency, intellectual disability, and seizures.	This establishes prenatal/postnatal growth deficiency as a characteristic feature of Wolf-Hirschhorn syndrome.	"{""explanation"": ""This establishes prenatal/postnatal growth deficiency as a characteristic feature of Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:30289612"", ""snippet"": ""Wolf-Hirschhorn syndrome (WHS) is a rare contiguous gene deletion disorder characterized by distinctive craniofacial features, prenatal/postnatal growth deficiency, intellectual disability, and seizures."", ""supports"": ""SUPPORT""}"
8361	7935	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	5	evidence	0	PMID:32914558	SUPPORT		Its core features are typical facial gestalt, growth retardation, intellectual disability, or developmental delay and seizures.	This identifies intellectual disability as one of the core features of Wolf-Hirschhorn syndrome.	"{""explanation"": ""This identifies intellectual disability as one of the core features of Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:32914558"", ""snippet"": ""Its core features are typical facial gestalt, growth retardation, intellectual disability, or developmental delay and seizures."", ""supports"": ""SUPPORT""}"
8362	7935	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	5	evidence	1	PMID:25137600	SUPPORT		"The major features of this disorder include a characteristic facial appearance known as the ""Greek helmet,"" delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."	This establishes intellectual disabilities as a major feature of the disorder.	"{""explanation"": ""This establishes intellectual disabilities as a major feature of the disorder."", ""reference"": ""PMID:25137600"", ""snippet"": ""The major features of this disorder include a characteristic facial appearance known as the \""Greek helmet,\"" delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."", ""supports"": ""SUPPORT""}"
8363	7935	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	5	evidence	2	PMID:18474167	SUPPORT		It was characterized by well-described facial appearance, seizures, microcephaly and midline closure defects along with growth and mental retardation.	This confirms mental retardation (intellectual disability) as a characteristic feature.	"{""explanation"": ""This confirms mental retardation (intellectual disability) as a characteristic feature."", ""reference"": ""PMID:18474167"", ""snippet"": ""It was characterized by well-described facial appearance, seizures, microcephaly and midline closure defects along with growth and mental retardation."", ""supports"": ""SUPPORT""}"
8364	7936	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	6	evidence	0	PMID:29199884	SUPPORT		"Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a ""Greek warrior helmet"" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal anomalies, cardiac defects, abnormal tooth development, and hearing loss."	This identifies developmental delay as one of the characteristic features of Wolf-Hirschhorn syndrome.	"{""explanation"": ""This identifies developmental delay as one of the characteristic features of Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:29199884"", ""snippet"": ""Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a \""Greek warrior helmet\"" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal anomalies, cardiac defects, abnormal tooth development, and hearing loss."", ""supports"": ""SUPPORT""}"
8365	7936	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	6	evidence	1	PMID:40404199	SUPPORT		Wolf-Hirschhorn syndrome (WHS) is associated with intellectual disability and multiple congenital anomalies.	This confirms the association of Wolf-Hirschhorn syndrome with intellectual disability and developmental impairment.	"{""explanation"": ""This confirms the association of Wolf-Hirschhorn syndrome with intellectual disability and developmental impairment."", ""reference"": ""PMID:40404199"", ""snippet"": ""Wolf-Hirschhorn syndrome (WHS) is associated with intellectual disability and multiple congenital anomalies."", ""supports"": ""SUPPORT""}"
8366	7937	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	7	evidence	0	PMID:32914558	SUPPORT		Its core features are typical facial gestalt, growth retardation, intellectual disability, or developmental delay and seizures.	This identifies seizures as one of the core features of Wolf-Hirschhorn syndrome.	"{""explanation"": ""This identifies seizures as one of the core features of Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:32914558"", ""snippet"": ""Its core features are typical facial gestalt, growth retardation, intellectual disability, or developmental delay and seizures."", ""supports"": ""SUPPORT""}"
8367	7937	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	7	evidence	1	PMID:25137600	SUPPORT		"The major features of this disorder include a characteristic facial appearance known as the ""Greek helmet,"" delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."	This establishes seizures as a major feature of the disorder.	"{""explanation"": ""This establishes seizures as a major feature of the disorder."", ""reference"": ""PMID:25137600"", ""snippet"": ""The major features of this disorder include a characteristic facial appearance known as the \""Greek helmet,\"" delayed growth and development; prenatally and postnatally, intellectual disabilities, and seizures."", ""supports"": ""SUPPORT""}"
8368	7937	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	7	evidence	2	PMID:18474167	SUPPORT		It was characterized by well-described facial appearance, seizures, microcephaly and midline closure defects along with growth and mental retardation.	This confirms seizures as a characteristic feature of Wolf-Hirschhorn syndrome.	"{""explanation"": ""This confirms seizures as a characteristic feature of Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:18474167"", ""snippet"": ""It was characterized by well-described facial appearance, seizures, microcephaly and midline closure defects along with growth and mental retardation."", ""supports"": ""SUPPORT""}"
8369	7938	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	8	evidence	0	PMID:29199884	SUPPORT		"Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a ""Greek warrior helmet"" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal anomalies, cardiac defects, abnormal tooth development, and hearing loss."	This establishes hypotonia as one of the characteristic features of Wolf-Hirschhorn syndrome.	"{""explanation"": ""This establishes hypotonia as one of the characteristic features of Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:29199884"", ""snippet"": ""Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a \""Greek warrior helmet\"" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal anomalies, cardiac defects, abnormal tooth development, and hearing loss."", ""supports"": ""SUPPORT""}"
8370	7939	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	9	evidence	0	PMID:29199884	SUPPORT		"Systemic findings included ""Greek warrior helmet"" facies, hypotonia, cleft palate, neonatal tooth eruption, talipes equinovarus, bilateral clinodactyly, clitoromegaly, partial agenesis of the corpus callosum, bilateral renal hypoplasia, and two atrial septal defects."	This case report documents partial agenesis of the corpus callosum as a structural CNS abnormality in Wolf-Hirschhorn syndrome.	"{""explanation"": ""This case report documents partial agenesis of the corpus callosum as a structural CNS abnormality in Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:29199884"", ""snippet"": ""Systemic findings included \""Greek warrior helmet\"" facies, hypotonia, cleft palate, neonatal tooth eruption, talipes equinovarus, bilateral clinodactyly, clitoromegaly, partial agenesis of the corpus callosum, bilateral renal hypoplasia, and two atrial septal defects."", ""supports"": ""SUPPORT""}"
8371	7939	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	9	evidence	1	PMID:34572183	SUPPORT		In some cases, we observed seizures, structural brain abnormalities, immunodeficiencies, and renal anomalies.	This study identifies structural brain abnormalities as a manifestation in some cases of Wolf-Hirschhorn syndrome.	"{""explanation"": ""This study identifies structural brain abnormalities as a manifestation in some cases of Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:34572183"", ""snippet"": ""In some cases, we observed seizures, structural brain abnormalities, immunodeficiencies, and renal anomalies."", ""supports"": ""SUPPORT""}"
8372	7940	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	10	evidence	0	PMID:29199884	SUPPORT		"Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a ""Greek warrior helmet"" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal anomalies, cardiac defects, abnormal tooth development, and hearing loss."	This identifies cardiac defects as one of the characteristic features of Wolf-Hirschhorn syndrome.	"{""explanation"": ""This identifies cardiac defects as one of the characteristic features of Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:29199884"", ""snippet"": ""Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a \""Greek warrior helmet\"" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal anomalies, cardiac defects, abnormal tooth development, and hearing loss."", ""supports"": ""SUPPORT""}"
8373	7940	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	10	evidence	1	PMID:33599186	SUPPORT		The infant had multiple congenital anomalies; a cleft palate, microcephalia, micrognathia, renal pelvicalyceal ectasia, atrial septal defect, transvers arcus hypoplasia, patent ductus arteriosus, hypospadias and undescended testicle.	This case report documents specific cardiac defects (atrial septal defect, patent ductus arteriosus) in Wolf-Hirschhorn syndrome.	"{""explanation"": ""This case report documents specific cardiac defects (atrial septal defect, patent ductus arteriosus) in Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:33599186"", ""snippet"": ""The infant had multiple congenital anomalies; a cleft palate, microcephalia, micrognathia, renal pelvicalyceal ectasia, atrial septal defect, transvers arcus hypoplasia, patent ductus arteriosus, hypospadias and undescended testicle."", ""supports"": ""SUPPORT""}"
8374	7941	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	11	evidence	0	PMID:29199884	SUPPORT		"Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a ""Greek warrior helmet"" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal anomalies, cardiac defects, abnormal tooth development, and hearing loss."	This identifies skeletal anomalies as one of the characteristic features of Wolf-Hirschhorn syndrome.	"{""explanation"": ""This identifies skeletal anomalies as one of the characteristic features of Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:29199884"", ""snippet"": ""Wolf-Hirschhorn syndrome is a rare genetic syndrome caused by a heterozygous deletion on chromosome 4p16.3 and is characterized by a \""Greek warrior helmet\"" facies, hypotonia, developmental delay, seizures, structural central nervous system defects, intrauterine growth restriction, sketelal anomalies, cardiac defects, abnormal tooth development, and hearing loss."", ""supports"": ""SUPPORT""}"
8375	7941	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	11	evidence	1	PMID:9774859	SUPPORT		Midline closure defects of the cervical spine bodies, lower jaw, and skull base were seen at postmortem radiography.	This case report documents specific skeletal abnormalities including cervical spine defects in Wolf-Hirschhorn syndrome.	"{""explanation"": ""This case report documents specific skeletal abnormalities including cervical spine defects in Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:9774859"", ""snippet"": ""Midline closure defects of the cervical spine bodies, lower jaw, and skull base were seen at postmortem radiography."", ""supports"": ""SUPPORT""}"
8376	7942	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	12	evidence	0	PMID:34572183	SUPPORT		In some cases, we observed seizures, structural brain abnormalities, immunodeficiencies, and renal anomalies.	This study identifies renal anomalies as a manifestation in some cases of Wolf-Hirschhorn syndrome.	"{""explanation"": ""This study identifies renal anomalies as a manifestation in some cases of Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:34572183"", ""snippet"": ""In some cases, we observed seizures, structural brain abnormalities, immunodeficiencies, and renal anomalies."", ""supports"": ""SUPPORT""}"
8377	7942	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	12	evidence	1	PMID:41225980	SUPPORT		It is characterized by intrauterine growth restriction (IUGR), developmental delay, epilepsy, distinctive facial features, and urinary tract anomalies, particularly renal hypoplasia.	This identifies renal hypoplasia as a characteristic urinary tract anomaly in Wolf-Hirschhorn syndrome.	"{""explanation"": ""This identifies renal hypoplasia as a characteristic urinary tract anomaly in Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:41225980"", ""snippet"": ""It is characterized by intrauterine growth restriction (IUGR), developmental delay, epilepsy, distinctive facial features, and urinary tract anomalies, particularly renal hypoplasia."", ""supports"": ""SUPPORT""}"
8378	7942	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	12	evidence	2	PMID:29199884	SUPPORT		"Systemic findings included ""Greek warrior helmet"" facies, hypotonia, cleft palate, neonatal tooth eruption, talipes equinovarus, bilateral clinodactyly, clitoromegaly, partial agenesis of the corpus callosum, bilateral renal hypoplasia, and two atrial septal defects."	This case report documents bilateral renal hypoplasia as a systemic finding in Wolf-Hirschhorn syndrome.	"{""explanation"": ""This case report documents bilateral renal hypoplasia as a systemic finding in Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:29199884"", ""snippet"": ""Systemic findings included \""Greek warrior helmet\"" facies, hypotonia, cleft palate, neonatal tooth eruption, talipes equinovarus, bilateral clinodactyly, clitoromegaly, partial agenesis of the corpus callosum, bilateral renal hypoplasia, and two atrial septal defects."", ""supports"": ""SUPPORT""}"
8379	7943	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	13	evidence	0	PMID:34572183	SUPPORT		In some cases, we observed seizures, structural brain abnormalities, immunodeficiencies, and renal anomalies.	This study identifies immunodeficiencies as a rare manifestation that should be looked for in Wolf-Hirschhorn syndrome.	"{""explanation"": ""This study identifies immunodeficiencies as a rare manifestation that should be looked for in Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:34572183"", ""snippet"": ""In some cases, we observed seizures, structural brain abnormalities, immunodeficiencies, and renal anomalies."", ""supports"": ""SUPPORT""}"
8380	7944	344	Wolf-Hirschhorn_Syndrome	Wolf-Hirschhorn_Syndrome.yaml	phenotypes	14	evidence	0	PMID:33599186	SUPPORT		The infant had multiple congenital anomalies; a cleft palate, microcephalia, micrognathia, renal pelvicalyceal ectasia, atrial septal defect, transvers arcus hypoplasia, patent ductus arteriosus, hypospadias and undescended testicle.	This case report documents cleft palate as one of the congenital anomalies in Wolf-Hirschhorn syndrome.	"{""explanation"": ""This case report documents cleft palate as one of the congenital anomalies in Wolf-Hirschhorn syndrome."", ""reference"": ""PMID:33599186"", ""snippet"": ""The infant had multiple congenital anomalies; a cleft palate, microcephalia, micrognathia, renal pelvicalyceal ectasia, atrial septal defect, transvers arcus hypoplasia, patent ductus arteriosus, hypospadias and undescended testicle."", ""supports"": ""SUPPORT""}"
8390	7952	345	Yaws	Yaws.yaml	phenotypes	0	evidence	0	PMID:40036381	SUPPORT		In the primary stage, patients develop a, usually painless, papilloma or ulcer, often on the lower extremities, which is highly contagious.	The abstract describes ulcer formation in primary yaws.	"{""explanation"": ""The abstract describes ulcer formation in primary yaws."", ""reference"": ""PMID:40036381"", ""snippet"": ""In the primary stage, patients develop a, usually painless, papilloma or ulcer, often on the lower extremities, which is highly contagious."", ""supports"": ""SUPPORT""}"
8395	7957	346	You-Hoover-Fong Syndrome	You-Hoover-Fong_Syndrome.yaml	phenotypes	0	evidence	0	PMID:37215500	SUPPORT		global development delay complicated with postnatal growth retardation for more than 1 year	Case report explicitly documents global developmental delay as a presenting feature in an infant with YHFS.	"{""explanation"": ""Case report explicitly documents global developmental delay as a presenting feature in an infant with YHFS."", ""reference"": ""PMID:37215500"", ""snippet"": ""global development delay complicated with postnatal growth retardation for more than 1 year"", ""supports"": ""SUPPORT""}"
8396	7958	346	You-Hoover-Fong Syndrome	You-Hoover-Fong_Syndrome.yaml	phenotypes	1	evidence	0	PMID:37215500	SUPPORT		extremely severe mental retardation	Severe intellectual disability is a core feature documented in YHFS cases.	"{""explanation"": ""Severe intellectual disability is a core feature documented in YHFS cases."", ""reference"": ""PMID:37215500"", ""snippet"": ""extremely severe mental retardation"", ""supports"": ""SUPPORT""}"
8397	7958	346	You-Hoover-Fong Syndrome	You-Hoover-Fong_Syndrome.yaml	phenotypes	1	evidence	1	PMID:33444416	SUPPORT		variants of TELO2 have been linked to an intellectual disability disorder, the You-Hoover-Fong syndrome	Intellectual disability is recognized as the defining feature of the syndrome.	"{""explanation"": ""Intellectual disability is recognized as the defining feature of the syndrome."", ""reference"": ""PMID:33444416"", ""snippet"": ""variants of TELO2 have been linked to an intellectual disability disorder, the You-Hoover-Fong syndrome"", ""supports"": ""SUPPORT""}"
8398	7959	346	You-Hoover-Fong Syndrome	You-Hoover-Fong_Syndrome.yaml	phenotypes	2	evidence	0	PMID:37215500	SUPPORT		microcephaly	Microcephaly is explicitly listed as a clinical feature in YHFS.	"{""explanation"": ""Microcephaly is explicitly listed as a clinical feature in YHFS."", ""reference"": ""PMID:37215500"", ""snippet"": ""microcephaly"", ""supports"": ""SUPPORT""}"
8399	7960	346	You-Hoover-Fong Syndrome	You-Hoover-Fong_Syndrome.yaml	phenotypes	3	evidence	0	PMID:37215500	SUPPORT		congenital cataract	Congenital cataracts are documented in YHFS; surgical correction improved visual responses.	"{""explanation"": ""Congenital cataracts are documented in YHFS; surgical correction improved visual responses."", ""reference"": ""PMID:37215500"", ""snippet"": ""congenital cataract"", ""supports"": ""SUPPORT""}"
8400	7962	346	You-Hoover-Fong Syndrome	You-Hoover-Fong_Syndrome.yaml	phenotypes	5	evidence	0	PMID:37215500	SUPPORT		abnormal hearing	Abnormal hearing is documented in YHFS cases.	"{""explanation"": ""Abnormal hearing is documented in YHFS cases."", ""reference"": ""PMID:37215500"", ""snippet"": ""abnormal hearing"", ""supports"": ""SUPPORT""}"
8401	7964	346	You-Hoover-Fong Syndrome	You-Hoover-Fong_Syndrome.yaml	phenotypes	7	evidence	0	PMID:37215500	SUPPORT		congenital atrial septal defect	Congenital heart defects including ASD are documented in YHFS.	"{""explanation"": ""Congenital heart defects including ASD are documented in YHFS."", ""reference"": ""PMID:37215500"", ""snippet"": ""congenital atrial septal defect"", ""supports"": ""SUPPORT""}"
